<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:content="http://purl.org/rss/1.0/modules/content/"
  xmlns:atom="http://www.w3.org/2005/Atom"
  xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#"
  xmlns:georss="http://www.georss.org/georss"
  xmlns:media="http://search.yahoo.com/mrss/" >
<channel>
  <title>バイオマーケットjp</title>
  <link>http://biomarket.jp/</link>
      <description>バイオ研究支援インターネットモール</description>
        <pubDate>Wed, 08 Sep 2010 21:15:14 +0900</pubDate>
        <lastBuildDate>Sun, 05 Sep 2010 01:00:06 +0900</lastBuildDate>
        <docs>http://backend.userland.com/rss/</docs>
        <generator>XOOPS rssc</generator>
        <category>RSS Center</category>
        <managingEditor>noreply@biomarket.jp (bioassociates)</managingEditor>
        <webMaster>noreply@biomarket.jp (bioassociates)</webMaster>
        <copyright>Copyright (c) 2010, bioassociates</copyright>
        <language>ja</language>
        <atom:link href="http://biomarket.jp/modules/rssc/rss.php?mode=rss&amp;query=&amp;andor=AND&amp;limit=500&amp;start=0" rel="self" type="application/rss+xml" />
      <item>
  <title>The grand challenge to decipher the cancer proteome.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-360.html</link>
      <description> Related Articles The grand challenge to decipher the cancer proteome. Nat Rev Cancer. 2010 Sep;10(9):652-60 Authors: Hanash S, Taguchi A The quest to decipher protein alterations in cancer has spanned well over half a century. The vast dynamic range of protein abundance coupled with a plethora of isoforms and disease heterogeneity have been formidable challenges. Progress in cancer proteomics has substantially paralleled technological developments. Advances in analytical techniques and the impl ...</description>
        <pubDate>Sun, 05 Sep 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-360.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The grand challenge to decipher the cancer proteome. Nat Rev Cancer. 2010 Sep;10(9):652-60 Authors: Hanash S, Taguchi A The quest to decipher protein alterations in cancer has spanned well over half a century. The vast dynamic range of protein abundance coupled with a plethora of isoforms and disease heterogeneity have been formidable challenges. Progress in cancer proteomics has substantially paralleled technological developments. Advances in analytical techniques and the implementation of strategies to de-complex the proteome into manageable components have allowed proteins across a wide dynamic range to be explored. The massive amounts of data that can currently be collected through proteomics allow the near-complete definition of cancer subproteomes, which reveals the alterations in signalling and developmental pathways. This allows the discovery of predictive biomarkers and the annotation of the cancer genome based on proteomic findings. There remains a considerable need for infrastructure development and the organized collaborative efforts to efficiently mine the cancer proteome. PMID: 20733593 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事癌のproteomeを解読する壮大な挑戦。 Cancer Nat. Rev。 9月2010日; 10 (9): 652-60書く: Hanash S、Taguchi Aは半世紀をはるかに越えて癌の蛋白質の変化を解読する探求及んだ。 isoformsおよび病気の不均質の茄多とつながれる蛋白質の豊富の広大なダイナミックレンジはずっと手強い挑戦である。 癌のproteomicsの進歩は大幅に技術開発を平行にした。 解析技法の前進およびde複雑への作戦の実施は処理しやすい部品へのproteome広いダイナミックレンジを渡る蛋白質が探検されるようにした。 proteomicsによって現在集めることができるデータの莫大な量は信号を送ることおよび進化の細道の変化を明らかにする癌のsubproteomesの近完全な定義を可能にする。 これは予言するbiomarkersの発見およびproteomic調査結果に基づいて癌のゲノムの注釈を可能にする。 そこに下部組織の開発のためのかなりの必要性に残り、効率的にへの整頓されていた共同の努力は癌のproteomeを採鉱する。 PMID: 20733593 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Epigenetics, copy number variation, and other molecular mechanisms underlying neurodevelopmental disabilities: new insights and diagnostic approaches.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-422.html</link>
      <description> Epigenetics, copy number variation, and other molecular mechanisms underlying neurodevelopmental disabilities: new insights and diagnostic approaches. J Dev Behav Pediatr. 2010 Sep;31(7):582-91 Authors: Gropman AL, Batshaw ML The diagnostic evaluation of children with intellectual disability (ID) and other neurodevelopmental disabilities (NDD) has become increasingly complex in recent years owing to a number of newly recognized genetic mechanisms and sophisticated methods to diagnose them. Prev ...</description>
        <pubDate>Sun, 05 Sep 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-422.html</guid>
        
      <content:encoded> <![CDATA[
    

        Epigenetics, copy number variation, and other molecular mechanisms underlying neurodevelopmental disabilities: new insights and diagnostic approaches.
        J Dev Behav Pediatr. 2010 Sep;31(7):582-91
        Authors:  Gropman AL, Batshaw ML
        The diagnostic evaluation of children with intellectual disability (ID) and other neurodevelopmental disabilities (NDD) has become increasingly complex in recent years owing to a number of newly recognized genetic mechanisms and sophisticated methods to diagnose them. Previous studies have attempted to address the diagnostic yield of finding a genetic cause in ID. The results have varied widely from 10% to 81%, with the highest percentage being found in studies using new array comparative genomic hybridization methodology especially in autism. Although many cases of ID/NDD result from chromosomal aneuploidy or structural rearrangements, single gene disorders and new categories of genome modification, including epigenetics and copy number variation play an increasingly important role in diagnosis and testing. Epigenetic mechanisms, such as DNA methylation and modifications to histone proteins, regulate high-order DNA structure and gene expression. Aberrant epigenetic and copy number variation mechanisms are involved in several neurodevelopmental and neurodegenerative disorders including Rett syndrome, fragile X syndrome, and microdeletion syndromes. This review will describe a number of the molecular genetic mechanisms that play a role in disorders leading to ID/NDD and will discuss the categories and technologies for diagnostic testing of these conditions.
        PMID: 20814257 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Serum pattern profiling for analyzing different types of stress by protein chip technology: a preliminary study.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-232.html</link>
      <description>Serum pattern profiling for analyzing different types of stress by protein chip technology: a preliminary study. Eur J Mass Spectrom (Chichester, Eng). 2010;16(5):619-23 Authors: Liu H, Hou D, Wu D, Yin H, Wu X ProteinChip is a widely accepted tool for exploring serum pattern profile to evaluate the risk of somatic diseases from different stressors. In this study, by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF), the serum proteome from mice unde ...</description>
        <pubDate>Sun, 05 Sep 2010 01:00:05 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-232.html</guid>
        
      <content:encoded> <![CDATA[
    Serum pattern profiling for analyzing different types of stress by protein chip technology: a preliminary study. Eur J Mass Spectrom (Chichester, Eng). 2010;16(5):619-23 Authors: Liu H, Hou D, Wu D, Yin H, Wu X ProteinChip is a widely accepted tool for exploring serum pattern profile to evaluate the risk of somatic diseases from different stressors. In this study, by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF), the serum proteome from mice under restraint and thermal stresses were profiled in detail and compared with the control group. Around 150 characteristic peaks were detected in all three groups, with m/z ranging from 1500-50,000, and most peaks within the 2000-20 000 m/z range. Compared with the control group, three significant protein peaks with m/z values of 2780, 3303, and 3450 appeared specifically in the restrained stress group and four other peaks with m/z values of 7500, 7811, 29950, and 38565 in the thermal stress group. Unexpectedly, no universal positive stress peaks were detected. These preliminary results clearly suggested that there might not be a common mechanism shared by various psychophysiological disorders under different stressors. By fast serum proteomics profiling, SELDI-TOF may be a convenient tool for evaluating the risk of stress-induced illness. PMID: 20814087 [PubMed - in process]（【斜め読み用】機械翻訳： 蛋白質の破片の技術によって異なったタイプの圧力を分析するために側面図を描く血清パターン: 予備の調査。 Eur J多くのSpectrom (チチェスター、英語)。 2010年; 16 (5): 619-23書く: 劉H、Hou D、ウーD、Yin H、ウーはX ProteinChip異なったstressorsからの体性病気の危険を評価するために血清パターンプロフィールを探検するための広く受け入れられた用具である。 表面高められたレーザーの脱着またはイオン化時間の飛行質量分析(SELDI-TOF)の使用によるこの調査では、制限の下のマウスからの血清のproteomeおよび熱圧力は詳しく側面図を描かれ、制御グループと比較された。 およそ150の独特のピークは1500-50,000から及んでいてm/zがすべての3グループ、および2000-20の内のほとんどのピークで000 m/zの範囲検出された。 、2780制御グループと比較されて、3303、および3450というm/zの値の3つの重要な蛋白質のピークは熱強勢群の7500、7811、29950、および38565というm/zの値の抑制された強勢群そして4つの他のピークでとりわけ現われた。 予想に反して、普遍的で肯定的な圧力のピークは検出されなかった。 これらの予備の結果ははっきり異なったstressorsの下でさまざまな心理生理学的な無秩序によって共有される共通のメカニズムがないかもしれないことを提案した。 側面図を描く速い血清のproteomicsによってSELDI-TOFはstress-induced病気の危険を評価するための便利な用具であるかもしれない。 PMID: 20814087 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Disruption of the SCN2A and SCN3A genes in a patient with mental retardation, neurobehavioral and psychiatric abnormalities, and a history of infantile seizures.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-413.html</link>
      <description> Disruption of the SCN2A and SCN3A genes in a patient with mental retardation, neurobehavioral and psychiatric abnormalities, and a history of infantile seizures. Clin Genet. 2010 Aug 2; Authors: Bartnik M, Chun-Hui Tsai A, Xia Z, Cheung SW, Stankiewicz P Bartnik M, Chun-Hui Tsai A, Xia Z, Cheung SW, Stankiewicz P. Disruption of the SCN2A and SCN3A genes in a patient with mental retardation, neurobehavioral and psychiatric abnormalities, and a history of infantile seizures. Mutations in genes en ...</description>
        <pubDate>Sat, 04 Sep 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-413.html</guid>
        
      <content:encoded> <![CDATA[
    

        Disruption of the SCN2A and SCN3A genes in a patient with mental retardation, neurobehavioral and psychiatric abnormalities, and a history of infantile seizures.
        Clin Genet. 2010 Aug 2;
        Authors:  Bartnik M, Chun-Hui Tsai A, Xia Z, Cheung SW, Stankiewicz P
        Bartnik M, Chun-Hui Tsai A, Xia Z, Cheung SW, Stankiewicz P. Disruption of the SCN2A and SCN3A genes in a patient with mental retardation, neurobehavioral and psychiatric abnormalities, and a history of infantile seizures. Mutations in genes encoding voltage-gated sodium channels are significant factors in the etiology of neurological diseases and psychiatric disorders, including various types of idiopathic epilepsy. Using a clinical exon-targeted oligonucleotide array comparative genomic hybridization (aCGH), we have identified a de novo approximately 110-kb deletion involving exons 1-2 of SCN2A and non-coding exon 1a of SCN3A in a 25-year-old female with mental retardation, neurobehavioral and psychiatric abnormalities, and a history of infantile seizures with abnormal EEG. We propose that haploinsufficiency of SCN2A may play an important role in the genetic basis of neurodevelopmental and neurobehavioral disorders and emphasize the efficacy of detecting exonic copy-number variation (CNV) by exon-targeted oligo aCGH.
        PMID: 20807223 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Subtelomeric rearrangements and copy number variations in people with intellectual disabilities.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-414.html</link>
      <description> Subtelomeric rearrangements and copy number variations in people with intellectual disabilities. J Intellect Disabil Res. 2010 Aug 30; Authors: Christofolini DM, de Paula Ramos MA, Kulikowski LD, da Silva Bellucco FT, Belangero SI, Brunoni D, Melaragno MI Abstract Background The most prevalent type of structural variation in the human genome is represented by copy number variations that can affect transcription levels, sequence, structure and function of genes. Method In the present study, we u ...</description>
        <pubDate>Sat, 04 Sep 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-414.html</guid>
        
      <content:encoded> <![CDATA[
    

        Subtelomeric rearrangements and copy number variations in people with intellectual disabilities.
        J Intellect Disabil Res. 2010 Aug 30;
        Authors:  Christofolini DM, de Paula Ramos MA, Kulikowski LD, da Silva Bellucco FT, Belangero SI, Brunoni D, Melaragno MI
        Abstract Background The most prevalent type of structural variation in the human genome is represented by copy number variations that can affect transcription levels, sequence, structure and function of genes. Method In the present study, we used the multiplex ligation-dependent probe amplification (MLPA) technique and quantitative PCR for the detection of copy number variation in 132 intellectually disabled male patients with normal karyotypes and negative fragile-X-testing. Results Ten of these patients (7.6%) showed copy number variation in the subtelomeric regions, including deletions and duplications. Discussion Duplications of the SECTM1 gene, located at 17q25.3, and of the FLJ22115 gene, located at 20p13, could be associated with phenotype alterations. This study highlights the relevance in the aetiology of intellectual disability of subtelomeric rearrangements that can be screened by MLPA and other molecular techniques.
        PMID: 20807304 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Integrating common and rare genetic variation in diverse human populations.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-421.html</link>
      <description> Integrating common and rare genetic variation in diverse human populations. Nature. 2010 Sep 2;467(7311):52-58 Authors: , , Altshuler DM, Gibbs RA, Peltonen L, , Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, , Schaffner SF, Yu F, Peltonen L, Dermitzakis E, Bonnen PE, Altshuler DM, Gibbs RA, , de Bakker PI, Deloukas P, Gabriel SB, Gwilliam R, Hunt S, Inouye M, Jia X, Palotie A, Parkin M, Whittaker P, , Yu F, Chang K, Hawes A, Lewis LR, Ren Y, Wheeler D, Gibbs RA, Marie Muzny D, , Barnes C,  ...</description>
        <pubDate>Sat, 04 Sep 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-421.html</guid>
        
      <content:encoded> <![CDATA[
    

        Integrating common and rare genetic variation in diverse human populations.
        Nature. 2010 Sep 2;467(7311):52-58
        Authors:   ,  , Altshuler DM, Gibbs RA, Peltonen L,  , Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E,  , Schaffner SF, Yu F, Peltonen L, Dermitzakis E, Bonnen PE, Altshuler DM, Gibbs RA,  , de Bakker PI, Deloukas P, Gabriel SB, Gwilliam R, Hunt S, Inouye M, Jia X, Palotie A, Parkin M, Whittaker P,  , Yu F, Chang K, Hawes A, Lewis LR, Ren Y, Wheeler D, Gibbs RA, Marie Muzny D,  , Barnes C, Darvishi K, Hurles M, Korn JM, Kristiansson K, Lee C, McCarroll SA, Nemesh J,  , Dermitzakis E, Keinan A, Montgomery SB, Pollack S, Price AL, Soranzo N,  , Bonnen PE, Gibbs RA, Gonzaga-Jauregui C, Keinan A, Price AL, Yu F,  , Anttila V, Brodeur W, Daly MJ, Leslie S, McVean G, Moutsianas L, Nguyen H, Schaffner SF, Zhang Q,  , Ghori MJ, McGinnis R, McLaren W, Pollack S, Price AL, Schaffner SF, Takeuchi F,  , Grossman SR, Shlyakhter I, Hostetter EB, Sabeti PC,  , Adebamowo CA, Foster MW, Gordon DR, Licinio J, Cristina Manca M, Marshall PA, Matsuda I, Ngare D, Ota Wang V, Reddy D, Rotimi CN, Royal CD, Sharp RR, Zeng C,  , Brooks LD, McEwen JE
        Despite great progress in identifying genetic variants that influence human disease, most inherited risk remains unexplained. A more complete understanding requires genome-wide studies that fully examine less common alleles in populations with a wide range of ancestry. To inform the design and interpretation of such studies, we genotyped 1.6 million common single nucleotide polymorphisms (SNPs) in 1,184 reference individuals from 11 global populations, and sequenced ten 100-kilobase regions in 692 of these individuals. This integrated data set of common and rare alleles, called 'HapMap 3', includes both SNPs and copy number polymorphisms (CNPs). We characterized population-specific differences among low-frequency variants, measured the improvement in imputation accuracy afforded by the larger reference panel, especially in imputing SNPs with a minor allele frequency of </=5%, and demonstrated the feasibility of imputing newly discovered CNPs and SNPs. This expanded public resource of genome variants in global populations supports deeper interrogation of genomic variation and its role in human disease, and serves as a step towards a high-resolution map of the landscape of human genetic variation.
        PMID: 20811451 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Phenotypic variability and genetic susceptibility to genomic disorders.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-415.html</link>
      <description> Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet. 2010 Aug 31; Authors: Girirajan S, Eichler EE The duplication architecture of the human genome predisposes our species to recurrent copy number variation and disease. Emerging data suggest that this mechanism of mutation contributes to both common and rare diseases. Two features regarding this form of mutation have emerged. First, common structural polymorphisms create susceptible and protective chromosomal a ...</description>
        <pubDate>Sat, 04 Sep 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-415.html</guid>
        
      <content:encoded> <![CDATA[
    

        Phenotypic variability and genetic susceptibility to genomic disorders.
        Hum Mol Genet. 2010 Aug 31;
        Authors:  Girirajan S, Eichler EE
        The duplication architecture of the human genome predisposes our species to recurrent copy number variation and disease. Emerging data suggest that this mechanism of mutation contributes to both common and rare diseases. Two features regarding this form of mutation have emerged. First, common structural polymorphisms create susceptible and protective chromosomal architectures. These structural polymorphisms occur at varying frequencies in populations leading to different susceptibility and ethnic predilection. Second, a subset of rearrangements shows extreme variability in expressivity. We propose that two types of genomic disorders may be distinguished: syndromic forms where the phenotypic features are largely invariant and those where the same molecular lesion associates with a diverse set of diagnoses including epilepsy, schizophrenia, autism, intellectual disability, and congenital malformations. Copy number variation analyses of patient genomes reveal that disease type and severity may be explained by the occurrence of additional rare events and their inheritance within families. We propose that the overall burden of copy number variants (CNVs) creates differing sensitized backgrounds during development leading to different thresholds and disease outcomes. We suggest that the accumulation of multiple high penetrant alleles of low frequency may serve as a more general model for complex genetic diseases, posing a significant challenge for diagnostics and disease management.
        PMID: 20807775 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>POD-FISH: A New Technique for Parental Origin Determination Based on Copy Number Variation Polymorphism.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-417.html</link>
      <description> POD-FISH: A New Technique for Parental Origin Determination Based on Copy Number Variation Polymorphism. Methods Mol Biol. 2010;659:291-8 Authors: Weise A, Gross M, Hinreiner S, Witthuhn V, Mkrtchyan H, Liehr T With the progress of array technologies and the enabled screening of individual human genomes, a new kind of polymorphism has been described - the so-called copy number variation (CNV) polymorphism. Copy number variants can be found in around 12% of the human genome sequence and have a s ...</description>
        <pubDate>Sat, 04 Sep 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-417.html</guid>
        
      <content:encoded> <![CDATA[
    

        POD-FISH: A New Technique for Parental Origin Determination Based on Copy Number Variation Polymorphism.
        Methods Mol Biol. 2010;659:291-8
        Authors:  Weise A, Gross M, Hinreiner S, Witthuhn V, Mkrtchyan H, Liehr T
        With the progress of array technologies and the enabled screening of individual human genomes, a new kind of polymorphism has been described - the so-called copy number variation (CNV) polymorphism. Copy number variants can be found in around 12% of the human genome sequence and have a size of up to several hundred kilobase pairs. These variants can not only differ between individuals, but also between corresponding alleles on homologous chromosomes. We recently developed a cytological assay for parental origin determination that relies on the design of CNV-based sets of probes for fluorescence in situ hybridization (POD-FISH). Here we describe an improved POD-FISH protocol that exploits "high frequency" variants for better discrimination of homologous chromosomes.
        PMID: 20809321 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Variable Tandem Repeats Accelerate Evolution of Coding and Regulatory Sequences.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-419.html</link>
      <description> Variable Tandem Repeats Accelerate Evolution of Coding and Regulatory Sequences. Annu Rev Genet. 2010 Aug 25; Authors: Gemayel R, Vinces MD, Legendre M, Verstrepen KJ Genotype-to-phenotype mapping commonly focuses on two major classes of mutations: single nucleotide polymorphisms (SNPs) and copy number variation (CNV). Here, we discuss an underestimated third class of genotypic variation: changes in microsatellite and minisatellite repeats. Such tandem repeats (TRs) are ubiquitous, unstable gen ...</description>
        <pubDate>Sat, 04 Sep 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-419.html</guid>
        
      <content:encoded> <![CDATA[
    

        Variable Tandem Repeats Accelerate Evolution of Coding and Regulatory Sequences.
        Annu Rev Genet. 2010 Aug 25;
        Authors:  Gemayel R, Vinces MD, Legendre M, Verstrepen KJ
        Genotype-to-phenotype mapping commonly focuses on two major classes of mutations: single nucleotide polymorphisms (SNPs) and copy number variation (CNV). Here, we discuss an underestimated third class of genotypic variation: changes in microsatellite and minisatellite repeats. Such tandem repeats (TRs) are ubiquitous, unstable genomic elements that have historically been designated as nonfunctional "junk DNA" and are therefore mostly ignored in comparative genomics. However, as many as 10% to 20% of eukaryotic genes and promoters contain an unstable repeat tract. Mutations in these repeats often have fascinating phenotypic consequences. For example, changes in unstable repeats located in or near human genes can lead to neurodegenerative diseases such as Huntington disease. Apart from their role in disease, variable repeats also confer useful phenotypic variability, including cell surface variability, plasticity in skeletal morphology, and tuning of the circadian rhythm. As such, TRs combine characteristics of genetic and epigenetic changes that may facilitate organismal evolvability. Expected final online publication date for the Annual Review of Genetics Volume 44 is November 03, 2010. Please see http://www.annualreviews.org/catalog/pubdates.aspx for revised estimates.
        PMID: 20809801 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Novel association strategy with copy number variation for identifying new risk Loci of human diseases.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-416.html</link>
      <description> Novel association strategy with copy number variation for identifying new risk Loci of human diseases. PLoS One. 2010;5(8): Authors: Chen X, Li X, Wang P, Liu Y, Zhang Z, Zhao G, Xu H, Zhu J, Qin X, Chen S, Hu L, Kong X BACKGROUND: Copy number variations (CNV) are important causal genetic variations for human disease; however, the lack of a statistical model has impeded the systematic testing of CNVs associated with disease in large-scale cohort. METHODOLOGY/PRINCIPAL FINDINGS: Here, we develop ...</description>
        <pubDate>Sat, 04 Sep 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-416.html</guid>
        
      <content:encoded> <![CDATA[
    

        Novel association strategy with copy number variation for identifying new risk Loci of human diseases.
        PLoS One. 2010;5(8):
        Authors:  Chen X, Li X, Wang P, Liu Y, Zhang Z, Zhao G, Xu H, Zhu J, Qin X, Chen S, Hu L, Kong X
        BACKGROUND: Copy number variations (CNV) are important causal genetic variations for human disease; however, the lack of a statistical model has impeded the systematic testing of CNVs associated with disease in large-scale cohort. METHODOLOGY/PRINCIPAL FINDINGS: Here, we developed a novel integrated strategy to test CNV-association in genome-wide case-control studies. We converted the single-nucleotide polymorphism (SNP) signal to copy number states using a well-trained hidden Markov model. We mapped the susceptible CNV-loci through SNP site-specific testing to cope with the physiological complexity of CNVs. We also ensured the credibility of the associated CNVs through further window-based CNV-pattern clustering. Genome-wide data with seven diseases were used to test our strategy and, in total, we identified 36 new susceptible loci that are associated with CNVs for the seven diseases: 5 with bipolar disorder, 4 with coronary artery disease, 1 with Crohn's disease, 7 with hypertension, 9 with rheumatoid arthritis, 7 with type 1 diabetes and 3 with type 2 diabetes. Fifteen of these identified loci were validated through genotype-association and physiological function from previous studies, which provide further confidence for our results. Notably, the genes associated with bipolar disorder converged in the phosphoinositide/calcium signaling, a well-known affected pathway in bipolar disorder, which further supports that CNVs have impact on bipolar disorder. CONCLUSIONS/SIGNIFICANCE: Our results demonstrated the effectiveness and robustness of our CNV-association analysis and provided an alternative avenue for discovering new associated loci of human diseases.
        PMID: 20808825 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Simple Copy Number Determination with Reference Query Pyrosequencing (RQPS).</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-420.html</link>
      <description> Simple Copy Number Determination with Reference Query Pyrosequencing (RQPS). Cold Spring Harb Protoc. 2010;2010:pdb.prot5491 Authors: Liu Z, Schneider DL, Kornfeld K, Kopan R INTRODUCTION The accurate measurement of the copy number (CN) for an allele is often desired. We have developed a simple pyrosequencing-based method, reference query pyrosequencing (RQPS), to determine the CN of any allele in any genome by taking advantage of the fact that pyrosequencing can accurately measure the molar ra ...</description>
        <pubDate>Sat, 04 Sep 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-420.html</guid>
        
      <content:encoded> <![CDATA[
    

        Simple Copy Number Determination with Reference Query Pyrosequencing (RQPS).
        Cold Spring Harb Protoc. 2010;2010:pdb.prot5491
        Authors:  Liu Z, Schneider DL, Kornfeld K, Kopan R
        INTRODUCTION The accurate measurement of the copy number (CN) for an allele is often desired. We have developed a simple pyrosequencing-based method, reference query pyrosequencing (RQPS), to determine the CN of any allele in any genome by taking advantage of the fact that pyrosequencing can accurately measure the molar ratio of DNA fragments in a mixture that differ by a single nucleotide. The method involves the preparation of an RQPS probe, which contains two linked DNA fragments that match a reference allele with a known CN and a query allele with an unknown CN. In each fragment, a single nucleotide variation (SNV) is engineered to differentiate it from its genomic counterparts when the probe is mixed with genomic DNA. The ratios of the two pairs of fragments (probe reference vs. genomic reference and probe query vs. genomic query) in the mixture reflect the ratio between the probe and the genomic DNA in a CN-dependent manner. Pyrosequencing can be used to quantify these ratios and thus determine the CN of the query allele. This method could be used to measure the CN of any transgene, differentiate homozygotes from heterozygotes, detect the copy number variation (CNV) of endogenous genes, and screen embryonic stem (ES) cells targeted with bacterial artificial chromosome (BAC) vectors that are not compatible with standard screening methods.
        PMID: 20810638 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A rare novel deletion of tyrosine hydroxylase gene in Parkinson disease.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-418.html</link>
      <description> A rare novel deletion of tyrosine hydroxylase gene in Parkinson disease. Hum Mutat. 2010 Aug 31; Authors: Bademci G, Edwards TL, Torres AL, Scott WK, ZÃ?chner S, Martin ER, Vance JM, Wang L Tyrosine hydroxylase (TH) enzyme is a rate limiting enzyme in dopamine biosynthesis. Missense mutation in both alleles of the TH gene is known to cause dopamine-related phenotypes, including dystonia and infantile Parkinsonism. However, it is not clear if single allele mutation in TH modifies the susceptib ...</description>
        <pubDate>Sat, 04 Sep 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-418.html</guid>
        
      <content:encoded> <![CDATA[
    

        A rare novel deletion of tyrosine hydroxylase gene in Parkinson disease.
        Hum Mutat. 2010 Aug 31;
        Authors:  Bademci G, Edwards TL, Torres AL, Scott WK, ZÃ?chner S, Martin ER, Vance JM, Wang L
        Tyrosine hydroxylase (TH) enzyme is a rate limiting enzyme in dopamine biosynthesis. Missense mutation in both alleles of the TH gene is known to cause dopamine-related phenotypes, including dystonia and infantile Parkinsonism. However, it is not clear if single allele mutation in TH modifies the susceptibility to the adult form of Parkinson disease (PD). We reported a novel deletion of entire TH gene in an adult with PD. The deletion was first identified by copy number variation (CNV) analysis in a genome-wide association study using Illumina Infinium BeadChips. After screening 635 cases and 642 controls, the deletion was found in one PD case but not in any control. The deletion was confirmed by multiple quantitative PCR (qPCR) assays. There is no additional exonic single nucleotide variant in the one copy of TH gene of the patient. The patient has an age-at-onset of 54 years, no evidence for dystonia, and was responsive to L-DOPA. This case supports the importance of the TH gene in PD pathogenesis and raises more attention to rare variants in candidate genes being a risk factor for Parkinson disease. (c) 2010 Wiley-Liss, Inc.
        PMID: 20809526 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Vandetanib alters the protein pattern in malignant glioma and normal brain in the BT4C rat glioma model.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-231.html</link>
      <description>Vandetanib alters the protein pattern in malignant glioma and normal brain in the BT4C rat glioma model. Int J Oncol. 2010 Oct;37(4):879-90 Authors: Wibom C, SandstrÃ¶m M, Henriksson R, Antti H, Johansson M, Bergenheim AT The treatment of glioblastoma is unsatisfactory. Improved understanding of the biological effects of treatment, together with development of new tools to predict outcome of the initiated treatment are therefore of great need. Vandetanib (ZD6474) is mainly a vascular endothel ...</description>
        <pubDate>Sat, 04 Sep 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-231.html</guid>
        
      <content:encoded> <![CDATA[
    Vandetanib alters the protein pattern in malignant glioma and normal brain in the BT4C rat glioma model. Int J Oncol. 2010 Oct;37(4):879-90 Authors: Wibom C, SandstrÃ¶m M, Henriksson R, Antti H, Johansson M, Bergenheim AT The treatment of glioblastoma is unsatisfactory. Improved understanding of the biological effects of treatment, together with development of new tools to predict outcome of the initiated treatment are therefore of great need. Vandetanib (ZD6474) is mainly a vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) receptor tyrosine kinase inhibitor. This study investigated the pattern of protein expression in brain tumor and normal brain tissue, following treatment with vandetanib in a rat glioma model. BT4C-cells were stereotactically implanted into the brain of BD IX rats. The rats were divided into three different experiments. The treatment schedule for experiments one and two consisted of daily, oral doses of vandetanib from day 6 until day 12 or 20 after implantation, respectively. In the third experiment, each animal received a single dose of vandetanib on day 19 after implantation and was then sacrificed 2, 8 or 24 h thereafter. The protein expression profiles were analyzed by SELDI-TOF-MS and evaluated with multivariate statistical methods. Following treatment with vandetanib, we found significantly altered protein expression pattern in malignant glioma and normal brain. Analyzing protein spectra is an interesting option to assess biological effects induced in brain tissue by signal transduction inhibitors such as vandetanib. PMID: 20811710 [PubMed - in process]（【斜め読み用】機械翻訳： Vandetanibは悪性のgliomaの蛋白質パターンおよびBT4Cのラットのgliomaモデルの正常な頭脳を変える。 Int J Oncol。 10月2010日; 37 (4): 879-90書く: Wibom C、SandstrÃ¶m M、Henriksson R、アンティH、Johansson M、glioblastomaの処置のBergenheimは不十分である。 従って始められた処置の結果を大きい必要性予測する新しいツールの開発とともに処置の生物学的作用の改善された理解は、である。 Vandetanib (ZD6474)は主に管のendothelial成長因子(VEGF)および表皮の成長因子(EGF)の受容器のチロシンのキナーゼ抑制剤である。 この調査はラットのgliomaモデルのvandetanibとの処置の後の脳腫瘍そして正常な脳組織の蛋白質の表現のパターンを、調査した。 BT4C細胞はBD IXのラットの頭脳にstereotactically植え付けられた。 ラットは3つの実験に分けられた。 実験のための処置のスケジュールは注入の後の日12または20までの日6からのvandetanibの毎日の、口頭線量から1つおよび2、それぞれ成っていた。 第3実験では、各動物は日19のvandetanibの単一の線量を後注入受け取り、次に2つ、8つか24のhその後犠牲になった。 蛋白質の表現のプロフィールはSELDI-TOF-MSによって分析され、多変量統計モデルと評価された。 vandetanibとの処置の後で、私達は悪性のgliomaおよび正常な頭脳のかなり変えられた蛋白質の表現パターンを見つけた。 蛋白質スペクトルを分析することはvandetanibのような信号のtransductionの抑制剤によって脳組織で引き起こされる生物学的作用を査定する興味深い選択である。 PMID: 20811710 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Applications of synthetic carbohydrates to chemical biology.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-358.html</link>
      <description> Related Articles Applications of synthetic carbohydrates to chemical biology. Curr Opin Chem Biol. 2010 Jun;14(3):404-11 Authors: Lepenies B, Yin J, Seeberger PH Access to synthetic carbohydrates is an urgent need for the development of carbohydrate-based drugs, vaccines, adjuvants as well as novel drug delivery systems. Besides traditional synthesis in solution, synthetic carbohydrates have been generated by chemoenzymatic methods as well as automated solid-phase synthesis. Synthetic oligosacc ...</description>
        <pubDate>Fri, 03 Sep 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-358.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Applications of synthetic carbohydrates to chemical biology. Curr Opin Chem Biol. 2010 Jun;14(3):404-11 Authors: Lepenies B, Yin J, Seeberger PH Access to synthetic carbohydrates is an urgent need for the development of carbohydrate-based drugs, vaccines, adjuvants as well as novel drug delivery systems. Besides traditional synthesis in solution, synthetic carbohydrates have been generated by chemoenzymatic methods as well as automated solid-phase synthesis. Synthetic oligosaccharides have proven to be useful for identifying ligands of carbohydrate-binding proteins such as C-type lectins and siglecs using glycan arrays. Furthermore, glyconanoparticles and glycodendrimers have been used for specific targeting of lectins of the immune system such as selectins, DC-SIGN, and CD22. This review focuses on how diverse carbohydrate structures can be synthetically derived and highlights the benefit of synthetic carbohydrates for glycobiology. PMID: 20227905 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 化学生物学への総合的な炭水化物の関連の記事の塗布。 Curr Opin Chem Biol. 6月2010日; 14 (3): 404-11書く: Lepenies B、Yin Jの総合的な炭水化物へのSeeberger PHのアクセスはcarbohydrate-based薬剤、ワクチン、新しい薬剤の伝達システムと同様、アジェバントの開発のための急務である。 解決の従来の統合のほかに、総合的な炭水化物は自動化されたsolid-phase統合と同様、chemoenzymatic方法によって発生した。 総合的なオリゴ糖類はglycan配列を使用してC-typeのlectinsおよびsiglecsのような蛋白質の炭水化物結合のligandsを識別するために有用であると証明した。 なお、glyconanoparticlesおよびglycodendrimersはselectins、DC-SIGNのような免疫組織のlectinsの特定に目標とすることのために、およびCD22使用された。 この検討は多様な炭水化物の構造が総合的にいかにに得ることができる焦点を合わせ、glycobiologyのための総合的な炭水化物の利点を強調するか。 PMID: 20227905 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Inverting character of family GH115 alpha-glucuronidases.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-359.html</link>
      <description>Inverting character of family GH115 alpha-glucuronidases. FEBS Lett. 2010 Aug 27; Authors: KolenovÃ¡ K, Ryabova O, VrÅ¡anskÃ¡ M, Biely P alpha-Glucuronidases of glycoside hydrolase family 115 of the xylose-fermenting yeast Pichia stipitis and wood-destroying fungus Schizophyllum commune liberate 4-O-methyl-D-glucuronic acid residues from aldouronic acids and glucuronoxylan. The specific activities of both enzymes increased with polymerization degree of the acidic xylooligosaccharides ...</description>
        <pubDate>Fri, 03 Sep 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-359.html</guid>
        
      <content:encoded> <![CDATA[
    Inverting character of family GH115 alpha-glucuronidases. FEBS Lett. 2010 Aug 27; Authors: KolenovÃ¡ K, Ryabova O, VrÅ¡anskÃ¡ M, Biely P alpha-Glucuronidases of glycoside hydrolase family 115 of the xylose-fermenting yeast Pichia stipitis and wood-destroying fungus Schizophyllum commune liberate 4-O-methyl-D-glucuronic acid residues from aldouronic acids and glucuronoxylan. The specific activities of both enzymes increased with polymerization degree of the acidic xylooligosaccharides and were inhibited by linear beta-1,4-xylooligosaccharides. These results suggest interaction of the enzyme with several xylopyranosyl residues of the xylan main chain. Using (1)H-NMR spectroscopy and reduced aldopentaouronic acid (MeGlcA(3)Xyl(4)-ol) as a substrate, it was found that both enzymes are inverting glycoside hydrolases releasing MeGlcA as its beta-anomer. PMID: 20804758 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 家族GH115のアルファglucuronidasesの特性を逆にすること。 FEBS Lett。 8月2010日27日; 著者: KolenovÃの¡ K、Ryabova O、VrÅの¡はanskÃの¡ M、キシロース発酵のイーストPichiaのstipitisのグリコシドの加水分解酵素の系列115のBiely PのアルファGlucuronidasesおよびSchizophyllumの木破壊の菌のコミューンaldouronic酸からの4 OメチルDグルクロン酸の残余をおよびglucuronoxylan解放する。 酸性xylooligosaccharidesの重合ある程度と増加した線形ベータ1,4 xylooligosaccharidesによって両方の酵素の比放射能は禁じられ。 これらの結果はキシランの主鎖の複数のxylopyranosylの残余が付いている酵素の相互作用を提案する。 (基質として1つの) H-NMRの分光学そして減らされたaldopentaouronic酸を使用して酵素が両方ともベータanomerようにMeGlcAを解放するグリコシドの加水分解酵素を逆にしていることが(MeGlcA (3) Xyl (4の) - ol)、分られた。 PMID: -出版業者によって供給される… 20804758 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Detecting copy number variation with mated short reads.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-412.html</link>
      <description> Detecting copy number variation with mated short reads. Genome Res. 2010 Aug 30; Authors: Medvedev P, Fiume M, Dzamba M, Smith T, Brudno M The development of high-throughput sequencing (HTS) technologies has opened the door to novel methods for detecting copy number variants (CNVs) in the human genome. While in the past CNVs have been detected based on array CGH data, recent studies have shown that depth-of-coverage information from HTS technologies can also be used for the reliable identificat ...</description>
        <pubDate>Fri, 03 Sep 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-412.html</guid>
        
      <content:encoded> <![CDATA[
    

        Detecting copy number variation with mated short reads.
        Genome Res. 2010 Aug 30;
        Authors:  Medvedev P, Fiume M, Dzamba M, Smith T, Brudno M
        The development of high-throughput sequencing (HTS) technologies has opened the door to novel methods for detecting copy number variants (CNVs) in the human genome. While in the past CNVs have been detected based on array CGH data, recent studies have shown that depth-of-coverage information from HTS technologies can also be used for the reliable identification of large copy-variable regions. Such methods, however, are hindered by sequencing biases that lead certain regions of the genome to be over- or under- sampled, lowering their resolution and ability to accurately identify the exact breakpoints of the variants. In this work, we develop a method for CNV detection that supplements the depth-of-coverage with paired-end mapping information, where matepairs mapping discordantly to the reference serve to indicate the presence of variation. Our algorithm, called CNVer, combines this information within a unified computational framework called the donor graph, allowing us to better mitigate the sequencing biases that cause uneven local coverage and accurately predict CNVs. We use CNVer to detect 4879 CNVs in the recently described genome of a Yoruban individual. Most of the calls (77%) coincide with previously known variants within the Database of Genomic Variants, while 81% of deletion copy number variants previously known for this individual coincide with one of our loss calls. Furthermore, we demonstrate that CNVer can reconstruct the absolute copy counts of segments of the donor genome and evaluate the feasibility of using CNVer with low coverage datasets.
        PMID: 20805290 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Complete mtDNA of Meretrix lusoria (Bivalvia: Veneridae) reveals the presence of an atp8 gene, length variation and heteroplasmy in the control region.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-410.html</link>
      <description> Complete mtDNA of Meretrix lusoria (Bivalvia: Veneridae) reveals the presence of an atp8 gene, length variation and heteroplasmy in the control region. Comp Biochem Physiol Part D Genomics Proteomics. 2010 Aug 3; Authors: Wang H, Zhang S, Li Y, Liu B The complete nucleotide sequence of the mitochondrial genome of the clam Meretrix lusoria (Bivalvia: Veneridae) was determined. It comprises 20,268 base pairs (bp) and contains 13 protein-coding genes, including ATPase subunit 8 (atp8), two ribosom ...</description>
        <pubDate>Sun, 29 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-410.html</guid>
        
      <content:encoded> <![CDATA[
    

        Complete mtDNA of Meretrix lusoria (Bivalvia: Veneridae) reveals the presence of an atp8 gene, length variation and heteroplasmy in the control region.
        Comp Biochem Physiol Part D Genomics Proteomics. 2010 Aug 3;
        Authors:  Wang H, Zhang S, Li Y, Liu B
        The complete nucleotide sequence of the mitochondrial genome of the clam Meretrix lusoria (Bivalvia: Veneridae) was determined. It comprises 20,268 base pairs (bp) and contains 13 protein-coding genes, including ATPase subunit 8 (atp8), two ribosomal RNAs, 22 transfer RNAs, and a non-coding control region. The atp8 encodes a protein of 39 amino acids. All genes are encoded on the same strand. A putative control region (CR or D-loop) was identified in the major non-coding region (NCR) between the tRNA(Gly) and tRNA(Gln). A 1087bp tandem repeat fragment was identified that comprises nearly 11 copies of a 101bp motif and accounts for approximately 41% of the NCR. The 101bp tandem repeat motif of the NCR can be folded into a stem-loop secondary structure. Samples of eight individuals from Hainan and Fujian provinces were collected and their NCR regions were successfully amplified and sequenced. The data revealed a highly polymorphic VNTR (variable number of tandem repeats) associated with high levels of heteroplasmy in the D-loop region. The size of the CR ranged from 1942 to 3354bp depending upon the copy number of the repeat sequence.
        PMID: 20797924 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A case-control study and meta-analysis of association between a common copy number variation of the glutathione S-transferase mu 1 (GSTM1) gene and schizophrenia.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-409.html</link>
      <description> A case-control study and meta-analysis of association between a common copy number variation of the glutathione S-transferase mu 1 (GSTM1) gene and schizophrenia. Schizophr Res. 2010 Aug 24; Authors: Watanabe Y, Nunokawa A, Kaneko N, Someya T PMID: 20797839 [PubMed - as supplied by publisher] </description>
        <pubDate>Sun, 29 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-409.html</guid>
        
      <content:encoded> <![CDATA[
    

        A case-control study and meta-analysis of association between a common copy number variation of the glutathione S-transferase mu 1 (GSTM1) gene and schizophrenia.
        Schizophr Res. 2010 Aug 24;
        Authors:  Watanabe Y, Nunokawa A, Kaneko N, Someya T
        
        PMID: 20797839 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Analysis of copy number variation in 8,842 Korean individuals reveals 39 genes associated with hepatic biomarkers AST and ALT.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-408.html</link>
      <description> Analysis of copy number variation in 8,842 Korean individuals reveals 39 genes associated with hepatic biomarkers AST and ALT. BMB Rep. 2010 Aug;43(8):547-53 Authors: Kim HY, Cho S, Yu J, Sung S, Kim H Biochemical tests such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) are useful for diagnosing patients with liver disease. In this study, we tested the association between copy number variation and the hepatic biomarkers AST and ALT based on 8,842 samples from population ...</description>
        <pubDate>Sun, 29 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-408.html</guid>
        
      <content:encoded> <![CDATA[
    

        Analysis of copy number variation in 8,842 Korean individuals reveals 39 genes associated with hepatic biomarkers AST and ALT.
        BMB Rep. 2010 Aug;43(8):547-53
        Authors:  Kim HY, Cho S, Yu J, Sung S, Kim H
        Biochemical tests such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) are useful for diagnosing patients with liver disease. In this study, we tested the association between copy number variation and the hepatic biomarkers AST and ALT based on 8,842 samples from population-based cohorts in Korea. We used Affymetrix Genome-Wide Human 5.0 arrays and identified 10,534 CNVs using HelixTree software. Of the CNVs tested using univariate linear regression, 100 CNVs were significant for AST and 16 were significant for ALT (P < 0.05). We identified 39 genes located within the CNV regions. DKK1 and HS3ST3B1 were shown to play roles in heparan sulfate biosynthesis and the Wnt signaling pathway, respectively. NAF1 and NPY1R were associated with glycoprotein processes and neuropeptide Y receptor activity based on GO categories. PTER, SOX14 and TM7SF4 were expressed in liver. DPYS and CTSC were found to be associated with dihydropyrimidinuria and Papillon-Lefevre syndrome phenotypes using OMIM. NPY5R was found to be associated with dyslipidemia using the Genetic Association Database. [BMB reports 2010; 43(8): 547-553].
        PMID: 20797317 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Gender-Specific Reduction in Contraction is Associated with Increased Estrogen Receptor Expression in Single Vascular Smooth Muscle Cells of Female Rat.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-411.html</link>
      <description>Related Articles Gender-Specific Reduction in Contraction is Associated with Increased Estrogen Receptor Expression in Single Vascular Smooth Muscle Cells of Female Rat. Cell Physiol Biochem. 2010;26(3):457-470 Authors: Ma Y, Qiao X, Falone AE, Reslan OM, Sheppard SJ, Khalil RA Gender differences in the incidence of cardiovascular disease have been related to plasma estrogen levels; however, the role of vascular estrogen receptor (ER) subtypes in these sex differences is less clear. We tested wh ...</description>
        <pubDate>Sun, 29 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-411.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Gender-Specific Reduction in Contraction is Associated with Increased Estrogen Receptor Expression in Single Vascular Smooth Muscle Cells of Female Rat. Cell Physiol Biochem. 2010;26(3):457-470 Authors: Ma Y, Qiao X, Falone AE, Reslan OM, Sheppard SJ, Khalil RA Gender differences in the incidence of cardiovascular disease have been related to plasma estrogen levels; however, the role of vascular estrogen receptor (ER) subtypes in these sex differences is less clear. We tested whether the gender differences in vascular smooth muscle (VSM) function reflect differential expression/activity of ERalpha, ERbeta and the newly-identified GPR30. Single aortic VSM cells (VSMCs) were freshly isolated from male and female Sprague-Dawley rats, and their contraction to phenylephrine (PHE, 10(-5) M), AngII (10(-7) M) and membrane-depolarization by KCl (51 mM) was measured in the absence or presence of 10(-6) M 17beta-estradiol (E2, stimulant of most ERs), PPT (ERalpha agonist), DPN (ERbeta agonist), and ICI 182,780 (an ERalpha/ERbeta antagonist with GPR30 agonistic properties). The cells were fixed and fluorescently labeled with ERalpha, ERbeta or GPR30 antibody, and the subcellular distribution of ERs was examined using digital imaging microscopy. The mRNA expression and protein amount of aortic ER subtypes was examined using RT-PCR and Western blots. PHE, AngII, and KCl caused less contraction in VSMCs of females than males. Pretreatment of VSMCs with E2 reduced PHE-, AngII- and KCl-induced contraction in both males and females. PPT caused similar inhibition of PHE-, AngII- and KCl-induced contraction as E2, suggesting a role of ERalpha. DPN mainly inhibited PHE and KCl contraction, suggesting an interaction between ERbeta and Ca(2+) channels. ICI 182,780 did not reduce aortic VSMC contraction, suggesting little role for GPR30. RT-PCR and Western blots revealed greater expression of ERalpha and ERbeta in VSMCs of females than males, but similar amounts of GPR30. The total immunofluorescence signal for ERalpha and ERbeta was greater in VSMCs of females than males, and was largely localized in the nucleus. GPR30 fluorescence was similar in VSMCs of males and females, and was mainly in the cytosol. In PPT treated cells, nuclear ERalpha signal was enhanced. DPN did not affect the distribution of ERbeta, and ICI 182,780 did not significantly increase GPR30 in the cell surface. Thus, ER subtypes demonstrate similar responsiveness to specific agonists in VSMCs of male and female rats. The reduced contraction in VSMCs of females could be due to gender-related increase in the expression of ERalpha and ERbeta. PMID: 20798531 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-153.html</link>
      <description> Related Articles Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study. J Bone Miner Res. 2009 Oct;24(10):1719-27 Authors: Freedman BI, Bowden DW, Ziegler JT, Langefeld CD, Lehtinen AB, Rudock ME, Lenchik L, Hruska KA, Register TC, Carr JJ Inverse relationships have been observed between BMD and vascular calcification (VC), suggesting an underlying metabolic pathway linking these processe ...</description>
        <pubDate>Sat, 28 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-153.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study. J Bone Miner Res. 2009 Oct;24(10):1719-27 Authors: Freedman BI, Bowden DW, Ziegler JT, Langefeld CD, Lehtinen AB, Rudock ME, Lenchik L, Hruska KA, Register TC, Carr JJ Inverse relationships have been observed between BMD and vascular calcification (VC), suggesting an underlying metabolic pathway linking these processes. Bone morphogenetic proteins (BMPs) are potential candidate genes that may mediate this relationship. Four single nucleotide polymorphisms (SNPs) in the BMP2 gene, 2 SNPs in BMP4, and 16 SNPs in BMP7 were tested for association with measures of VC using CT (coronary and carotid arteries, abdominal aorta), and BMD was measured using DXA (lumbar spine, hip, and distal radius) and quantitative CT (QCT; thoracic and lumbar spine) in 920 European Americans from 374 Diabetes Heart Study families: 762 with type 2 diabetes. Variance components quantitative trait locus association analysis was computed using SOLAR software, and a bivariate principal component analysis (PCA) assessed for genetic relationships between BMD and VC. Association was observed between several measures of BMD and BMP7 rs17404303 (thoracic spine QCT p = 0.03; lumbar spine QCT p = 0.02; hip DXA p = 0.06, dominant models). In addition, 6 of 16 BMP7 SNPs showed significant and opposing effects on the bivariate PCA for VC and BMD (two-sided exact test, p = 0.0143). Polymorphisms in BMP7 are associated with inverse relationships between bone mineralization and VC in the coronary, carotid, and abdominal aorta in a diabetes-enriched cohort of European Americans. PMID: 19453255 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事の骨morphogenetic蛋白質7の(BMP7)遺伝子の多形は管の石灰化とBMD間の反対関係と関連付けられる: 糖尿病の中心の調査。 Jは抗夫Resの骨を抜く。 10月2009日; 24 (10): 1719-27書く: 自由民のBI、Bowden DW、Ziegler JTのLangefeldのCD、Lehtinen AB、Rudockはこれらのプロセスをつなぐ根本的な新陳代謝の細道を提案するBMDと管の石灰化の間で私、Lenchik LのHruskaのKA、記録TCのCarr JJの反対関係(VC)観察された。 骨のmorphogenetic蛋白質(BMPs)はこの関係を仲介するかもしれない潜在的な候補の遺伝子である。 BMP2遺伝子の4つの単一のヌクレオチドの多形(SNPs)、BMP4の2つSNPs、およびBMP7の16 SNPsはCT (冠状および頸動脈、腹大動脈)を使用して手段の連合のためにのVCテストされ、BMDはDXA (腰神経脊柱、ヒップおよび遠位半径)および量的なCT (QCTを使用して測定された; 374の糖尿病の中心の調査家族からの920人のヨーロッパのアメリカ人の胸部および腰神経脊柱): タイプ2の糖尿病との762。 変動部品の量的な特性の位置連合の分析は太陽ソフトウェアおよびBMDとVC間の遺伝関係のために査定された二変数の主成分の分析(PCA)を使用して計算された。 連合はBMDの複数の手段とBMP7 rs17404303 (胸部の脊柱QCT p = 0.03の間で観察された; 腰神経脊柱QCT p = 0.02; ヒップDXA p = 0.06の支配的なモデル)。 さらに、VCのための二変数PCAに対する16のBMP7のSNPsによっての示されている重要な、反対の効果の6およびBMD (両面厳密なテスト、p = 0.0143)。 BMP7の多形はヨーロッパのアメリカ人の糖尿病富ませたグループの冠状、carotid、および腹大動脈で骨の鉱化とVC間の反対関係と関連付けられる。 PMID: 19453255 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-129.html</link>
      <description> Related Articles PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells. Prostate. 2009 Feb 1;69(2):168-80 Authors: Graham TR, Odero-Marah VA, Chung LW, Agrawal KC, Davis R, Abdel-Mageed AB BACKGROUND: Bone morphogenetic proteins (BMPs) exert osteoinductive effects in prostate cancer (PC) via uncharacterized mechanisms. In this study, we investigated whether the nuclear transcription factor NF-kappaB, implicated in P ...</description>
        <pubDate>Sat, 28 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-129.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells. Prostate. 2009 Feb 1;69(2):168-80 Authors: Graham TR, Odero-Marah VA, Chung LW, Agrawal KC, Davis R, Abdel-Mageed AB BACKGROUND: Bone morphogenetic proteins (BMPs) exert osteoinductive effects in prostate cancer (PC) via uncharacterized mechanisms. In this study, we investigated whether the nuclear transcription factor NF-kappaB, implicated in PC metastasis, is involved in transcriptional regulation and activation of BMP-2 or BMP-4/Smad signaling in PC cells. METHODS: NF-kappaB inhibition was achieved by IkappaBalpha super-repressor adenoviral vector and activation was monitored by EMSA and reporter assays. BMP expression and activation was measured by PCR and reporter assays. Promoter binding assay was performed by chromatin immunoprecipitation (ChIP) assay. Smad1/5/8 phosphorylation was measured by Western blot analysis. RESULTS: PCR and chimeric BMP-2 and BMP-4 luciferase assays demonstrate that NF-kappaB confers robust and selective activation of BMP-2 in p65 overexpressing or rhTNF-alpha-stimulated PC cells. Inhibition of NF-kappaB significantly reduced transcript levels and autocrine production of BMP-2 by rhTNF-alpha stimulated C4-2B cells and to a lesser extent by the parental LNCaP cells. Selective inhibition of PI3K/Akt suppressed the NF-kappaB-induced BMP-2 promoter activity. Furthermore, suppression of NF-kappaB activation decreased the transcript levels and BMP-2-induced phosphorylation of Smad1/5/8, critical downstream targets of BMP-2 signaling in PC cells. Notably, the activation of BMPRII by BMP-2 is required for modulation of Smad activation by NF-kappaB in PC cells. Based on ChIP analysis, the transcriptional regulation of BMP-2 gene by NF-kappaB may be partially attributed to binding to kappab site on the BMP-2 promoter. CONCLUSIONS: The data suggest that PI3K/Akt-NF-kappaB axis may promote PC bone metastasis in part by regulating transcription and activation of the BMP-2-Smad signaling cascade in osteotropic PC cells. PMID: 18942118 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-145.html</link>
      <description> Related Articles The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients. Lung Cancer. 2009 Dec;66(3):319-26 Authors: Bieniasz M, Oszajca K, Eusebio M, Kordiak J, Bartkowiak J, Szemraj J Lung cancer is a particular challenge in oncology. More than 1 million new cases occur worldwide every year and despite many clinical trials and modern diagnostic techniques, long-term survival rate has only marginally improved. The aim of the curre ...</description>
        <pubDate>Sat, 28 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-145.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients. Lung Cancer. 2009 Dec;66(3):319-26 Authors: Bieniasz M, Oszajca K, Eusebio M, Kordiak J, Bartkowiak J, Szemraj J Lung cancer is a particular challenge in oncology. More than 1 million new cases occur worldwide every year and despite many clinical trials and modern diagnostic techniques, long-term survival rate has only marginally improved. The aim of the current research is to explore new molecular prognostic factors and identify new targets for anticancer therapy. Current evidence shows that angiogenesis is controlled by several angiogenic factors including VEGF and BMP-2. It has been also demonstrated that VEGF plays a key role in this process that is essential in carcinogenesis. Our study has shown that the expressions of the VEGF, BMP-2 and BMP-4 mRNAs were significantly higher (7.1-fold, 25.6-fold and 2.3-fold, respectively) in lung cancer samples than in adjacent normal lung tissues (real-time RT-PCR). Analysis based on the Pearson's correlation coefficient indicated the positive correlation between VEGF and BMP-2 gene expression, whereas no significant correlation between VEGF and BMP-4 gene expression was found. The mean+/-standard deviation serum level of VEGF was 423+/-136 pg/ml. Significant differences in the serum levels of VEGF between patients with T1 tumors and patients with T2, T3 or T4 tumors were observed. Patients with T2, T3 and T4 tumors, respectively, had 1.6-fold, 1.8-fold and 2.3-fold greater serum levels of VEGF than their peers with T1 tumors. In current study patients homozygous for the 936T allele of the +936C/T VEGF gene polymorphism had 12-fold lower VEGF gene expression and 1.3-fold lower VEGF serum level than patients homozygous for the 936C allele. In conclusion, our findings underline the importance of the two angiogenic factors namely VEGF and BMP-2 as well as +936C/T VEGF gene polymorphism in the evaluation of lung cancer patients. PMID: 19324447 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-121.html</link>
      <description> Related Articles BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling. Blood. 2008 Oct 15;112(8):3154-63 Authors: Jeanpierre S, Nicolini FE, Kaniewski B, Dumontet C, Rimokh R, Puisieux A, Maguer-Satta V Activin A, BMP2, and BMP4, 3 members of the transforming growth factor-beta family, are involved in the regulation of hematopoiesis. Here, we explored the role of these molecules in human megakaryopoiesis using an in vitro serum-free assay. Our results  ...</description>
        <pubDate>Sat, 28 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-121.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling. Blood. 2008 Oct 15;112(8):3154-63 Authors: Jeanpierre S, Nicolini FE, Kaniewski B, Dumontet C, Rimokh R, Puisieux A, Maguer-Satta V Activin A, BMP2, and BMP4, 3 members of the transforming growth factor-beta family, are involved in the regulation of hematopoiesis. Here, we explored the role of these molecules in human megakaryopoiesis using an in vitro serum-free assay. Our results highlight for the first time that, in the absence of thrombopoietin, BMP4 is able to induce CD34(+) progenitor differentiation into megakaryocytes through all stages. Although we have previously shown that activin A and BMP2 are involved in erythropoietic commitment, these molecules have no effect on human megakaryopoietic engagement and differentiation. Using signaling pathway-specific inhibitors, we show that BMP4, like thrombopoietin, exerts its effects on human megakaryopoiesis through the JAK/STAT and mTor pathways. Inhibition of the BMP signaling pathway with blocking antibodies, natural soluble inhibitors (FLRG or follistatin), or soluble BMP receptors reveals that thrombopoietin uses the BMP4 pathway to induce megakaryopoiesis, whereas the inverse is not occurring. Finally, we show that thrombopoietin up-regulates the BMP4 autocrine loop in megakaryocytic progenitors by inducing their production of BMP4 and up-regulating BMP receptor expression. In summary, this work indicates that BMP4 plays an important role in the control of human megakaryopoiesis. PMID: 18664625 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 人間のmegakaryocytic微分の関連の記事BMP4の規則はthrombopoietinシグナリングにかかわる。 血。 10月2008日15日; 112 (8): 3154-63書く: ジャン・ピエールS、Kaniewski B、Dumontet C、Rimokh R、Puisieux A、Maguer-Satta V Activin A、BMP2およびBMP4の変形の成長要因ベータ家族の3人のメンバー、Nicolini FEはhematopoiesisの規則にかかわる。 ここでは、私達は生体外のserum-free試金を使用して人間のmegakaryopoiesisに於いてのこれらの分子の役割を探検した。 私達の結果は、thrombopoietinがない時、BMP4がすべての段階を通してmegakaryocytesにCD34 (+)祖先の微分を引き起こせることはじめて強調する。 activin AおよびBMP2はerythropoietic責任にかかわることを私達が前に示してしまったが、これらの分子は人間のmegakaryopoietic約束および微分に対する効果をもたらさない。 シグナリング細道特定の抑制剤を使用して、私達はBMP4が、thrombopoietinのようなJAK/STATおよびmTorの細道によって、人間のmegakaryopoiesisに対する効果を出すことを示す。 抗体、自然な溶ける抑制剤(FLRGかfollistatin)、または溶けるBMPの受容器の妨害を用いるBMPシグナリング細道の阻止はinverseが起こっていない一方megakaryopoiesisを引き起こすのにthrombopoietinがBMP4細道を使用することを明らかにする。 最後に、私達はthrombopoietinがBMP4の彼らの生産を引き起こすことおよびBMPの受容器の表現をことを調整することによってmegakaryocytic祖先のBMP4 autocrineのループを調整することを示す。 要約すると、この仕事はBMP4が人間のmegakaryopoiesisの制御の重要な役割を担うことを示す。 PMID: 18664625 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>In the limb AER Bmp2 and Bmp4 are required for dorsal-ventral patterning and interdigital cell death but not limb outgrowth.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-137.html</link>
      <description> Related Articles In the limb AER Bmp2 and Bmp4 are required for dorsal-ventral patterning and interdigital cell death but not limb outgrowth. Dev Biol. 2009 Mar 15;327(2):516-23 Authors: Maatouk DM, Choi KS, Bouldin CM, Harfe BD The apical ectodermal ridge (AER) in the vertebrate limb is required for limb outgrowth and patterning. To investigate the role BMP ligands expressed in the AER play in limb development we selectively inactivated both Bmp2 and Bmp4 in this tissue. The autopods of mice l ...</description>
        <pubDate>Sat, 28 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-137.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles In the limb AER Bmp2 and Bmp4 are required for dorsal-ventral patterning and interdigital cell death but not limb outgrowth. Dev Biol. 2009 Mar 15;327(2):516-23 Authors: Maatouk DM, Choi KS, Bouldin CM, Harfe BD The apical ectodermal ridge (AER) in the vertebrate limb is required for limb outgrowth and patterning. To investigate the role BMP ligands expressed in the AER play in limb development we selectively inactivated both Bmp2 and Bmp4 in this tissue. The autopods of mice lacking both of these genes contained extra digits, digit bifurcations and interdigital webbing due to a decrease in programmed cell death and an increase in cell proliferation in the underlying mesoderm. Upon removal of Bmp2 and Bmp4 in the AER, no defects in proximal-distal patterning were observed. At the molecular level, removal of Bmp2 and Bmp4 in the AER caused an increase in Fgf expression, which correlated with an increase in both the width and length of the AER. Investigation of Engrailed-1 (En1) expression in the AER of limb buds in which Bmp2 and Bmp4 had been removed indicated that En1 expression was absent from this tissue. Our data suggests that AER expression of Bmp2 and Bmp4 is required for digit and dorsal-ventral patterning but surprisingly not for limb outgrowth. PMID: 19210962 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 肢AER Bmp2およびBmp4の関連の記事は背面腹部の模造およびinterdigital細胞死ない肢の結果に要求される。 Dev Biol. 3月2009日15日; 327 (2): 516-23書く: Maatouk DM、Choi KS、Bouldin CM、Harfe BDは肢の結果および模造に脊椎動物の肢の頂点のectodermal隆起部分(AER)要求される。 肢の開発のAERの演劇に表現された役割BMPのligandsを調査するためには私達は選択式にこのティッシュのBmp2そしてBmp4を両方不活性にした。 両方の遺伝子に欠けているマウスのautopodsはプログラムされた細胞死の減少および根本的なmesodermの細胞増殖の増加による余分ディジット、ディジットの分岐点およびinterdigitalウェビングを含んでいた。 AERのBmp2そしてBmp4の取り外しに、近位遠位模造の欠陥は観察されなかった。 分子レベルで、Bmp2の取り外しによりおよびAERのBmp4はAERの幅そして長さ両方の増加に関連したFgfの表現の増加を引き起こした。 肢のAERのEngrailed1 (En1)表現の調査はでEn1表現はこのティッシュから不在だったことをどのBmp2およびBmp4が示した取除かれたか発芽する。 私達のデータはBmp2およびBmp4のAERの表現がディジットおよび背面腹部の模造に意外にもない肢の結果に要求されることを提案する。 PMID: 19210962 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Changes in expression of bone morphogenetic proteins, their receptors and inhibin co-receptor betaglycan during bovine antral follicle development: inhibin can antagonise the suppressive effect of BMPs on thecal androgen production.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-205.html</link>
      <description>Changes in expression of bone morphogenetic proteins, their receptors and inhibin co-receptor betaglycan during bovine antral follicle development: inhibin can antagonise the suppressive effect of BMPs on thecal androgen production. Reproduction. 2010 Aug 25; Authors: Glister C, Satchell L, Knight PG We reported previously that BMPs potently suppress CYP17 expression and androgen production by bovine theca interna cells (TC) in vitro. In this study, real-time PCR was used to analyse gene express ...</description>
        <pubDate>Sat, 28 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-205.html</guid>
        
      <content:encoded> <![CDATA[
    Changes in expression of bone morphogenetic proteins, their receptors and inhibin co-receptor betaglycan during bovine antral follicle development: inhibin can antagonise the suppressive effect of BMPs on thecal androgen production. Reproduction. 2010 Aug 25; Authors: Glister C, Satchell L, Knight PG We reported previously that BMPs potently suppress CYP17 expression and androgen production by bovine theca interna cells (TC) in vitro. In this study, real-time PCR was used to analyse gene expression in TC and granulosa (GC) layers from developing bovine antral follicles (1-18mm). Abundance of mRNA transcripts for four BMPs (BMP2, BMP4, BMP6, BMP7) and associated type-I (BMPR1A, BMPR1B, ACVR1, ACVR1B) and type-II (BMPR2, ACVR2A, ACVR2B) receptors showed relatively modest, though significant, changes during follicle development. BMP2 was selectively expressed in GC while BMP6, BMP7 and betaglycan (TGFBR3) were more abundant in TC. Abundance of betaglycan mRNA (inhibin co-receptor) in TC increased progressively (5-fold; P<0.001) as follicles grew from 1-2mm to 9-10mm. This suggests a shift in thecal responsiveness to GC-derived inhibin, produced in increasing amounts as follicles achieve dominance. This prompted us to investigate whether inhibin can function as a physiological antagonist of BMP action on bovine TC in vitro, in a manner comparable to that for activin signalling. BMP-4, -6 and -7 abolished LH-induced androstenedione secretion and suppressed CYP17 mRNA >200-fold (P<0.001) while co-treatment with inhibin-A reversed the suppressive action of BMP in each case (P<0.001). Results support a physiological role for granulosa-derived inhibin as an antagonist of BMP action on thecal androgen synthesis. A shift in intrafollicular balance between thecal BMP signalling (inhibitory for androgen synthesis) and betaglycan-dependent inhibin signalling (stimulatory for androgen synthesis) accords with the physiological requirement to deliver an adequate supply of aromatase substrate to GC of developing follicles. PMID: 20739376 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of epistatic effects using a protein-protein interaction database.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-407.html</link>
      <description> Identification of epistatic effects using a protein-protein interaction database. Hum Mol Genet. 2010 Aug 24; Authors: Sun YV, Kardia SL Epistasis (i.e. gene-gene interactions) has long been recognized as an important mechanism underlying the complexity of the genetic architecture of human traits. Definitions of epistasis range from the purely molecular to the traditional statistical measures of interaction. The statistical detection of epistasis usually does not map onto or easily relate to th ...</description>
        <pubDate>Fri, 27 Aug 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-407.html</guid>
        
      <content:encoded> <![CDATA[
    

        Identification of epistatic effects using a protein-protein interaction database.
        Hum Mol Genet. 2010 Aug 24;
        Authors:  Sun YV, Kardia SL
        Epistasis (i.e. gene-gene interactions) has long been recognized as an important mechanism underlying the complexity of the genetic architecture of human traits. Definitions of epistasis range from the purely molecular to the traditional statistical measures of interaction. The statistical detection of epistasis usually does not map onto or easily relate to the biological interactions between genetic variations through their combined influence on gene expression or through their interactions at the gene product (i.e. protein) or DNA level. Recently, greater high-dimensional data on protein-protein interaction (PPI) and gene expression profiles have been collected that enumerate sets of biological interactions. To better align statistical and molecular models of epistasis, we present an example of how to incorporate the PPI information into the statistical analysis of interactions between copy number variations (CNVs). Among the 23,640 pairs of known human PPIs and the 1,141 common CNVs detected among HapMap samples, we identified 37 pairs of CNVs overlapping with both genes of a PPI pair. Two CNV pairs provided sufficient genotype variation to search for epistatic effects on gene expression. Using 47,294 probe-specific gene expression levels as the outcomes, five epistatic effects were identified with p-value less than 10(-6). We found a CNV-CNV interaction significantly associated with gene expression of TP53TG3 (p-value of 2x10(-20)). The proteins associated with the CNV pair also bind TP53 which regulates the transcription of TP53TG3. This study demonstrates that using PPI data can assist in targeting statistical hypothesis testing to biological plausible epistatic interaction that reflects molecular mechanisms.
        PMID: 20736252 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Concanavalin A-immobilized magnetic nanoparticles for selective enrichment of glycoproteins and application to glycoproteomics in hepatocelluar carcinoma cell line.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-357.html</link>
      <description> Related Articles Concanavalin A-immobilized magnetic nanoparticles for selective enrichment of glycoproteins and application to glycoproteomics in hepatocelluar carcinoma cell line. Proteomics. 2010 May;10(10):2000-14 Authors: Tang J, Liu Y, Yin P, Yao G, Yan G, Deng C, Zhang X Protein glycosylation is one of the most important PTMs in biological organism. Lectins such as concanavalin A (Con A) have been widely applied to N-glycosylated protein investigation. In this study, we developed Con A-i ...</description>
        <pubDate>Thu, 26 Aug 2010 01:00:12 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-357.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Concanavalin A-immobilized magnetic nanoparticles for selective enrichment of glycoproteins and application to glycoproteomics in hepatocelluar carcinoma cell line. Proteomics. 2010 May;10(10):2000-14 Authors: Tang J, Liu Y, Yin P, Yao G, Yan G, Deng C, Zhang X Protein glycosylation is one of the most important PTMs in biological organism. Lectins such as concanavalin A (Con A) have been widely applied to N-glycosylated protein investigation. In this study, we developed Con A-immobilized magnetic nanoparticles for selective separation of glycoproteins. At first, a facile immobilization of Con A on aminophenylboronic acid-functionalized magnetic nanoparticles was performed by forming boronic acid-sugar-Con A bond in sandwich structure using methyl alpha-D-mannopyranoside as an intermedium. The selective capture ability of Con A-modified magnetic nanoparticles for glycoproteins was tested using standard glycoproteins and cell lysate of human hepatocelluar carcinoma cell line 7703. In total 184 glycosylated sites were detected within 172 different glycopeptides corresponding to 101 glycoproteins. Also, the regeneration of the protein-immobilized nanoparticles can easily be performed taking advantage of the reversible binding mechanism between boronic acid and sugar chain. The experiment results demonstrated that Con A-modified magnetic nanoparticles by the facile and low-cost synthesis provided a convenient and efficient enrichment approach for glycoproteins, and are promising candidates for large-scale glycoproteomic research in complicated biological samples. PMID: 20217867 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事のConcanavalinはhepatocelluar癌腫の細胞ラインのglycoproteomicsに糖蛋白質および適用の選択的な強化のための磁気nanoparticlesを固定した。 Proteomics。 5月2010日; 10 (10): 2000-14書く: 独特の味J、劉Y、Yin P、矢尾G、沿G、Deng CのチャンX蛋白質のglycosylationは生物的有機体の最も重要なPTMsの1つである。 concanavalin AのようなLectins (詐欺A)はNglycosylated蛋白質の調査に広く加えられた。 この調査では、私達は詐欺を糖蛋白質の選択的な分離のための固定された磁気nanoparticles開発した。 最初に、aminophenylboronic酸functionalizedの磁気nanoparticlesの詐欺Aの容易な固定はboronic形成によってintermediumとしてメチルのアルファD MANNOPYRANOSIDEを使用して酸砂糖騙すサンドイッチ構造のAの結束を行われた。 糖蛋白質のための詐欺によって変更された磁気nanoparticlesの選択的な捕獲の能力は人間のhepatocelluar癌腫の細胞の行の7703標準的な糖蛋白質そして細胞のlysateを使用してテストされた。 合計184でglycosylated場所は101の糖蛋白質に相当して172の糖蛋白質の内で検出された。 また、蛋白質固定されたnanoparticlesの再生は容易に行うことができboronic酸と砂糖の鎖間のリバーシブルのバインディングメカニズムを利用する。 実験の結果は低価格の統合が糖蛋白質に便利で、有効な強化のアプローチを変更し、示したり、複雑な生物的サンプルの大規模なglycoproteomic研究のための有望な候補者提供したことを詐欺が容易のによって磁気nanoparticlesをことをである。 PMID: 20217867 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>{alpha}-Synuclein gene duplication impairs reward learning.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-404.html</link>
      <description> {alpha}-Synuclein gene duplication impairs reward learning. Proc Natl Acad Sci U S A. 2010 Aug 23; Authors: KÃ©ri S, Moustafa AA, Myers CE, Benedek G, Gluck MA alpha-Synuclein (SNCA) plays an important role in the regulation of dopaminergic neurotransmission and neurodegeneration in Parkinson disease. We investigated reward and punishment learning in asymptomatic carriers of a rare SNCA gene duplication who were healthy siblings of patients with Parkinson disease. Results revealed that heal ...</description>
        <pubDate>Thu, 26 Aug 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-404.html</guid>
        
      <content:encoded> <![CDATA[
    

        {alpha}-Synuclein gene duplication impairs reward learning.
        Proc Natl Acad Sci U S A. 2010 Aug 23;
        Authors:  KÃ©ri S, Moustafa AA, Myers CE, Benedek G, Gluck MA
        alpha-Synuclein (SNCA) plays an important role in the regulation of dopaminergic neurotransmission and neurodegeneration in Parkinson disease. We investigated reward and punishment learning in asymptomatic carriers of a rare SNCA gene duplication who were healthy siblings of patients with Parkinson disease. Results revealed that healthy SNCA duplication carriers displayed impaired reward and intact punishment learning compared with noncarriers. These results demonstrate that a copy number variation of the SNCA gene is associated with selective impairments on reinforcement learning in asymptomatic carriers without the motor symptoms of Parkinson disease.
        PMID: 20733075 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Somatic mosaicism for chromosome X and Y aneuploidies in monozygotic twins heterozygous for sickle cell disease mutation.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-405.html</link>
      <description> Somatic mosaicism for chromosome X and Y aneuploidies in monozygotic twins heterozygous for sickle cell disease mutation. Am J Med Genet A. 2010 Aug 23; Authors: Razzaghian HR, Shahi MH, Forsberg LA, de StÃ?hl TD, Absher D, Dahl N, Westerman MP, Dumanski JP Somatic genetic variation in health and disease is poorly explored. Monozygotic (MZ) twins are a suitable model for studies of somatic mosaicism since genetic differences in twins derived from the same zygote represent an irrefutable examp ...</description>
        <pubDate>Thu, 26 Aug 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-405.html</guid>
        
      <content:encoded> <![CDATA[
    

        Somatic mosaicism for chromosome X and Y aneuploidies in monozygotic twins heterozygous for sickle cell disease mutation.
        Am J Med Genet A. 2010 Aug 23;
        Authors:  Razzaghian HR, Shahi MH, Forsberg LA, de StÃ?hl TD, Absher D, Dahl N, Westerman MP, Dumanski JP
        Somatic genetic variation in health and disease is poorly explored. Monozygotic (MZ) twins are a suitable model for studies of somatic mosaicism since genetic differences in twins derived from the same zygote represent an irrefutable example of somatic variation. We report the analysis of a pair of generally healthy female MZ twins, discordant for somatic mosaicism for aneuploidy of chromosomes X and Y. Both twins are heterozygous carriers of sickle cell disease mutation. Genotyping of blood DNA from both twins using Illumina Human 610 SNP array revealed a copy number imbalance for chromosome X in a proportion of cells in one twin. Fluorescent in situ hybridization (FISH) analysis confirmed monosomy X (45,X) in 7% of proband nucleated blood cells. Unexpectedly, FISH analysis of cells from the other twin revealed 45,X and 46,XY lineages, both present in 1% of cells. The mechanism behind formation of these aneuploidies suggests several aberrant chromosome segregation events in meiosis and mitoses following conception. Our report contributes to the delineation of the frequency of somatic structural genomic variation in normal MZ twins. These results also illustrate the plasticity of the human genome for tolerating large copy number changes in healthy subjects and show the sensitivity of the Illumina platform for detection of aberrations that are present in a minority of the studied cells. (c) 2010 Wiley-Liss, Inc.
        PMID: 20734341 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-406.html</link>
      <description>Related Articles TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice. Lab Invest. 2010 Aug 23; Authors: Dasu MR, Thangappan RK, Bourgette A, Dipietro LA, Isseroff R, Jialal I Toll-like receptor-2 (TLR2) is a pivotal pathogen recognition receptor that has a key role in inflammation, diabetes, and injury. Hyperglycemia, inflammation, and oxidative stress induce TLR2-myeloid differentiation factor-88 (MyD88) expression and signaling, and are major pathophysiol ...</description>
        <pubDate>Thu, 26 Aug 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-406.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice. Lab Invest. 2010 Aug 23; Authors: Dasu MR, Thangappan RK, Bourgette A, Dipietro LA, Isseroff R, Jialal I Toll-like receptor-2 (TLR2) is a pivotal pathogen recognition receptor that has a key role in inflammation, diabetes, and injury. Hyperglycemia, inflammation, and oxidative stress induce TLR2-myeloid differentiation factor-88 (MyD88) expression and signaling, and are major pathophysiological mechanisms in the impaired diabetic wound-healing process. The aim of the study was to examine the contribution of TLR2-MyD88 expression and signaling to the prolonged inflammation observed in diabetic wounds. Diabetes was induced in male C57BL/6J and TLR2(-/-) mice using streptozotocin (STZ) with matching nondiabetic mice as control. In addition, nonobese diabetic (NOD) mice were used to represent the spontaneous type 1 diabetes condition. After 2 weeks of persistent hyperglycemia in the mice, full-thickness excision wounds were made on the backs aseptically. Total RNA and protein were subjected to real-time PCR and western blot analyses. Wound sizes were measured using digital planimetry. TLR2 mRNA and protein expression increased significantly in wounds of C57BL/6J+STZ and NOD mice (P<0.05) compared with nondiabetic C57BL/6J mice. MyD88 expression, interleukin receptor-associated kinase-1 phosphorylation, and nuclear factor-kappa B (NF-kappaB) activation were increased in diabetic wounds compared with nondiabetic wounds. Wounds of TLR2(-/-)+STZ mice showed less oxidative stress, decreased MyD88 signaling, NF-kappaB activation, and cytokine secretion. The wound closure was significant in TLR2(-/-)+ STZ mice compared with C57BL/6J+STZ mice. Collectively, our findings show that increased TLR2 mRNA and protein expression, signaling, and activation contribute to the prolonged inflammation in the diabetic wounds and that absence of TLR2 may result in decreased inflammation and improved wound healing.Laboratory Investigation advance online publication, 23 August 2010; doi:10.1038/labinvest.2010.158. PMID: 20733560 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The RINGS Resource for Glycome Informatics Analysis and Data Mining on the Web.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-356.html</link>
      <description>The RINGS Resource for Glycome Informatics Analysis and Data Mining on the Web. OMICS. 2010 Aug;14(4):475-86 Authors: Akune Y, Hosoda M, Kaiya S, Shinmachi D, Aoki-Kinoshita KF Abstract In the bioinformatics field, many computer algorithmic and data mining technologies have been developed for gene prediction, protein-protein interaction analysis, sequence analysis, and protein folding predictions, to name a few. This kind of research has branched off from the genomics field, creating the transcr ...</description>
        <pubDate>Wed, 25 Aug 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-356.html</guid>
        
      <content:encoded> <![CDATA[
    The RINGS Resource for Glycome Informatics Analysis and Data Mining on the Web. OMICS. 2010 Aug;14(4):475-86 Authors: Akune Y, Hosoda M, Kaiya S, Shinmachi D, Aoki-Kinoshita KF Abstract In the bioinformatics field, many computer algorithmic and data mining technologies have been developed for gene prediction, protein-protein interaction analysis, sequence analysis, and protein folding predictions, to name a few. This kind of research has branched off from the genomics field, creating the transcriptomics, proteomics, metabolomics, and glycomics research areas in the postgenomic age. In the glycomics field, given the complexity of glycan structures with their branches of monosaccharides in various conformations, new data mining and algorithmic methods have been developed in an attempt to gain a better understanding of glycans. However, these methods have not all been implemented as tools such that the glycobiology community may utilize them in their research. Thus, we have developed RINGS (Resource for INformatics of Glycomes at Soka) as a freely available Web resource for glycobiologists to analyze their data using the latest data mining and algorithmic techniques. It provides a number of tools including a 2D glycan drawing and querying interface called DrawRINGS, a Glycan Pathway Predictor (GPP) tool for dynamically computing the N-glycan biosynthesis pathway from a given glycan structure, and data mining tools Glycan Miner Tool and Profile PSTMM. These tools and other utilities provided by RINGS will be described. The URL for RINGS is http://rings.t.soka.ac.jp/ . PMID: 20726803 [PubMed - in process]（【斜め読み用】機械翻訳： 網のGlycomeの情報科学の分析およびデータマイニングのためのリング資源。 OMICS. 8月2010日; 14 (4): 475-86書く: Akune Y、Hosoda M、Kaiya S、Shinmachi Dの多くの遺伝子の予言、蛋白質蛋白質の相互作用の分析、順序の分析および蛋白質折りたたみの予言のために生物情報学分野のAoki-Kinoshita KFの概要はコンピュータアルゴリズムおよびデータマイニングの技術、少数を示すために開発された。 この種類の研究はpostgenomic年齢でtranscriptomics、proteomics、metabolomicsおよびglycomicsの研究分野を作成するゲノミクス分野から分岐した。 さまざまな構造の単糖類の枝が付いているglycan構造の複雑さがあるglycomics分野ではglycansのよりよい理解を得るために新しいデータマイニングおよびアルゴリズム方法は開発された。 但し、これらの方法は用具としてすべてglycobiologyのコミュニティが研究のそれらを利用するかもしれないことそのような物実行されなかった。 従って、私達はglycobiologistsのための自由に利用できる網資源として最も最近のデータマイニングおよびアルゴリズムの技術を使用して彼らのデータを分析するためにリング(SokaのGlycomesの情報科学のための資源)を開発した。 それは第2 glycanデッサンを含むいくつかの用具およびインターフェイスによって呼ばれるDrawRINGSをただすこと、動的にある特定のglycan構造からN-glycanの生合成の細道を計算するためのGlycanの細道の予言者(GPP)用具、およびデータマイニング用具のGlycan抗夫用具およびプロフィールPSTMM提供する。 RINGSが提供したこれらの用具および他の実用性は記述される。 リングのためのURLはhttp://rings.t.soka.ac.jp/である。 PMID: 20726803 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glycomics: technologies taming a frontier omics field.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-354.html</link>
      <description>Glycomics: technologies taming a frontier omics field. OMICS. 2010 Aug;14(4):385-7 Authors: Turnbull JE, Sasisekharan R PMID: 20726798 [PubMed - in process]（【斜め読み用】機械翻訳： Glycomics: フロンティアのomicsを飼いならす技術は守備につく。 OMICS. 8月2010日; 14 (4): 385-7書く: Turnbull JE、Sasisekharan R PMID: 20726798 [PubMed -プロセスの…）</description>
        <pubDate>Wed, 25 Aug 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-354.html</guid>
        
      <content:encoded> <![CDATA[
    Glycomics: technologies taming a frontier omics field. OMICS. 2010 Aug;14(4):385-7 Authors: Turnbull JE, Sasisekharan R  PMID: 20726798 [PubMed - in process]（【斜め読み用】機械翻訳： Glycomics: フロンティアのomicsを飼いならす技術は守備につく。 OMICS. 8月2010日; 14 (4): 385-7書く: Turnbull JE、Sasisekharan R PMID: 20726798 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Lectin microarrays for glycomic analysis.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-355.html</link>
      <description>Lectin microarrays for glycomic analysis. OMICS. 2010 Aug;14(4):419-36 Authors: Gupta G, Surolia A, Sampathkumar SG Abstract Glycomics is the study of comprehensive structural elucidation and characterization of all glycoforms found in nature and their dynamic spatiotemporal changes that are associated with biological processes. Glycocalyx of mammalian cells actively participate in cell-cell, cell-matrix, and cell-pathogen interactions, which impact embryogenesis, growth and development, homeost ...</description>
        <pubDate>Wed, 25 Aug 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-355.html</guid>
        
      <content:encoded> <![CDATA[
    Lectin microarrays for glycomic analysis. OMICS. 2010 Aug;14(4):419-36 Authors: Gupta G, Surolia A, Sampathkumar SG Abstract Glycomics is the study of comprehensive structural elucidation and characterization of all glycoforms found in nature and their dynamic spatiotemporal changes that are associated with biological processes. Glycocalyx of mammalian cells actively participate in cell-cell, cell-matrix, and cell-pathogen interactions, which impact embryogenesis, growth and development, homeostasis, infection and immunity, signaling, malignancy, and metabolic disorders. Relative to genomics and proteomics, glycomics is just growing out of infancy with great potential in biomedicine for biomarker discovery, diagnosis, and treatment. However, the immense diversity and complexity of glycan structures and their multiple modes of interactions with proteins pose great challenges for development of analytical tools for delineating structure function relationships and understanding glyco-code. Several tools are being developed for glycan profiling based on chromatography, mass spectrometry, glycan microarrays, and glyco-informatics. Lectins, which have long been used in glyco-immunology, printed on a microarray provide a versatile platform for rapid high throughput analysis of glycoforms of biological samples. Herein, we summarize technological advances in lectin microarrays and critically review their impact on glycomics analysis. Challenges remain in terms of expansion to include nonplant derived lectins, standardization for routine clinical use, development of recombinant lectins, and exploration of plant kingdom for discovery of novel lectins. PMID: 20726799 [PubMed - in process]（【斜め読み用】機械翻訳： glycomic分析のためのLectinのマイクロアレイ。 OMICS. 8月2010日; 14 (4): 419-36書く: Gupta G、Surolia A、抽象的なGlycomics Sampathkumar SGは広範囲の構造説明の調査であり、生物学的過程と関連付けられるすべてのglycoformsの性格描写はおよび動的spatiotemporal変更実際のところ見つけた。 哺乳類細胞のGlycocalyxは細胞細胞に積極的に、細胞マトリックスおよび胚形成に、成長、ホメオスタティス、伝染および免除、シグナリング、敵意および新陳代謝の無秩序影響を与える細胞病原体の相互作用加わる。 ゲノミクスおよびproteomicsに関連して、glycomicsはbiomarkerの発見、診断および処置のための生物医学の大きい潜在性の幼年時代からちょうど育っている。 但し、蛋白質との相互作用のglycan構造そして多重モードの広大な多様性そして複雑さは構造機能関係の輪郭を描き、glycoコードを理解するための分析的な用具の開発のための大きい挑戦を提起する。 クロマトグラフィー、質量分析、glycanマイクロアレイおよびglyco情報科学に基づいてglycan側面図を描く複数の用具は発達している。 Lectinsは生物的サンプルのglycoformsの急速で高い効率の分析にマイクロアレイで、glyco免疫学で長く使用されてしまった、提供する多目的なプラットホームを印刷した。 ここに、私達はlectinのマイクロアレイで技術的進歩を要約し、批判的にglycomicsの分析の彼らの影響を見直す。 挑戦は拡張の点では定期的な臨床使用のためのnonplant得られたlectins、標準化、組換えのlectinsの開発、および新しいlectinsの発見のための植物王国の調査を含むことを残る。 PMID: 20726799 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Functional mode of FoxD1/CBF2 for the establishment of temporal retinal specificity in the developing chick retina.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-152.html</link>
      <description> Related Articles Functional mode of FoxD1/CBF2 for the establishment of temporal retinal specificity in the developing chick retina. Dev Biol. 2009 Jul 15;331(2):300-10 Authors: Takahashi H, Sakuta H, Shintani T, Noda M Two winged-helix transcription factors, FoxG1 (previously called chick brain factor1, CBF1) and FoxD1 (chick brain factor2, CBF2), are expressed specifically in the nasal and temporal regions of the developing chick retina, respectively. We previously demonstrated that FoxG1 con ...</description>
        <pubDate>Wed, 25 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-152.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Functional mode of FoxD1/CBF2 for the establishment of temporal retinal specificity in the developing chick retina. Dev Biol. 2009 Jul 15;331(2):300-10 Authors: Takahashi H, Sakuta H, Shintani T, Noda M Two winged-helix transcription factors, FoxG1 (previously called chick brain factor1, CBF1) and FoxD1 (chick brain factor2, CBF2), are expressed specifically in the nasal and temporal regions of the developing chick retina, respectively. We previously demonstrated that FoxG1 controls the expression of topographic molecules including FoxD1, and determines the regional specificity of the nasal retina. FoxD1 is known to prescribe temporal specificity, however, molecular mechanisms and downstream targets have not been elucidated. Here we addressed the genetic mechanisms for establishing temporal specificity in the developing retina using an in ovo electroporation technique. Fibroblast growth factor (Fgf) and Wnt first play pivotal roles in inducing the region-specific expression of FoxG1 and FoxD1 in the optic vesicle. Misexpression of FoxD1 represses the expression of FoxG1, GH6, SOHo1, and ephrin-A5, and induces that of EphA3 in the retina. GH6 and SOHo1 repress the expression of FoxD1. In contrast to the inhibitory effect of FoxG1 on bone morphogenic protein (BMP) signaling, FoxD1 does not alter the expression of BMP4 or BMP2. Studies with chimeric mutants of FoxD1 showed that FoxD1 acts as a transcription repressor in controlling its downstream targets in the retina. Taken together with previous findings, our data suggest that FoxG1 and FoxD1 are located at the top of the gene cascade for regional specification along the nasotemporal (anteroposterior) axis in the retina, and FoxD1 determines temporal specificity. PMID: 19450575 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 成長のひよこの網膜の一時的な網膜の特定性の確立のためのFoxD1/CBF2の関連の記事の機能モード。 Dev Biol. 7月2009日15日; 331 (2): 300-10書く: Takahashi H、Sakuta H、Shintani T、野田M 2の飛螺旋形のトランスクリプション要因、FoxG1 (前にひよこの頭脳factor1、CBF1と呼ばれる)およびFoxD1 (ひよこの頭脳factor2、CBF2)は成長のひよこの網膜の鼻および一時的な地域に、それぞれとりわけ表現される。 私達は前にFoxG1がFoxD1を含む地勢分子の表現を制御する示し、鼻の網膜の地方特定性をことを定める。 FoxD1は一時的な特定性を規定すると知られているしかし、分子メカニズムおよび下流ターゲットは明瞭にならなかった。 ここで私達はovoのelectroporationの技術のを使用して成長の網膜に一時的な特定性を確立するための遺伝のメカニズムに演説した。 繊維芽細胞の成長因子(Fgf)および視覚の小胞のFoxG1そしてFoxD1の地域特定の表現を引き起こすことに於いてのWntの最初演劇の極めて重要な役割。 FoxD1のMisexpressionはFoxG1、GH6、SOHo1およびephrin-A5の表現を抑圧し、網膜のEphA3のそれを引き起こす。 GH6およびSOHo1はFoxD1の表現を抑圧する。 骨morphogenic蛋白質(BMP)シグナリングに対するFoxG1の抑制的な効果と対照をなして、FoxD1はBMP4またはBMP2の表現を変えない。 FoxD1の想像上の突然変異体との調査はFoxD1が網膜ことをの下流ターゲットの制御のトランスクリプションリプレッサーとして機能することを示した。 前の調査結果とともに取られて、私達のデータはFoxG1およびFoxD1がnasotemporal (anteroposterior)軸線に沿う地方指定のための遺伝子の滝の上に網膜にある、およびFoxD1は一時的な特定性を定めることを提案する。 PMID: 19450575 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Evidence for an inhibitory role of bone morphogenetic protein(s) in the follicular-luteal transition in cattle.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-128.html</link>
      <description> Related Articles Evidence for an inhibitory role of bone morphogenetic protein(s) in the follicular-luteal transition in cattle. Reproduction. 2009 Jan;137(1):67-78 Authors: Kayani AR, Glister C, Knight PG Bone morphogenetic proteins (BMPs) and their receptors are expressed in ovarian theca cells (TC) and granulosa cells (GC) and BMPs have been implicated in the regulation of several aspects of follicle development including thecal androgen production and granulosal oestrogen production. Their  ...</description>
        <pubDate>Wed, 25 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-128.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Evidence for an inhibitory role of bone morphogenetic protein(s) in the follicular-luteal transition in cattle. Reproduction. 2009 Jan;137(1):67-78 Authors: Kayani AR, Glister C, Knight PG Bone morphogenetic proteins (BMPs) and their receptors are expressed in ovarian theca cells (TC) and granulosa cells (GC) and BMPs have been implicated in the regulation of several aspects of follicle development including thecal androgen production and granulosal oestrogen production. Their potential involvement in luteal function has received less attention. In this study, we first compared relative abundance of mRNA transcripts for BMPs, activin-betaA and BMP/activin receptors in bovine corpus luteum (CL) and follicular theca and granulosa layers before undertaking functional in vitro experiments to test the effect of selected ligands (BMP6 and activin A) on luteinizing bovine TC and GC. Relative to beta-actin transcript abundance, CL tissue contained more BMP4 and -6 mRNA than granulosa, more BMP2 mRNA than theca but much less activin-betaA mRNA than both granulosa and theca. Transcripts for all seven BMP/activin receptors were readily detected in each tissue and two transcripts (BMPRII, ActRIIA) were more abundant in CL than either theca or granulosa, consistent with tissue responsiveness. In vitro luteinization of TC and GC from antral follicles (4-6 mm) was achieved by culturing with 5% serum for 6 days. Treatment with BMP6 (0, 2, 10, and 50 ng/ml) and activin A (0, 2, 10 and 50 ng/ml) under these conditions dose-dependently suppressed forskolin-induced progesterone (P4) secretion from both cell types without affecting cell number. BMP6 reduced forskolin-stimulated upregulation of STAR mRNA and raised 'basal' CYP17A1 mRNA level in theca-lutein cells without affecting expression of CYP11A1 or hydroxy-Delta-5-steroid dehydrogenase, 3 beta- and steroid Delta-isomerase 1 (HSD3B1). In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas forskolin-induced expression of CYP11A1, HSD3B1, CYP19A1 and oxytocin transcripts was reduced. In both cell types, follistatin attenuated the suppressive effect of activin A and BMP6 on forskolin-induced P4 secretion but had no effect alone. Granulosa-lutein cells secreted low levels of endogenous activin A ( approximately 1 ng/ml); BMP6 reduced this, while raising follistatin secretion thus decreasing activin A:follistatin ratio. Collectively, these findings support inhibitory roles for BMP/activin signalling in luteinization and steroidogenesis in both TC and GC. PMID: 18936084 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Sonic hedgehog signaling regulates reciprocal epithelial-mesenchymal interactions controlling palatal outgrowth.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-144.html</link>
      <description> Related Articles Sonic hedgehog signaling regulates reciprocal epithelial-mesenchymal interactions controlling palatal outgrowth. Development. 2009 Apr;136(8):1387-96 Authors: Lan Y, Jiang R The mammalian secondary palate arises by outgrowth from the oral side of the paired maxillary processes flanking the primitive oral cavity. Palatal growth depends on reciprocal interactions between the oral ectoderm and the underlying neural-crest-derived mesenchyme. Previous studies have implicated sonic h ...</description>
        <pubDate>Wed, 25 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-144.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Sonic hedgehog signaling regulates reciprocal epithelial-mesenchymal interactions controlling palatal outgrowth. Development. 2009 Apr;136(8):1387-96 Authors: Lan Y, Jiang R The mammalian secondary palate arises by outgrowth from the oral side of the paired maxillary processes flanking the primitive oral cavity. Palatal growth depends on reciprocal interactions between the oral ectoderm and the underlying neural-crest-derived mesenchyme. Previous studies have implicated sonic hedgehog (Shh) as an important epithelial signal for regulating palatal growth. However, the cellular and molecular mechanisms through which Shh regulates palatal development in vivo have not been directly analyzed, due in part to early embryonic lethality of mice lacking Shh or other essential components of the Shh signaling pathway. Using Cre/loxP-mediated tissue-specific inactivation of the smoothened (Smo) gene in the developing palatal mesenchyme, we show that the epithelially expressed Shh signals directly to the palatal mesenchyme to regulate palatal mesenchyme cell proliferation through maintenance of cyclin D1 (Ccnd1) and Ccnd2 expression. Moreover, we show that Shh-Smo signaling specifically regulates the expression of the transcription factors Foxf1a, Foxf2 and Osr2 in the developing palatal mesenchyme. Furthermore, we show that Shh signaling regulates Bmp2, Bmp4 and Fgf10 expression in the developing palatal mesenchyme and that specific inactivation of Smo in the palatal mesenchyme indirectly affects palatal epithelial cell proliferation. Together with previous reports that the mesenchymally expressed Fgf10 signals to the palatal epithelium to regulate Shh mRNA expression and cell proliferation, these data demonstrate that Shh signaling plays a central role in coordinating the reciprocal epithelial-mesenchymal interactions controlling palatal outgrowth. PMID: 19304890 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：  関連の記事の音波のハリネズミシグナリングはpalatal結果を制御する相互上皮性mesenchymal相互作用を調整する。 開発。 4月2009日; 136 (8): 1387-96書く: LAN Y、江Rは原始口腔を並べる組み合わせられた顎プロセスの口頭側面からの結果によって哺乳類の二次口蓋起こる。 Palatal成長は口頭ectodermおよび下にある神経頂上得られたmesenchyme間の相互相互作用によって決まる。 前の調査はpalatal成長を調整するための重要な上皮性信号として音波のハリネズミ(Shh)を関係させた。 但し、Shhがpalatal開発を生体内で調整する細胞および分子メカニズムは直接、Shhに欠けているマウスまたはShhシグナリング細道の他の必要な部品の早い萌芽期の致死率が一部には原因で分析されてしまわなかった。 成長のpalatal mesenchymeの(Smoの)滑らかにされた遺伝子のCre/loxP仲介されたティッシュ特定の不活性化を使用して、私達はcyclinのD1 (Ccnd1)およびCcnd2調整するためにepithelially表現されたShhがpalatal mesenchymeに直接表現の維持によってpalatal mesenchymeの細胞増殖を信号を送ることを示す。 さらに、私達はShh-Smoシグナリングがとりわけ成長のpalatal mesenchymeのトランスクリプション要因Foxf1a、Foxf2およびOsr2の表現を調整することを示す。 なお、私達はShhシグナリングが成長のpalatal mesenchymeのBmp2、Bmp4およびFgf10表現を調整すること、そしてpalatal mesenchymeのSmoの特定の不活性化が間接的にpalatal上皮細胞拡散に影響を与えることを示す。 Shhシグナリングがpalatal結果をことを制御する相互上皮性mesenchymal相互作用の調整の中心的役割を担うことをShh mRNAの表現および細胞増殖のこれらのデータを調整するpalatal上皮へのmesenchymally表現されたFgf10信号が示すという前のレポートとともに。 PMID: 19304890 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A late role for bmp2b in the morphogenesis of semicircular canal ducts in the zebrafish inner ear.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-136.html</link>
      <description> Related Articles A late role for bmp2b in the morphogenesis of semicircular canal ducts in the zebrafish inner ear. PLoS One. 2009;4(2):e4368 Authors: Hammond KL, Loynes HE, Mowbray C, Runke G, Hammerschmidt M, Mullins MC, Hildreth V, Chaudhry B, Whitfield TT BACKGROUND: The Bone Morphogenetic Protein (BMP) genes bmp2 and bmp4 are expressed in highly conserved patterns in the developing vertebrate inner ear. It has, however, proved difficult to elucidate the function of BMPs during ear developm ...</description>
        <pubDate>Wed, 25 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-136.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles A late role for bmp2b in the morphogenesis of semicircular canal ducts in the zebrafish inner ear. PLoS One. 2009;4(2):e4368 Authors: Hammond KL, Loynes HE, Mowbray C, Runke G, Hammerschmidt M, Mullins MC, Hildreth V, Chaudhry B, Whitfield TT BACKGROUND: The Bone Morphogenetic Protein (BMP) genes bmp2 and bmp4 are expressed in highly conserved patterns in the developing vertebrate inner ear. It has, however, proved difficult to elucidate the function of BMPs during ear development as mutations in these genes cause early embryonic lethality. Previous studies using conditional approaches in mouse and chicken have shown that Bmp4 has a role in semicircular canal and crista development, but there is currently no direct evidence for the role of Bmp2 in the developing inner ear. METHODOLOGY/PRINCIPAL FINDINGS: We have used an RNA rescue strategy to test the role of bmp2b in the zebrafish inner ear directly. Injection of bmp2b or smad5 mRNA into homozygous mutant swirl (bmp2b(-/-)) embryos rescues the early patterning defects in these mutants and the fish survive to adulthood. As injected RNA will only last, at most, for the first few days of embryogenesis, all later development occurs in the absence of bmp2b function. Although rescued swirl adult fish are viable, they have balance defects suggestive of vestibular dysfunction. Analysis of the inner ears of these fish reveals a total absence of semicircular canal ducts, structures involved in the detection of angular motion. All other regions of the ear, including the ampullae and cristae, are present and appear normal. Early stages of otic development in rescued swirl embryos are also normal. CONCLUSIONS/SIGNIFICANCE: Our findings demonstrate a critical late role for bmp2b in the morphogenesis of semicircular canals in the zebrafish inner ear. This is the first demonstration of a developmental role for any gene during post-embryonic stages of otic morphogenesis in the zebrafish. Despite differences in the early stages of semicircular canal formation between zebrafish and amniotes, the role of Bmp2 in semicircular canal duct outgrowth is likely to be conserved between different vertebrate species. PMID: 19190757 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Molecular determinants of Xolloid action in vivo.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-120.html</link>
      <description> Related Articles Molecular determinants of Xolloid action in vivo. J Biol Chem. 2008 Oct 3;283(40):27057-63 Authors: Geach TJ, Dale L Xld (Xolloid) is a member of the Tolloid family of metalloproteases found in embryos of the frog Xenopus laevis. It cleaves Chordin, an inhibitory binding protein for BMP2/4, releasing fragments with reduced affinity for these important ventralizing signals. As a consequence, increasing Xld activity ventralizes Xenopus embryos. We have used this phenotype as an a ...</description>
        <pubDate>Wed, 25 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-120.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Molecular determinants of Xolloid action in vivo. J Biol Chem. 2008 Oct 3;283(40):27057-63 Authors: Geach TJ, Dale L Xld (Xolloid) is a member of the Tolloid family of metalloproteases found in embryos of the frog Xenopus laevis. It cleaves Chordin, an inhibitory binding protein for BMP2/4, releasing fragments with reduced affinity for these important ventralizing signals. As a consequence, increasing Xld activity ventralizes Xenopus embryos. We have used this phenotype as an assay to determine the requirement for the C-terminal, nonprotease component of Xld for in vivo activity. This part of the protein is composed of five complement C1r/C1s-sea urchin epidermal growth factor-BMP1 (CUB) and two epidermal growth factor domains, which are thought to be involved in protein-protein interactions and may confer substrate specificity. Our results show that the protease coupled to CUB1 and CUB2 is the minimum domain structure required to ventralize Xenopus embryos and to block the dorsal axis-inducing activity of Chordin. Xld-CUB1-CUB2 cleaves Chordin, and a protease-inactive version co-precipitates Chordin. Our results indicate that the first and second CUB domains bind Chordin and present it to the protease domain. Protease-inactive Xld blocks the cleavage of Chordin by wild-type Xld and dorsalizes injected Xenopus embryos. We find that protease-inactive Xld-CUB1-CUB2 does not share this activity and that all of the C-terminal domains are required to generate the dorsalized phenotype. PMID: 18664565 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 生体内でXolloidの行為の関連の記事の分子決定要因。 J Biol Chem。 10月2008日3日; 283 (40): 27057-63書く: Geach TJの谷L Xld (Xolloid)はカエルのXenopusのlaevisの胚で見つけられるmetalloproteasesのTolloidの系列のメンバーである。 それはChordinのこれらの重要なventralizing信号のための減らされた類縁の片を解放するBMP2/4のための抑制的な結合蛋白質を裂く。 結果として、増加するXldの活動はXenopusの胚をventralizes。 私達は試金としてCターミナルのための条件、生体内の活動のためのXldのnonproteaseの部品を定めるのにこの表現型を使用した。 蛋白質のこの一部分は5つの補足物のC1r/C1s海の少年の蛋白質蛋白質の相互作用にかかわると考えられ、基質の相談するかもしれない特定性2つの表皮の成長因子の範囲構成される、および表皮の成長の要因(カブス)で。 私達の結果はプロテアーゼがCUB1につなぎ、CUB2がXenopusの胚をventralize、Chordinの背面の軸線引き起こす活動を妨げるために必要な最低のドメイン構造であることを示す。 Xld-CUB1-CUB2はChordinを裂き、プロテアーゼ不活性版はChordinを共沈させる。 私達の結果はカブスの第1及び第2範囲がChordinを結合する示し、プロテアーゼの範囲にそれをことを示す。 プロテアーゼ不活性Xldは野生タイプXldによってChordinの開裂を妨げ、注入されたXenopusの胚をdorsalizes。 私達はプロテアーゼ不活性Xld-CUB1-CUB2がこの活動を共有しないことが、そしてdorsalized表現型を発生させるようにCターミナル範囲すべてが要求されることを分る。 PMID: 18664565 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Modulation of BMP signaling by Noggin is required for the maintenance of palatal epithelial integrity during palatogenesis.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-204.html</link>
      <description>Related Articles Modulation of BMP signaling by Noggin is required for the maintenance of palatal epithelial integrity during palatogenesis. Dev Biol. 2010 Aug 18; Authors: He F, Xiong W, Wang Y, Matsui M, Yu X, Chai Y, Klingensmith J, Chen Y BMP signaling plays many important roles during organ development, including palatogenesis. Loss of BMP signaling leads to cleft palate formation. During development, BMP activities are finely tuned by a number of modulators at the extracellular and intrace ...</description>
        <pubDate>Wed, 25 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-204.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Modulation of BMP signaling by Noggin is required for the maintenance of palatal epithelial integrity during palatogenesis. Dev Biol. 2010 Aug 18; Authors: He F, Xiong W, Wang Y, Matsui M, Yu X, Chai Y, Klingensmith J, Chen Y BMP signaling plays many important roles during organ development, including palatogenesis. Loss of BMP signaling leads to cleft palate formation. During development, BMP activities are finely tuned by a number of modulators at the extracellular and intracellular levels. Among the extracellular BMP antagonists is Noggin, which preferentialy binds to BMP2, BMP4 and BMP7, all of which are expressed in the developing palatal shelves. Here we use targeted Noggin mutant mice as a model for gain of BMP signaling function to investigate the role of BMP signaling in palate development. We find prominent Noggin expression in the palatal epithelium along the anterior-posterior axis during early palate development. Loss of Noggin function leads to overactive BMP signaling, particularly in the palatal epithelium. This results in disregulation of cell proliferation, excessive cell death, and changes in gene expression, leading to formation of complete palatal cleft. The excessive cell death in the epithelium disrupts the palatal epithelium integrity, which in turn leads to an abnormal palate-mandible fusion and prevents palatal shelf elevation. This phenotype is recapitulated by ectopic expression of a constitutively active form of BMPR-IA but not BMPR-IB in the epithelium of the developing palate; this suggests a role for BMPR-IA in mediating overactive BMP signaling in the absence of Noggin. Together with the evidence that overexpression of Noggin in the palatal epithelium does not cause a cleft palate defect, we conclude from our results that Noggin mediated modulation of BMP signaling is essential for palatal epithelium integrity and for normal palate development. PMID: 20727875 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：NogginによるBMPシグナリングの関連の記事調節はpalatogenesisの間にpalatal上皮性の完全性の維持に要求される。 Dev Biol. 8月2010日18日; 著者: 彼はpalatogenesisを含む器官の開発の間にF、Xiong W、Wang Y、Matsui M、Yu X、シェY、Klingensmith Jの陳Y BMPシグナリング多くの重要な役割を、担う。 BMPのの損失は口蓋破裂の形成にシグナリングリード。 開発の間に、BMPの活動は細胞外および細胞内のレベルのいくつかの変調器によって精巧に調整される。 細胞外BMPの中で反対者は成長のpalatal棚に表現される、BMP2、BMP4およびBMP7にpreferentialy結合するNogginである。 ここに私達はBMPシグナリング機能の利益のためにモデルとして口蓋の開発に於いてのBMPシグナリングの役割を調査するのに目標とされたNogginの突然変異体のマウスを使用する。 私達は早い口蓋の開発の間に前方後部の軸線に沿うpalatal上皮のNogginの顕著な表現を見つける。 Noggin機能の損失はpalatal上皮の過剰に活動するBMPシグナリングを、特にもたらす。 これは細胞増殖、余分な細胞死のdisregulationで起因し、完全なpalatal裂け目の形成をもたらす遺伝子発現で変わる。 上皮の余分な細胞死は異常な口蓋あごの融合をそれからもたらし、palatal棚の高度を防ぐpalatal上皮の完全性を破壊する。 この表現型はBMPR-IA成長の口蓋の上皮のないBMPR-IBの本質的に活動的な形態の異所性の表現によって要約される; これはNogginがない時過剰に活動するBMPシグナリングを仲介することに於いてのBMPR-IAのための役割を提案する。 palatal上皮のNogginのoverexpressionにより口蓋破裂の欠陥を引き起こさないという証拠とともにBMPシグナリングのNogginによって仲介される調節がpalatal上皮の完全性と正常な口蓋の開発のために必要であることを、私達は私達の結果から結論を出す。 PMID: -出版業者によって供給される… 20727875 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Variable Numbers of Tandem Repeats in Plasmodium falciparum Genes.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-403.html</link>
      <description> Variable Numbers of Tandem Repeats in Plasmodium falciparum Genes. J Mol Evol. 2010 Aug 22; Authors: Tan JC, Tan A, Checkley L, Honsa CM, Ferdig MT Genome variation studies in Plasmodium falciparum have focused on SNPs and, more recently, large-scale copy number polymorphisms and ectopic rearrangements. Here, we examine another source of variation: variable number tandem repeats (VNTRs). Interspersed low complexity features, including the well-studied P. falciparum microsatellite sequences, are ...</description>
        <pubDate>Wed, 25 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-403.html</guid>
        
      <content:encoded> <![CDATA[
    

        Variable Numbers of Tandem Repeats in Plasmodium falciparum Genes.
        J Mol Evol. 2010 Aug 22;
        Authors:  Tan JC, Tan A, Checkley L, Honsa CM, Ferdig MT
        Genome variation studies in Plasmodium falciparum have focused on SNPs and, more recently, large-scale copy number polymorphisms and ectopic rearrangements. Here, we examine another source of variation: variable number tandem repeats (VNTRs). Interspersed low complexity features, including the well-studied P. falciparum microsatellite sequences, are commonly classified as VNTRs; however, this study is focused on longer coding VNTR polymorphisms, a small class of copy number variations. Selection against frameshift mutation is a main constraint on tandem repeats (TRs) in coding regions, while limited propagation of TRs longer than 975 nt total length is a minor restriction in coding regions. Comparative analysis of three P. falciparum genomes reveals that more than 9% of all P. falciparum ORFs harbor VNTRs, much more than has been reported for any other species. Moreover, genotyping of VNTR loci in a drug-selected line, progeny of a genetic cross, and 334 field isolates demonstrates broad variability in these sequences. Functional enrichment analysis of ORFs harboring VNTRs identifies stress and DNA damage responses along with chromatin modification activities, suggesting an influence on genome mutability and functional variation. Analysis of the repeat units and their flanking regions in both P. falciparum and Plasmodium reichenowi sequences implicates a replication slippage mechanism in the generation of TRs from an initially unrepeated sequence. VNTRs can contribute to rapid adaptation by localized sequence duplication. They also can confound SNP-typing microarrays or mapping short-sequence reads and therefore must be accounted for in such analyses.
        PMID: 20730584 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Targeting phosphoprotein profiling by combination of hydroxyapatite-based phosphoprotein enrichment and SELDI-TOF MS.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-230.html</link>
      <description>Related Articles Targeting phosphoprotein profiling by combination of hydroxyapatite-based phosphoprotein enrichment and SELDI-TOF MS. Arch Physiol Biochem. 2010 Aug 23; Authors: Vormbrock I, Kaber G, Hartwig S, Eckel J, SchrÃ¶r K, Lehr S Over the last decade surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) has evolved as a versatile tool in the field of proteomic research. Although the chromatographic matrices on the currently provided SELDI affini ...</description>
        <pubDate>Wed, 25 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-230.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Targeting phosphoprotein profiling by combination of hydroxyapatite-based phosphoprotein enrichment and SELDI-TOF MS. Arch Physiol Biochem. 2010 Aug 23; Authors: Vormbrock I, Kaber G, Hartwig S, Eckel J, SchrÃ¶r K, Lehr S Over the last decade surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) has evolved as a versatile tool in the field of proteomic research. Although the chromatographic matrices on the currently provided SELDI affinity arrays allow efficient on-chip protein enrichment, it can be advantageous to combine SELDI with additional sample pre-fractionation steps. In this study, we demonstrate the potential of combining hydroxyapatite-based phosphoprotein enrichment with SELDI-TOF MS analysis. A straightforward method for the enrichment of phosphoproteins on ceramic hydroxyapatite was developed using fluorescently-labelled model proteins. Hydroxyapatite-based pre-fractionation of proteins derived from cell lysates was performed. SELDI-TOF MS analysis of the pre-fractionation eluate confirmed a considerable reduction of sample complexity and an enhancement of selected protein signals. PMID: 20726833 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：リン蛋白質の強化およびSELDI-TOF氏アーチのPhysiol hydroxyapatite基づかせていたBiochemの組合せによって側面図を描くリン蛋白質を目標とする関連の記事。 8月2010日23日; 著者: Vormbrock I、Kaber G、ハートウィグS、Eckel J、SchrÃ¶r K、最後の十年にわたるLehr Sはレーザーの脱着を表面高めたまたはイオン化時間の飛行質量分析(SELDI-TOF MS)はproteomic研究の分野の多目的な用具として展開した。 現在提供されたSELDIの類縁の配列のクロマトグラフのマトリックスが有効な破片蛋白質の強化を可能にするが、付加的なサンプル前分別のステップとSELDIを結合することは有利である場合もある。 この調査では、私達はSELDI-TOF MSの分析とhydroxyapatite基づかせていたリン蛋白質の強化を結合することの潜在性を示す。 陶磁器のhydroxyapatiteのリン蛋白質の強化のための簡単な方法は蛍光分類されたモデル蛋白質を使用して開発された。 細胞のlysatesから得られた蛋白質のHydroxyapatite基づかせていた前分別は行われた。 前分別の溶出液のSELDI-TOF MSの分析はサンプル複雑さのかなりの減少および指定蛋白質信号の強化を確認した。 PMID: -出版業者によって供給される… 20726833 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Amplification of CyclinL1 in uterine cervical carcinoma has prognostic implications.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-402.html</link>
      <description>Related Articles Amplification of CyclinL1 in uterine cervical carcinoma has prognostic implications. Mol Carcinog. 2010 Aug 18; Authors: Mitra S, Mazumder &apos; Indra &apos; D, Basu PS, Mondal RK, Roy A, Roychoudhury S, Panda CK The chromosomal 3q25.31 region was consistently amplified in primary cancer of cervix (CACX). CyclinL1 is a candidate gene of this region and already have been implicated as an oncogene in head and neck cancers. In this study, we aimed to investigate the involvement of CyclinL1  ...</description>
        <pubDate>Sun, 22 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-402.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Amplification of CyclinL1 in uterine cervical carcinoma has prognostic implications.
        Mol Carcinog. 2010 Aug 18;
        Authors:  Mitra S, Mazumder ' Indra ' D, Basu PS, Mondal RK, Roy A, Roychoudhury S, Panda CK
        The chromosomal 3q25.31 region was consistently amplified in primary cancer of cervix (CACX). CyclinL1 is a candidate gene of this region and already have been implicated as an oncogene in head and neck cancers. In this study, we aimed to investigate the involvement of CyclinL1 in cervical carcinogenesis and for this purpose its copy number variation (CNV) was studied in 23 cervical intraepithelial neoplasia (CIN) and 110 CACX samples. In CIN lesions CyclinL1 was not amplified; however, the amplification frequency was 16% (9/56) in stage I/II tumors which remained comparable during subsequent stages of tumorigenesis. This implied association of CyclinL1 amplification with development of early invasiveness. Quantitation of mRNA expression revealed 2.6 +/- 1.53-fold overexpression of this gene in primary CACX. The amplification/copy number gain of CyclinL1 and its mRNA profile were concordant, in tumors. Immunohistochemical (IHC) analysis in primary CACX, cell lines: SiHa and HeLa revealed intense nuclear expression of cyclinL1, which was further confirmed by Western blot in the cell lines. However 47% (7/15) CACX samples expressed high/intermediate level of cyclin L1. Kaplan-Meier survival analysis indicated CyclinL1 amplification as a determinant of poor patient outcome. Tumor radio-resistance developed as a consequence of CyclinL1 amplification. Cox multivariate analysis revealed that multiparous (>/=5) CACX patients with amplified CyclinL1 locus along with advanced tumor stage (III/IV) had worst prognosis. Our data suggest importance of CyclinL1 in cervical carcinogenesis with its associated pathways viz: pre-mRNA splicing, cell-cycle regulation (G(0)/G(1) and G(2)/M) being potential targets of therapeutic interventions in CACX. (c) 2010 Wiley-Liss, Inc.
        PMID: 20721974 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Genomics and Pharmacogenomics of Schizophrenia.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-401.html</link>
      <description>Related Articles Genomics and Pharmacogenomics of Schizophrenia. CNS Neurosci Ther. 2010 Aug 16; Authors: Cacabelos R, MartÃ?nez-Bouza R SUMMARY Schizophrenia (SCZ) is among the most disabling of mental disorders. Several neurobiological hypotheses have been postulated as responsible for SCZ pathogenesis: polygenic/multifactorial genomic defects, intrauterine and perinatal environment-genome interactions, neurodevelopmental defects, dopaminergic, cholinergic, serotonergic, gamma-aminobutiric a ...</description>
        <pubDate>Sun, 22 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-401.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Genomics and Pharmacogenomics of Schizophrenia.
        CNS Neurosci Ther. 2010 Aug 16;
        Authors:  Cacabelos R, MartÃ?nez-Bouza R
        SUMMARY Schizophrenia (SCZ) is among the most disabling of mental disorders. Several neurobiological hypotheses have been postulated as responsible for SCZ pathogenesis: polygenic/multifactorial genomic defects, intrauterine and perinatal environment-genome interactions, neurodevelopmental defects, dopaminergic, cholinergic, serotonergic, gamma-aminobutiric acid (GABAergic), neuropeptidergic and glutamatergic/N-Methyl-D-Aspartate (NMDA) dysfunctions, seasonal infection, neuroimmune dysfunction, and epigenetic dysregulation. SCZ has a heritability estimated at 60-90%. Genetic studies in SCZ have revealed the presence of chromosome anomalies, copy number variants, multiple single-nucleotide polymorphisms of susceptibility distributed across the human genome, aberrant single nucleotide polymorphisms (SNPs) in microRNA genes, mitochondrial DNA mutations, and epigenetic phenomena. Pharmacogenetic studies of psychotropic drug response have focused on determining the relationship between variation in specific candidate genes and the positive and adverse effects of drug treatment. Approximately, 18% of neuroleptics are major substrates of CYP1A2 enzymes, 40% of CYP2D6, and 23% of CYP3A4; 24% of antidepressants are major substrates of CYP1A2 enzymes, 5% of CYP2B6, 38% of CYP2C19, 85% of CYP2D6, and 38% of CYP3A4; 7% of benzodiazepines are major substrates of CYP2C19 enzymes, 20% of CYP2D6, and 95% of CYP3A4. About 10-20% of Western populations are defective in genes of the CYP superfamily. Only 26% of Southern Europeans are pure extensive metabolizers for the trigenic cluster integrated by the CYP2D6+CYP2C19+CYP2C9 genes. The pharmacogenomic response of SCZ patients to conventional psychotropic drugs also depends on genetic variants associated with SCZ-related genes. Consequently, the incorporation of pharmacogenomic procedures both to drugs in development and drugs on the market would help to optimize therapeutics in SCZ and other central nervous system (CNS) disorders.
        PMID: 20718829 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Amelioration of excess collagen IalphaI, fibrosis, and smooth muscle growth in TNBS-induced colitis in IGF-I(+/-) mice.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-400.html</link>
      <description>Amelioration of excess collagen IalphaI, fibrosis, and smooth muscle growth in TNBS-induced colitis in IGF-I(+/-) mice. Inflamm Bowel Dis. 2010 Aug 18; Authors: Mahavadi S, Flynn RS, Grider JR, Qiao LY, Murthy KS, Hazelgrove KB, Kuemmerle JF BACKGROUND:: Strictures occur in approximately 30% of patients with Crohn&apos;s disease (CD) and are characterized by intestinal smooth muscle hyperplasia, hypertrophy, and fibrosis due to excess extracellular matrix production including collagen. Insulin-like g ...</description>
        <pubDate>Sat, 21 Aug 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-400.html</guid>
        
      <content:encoded> <![CDATA[
    Amelioration of excess collagen IalphaI, fibrosis, and smooth muscle growth in TNBS-induced colitis in IGF-I(+/-) mice. Inflamm Bowel Dis. 2010 Aug 18; Authors: Mahavadi S, Flynn RS, Grider JR, Qiao LY, Murthy KS, Hazelgrove KB, Kuemmerle JF BACKGROUND:: Strictures occur in approximately 30% of patients with Crohn's disease (CD) and are characterized by intestinal smooth muscle hyperplasia, hypertrophy, and fibrosis due to excess extracellular matrix production including collagen. Insulin-like growth factor-I (IGF-I) expression is increased in smooth muscle cells of the muscularis propria in CD and in animal models of CD, including trinitrobenzene sulfonic acid (TNBS)-induced colitis. While upregulated IGF-I is conjectured to cause smooth muscle cell growth and collagen production in the inflamed intestine, its role in the development of fibrosis has not been directly demonstrated. METHODS:: Colitis was induced in IGF-I(+/-) or wildtype C57BL/6J mice by rectal administration of TNBS or ethanol vehicle. After 7 days, colonic smooth muscle cells were isolated and used to prepare RNA or protein lysates. Transcript levels of IGF-IEa, IGF binding protein (IGFBP)-3, IGFBP-5, TGF-beta1, and collagen IalphaI were measured by quantitative reverse-transcription polymerase chain reaction (RT-PCR). Corresponding protein levels were measured by Western blot or enzyme-linked immunosorbent assay (ELISA). Fibrosis was measured using digital image analysis of Masson's trichrome-stained histologic sections. RESULTS:: In IGF-I(+/-) mice, which express significantly lower levels of IGF-I than wildtype, the response to TNBS-induced colitis: upregulation of IGF-I, IGFBP-3, IGFBP-5 muscle growth, and collagen IalphaI expression, the resulting collagen deposition, and fibrosis are all significantly diminished compared to C57BL/6J wildtype controls. TGF-beta1 expression and its increase following TNBS administration are not altered in IGF-I(+/-) mice compared to wildtype. CONCLUSIONS:: The findings indicate that IGF-I is a key regulator in intestinal smooth muscle hyperplasia and excess collagen production that leads to fibrosis and long term to stricture formation. (Inflamm Bowel Dis 2010;). PMID: 20722057 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The influence of different land uses on the structure of archaeal communities in Amazonian anthrosols based on 16S rRNA and amoA genes.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-399.html</link>
      <description> Related Articles The influence of different land uses on the structure of archaeal communities in Amazonian anthrosols based on 16S rRNA and amoA genes. Microb Ecol. 2010 May;59(4):734-43 Authors: Taketani RG, Tsai SM Soil from the Amazonian region is usually regarded as unsuitable for agriculture because of its low organic matter content and low pH; however, this region also contains extremely rich soil, the Terra Preta Anthrosol. A diverse archaeal community usually inhabits acidic soils, suc ...</description>
        <pubDate>Fri, 20 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-399.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        The influence of different land uses on the structure of archaeal communities in Amazonian anthrosols based on 16S rRNA and amoA genes.
        Microb Ecol. 2010 May;59(4):734-43
        Authors:  Taketani RG, Tsai SM
        Soil from the Amazonian region is usually regarded as unsuitable for agriculture because of its low organic matter content and low pH; however, this region also contains extremely rich soil, the Terra Preta Anthrosol. A diverse archaeal community usually inhabits acidic soils, such as those found in the Amazon. Therefore, we hypothesized that this community should be sensitive to changes in the environment. Here, the archaeal community composition of Terra Preta and adjacent soil was examined in four different sites in the Brazilian Amazon under different anthropic activities. The canonical correspondence analysis of terminal restriction fragment length polymorphisms has shown that the archaeal community structure was mostly influenced by soil attributes that differentiate the Terra Preta from the adjacent soil (i.e., pH, sulfur, and organic matter). Archaeal 16S rRNA gene clone libraries indicated that the two most abundant genera in both soils were Candidatus nitrosphaera and Canditatus nitrosocaldus. An ammonia monoxygenase gene (amoA) clone library analysis indicated that, within each site, there was no significant difference between the clone libraries of Terra Preta and adjacent soils. However, these clone libraries indicated there were significant differences between sites. Quantitative PCR has shown that Terra Preta soils subjected to agriculture displayed a higher number of amoA gene copy numbers than in adjacent soils. On the other hand, soils that were not subjected to agriculture did not display significant differences on amoA gene copy numbers between Terra Preta and adjacent soils. Taken together, our findings indicate that the overall archaeal community structure in these Amazonian soils is determined by the soil type and the current land use.
        PMID: 20204349 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The Drosophila DPP signal is produced by cleavage of its proprotein at evolutionary diversified furin-recognition sites.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-151.html</link>
      <description> Related Articles The Drosophila DPP signal is produced by cleavage of its proprotein at evolutionary diversified furin-recognition sites. Proc Natl Acad Sci U S A. 2009 May 26;106(21):8501-6 Authors: KÃ?nnapuu J, BjÃ¶rkgren I, Shimmi O Maturation of bone morphogenetic proteins (BMPs) requires cleavage of their precursor proteins by furin-type proprotein convertases. Here, we find that cleavage sites of the BMP2/4/decapentaplegic (DPP) subfamily have been evolutionary diversified and can be ...</description>
        <pubDate>Thu, 19 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-151.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles The Drosophila DPP signal is produced by cleavage of its proprotein at evolutionary diversified furin-recognition sites. Proc Natl Acad Sci U S A. 2009 May 26;106(21):8501-6 Authors: KÃ?nnapuu J, BjÃ¶rkgren I, Shimmi O Maturation of bone morphogenetic proteins (BMPs) requires cleavage of their precursor proteins by furin-type proprotein convertases. Here, we find that cleavage sites of the BMP2/4/decapentaplegic (DPP) subfamily have been evolutionary diversified and can be categorized into 4 different types. Cnidaria BMP2/4/DPP is considered to be a prototype containing only 1 furin site. Bilateria BMP2/4/DPP acquired an additional cleavage site with either the combination of minimal-optimal or optimal-optimal furin sites. DPPs belonging to Diptera, such as Drosophila and mosquito, and Lepidoptera of silkworm contain a third cleavage site between the 2 optimal furin sites. We studied how the 3 furin sites (FSI-III) of Drosophila DPP coordinate maturation of ligands and contribute to signals in vivo. Combining mutational analysis of furin-recognition sites and RNAi experiments, we found that the Drosophila DPP precursor is initially cleaved at an upstream furin-recognition site (FSII), with consequent cleavages at 2 furin sites (FSI and FSIII). Both Dfurin1 and Dfurin2 are involved in the processing of DPP proproteins. Biochemical and genetic analyses using cleavage mutants of DPP suggest the first cleavage at FSII to be critical and sufficient for long-range DPP signaling. Our data suggest that the Drosophila DPP precursor is cleaved in a different manner from vertebrate BMP4 even though they are functional orthologs. This indicates that the furin-cleavage sites in BMP2/4/DPP precursors are tolerant to mutations acquired through evolution and have adapted to different systems in diversified species. PMID: 19433798 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：  関連の記事は発展の多様化させたfurin認識の場所のproproteinの開裂によってショウジョウバエDPP信号作り出される。 Proc国民のAcad Sci米国。 5月2009日26日; 106 (21): 8501-6書く: KÃの?のnnapuu J、BjÃ¶rkgren Iの骨のmorphogenetic蛋白質(BMPs)のShimmi Oの成熟はfurinタイプproproteinのconvertasesによって前駆物質蛋白質の開裂を要求する。 ここでは、私達はBMP2/4/decapentaplegic (DPP)のsubfamilyの開裂の場所が発展の多様化させて分り、4つのタイプにことが分類することができる。 Cnidaria BMP2/4/DPPは1つのfurinの場所だけ含んでいるプロトタイプであると考慮される。 Bilateria BMP2/4/DPPは最低最適か最適最適のfurinの場所の組合せを用いる付加的な開裂の場所を得た。 ショウジョウバエのようなDipteraに、およびカ属するDPPsおよびカイコのLepidopteraは2つの最適のfurinの場所間の第3開裂の場所を含んでいる。 私達はいかにligandsのショウジョウバエDPPの等位の成熟の3つのfurinの場所(FSI-III)調査し、信号に生体内で貢献する。 furin認識の場所およびRNAiのmutational分析を結合することは実験する、ショウジョウバエDPPの前駆物質が2つのfurinの場所の必然的な開裂を用いる上流のfurin認識の場所(FSII)で最初に、裂かれることが私達は分った(FSIおよびFSIII)。 Dfurin1およびDfurin2は両方DPPのproproteinsの処理にかかわる。 DPPの開裂の突然変異体を使用して生化学的な、遺伝の分析はFSIIで長距離DPPシグナリングのために決定的、十分であるために最初の開裂を提案する。 私達のデータは機能orthologsであるのにショウジョウバエDPPの前駆物質が脊椎動物BMP4から別の方法で裂かれることを提案する。 これはBMP2/4/DPPの前駆物質のfurin開裂の場所が進化によって得られる突然変異に耐久性があり、多様化させた種の異なったシステムに合わせたことを示す。 PMID: 19433798 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Msx and dlx homeogene expression in epithelial odontogenic tumors.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-127.html</link>
      <description> Related Articles Msx and dlx homeogene expression in epithelial odontogenic tumors. J Histochem Cytochem. 2009 Jan;57(1):69-78 Authors: Ruhin-Poncet B, Ghoul-Mazgar S, Hotton D, Capron F, Jaafoura MH, Goubin G, Berdal A Epithelial odontogenic tumors are rare jaw pathologies that raise clinical diagnosis and prognosis dilemmas notably between ameloblastomas and clear cell odontogenic carcinomas (CCOCs). In line with previous studies, the molecular determinants of tooth development-amelogenin, Ms ...</description>
        <pubDate>Thu, 19 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-127.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Msx and dlx homeogene expression in epithelial odontogenic tumors. J Histochem Cytochem. 2009 Jan;57(1):69-78 Authors: Ruhin-Poncet B, Ghoul-Mazgar S, Hotton D, Capron F, Jaafoura MH, Goubin G, Berdal A Epithelial odontogenic tumors are rare jaw pathologies that raise clinical diagnosis and prognosis dilemmas notably between ameloblastomas and clear cell odontogenic carcinomas (CCOCs). In line with previous studies, the molecular determinants of tooth development-amelogenin, Msx1, Msx2, Dlx2, Dlx3, Bmp2, and Bmp4-were analyzed by RT-PCR, ISH, and immunolabeling in 12 recurrent ameloblastomas and in one case of CCOC. Although Msx1 expression imitates normal cell differentiation in these tumors, other genes showed a distinct pattern depending on the type of tumor and the tissue involved. In benign ameloblastomas, ISH localized Dlx3 transcripts and inconstantly detected Msx2 transcripts in epithelial cells. In the CCOC, ISH established a lack of both Dlx3 and Msx2 transcripts but allowed identification of the antisense transcript of Msx1, which imitates the same scheme of distribution between mesenchyme and epithelium as in the cup stage of tooth development. Furthermore, while exploring the expression pattern of signal molecules by RT-PCR, Bmp2 was shown to be completely inactivated in the CCOC and irregularly noticeable in ameloblastomas. Bmp4 was always expressed in all the tumors. Based on the established roles of Msx and Dlx transcription factors in dental cell fates, these data suggest that their altered expression is a proposed trail to explain the genesis and/or the progression of odontogenic tumors. PMID: 18854600 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：  関連の記事Msxおよび上皮性のodontogenic腫瘍のdlxのhomeogeneの表現。 J Histochem Cytochem。 1月2009日; 57 (1): 69-78書く: Ruhin-Poncet Bの悪鬼Mazgar S、Hotton D、Capron F、Jaafoura MH、Goubin G、Berdalは上皮性のodontogenic腫瘍ameloblastomasと明確な細胞のodontogenic癌腫(CCOCs)の間で臨床診断および予想のジレンマを特に上げるまれな顎の病理学である。 前の調査と一直線に、歯の開発amelogenin、Msx1、Msx2、Dlx2、Dlx3、Bmp2の分子決定要因は12再発ameloblastomasとCCOCの1つの場合のRT-PCR、ISH、およびimmunolabelingによって、Bmp4分析され。 Msx1表現がこれらの腫瘍の正常な細胞分化を模倣するが、他の遺伝子は腫瘍およびティッシュのタイプによる明瞭なパターンが含んだことを示した。 温和なameloblastomasでは、ISHはDlx3コピーを集中させ、不定に上皮細胞のMsx2コピーを検出した。 CCOCでは、ISHはDlx3およびMsx2両方の欠乏をコピー確立したが、歯の発生のコップの段階のとmesenchymeと上皮間の配分の同じ機構を模倣するMsx1のantisenseコピーの同一証明を可能にした。 なお、信号の分子の表現パターンをRT-PCRによって探検している間、Bmp2がおよび不規則にameloblastomasで顕著完全にCCOCで不活性になるために示されていた。 Bmp4はすべての腫瘍に常に表現された。 歯科細胞の運命のMsxおよびDlxのトランスクリプションの確立された役割に基づいて要因は、これらのデータ変えられた表現がodontogenic腫瘍の起源や進行を説明する提案された道であることを提案する。 PMID: 18854600 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-143.html</link>
      <description> Related Articles NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development. J Cell Sci. 2009 Apr 15;122(Pt 8):1145-54 Authors: Hu Z, Wang C, Xiao Y, Sheng N, Chen Y, Xu Y, Zhang L, Mo W, Jing N, Hu G Heparan sulfate proteoglycans (HSPGs) are required for various signaling pathways, one of which is the bone morphogenetic protein (BMP) signaling pathway. N-deacetylase/N-sulfotransferase-1 (NDST1) participates in synthesizing heparan sulfate (HS) chains of HSP ...</description>
        <pubDate>Thu, 19 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-143.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development. J Cell Sci. 2009 Apr 15;122(Pt 8):1145-54 Authors: Hu Z, Wang C, Xiao Y, Sheng N, Chen Y, Xu Y, Zhang L, Mo W, Jing N, Hu G Heparan sulfate proteoglycans (HSPGs) are required for various signaling pathways, one of which is the bone morphogenetic protein (BMP) signaling pathway. N-deacetylase/N-sulfotransferase-1 (NDST1) participates in synthesizing heparan sulfate (HS) chains of HSPGs, and is involved in bone and lung development. Here, we report that in spite of the redundant expression of Ndst2, Ndst3 and Ndst4 genes, Ndst1(-/-) mice display defective differentiation of lung cells and increased cell proliferation. Loss of Ndst1 in the lung enhances downstream BMP signaling in vivo. Noggin, which is an antagonist of BMP, can rescue the Ndst1(-/-) lung morphogenetic defects in explant cultures. Further studies in vitro indicated that loss of Ndst1 significantly impairs BMP internalization by decreasing BMP binding to endogenous HS. Exogenous heparin can rescue both the BMP signaling and BMP internalization abnormalities in Ndst1(-/-) lung. Thus, we propose that HS regulates BMP signaling by controlling the balance between BMP binding to HS, and that BMP receptors and NDST1-dependent modification are essential for this process. The results suggest that NDST1-dependent HS is essential for proper functioning of BMP in embryonic lung development. PMID: 19299468 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事のNDST1依存したheparanの硫酸塩は肺開発のBMPのシグナリングそして内面化を調整する。 Jの細胞Sci。 4月2009日15日; 122 (Pt 8): 1145-54書く: Hu Z、Wang C、シャオY、Sheng N、陳Y、Xu Y、チャンL、Mo W、Jing N、そのうちの一つ、proteoglycans (HSPGs)要求されるG Heparanがさまざまなシグナリング細道に硫酸塩のHuある骨morphogenetic蛋白質(BMP)シグナリング細道が。 N-deacetylase/N-sulfotransferase-1 (NDST1)はHSPGsのheparanの硫酸塩(HS)の鎖の総合に加わり、骨および肺開発にかかわる。 ここでは、私達はNdst2、Ndst3およびNdst4遺伝子の余分な表現にもかかわらず、Ndst1 () - /-マウス肺細胞および高められた細胞増殖の不完全な微分を表示しなさいことを報告する。 肺のNdst1の損失は下流BMPシグナリングを生体内で高める。 BMPの反対者であるNogginはexplant文化のNdst1 () - /-肺morphogenetic欠陥を救助できる。 それ以上の調査は生体外でNdst1の損失が内生HSに結合する減少BMPによってかなりBMPの内面化を損なうことを示した。 外因性のヘパリンは肺のBMPシグナリングおよびBMPの内面化の異常を両方Ndst1 () - /-救助できる。 従って、私達は調整すること、そしてBMPの受容器およびNDST1依存した修正がこのプロセスことをのために必要HSがHSに結合するBMP間のバランスの制御によってBMPシグナリングをであることを提案する。 結果はNDST1依存したHSが萌芽期の肺開発のBMPの適切な作用のために必要であることを提案する。 PMID: 19299468 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Bmp signaling is necessary and sufficient for ventrolateral endoderm specification in Xenopus.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-119.html</link>
      <description> Related Articles Bmp signaling is necessary and sufficient for ventrolateral endoderm specification in Xenopus. Dev Dyn. 2008 Aug;237(8):2177-86 Authors: Wills A, Dickinson K, Khokha M, Baker JC Here we show that Bmp signaling is necessary and sufficient for the specification of ventral endoderm in Xenopus embryos. Overexpression of Bmp4 in ectoderm induces markers of endoderm, including Sox17beta, Mixer, and VegT, but cannot induce the expression of the dorsoanterior markers, Xhex and Cerberus ...</description>
        <pubDate>Thu, 19 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-119.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Bmp signaling is necessary and sufficient for ventrolateral endoderm specification in Xenopus. Dev Dyn. 2008 Aug;237(8):2177-86 Authors: Wills A, Dickinson K, Khokha M, Baker JC Here we show that Bmp signaling is necessary and sufficient for the specification of ventral endoderm in Xenopus embryos. Overexpression of Bmp4 in ectoderm induces markers of endoderm, including Sox17beta, Mixer, and VegT, but cannot induce the expression of the dorsoanterior markers, Xhex and Cerberus. Furthermore, knockdown approaches using overexpression of Bmp antagonists and morpholinos designed against Bmp4, Bmp2, and Bmp7 demonstrate that Bmp signaling is critical for ventral, but not dorsoanterior endoderm formation. This activity is not simply a result of embryonic dorsalization as markers for dorsal endoderm are not expanded. We further show that endodermal cells of either ventral or dorsal character do not form when both Wnt and Bmp signals are abolished. Overall, this report strongly suggests that Bmp plays an essential role in ventral endoderm specification. PMID: 18651654 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事BmpシグナリングはXenopusのventrolateral内胚葉の指定のために必要、十分である。 Dev Dyn。 8月2008日; 237 (8): 2177-86書く: 意志A、Dickinson K、Khokha Mのここのパン屋JC私達はBmpシグナリングがXenopusの胚の腹部の内胚葉の指定のために必要、十分であることを示す。 ectodermのBmp4のOverexpressionは内胚葉のマーカーを、Sox17betaを含んで、ミキサーおよびVegT引き起こしたり、dorsoanteriorのマーカー、XhexおよびCerberusの表現を引き起こすことができない。 なお、Bmpの反対者およびmorpholinosのoverexpressionを使用して打撃のアプローチはBmp4、Bmp2に対して設計し、Bmpシグナリングが腹部のために重大である、しかしないdorsoanteriorの内胚葉の形成示すことをBmp7は。 この活動は背面の内胚葉のためのマーカーが拡大されないので萌芽期のdorsalizationの結果単にではない。 私達は更にWntおよびBmp両方信号が廃止されるとき腹部か背面の特性のendodermal細胞が形作らないことを示す。 全体的にみて、このレポートは強くBmpが腹部の内胚葉の指定の必要な役割を担うことを提案する。 PMID: 18651654 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Temporomandibular joint ankylosis caused by chondroid hyperplasia from the callus of condylar neck fracture.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-135.html</link>
      <description> Related Articles Temporomandibular joint ankylosis caused by chondroid hyperplasia from the callus of condylar neck fracture. J Craniofac Surg. 2009 Jan;20(1):240-2 Authors: Kim SM, Park JM, Kim JH, Kwon KJ, Park YW, Lee JH, Lee SS, Lee SK A patient who complained of difficulty in opening his mouth after condylar neck fracture 1 year ago presented typical features of temporomandibular joint ankylosis in clinical and radiologic examinations. To demonstrate a possible pathogenesis of temporomandi ...</description>
        <pubDate>Thu, 19 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-135.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Temporomandibular joint ankylosis caused by chondroid hyperplasia from the callus of condylar neck fracture. J Craniofac Surg. 2009 Jan;20(1):240-2 Authors: Kim SM, Park JM, Kim JH, Kwon KJ, Park YW, Lee JH, Lee SS, Lee SK A patient who complained of difficulty in opening his mouth after condylar neck fracture 1 year ago presented typical features of temporomandibular joint ankylosis in clinical and radiologic examinations. To demonstrate a possible pathogenesis of temporomandibular joint ankylosis after condylar neck fracture, the fractured condylar portion removed was examined by histologic and immunohistochemical stainings. Interpositional gap arthroplasty was performed by removing the inferomesially displaced fractured condyle, and reconstruction with subcutaneous dermis to the previous vertical height was performed immediately. The fractured condylar portion was almost intact with slight erosion of the condylar cartilage. In the hematoxylin and eosin and Masson trichrome stainings, an extensive chondroid hyperplasia with abundant hyaline cartilage was shown in the removed condylar portion. There were also hyperplastic features of the synovial membrane, which were abnormally distributed throughout the chondroid tissues. In the immunohistochemical stainings of proliferating cell nuclear antigen (PCNA) and bone morphogenetic protein (BMP)-2 and BMP-4, the chondroid tissues were conspicuously hyperplastic and strongly positive for BMP-4 but sparse for BMP-2. From these results, we think that the hyperplastic chondroid tissue was derived from the callus of the primary fractured site of the condylar neck and propose that the chondroid tissue could proliferate continuously because of synovial tissue support from around the temporomandibular joint, resulting in temporomandibular joint ankylosis. This pathogenesis is quite different from those of other diaphyseal fracture of long bones. PMID: 19165036 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： condylar首のひびのカルスからのchondroid増殖によって引き起こされる関連の記事のTemporomandibular接合箇所の関節の硬直。 J Craniofac Surg。 1月2009日; 20 (1): 240-2書く: 金SMの公園JM、金JH、Kwon KJの公園YW、リーJH、リーSSの前にcondylar首のひびの後で彼の口を臨床およびradiologic検査のtemporomandibular接合箇所の関節の硬直の1年の開けることの難しさの示された典型的な特徴不平を言ったリーSK Aの患者。 condylar首のひびの後でtemporomandibular接合箇所の関節の硬直の可能な病因を示すためには、取除かれた折られたcondylar部分は組織学的およびimmunohistochemical stainingsによって検査された。 Interpositionalのギャップの関節形成はinferomesially転置された折られた関節丘を取除くことによって行われ、前の縦の高さへのsubcutaneous皮膚との復元はすぐに行われた。 折られたcondylar部分はcondylar軟骨のわずかな腐食とほとんどそのままだった。 Massonのhematoxylinおよびエオシンおよびtrichrome stainingsでは、豊富なガラス質軟骨を搭載する広範なchondroid増殖は取除かれたcondylar部分で示されていた。 またchondroidティッシュ中異常に配られたsynovial膜のhyperplastic特徴があった。 増殖の細胞の核抗原(PCNA)および骨のmorphogenetic蛋白質(BMP)のimmunohistochemical stainingsでは- 2つおよびBMP-4は、chondroidティッシュBMP-4のための著しくhyperplasticおよび強く陽性しかしBMP-2のための希薄でありではなかった。 これらの結果から、私達はhyperplastic chondroidティッシュがcondylar首の第一次折られた場所のカルスから得られた考え、temporomandibular接合箇所の関節の硬直に終ってとchondroidティッシュがtemporomandibular接合箇所のまわりでからのsynovialティッシュサポートのために絶えず増殖できることを提案する。 この病因は長い骨の他のdiaphysealひびのそれらとかなり異なっている。 PMID: 19165036 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Involvement of cytoskeleton-associated proteins in the commitment of C3H10T1/2 pluripotent stem cells to adipocyte lineage induced by BMP2/4.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-203.html</link>
      <description>Involvement of cytoskeleton-associated proteins in the commitment of C3H10T1/2 pluripotent stem cells to adipocyte lineage induced by BMP2/4. Mol Cell Proteomics. 2010 Aug 16; Authors: Huang HY, Hu LL, Song TJ, Li X, He Q, Sun X, Li YM, Lu HJ, Yang PY, Tang QQ The developmental pathway that gives rise to mature adipocytes involves two distinct stages: commitment and terminal differentiation. Although the important proteins/factors contributing to terminal adipocyte differentiation have been well ...</description>
        <pubDate>Thu, 19 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-203.html</guid>
        
      <content:encoded> <![CDATA[
    Involvement of cytoskeleton-associated proteins in the commitment of C3H10T1/2 pluripotent stem cells to adipocyte lineage induced by BMP2/4. Mol Cell Proteomics. 2010 Aug 16; Authors: Huang HY, Hu LL, Song TJ, Li X, He Q, Sun X, Li YM, Lu HJ, Yang PY, Tang QQ The developmental pathway that gives rise to mature adipocytes involves two distinct stages: commitment and terminal differentiation. Although the important proteins/factors contributing to terminal adipocyte differentiation have been well defined, the proteins/factors in commitment of mesenchymal stem cells (MSCs) to the adipocyte lineage cells have not. In this study, we applied proteomic analysis profiling to characterize differences between uncommitted C3H10T1/2 pluripotent stem cells and those which have been committed to adipocyte lineage by BMP4 or BMP2 with the goal to identify such proteins/factors and to understand the molecular mechanisms that govern the earliest stages of adipocyte lineage commitment. 8 proteins were found to be up-regulated by BMP2 and 27 proteins were up-regulated by BMP4, while a total of 5 unique proteins were up-regulated at least 10-fold by both BMP2/4, including 3 cytoskeleton-associated proteins (i.e. lysyl oxidase (Lox), translationally-controlled tumor protein 1 (Tpt1) and alphaB crystallin). Western blotting further confirmed the induction of the expression of these cytoskeleton-associated proteins in the committed C3H10T1/2 induced by BMP2/4. Importantly knock-down of Lox expression totally prevented the commitment, while knock-down of Tpt1 and alphaB crystallin expression partially inhibit the commitment. Several published reports suggest that cell shape can influence the differentiation of partially committed precursors of adipocytes, osteoblasts, and chondrocytes, we observed a dramatic change of cell shape during the commitment process, and we showed that knockdown of these cytoskeleton-associated proteins prevented the cell shape change and restored F-actin organization into stress fiber and inhibited the commitment to adipocyte lineage. Our studies indicate that these differentially expressed cytoskeleton-associate proteins might determine the fate of MSCs to commit to adipocyte lineage through cell shape regulation. PMID: 20713452 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A proteomic analysis reveals differential regulation of the {sigma}S-dependent yciGFE(katN) locus by YncC and H-NS in Salmonella and Escherichia coli K-12.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-229.html</link>
      <description>Related Articles A proteomic analysis reveals differential regulation of the {sigma}S-dependent yciGFE(katN) locus by YncC and H-NS in Salmonella and Escherichia coli K-12. Mol Cell Proteomics. 2010 Aug 16; Authors: Beraud M, Kolb A, Monteil V, D&apos;Alayer J, Norel F The stationary phase sigma factor sigmaS (RpoS) controls a regulon required for general stress resistance of the closely related enterobacteria Salmonella and Escherichia coli. The sigmaS-dependent yncC gene encodes a putative DNA bind ...</description>
        <pubDate>Thu, 19 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-229.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles A proteomic analysis reveals differential regulation of the {sigma}S-dependent yciGFE(katN) locus by YncC and H-NS in Salmonella and Escherichia coli K-12. Mol Cell Proteomics. 2010 Aug 16; Authors: Beraud M, Kolb A, Monteil V, D'Alayer J, Norel F The stationary phase sigma factor sigmaS (RpoS) controls a regulon required for general stress resistance of the closely related enterobacteria Salmonella and Escherichia coli. The sigmaS-dependent yncC gene encodes a putative DNA binding regulatory protein. Application of the Surface-Enhanced Laser Desorption/Ionization -time of flight (SELDI-TOF) ProteinChip technology for proteome profiling of wild-type and mutant strains of Salmonella enterica serovar Typhimurium revealed potential protein targets for YncC regulation, which were identified by mass spectrometry, and subsequently validated. These proteins are encoded by the sigmaS-dependent operon yciGFEkatN and regulation of their expression by YncC operates at the transcriptional level, as demonstrated by gene fusion analyses and by in vitro transcription and DNase I footprinting experiments with purified YncC. The yciGFE genes are present (without katN) in E. coli K-12 but are poorly expressed, compared to the situation in Salmonella. We report that the yciGFE(katN) locus is silenced by the histone-like protein H-NS in both species, but that sigmaS efficiently relieves silencing in Salmonella but not in E. coli K-12. In Salmonella, YncC acts in concert with sigmaS to activate transcription at the yciG promoter (pyciG). When overproduced, YncC also activated sigmaS-dependent transcription at pyciG in E. coli K-12, but solely by countering the negative effect of H-NS. Our results indicate that differences between Salmonella and E. coli K-12, in the architecture of cis-acting regulatory sequences upstream of pyciG, contribute to the differential regulation of the yciGFE(katN) genes by H-NS and YncC in these two enterobacteria. In E. coli, this locus is subject to gene rearrangements and also likely to horizontal gene transfer, consistent with its repression by the xenogeneic silencer H-NS. PMID: 20713450 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Effects of Post-Mortem Intervals on Regional Brain Protein Profiles in Rats using SELDI-TOF MS Analysis.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-227.html</link>
      <description>Effects of Post-Mortem Intervals on Regional Brain Protein Profiles in Rats using SELDI-TOF MS Analysis. Neurochem Int. 2010 Aug 10; Authors: Machaalani R, Gozal E, Berger F, Waters KA, Dematteis M Identification of disease-associated proteins is critical for elucidating CNS disease mechanisms and elaborating novel treatment strategies. It requires post-mortem tissue analysis which can be significantly affected by the collection process, post-mortem intervals (PMI), and storage conditions. To as ...</description>
        <pubDate>Wed, 18 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-227.html</guid>
        
      <content:encoded> <![CDATA[
    Effects of Post-Mortem Intervals on Regional Brain Protein Profiles in Rats using SELDI-TOF MS Analysis. Neurochem Int. 2010 Aug 10; Authors: Machaalani R, Gozal E, Berger F, Waters KA, Dematteis M Identification of disease-associated proteins is critical for elucidating CNS disease mechanisms and elaborating novel treatment strategies. It requires post-mortem tissue analysis which can be significantly affected by the collection process, post-mortem intervals (PMI), and storage conditions. To assess the effect of time and storage conditions on brain protein stability, SELDI-TOF-MS protein profiles were assessed in rat frontal cortex, caudate-putamen, hippocampus and medulla samples collected after various PMIs (0, 6, 12, 24, 48, and 72h) at 4 degrees C or at room temperature (RT) storage. Regions of interest were isolated from cryosections (tissue apposition, TA), or micropunched from cryosections apposed on filter paper (paper apposition, PA), and applied onto an NP20 proteinchip array. Protein alterations, while greater at RT than at 4 degrees C, were detected at 6h then differentially evolved in the various brain regions, with greater alterations in the caudate putamen (60%) and the cortex (48%). Overall, our sensitive analytical method allowed unveiling of different patterns of protein susceptibility to PMI and to storage temperature in the various brain regions. Some protein peaks were altered in all brain regions and may potentially serve as markers of the PMI status of the brain, or for reference values when studying new proteins. Changes in disease-related proteins within post-mortem samples can be greatly affected by PMI and storage conditions, particularly when studying fragile and/or low abundant protein/peptides in tissues sampled from the caudate-putamen and neocortex. PMID: 20708053 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： SELDI-TOF MSの分析を使用してラットの地方頭脳蛋白質のプロフィールに対する死後間隔の効果。 Neurochem Int。 8月2010日10日; 著者: Machaalani R、Gozal E、Berger Fの水KA、病気準蛋白質のDematteis Mの同一証明はCNSの病気のメカニズムおよび詳しく説明する新しい処置の作戦を明瞭にするために重大である。 それはコレクションプロセス、死後間隔(PMI)、および貯蔵条件によってかなり影響されることができる死後のティッシュの分析を要求する。 頭脳蛋白質の安定性に対する時間および貯蔵条件の効果を査定するためには、SELDI-TOF-MS蛋白質のプロフィールはさまざまなPMIs (0、6、12、24、48、および72h)の後で集められたラットの前頭皮質、caudateputamen、海馬および髄質のサンプルで4つの摂氏温度または室温(RT)の貯蔵で査定された。 興味の地域はcryosections (ティッシュの同格、TA)から隔離された、またはcryosectionsからmicropunchedフィルターペーパー(ペーパー同格、PA)で並置し、NP20 proteinchipの配列に適用した。 蛋白質の変化は特異的にさまざまな頭脳の地域で展開した6hで、間4つの摂氏温度でよりRTで大きい、それから検出されたcaudateのより大きい変化と(60%)および皮質(48%) putamen。 全体的にみて、私達の敏感で分析的な方法はPMIとさまざまな頭脳の地域の保管温度への蛋白質の感受性の異なったパターンのベールを取ることを可能にした。 ある蛋白質のピークはすべての頭脳の地域で新しい蛋白質を調査するとき変わり、頭脳の、または基準値のためのPMIの状態のマーカーとして可能性としては役立つかもしれない。 caudateputamenおよびneocortexからの組織サンプルの死後のサンプル内の病気関係した蛋白質の変更は特に壊れやすくおよび/または低く豊富な蛋白質かペプチッドを調査するときPMIによっておよび貯蔵条件非常に影響されることができる。 PMID: -出版業者によって供給される… 20708053 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Is SELDI-TOF a valid tool for diagnostic biomarkers?</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-228.html</link>
      <description>Is SELDI-TOF a valid tool for diagnostic biomarkers? Trends Parasitol. 2010 Aug 12; Authors: Ndao M, Rainczuk A, Rioux MC, Spithill TW, Ward J The genome revolution is providing fresh insights into host and parasite genomes, and new tools are becoming available for examining host-parasite interactions at the proteome level. Technologies such as surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry (MS) can be applied to discover biomarkers (alterations in both ...</description>
        <pubDate>Wed, 18 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-228.html</guid>
        
      <content:encoded> <![CDATA[
    Is SELDI-TOF a valid tool for diagnostic biomarkers? Trends Parasitol. 2010 Aug 12; Authors: Ndao M, Rainczuk A, Rioux MC, Spithill TW, Ward J The genome revolution is providing fresh insights into host and parasite genomes, and new tools are becoming available for examining host-parasite interactions at the proteome level. Technologies such as surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry (MS) can be applied to discover biomarkers (alterations in both host and parasite proteomes) associated with parasitic diseases. Such biomarkers can represent host proteins, fragments of host proteins or parasite proteins that appear in body fluids or tissues following infection. Individual biomarkers or biomarker patterns not only have diagnostic utility (e.g. in active disease, prognosis, tests of cure) but can also provide unique insights into the mechanisms underlying host responses and pathogenesis. PMID: 20708969 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： SELDI-TOFは診断biomarkersのための有効な用具であるか。 傾向Parasitol。 8月2010日12日; 著者: Ndao M、Rainczuk A、Rioux MC、Spithill TWの区Jはホストおよび寄生虫のゲノムにゲノムの回転新しい洞察力を提供して、新しいツールはproteomeのレベルでhost-parasite相互作用を検査するために利用できるようになっている。 表面高められたレーザーの脱着またはイオン化時間の飛行(SELDI-TOF)質量分析(MS)のような技術は寄生病気と関連付けられるbiomarkers (ホストおよび寄生虫の両方proteomesの変化)を発見するために適用することができる。 そのようなbiomarkersは伝染の後の体液かティッシュで現われるホスト蛋白質のホスト蛋白質、片をまたは寄生虫蛋白質を表すことができる。 個々のbiomarkersかbiomarkerパターンはまたホストの応答および病因の下にあるメカニズムにただ診断実用性を持つために(例えば治療の活動的な病気、予想、テストで)しかし独特な洞察力を提供できる。 PMID: -出版業者によって供給される… 20708969 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>バイオ創薬研究・特集コラム「機能性食品開発：自然免疫賦活素材の評価と免疫食品の開発」コンテンツ更新</title>
  <link>http://biomarket.jp/modules/bulletin/index.php?page=article&amp;storyid=32</link>
      <description>バイオ創薬研究・特集コラム「機能性食品開発：自然免疫賦活素材の評価と免疫食品の開発」に新規コンテンツ「自然免疫研究の再出発：TLR (toll like receptor: トル様受容体)の発見」が追加されました。</description>
        <pubDate>Tue, 17 Aug 2010 11:30:56 +0900</pubDate>
        <guid>http://biomarket.jp/modules/bulletin/index.php?page=article&amp;storyid=32</guid>
        <category>General</category>
      
      <content:encoded> <![CDATA[
    バイオ創薬研究・特集コラム「機能性食品開発：自然免疫賦活素材の評価と免疫食品の開発」に新規コンテンツ「自然免疫研究の再出発：TLR (toll like receptor: トル様受容体)の発見」が追加されました。
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-353.html</link>
      <description>Related Articles Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat. Mol Cancer. 2010 Aug 12;9(1):215 Authors: Fang M, Dewaele S, Zhao YP, Starkel P, Vanhooren V, Chen YM, Ji X, Luo M, Sun BM, Horsmans Y, Dell A, Haslam SM, Grassi P, Libert C, Gao CF, Chen CC ABSTRACT: BACKGROUND: There is a demand for serum markers for the routine assessment of the progression of liver cancer. We previously found that serum N-linked sugar chains are altered in h ...</description>
        <pubDate>Sun, 15 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-353.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat. Mol Cancer. 2010 Aug 12;9(1):215 Authors: Fang M, Dewaele S, Zhao YP, Starkel P, Vanhooren V, Chen YM, Ji X, Luo M, Sun BM, Horsmans Y, Dell A, Haslam SM, Grassi P, Libert C, Gao CF, Chen CC ABSTRACT: BACKGROUND: There is a demand for serum markers for the routine assessment of the progression of liver cancer. We previously found that serum N-linked sugar chains are altered in hepatocellular carcinoma (HCC). Here, we studied glycomics during development of HCC in a rat model. RESULTS: Rat HCC was induced by the hepatocarcinogen, diethylnitrosamine (DENA). N-glycans were profiled using the DSA-FACE technique developed in our laboratory. In comparison with control rats, DENA rats showed a gradual but significant increase in two glycans (R5a and R5b) in serum total N-glycans during progression of liver cirrhosis and cancer, and a decrease in a biantennary glycan (P5). The log of the ratio of R5a to P1 (NGA2F) and R5b to P1 [log(R5a/P1) and log(R5b/P1)] were significantly (p<0.0001) elevated in HCC rats, but not in rats with cirrhosis or fibrosis or in control rats. We thus propose a GlycoTest model using the above-mentioned serum glycan markers to monitor the progression of cirrhosis and HCC in the DENA-treated rat model. When DENA-treated rats were subsequently treated with farnesylthiosalicyclic acid, an anticancer drug, progression to HCC was prevented and GlycoTest markers (P5, R5a and R5b) reverted towards non-DENA levels, and the HCC-specific markers, log(R5a/P1) and log(R5b/P1), normalized completely. Conclusions: We found an increase in core-alpha-1,6-fucosylated glycoproteins in serum and liver of rats with HCC, which demonstrates that fucosylation is altered during progression of HCC. Our GlycoTest model can be used to monitor progression of HCC and to follow up treatment of liver tumors in the DENA rat. This GlycoTest model is particularly important because a rapid non-invasive diagnostic procedure for tumour progression in this rat model would greatly facilitate the search for anticancer drugs. PMID: 20704698 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Selected summaries from the XVII World Congress of Psychiatric Genetics, San Diego, California, USA, 4-8 November 2009.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-398.html</link>
      <description>Related Articles Selected summaries from the XVII World Congress of Psychiatric Genetics, San Diego, California, USA, 4-8 November 2009. Psychiatr Genet. 2010 Aug 11; Authors: Amstadter AB, Balachandar V, Bergen SE, Ceulemans S, Christensen JH, Cole J, De Luca V, Ducci F, Tee SF, Hartz S, Keers R, Medland S, Melas PA, MÃ?hleisen TW, Ozomaro U, Pidsley R, Scott AP, Sha L, Talati A, Teltsh O, VidetiÄ? A, Wang K, Wong CC, Delisi LE The XVII World Congress of Psychiatric Genetics, sponsored by T ...</description>
        <pubDate>Sun, 15 Aug 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-398.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Selected summaries from the XVII World Congress of Psychiatric Genetics, San Diego, California, USA, 4-8 November 2009.
        Psychiatr Genet. 2010 Aug 11;
        Authors:  Amstadter AB, Balachandar V, Bergen SE, Ceulemans S, Christensen JH, Cole J, De Luca V, Ducci F, Tee SF, Hartz S, Keers R, Medland S, Melas PA, MÃ?hleisen TW, Ozomaro U, Pidsley R, Scott AP, Sha L, Talati A, Teltsh O, VidetiÄ? A, Wang K, Wong CC, Delisi LE
        The XVII World Congress of Psychiatric Genetics, sponsored by The International Society of Psychiatric Genetics (ISPG) took place in San Diego, California from 4 to 8 November 2009. Approximately 550 participants gathered to discuss the latest molecular genetic findings relevant to serious mental illness, including schizophrenia, mood disorders, substance abuse, autism, and attention deficit disorder. Recent advances in the field were discussed, including the genome-wide association studies results, copy number variation (CNV) in the genome, genomic imaging, and large multicenter collaborations. The following report, written by junior travel awardees who were assigned sessions as rapporteurs represents some of the areas covered in oral presentation during the conference, and reports on some of the notable major new findings described at this 2009 World Congress of Psychiatric Genetics.
        PMID: 20706171 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteomic Analysis of PichindÃ© virus Infection Identifies Differential Expression of Prothymosin-alpha.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-226.html</link>
      <description>Proteomic Analysis of PichindÃ© virus Infection Identifies Differential Expression of Prothymosin-alpha. J Biomed Biotechnol. 2010;2010: Authors: Bowick GC, Soman KV, Wang H, Aronson JF, Luxon BA, Lomas LO, Gorenstein DG, Herzog NK The arenaviruses include a number of important pathogens including Lassa virus and Junin virus. Presently, the only treatment is supportive care and the antiviral Ribavirin. In the event of an epidemic, patient triage may be required to more effectively manage res ...</description>
        <pubDate>Sun, 15 Aug 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-226.html</guid>
        
      <content:encoded> <![CDATA[
    Proteomic Analysis of PichindÃ© virus Infection Identifies Differential Expression of Prothymosin-alpha. J Biomed Biotechnol. 2010;2010: Authors: Bowick GC, Soman KV, Wang H, Aronson JF, Luxon BA, Lomas LO, Gorenstein DG, Herzog NK The arenaviruses include a number of important pathogens including Lassa virus and Junin virus. Presently, the only treatment is supportive care and the antiviral Ribavirin. In the event of an epidemic, patient triage may be required to more effectively manage resources; the development of prognostic biomarker signatures, correlating with disease severity, would allow rational triage. Using a pair of arenaviruses, which cause mild or severe disease, we analyzed extracts from infected cells using SELDI mass spectrometry to characterize potential biomarker profiles. EDGE analysis was used to analyze longitudinal expression differences. Extracts from infected guinea pigs revealed protein peaks which could discriminate between mild or severe infection, and between times post-infection. Tandem mass-spectrometry identified several peaks, including the transcriptional regulator prothymosin-alpha. Further investigation revealed differences in secretion of this peptide. These data show proof of concept that proteomic profiling of host markers could be used as prognostic markers of infectious disease. PMID: 20706531 [PubMed - in process]（【斜め読み用】機械翻訳： PichindÃ©のウイルスの伝染のProteomicの分析はProthymosinアルファの差動表現を識別する。 J Biomed Biotechnol。 2010年; 2010年: 著者: BowickのGC、ソマンKV、Wang H、Aronson JFのLuxonのBA、ローマスLO、Gorenstein DG、Herzog NKはarenaviruses LassaのウイルスおよびJuninのウイルスを含むいくつかの重要な病原体が含まれている。 現在、唯一の処置は支える心配および抗ウィルス性のRibavirinである。 伝染病の場合に、忍耐強いトリアージはもっと効果的に管理する資源をに要求されるかもしれない; 病気の厳格に関連する予想biomarkerの署名の開発は理性的なトリアージを可能にする。 穏やかか厳しい病気を引き起こす組のarenavirusesを使用して、私達はSELDIの質量分析を使用して潜在的なbiomarkerのプロフィールを特徴付けるために感染させた細胞からのエキスを分析した。 端の分析が縦方向の表現の相違を分析するのに使用された。 感染させたモルモットからのエキスは穏やかか厳しい伝染の間で区別できるおよび明らかにした時のポスト伝染間の蛋白質のピークを。 タンデム固まり分光測定はtranscriptional調整装置のprothymosinアルファを含む複数のピークを、識別した。 より詳しい調査はこのペプチッドの分泌の相違を明らかにした。 これらのデータはホストのマーカーのproteomic側面図を描くことが感染症の予想マーカーとして使用できる概念実証を示す。 PMID: 20706531 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Genome-wide association analysis of copy number variations in subarachnoid aneurysmal hemorrhage.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-397.html</link>
      <description>Related Articles Genome-wide association analysis of copy number variations in subarachnoid aneurysmal hemorrhage. J Hum Genet. 2010 Aug 12; Authors: Bae JS, Cheong HS, Park BL, Kim LH, Park TJ, Kim JY, Pasaje CF, Lee JS, Cui T, Inoue I, Shin HD Subarachnoid aneurysmal hemorrhage (SAH) due to cerebral aneurysm rupture is a very serious disease resulting in high mortality rate. It has been known that genetic factors are involved in the risk of SAH. A recent breakthrough in genomic variation calle ...</description>
        <pubDate>Sat, 14 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-397.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Genome-wide association analysis of copy number variations in subarachnoid aneurysmal hemorrhage.
        J Hum Genet. 2010 Aug 12;
        Authors:  Bae JS, Cheong HS, Park BL, Kim LH, Park TJ, Kim JY, Pasaje CF, Lee JS, Cui T, Inoue I, Shin HD
        Subarachnoid aneurysmal hemorrhage (SAH) due to cerebral aneurysm rupture is a very serious disease resulting in high mortality rate. It has been known that genetic factors are involved in the risk of SAH. A recent breakthrough in genomic variation called copy number variation (CNV) has been revealed to be involved in risks of human diseases. In this study, we hypothesized that CNVs can predict the risk of SAH. We used the Illumina HumanHap300 BeadChip (317 503 markers) to genotype 497 individuals in a Japanese population. Furthermore, individual CNVs were identified using signal and allelic intensities. The genetic effect of CNV on the risk of SAH was evaluated using multivariate logistic regression controlling for age and gender in 187 common CNV regions (frequency >1%). From a total of 4574 individual CNVs identified in this study (9.7 CNVs per individual), we were able to discover 1644 unique CNV regions containing 1232 genes. The identified variations were validated using visual examination of the genoplot image, overlapping analysis with the Database of Genomic Variants (73.2%), CNVpartition (72.4%) and quantitative PCR. Interestingly, two CNV regions, chr4:153210505-153212191 (deletion, 4q31.3, P=0.0005, P(corr) (corrected P-value)=0.04) and chr10:6265006-6267388 (duplication, 10p15.1, P=0.0006, P(corr)=0.05), were significantly associated with the risk of SAH after multiple testing corrections. Our results suggest that the newly identified CNV regions may contribute to SAH disease susceptibility.Journal of Human Genetics advance online publication, 12 August 2010; doi:10.1038/jhg.2010.97.
        PMID: 20703242 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Difference in larval type explains patterns of nonsynonymous substitutions in two ancient paralogs of the histone H3 gene in sea stars.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-395.html</link>
      <description> Related Articles Difference in larval type explains patterns of nonsynonymous substitutions in two ancient paralogs of the histone H3 gene in sea stars. Evol Dev. 2010 Mar;12(2):222-30 Authors: Foltz DW, Mah CL Paralogous genes frequently show differences in patterns and rates of substitution that are typically attributed to different selection regimes, mutation rates, or local recombination rates. Here, two anciently diverged paralogous copies of the histone H3 gene in sea stars, the tandem-re ...</description>
        <pubDate>Sat, 14 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-395.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Difference in larval type explains patterns of nonsynonymous substitutions in two ancient paralogs of the histone H3 gene in sea stars.
        Evol Dev. 2010 Mar;12(2):222-30
        Authors:  Foltz DW, Mah CL
        Paralogous genes frequently show differences in patterns and rates of substitution that are typically attributed to different selection regimes, mutation rates, or local recombination rates. Here, two anciently diverged paralogous copies of the histone H3 gene in sea stars, the tandem-repetitive early-stage gene and a newly isolated gene with lower copy number that was termed the "putative late-stage histone H3 gene" were analyzed in 69 species with varying mode of larval development. The two genes showed differences in relative copy number, overall substitution rates, nucleotide composition, and codon usage, but similar patterns of relative nonsynonymous substitution rates, when analyzed by the d(N)/d(S) ratio. Sea stars with a nonpelagic and nonfeeding larval type (i.e., brooding lineages) were observed to have d(N)/d(S) ratios that were larger than for nonbrooders but equal between the two paralogs. This finding suggested that demographic differences between brooding and nonbrooding lineages were responsible for the elevated d(N)/d(S) ratios observed for brooders and refuted a suggestion from a previous analysis of the early-stage gene that the excess nonsynonymous substitutions were due to either (1) gene expression differences at the larval stage between brooders and nonbrooders or (2) the highly repetitive structure of the early-stage histone H3 gene.
        PMID: 20433461 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Reconstructing CNV genotypes using segregation analysis: combining pedigree information with CNV assay.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-396.html</link>
      <description>Related Articles Reconstructing CNV genotypes using segregation analysis: combining pedigree information with CNV assay. Genet Sel Evol. 2010 Aug 12;42(1):34 Authors: Henshall JM, Whan VA, Norris BJ ABSTRACT: BACKGROUND: Repeated blocks of genome sequence have been shown to be associated with genetic diversity and disease risk in humans, and with phenotypic diversity in model organisms and domestic animals. Reliable tests are desirable to determine whether individuals are carriers of copy number ...</description>
        <pubDate>Sat, 14 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-396.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Reconstructing CNV genotypes using segregation analysis: combining pedigree information with CNV assay.
        Genet Sel Evol. 2010 Aug 12;42(1):34
        Authors:  Henshall JM, Whan VA, Norris BJ
        ABSTRACT: BACKGROUND: Repeated blocks of genome sequence have been shown to be associated with genetic diversity and disease risk in humans, and with phenotypic diversity in model organisms and domestic animals. Reliable tests are desirable to determine whether individuals are carriers of copy number variants associated with disease risk in humans and livestock, or associated with economically important traits in livestock. In some cases, copy number variants affect the phenotype through a dosage effect but in other cases, allele combinations have non-additive effects. In the latter cases, it has been difficult to develop tests because assays typically return an estimate of the sum of the copy number counts on the maternally and paternally inherited chromosome segments, and this sum does not uniquely determine the allele configuration. In this study, we show that there is an old solution to this new problem: segregation analysis, which has been used for many years to infer alleles in pedigreed populations. METHODS: Segregation analysis was used to estimate copy number alleles from assay data on simulated half-sib sheep populations. Copy number variation at the Agouti locus, known to be responsible for the recessive self-colour black phenotype, was used as a model for the simulation and an appropriate penetrance function was derived. The precision with which carriers and non-carriers of the undesirable single copy allele could be identified, was used to evaluate the method for various family sizes, assay strategies and assay accuracies. RESULTS: Using relationship data and segregation analysis, the probabilities of carrying the copy number alleles responsible for black or white fleece were estimated with much greater precision than by analyzing assay results for animals individually. The proportion of lambs correctly identified as non-carriers of the undesirable allele increased from 7% when the lambs were analysed alone to 80% when the lambs were analysed in half-sib families. CONCLUSIONS: When a quantitative assay is used to estimate copy number alleles, segregation analysis of related individuals can greatly improve the precision of the estimates. Existing software for segregation analysis would require little if any change to accommodate the penetrance function for copy number assay data.
        PMID: 20701809 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Graphene-Based SELDI Probe with Ultrahigh Extraction and Sensitivity for DNA Oligomer.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-225.html</link>
      <description>Graphene-Based SELDI Probe with Ultrahigh Extraction and Sensitivity for DNA Oligomer. J Am Chem Soc. 2010 Aug 18;132(32):10976-7 Authors: Tang LA, Wang J, Loh KP We demonstrate that graphene can be used as an ultrahigh efficiency preconcentration and detection platform for ssDNA. DNA-adsorbed graphene can be used directly for Surface Enhanced Laser Desorption Ionization-Time of Flight-Mass Spectrometry (SELDI-TOF-MS). The rapid enrichment of biomolecules and direct, label-free detection are pot ...</description>
        <pubDate>Fri, 13 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-225.html</guid>
        
      <content:encoded> <![CDATA[
    Graphene-Based SELDI Probe with Ultrahigh Extraction and Sensitivity for DNA Oligomer. J Am Chem Soc. 2010 Aug 18;132(32):10976-7 Authors: Tang LA, Wang J, Loh KP We demonstrate that graphene can be used as an ultrahigh efficiency preconcentration and detection platform for ssDNA. DNA-adsorbed graphene can be used directly for Surface Enhanced Laser Desorption Ionization-Time of Flight-Mass Spectrometry (SELDI-TOF-MS). The rapid enrichment of biomolecules and direct, label-free detection are potentially useful for analysis in proteomics and genomics. PMID: 20698647 [PubMed - in process]（【斜め読み用】機械翻訳： 超高度の抽出が付いているGraphene基づかせていたSELDIの調査およびDNAのオリゴマーのための感受性。 J AM Chem Soc. 8月2010日18日; 132 (32): 10976-7書く: 独特の味のLA、Wang J、Loh KP私達はgrapheneがssDNAのために超高度の効率のpreconcentrationおよび検出のプラットホームとして使用することができることを示す。 DNA吸着されたgrapheneは飛行固まりの分光測定(SELDI-TOF-MS)の表面によって高められるレーザーの脱着のイオン化時間の間直接使用することができる。 biomoleculesの急速な強化および直接、分類自由な検出はproteomicsおよびゲノミクスに分析のために役に立ちそうである。 PMID: 20698647 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Long-term conservation vs high sequence divergence: the case of an extraordinarily old satellite DNA in bivalve mollusks.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-393.html</link>
      <description> Related Articles Long-term conservation vs high sequence divergence: the case of an extraordinarily old satellite DNA in bivalve mollusks. Heredity. 2010 Jun;104(6):543-51 Authors: Plohl M, PetroviÄ? V, Luchetti A, Ricci A, SatoviÄ? E, Passamonti M, Mantovani B The ubiquity of satellite DNA (satDNA) sequences has raised much controversy over the abundance of divergent monomer variants and the long-time nucleotide sequence stability observed for many satDNA families. In this work, we describ ...</description>
        <pubDate>Thu, 12 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-393.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Long-term conservation vs high sequence divergence: the case of an extraordinarily old satellite DNA in bivalve mollusks.
        Heredity. 2010 Jun;104(6):543-51
        Authors:  Plohl M, PetroviÄ? V, Luchetti A, Ricci A, SatoviÄ? E, Passamonti M, Mantovani B
        The ubiquity of satellite DNA (satDNA) sequences has raised much controversy over the abundance of divergent monomer variants and the long-time nucleotide sequence stability observed for many satDNA families. In this work, we describe the satDNA BIV160, characterized in nine species of the three main bivalve clades (Protobranchia, Pteriomorphia and Heteroconchia). BIV160 monomers are similar in repeat size and nucleotide sequence to satDNAs described earlier in oysters and in the clam Donax trunculus. The broad distribution of BIV160 satDNA indicates that similar variants existed in the ancestral bivalve species that lived about 540 million years ago; this makes BIV160 the most ancient satDNA described so far. In the species examined, monomer variants are distributed in quite a complex pattern. This pattern includes (i) species characterized by a specific group of variants, (ii) species that share distinct group(s) of variants and (iii) species with both specific and shared types. The evolutionary scenario suggested by these data reconciles sequence uniformity in homogenization-maintained satDNA arrays with the genomic richness of divergent monomer variants formed by diversification of the same ancestral satDNA sequence. Diversified repeats can continue to evolve in a non-concerted manner and behave as independent amplification-contraction units in the framework of a 'library of satDNA variants' representing a permanent source of monomers that can be amplified into novel homogeneous satDNA arrays. On the whole, diversification of satDNA monomers and copy number fluctuations provide a highly dynamic genomic environment able to form and displace satDNA sequence variants rapidly in evolution.
        PMID: 19844270 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-394.html</link>
      <description> Related Articles Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum. Malar J. 2010;9:139 Authors: Parquet V, Henry M, Wurtz N, Dormoi J, Briolant S, Gil M, Baret E, Amalvict R, Rogier C, Pradines B BACKGROUND: Quinine (QN) remains the first line anti-malarial drug for the treatment of complicated malaria in Europe and Africa. The emergence of QN resistance has been documented. QN resistance is not yet a significan ...</description>
        <pubDate>Thu, 12 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-394.html</guid>
        
      <content:encoded> <![CDATA[
    
  Related Articles
        Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.
        Malar J. 2010;9:139
        Authors:  Parquet V, Henry M, Wurtz N, Dormoi J, Briolant S, Gil M, Baret E, Amalvict R, Rogier C, Pradines B
        BACKGROUND: Quinine (QN) remains the first line anti-malarial drug for the treatment of complicated malaria in Europe and Africa. The emergence of QN resistance has been documented. QN resistance is not yet a significant problem, but there is an urgent need to discover partners for use in combination with QN. The aim of the study was to assess the in vitro potentiating effects of atorvastatin (AVA), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, in combination with QN against Plasmodium falciparum and to evaluate whether the effects of AVA could be associated with gene copy number or mutations in genes involved in QN resistance, such as pfcrt, pfmdr1, pfmrp and pfnhe. METHODS: The susceptibilities to combination of AVA with QN were assessed against 21 parasite strains using the in vitro isotopic microtest. Genotypes and gene copy number were assessed for pfcrt, pfmdr1, pfmdr2, pfmrp genes. In addition, the number of DNNND, DDNHNDNHNN repeats in pfnhe-1 ms4760 and the ms4760 profile were determined for each strains of P. falciparum. RESULTS: AVA demonstrated synergistic effects in combination with QN against 21 P. falciparum strains. The QN IC50 was reduced by 5% (0% to 15%; 95%CI: 1%-8%), 10% (3% to 23%; 95%CI: 7%-14%) and 22% (14% to 40%; 95%CI: 19%-25%) in presence of AVA at concentrations of 0.1, 0.5 and 1.0 microM, respectively. These reductions were all significant (p < 0.009). The reduction in the QN IC50 in presence of AVA was not significantly correlated with the QN IC50 (r = 0.22, P = 0.3288) or the AVA IC50 (r = 0.03, P = 0.8946). The synergistic effect of AVA in combination with QN was not significantly associated with polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe-1 genes that could be involved in QN resistance. The synergistic effect of AVA on QN responses was not significantly associated with pfmdr1 copy number (P = 0.0428). CONCLUSION: The synergistic effect of AVA in combination with QN was found to be unrelated to mutations occurring in transport protein genes involved in QN drug resistance. The different mechanisms of drug uptake and/or mode of action for AVA compared to the other anti-malarial drugs, as well as the AVA-mediated synergy of the anti-malarial effect of QN, suggests that AVA will be a good candidate for combinatorial malaria treatment. All of these observations support calls for both an in vivo evaluation with pharmacokinetic component and clinical trials of AVA as an anti-malarial therapy.
        PMID: 20497586 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The N-Glycome of Human Plasma.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-352.html</link>
      <description>The N-Glycome of Human Plasma. J Proteome Res. 2010 Aug 6; Authors: Stumpo KA, Reinhold VN N-linked glycans isolated from human plasma proteins have been profiled and sequenced by mass spectrometry using an ion trap instrument (ITMS(n)). The released glycans were prepared as reduced, methylated analogues and directly infused into a chip-based nanoelectrospray ionization system and analyzed by ITMS(n). The resulting mass profiles (MS(1)) of IgG-depleted and nondepleted plasma samples were contras ...</description>
        <pubDate>Wed, 11 Aug 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-352.html</guid>
        
      <content:encoded> <![CDATA[
    The N-Glycome of Human Plasma. J Proteome Res. 2010 Aug 6; Authors: Stumpo KA, Reinhold VN N-linked glycans isolated from human plasma proteins have been profiled and sequenced by mass spectrometry using an ion trap instrument (ITMS(n)). The released glycans were prepared as reduced, methylated analogues and directly infused into a chip-based nanoelectrospray ionization system and analyzed by ITMS(n). The resulting mass profiles (MS(1)) of IgG-depleted and nondepleted plasma samples were contrasted and these results were again compared with recent literature reports. Before depletion, approximately 50 independent glycan ions were detected; this more than doubled to 106 after depletion. The mass range profiled was 1-5 kDa which included many doubly and triply charged ions that were resolved by higher MS resolution. Selected ions in the depleted sample were disassembled to define their detailed structure providing a high-performance sequencing result. The simplicity of this nonchromatographic, direct infusion and gas-phase structural characterization compares most favorably with the latest reports using alternative instrumentation and adjunct techniques. PMID: 20690605 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 人間血しょうのN-Glycome。 J Proteome Res。 8月2010日6日; 著者: StumpoのKA、ラインホルトVNはイオントラップの器械(を使用して質量分析によって人間血しょう蛋白質から隔離されたglycansを側面図を描かれ、配列されたITMS Nつないだ(n))。 解放されたglycansは減らされ、メチル化され、アナログとしてそしてITMS (n)によってchip-based nanoelectrosprayイオン化システムに直接注ぎこまれ、分析される準備された。 生じる多くのプロフィール(IgG減らされ、nondepleted血しょうサンプルのMSは(1))対比され、これらの結果は最近の文献のレポートと再度比較された。 枯渇の前に、およそ50の独立したglycanイオンは検出された; この枯渇の後で106に多くにより倍増されて。 側面図を描かれた多くの範囲は多数をより高いMSの決断によって解決された二倍にそして三重に満たされたイオンを含んでいた1-5 kDaだった。 減らされたサンプルの指定イオンは高性能配列の結果を提供する詳しい構造を定義するために分解された。 このnonchromatographic、直接注入および気相塩基性の構造性格描写の簡易性は代わりとなる器械使用および付加物の技術を使用して最も最近のレポートと最も好意的に比較する。 PMID: -出版業者によって供給される… 20690605 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Hesperetin stimulates differentiation of primary rat osteoblasts involving the BMP signalling pathway.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-150.html</link>
      <description> Related Articles Hesperetin stimulates differentiation of primary rat osteoblasts involving the BMP signalling pathway. J Nutr Biochem. 2010 May;21(5):424-31 Authors: Trzeciakiewicz A, Habauzit V, Mercier S, Lebecque P, Davicco MJ, Coxam V, Demigne C, Horcajada MN Hesperidin found in citrus fruits has been reported to be a promising bioactive compound for maintaining an optimal bone status in ovariectomized rodent models. In this study, we examined the capacity of hesperetin (Hp) to affect the  ...</description>
        <pubDate>Wed, 11 Aug 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-150.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Hesperetin stimulates differentiation of primary rat osteoblasts involving the BMP signalling pathway. J Nutr Biochem. 2010 May;21(5):424-31 Authors: Trzeciakiewicz A, Habauzit V, Mercier S, Lebecque P, Davicco MJ, Coxam V, Demigne C, Horcajada MN Hesperidin found in citrus fruits has been reported to be a promising bioactive compound for maintaining an optimal bone status in ovariectomized rodent models. In this study, we examined the capacity of hesperetin (Hp) to affect the proliferation, differentiation and mineralization of rodent primary osteoblasts. Then, the impact of Hp on signalling pathways known to be implicated in bone formation was explored. We exposed osteoblasts to physiological concentrations of 1 microM Hp (Hp1) and 10 microM Hp (Hp10). Neither proliferation nor mineralization was affected by Hp at either dose during 19 days of exposure. Hp at both doses enhanced differentiation by significantly increasing alkaline phosphatase (ALP) activity from Day 14 of exposure (Day 19: Hp1: +9%, Hp10: +14.8% vs. control; P<.05). However, Hp did not induce an obvious formation of calcium nodules. The effect of Hp10 on ALP was inhibited by addition of noggin protein, suggesting a possible action of this flavanone through the bone morphogenetic protein (BMP) pathway. Indeed, Hp10 significantly induced (1.2- to 1.4-fold) mRNA expression of genes involved in this signalling pathway (i.e., BMP2, BMP4, Runx2 and Osterix) after 48 h of exposure. This was strengthened by enhanced phosphorylation of the complex Smad1/5/8. Osteocalcin mRNA level was up-regulated by Hp only at 10 microM (2.2 fold vs. control). The same dose of Hp significantly decreased osteopontin (OPN) protein level (50% vs. control) after 14 days of culture. Our findings suggest that Hp may regulate osteoblast differentiation through BMP signalling and may influence the mineralization process by modulating OPN expression. PMID: 19427185 [PubMed - in process]（【斜め読み用】機械翻訳： 関連の記事Hesperetinは細道に信号を送るBMPを含む第一次ラットのosteoblastsの微分を刺激する。 J Nutr Biochem。 5月2010日; 21 (5): 424-31書く: Trzeciakiewicz A、Habauzit V、Mercier S、Lebecque P、Davicco MJ、Coxam V、Demigne Cの柑橘類で見つけられるovariectomized齧歯動物モデルの最適の骨の状態を維持するための有望なbioactive混合物であるためにHorcajada MNのヘスペリジンは報告された。 この調査では齧歯動物の第一次osteoblastsの拡散、微分および鉱化に影響を与える、私達はhesperetin (馬力)の容量を検査した。 それから、骨の形成で関係すると知られていた細道に信号を送ることの馬力の影響は探検された。 私達は1つのmicroMの馬力(Hp1)および10のmicroMの馬力(Hp10)の生理学的な集中--にosteoblastsをさらした。 拡散も鉱化も19日の露出の間にどちらかの線量のHpで影響されなかった。 両方の線量の馬力はかなり露出(日19の日14からアルカリホスファターゼ(アルプス)の活動を高めることによって微分を高めた: Hp1: +9%、Hp10: 制御対+14.8%; P< .05)。 但し、馬力はカルシウム小節の明らかな形成を引き起こさなかった。 アルプスに対するHp10の効果は骨morphogenetic蛋白質(BMP)の細道によるこのフラバノンの可能なアクションを提案するnoggin蛋白質の付加によって禁じられた。 実際に、Hp10はかなり(1.2 - 1.4折りなさい)露出の48 hの後でこの信号を送る細道(すなわち、BMP2、BMP4、Runx2およびOsterix)にかかわった遺伝子のmRNAの表現を引き起こした。 これは10 microMのだけHpで複雑なSmad1/5/8. Osteocalcin mRNAのレベルの高められたリン酸化によって調整された増強された(2.2折目対制御)。 馬力の同じ線量は14日の文化後にかなりosteopontin (OPN)蛋白質のレベル(制御対50%)を減らした。 私達の調査結果は馬力が信号を送るBMPを通してosteoblastの微分を調整するかもしれない提案し、OPNの表現の調整によってことを鉱化プロセスに影響を及ぼすことができる。 PMID: 19427185 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-126.html</link>
      <description> Related Articles Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2137-43 Authors: Smadja DM, BiÃ¨che I, Silvestre JS, Germain S, Cornet A, Laurendeau I, Duong-Van-Huyen JP, Emmerich J, Vidaud M, Aiach M, Gaussem P OBJECTIVE: Endothelial progenitor cells are currently identified either by their surface antigen expression or by their generation of early colon ...</description>
        <pubDate>Wed, 11 Aug 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-126.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2137-43 Authors: Smadja DM, BiÃ¨che I, Silvestre JS, Germain S, Cornet A, Laurendeau I, Duong-Van-Huyen JP, Emmerich J, Vidaud M, Aiach M, Gaussem P OBJECTIVE: Endothelial progenitor cells are currently identified either by their surface antigen expression or by their generation of early colonies in culture (CFU-Hill). Another population, endothelial colony-forming cells (ECFCs), has strong vessel-forming capacity but is less well characterized. Given the potential usefulness of CFU-Hill and ECFCs as cell therapy products, their thorough characterization is of major importance. METHODS AND RESULTS: CFU-Hill and ECFCs were expanded from human cord and adult blood. Bone morphogenetic proteins 2 and 4 (BMP2/4) were selectively expressed by ECFCs but not by CFU-Hill. The BMP pathway was involved in ECFC commitment and angiogenic potential in vitro. In vivo, BMP inhibition strongly reduced plug vascularization in bFGF-containing Matrigel plugs implanted in C57/Bl6 mice. Moreover, ECFC exposure to BMP increased their therapeutic potential in a nude mouse model of hindlimb ischemia. In amputation specimens from patients with critical leg ischemia who had received a local therapeutic injection of bone marrow mononuclear cells, newly formed vessels were strongly positive for BMP2/4, suggesting that endothelial cells involved in neovascularization have an ECFC-like phenotype. CONCLUSIONS: BMP2/4 are a marker of ECFCs and play a key role in ECFC commitment and outgrowth during neovascularization. PMID: 18818419 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事はmorphogenetic蛋白質2の骨を抜き、4つは遅い結果のendothelial祖先の細胞によって選択式に表現され、neoangiogenesisを促進する。 Arterioscler Thromb Vasc Biol. 12月2008日; 28 (12): 2137-43書く: Smadja DM、BiÃ¨che I、Silvestre JS、ジェルマンSのコルネットA、Laurendeau I、ズオンヴァンHuyen JP、Emmerich J、Vidaud M、Aiach MのGaussem Pの目的: Endothelial祖先の細胞は表面の抗原の表現または文化(CFU丘)の早いコロニーの生成によって現在識別される。 特徴付けられるもう一人の人口、endothelial colony-formingの細胞(ECFCs)に、強い容器形成容量があるが、より少なく健康である。 CFU丘およびECFCsの潜在的な実用性を細胞療法プロダクトとして与えられて、詳細な性格描写は主な重要性をもつ。 方法および結果: CFU丘およびECFCsは人間のコードおよび大人の血から拡大された。 骨のmorphogenetic蛋白質2および4 (BMP2/4)はECFCsによってないCFU丘によって選択式に表現された。 BMPの細道はECFCの責任およびangiogenic潜在的な生体外にかかわった。 生体内で、BMPの阻止は強くC57/Bl6マウスで植え付けられたMatrigelのbFGF含んでいるプラグのプラグのvascularizationを減らした。 さらに、BMPへのECFCの露出はhindlimbのischemiaの裸のマウスモデルの治療上の潜在性を高めた。 骨髄の単核の細胞のローカル治療上の注入を受け取った重大な足のischemiaの患者からの切断の標本では、新興の容器はBMP2/4のために強く肯定的、neovascularizationにかかわるendothelial細胞に表現型ECFCのようにあることを提案するであり。 結論: BMP2/4はECFCsのマーカー、neovascularizationの間にECFCの責任に於いての重要な役割および結果をする。 PMID: 18818419 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-142.html</link>
      <description> Related Articles A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum. BMC Cell Biol. 2009;10:20 Authors: Herrera B, Inman GJ BACKGROUND: Bone morphogenetic proteins (BMPs) are pleiotropic members of the TGF-beta superfamily which regulate many biological processes during development and adult tissue homeostasis and are implicated in the pathogenesis of a number ...</description>
        <pubDate>Wed, 11 Aug 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-142.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum. BMC Cell Biol. 2009;10:20 Authors: Herrera B, Inman GJ BACKGROUND: Bone morphogenetic proteins (BMPs) are pleiotropic members of the TGF-beta superfamily which regulate many biological processes during development and adult tissue homeostasis and are implicated in the pathogenesis of a number of human diseases. Their involvement in both normal and aberrant physiology creates a need for rapid, sensitive and methodologically simple assays to evaluate their activity from a variety of biological samples. Previously alkaline phosphatase based assays, ELISA and luciferase based bioassays have been developed to evaluate either individual or total BMP activity. In this paper, we describe a highly sensitive, rapid and specific cell based assay for the simultaneous quantification of total and isoform specific BMP activity from biological samples. RESULTS: A C2C12 cell line stably transfected with a reporter plasmid consisting of the BMP response element (BRE) from the Id1 promoter fused to a luciferase reporter gene was generated. Exposure of this cell line to human recombinant BMP2, BMP4, BMP6, BMP7, BMP9 and BMP10 induced the expression of luciferase which was quantified using a luminometer. This assay was specific for BMP activity as the other TGF-beta superfamily members TGF-beta 1, Nodal and Mullerian Inhibiting Substance (MIS) did not induce the reporter. Pretreatment of samples with isoform specific BMP blocking antibodies coupled with isoform specific titration analysis allowed the simultaneous identification and quantification of BMP4, BMP6 and BMP9 in serum samples. CONCLUSION: The assay is rapid (<48 hours) and can be used to simultaneously measure isoform specific and total BMP activity in complex solutions. PMID: 19298647 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：  急速な関連の記事Aおよび多数の骨のmorphogenetic蛋白質の同時測定のための敏感な生物検定。 牛のような、人間の血清のBMP4、BMP6およびBMP9の同一証明そして定量化。 BMCの細胞Biol. 2009年; 10: 20人の著者: エレーラBのInman GJの背景: 骨のmorphogenetic蛋白質(BMPs)は開発および大人のティッシュホメオスタティスの間に多くの生物学的過程を調整する、いくつかの人間の病気の病因で関係するTGFベータsuperfamilyのpleiotropicメンバー。 正常で、異常な生理学の介入は急速、敏感なのための必要性をおよび方法論的に簡単な試金いろいろ生物的サンプルからの活動を評価する作成する。 以前はアルカリホスファターゼは試金を基づかせていた個々か総BMPの活動を評価するために、ELISAおよびluciferaseによって基づく生物検定は開発された。 このペーパーでは、私達は生物的サンプルからの合計そしてisoform特定のBMPの活動の同時定量化のための感度が高く、急速な特定の細胞に基づく試金を記述する。 結果: A.C. 2C12の細胞ラインは遺伝子が発生したluciferaseレポーターに溶けたId1促進者からのBMPの応答の要素(BRE)から成っているレポーターのプラスミッドと固定してtransfected。 人間の組換えBMP2、BMP4、BMP6、BMP7、BMP9およびBMP10へのこの細胞ラインの露出はluminometerを使用して量を示されたluciferaseの表現を引き起こした。 この試金は他のTGFベータsuperfamilyのメンバーTGFベータ1としてBMPの活動のために特定、節であり、Mullerianの物質禁止(MIS)はレポーターを引き起こさなかった。 isoformの特定の滴定の分析とつながれた抗体を妨げるisoform特定のBMPが付いているサンプルの前処理は血清のサンプルのBMP4、BMP6およびBMP9の同時同一証明そして定量化を可能にした。 結論: 試金は急流(&ltである; 48時間が)同時に複雑な解決のisoformの特定および総BMPの活動を測定するのに使用され。 PMID: 19298647 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Unique and shared gene expression patterns in Atlantic salmon (Salmo salar) tooth development.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-118.html</link>
      <description> Related Articles Unique and shared gene expression patterns in Atlantic salmon (Salmo salar) tooth development. Dev Genes Evol. 2008 Aug;218(8):427-37 Authors: Huysseune A, Takle H, Soenens M, Taerwe K, Witten PE To validate the use of Atlantic salmon (Salmo salar L.) as a model species in research on the mechanism of continuous tooth replacement, we have started to collect data on the molecular control underlying tooth formation in this species. This study reports expression patterns in the lo ...</description>
        <pubDate>Wed, 11 Aug 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-118.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Unique and shared gene expression patterns in Atlantic salmon (Salmo salar) tooth development. Dev Genes Evol. 2008 Aug;218(8):427-37 Authors: Huysseune A, Takle H, Soenens M, Taerwe K, Witten PE To validate the use of Atlantic salmon (Salmo salar L.) as a model species in research on the mechanism of continuous tooth replacement, we have started to collect data on the molecular control underlying tooth formation in this species. This study reports expression patterns in the lower jaw dentition of a number of key regulatory genes such as bmp2, bmp4, and sox9 and structural genes such as col1alpha 1 and osteocalcin (= bgp, Bone Gla Protein) by means of in situ hybridization using salmon-specific, digoxygenin-labeled antisense riboprobes. We compare expression of these genes to that in other skeletogenic cells in the lower jaw (osteoblasts, chondroblasts, and chondrocytes). Our studies reveal both expression patterns that are in accordance to studies on mammalian tooth development and patterns that are specific to salmon, or teleosts. The epithelial expression of sox9 and a shift of the expression of bmp2 from epithelium to mesenchyme have also been observed during mammalian tooth development. Different from previous reports are the expressions of col1alpha 1 and osteocalcin. In contrast to what has been reported for zebrafish, osteocalcin is not expressed in odontoblasts, nor in the osteoblasts involved in the attachment of the teeth. At the lower jaw, osteocalcin is expressed in mature and/or resting osteoblasts only. As expected, col1alpha 1 is expressed in odontoblasts. Surprisingly, it is also strongly expressed in the inner dental epithelium, representing the first report of ameloblast involvement in collagen type I transcription. Whether the collagen is translated and secreted into the enameloid remains to be demonstrated. PMID: 18642027 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 独特な関連の記事および大西洋サケ(Salmo salar)の歯の発生の共用遺伝子発現パターン。 Devの遺伝子Evol。 8月2008日; 218 (8): 427-37書く: Huysseune A、Takle H、Soenens M、Taerwe Kの連続的な歯の取り替えのメカニズムの研究のモデル種として大西洋サケ(Salmo salar L.)の使用を認可するWittenのPE私達はこの種の分子制御根本的な歯の形成のデータを集め始めた。 この調査はbmp2、bmp4のようないくつかの主規定する遺伝子の下顎の歯牙発生の表現パターンを報告し、col1alpha 1およびサケ特定を使用してそのままの交配によるosteocalcinのようなsox9および構造遺伝子は(= bgpの骨のGla蛋白質)、antisense riboprobesをdigoxygenin分類した。 私達は下顎(osteoblasts、chondroblastsおよびchondrocytes)の他のskeletogenic細胞のそれとこれらの遺伝子の表現を比較する。 私達の調査はサケに特定である、またはteleostsある哺乳類の歯の発生の調査に調和におよびパターン表現両方パターンを明らかにする。 sox9の上皮性の表現および上皮からのmesenchymeへのbmp2の表現の転位はまた哺乳類の歯の発生の間に観察された。 前のレポートと異なっているcol1alpha 1およびosteocalcinの表現は。 報告されたことがと対照をなしてzebrafishのために、osteocalcinはodontoblastsに、歯の付属品にかかわるosteoblastsに表現されない。 下顎で、osteocalcinは成長したおよび/または休息のosteoblastsだけに表現される。 期待どおりに、col1alpha 1はodontoblastsに表現される。 意外にも、それはまたコラーゲンのタイプIのトランスクリプションのameloblast介入の最初のレポートを表す内部の歯科上皮に強く表現される。 コラーゲンはenameloidに翻訳され、分泌するかどうか示されることを残る。 PMID: 18642027 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Histone deacetylase inhibitor, trichostatin A, affects gene expression patterns during morphogenesis of chicken limb buds in vivo.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-134.html</link>
      <description> Related Articles Histone deacetylase inhibitor, trichostatin A, affects gene expression patterns during morphogenesis of chicken limb buds in vivo. Cells Tissues Organs. 2009;190(3):121-34 Authors: Zhao W, Dai F, Bonafede A, Schafer S, Jung M, Yusuf F, Gamel AJ, Wang J, Brand-Saberi B Acetylation is one of the key chromatin modifications that control gene transcription during embryonic development and tumorigenesis. The types of genes sensitive to such modifications in vivo are not known to dat ...</description>
        <pubDate>Wed, 11 Aug 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-134.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Histone deacetylase inhibitor, trichostatin A, affects gene expression patterns during morphogenesis of chicken limb buds in vivo. Cells Tissues Organs. 2009;190(3):121-34 Authors: Zhao W, Dai F, Bonafede A, Schafer S, Jung M, Yusuf F, Gamel AJ, Wang J, Brand-Saberi B Acetylation is one of the key chromatin modifications that control gene transcription during embryonic development and tumorigenesis. The types of genes sensitive to such modifications in vivo are not known to date. We investigated the expression of a number of genes involved in embryonic development after treatment with trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, in the limbs of chicken embryos. Our results show that TSA affects the expression profiles of some genes that play important roles during limb development. The expression of BMP4, SF/HGF and Twist1 increased, whereas the expression of BMP2, FGF8, Shh, Scleraxis, Myf5 and MyoD was decreased or even inhibited. In contrast, the expression of Pax3, Paraxis, Msx1, CREB, and PCNA was not affected. Our results indicate that the chicken embryo can serve as an effective in vivo model for studying the effect of HDAC inhibitors on gene expression and can be helpful for understanding the role of chromatin remodeling and epigenetic control of gene expression. PMID: 19147985 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事のヒストンのdeacetylaseの抑制剤、trichostatin Aは鶏の肢の芽の形態形成の間に、遺伝子発現パターンに生体内で影響を与える。 細胞のティッシュ器官。 2009年; 190 (3): 121-34書く: 肇W、戴F、Bonafede A、Schafer S、Jung M、Yusuf F、Wang J AJのGamelブランドSaberi Bのアセチル化は萌芽期の開発およびtumorigenesisの間に遺伝子のトランスクリプションを制御する主chromatinの修正の1才である。 そのような修正に敏感な遺伝子のタイプは生体内で今までに知られていない。 私達はtrichostatin A (TSA)と処置の後で萌芽期の開発に、鶏の胚の肢のヒストンのdeacetylase (HDAC)の抑制剤、かかわったいくつかの遺伝子の表現を調査した。 私達の結果はTSAが肢の開発の間に重要な役割を担うある遺伝子の表現のプロフィールに影響を与えることを示す。 BMP4、SF/HGFおよびTwist1の表現はBMP2、FGF8、Shh、Scleraxis、Myf5およびMyoDの表現が減ったりまた更に禁じられた一方、増加した。 それに対して、Pax3の表現、Paraxis、Msx1、CREBおよびPCNAは影響を受けていなかった。 私達の結果は鶏の胚が遺伝子発現に対するHDACの抑制剤の効果を調査するための有効な生体内のモデルとして役立ち、chromatinの改造の役割および遺伝子発現の後成制御を理解するために有用である場合もあることを示す。 PMID: 19147985 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Highly efficient osteogenic differentiation of human mesenchymal stem cells by eradication of STAT3 signaling.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-202.html</link>
      <description>Highly efficient osteogenic differentiation of human mesenchymal stem cells by eradication of STAT3 signaling. Int J Biochem Cell Biol. 2010 Aug 3; Authors: Levy O, Ruvinov E, Reem T, Granot Y, Cohen S Human bone marrow-derived mesenchymal stem cells (hMSCs) are promising candidates for cellular therapy owing to their multipotency to differentiate into several cell lineages. Elucidating the signaling events involved in the response of hMSCs to diverse stimulants affecting their differentiation m ...</description>
        <pubDate>Wed, 11 Aug 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-202.html</guid>
        
      <content:encoded> <![CDATA[
    Highly efficient osteogenic differentiation of human mesenchymal stem cells by eradication of STAT3 signaling. Int J Biochem Cell Biol. 2010 Aug 3; Authors: Levy O, Ruvinov E, Reem T, Granot Y, Cohen S Human bone marrow-derived mesenchymal stem cells (hMSCs) are promising candidates for cellular therapy owing to their multipotency to differentiate into several cell lineages. Elucidating the signaling events involved in the response of hMSCs to diverse stimulants affecting their differentiation may considerably promote their clinical use. In this study, we attempted to illuminate the molecular signaling networks involved in bone morphogenetic protein (BMP)-stimulated hMSC osteogenic differentiation. We demonstrate that eradication of signal transducers and activators of transcription (STAT) signaling considerably enhances BMP-induced osteogenic differentiation of hMSCs. BMP 2 and 4 are shown for the first time to activate the Janus-activated kinase (JAK)-STAT pathway in hMSC. Specifically, we reveal that JAK2 mediates STAT3 tyrosine phosphorylation in response to the two BMPs, whereas BMP2- and BMP4-induced STAT3 serine phosphorylation involves two divergent cascades, namely the mTOR and ERK1/2 cascades, respectively. Furthermore, elimination of the STAT3 signaling pathway by the inhibitors, AG490 or STAT3 siRNA, results in the acceleration and augmentation of BMPs-induced osteogenic differentiation, thus proposing a role for JAK-STAT signaling as a negative regulator of this process in MSCs. We believe that the findings presented in this study may be the basis for the development of a useful strategy to better control stem cell fate through intervention in molecular signaling networks. Hopefully, such a strategy will include the development of more efficient and controllable protocols for hMSC differentiation and facilitate their use in regenerative medicine. PMID: 20691278 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： STAT3シグナリングの絶滅による人間のmesenchymal幹細胞の非常に能率的なosteogenic微分。 Int J Biochemの細胞Biol. 8月2010日3日; 著者: 徴税O、Ruvinov E、Reem T、Granot YのCohen Sの人間の骨によって髄得られるmesenchymal幹細胞(hMSCs)は複数の細胞の血統に区別するべきmultipotencyのために細胞療法のための有望な候補者である。 微分に影響を与える多様な興奮剤へのhMSCsの応答にかかわるシグナリングでき事を明瞭にすることはかなり臨床使用を促進するかもしれない。 この調査では、私達は骨のmorphogenetic蛋白質(BMP)にかかわった分子シグナリングネットワーク-刺激されたhMSCのosteogenic微分を照らすように試みた。 私達はトランスクリプション(STAT)シグナリングの信号のトランスデューサーそして活性剤の絶滅がかなりhMSCsのBMP引き起こされたosteogenic微分を高めることを示す。 BMP 2および4はJanus活動化させたキナーゼ(JAK) - hMSCのSTATの細道を活動化させるためにはじめて示されている。 具体的には、私達はBMP2-およびBMP4引き起こされたSTAT3セリーンのリン酸化2つの広がった滝を、即ちmTORおよびERK1/2滝が含む一方、JAK2が2つのBMPsに応じてSTAT3チロシンのリン酸化をそれぞれ仲介することを明らかにする。 従ってなお、抑制剤によるSTAT3シグナリング細道、AG490かSTAT3 siRNAの除去はBMPs引き起こされたosteogenic微分の加速そして増加で、起因し、このプロセスの否定的な調整装置としてMSCsに於いてのJAK-STATシグナリングのための役割を提案する。 私達はこの調査で示される調査結果が分子シグナリングネットワークの介在によって制御幹細胞の運命をよくする有用な作戦の開発のための基礎であるかもしれないことを信じる。 うまくいけば、そのような作戦はhMSCの微分のためのより有効で、より制御可能な議定書の開発が含まれ、再生薬の使用を促進する。 PMID: -出版業者によって供給される… 20691278 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>RankProdIt : A web-interactive Rank Products analysis tool.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-391.html</link>
      <description> RankProdIt : A web-interactive Rank Products analysis tool. BMC Res Notes. 2010 Aug 6;3(1):221 Authors: Laing E, Smith CP ABSTRACT: BACKGROUND: The first objective of a DNA microarray experiment is typically to generate a list of genes or probes that are found to be differentially expressed or represented (in the case of comparative genomic hybridizations and/or copy number variation) between two conditions or strains. Rank Products analysis comprises a robust algorithm for deriving such lists  ...</description>
        <pubDate>Wed, 11 Aug 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-391.html</guid>
        
      <content:encoded> <![CDATA[
    

        RankProdIt : A web-interactive Rank Products analysis tool.
        BMC Res Notes. 2010 Aug 6;3(1):221
        Authors:  Laing E, Smith CP
        ABSTRACT: BACKGROUND: The first objective of a DNA microarray experiment is typically to generate a list of genes or probes that are found to be differentially expressed or represented (in the case of comparative genomic hybridizations and/or copy number variation) between two conditions or strains. Rank Products analysis comprises a robust algorithm for deriving such lists from microarray experiments that comprise small numbers of replicates, for example, less than the number required for the commonly used t-test. Currently, users wishing to apply Rank Products analysis to their own microarray data sets have been restricted to the use of command line-based software which can limit its usage within the biological community. FINDINGS: Here we have developed a web interface to existing Rank Products analysis tools allowing users to quickly process their data in an intuitive and step-wise manner to obtain the respective Rank Product or Rank Sum, probability of false prediction and p-values in a downloadable file. CONCLUSIONS: The online interactive Rank Products analysis tool RankProdIt, for analysis of any data set containing measurements for multiple replicated conditions, is available at: http://strep-microarray.sbs.surrey.ac.uk/RankProducts.
        PMID: 20691047 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Microdeletions of 3q29 Confer High Risk for Schizophrenia.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-392.html</link>
      <description> Microdeletions of 3q29 Confer High Risk for Schizophrenia. Am J Hum Genet. 2010 Aug 4; Authors: Mulle JG, Dodd AF, McGrath JA, Wolyniec PS, Mitchell AA, Shetty AC, Sobreira NL, Valle D, Rudd MK, Satten G, Cutler DJ, Pulver AE, Warren ST Schizophrenia (SZ) is a severe psychiatric illness that affects approximately 1% of the population and has a strong genetic underpinning. Recently, genome-wide analysis of copy-number variation (CNV) has implicated rare and de novo events as important in SZ. Her ...</description>
        <pubDate>Wed, 11 Aug 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-392.html</guid>
        
      <content:encoded> <![CDATA[
    

        Microdeletions of 3q29 Confer High Risk for Schizophrenia.
        Am J Hum Genet. 2010 Aug 4;
        Authors:  Mulle JG, Dodd AF, McGrath JA, Wolyniec PS, Mitchell AA, Shetty AC, Sobreira NL, Valle D, Rudd MK, Satten G, Cutler DJ, Pulver AE, Warren ST
        Schizophrenia (SZ) is a severe psychiatric illness that affects approximately 1% of the population and has a strong genetic underpinning. Recently, genome-wide analysis of copy-number variation (CNV) has implicated rare and de novo events as important in SZ. Here, we report a genome-wide analysis of 245 SZ cases and 490 controls, all of Ashkenazi Jewish descent. Because many studies have found an excess burden of large, rare deletions in cases, we limited our analysis to deletions over 500 kb in size. We observed seven large, rare deletions in cases, with 57% of these being de novo. We focused on one 836 kb de novo deletion at chromosome 3q29 that falls within a 1.3-1.6 Mb deletion previously identified in children with intellectual disability (ID) and autism, because increasing evidence suggests an overlap of specific rare copy-number variants (CNVs) between autism and SZ. By combining our data with prior CNV studies of SZ and analysis of the data of the Genetic Association Information Network (GAIN), we identified six 3q29 deletions among 7545 schizophrenic subjects and one among 39,748 controls, resulting in a statistically significant association with SZ (p = 0.02) and an odds ratio estimate of 17 (95% confidence interval: 1.36-1198.4). Moreover, this 3q29 deletion region contains two linkage peaks from prior SZ family studies, and the minimal deletion interval implicates 20 annotated genes, including PAK2 and DLG1, both paralogous to X-linked ID genes and now strong candidates for SZ susceptibility.
        PMID: 20691406 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Prenatal diagnosis of fetal aneuploidies: post-genomic developments.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-390.html</link>
      <description>Related Articles Prenatal diagnosis of fetal aneuploidies: post-genomic developments. Genome Med. 2010 Aug 5;2(8):50 Authors: Hahn S, Jackson LG, Zimmermann BG ABSTRACT: Prenatal diagnosis of fetal aneuploidies and chromosomal anomalies is likely to undergo a profound change in the near future. On the one hand this is mediated by new technical developments, such as chromosomal microarrays, which allow a much more precise delineation of minute sub-microscopic chromosomal aberrancies than the clas ...</description>
        <pubDate>Mon, 09 Aug 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-390.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Prenatal diagnosis of fetal aneuploidies: post-genomic developments. Genome Med. 2010 Aug 5;2(8):50 Authors: Hahn S, Jackson LG, Zimmermann BG ABSTRACT: Prenatal diagnosis of fetal aneuploidies and chromosomal anomalies is likely to undergo a profound change in the near future. On the one hand this is mediated by new technical developments, such as chromosomal microarrays, which allow a much more precise delineation of minute sub-microscopic chromosomal aberrancies than the classical G-band karyotype. This will be of particular interest when investigating pregnancies at risk of unexplained development delay, intellectual disability or certain forms of autism. On the other hand, great strides have been made in the non-invasive determination of fetal genetic traits, largely through the analysis of cell-free fetal nucleic acids. It is hoped that, with the assistance of cutting-edge tools such as digital PCR or next generation sequencing, the long elusive goal of non-invasive prenatal diagnosis for fetal aneuploidies can finally be attained. PMID: 20687900 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：胎児の異数性の関連の記事の出生前の診断: ポストgenomicの開発。 ゲノムMed。 8月2010日5日; 2 (8): 50人の著者: Hahn S、ジャクソンLGのZimmermann BGの概要: 胎児の異数性および染色体変則の出生前の診断は本当らしい深遠な変更を近い将来に経るために。 一方でこれは新しい技術的な開発によって、古典的なGバンドkaryotypeより微細なsub-microscopic染色体のaberranciesのはるかに精密な描写を可能にする染色体のマイクロアレイのような仲介される。 これは特別な関心妊娠を自閉症の説明されていない開発の遅れ、知的な不能またはある特定の形態の危険がある状態に調査するときである。 一方で、すばらしい大またはcell-free胎児の核酸の分析による胎児の遺伝の特性の非侵襲的な決定で、主としてなされた。 、胎児の異数性のための配列するデジタルPCRまたは次世代のような最先端の用具の援助と非侵襲的な出生前の診断の長いはっきりしない目的が最終的に達成することができること期待される。 PMID: -出版業者によって供給される… 20687900 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Single integration and spread of a Copia-like sequence nested in rDNA intergenic spacers of Allium cernuum (Alliaceae).</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-388.html</link>
      <description> Related Articles Single integration and spread of a Copia-like sequence nested in rDNA intergenic spacers of Allium cernuum (Alliaceae). Cytogenet Genome Res. 2010 Jul;129(1-3):35-46 Authors: Chester M, Sykorova E, Fajkus J, Leitch AR The 35S ribosomal DNA (rDNA) intergenic spacer (IGS) of Allium cernuum is examined. Initial sequencing of IGS clones revealed that some rDNA units contain a truncated retrotransposon sequence most similar to members of the Copia superfamily. Fluorescence in situ h ...</description>
        <pubDate>Sun, 08 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-388.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Single integration and spread of a Copia-like sequence nested in rDNA intergenic spacers of Allium cernuum (Alliaceae).
        Cytogenet Genome Res. 2010 Jul;129(1-3):35-46
        Authors:  Chester M, Sykorova E, Fajkus J, Leitch AR
        The 35S ribosomal DNA (rDNA) intergenic spacer (IGS) of Allium cernuum is examined. Initial sequencing of IGS clones revealed that some rDNA units contain a truncated retrotransposon sequence most similar to members of the Copia superfamily. Fluorescence in situ hybridisation (FISH) to metaphase chromosomes indicates that this element is dispersed along both pairs of major rDNA arrays. Southern hybridisation confirmed the presence of this 'relic' Copia-like element in more than 10% of 35S rDNA units, in the same position within the IGS. To measure the intragenomic divergence of the relic retroelement and its flanking sequences amongst different rDNA units, a 1.1-kb region was amplified and cloned. These data collectively point to a single origin for units containing the putative retrotransposon fragment. It is likely that units containing the putative retroelement increased in copy number and dispersed via rDNA homogenisation mechanisms, rather than by multiple retrotransposition events.
        PMID: 20516662 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Diversity of chromosomal karyotypes in maize and its relatives.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-389.html</link>
      <description> Related Articles Diversity of chromosomal karyotypes in maize and its relatives. Cytogenet Genome Res. 2010 Jul;129(1-3):6-16 Authors: Albert PS, Gao Z, Danilova TV, Birchler JA Maize is a highly diverse species on the gene sequence level. With the recent development of methods to distinguish each of the 10 pairs of homologues in somatic root tip spreads, a wide collection of maize lines was subjected to karyotype analysis to serve as a reference for the community and to examine the spectrum of ...</description>
        <pubDate>Sun, 08 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-389.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Diversity of chromosomal karyotypes in maize and its relatives.
        Cytogenet Genome Res. 2010 Jul;129(1-3):6-16
        Authors:  Albert PS, Gao Z, Danilova TV, Birchler JA
        Maize is a highly diverse species on the gene sequence level. With the recent development of methods to distinguish each of the 10 pairs of homologues in somatic root tip spreads, a wide collection of maize lines was subjected to karyotype analysis to serve as a reference for the community and to examine the spectrum of chromosomal features in the species. The core nested association mapping progenitor collection and additional selections of diversity lines were examined. Commonly used inbred lines were included in the analysis. The centromere 4 specific repeat and ribosomal RNA loci were invariant. The CentC centromere repeat exhibited extensive differences in quantity on any particular chromosome across lines. Knob heterochromatin was highly variable with locations at many sites in the genome. Lastly, representative examples from other species in the genus Zea (teosintes) were examined, which provide information on the evolution of chromosomal features.
        PMID: 20551613 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>High-Throughput Profiling of the Serum N-Glycome on Capillary Electrophoresis Microfluidics Systems: Toward Clinical Implementation of GlycoHepatoTest.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-351.html</link>
      <description>High-Throughput Profiling of the Serum N-Glycome on Capillary Electrophoresis Microfluidics Systems: Toward Clinical Implementation of GlycoHepatoTest. Anal Chem. 2010 Aug 4; Authors: Vanderschaeghe D, SzekreÌ?nyes A, Wenz C, Gassmann M, Naik N, Bynum M, Yin H, Delanghe J, Guttman A, Callewaert N We developed a 3 h procedure for preparing serum N-glycans and labeling them with 8-aminopyrene-1,3,6-trisulfonic acid (APTS) by sequential addition of reagents to the serum and incubation in a polyme ...</description>
        <pubDate>Sat, 07 Aug 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-351.html</guid>
        
      <content:encoded> <![CDATA[
    High-Throughput Profiling of the Serum N-Glycome on Capillary Electrophoresis Microfluidics Systems: Toward Clinical Implementation of GlycoHepatoTest. Anal Chem. 2010 Aug 4; Authors: Vanderschaeghe D, SzekreÌ?nyes A, Wenz C, Gassmann M, Naik N, Bynum M, Yin H, Delanghe J, Guttman A, Callewaert N We developed a 3 h procedure for preparing serum N-glycans and labeling them with 8-aminopyrene-1,3,6-trisulfonic acid (APTS) by sequential addition of reagents to the serum and incubation in a polymerase chain reaction (PCR) thermocycler. Moreover, we succeeded in analyzing these samples by capillary electrophoresis on three commercial microfluidics-based platforms: the MCE-202 MultiNA, the 2100 Bioanalyzer, and a modified prototype of the eGene system which were originally designed for nucleic acid separation and detection. Although these instruments use short separation channels, our technical improvements made it possible to reliably measure the N-glycans constituting GlycoHepatoTest. This test comprises a panel of biomarkers that allows follow-up of liver fibrosis patients starting from the early stage. In this way and for the first time, we demonstrate a clinical glycomics assay on an affordable, robust platform so that clinical chemistry laboratories can exploit glycomics in the diagnosis and monitoring of chronic liver disease. Another potential application is the rapid screening of the N-glycosylation of recombinant glycoproteins produced for pharmaceutical use. PMID: 20684520 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 電気泳動のMicrofluidics毛管システムの血清N-Glycomeの高効率の側面図を描くこと: GlycoHepatoTestの臨床実施の方。 肛門のChem。 8月2010日4日; 著者: Vanderschaeghe DのSzekreÌの?のnyes A、Wenz C、Gassmann M、Naik N、Bynum M、Yin H、Delanghe J、Guttman A、Callewaert N私達はポリメラーゼの連鎖反応(PCR)のthermocyclerの血清そして孵化に試薬の順次付加によって血清N-glycansを準備し、8-aminopyrene-1,3,6-trisulfonic酸とのそれらを(APTS)分類する為の3つのhの手順を開発した。 さらに、私達は3つの商業microfluidics基づかせていたプラットホームの毛管電気泳動によってこれらのサンプルの分析に成功した: 核酸の分離および検出のために最初に設計されていたeGeneシステムの変更されたプロトタイプおよびMCE-202 MultiNA、2100 Bioanalyzer。 これらの器械が短い分離チャネルを使用するが、私達の技術的な改善は確実にGlycoHepatoTestを構成するN-glycansを測定することを可能にした。 このテストはbiomarkersで初期から始まってレバー線維症の患者のフォローアップを可能にするパネルを構成する。 このようにそしてはじめて、私達は臨床化学の実験室が慢性の肝臓病の診断そして監視のglycomicsを開発できるように現実的で、強いプラットホームの臨床glycomicsの試金を示す。 もう一つの潜在的な適用は薬剤の使用のために作り出される組換えの糖蛋白質のN-glycosylationの急速なスクリーニングである。 PMID: -出版業者によって供給される… 20684520 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus]</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-350.html</link>
      <description>Related Articles [N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus] Zhonghua Gan Zang Bing Za Zhi. 2008 Jan;16(1):74-5 Authors: Liu XE, Desmyter L, Gao CF, Laroy W, Dewaele S, Vanhooren V, Wang L, Zhuang H, Callewaert N, Libert C, Contreras R, Chen CY PMID: 18226355 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：記事の[N-glycomicは肝炎のウイルスが引き起こす肝硬変のhepatocellular癌腫の患者で変わる] Zhonghua関連のGan ZangビングZa Zh ...</description>
        <pubDate>Sat, 07 Aug 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-350.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus] Zhonghua Gan Zang Bing Za Zhi. 2008 Jan;16(1):74-5 Authors: Liu XE, Desmyter L, Gao CF, Laroy W, Dewaele S, Vanhooren V, Wang L, Zhuang H, Callewaert N, Libert C, Contreras R, Chen CY  PMID: 18226355 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：記事の[N-glycomicは肝炎のウイルスが引き起こす肝硬変のhepatocellular癌腫の患者で変わる] Zhonghua関連のGan ZangビングZa Zhi。 1月2008日; 16 (1): 74-5書く: 劉XE、Desmyter Lの高のCF、Laroy W、Dewaele S、Vanhooren V、Wang L、Zhuang H、Callewaert N、Libert C、Contreras R、陳CY PMID: 18226355 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-224.html</link>
      <description>Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis. Talanta. 2010 Jun 30;82(1):245-254 Authors: De Bock M, de Seny D, Meuwis MA, Servais AC, Minh TQ, Closset J, Chapelle JP, Louis E, Malaise M, Merville MP, Fillet M In most diseases, the clinical need for serum/plasma markers has never been so crucial, not only for diagnosis, but also for the selection of the most efficient therapies, as well as exclusion of ineffe ...</description>
        <pubDate>Sat, 07 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-224.html</guid>
        
      <content:encoded> <![CDATA[
    Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis. Talanta. 2010 Jun 30;82(1):245-254 Authors: De Bock M, de Seny D, Meuwis MA, Servais AC, Minh TQ, Closset J, Chapelle JP, Louis E, Malaise M, Merville MP, Fillet M In most diseases, the clinical need for serum/plasma markers has never been so crucial, not only for diagnosis, but also for the selection of the most efficient therapies, as well as exclusion of ineffective or toxic treatment. Due to the high sample complexity, prefractionation is essential for exploring the deep proteome and finding specific markers. In this study, three different sample preparation methods (i.e., highly abundant protein precipitation, restricted access materials (RAM) combined with IMAC chromatography and peptide ligand affinity beads) were investigated in order to select the best fractionation step for further differential proteomic experiments focusing on the LMW proteome (MW inferior to 40,000Da). Indeed, the aim was not to cover the entire plasma/serum proteome, but to enrich potentially interesting tissue leakage proteins. These three methods were evaluated on their reproducibility, on the SELDI-TOF-MS peptide/protein peaks generated after fractionation and on the information supplied. The studied methods appeared to give complementary information and presented good reproducibility (below 20%). Peptide ligand affinity beads were found to provide efficient depletion of HMW proteins and peak enrichment in protein/peptide profiles. PMID: 20685463 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 分別のための3つの方法の比較およびSELDI-TOF-MSの微分解析のための低分子量蛋白質の強化。 Talanta。 6月2010日30日; 82 (1): 245-254書く: De Bock M、de Seny D、ほとんどの病気のMeuwis MA、セルベAC、Minh TQ、Closset J、Chapelle JP、ルイE、けん怠感M、Merville MP、肉付けM、血清のための臨床必要性または血しょうマーカーはいままで決してあまり重大、の診断のためだけ、非効果的か有毒な処置の排除と同様、また最も有効な療法の選択、ではなかった。 高いサンプル複雑さ、prefractionationが原因で深いproteomeを探検し、特定のマーカーを見つけるために必要がある。 この調査ではLMWのproteome (40,000DaへのMWの劣ったもの)に焦点を合わせるそれ以上の差動proteomic実験に最もよい分別のステップを選ぶために、3つのサンプル準備方法(すなわち、非常に豊富な蛋白質の沈殿物、IMACクロマトグラフィーおよびペプチッドligandの類縁のビードと結合される限られたアクセス材料(RAM)は)調査された。 実際に、目標は全体の血しょうまたは血清のproteomeをカバーすること、可能性としては興味深いティッシュの漏出蛋白質を富ませたでなく。 この3つの方法は再現性で、分別の後で発生したSELDI-TOF-MSペプチッドまたは蛋白質のピークと供給された情報で評価された。 調査された方法は補足情報を与えたようで、よい再現性を示した(20%の下で)。 ペプチッドligandの類縁のビードは蛋白質またはペプチッドプロフィールのHMW蛋白質そしてピーク強化の有効な枯渇を提供すると見つけられた。 PMID: -出版業者によって供給される… 20685463 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A sequence-based approach to identify reference genes for gene expression analysis.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-385.html</link>
      <description>A sequence-based approach to identify reference genes for gene expression analysis. BMC Med Genomics. 2010 Aug 3;3(1):32 Authors: Chari R, Lonergan KM, Pikor LA, Coe BP, Zhu CQ, Chan TH, Macaulay CE, Tsao MS, Lam S, Ng RT, Lam WL ABSTRACT: BACKGROUND: An important consideration when analyzing both microarray and quantitative PCR expression data is the selection of appropriate genes as endogenous controls or reference genes. This step is especially critical when identifying genes differentially e ...</description>
        <pubDate>Fri, 06 Aug 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-385.html</guid>
        
      <content:encoded> <![CDATA[
    A sequence-based approach to identify reference genes for gene expression analysis. BMC Med Genomics. 2010 Aug 3;3(1):32 Authors: Chari R, Lonergan KM, Pikor LA, Coe BP, Zhu CQ, Chan TH, Macaulay CE, Tsao MS, Lam S, Ng RT, Lam WL ABSTRACT: BACKGROUND: An important consideration when analyzing both microarray and quantitative PCR expression data is the selection of appropriate genes as endogenous controls or reference genes. This step is especially critical when identifying genes differentially expressed between datasets. Moreover, reference genes suitable in one context (e.g. lung cancer) may not be suitable in another (e.g. breast cancer). Currently, the main approach to identify reference genes involves the mining of expression microarray data for highly expressed and relatively constant transcripts across a sample set. A caveat here is the requirement for transcript normalization prior to analysis, and measurements obtained are relative, not absolute. Alternatively, as sequencing-based technologies provide digital quantitative output, absolute quantification ensues, and reference gene identification becomes more accurate. METHODS: Serial analysis of gene expression (SAGE) profiles of non-malignant and malignant lung samples were compared using a permutation test to identify the most stably expressed genes across all samples. Subsequently, the specificity of the reference genes was evaluated across multiple tissue types, their constancy of expression was assessed using quantitative RT-PCR (qPCR), and their impact on differential expression analysis of microarray data was evaluated. RESULTS: We show that (i) conventional references genes such as ACTB and GAPDH are highly variable between cancerous and non-cancerous samples, (ii) reference genes identified for lung cancer do not perform well for other cancer types (breast and brain), (iii) reference genes identified through SAGE show low variability using qPCR in a different cohort of samples, and (iv) normalization of a lung cancer gene expression microarray dataset with or without our reference genes, yields different results for differential gene expression and subsequent analyses. Specifically, key established pathways in lung cancer exhibit higher statistical significance using a dataset normalized with our reference genes relative to normalization without using our reference genes. CONCLUSIONS: Our analyses found NDUFA1, RPL19, RAB5C, and RPS18 to occupy the top ranking positions among 15 suitable reference genes optimal for normalization of lung tissue expression data. Significantly, the approach used in this study can be applied to data generated using new generation sequencing platforms for the identification of reference genes optimal within diverse contexts. PMID: 20682026 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Copy number variation analysis in single-suture craniosynostosis: Multiple rare variants including RUNX2 duplication in two cousins with metopic craniosynostosis.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-387.html</link>
      <description> Copy number variation analysis in single-suture craniosynostosis: Multiple rare variants including RUNX2 duplication in two cousins with metopic craniosynostosis. Am J Med Genet A. 2010 Aug 3; Authors: Mefford HC, Shafer N, Antonacci F, Tsai JM, Park SS, Hing AV, Rieder MJ, Smyth MD, Speltz ML, Eichler EE, Cunningham ML Little is known about genes that underlie isolated single-suture craniosynostosis. In this study, we hypothesize that rare copy number variants (CNV) in patients with isolated s ...</description>
        <pubDate>Fri, 06 Aug 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-387.html</guid>
        
      <content:encoded> <![CDATA[
    

        Copy number variation analysis in single-suture craniosynostosis: Multiple rare variants including RUNX2 duplication in two cousins with metopic craniosynostosis.
        Am J Med Genet A. 2010 Aug 3;
        Authors:  Mefford HC, Shafer N, Antonacci F, Tsai JM, Park SS, Hing AV, Rieder MJ, Smyth MD, Speltz ML, Eichler EE, Cunningham ML
        Little is known about genes that underlie isolated single-suture craniosynostosis. In this study, we hypothesize that rare copy number variants (CNV) in patients with isolated single-suture craniosynostosis contain genes important for cranial development. Using whole genome array comparative genomic hybridization (CGH), we evaluated DNA from 186 individuals with single-suture craniosynostosis for submicroscopic deletions and duplications. We identified a 1.1 Mb duplication encompassing RUNX2 in two affected cousins with metopic synostosis and hypodontia. Given that RUNX2 is required as a master switch for osteoblast differentiation and interacts with TWIST1, mutations in which also cause craniosynostosis, we conclude that the duplication in this family is pathogenic, albeit with reduced penetrance. In addition, we find that a total of 7.5% of individuals with single-suture synostosis in our series have at least one rare deletion or duplication that contains genes and that has not been previously reported in unaffected individuals. The genes within and disrupted by CNVs in this cohort are potential novel candidate genes for craniosynostosis. (c) 2010 Wiley-Liss, Inc.
        PMID: 20683987 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Genetic variability at the PARK16 locus.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-386.html</link>
      <description> Genetic variability at the PARK16 locus. Eur J Hum Genet. 2010 Aug 4; Authors: Tucci A, Nalls MA, Houlden H, Revesz T, Singleton AB, Wood NW, Hardy J, PaisÃ¡n-Ruiz C Parkinson&apos;s disease (PD) is a complex neurodegenerative disease which is clinically heterogeneous and pathologically consists of loss of dopaminergic neurons in the substantia nigra and intracytoplasmic neuronal inclusions containing alpha-synuclein aggregations known as Lewy bodies. Although the majority of PD is idiopathic, p ...</description>
        <pubDate>Fri, 06 Aug 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-386.html</guid>
        
      <content:encoded> <![CDATA[
    

        Genetic variability at the PARK16 locus.
        Eur J Hum Genet. 2010 Aug 4;
        Authors:  Tucci A, Nalls MA, Houlden H, Revesz T, Singleton AB, Wood NW, Hardy J, PaisÃ¡n-Ruiz C
        Parkinson's disease (PD) is a complex neurodegenerative disease which is clinically heterogeneous and pathologically consists of loss of dopaminergic neurons in the substantia nigra and intracytoplasmic neuronal inclusions containing alpha-synuclein aggregations known as Lewy bodies. Although the majority of PD is idiopathic, pathogenic mutations in several mendelian genes have been successfully identified through linkage analyses. To identify susceptibility loci for idiopathic PD, several genome-wide association studies (GWAS) within different populations have recently been conducted in both idiopathic and familial forms of PD. These analyses have confirmed SNCA and MAPT as loci harboring PD susceptibility. In addition, the GWAS identified several other genetic loci suggestively associated with the risk of PD; among these, only one was replicated by two different studies of European and Asian ancestries. Hence, we investigated this novel locus known as PARK16 for coding mutations in a large series of idiopathic pathologically proven PD cases, and also conducted an association study in a case-control cohort from the United Kingdom. An association between a novel RAB7L1 mutation, c.379-12insT, and disease (P-value=0.0325) was identified. Two novel coding variants present only in the PD cohort were also identified within the RAB7L1 (p.K157R) and SLC41A1 (p.A350V) genes. No copy number variation analyses have yet been performed within this recently identified locus. We concluded that, although both coding variants and risk alleles within the PARK16 locus seem to be rare, further molecular analyses within the PARK16 locus and within different populations are required in order to examine its biochemical role in the disease process.European Journal of Human Genetics advance online publication, 4 August 2010; doi:10.1038/ejhg.2010.125.
        PMID: 20683486 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-149.html</link>
      <description> Related Articles Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood. 2009 Jul 2;114(1):181-6 Authors: Tanno T, Porayette P, Sripichai O, Noh SJ, Byrnes C, Bhupatiraju A, Lee YT, Goodnough JB, Harandi O, Ganz T, Paulson RF, Miller JL In thalassemia and other iron loading anemias, ineffective erythropoiesis and erythroid signaling molecules are thought to cause inappropriate suppression of a small peptide produced by hepatocytes n ...</description>
        <pubDate>Thu, 05 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-149.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood. 2009 Jul 2;114(1):181-6 Authors: Tanno T, Porayette P, Sripichai O, Noh SJ, Byrnes C, Bhupatiraju A, Lee YT, Goodnough JB, Harandi O, Ganz T, Paulson RF, Miller JL In thalassemia and other iron loading anemias, ineffective erythropoiesis and erythroid signaling molecules are thought to cause inappropriate suppression of a small peptide produced by hepatocytes named hepcidin. Previously, it was reported that the erythrokine GDF15 is expressed at very high levels in thalassemia and suppresses hepcidin expression. In this study, erythroblast expression of a second molecule named twisted gastrulation (TWSG1) was explored as a potential erythroid regulator of hepcidin. Transcriptome analyses suggest TWSG1 is produced during the earlier stages of erythropoiesis. Hepcidin suppression assays demonstrated inhibition by TWSG1 as measured by quantitative polymerase chain reaction (PCR) in dosed assays (1-1000 ng/mL TWSG1). In human cells, TWSG1 suppressed hepcidin indirectly by inhibiting the signaling effects and associated hepcidin up-regulation by bone morphogenic proteins 2 and 4 (BMP2/BMP4). In murine hepatocytes, hepcidin expression was inhibited by murine Twsg1 in the absence of additional BMP. In vivo studies of Twsg1 expression were performed in healthy and thalassemic mice. Twsg1 expression was significantly increased in the spleen, bone marrow, and liver of the thalassemic animals. These data demonstrate that twisted gastrulation protein interferes with BMP-mediated hepcidin expression and may act with GDF15 to dysregulate iron homeostasis in thalassemia syndromes. PMID: 19414861 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： ネズミ科およびヒト細胞のhepcidinの表現の第2新しいerythroid調整装置としてTWSG1の関連の記事の同一証明。 血。 7月2009日2日; 114 (1): 181-6書く: TannoによりT、Porayette P、Sripichai O、Noh SJ、Byrnes C、Bhupatiraju A、リーYT、Goodnough JB、Harandi O、Ganz T、Paulson RF、サラセミアのミラーJLおよび他の鉄のローディングの貧血症、非効果的な赤血球生成およびerythroidシグナリング分子はhepcidinと示されるhepatocytesによって作り出される小さいペプチッドの不適当な抑制を引き起こすと考えられる。 以前はerythrokine GDF15がサラセミアに非常に高いレベルに表現され、hepcidinの表現を抑制することが、報告された。 この調査では、第2分子のerythroblastの表現はhepcidinの潜在的なerythroid調整装置として歪んだgastrulation (TWSG1)を探検された示した。 Transcriptomeの分析はTWSG1が赤血球生成の初期の間に作り出されることを提案する。 Hepcidinの抑制は投薬された試金(1-1000 ng/mL TWSG1)の量的なポリメラーゼの連鎖反応(PCR)によって測定されるようにTWSG1によって示した阻止を試金する。 ヒト細胞では、TWSG1はシグナリング効果の禁止によってhepcidinを間接的に抑制し、骨のmorphogenic蛋白質2および4によってhepcidinの規則を関連付けた(BMP2/BMP4)。 ネズミ科のhepatocytesでは、hepcidinの表現は付加的なBMPがない時ネズミ科Twsg1によって禁じられた。 Twsg1表現の生体内の調査は健康な、thalassemicマウスで行われた。 Twsg1表現はthalassemic動物の脾臓、骨髄およびレバーでかなり高められた。 これらのデータは歪んだgastrulation蛋白質がBMP仲介されたhepcidinの表現と干渉し、GDF15とサラセミアシンドロームのdysregulateの鉄ホメオスタティスに機能するかもしれないことを示す。 PMID: 19414861 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-125.html</link>
      <description> Related Articles Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation. J Endocrinol. 2008 Dec;199(3):445-55 Authors: Takahashi M, Otsuka F, Miyoshi T, Otani H, Goto J, Yamashita M, Ogura T, Makino H, Doihara H Estrogen is involved in the development and progression of breast cancer. Here, we investigated the effects of bone morphogenetic proteins (BMPs) on breast cancer cell prol ...</description>
        <pubDate>Thu, 05 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-125.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation. J Endocrinol. 2008 Dec;199(3):445-55 Authors: Takahashi M, Otsuka F, Miyoshi T, Otani H, Goto J, Yamashita M, Ogura T, Makino H, Doihara H Estrogen is involved in the development and progression of breast cancer. Here, we investigated the effects of bone morphogenetic proteins (BMPs) on breast cancer cell proliferation caused by estrogen using human breast cancer MCF-7 cells. MCF-7 cells express estrogen receptors (ESR1 and ESR2), BMP receptors, and SMAD signaling molecules. Estradiol and membrane-impermeable estradiol stimulated MCF-7 cell proliferation. Estradiol also reduced mRNA levels of ESR1, aromatase, and steroid sulfatase. Treatment with BMPs and activin had no effects on MCF-7 cell proliferation. However, BMP2, BMP4, BMP6, BMP7, and activin suppressed estradiol-induced cell mitosis, with the effects of BMP6, BMP7, and activin being more prominent than those of BMP2 and BMP4. Activin decreased ESR1 mRNA expression, while BMP6 and BMP7 impaired steroid sulfatase expression in MCF-7 cells. Interestingly, SMAD1,5,8 activation elicited by BMP6 and BMP7, but not by BMP2 and BMP4, was preserved even under the exposure of a high concentration of estradiol. The difference of BMP responsiveness was likely due to the differential modulation of BMP receptor expression induced by estradiol. In this regard, estradiol decreased the expression levels of BMPR1A, BMPR1B, ACVR2A, and ACVR2B but did not affect ACVR1 and BMPRII, leading to the sustained effects of BMP6 and BMP7 in estrogen-treated MCF-7 cells. Estradiol rapidly activated MAPK phosphorylation including extracellular signal-regulated kinase 1/2, p38, and stress-activated protein kinase/c-Jun NH2-terminal kinase pathways and BMP6, BMP7, and activin preferentially inhibited estradiol-induced p38 phosphorylation. SB203580, a selective p38 MAPK inhibitor effectively suppressed estradiol-induced cell mitosis, suggesting that p38 MAPK plays a key role in estrogen-sensitive breast cancer cell proliferation. Thus, a novel interrelationship between estrogen and the breast cancer BMP system was uncovered, in which inhibitory effects of BMP6 and BMP7 on p38 signaling and steroid sulfatase expression were functionally involved in the suppression of estrogen-induced mitosis of breast cancer cells. PMID: 18780779 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The expression and crucial roles of BMP signaling in development of smooth muscle progenitor cells in the mouse embryonic gut.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-141.html</link>
      <description> Related Articles The expression and crucial roles of BMP signaling in development of smooth muscle progenitor cells in the mouse embryonic gut. Differentiation. 2009 Mar;77(3):277-89 Authors: Torihashi S, Hattori T, Hasegawa H, Kurahashi M, Ogaeri T, Fujimoto T Bone morphogenetic protein (BMP) signaling is essential for normal development of the gastrointestinal (GI) tract. BMPs also play multiple roles in vascular smooth muscle cells; however, the BMP signaling in the development of the GI mus ...</description>
        <pubDate>Thu, 05 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-141.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The expression and crucial roles of BMP signaling in development of smooth muscle progenitor cells in the mouse embryonic gut. Differentiation. 2009 Mar;77(3):277-89 Authors: Torihashi S, Hattori T, Hasegawa H, Kurahashi M, Ogaeri T, Fujimoto T Bone morphogenetic protein (BMP) signaling is essential for normal development of the gastrointestinal (GI) tract. BMPs also play multiple roles in vascular smooth muscle cells; however, the BMP signaling in the development of the GI musculature remains to be clarified. We investigated the expression of BMPs and their receptors in mouse embryonic GI tracts by immunohistochemistry and in situ hybridization. We demonstrated that BMP2, BMP receptor Ib and BMP receptor II were expressed in the smooth muscle progenitors from E12 to E13 for the first time. BMP signaling on smooth muscle differentiation was examined by implantation of agarose beads soaked with BMPs in the in vitro developmental model that is gut-like structures from mouse embryonic stem (ES) cells. BMP2 rather than BMP4 beads enhanced smooth muscle differentiation, and increased gut-like structures showing spontaneous contractions and expressing intensive alpha-smooth muscle actin immunoreactivity. This increase was confirmed by up-regulation of SM22 mRNA shown by real-time PCR. By addition of noggin beads or noggin to the medium at BMP2 bead implantation, the ratio of contractive gut-like structures decreased. Implantation of BMP2 beads at EB7 (EB--embryoid bodies) (corresponding to E12 or E13 of mouse embryo) showed the highest effects and up-regulation of transcription factors msx-1 after 24h. This increase was blocked by noggin, and msx-1 decreased to almost the control level after 60 h. BMP2 beads at EB7 increased platelet-derived growth factor-A (PDGF-A) in the differentiating smooth muscle cells. We have recently reported that PDGF-A is expressed in the developing inner circular smooth muscle and is crucial for the longitudinal smooth muscle differentiation. Taken together, BMP signaling was expressed for a short window in the smooth muscle progenitors and the signal, especially BMP2, plays an essential role in smooth muscle differentiation in cooperation with PDGF signaling. PMID: 19272526 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Histone deacetylases control neurogenesis in embryonic brain by inhibition of BMP2/4 signaling.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-117.html</link>
      <description> Related Articles Histone deacetylases control neurogenesis in embryonic brain by inhibition of BMP2/4 signaling. PLoS One. 2008;3(7):e2668 Authors: ShakÃ¨d M, WeissmÃ?ller K, Svoboda H, Hortschansky P, Nishino N, WÃ¶lfl S, Tucker KL BACKGROUND: Histone-modifying enzymes are essential for a wide variety of cellular processes dependent upon changes in gene expression. Histone deacetylases (HDACs) lead to the compaction of chromatin and subsequent silencing of gene transcription, and they  ...</description>
        <pubDate>Thu, 05 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-117.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Histone deacetylases control neurogenesis in embryonic brain by inhibition of BMP2/4 signaling. PLoS One. 2008;3(7):e2668 Authors: ShakÃ¨d M, WeissmÃ?ller K, Svoboda H, Hortschansky P, Nishino N, WÃ¶lfl S, Tucker KL BACKGROUND: Histone-modifying enzymes are essential for a wide variety of cellular processes dependent upon changes in gene expression. Histone deacetylases (HDACs) lead to the compaction of chromatin and subsequent silencing of gene transcription, and they have recently been implicated in a diversity of functions and dysfunctions in the postnatal and adult brain including ocular dominance plasticity, memory consolidation, drug addiction, and depression. Here we investigate the role of HDACs in the generation of neurons and astrocytes in the embryonic brain. PRINCIPAL FINDINGS: As a variety of HDACs are expressed in differentiating neural progenitor cells, we have taken a pharmacological approach to inhibit multiple family members. Inhibition of class I and II HDACs in developing mouse embryos with trichostatin A resulted in a dramatic reduction in neurogenesis in the ganglionic eminences and a modest increase in neurogenesis in the cortex. An identical effect was observed upon pharmacological inhibition of HDACs in in vitro-differentiating neural precursors derived from the same brain regions. A reduction in neurogenesis in ganglionic eminence-derived neural precursors was accompanied by an increase in the production of immature astrocytes. We show that HDACs control neurogenesis by inhibition of the bone morphogenetic protein BMP2/4 signaling pathway in radial glial cells. HDACs function at the transcriptional level by inhibiting and promoting, respectively, the expression of Bmp2 and Smad7, an intracellular inhibitor of BMP signaling. Inhibition of the BMP2/4 signaling pathway restored normal levels of neurogenesis and astrogliogenesis to both ganglionic eminence- and cortex-derived cultures in which HDACs were inhibited. CONCLUSIONS: Our results demonstrate a transcriptionally-based regulation of BMP2/4 signaling by HDACs both in vivo and in vitro that is critical for neurogenesis in the ganglionic eminences and that modulates cortical neurogenesis. The results also suggest that HDACs may regulate the developmental switch from neurogenesis to astrogliogenesis that occurs in late gestation. PMID: 18628975 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Investigation of the association of BMP gene variants with nephropathy in Type 1 diabetes mellitus.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-200.html</link>
      <description> Related Articles Investigation of the association of BMP gene variants with nephropathy in Type 1 diabetes mellitus. Diabet Med. 2010 Jun;27(6):624-30 Authors: McKnight AJ, Pettigrew KA, Patterson CC, Kilner J, Sadlier DM, Maxwell AP, AIMS: Diabetic nephropathy is a leading cause of end-stage renal disease. The transforming growth factor beta-bone morphogenic protein (BMP) pathway is implicated in the pathogenesis of diabetic nephropathy. The BMP2, BMP4 and BMP7 genes are located near linkage p ...</description>
        <pubDate>Thu, 05 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-200.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Investigation of the association of BMP gene variants with nephropathy in Type 1 diabetes mellitus. Diabet Med. 2010 Jun;27(6):624-30 Authors: McKnight AJ, Pettigrew KA, Patterson CC, Kilner J, Sadlier DM, Maxwell AP,  AIMS: Diabetic nephropathy is a leading cause of end-stage renal disease. The transforming growth factor beta-bone morphogenic protein (BMP) pathway is implicated in the pathogenesis of diabetic nephropathy. The BMP2, BMP4 and BMP7 genes are located near linkage peaks for renal dysfunction, and we hypothesize that genetic polymorphisms in these biological and positional candidate genes may be risk factors for diabetic kidney disease. METHODS: The BMP7 gene was screened, variants identified and allele frequencies determined by bidirectionally sequencing 46 individuals to facilitate selection of tag SNPs (n = 4). For BMP2 and BMP4 genes, data were downloaded for 19 single nucleotide polymorphisms (SNPs) from the International HapMap project and six tag SNPs selected. RESULTS: The BMP7 gene was screened for novel genetic polymorphisms, haplotypes were identified, an appropriate subset of variants selected for the investigation of common genetic risk factors, and BMP2, BMP4 and BMP7 genes assessed for association with diabetic nephropathy in 1808 individuals. Thirty-two SNPs were identified, of which 11 were novel, including an amino-acid changing SNP (+63639C>T). No significant differences (P > 0.2) were observed when comparing genotype or allele or haplotype frequencies between 864 individuals with Type 1 diabetes and nephropathy compared with 944 individuals with Type 1 diabetes without nephropathy, stratified by recruitment centre. CONCLUSIONS: Common polymorphisms in these BMP genes do not strongly influence genetic susceptibility to diabetic nephropathy in White individuals with Type 1 diabetes mellitus. PMID: 20546278 [PubMed - in process]（【斜め読み用】機械翻訳： タイプ1の糖尿病mellitusのネフロパシーを用いるBMPの遺伝子の変形の連合の関連の記事の調査。 Diabet Med。 6月2010日; 27 (6): 624-30書く: 、PettigrewのKA AJ、McKnight Patterson CC、Kilner J、Sadlier DMのマックスウェルAPは、向ける: 糖尿病性のネフロパシーは末期の腎臓病の一流の原因である。 形質転換成長因子のベータ骨morphogenic蛋白質(BMP)の細道は糖尿病性のネフロパシーの病因で関係する。 BMP2、BMP4およびBMP7遺伝子は腎臓の機能障害のための連結ピーク近くにあり、これらの生物的および定位置候補者の遺伝子の遺伝の多形が糖尿病性の腎臓病のための危険率であるかもしれないことを私達は仮定する。 方法: BMP7遺伝子は選別された、変形および二方向に札SNPsの選択を促進するために46人の個人を配列することによって定められた対立遺伝子の頻度は識別された(n = 4)。 BMP2およびBMP4遺伝子のために、データはHapMapの国際的なプロジェクトからの19の単一のヌクレオチドの多形(SNPs)のためにダウンロードされ、6札SNPsは選んだ。 結果: BMP7遺伝子は新しい遺伝の多形、haplotypesのために識別された選別された、共通の遺伝の危険率の調査に、およびBMP2選ばれた、変形の適切なサブセットBMP4およびBMP7遺伝子は1808人の個人の糖尿病性のネフロパシーを用いる連合のために査定された。 11が新しかった32 SNPsはSNP (+63639C&gtを変えるアミノ酸を含んで識別された; T)。 重要な相違無し(Pの> 0.2は)遺伝子型を比較するとき観察されたまたはタイプ1の糖尿病を持つ864人の個人とネフロパシー間の対立遺伝子またはhaplotypeの頻度は募集の中心によって成層化したネフロパシーなしでタイプ1の糖尿病を持つ944人の個人と比較した。 結論: これらのBMPの遺伝子の共通の多形は強くタイプ1の糖尿病mellitusの白い個人の糖尿病性のネフロパシーへの遺伝の感受性に影響を及ぼさない。 PMID: 20546278 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The bone morphogenetic protein antagonist gremlin promotes vascular smooth muscle cell apoptosis.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-133.html</link>
      <description> Related Articles The bone morphogenetic protein antagonist gremlin promotes vascular smooth muscle cell apoptosis. J Vasc Res. 2009;46(4):325-32 Authors: Maciel TT, Melo RS, Campos AH BACKGROUND: Previous studies from our laboratory demonstrated that gremlin significantly increases vascular smooth muscle cell (VSMC) proliferation and migration. The present study investigates gremlin expression in the initial stages of rat carotid balloon injury and its effects on VSMC apoptosis. METHODS: Gremli ...</description>
        <pubDate>Thu, 05 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-133.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The bone morphogenetic protein antagonist gremlin promotes vascular smooth muscle cell apoptosis. J Vasc Res. 2009;46(4):325-32 Authors: Maciel TT, Melo RS, Campos AH BACKGROUND: Previous studies from our laboratory demonstrated that gremlin significantly increases vascular smooth muscle cell (VSMC) proliferation and migration. The present study investigates gremlin expression in the initial stages of rat carotid balloon injury and its effects on VSMC apoptosis. METHODS: Gremlin mRNA expression was evaluated in rat carotids and cultured VSMCs by quantitative PCR. Apoptosis was analyzed in A7r5 cells and rabbit primary VSMCs following gremlin gene overexpression or silencing by chromatin morphology and caspase-3 activity. RESULTS: Vascular injury promoted a significant decrease in gremlin mRNA levels. In addition, platelet-derived growth factor, angiotensin II and transforming growth factor (TGF)-beta1 promoted coordinated regulation of gremlin and bone morphogenetic protein (BMP)-4 expression in opposite directions according to the confluence status of VSMC culture. In A7r5 cells, gremlin overexpression was able to increase apoptosis, as demonstrated by chromatin morphology and caspase-3 activity, while BMP administration promoted opposite effects. Finally, in agreement with our results, gremlin gene silencing effectively suppressed apoptosis in A7r5 cells and rabbit VSMCs. CONCLUSION: Gremlin is regulated by growth factors and vascular injury and is involved in modulation of VSMC apoptosis. Modifications of gremlin expression during vascular injury may contribute to the apoptosis resistance of VSMCs. PMID: 19142012 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事は骨morphogenetic蛋白質の反対者のgremlin管の滑らかな筋肉細胞のapoptosisを促進する。 J Vasc Res。 2009年; 46 (4): 325-32書く: Maciel TT、Melo RSのカンポスのああ背景: 私達の実験室からの前の調査はgremlinがかなり管の滑らかな筋肉細胞(VSMC)拡散および移動を高めることを示した。 現在の調査はラットのVSMCのapoptosisに対するcarotid気球の傷害そして効果の最初の段階のgremlinの表現を調査する。 方法: Gremlin mRNAの表現はラットのcarotidsで評価され、量的なPCRによってVSMCsを培養した。 ApoptosisはA7r5細胞およびgremlinの遺伝子のoverexpressionの後のウサギ第一次VSMCsまたはchromatinの形態およびcaspase-3活動によって沈黙で分析された。 結果: 管の傷害はgremlin mRNAのレベルの重要な減少を促進した。 さらに、血小板得られた成長因子、アンギオテンシンIIおよび形質転換成長因子(TGF) -促進されたbeta1 gremlinおよび骨のmorphogenetic蛋白質(BMP)はの規則を-調整したVSMC文化の合流の状態に従う反対の方向の4表現。 A7r5細胞では、gremlinのoverexpressionはBMPの管理は効果の反対に促進したがchromatinの形態およびcaspase-3活動によって示されるようにapoptosisを、増加できた。 最後に、私達の結果に一致して、効果的に沈黙するgremlinの遺伝子はA7r5細胞およびウサギVSMCsのapoptosisを抑制した。 結論: Gremlinは成長因子および管の傷害によって調整され、VSMCのapoptosisの調節にかかわる。 管の傷害の間のgremlinの表現の修正はVSMCsのapoptosisの抵抗に貢献するかもしれない。 PMID: 19142012 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Divergent Modulation of Adipose-Derived Stromal Cell Differentiation by TGF-beta1 Based on Species of Derivation.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-201.html</link>
      <description>Divergent Modulation of Adipose-Derived Stromal Cell Differentiation by TGF-beta1 Based on Species of Derivation. Plast Reconstr Surg. 2010 Aug;126(2):412-25 Authors: Levi B, James AW, Xu Y, Commons GW, Longaker MT BACKGROUND:: Adipose-derived stromal cells hold promise for skeletal tissue engineering. However, various studies have observed that adipose-derived stromal cells differ significantly in their biology depending on species of derivation. In the following study, the authors sought to de ...</description>
        <pubDate>Thu, 05 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-201.html</guid>
        
      <content:encoded> <![CDATA[
    Divergent Modulation of Adipose-Derived Stromal Cell Differentiation by TGF-beta1 Based on Species of Derivation. Plast Reconstr Surg. 2010 Aug;126(2):412-25 Authors: Levi B, James AW, Xu Y, Commons GW, Longaker MT BACKGROUND:: Adipose-derived stromal cells hold promise for skeletal tissue engineering. However, various studies have observed that adipose-derived stromal cells differ significantly in their biology depending on species of derivation. In the following study, the authors sought to determine the species-specific response of adipose-derived stromal cells to recombinant TGF-beta1 (rTGF-beta1). METHODS:: Adipose-derived stromal cells were derived from mouse and human sources. Recombinant TGF-beta1 was added to culture medium (2.5 to 10 ng/ml); proliferation and osteogenic and adipogenic differentiation were assessed by standardized parameters, including cell counting, alkaline phosphatase, alizarin red, oil red O staining, and quantitative real-time polymerase chain reaction. RESULTS:: Recombinant TGF-beta1 was found to significantly repress cellular proliferation in both mouse and human adipose-derived stromal cells (p < 0.01). Recombinant TGF-beta1 was found to significantly repress osteogenic differentiation in mouse adipose-derived stromal cells. In contrast, osteogenic differentiation of human adipose-derived stromal cells proceeded unimpeded in either the presence or the absence of rTGF-beta1. Interestingly, rTGF-beta1 induced expression of a number of osteogenic genes in human adipose-derived stromal cells, including BMP2 and BMP4. CONCLUSIONS:: The authors' results further detail an important facet in which mouse and human adipose-derived stromal cells differ. Mouse adipose-derived stromal cell osteogenesis is completely inhibited by rTGF-beta1, whereas human adipose-derived stromal cell osteogenesis progresses in the presence of rTGF-beta1. These data highlight the importance of species of derivation in basic adipose-derived stromal cell biology. Future studies will examine in more detail the species-specific differences among adipose-derived stromal cell populations. PMID: 20679827 [PubMed - in process]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>NU-IN: Nucleotide evolution and input module for the EvolSimulator genome simulation platform.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-383.html</link>
      <description> NU-IN: Nucleotide evolution and input module for the EvolSimulator genome simulation platform. BMC Res Notes. 2010 Aug 2;3(1):217 Authors: Dlugosch KM, Barker MS, Rieseberg LH ABSTRACT: BACKGROUND: There is increasing demand to test hypotheses that contrast the evolution of genes and gene families among genomes, using simulations that work across these levels of organization. The EvolSimulator program was developed recently to provide a highly flexible platform for forward simulations of amino  ...</description>
        <pubDate>Thu, 05 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-383.html</guid>
        
      <content:encoded> <![CDATA[
    

        NU-IN: Nucleotide evolution and input module for the EvolSimulator genome simulation platform.
        BMC Res Notes. 2010 Aug 2;3(1):217
        Authors:  Dlugosch KM, Barker MS, Rieseberg LH
        ABSTRACT: BACKGROUND: There is increasing demand to test hypotheses that contrast the evolution of genes and gene families among genomes, using simulations that work across these levels of organization. The EvolSimulator program was developed recently to provide a highly flexible platform for forward simulations of amino acid evolution in multiple related lineages of haploid genomes, permitting copy number variation and lateral gene transfer. Synonymous nucleotide evolution is not currently supported, however, and would be highly advantageous for comparisons to full genome, transcriptome, and single nucleotide polymorphism (SNP) datasets. In addition, EvolSimulator creates new genomes for each simulation, and does not allow the input of user-specified sequences and gene family information, limiting the incorporation of further biological realism and/or user manipulations of the data. FINDINGS: We present modified C++ source code for the EvolSimulator platform, which we provide as the extension module NU-IN. With NU-IN, synonymous and non-synonymous nucleotide evolution is fully implemented, and the user has the ability to use real or previously-simulated sequence data to initiate a simulation of one or more lineages. Gene family membership can be optionally specified, as well as gene retention probabilities that model biased gene retention. We provide PERL scripts to assist the user in deriving this information from previous simulations. We demonstrate the features of NU-IN by simulating genome duplication (polyploidy) in the presence of ongoing copy number variation in an evolving lineage. This example is initiated with real genomic data, and produces output that we analyse directly with existing bioinformatic pipelines. CONCLUSIONS: The NU-IN extension module is a publicly available open source software (GNU GPLv3 license) extension to EvolSimulator. With the NU-IN module, users are now able to simulate both drift and selection at the nucleotide, amino acid, copy number, and gene family levels across sets of related genomes, for user-specified starting sequences and associated parameters. These features can be used to generate simulated genomic datasets under an extremely broad array of conditions, and with a high degree of biological realism.
        PMID: 20678216 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A large-scale survey of the novel 15q24 microdeletion syndrome in autism spectrum disorders identifies an atypical deletion that narrows the critical region.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-384.html</link>
      <description>A large-scale survey of the novel 15q24 microdeletion syndrome in autism spectrum disorders identifies an atypical deletion that narrows the critical region. Mol Autism. 2010;1(1):5 Authors: McInnes LA, Nakamine A, Pilorge M, Brandt T, JimÃ©nez GonzÃ¡lez P, Fallas M, Manghi ER, Edelmann L, Glessner J, Hakonarson H, Betancur C, Buxbaum JD ABSTRACT: BACKGROUND: The 15q24 microdeletion syndrome has been recently described as a recurrent, submicroscopic genomic imbalance found in individuals ...</description>
        <pubDate>Thu, 05 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-384.html</guid>
        
      <content:encoded> <![CDATA[
    A large-scale survey of the novel 15q24 microdeletion syndrome in autism spectrum disorders identifies an atypical deletion that narrows the critical region. Mol Autism. 2010;1(1):5 Authors: McInnes LA, Nakamine A, Pilorge M, Brandt T, JimÃ©nez GonzÃ¡lez P, Fallas M, Manghi ER, Edelmann L, Glessner J, Hakonarson H, Betancur C, Buxbaum JD ABSTRACT: BACKGROUND: The 15q24 microdeletion syndrome has been recently described as a recurrent, submicroscopic genomic imbalance found in individuals with intellectual disability, typical facial appearance, hypotonia, and digital and genital abnormalities. Gene dosage abnormalities, including copy number variations (CNVs), have been identified in a significant fraction of individuals with autism spectrum disorders (ASDs). In this study we surveyed two ASD cohorts for 15q24 abnormalities to assess the frequency of genomic imbalances in this interval. METHODS: We screened 173 unrelated subjects with ASD from the Central Valley of Costa Rica and 1336 subjects with ASD from 785 independent families registered with the Autism Genetic Resource Exchange (AGRE) for CNVs across 15q24 using oligonucleotide arrays. Rearrangements were confirmed by array comparative genomic hybridization and quantitative PCR. RESULTS: Among the patients from Costa Rica, an atypical de novo deletion of 3.06 Mb in 15q23-q24.1 was detected in a boy with autism sharing many features with the other 13 subjects with the 15q24 microdeletion syndrome described to date. He exhibited intellectual disability, constant smiling, characteristic facial features (high anterior hairline, broad medial eyebrows, epicanthal folds, hypertelorism, full lower lip and protuberant, posteriorly rotated ears), single palmar crease, toe syndactyly and congenital nystagmus. The deletion breakpoints are atypical and lie outside previously characterized low copy repeats (69,838-72,897 Mb). Genotyping data revealed that the deletion had occurred in the paternal chromosome. Among the AGRE families, no large 15q24 deletions were observed. CONCLUSIONS: From the current and previous studies, deletions in the 15q24 region represent rare causes of ASDs with an estimated frequency of 0.1 to 0.2% in individuals ascertained for ASDs, although the proportion might be higher in sporadic cases. These rates compare with a frequency of about 0.3% in patients ascertained for unexplained intellectual disability and congenital anomalies. This atypical deletion reduces the minimal interval for the syndrome from 1.75 Mb to 766 kb, implicating a reduced number of genes (15 versus 38). Sequencing of genes in the 15q24 interval in large ASD and intellectual disability samples may identify mutations of etiologic importance in the development of these disorders. PMID: 20678247 [PubMed - in process]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A domain insertion in Escherichia coli GyrB adopts a novel fold that plays a critical role in gyrase function.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-382.html</link>
      <description> A domain insertion in Escherichia coli GyrB adopts a novel fold that plays a critical role in gyrase function. Nucleic Acids Res. 2010 Jul 31; Authors: Schoeffler AJ, May AP, Berger JM DNA topoisomerases manage chromosome supercoiling and organization in all forms of life. Gyrase, a prokaryotic heterotetrameric type IIA topo, introduces negative supercoils into DNA by an ATP-dependent strand passage mechanism. All gyrase orthologs rely on a homologous set of catalytic domains for function; howe ...</description>
        <pubDate>Wed, 04 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-382.html</guid>
        
      <content:encoded> <![CDATA[
    

        A domain insertion in Escherichia coli GyrB adopts a novel fold that plays a critical role in gyrase function.
        Nucleic Acids Res. 2010 Jul 31;
        Authors:  Schoeffler AJ, May AP, Berger JM
        DNA topoisomerases manage chromosome supercoiling and organization in all forms of life. Gyrase, a prokaryotic heterotetrameric type IIA topo, introduces negative supercoils into DNA by an ATP-dependent strand passage mechanism. All gyrase orthologs rely on a homologous set of catalytic domains for function; however, these enzymes also can possess species-specific auxiliary regions. The gyrases of many gram-negative bacteria harbor a 170-amino acid insertion of unknown architecture and function in the metal- and DNA-binding TOPRIM domain of the GyrB subunit. We have determined the structure of the 212 kDa Escherichia coli gyrase DNA binding and cleavage core containing this insert to 3.1 A resolution. We find that the insert adopts a novel, extended fold that braces the GyrB TOPRIM domain against the coiled-coil arms of its partner GyrA subunit. Structure-guided deletion of the insert greatly reduces the DNA binding, supercoiling and DNA-stimulated ATPase activities of gyrase. Mutation of a single amino acid at the contact point between the insert and GyrA more modestly impairs supercoiling and ATP turnover, and does not affect DNA binding. Our data indicate that the insert has two functions, acting as a steric buttress to pre-configure the primary DNA-binding site, and serving as a relay that may help coordinate communication between different functional domains.
        PMID: 20675723 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Useful genetic variation databases for oncologists investigating the genetic basis of variable treatment response and survival in cancer.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-380.html</link>
      <description> Useful genetic variation databases for oncologists investigating the genetic basis of variable treatment response and survival in cancer. Acta Oncol. 2010 Jul 29; Authors: Savas S Abstract Identification of the genetic basis of variable treatment response, prognosis and survival in cancer patients (i.e. personalized medicine) is an important aim in current medicine. Millions of genetic variations exist in the human genome, some of which are already found to be directly involved in variable trea ...</description>
        <pubDate>Sun, 01 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-380.html</guid>
        
      <content:encoded> <![CDATA[
    

        Useful genetic variation databases for oncologists investigating the genetic basis of variable treatment response and survival in cancer.
        Acta Oncol. 2010 Jul 29;
        Authors:  Savas S
        Abstract Identification of the genetic basis of variable treatment response, prognosis and survival in cancer patients (i.e. personalized medicine) is an important aim in current medicine. Millions of genetic variations exist in the human genome, some of which are already found to be directly involved in variable treatment response and survival among cancer patients. Genetic variation databases. Special databases curate, compile, organize and post information related to these genetic variations for the scientific community in a user friendly and free-to-access manner via the World Wide Web. Future directions and conclusion. Clinicians have a critical role in genetic predictive and prognostic studies. In this review, main public-domain databases on genetic variations, including the two comprehensive genetic variation databases (dbSNP and HapMap), a pharmacogenomics database (PharmGKB), two resequencing-based genetic variation databases (SeattleSNPs and EGP), a population-based genetic variation database (JSNPs), and a copy-number variant database (DGV), and their utility in cancer research are discussed. Utilization of these databases can assist clinicians in their studies related to treatment response and prognosis in cancer patients.
        PMID: 20670087 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Varietas: a functional variation database portal.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-381.html</link>
      <description> Varietas: a functional variation database portal. Database (Oxford). 2010;2010:baq016 Authors: Paananen J, Ciszek R, Wong G Current high-throughput technologies for investigating genomic variation in large population based samples produce data on a scale of millions of variations. Browsing through these results and identifying relevant functional variations is a major hurdle in these genome-wide association studies. In order to help researchers locate the most promising associations, we have de ...</description>
        <pubDate>Sun, 01 Aug 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-381.html</guid>
        
      <content:encoded> <![CDATA[
    

        Varietas: a functional variation database portal.
        Database (Oxford). 2010;2010:baq016
        Authors:  Paananen J, Ciszek R, Wong G
        Current high-throughput technologies for investigating genomic variation in large population based samples produce data on a scale of millions of variations. Browsing through these results and identifying relevant functional variations is a major hurdle in these genome-wide association studies. In order to help researchers locate the most promising associations, we have developed a web-based database portal called Varietas. Varietas can be used for retrieving information concerning genomic variations such as single-nucleotide polymorphisms (SNPs), copy number variants and insertions/deletions, while enabling users to annotate large number of variations in a batch like manner and to find information about related genes, phenotypes and diseases. Varietas also links out to various external genomic databases, allowing users to quickly browse through a set of variations and follow the most promising leads. Varietas periodically integrates data from the major SNP and genome databases, including Ensembl genome database, NCBI dbSNP database, The Genomic Association Database and SNPedia. Database URL: http://kokki.uku.fi/bioinformatics/varietas/
        PMID: 20671203 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>URINE PROTEOME ANALYSIS MAY ALLOW NON-INVASIVE DIFFERENTIAL DIAGNOSIS OF DIABETIC NEPHROPATHY.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-223.html</link>
      <description>URINE PROTEOME ANALYSIS MAY ALLOW NON-INVASIVE DIFFERENTIAL DIAGNOSIS OF DIABETIC NEPHROPATHY. Diabetes Care. 2010 Jul 29; Authors: Papale M, Di Paolo S, Magistroni R, Lamacchia O, De Mattia A, Teresa Rocchetti M, Furci L, Pasquali S, De Cosmo S, Cignarelli M, Gesualdo L AbstractObjective: Chronic renal insufficiency and/or proteinuria in type 2 diabetes may stem from chronic renal diseases (CKD) other than classic diabetic nephropathy (DN) in over one third of cases. We interrogated urine prote ...</description>
        <pubDate>Sun, 01 Aug 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-223.html</guid>
        
      <content:encoded> <![CDATA[
    URINE PROTEOME ANALYSIS MAY ALLOW NON-INVASIVE DIFFERENTIAL DIAGNOSIS OF DIABETIC NEPHROPATHY. Diabetes Care. 2010 Jul 29; Authors: Papale M, Di Paolo S, Magistroni R, Lamacchia O, De Mattia A, Teresa Rocchetti M, Furci L, Pasquali S, De Cosmo S, Cignarelli M, Gesualdo L AbstractObjective: Chronic renal insufficiency and/or proteinuria in type 2 diabetes may stem from chronic renal diseases (CKD) other than classic diabetic nephropathy (DN) in over one third of cases. We interrogated urine proteomic profiles generated by SELDI-TOF/MS with the aim to isolate a set of biomarkers able to reliably identify biopsy-proven DN and to establish a stringent correlation with the different patterns of renal injury. Research design and methods: Ten mug urine proteins from 190 subjects [20 healthy subjects (HS), 20 normoalbuminuric (NAD) and 18 microalbuminuric (MICRO) diabetic patients, and 132 patients with biopsy-proven nephropathy (65 DN, 10 diabetics with non-diabetic CKD (nd-CKD) and 57 non-diabetic patients with CKD)] were run by CM10 ProteinChip array and analysed by supervised learning methods (CART analysis). Results: The classification model correctly identified 75% NAD, 87.5% MICRO and 87.5% DN when applied to a blinded testing set. Most importantly, it was able to reliably differentiate DN from nd-CKD in both diabetic and non-diabetic patients. Among the best predictors of the classification model, we identified and validated 2 proteins, ubiquitin and ss2-microglobulin. Conclusions: Our data suggest the presence of a specific urine proteomic signature able to reliably identify type 2 diabetic patients with diabetic glomerulosclerosis. PMID: 20671095 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 尿PROTEOMEの分析は糖尿病性のネフロパシーの非侵襲的な差動診断を可能にするかもしれない。 糖尿病の心配。 7月2010日29日; 著者: Papale M、DiパウロS、Magistroni R、Lamacchia O、De Mattia、テレサRocchetti M、Furci L、Pasquali S、De Cosmo S、Cignarelli M、Gesualdo L AbstractObjective: タイプ2の糖尿病の慢性の腎臓不十分やproteinuriaは慢性の腎臓病(CKD)から場合の3分の1上の古典的な糖尿病性のネフロパシー(DN)以外生じるかもしれない。 私達は確実にバイオプシー証明されたDNを識別し、腎臓の傷害の異なったパターンとの厳しい相関関係を確立することできる一組のbiomarkersを隔離するために目標を用いるSELDI-TOF/MSによって発生した尿のproteomicプロフィールに質問した。 研究設計および方法: 190人の主題[20人の健常者(HS)からの10のマグの尿蛋白質、20 normoalbuminuric (NAD)および18人のmicroalbuminuric (マイクロ)糖尿病性の患者およびバイオプシー証明されたネフロパシー(65 DN、10人の糖尿病患者およびCKDを持つ非糖尿病性CKD (ndCKD)を用いる132人の患者を持つ57人の非糖尿病性の患者)] CM10 ProteinChipの配列によって動かされ、指示された学習方法(カートの分析)によって分析された。 結果: 分類モデルは正しく盲目にされたテストに適用されたとき75% NAD、マイクロ87.5%および87.5% DNを置いた識別した。 最も重要な点として、それは確実に糖尿病性および非糖尿病性の患者のndCKDからのDNを区別ことはできた。 分類モデルの最もよい予言者の間で、私達は2蛋白質、ubiquitinおよびss2-microglobulinを識別し、認可した。 結論: 私達のデータは確実に糖尿病性のglomerulosclerosisのタイプ2の糖尿病性の患者を識別することできる特定の尿のproteomic署名の存在を提案する。 PMID: -出版業者によって供給される… 20671095 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A genomewide scan for common alleles affecting risk for autism.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-379.html</link>
      <description> A genomewide scan for common alleles affecting risk for autism. Hum Mol Genet. 2010 Jul 27; Authors: Anney R, Klei L, Pinto D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, Sykes N, Pagnamenta AT, Almeida J, Bacchelli E, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, BÃ¶lte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Carson AR, Casallo G, Casey J, Chu S, Cochrane L, Corsello C, Crawford EL, Crossett A, Dawson G, de Jonge M, Delorme R, Drmic I, Duketis E, Duque F, Este ...</description>
        <pubDate>Fri, 30 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-379.html</guid>
        
      <content:encoded> <![CDATA[
    

        A genomewide scan for common alleles affecting risk for autism.
        Hum Mol Genet. 2010 Jul 27;
        Authors:  Anney R, Klei L, Pinto D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, Sykes N, Pagnamenta AT, Almeida J, Bacchelli E, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, BÃ¶lte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Carson AR, Casallo G, Casey J, Chu S, Cochrane L, Corsello C, Crawford EL, Crossett A, Dawson G, de Jonge M, Delorme R, Drmic I, Duketis E, Duque F, Estes A, Farrar P, Fernandez BA, Folstein SE, Fombonne E, Freitag CM, Gilbert J, Gillberg C, Glessner JT, Goldberg J, Green A, Green J, Guter SJ, Hakonarson H, Heron EA, Hill M, Holt R, Howe JL, Hughes G, Hus V, Igliozzi R, Kim C, Klauck SM, Kolevzon A, Korvatska O, Kustanovich V, Lajonchere CM, Lamb JA, Laskawiec M, Leboyer M, Le Couteur A, Leventhal BL, Lionel AC, Liu XQ, Lord C, Lotspeich L, Lund SC, Maestrini E, Mahoney W, Mantoulan C, Marshall CR, McConachie H, McDougle CJ, McGrath J, McMahon WM, Melhem NM, Merikangas A, Migita O, Minshew NJ, Mirza GK, Munson J, Nelson SF, Noakes C, Noor A, Nygren G, Oliveira G, Papanikolaou K, Parr JR, Parrini B, Paton T, Pickles A, Piven J, Posey DJ, Poustka A, Poustka F, Prasad A, Ragoussis J, Renshaw K, Rickaby J, Roberts W, Roeder K, Roge B, Rutter ML, Bierut LJ, Rice JP, Salt J, Sansom K, Sato D, Segurado R, Senman L, Shah N, Sheffield VC, Soorya L, Sousa I, Stoppioni V, Strawbridge C, Tancredi R, Tansey K, Thiruvahindrapduram B, Thompson AP, Thomson S, Tryfon A, Tsiantis J, Van Engeland H, Vincent JB, Volkmar F, Wallace S, Wang K, Wang Z, Wassink TH, Wing K, Wittemeyer K, Wood S, Yaspan BL, Zurawiecki D, Zwaigenbaum L, Betancur C, Buxbaum JD, Cantor RM, Cook EH, Coon H, Cuccaro ML, Gallagher L, Geschwind DH, Gill M, Haines JL, Miller J, Monaco AP, Nurnberger JI, Paterson AD, Pericak-Vance MA, Schellenberg GD, Scherer SW, Sutcliffe JS, Szatmari P, Vicente AM, Vieland VJ, Wijsman EM, Devlin B, Ennis S, Hallmayer J
        While autism spectrum disorders (ASDs) have a substantial genetic basis, most of the known genetic risk has been traced to rare variants, principally copy number variants (CNVs). To identify common risk variation, the Autism Genome Project (AGP) Consortium genotyped 1,558 rigorously defined ASD families for one million single nucleotide polymorphisms (SNPs) and analyzed these SNP genotypes for association with ASD. In one of four primary association analyses, the association signal for marker rs4141463, located within MACROD2, crossed the genome-wide association significance threshold of P<5x10(-8). When a smaller replication sample was analyzed, the risk allele at rs4141463 was again over-transmitted; yet, consistent with the winner's curse, its effect size in the replication sample was much smaller; and, for the combined samples, the association signal barely fell below the P<5x10(-8) threshold. Exploratory analyses of phenotypic subtypes yielded no significant associations after correction for multiple testing. They did, however, yield strong signals within several genes, KIAA0564, PLD5, POU6F2, ST8SIA2, and TAF1C.
        PMID: 20663923 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>ProteoMiner() and SELDI-TOF-MS: A robust and highly reproducible combination for biomarker discovery from whole blood serum.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-221.html</link>
      <description>ProteoMiner() and SELDI-TOF-MS: A robust and highly reproducible combination for biomarker discovery from whole blood serum. Arch Physiol Biochem. 2010 Jul 22; Authors: FrÃ¶bel J, Hartwig S, PaÃ?lack W, Eckel J, Haas R, Czibere A, Lehr S Surface-enhanced laser desorption ionization time of flight mass spectrometry (SELDI-TOF-MS) has been recognized as an appropriate technology for biomarker discovery. Nevertheless, whenever human blood serum is studied, its sensitivity is restricted due to  ...</description>
        <pubDate>Fri, 30 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-221.html</guid>
        
      <content:encoded> <![CDATA[
    ProteoMiner() and SELDI-TOF-MS: A robust and highly reproducible combination for biomarker discovery from whole blood serum. Arch Physiol Biochem. 2010 Jul 22; Authors: FrÃ¶bel J, Hartwig S, PaÃ?lack W, Eckel J, Haas R, Czibere A, Lehr S Surface-enhanced laser desorption ionization time of flight mass spectrometry (SELDI-TOF-MS) has been recognized as an appropriate technology for biomarker discovery. Nevertheless, whenever human blood serum is studied, its sensitivity is restricted due to the wide dynamic range of serum protein concentrations. In this context, sample pre-fractionation targeting the low abundant proteins may help to overcome these limitations. Here, we evaluate the combination of ProteoMiner pre-fractionation and SELDI based protein profiling. We introduce a simplified workflow and demonstrate the high sensitivity and reproducibility of this combined profiling approach. Our analyses show that this combination is suitable for large-scale serum proteome profiling studies yielding reliable and reproducible results. PMID: 20662595 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： ProteoMiner ()およびSELDI-TOF-MS: 全血の血清からのbiomarkerの発見のための強く、非常に再生可能な組合せ。 アーチのPhysiol Biochem。 7月2010日22日; 著者: FrÃ¶bel J、ハートウィグSのPaÃの?の欠乏W、Eckel J、Haas R、Czibere A、質量分析(SELDI-TOF-MS)レーザーの脱着のイオン化表面高められるbiomarkerの発見のための適切な技術としてLehr Sは経過時間確認された。 それにもかかわらず、人の血液の血清が調査される時はいつでも、感受性は血清蛋白質の集中の広いダイナミックレンジが限られた原因である。 この文脈では、低く豊富な蛋白質を目標とするサンプル前分別はこれらの限定の克服を助けるかもしれない。 ここでは、私達はProteoMinerの前分別およびSELDIによって基づく蛋白質の側面図を描くことの組合せを評価する。 私達は簡単だったワークフローを導入し、結合されるこれの高い感受性そして再現性を示しアプローチの側面図を描く。 私達の分析はこの組合せが信頼でき、再生可能な結果をもたらす調査の側面図を描く大規模な血清のproteomeのために適していることを示す。 PMID: -出版業者によって供給される… 20662595 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Detection of nasopharyngeal carcinoma using surface-enhanced laser desorption and ionization mass spectrometry profiles of the serum proteome.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-222.html</link>
      <description>Detection of nasopharyngeal carcinoma using surface-enhanced laser desorption and ionization mass spectrometry profiles of the serum proteome. Chin J Cancer. 2010 Aug;29(8):721-8 Authors: Cao SM, Yu JK, Chen QY, Li NW, Xiang YQ, Qian CN, Hu X, Zhang CQ, Xie D, Guo X Background and Objective: Early diagnosis of nasopharyngeal carcinoma (NPC) is difficult due to the insufficient specificity of the conventional examination method. This study was to investigate potential and consistent biomarkers fo ...</description>
        <pubDate>Fri, 30 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-222.html</guid>
        
      <content:encoded> <![CDATA[
    Detection of nasopharyngeal carcinoma using surface-enhanced laser desorption and ionization mass spectrometry profiles of the serum proteome. Chin J Cancer. 2010 Aug;29(8):721-8 Authors: Cao SM, Yu JK, Chen QY, Li NW, Xiang YQ, Qian CN, Hu X, Zhang CQ, Xie D, Guo X Background and Objective: Early diagnosis of nasopharyngeal carcinoma (NPC) is difficult due to the insufficient specificity of the conventional examination method. This study was to investigate potential and consistent biomarkers for NPC, particularly for early detection of NPC. Methods: A proteomic pattern was identified in a training set (134 NPC patients and 73 control individuals) using the surface-enhanced laser desorption and ionization-mass spectrometry (SELDI-MS), and used to screen the test set (44 NPC patients and 25 control individuals) to determine the screening accuracy. To confirm the accuracy, it was used to test another group of 52 NPC patients and 32 healthy individuals at 6 months later. Results: Eight proteomic biomarkers with top-scored peak mass/charge ratios (m/z) of 8605 Da, 5320 Da, 5355 Da, 5380 Da, 5336 Da, 2791 Da, 7154 Da, and 9366 Da were selected as the potential biomarkers of NPC with a sensitivity of 90.9% (40/44) and a specificity of 92.0% (23/25). The performance was better than the current diagnostic method by using the Epstein-Barr virus (EBV) capsid antigen IgA antibodies (VCA/IgA). Similar sensitivity (88.5%) and specificity (90.6%) were achieved in another group of 84 samples. Conclusion: SELDI-MS profiling might be a potential tool to identify patients with NPC, particularly at early clinical stages. PMID: 20663318 [PubMed - in process]（【斜め読み用】機械翻訳： 血清のproteomeの表面高められたレーザーの脱着およびイオン化質量分析のプロフィールを使用してnasopharyngeal癌腫の検出。 顎Jの蟹座。 8月2010日; 29 (8): 721-8書く: Cao SM、Yu JK、陳QY、李NW、Xiang YQ、チエンCN、Hu X、チャンCQ、Xie D、郡野Xの背景および目的: nasopharyngeal癌腫(NPC)の早い診断は慣習的な検査方法の不十分な特定性が困難な原因である。 この調査はNPCの早期発見のNPCのための潜在的な、一貫したbiomarkersを、特に調査することだった。 方法: 表面高められたレーザーの脱着およびイオン化固まりの分光測定(SELDI-MS)を使用して訓練セット(134人のNPCの患者および73人の制御個人)でproteomicパターンが識別されたり、およびスクリーニングの正確さを定めるためにテストセット(44人のNPCの患者および25人の制御個人)を選別するのに使用された。 正確さを確認するためには、後で6か月で52人のNPCの患者および32人の健康な個人のもう一人のグループをテストすることを使用した。 結果: 8605 Daは、5320 Da、5355 Da、5380 Da、5336 Da、2791 Da、7154 Da、および9366 Daの上記録されたピーク多くまたは充満比率の8 proteomic biomarkers (m/z)選ばれた90.9%の感受性のNPCの潜在的なbiomarkers (40/44)および92.0%の特定性として(23/25)。 性能はEpstein-Barrウイルス(EBV)のcapsidの抗原のIgAの抗体(VCA/IgA)の使用によって現在の診断方法よりよかった。 同じような感受性(88.5%)および特定性(90.6%)は84のサンプルの別のグループで達成された。 結論: SELDI-MSの側面図を描くことは早い臨床段階でNPCの患者を、特に識別する潜在的な用具であるかもしれない。 PMID: 20663318 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-378.html</link>
      <description> Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease. Clin Exp Immunol. 2010 Jul 23; Authors: Colobran R, Pedrosa E, Carretero-Iglesia L, Juan M Summary Genome copy number changes (copy number variations: CNVs) include inherited, de novo and somatically acquired deviations from a diploid state within a particular chromosomal segment. CNVs are frequent in higher eukaryotes and associated with a substantial portion of inherited and acquired  ...</description>
        <pubDate>Thu, 29 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-378.html</guid>
        
      <content:encoded> <![CDATA[
    

        Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease.
        Clin Exp Immunol. 2010 Jul 23;
        Authors:  Colobran R, Pedrosa E, Carretero-Iglesia L, Juan M
        Summary Genome copy number changes (copy number variations: CNVs) include inherited, de novo and somatically acquired deviations from a diploid state within a particular chromosomal segment. CNVs are frequent in higher eukaryotes and associated with a substantial portion of inherited and acquired risk for various human diseases. CNVs are distributed widely in the genomes of apparently healthy individuals and thus constitute significant amounts of population-based genomic variation. Human CNV loci are enriched for immune genes and one of the most striking examples of CNV in humans involves a genomic region containing the chemokine genes CCL3L and CCL4L. The CCL3L-CCL4L copy number variable region (CNVR) shows extensive architectural complexity, with smaller CNVs within the larger ones and with interindividual variation in breakpoints. Furthermore, the individual genes embedded in this CNVR account for an additional level of genetic and mRNA complexity: CCL4L1 and CCL4L2 have identical exonic sequences but produce a different pattern of mRNAs. CCL3L2 was considered previously as a CCL3L1 pseudogene, but is actually transcribed. Since 2005, CCL3L-CCL4L CNV has been associated extensively with various human immunodeficiency virus-related outcomes, but some recent studies called these associations into question. This controversy may be due in part to the differences in alternative methods for quantifying gene copy number and differentiating the individual genes. This review summarizes and discusses the current knowledge about CCL3L-CCL4L CNV and points out that elucidating their complete phenotypic impact requires dissecting the combinatorial genomic complexity posed by various proportions of distinct CCL3L and CCL4L genes among individuals.
        PMID: 20659124 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Red blood cell proteomics.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-348.html</link>
      <description>Red blood cell proteomics. Transfus Clin Biol. 2010 Jul 22; Authors: Pasini EM, Mann M, Thomas AW Since its discovery in the 17th century, the red blood cell, recognized in time as the critical cell component for survival, has been the focus of much attention. Its unique role in gas exchange (oxygen/CO(2) transport) and its distinct characteristics (absence of nucleus; biconcave cell shape) together with an - in essence - unlimited supply lead to extensive targeted biochemical, molecular and str ...</description>
        <pubDate>Wed, 28 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-348.html</guid>
        
      <content:encoded> <![CDATA[
    Red blood cell proteomics. Transfus Clin Biol. 2010 Jul 22; Authors: Pasini EM, Mann M, Thomas AW Since its discovery in the 17th century, the red blood cell, recognized in time as the critical cell component for survival, has been the focus of much attention. Its unique role in gas exchange (oxygen/CO(2) transport) and its distinct characteristics (absence of nucleus; biconcave cell shape) together with an - in essence - unlimited supply lead to extensive targeted biochemical, molecular and structural studies. A quick PubMed query with the word "erythrocyte" results in 198 013 scientific articles of which 162 are red blood cell proteomics studies, indicating that this new technique has been only recently applied to the red blood cell and related fields. Standard and comparative proteomics have been widely used to study different blood components. A growing body of proteomics literature has since developed, which deals with the characterization of red blood cells in health and disease. The possibility offered by proteomics to obtain a global snapshot of the whole red blood cell protein make-up, has provided unique insights to many fields including transfusion medicine, anaemia studies, intra-red blood cell parasite biology and translational research. While the contribution of proteomics is beyond doubt, a full red blood cell understanding will ultimately require, in addition to proteomics, lipidomics, glycomics, interactomics and study of post-translational modifications. In this review we will briefly discuss the methodology and limitations of proteomics, the contribution it made to the understanding of the erythrocyte and the advances in red blood cell-related fields brought about by comparative proteomics. PMID: 20655788 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 赤血球のproteomics。 Transfus Clin Biol. 7月2010日22日; 著者: Pasini EM、マンM、17世紀、重大な細胞の部品として存続の時間に確認される赤血球の発見以来のトマスAWは、ずっと多くの注意の焦点である。 ガス交換(oxygen/CO (2)輸送)に於いてのその独特な役割および明瞭な特徴(核心の不在; -本質的に-無制限の供給とともに両凹細胞の形は)広範な目標とされた生化学的な、分子構造調査をもたらす。 単語「赤血球」のPubMedの速い問い合わせは162が赤血球のproteomicsの調査であるこの新しい技術が赤血球および関連分野にだけ最近適用されてしまったことを示す198の013の科学的な記事で起因する。 標準的な、比較proteomicsは広く利用されているずっと異なった血の部品を調査するために。 健康および病気の赤血球の性格描写を取扱うproteomicsの文献の成長するボディはその後成長していた。 全体の赤血球蛋白質の構造の全体的なスナップショットを得るためにproteomicsによって提供される可能性は注入の薬、貧血症の調査、内部赤い血球寄生虫の生物学および翻訳の研究を含む多くの分野に独特な洞察力を提供した。 proteomicsの貢献が明白な間、完全な赤血球の理解はポスト翻訳の修正のproteomics、lipidomics、glycomics、interactomicsおよび調査に加えて最終的に、要求する。 この検討では私達は簡潔にproteomics、赤血球の理解に作った赤い血の細胞関係した分野の前進は比較proteomicsによってもたらした貢献の方法そして限定を論議し。 PMID: -出版業者によって供給される… 20655788 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Involvement of ST6Gal I in the biosynthesis of a unique human colon cancer biomarker candidate, {alpha}2,6-sialylated blood group type 2 H (ST2H) antigen.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-349.html</link>
      <description>Involvement of ST6Gal I in the biosynthesis of a unique human colon cancer biomarker candidate, {alpha}2,6-sialylated blood group type 2 H (ST2H) antigen. J Biochem. 2010 Jul 23; Authors: Korekane H, Matsumoto A, Ota F, Hasegawa T, Misonou Y, Shida K, Miyamoto Y, Taniguchi N The alpha2,6-sialylated blood group type 2 H (ST2H) antigen (Fucalpha 1-2(NeuAcalpha2-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc-Cer) is a fucoganglioside found in human colon cancer tissues. To elucidate an enzyme responsible f ...</description>
        <pubDate>Wed, 28 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-349.html</guid>
        
      <content:encoded> <![CDATA[
    Involvement of ST6Gal I in the biosynthesis of a unique human colon cancer biomarker candidate, {alpha}2,6-sialylated blood group type 2 H (ST2H) antigen. J Biochem. 2010 Jul 23; Authors: Korekane H, Matsumoto A, Ota F, Hasegawa T, Misonou Y, Shida K, Miyamoto Y, Taniguchi N The alpha2,6-sialylated blood group type 2 H (ST2H) antigen (Fucalpha 1-2(NeuAcalpha2-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc-Cer) is a fucoganglioside found in human colon cancer tissues. To elucidate an enzyme responsible for the ST2H antigen formation, we screened some partially purified candidate enzymes, alpha2,6-sialyltransferases, ST6Gal I and ST6Gal II, and alpha1,2-fucosyltransferases, FUT1 and FUT2 for their activities toward pyridylaminated type 2 H (Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc-PA) or LS-tetrasaccharide c (LST-c: NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc-PA) as acceptor substrates. Here we show the ST6Gal I transfers NeuAc from the donor CMP-NeuAc to the terminal Gal of PA-type 2 H, which formed the ST2H antigen, but the others could not synthesize it. Using a recombinant ST6Gal I, enzymatic reactions with two types of acceptors, PA-type 2 H and PA-lacto-N-neotetraose (LNnT), were kinetically analyzed. On the basis of catalytic efficiency (V(max)/K(m)), the specificity of ST6Gal I toward the PA-type 2 H was estimated to be 42 times lower than that for PA-LNnT. The overexpression of ST6Gal I in human colon cancer DLD-1 cells effectively resulted in the ST2H antigen formation, as judged by LC-ESI-IT-MS. Many lines of evidence suggest the up-regulation of ST6Gal I in human colon cancer specimens. Collectively, these findings indicate that ST6Gal I is responsible for ST2H antigen biosynthesis in human colon cancer cells. PMID: 20656882 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 独特な人間の結腸癌のbiomarkerの候補者の生合成のST6Gal Iの介入、{アルファ} 2,6-sialylated血液型のタイプ2 H (ST2H)の抗原。 J Biochem。 7月2010日23日; 著者: Korekane H、松本A、Ota F、長谷川T、Misonou Y、Shida K、Miyamoto Y、Taniguchi Nはalpha2,6-sialylatedの血液型のタイプ2 H (ST2H)の抗原(Fucalpha 1-2 (NeuAcalpha2-6) Galbeta1 4GlcNAcbeta1 3Galbeta1 4GlcCer)人間の結腸癌のティッシュで見つけられるfucogangliosideである。 ST2Hの抗原の形成に責任がある酵素を明瞭にするためには私達はpyridylaminatedタイプ2 H (Fucalpha1 2Galbeta1 4GlcNAcbeta1 3Galbeta1 4GlcPA)の方にある部分的に浄化された候補者の酵素、alpha2,6-sialyltransferases、ST6Gal IおよびST6Gal II、および彼らの活動のためのalpha1,2-fucosyltransferases、FUT1およびFUT2またはLStetrasaccharide c (リストc選別した: アクセプターの基質としてNeuAcalpha2 6Galbeta1 4GlcNAcbeta1 3Galbeta1 4GlcPA)。 ここに私達は提供者CMPNeuAcからのST2Hの抗原を形作った、他の人々はそれを総合できなかったPAタイプ2 HのターミナルGalへのST6Gal Iの移動NeuAcを示す。 組換えST6Gal Iを使用して、2つのタイプのアクセプターとの酵素の反作用、PAタイプ2 HおよびPAlacto N NEOTETRAOSe (LNnT)は、運動学上分析された。 触媒作用の効率に基づいて(V (PALNnTのためのそれの42倍であるために最高の) /Kは(m))、PAタイプ2 Hの方のST6Gal Iの特定性低く推定された。 人間の結腸癌DLD-1の細胞のST6Gal IのoverexpressionはLC-ESI-IT-MSによって判断されるようにST2Hの抗原の形成で効果的に、起因した。 証拠の多くのラインは人間の結腸癌の標本のST6Gal Iの規則を提案する。 一まとめに、これらの調査結果はST6Gal Iが人間の結腸癌の細胞のST2Hの抗原の生合成に責任があることを示す。 PMID: -出版業者によって供給される… 20656882 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Seal capability of interim post and core crown with temporary cements.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-377.html</link>
      <description>Seal capability of interim post and core crown with temporary cements. Braz Oral Res. 2010 Jun;24(2):238-44 Authors: BÃ¶necker-Valverde G, Maniglia-Ferreira C, Abi-Rached GP, Gomes BP, Mesquita MF The purpose of the present study was to evaluate the in vitro seal capability of interim post and core crown restorations. Eighty teeth were selected and divided into 8 groups. Four experimental groups received interim posts and core crowns. Half of each group was decoronated at the cementum-enamel  ...</description>
        <pubDate>Wed, 28 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-377.html</guid>
        
      <content:encoded> <![CDATA[
    Seal capability of interim post and core crown with temporary cements. Braz Oral Res. 2010 Jun;24(2):238-44 Authors: BÃ¶necker-Valverde G, Maniglia-Ferreira C, Abi-Rached GP, Gomes BP, Mesquita MF The purpose of the present study was to evaluate the in vitro seal capability of interim post and core crown restorations. Eighty teeth were selected and divided into 8 groups. Four experimental groups received interim posts and core crowns. Half of each group was decoronated at the cementum-enamel junction, groups PCCH and PCZO. The other half was sectioned 2 mm coronal to the cementum-enamel junction, groups PCrZO and PCrCH. The interim post and core crowns were luted with Rely X Temp NE, groups PCrZO and PCZO; Hydro C was used for Groups PCrCH and PCCH. The control groups, PC and PCr, received uncoated post and core crowns; groups OTg and OT were left without interim post and core crowns and were totally open. Infiltration was accessed by dye exposure followed by demineralization of the teeth. The length of the infiltration was measured using digital images taken from the specimens. The images were inserted into the Image Tool 3.0 software. Kruskal-Wallis analysis of variance and Dunn's multiple comparison method were used to test for significant differences among test groups (P < .05). Groups PCrZO and PCrCH showed the least dye penetration, followed by groups PCZO and PCCH. Teeth restored with interim post and core crowns will be subject to leakage. Ethics Committee: 095/2008. PMID: 20658045 [PubMed - in process]（【斜め読み用】機械翻訳： 暫時ポストのシールの機能および中心は一時的なセメントと戴冠する。 Braz口頭Res。 6月2010日; 24 (2): 238-44書く: BÃ¶neckerValverde G、ManigliaフェレイラC、Abi-Rached GP、Gomes BP、Mesquita MFは現在の調査の目的暫時ポストおよび中心の王冠の復帰の生体外のシールの機能を評価することだった。 80本の歯は8グループに選ばれ、分けられた。 4つの実験グループは暫時ポストおよび中心の王冠を受け取った。 各グループの半分はcementumエナメルの接続点、グループPCCHおよびPCZOでdecoronated。 残りの半分はcementumエナメルの接続点、グループPCrZOおよびPCrCHへ区分された2つのmmのcoronalだった。 暫時ポストおよび中心の王冠はと頼るXの臨時雇用者NE、グループPCrZOおよびPCZO封泥で封じられた; ハイドロCはグループPCrCHおよびPCCHのために使用された。 制御グループ、PCおよびPCrは、光沢が無いポストおよび中心の王冠を受け取った; グループOTgおよびOTは暫時ポストおよび中心の王冠なしで残って、全く開いていた。 浸潤は歯の脱塩に先行している染料の露出によってアクセスされた。 浸潤の長さは標本から撮られたデジタル画像を使用して測定された。 イメージはイメージ用具3.0ソフトウェアに挿入された。 テストグループ(Pの&lt間の重要な相違のためにテストするのに変動のKruskalウォリスの分析およびDunnの多数の比較方法が使用された; .05)。 グループPCrZOおよびPCrCHはgroups PCZOが先行させている最少の染料の浸透をおよびPCCH示した。 暫時ポストおよび中心の王冠によって元通りになった歯は漏出に応じてある。 倫理委員会: 095/2008。 PMID: 20658045 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Study on proteomics of inhibitory effects of elemene on proliferation of human lens epithelial cell.]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-219.html</link>
      <description>[Study on proteomics of inhibitory effects of elemene on proliferation of human lens epithelial cell.] Zhonghua Yan Ke Za Zhi. 2010 May;46(5):427-31 Authors: Hu YH, Huang XR, Qi MX, Hou BY OBJECTIVE: To investigate the inhibitory effects of natural medicinal monomer elemene (Ele) on proliferation of human lens epithelial cells B3 (HLE-B3) inducing by recombinant human basic fibroblast growth factor(rhbFGF) and to pursue the proteomics regularity of the inhibitory effects of Ele on proliferation  ...</description>
        <pubDate>Wed, 28 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-219.html</guid>
        
      <content:encoded> <![CDATA[
    [Study on proteomics of inhibitory effects of elemene on proliferation of human lens epithelial cell.] Zhonghua Yan Ke Za Zhi. 2010 May;46(5):427-31 Authors: Hu YH, Huang XR, Qi MX, Hou BY OBJECTIVE: To investigate the inhibitory effects of natural medicinal monomer elemene (Ele) on proliferation of human lens epithelial cells B3 (HLE-B3) inducing by recombinant human basic fibroblast growth factor(rhbFGF) and to pursue the proteomics regularity of the inhibitory effects of Ele on proliferation of HLE-B3. METHODS: Experimental study. This study is divided into three group: control group, rhbFGF group and Ele group. Using 10 microg/L rhbFGF to induce proliferation of HLE-B3. Proliferative HLE-B3 were incubated with 80 mg/L Ele in CO(2) incubator for 24 hours. Then the inhibitory effects of Ele on proliferation of HLE-B3 was detected by methyl thiazolyl tetrazolium (MTT). The change of expressions of all protein in HLE-B3 was assayed and analyzed by protein array and surface-enhanced laser desorption ionization time of flight mass spectrometry (SELDI-TOF-MS) proteomics technology. RESULTS: MTT test showed that the A values of rhbFGF (0.599 +/- 0.053) group were higher than that of control group (0.409 +/- 0.042) remarkably. The A values of Ele group (0.450 +/- 0.061) decreased obviously compared to rhbFGF group, the inhibition rates were 24.90% (F = 28.886, P = 0.000). Five different protein spots were obtained in proliferative HLE-B3 induced by rhbFGF. The expressions were up-regulated in two of the five protein spots at the ratios of mass/charge (m/z) of 8093 and 9516, while the expressions were down-regulated in three of the five protein spots at m/z of 5361, 9666 and 13 767. Ten different protein spots were obtained in HLE-B3 incubated with Ele. The expressions were up-regulated in four of the ten protein spots at m/z of 2487, 4392, 8566 and 11 600, while the expressions were down-regulated in six of the ten protein spots at m/z of 3679, 4826, 6861, 9516, 9557 and 9672. CONCLUSIONS: Ele could effectively inhibit HLE-B3 proliferation induced by rhbFGF. The protein spot at m/z of 9516 might be the target of proliferative inhibition in HLE-B3 by Ele. PMID: 20654217 [PubMed - in process]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Effect of contact lenses on the protein composition in tear film: a ProteinChip study.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-220.html</link>
      <description>Effect of contact lenses on the protein composition in tear film: a ProteinChip study. Graefes Arch Clin Exp Ophthalmol. 2010 Jul 26; Authors: Kramann C, Boehm N, Lorenz K, Wehrwein N, Stoffelns BM, Pfeiffer N, Grus FH BACKGROUND: The aim of this study was to analyze and compare the effects of rigid gas permeable and soft contact lenses on the protein composition in the tear film of contact lens wearers. METHODS: Wearers of soft contact lenses (CL_S, n = 13) and rigid gas permeable contact lense ...</description>
        <pubDate>Wed, 28 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-220.html</guid>
        
      <content:encoded> <![CDATA[
    Effect of contact lenses on the protein composition in tear film: a ProteinChip study. Graefes Arch Clin Exp Ophthalmol. 2010 Jul 26; Authors: Kramann C, Boehm N, Lorenz K, Wehrwein N, Stoffelns BM, Pfeiffer N, Grus FH BACKGROUND: The aim of this study was to analyze and compare the effects of rigid gas permeable and soft contact lenses on the protein composition in the tear film of contact lens wearers. METHODS: Wearers of soft contact lenses (CL_S, n = 13) and rigid gas permeable contact lenses (CL_H, n = 13) were recruited for this study. Thirteen non-contact lens wearers were also included as the control. Tears were collected using Schirmer strips and frozen until use. The tears were eluted and analyzed on ProteinChips SELDI-TOF (surface-enhanced laser desorption and ionization in time of flight mass spectrometry; Bio-Rad, USA) with different chromatographic surfaces (cationic and anionic exchanger and reversed phase surface). The SELDI spectra were analyzed by multivariate statistical analysis and artificial neural networks in order to find a biomarker panel which differentiates best between the groups. In order to identify protein/peptide peaks from SELDI spectra which showed a significant difference between groups, fractionated tear samples were analyzed using MALDI-TOF MS (matrix-assisted laser desorption/ionization time-of-flight mass spectrometry). For validation of biomarkers, we used an antibody microarray approach. RESULTS: Complex patterns of tear proteins and peptides were detected in the control group and in both contact lens groups. The tear protein composition in both wearers of rigid gas permeable (CL_H) and soft contact lenses (CL_S) differed significantly from protein composition in non-contact lens wearers (p < 0.01). The identification of biomarkers revealed an increase of Protein S100 A8 in the group of wearers of soft contact lenses (CL_S) and a decrease of a main tear protein, lysozyme, in both contact lens groups. The identified biomarker cystatin was upregulated in the group of rigid gas permeable lens wearers (CL_H), whereas the protein intensity of secretoglobin was significantly reduced in this group. Using the microarray approach, detected alterations could be confirmed. CONCLUSIONS: Contact lens wear alters the protein profiles in a complex manner. This study demonstrates that significant changes can be found in wearers of soft contact lenses (CL_S) and rigid gas permeable contact lenses (CL_H). Some biomarker intensities are significantly altered only in the group of rigid gas permeable lens wearers (CL_H). PMID: 20658346 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Involvement of aberrant glycosylation in thyroid cancer.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-347.html</link>
      <description>Related Articles Involvement of aberrant glycosylation in thyroid cancer. J Oncol. 2010;2010:816595 Authors: Miyoshi E, Ito Y, Miyoshi Y Glycosylation is one of the most common posttranslational modification reactions and nearly half of all known proteins in eukaryotes are glycosylated. In fact, changes in oligosaccharides structures are associated with many physiological and pathological events, including cell growth, migration and differentiation, and tumor invasion. Therefore, functional glyc ...</description>
        <pubDate>Sun, 25 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-347.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Involvement of aberrant glycosylation in thyroid cancer. J Oncol. 2010;2010:816595 Authors: Miyoshi E, Ito Y, Miyoshi Y Glycosylation is one of the most common posttranslational modification reactions and nearly half of all known proteins in eukaryotes are glycosylated. In fact, changes in oligosaccharides structures are associated with many physiological and pathological events, including cell growth, migration and differentiation, and tumor invasion. Therefore, functional glycomics, which is a comprehensive study of the structures and functions of glycans, is attracting the increasing attention of scientists in various fields of life science. In cases of thyroid cancer, the biological characters and prognosis are completely different in each type of histopathology, and their oligosaccharide structures as well as the expression of glycosyltransferases are also different. In this review, we summarized our previous papers on oligosaccharides and thyroid cancers and discussed a possible function of oligosaccharides in the carcinogenesis in thyroid cancer. PMID: 20652009 [PubMed - in process]（【斜め読み用】機械翻訳：甲状腺癌の異常なglycosylationの関連の記事介入。 J Oncol。 2010年; 2010年: 816595人の著者: Miyoshi E、Ito Y、Miyoshi Y Glycosylationは共通のposttranslationalの修正の反作用の1つであり、eukaryotesのすべての知られていた蛋白質のほぼ半分はglycosylatedである。 実際は、オリゴ糖類の構造の変更は多くの生理学的な、病理学のでき事と、細胞の成長を含んで、移動および微分および腫瘍の侵入関連付けられる。 従って、glycansの構造そして機能の広範囲の調査である機能glycomicsは生命科学のさまざまな分野の科学者の増加する注意を引き付けている。 甲状腺癌の場合では、glycosyltransferasesの表現がまた異なっている、また生物的特性および予想は各タイプの組織病理学で全く異なる、およびオリゴ糖類の構造。 この検討では、私達はオリゴ糖類および甲状腺癌の私達の前のペーパーを要約し、甲状腺癌の発癌でオリゴ糖類の可能な機能を論議した。 PMID: 20652009 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The basis for haplotype complexity in VCBPs, an immune-type receptor in amphioxus.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-376.html</link>
      <description> The basis for haplotype complexity in VCBPs, an immune-type receptor in amphioxus. Immunogenetics. 2010 Jul 22; Authors: Dishaw LJ, Ota T, Mueller MG, Cannon JP, Haire RN, Gwatney NR, Litman RT, Litman GW Innate immune gene repertoires are restricted primarily to germline variation. Adaptive immunity, by comparison, relies on somatic variation of germline-encoded genes to generate extraordinarily large numbers of non-heritable antigen recognition motifs. Invertebrates lack the key features of v ...</description>
        <pubDate>Sun, 25 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-376.html</guid>
        
      <content:encoded> <![CDATA[
    

        The basis for haplotype complexity in VCBPs, an immune-type receptor in amphioxus.
        Immunogenetics. 2010 Jul 22;
        Authors:  Dishaw LJ, Ota T, Mueller MG, Cannon JP, Haire RN, Gwatney NR, Litman RT, Litman GW
        Innate immune gene repertoires are restricted primarily to germline variation. Adaptive immunity, by comparison, relies on somatic variation of germline-encoded genes to generate extraordinarily large numbers of non-heritable antigen recognition motifs. Invertebrates lack the key features of vertebrate adaptive immunity, but have evolved a variety of alternative mechanisms to successfully protect the integrity of "self"; in many cases, these appear to be taxon-specific innovations. In the protochordate Branchiostoma floridae (amphioxus), the variable region-containing chitin-binding proteins (VCBPs) constitute a multigene family (comprised of VCBPs 1-5), which possesses features that are consistent with innate immune-type function. A large number of VCBP alleles and haplotypes are shown to exhibit levels of polymorphism exceeding the elevated overall levels determined for the whole amphioxus genome (JGI). VCBP genes of the 2 and 5 types are distinguished further by a highly polymorphic segment (exon 2) in the N-terminal immunoglobulin domain, defined previously as a "hypervariable region" or a "hotspot." Genomic deoxyribonucleic acid (DNA) and complementary DNA (cDNA) sequences from large numbers of animals representing different populations reveal further significant differences in sequence complexity within and across VCBP2/5 haplotypes that arise through overlapping mechanisms of genetic exchange, gene copy number variation as well as mutation and give rise to distinct allelic lineages. The collective observations suggest that mechanisms were in place at the time of divergence of the cephalochordates that could selectively hyperdiversify immune-type receptors within a multigene family.
        PMID: 20652563 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Serum Free Circulating DNA Is a Useful Biomarker to Distinguish Benign versus Malignant Prostate Disease.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-375.html</link>
      <description>Serum Free Circulating DNA Is a Useful Biomarker to Distinguish Benign versus Malignant Prostate Disease. Cancer Epidemiol Biomarkers Prev. 2010 Jul 20; Authors: Gordian E, Ramachandran K, Reis IM, Manoharan M, Soloway MS, Singal R BACKGROUND: Free circulating DNA (fcDNA) has been shown to be elevated in serum of prostate cancer patients compared with benign controls. However, studies evaluating the role of fcDNA as a biomarker in a &quot;representative&quot; patient group who have undergone prostate canc ...</description>
        <pubDate>Fri, 23 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-375.html</guid>
        
      <content:encoded> <![CDATA[
    Serum Free Circulating DNA Is a Useful Biomarker to Distinguish Benign versus Malignant Prostate Disease. Cancer Epidemiol Biomarkers Prev. 2010 Jul 20; Authors: Gordian E, Ramachandran K, Reis IM, Manoharan M, Soloway MS, Singal R BACKGROUND: Free circulating DNA (fcDNA) has been shown to be elevated in serum of prostate cancer patients compared with benign controls. However, studies evaluating the role of fcDNA as a biomarker in a "representative" patient group who have undergone prostate cancer screening are lacking. Our study examined the use of serum fcDNA levels as a biomarker of prostate cancer in such a setting. METHODS: The study included 252 men, with prostate-specific antigen (PSA) levels >4 ng/mL and/or abnormal digital rectal exam. fcDNA levels in serum before prostate biopsy were quantitated by real-time PCR amplification of the glutathione S-transferase, pi, gene. RESULTS: Patients with PSA </= 10 ng/mL with fcDNA > 180 ng/mL were at increased risk for prostate cancer compared with those with fcDNA </=180 ng/mL (odds ratio, 4.27; 95% confidence interval, 2.05-8.88; P < 0.001; area under the curve, 0.742). The multivariate model including age, race, PSA, fcDNA, and interaction between fcDNA and PSA yielded a high negative predictive value of 93.1% and increased specificity of 33.1% compared with negative predictive value of 73.3% and specificity of 6.7% in the model excluding fcDNA. CONCLUSIONS: Our results indicate that fcDNA may improve the specificity of prostate cancer screening. Impact: Our study shows that adding fcDNA to prostate cancer screening can reduce the number of unnecessary prostate biopsies. Cancer Epidemiol Biomarkers Prev; 19(8); OF1-8. (c)2010 AACR. PMID: 20647404 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 血清自由な循環DNAは悪性の前立腺の病気対温和区別する有用なBiomarkerである。 蟹座Epidemiol Biomarkers Prev。 7月2010日20日; 著者: Gordian E、Ramachandran K、Reis IM、Manoharan M、Soloway MSのSingal Rの背景: 自由な循環DNA (fcDNA)は温和な制御と比較される前立腺癌の患者の血清で上がるために示されていた。 但し、「代表的な」忍耐強いグループに於いてのbiomarkerとしてfcDNAの役割を評価する前立腺癌のスクリーニングを経た調査は欠けている。 私達の調査はそのような設定の前立腺癌のbiomarkerとして血清のfcDNAのレベルの使用を検査した。 方法: 調査は前立腺特定の抗原(PSA)のレベルの&gtを持つ252人を、含んでいた; 4 ng/mLや異常なデジタル直腸の検査。 前立腺のバイオプシーがグルタチオンのSトランスフェラーゼの実時間PCRの拡大、piの遺伝子によって量的に表わされた前に血清のfcDNAのレベル。 結果: PSAの&ltを持つ患者; fcDNAの&gtとの/= 10 ng/mL; 180 ng/mLはfcDNAの&ltとのそれらと比較された前立腺癌のための高められた危険にあった; /=180 ng/mL (確率の比率、4.27; 95%の信頼区間、2.05-8.88; Pの< 0.001; カーブの下の区域、0.742)。 fcDNAとPSA間の年齢、競争、PSA、fcDNAおよび相互作用を含む多変数モデルは93.1%という高く否定的な予言する値をもたらし、73.3%という否定的な予言する値と比較された33.1%の特定性およびfcDNAを除くモデルの6.7%の特定性を高めた。 結論: 私達の結果はfcDNAが前立腺癌のスクリーニングの特定性を改善するかもしれないことを示す。 影響: 私達の調査はそれ前立腺癌のスクリーニングへfcDNAを加えることが不必要な前立腺のバイオプシーの数を減らすことができることを示す。 蟹座Epidemiol Biomarkers Prev; 19 (8); OF1-8. (c) 2010 AACR。 PMID: -出版業者によって供給される… 20647404 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Ethical issues raised by common copy number variants and single nucleotide polymorphisms of certain and uncertain significance in general medical practice.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-371.html</link>
      <description> Ethical issues raised by common copy number variants and single nucleotide polymorphisms of certain and uncertain significance in general medical practice. Genome Med. 2010 Jul 17;2(7):42 Authors: Beaudet AL ABSTRACT: The ethical issues surrounding genotyping for single nucleotide polymorphisms (SNPs) or for copy number variation (CNV) are very different. SNP genotyping can focus on ancestry, risk probability, single gene diagnosis, pharmacogenetics, and carrier testing, and the combination of  ...</description>
        <pubDate>Thu, 22 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-371.html</guid>
        
      <content:encoded> <![CDATA[
    

        Ethical issues raised by common copy number variants and single nucleotide polymorphisms of certain and uncertain significance in general medical practice.
        Genome Med. 2010 Jul 17;2(7):42
        Authors:  Beaudet AL
        ABSTRACT: The ethical issues surrounding genotyping for single nucleotide polymorphisms (SNPs) or for copy number variation (CNV) are very different. SNP genotyping can focus on ancestry, risk probability, single gene diagnosis, pharmacogenetics, and carrier testing, and the combination of these in a single test can present difficulties. The interpretation of such tests, inconsistencies between laboratories, and access to genotype information for future reference need to be considered, as well as the value of genotypes of known clinical significance compared with those that provide modest risk modifications with limited potential to take medically useful steps. For CNV genotyping, the major concerns relate to CNVs of uncertain significance and to those with incomplete penetrance. Such CNVs present acute difficulties in counseling symptomatic and asymptomatic individuals and have substantial potential for stigmatization of both groups, as well as raising difficulties when detected in prenatal diagnosis. Improved prenatal diagnosis of many disorders provided by array tests compared with the traditional karyotype probably outweighs the uncertainties for families who would terminate pregnancies with findings associated with severe disabilities. There are substantive concerns about offering SNP or CNV genotyping direct to consumers without a physician or counselor to provide guidance for interpretation of the results.
        PMID: 20642868 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Genetic bottlenecks and the hazardous game of population reduction in cell line based research.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-372.html</link>
      <description> Genetic bottlenecks and the hazardous game of population reduction in cell line based research. Exp Cell Res. 2010 Jul 16; Authors: Gisselsson D, Lindgren D, Mengelbier LH, Ora I, Yeger H Established tumour cell lines are ubiquitous tools in research, but their representativity is often debated. One possible caveat is that many cell lines are derived from cells with genomic instability, potentially leading to genotype changes in vitro. We applied SNP-array analysis to an established tumour cell ...</description>
        <pubDate>Thu, 22 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-372.html</guid>
        
      <content:encoded> <![CDATA[
    

        Genetic bottlenecks and the hazardous game of population reduction in cell line based research.
        Exp Cell Res. 2010 Jul 16;
        Authors:  Gisselsson D, Lindgren D, Mengelbier LH, Ora I, Yeger H
        Established tumour cell lines are ubiquitous tools in research, but their representativity is often debated. One possible caveat is that many cell lines are derived from cells with genomic instability, potentially leading to genotype changes in vitro. We applied SNP-array analysis to an established tumour cell line (WiT49). Even though WiT49 exhibited chromosome segregation errors in 30% of cell divisions, only a single chromosome segment exhibited a shift in copy number after 20 population doublings in culture. In contrast, sub-populations derived from single cells expanded for an equal number of population doublings showed on average 5.8 and 8.9 altered segments compared to the original culture and to each other, respectively. Most copy number variants differentiating these single cell clones corresponded to pre-existing variations in the original culture. Furthermore, no sub-clonal variation was detected in any of the populations derived from single cells. This indicates that genetic bottlenecks resulting from population reduction poses a higher threat to genetic representativity than prolonged culture per se, even in cell lines with a high rate of genomic instability. Genetic bottlenecks should therefore be considered a potential caveat in all studies involving sub-cloning, transfection and other conditions leading to a temporary reduction in cell number.
        PMID: 20643124 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Toward a more uniform sampling of human genetic diversity: A survey of worldwide populations by high-density genotyping.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-373.html</link>
      <description> Toward a more uniform sampling of human genetic diversity: A survey of worldwide populations by high-density genotyping. Genomics. 2010 Jul 16; Authors: Xing J, Watkins WS, Shlien A, Walker E, Huff CD, Witherspoon DJ, Zhang Y, Simonson TS, Weiss RB, Schiffman JD, Malkin D, Woodward SR, Jorde LB High-throughput genotyping data are useful for making inferences about human evolutionary history. However, the populations sampled to date are unevenly distributed, and some areas (e.g., South and Centr ...</description>
        <pubDate>Thu, 22 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-373.html</guid>
        
      <content:encoded> <![CDATA[
    

        Toward a more uniform sampling of human genetic diversity: A survey of worldwide populations by high-density genotyping.
        Genomics. 2010 Jul 16;
        Authors:  Xing J, Watkins WS, Shlien A, Walker E, Huff CD, Witherspoon DJ, Zhang Y, Simonson TS, Weiss RB, Schiffman JD, Malkin D, Woodward SR, Jorde LB
        High-throughput genotyping data are useful for making inferences about human evolutionary history. However, the populations sampled to date are unevenly distributed, and some areas (e.g., South and Central Asia) have rarely been sampled in large-scale studies. To assess human genetic variation more evenly, we sampled 296 individuals from 13 worldwide populations that are not covered by previous studies. By combining these samples with a data set from our laboratory and the HapMap II samples, we assembled a final dataset of ~250,000 SNPs in 850 individuals from 40 populations. With more uniform sampling, the estimate of global genetic differentiation (F(ST)) substantially decreases from ~16% with the HapMap II samples to ~11%. A panel of copy number variations typed in the same populations shows patterns of diversity similar to the SNP data, with highest diversity in African populations. This unique sample collection also permits new inferences about human evolutionary history. The comparison of haplotype variation among populations supports a single out-of-Africa migration event and suggests that the founding population of Eurasia may have been relatively large but isolated from Africans for a period of time. We also found a substantial affinity between populations from central Asia (Kyrgyzstani and Mongolian Buryat) and America, suggesting a central Asian contribution to New World founder populations.
        PMID: 20643205 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Clinically detectable copy number variations in a Canadian catchment population of schizophrenia.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-374.html</link>
      <description> Clinically detectable copy number variations in a Canadian catchment population of schizophrenia. J Psychiatr Res. 2010 Jul 17; Authors: Bassett AS, Costain G, Alan Fung WL, Russell KJ, Pierce L, Kapadia R, Carter RF, Chow EW, Forsythe PJ Copy number variation (CNV) is a highly topical area of research in schizophrenia, but the clinical relevance is uncertain and the translation to clinical practice is under-studied. There is a paucity of research involving truly community-based samples of schi ...</description>
        <pubDate>Thu, 22 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-374.html</guid>
        
      <content:encoded> <![CDATA[
    

        Clinically detectable copy number variations in a Canadian catchment population of schizophrenia.
        J Psychiatr Res. 2010 Jul 17;
        Authors:  Bassett AS, Costain G, Alan Fung WL, Russell KJ, Pierce L, Kapadia R, Carter RF, Chow EW, Forsythe PJ
        Copy number variation (CNV) is a highly topical area of research in schizophrenia, but the clinical relevance is uncertain and the translation to clinical practice is under-studied. There is a paucity of research involving truly community-based samples of schizophrenia and widely available laboratory techniques. Our objective was to determine the prevalence of clinically detectable CNVs in a community sample of schizophrenia, while mimicking typical clinical practice conditions. We used a brief clinical screening protocol for developmental features in adults with schizophrenia for identifying individuals with 22q11.2 deletions and karyotypically detectable chromosomal anomalies in 204 consecutive patients with schizophrenia from a single Canadian catchment area. Twenty-seven (13.2%) subjects met clinical criteria for a possible syndrome, and 26 of these individuals received clinical genetic testing. Five of these, representing 2.5% of the total sample (95% CI: 0.3%-4.6%), including two of ten patients with mental retardation, had clinically detectable anomalies: two 22q11.2 deletions (1.0%), one 47, XYY, and two other novel CNVs - an 8p23.3-p23.1 deletion and a de novo 19p13.3-p13.2 duplication. The results support the utility of screening and genetic testing to identify genetic syndromes in adults with schizophrenia in clinical practice. Identifying large, rare CNVs (particularly 22q11.2 deletions) can lead to significant changes in management, follow-up, and genetic counselling that are helpful to the patient, family, and clinicians.
        PMID: 20643418 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-207.html</link>
      <description> Related Articles High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins. Amino Acids. 2010 May 22; Authors: Bellei E, Bergamini S, Monari E, Fantoni LI, Cuoghi A, Ozben T, Tomasi A In clinical and pharmaceutical proteomics, serum and plasma are frequently used for detection of early diagnostic biomarkers for therapeutic targets. Although obtaining these body fluid samples is non-invasive and easy, they contain some abundant proteins that mas ...</description>
        <pubDate>Thu, 22 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-207.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins. Amino Acids. 2010 May 22; Authors: Bellei E, Bergamini S, Monari E, Fantoni LI, Cuoghi A, Ozben T, Tomasi A In clinical and pharmaceutical proteomics, serum and plasma are frequently used for detection of early diagnostic biomarkers for therapeutic targets. Although obtaining these body fluid samples is non-invasive and easy, they contain some abundant proteins that mask other protein components present at low concentrations. The challenge in identifying serum biomarkers is to remove the abundant proteins, uncovering and enriching at the same time the low-abundance ones. The depletion strategies, however, could lead to the concomitant removal of some non-targeted proteins that may be of potential interest. In this study, we compared three different methods aimed to deplete high-abundance proteins from human serum, focusing on the identification of non-specifically bound proteins which might be eventually removed. A Cibacron blue-dye-based method for albumin removal, an albumin and IgG immunodepletion method and an immunoaffinity column (Multiple Affinity Removal System) that simultaneously removes a total of six high-abundance proteins, were investigated. The bound proteins were eluted, separated by two-dimensional gel electrophoresis and identified by Nano LC-CHIP-MS system. Flow-through fractions and bound fractions were also analysed with the ProteinChip technology SELDI-TOF-MS. Our results showed that the methods tested removed not only the targeted proteins with high efficiency, but also some non-targeted proteins. We found that the Multiple Affinity Removal Column improved the intensity of low-abundance proteins, displayed new protein spots and increased resolution. Notably, the column showed the lowest removal of untargeted proteins, proved to be the most promising depletion approach and a reliable method for serum preparation prior to proteomic studies. PMID: 20495836 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteomic profiling of cerebrospinal fluid in parkinsonian disorders.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-217.html</link>
      <description>Related Articles Proteomic profiling of cerebrospinal fluid in parkinsonian disorders. Parkinsonism Relat Disord. 2010 Jul 8; Authors: Constantinescu R, Andreasson U, Li S, Podust VN, Mattsson N, AnckarsÃ¤ter R, AnckarsÃ¤ter H, Rosengren L, Holmberg B, Blennow K, WikkelsÃ¶ C, RÃ?etschi U, Zetterberg H Parkinson&apos;s disease (PD) and atypical parkinsonian disorders (APD), including multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD),  ...</description>
        <pubDate>Thu, 22 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-217.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Proteomic profiling of cerebrospinal fluid in parkinsonian disorders. Parkinsonism Relat Disord. 2010 Jul 8; Authors: Constantinescu R, Andreasson U, Li S, Podust VN, Mattsson N, AnckarsÃ¤ter R, AnckarsÃ¤ter H, Rosengren L, Holmberg B, Blennow K, WikkelsÃ¶ C, RÃ?etschi U, Zetterberg H Parkinson's disease (PD) and atypical parkinsonian disorders (APD), including multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD), are a group of neurodegenerative diseases sharing many similar signs and symptoms but distinguished by their particular clinical features, treatment response, prognosis and mortality. The differential diagnosis may be challenging, especially in early disease stages. Considering the importance of an accurate diagnosis both for clinical management and for research, new diagnostic tools are needed. In this study, we investigated 56 PD, 42 MSA, 39 PSP, 9 CBD patients, and 24 healthy controls. After screening the cerebrospinal fluid (CSF) proteome using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS), we identified 4 proteins (ubiquitin [mass-to-charge ratio (m/z) 8590], beta2-microglobulin [m/z 11730], and 2 secretogranin 1 [chromogranin B] fragments [m/z 7260 and m/z 6250]) that differentiated healthy controls and PD patients from patients with APD. However, they could not differentiate PD patients from controls. As none of these changes were APD subgroup-specific, they most likely reflect the intensity and/or extent of the neurodegenerative process in general. PMID: 20620095 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：parkinsonian無秩序の脳脊髄液体の記事のProteomicの関連に側面図を描くこと。 Parkinsonism Relat Disord。 7月2010日8日; 著者: Constantinescu R、Andreasson U、李S、Podust VN、Mattsson N、AnckarsÃ¤ter R、AnckarsÃ¤ter H、Rosengren L、Holmberg B、Blennow K、WikkelsÃ¶ C、RÃの?のetschi U、Zetterberg Hパーキンソン病(PD)および非定型のparkinsonian無秩序(APD)は、複数システムの萎縮(MSA)を含む、進歩的なsupranuclear麻痺(PSP)、およびcorticobasal退化(CBD)、多くの同じような印および徴候を共有する特定の臨床特徴によって、処置の応答区別される、neurodegenerative病気のグループ予想および死亡率でありではない。 差動診断は早い病気の段階で挑戦的、特にかもしれない。 臨床管理と研究のための正確な診断の重要性を考えると、新しい診察道具は必要である。 この調査では、私達は56 PD、42 MSA、39 PSP、9人のCBDの患者および24の健康な制御を調査した。 表面高められたレーザーの脱着またはイオン化時間の飛行質量分析(SELDI-TOF MS)を使用して脳脊髄液体(CSF) proteomeを選別した後、私達はAPDの患者からの健康な制御そしてPDの患者を区別した4つの蛋白質(ubiquitin識別した[比率(m/z) 8590]、beta2-microglobulin [m/z 11730]、および2つのsecretogranin 1 [chromogranin Bの]片[m/z 7260およびm/z 6250を固まりに満たしなさい])。 但し、彼らは制御からのPDの患者を区別できなかった。 これらの変更のどれも小群特定のAPDではなかったので多分neurodegenerativeプロセスの強度や範囲を一般に反映する。 PMID: -出版業者によって供給される… 20620095 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Depicting the Spatial Distribution of Proteins in Human Tumor Tissue Combining SELDI, MALDI Imaging, and Immunohistochemistry.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-218.html</link>
      <description>Depicting the Spatial Distribution of Proteins in Human Tumor Tissue Combining SELDI, MALDI Imaging, and Immunohistochemistry. J Histochem Cytochem. 2010 Jul 19; Authors: Wehder L, Ernst G, Crecelius AC, Guntinas-Lichius O, Melle C, Schubert US, von Eggeling F Carcinoma tissue does not only consist of tumor cells but also of fibroblasts, endothelial cells or vascular structures, and inflammatory cells forming the supportive tumor stroma. Therefore, the spatial distribution of proteins which prom ...</description>
        <pubDate>Thu, 22 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-218.html</guid>
        
      <content:encoded> <![CDATA[
    Depicting the Spatial Distribution of Proteins in Human Tumor Tissue Combining SELDI, MALDI Imaging, and Immunohistochemistry. J Histochem Cytochem. 2010 Jul 19; Authors: Wehder L, Ernst G, Crecelius AC, Guntinas-Lichius O, Melle C, Schubert US, von Eggeling F Carcinoma tissue does not only consist of tumor cells but also of fibroblasts, endothelial cells or vascular structures, and inflammatory cells forming the supportive tumor stroma. Therefore, the spatial distribution of proteins which promote growth and proliferation in these complex functional units is of high interest. Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS) is a newly developed technique that generates spatial resolved profiles of protein signals directly from thin tissue sections. Surface-enhanced laser desorption/ionization (SELDI) mass spectrometry (MS) combined with tissue microdissection allows us to analyze defined parts of the tissue with a higher sensitivity and a broader mass range. Nevertheless, both MS-based techniques have a limited spatial resolution. Immunohistochemistry is a technique that allows a resolution down to the sub-cellular level. However, the detection and measurement of a specific protein expression level is possible only by semi-quantitative methods. Moreover, prior knowledge about the identity of the proteins of interest is necessary. In this study we combined all three techniques to gain highest spatial resolution, sensitivity and quantitative information. We used frozen tissue from head and neck tumors and chose two exemplary proteins (HNP1-3 and S100A8) to highlight the advantages and disadvantages of each technique. It could be shown that the combination of these three techniques results in congruent, but also synergetic data. PMID: 20644210 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： SELDI、MALDIイメージ投射およびImmunohistochemistryを結合する人間の腫瘍のティッシュの蛋白質の空間的な配分の描写。 J Histochem Cytochem。 7月2010日19日; 著者: Wehder L、エルンストG、Crecelius AC、Guntinas-Lichius O、Melle C、Schubert米国のフォンEggeling Fの癌腫のティッシュは腫瘍の細胞からまた繊維芽細胞からしか、endothelial細胞または管構造および支える腫瘍のstromaを形作る炎症性細胞成っていない。 従って、これらの複雑な機能ユニットの成長そして拡散を促進する蛋白質の空間的な配分は利率が高いである。 マトリックス助けられたレーザーの脱着またはイオン化(MALDI)イメージ投射質量分析(IMS)は薄いティッシュセクションからの蛋白質信号の空間的な解決するプロフィールを直接発生させる新開発の技術である。 ティッシュのmicrodissectionと結合される表面高められたレーザーの脱着またはイオン化(SELDI)質量分析(MS)は私達がより高い感受性およびより広い多くの範囲が付いているティッシュの定義された部分を分析することを可能にする。 それにもかかわらず、氏基づかせていた技術に両方とも限られた空間分解能がある。 Immunohistochemistryは細胞レベル下のレベルに決断を可能にする技術である。 但し、特定の蛋白質の表現のレベルの検出そして測定は半定量的な方法によってだけ可能である。 さらに、興味の蛋白質のアイデンティティについての前の知識は必要である。 この調査では私達は最も高い空間分解能、感受性および定量的情報を得るために3つの技術をすべて結合した。 私達は頭部および首の腫瘍からの凍結するティッシュを使用し、各技術の利点そして不利な点を強調するために2つの模範的な蛋白質を(HNP1-3およびS100A8)選んだ。 それは一致した、また共働データでことこの3つの技術の結果の組合せ示すことができる。 PMID: -出版業者によって供給される… 20644210 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>R-Gada: a fast and flexible pipeline for copy number analysis in association studies.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-370.html</link>
      <description> R-Gada: a fast and flexible pipeline for copy number analysis in association studies. BMC Bioinformatics. 2010 Jul 16;11(1):380 Authors: Pique-Regi R, Caceres A, Gonzalez JR ABSTRACT: BACKGROUND: Genome-wide association studies (GWAS) using Copy Number Variation (CNV) are becoming a central focus of genetic research. CNVs have successfully provided target genome regions for some disease conditions where simple genetic variation (i.e., SNPs) has previously failed to provide a clear association.  ...</description>
        <pubDate>Wed, 21 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-370.html</guid>
        
      <content:encoded> <![CDATA[
    

        R-Gada: a fast and flexible pipeline for copy number analysis in association studies.
        BMC Bioinformatics. 2010 Jul 16;11(1):380
        Authors:  Pique-Regi R, Caceres A, Gonzalez JR
        ABSTRACT: BACKGROUND: Genome-wide association studies (GWAS) using Copy Number Variation (CNV) are becoming a central focus of genetic research. CNVs have successfully provided target genome regions for some disease conditions where simple genetic variation (i.e., SNPs) has previously failed to provide a clear association. RESULTS: Here we present a new R package, that integrates: (i) data import from most common formats of Affymetrix, Illumina and aCGH arrays; (ii) a fast and accurate segmentation algorithm to call CNVs based on Genome Alteration Detection Analysis (GADA); and (iii) functions for displaying and exporting the Copy Number calls, identification of recurrent CNVs, multivariate analysis of population structure, and tools for performing association studies. Using a large dataset containing 270 HapMap individuals (Affymetrix Human SNP Array 6.0 Sample Dataset) we demonstrate a flexible pipeline implemented with the package. It requires less than one minute per sample (3 million probe arrays) on a single core computer, and provides a flexible parallelization for very large datasets. Case-control data were generated from the HapMap dataset to demonstrate a GWAS analysis. CONCLUSIONS: The package provides the tools for creating a complete integrated pipeline from data normalization to statistical association. It can efficiently handle a massive volume of data consisting of millions of genetic markers and hundreds or thousands of samples with very accurate results.
        PMID: 20637081 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Molecular analysis of germline t(3;6) and t(3;12) associated with conventional renal cell carcinomas indicates their rate-limiting role and supports the three-hit model of carcinogenesis.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-369.html</link>
      <description>Related Articles Molecular analysis of germline t(3;6) and t(3;12) associated with conventional renal cell carcinomas indicates their rate-limiting role and supports the three-hit model of carcinogenesis. Cancer Genet Cytogenet. 2010 Aug;201(1):15-23 Authors: Yusenko MV, Nagy A, Kovacs G We describe the molecular analysis of chromosomal rearrangements in familial t(3;6)(p12.3;q24.3) and t(3;12)(q13.13;q24.23) associated with the development of conventional renal cell carcinomas (RCC). We mapped  ...</description>
        <pubDate>Tue, 20 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-369.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Molecular analysis of germline t(3;6) and t(3;12) associated with conventional renal cell carcinomas indicates their rate-limiting role and supports the three-hit model of carcinogenesis.
        Cancer Genet Cytogenet. 2010 Aug;201(1):15-23
        Authors:  Yusenko MV, Nagy A, Kovacs G
        We describe the molecular analysis of chromosomal rearrangements in familial t(3;6)(p12.3;q24.3) and t(3;12)(q13.13;q24.23) associated with the development of conventional renal cell carcinomas (RCC). We mapped the breakpoints by high-density oligo array comparative genomic hybridization of tumor cells in t(3;6) at chromosome 3p12.3 between PDZRN3 and CNTN3; the chromosomal rearrangement at 6q24.3 was mapped within the seventh intron of the STXBP5 gene. In the second case, the break at 3q13.13 was mapped downstream of PVRL3 and the breakpoint at 12q24.23 between HSPB8 and CCDC60, one allele of the latter being deleted. Reverse transcriptase polymerase chain reaction analysis of the PDZRN3, CNTN3, STXBP5, PVRL3, HSPB8, and CCDC60 genes revealed slight variation in the copy number of transcripts, but without correlation to the chromosomal rearrangements in translocation-associated and sporadic conventional RCCs. Loss of heterozygosity at chromosome 3p and mutation of VHL occurred at the same frequency in both familial and sporadic cases. Based on our model of nonhomologous chromatid exchange and the data on molecular studies, we suggest that the germline translocation serves as a rate-limiting step toward tumor development by generating a high number of cells with loss of the derivative chromosome carrying the 3p segment.
        PMID: 20633763 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Repetitive sequences in the lamprey mitochondrial DNA control region and speciation of Lethenteron.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-360.html</link>
      <description> Related Articles Repetitive sequences in the lamprey mitochondrial DNA control region and speciation of Lethenteron. Gene. 2010 Jun 25; Authors: Okada K, Yamazaki Y, Yokobori S, Wada H The sequence of the mitochondrial DNA control region was examined in four species of lamprey in the genus Lethenteron. The 3&apos; half of the control region contains highly variable repeat sequences, showing variation in both copy number and nucleotide sequence, even within local populations. Detailed analyses of the ...</description>
        <pubDate>Sat, 17 Jul 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-360.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Repetitive sequences in the lamprey mitochondrial DNA control region and speciation of Lethenteron.
        Gene. 2010 Jun 25;
        Authors:  Okada K, Yamazaki Y, Yokobori S, Wada H
        The sequence of the mitochondrial DNA control region was examined in four species of lamprey in the genus Lethenteron. The 3' half of the control region contains highly variable repeat sequences, showing variation in both copy number and nucleotide sequence, even within local populations. Detailed analyses of the sequences of the repeats allowed us to deduce that slipped-strand mispairing during DNA replication, accompanied by a high rate of substitutions and indels, was primarily responsible for the variation in the repeats. We also found that some cases might be better explained by gene conversion, due to intermolecular recombination. Based on the observed variable nature of the mitochondrial control region, we searched for molecular markers in mitochondrial DNA, because there are few fixed genetic markers for distinguishing between Lethenteron japonicum and Lethenteron kessleri. However, we found no reliable markers in the control region. No fixed substitution was observed in intron sequences of the nuclear gene SoxD. Thus, these two species likely diverged quite recently and may possess only a limited number of fixed genetic loci.
        PMID: 20599597 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>R2 dynamics in Triops cancriformis (Bosc, 1801) (Crustacea, Branchiopoda, Notostraca): turnover rate and 28S concerted evolution.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-368.html</link>
      <description>Related Articles R2 dynamics in Triops cancriformis (Bosc, 1801) (Crustacea, Branchiopoda, Notostraca): turnover rate and 28S concerted evolution. Heredity. 2010 Jul 14; Authors: Mingazzini V, Luchetti A, Mantovani B The R2 retrotransposon is here characterized in bisexual populations of the European crustacean Triops cancriformis. The isolated element matches well with the general aspects of the R2 family and it is highly differentiated from that of the congeneric North American Triops longicau ...</description>
        <pubDate>Sat, 17 Jul 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-368.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        R2 dynamics in Triops cancriformis (Bosc, 1801) (Crustacea, Branchiopoda, Notostraca): turnover rate and 28S concerted evolution.
        Heredity. 2010 Jul 14;
        Authors:  Mingazzini V, Luchetti A, Mantovani B
        The R2 retrotransposon is here characterized in bisexual populations of the European crustacean Triops cancriformis. The isolated element matches well with the general aspects of the R2 family and it is highly differentiated from that of the congeneric North American Triops longicaudatus. The analysis of 5' truncations indicates that R2 dynamics in T. cancriformis populations show a high turnover rate as observed in Drosophila simulans. For the first time in the literature, though, individuals harboring truncation variants, but lacking the complete element, are found. Present results suggest that transposition-mediated deletion mechanisms, possibly involving genomic turnover processes acting on rDNAs, can dramatically decrease the copy number or even delete R2 from the ribosomal locus. The presence of R2 does not seem to impact on the nucleotide variation of inserted 28S rDNA with respect to the uninserted genes. On the other hand, a low level of polymorphism characterizes rDNA units because new 28S variants continuously spread across the ribosomal array. Again, the interplay between transposition-mediated deletion and molecular drive may explain this pattern.Heredity advance online publication, 14 July 2010; doi:10.1038/hdy.2010.86.
        PMID: 20628416 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of gene copy number variations in patients with mental retardation using array-CGH: Novel syndromes in a large French series.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-366.html</link>
      <description> Related Articles Identification of gene copy number variations in patients with mental retardation using array-CGH: Novel syndromes in a large French series. Eur J Med Genet. 2010 Mar-Apr;53(2):66-75 Authors: Jaillard S, Drunat S, Bendavid C, Aboura A, Etcheverry A, Journel H, Delahaye A, Pasquier L, Bonneau D, Toutain A, Burglen L, Guichet A, Pipiras E, Gilbert-Dussardier B, Benzacken B, Martin-Coignard D, Henry C, David A, Lucas J, Mosser J, David V, Odent S, Verloes A, Dubourg C Array-CGH ha ...</description>
        <pubDate>Sat, 17 Jul 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-366.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Identification of gene copy number variations in patients with mental retardation using array-CGH: Novel syndromes in a large French series.
        Eur J Med Genet. 2010 Mar-Apr;53(2):66-75
        Authors:  Jaillard S, Drunat S, Bendavid C, Aboura A, Etcheverry A, Journel H, Delahaye A, Pasquier L, Bonneau D, Toutain A, Burglen L, Guichet A, Pipiras E, Gilbert-Dussardier B, Benzacken B, Martin-Coignard D, Henry C, David A, Lucas J, Mosser J, David V, Odent S, Verloes A, Dubourg C
        Array-CGH has revealed a large number of copy number variations (CNVs) in patients with multiple congenital anomalies and/or mental retardation (MCA/MR). According to criteria recently listed, pathogenicity was clearly suspected for some CNVs but benign CNVs, considered as polymorphisms, have complicated the interpretation of the results. In this study, genomic DNAs from 132 French patients with unexplained mental retardation were analysed by genome wide high-resolution Agilent 44K oligonucleotide arrays. The results were in accordance with those observed in previous studies: the detection rate of pathogenic CNVs was 14.4%. A non-random involvement of several chromosomal regions was observed. Some of the microimbalances recurrently involved regions (1q21.1, 2q23.1, 2q32q33, 7p13, 17p13.3, 17p11.2, 17q21.31) corresponding to known or novel syndromes. For all the pathogenic CNVs, further cases are needed to allow more accurate genotype-phenotype correlations underscoring the importance of databases to group patients with similar molecular data.
        PMID: 19878743 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Rice structural variation: a comparative analysis of structural variation between rice and three of its closest relatives in the genus Oryza.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-367.html</link>
      <description>Related Articles Rice structural variation: a comparative analysis of structural variation between rice and three of its closest relatives in the genus Oryza. Plant J. 2010 Jul 8; Authors: Hurwitz BL, Kudrna D, Yu Y, Sebastian A, Zuccolo A, Jackson SA, Ware D, Wing RA, Stein L SUMMARY Rapid progress in comparative genomics among the grasses has revealed similar gene content and order despite exceptional differences in chromosome size and number. Large and small-scale genomic variations are of pa ...</description>
        <pubDate>Sat, 17 Jul 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-367.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Rice structural variation: a comparative analysis of structural variation between rice and three of its closest relatives in the genus Oryza.
        Plant J. 2010 Jul 8;
        Authors:  Hurwitz BL, Kudrna D, Yu Y, Sebastian A, Zuccolo A, Jackson SA, Ware D, Wing RA, Stein L
        SUMMARY Rapid progress in comparative genomics among the grasses has revealed similar gene content and order despite exceptional differences in chromosome size and number. Large and small-scale genomic variations are of particular interest, especially among cultivated and wild species, since they encode rapidly evolving features that may be important in adaptation to particular environments. We present a genome-wide study of intermediate-sized structural variation (SV) among rice (O. sativa) and three of its closest relatives in the genus Oryza (O. nivara, O. rufipogon, and O. glaberrima). We computationally identified regional expansions, contractions, and inversions in the Oryza species genomes relative to O. sativa by combining data from paired-end clone alignments to the O. sativa reference genome and physical maps. A subset of the computational predictions was validated using a new approach for BAC size determination. The result was a confirmed catalog of 674 expansions (25-38 Mb) and 611 (4-19 Mb) contractions, and 140 putative inversions (14-19 Mb) between the three Oryza species and O. sativa. In the expanded regions unique to O. sativa, we found enrichment in transposable elements (TE); LTRs were randomly located across the chromosomes and their insertion times corresponded to the date of the A genome radiation. Also, rice expanded regions contained an over-representation of single copy genes related to defense factors in the environment. This catalog of confirmed SV in reference to O. sativa provides an entry point for future research in genome evolution, speciation, domestication, and novel gene discovery.
        PMID: 20626650 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>8th HUPO World Congress: The Human Disease Glycomics/Proteomics Initiative (HGPI) Session 26 September 2009, Toronto, Canada.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-345.html</link>
      <description>Related Articles 8th HUPO World Congress: The Human Disease Glycomics/Proteomics Initiative (HGPI) Session 26 September 2009, Toronto, Canada. Proteomics. 2010 May;10(10):1899-902 Authors: Narimatsu H The Human Disease Glycomics/Proteomics Initiative (HGPI) Session at the HUPO World Congress was held in Toronto on 26 September 2009. In this report, we summarize the presentation of the HGPI workshop as follows: (i) The results of the past HGPI pilot studies (first and second) in which we analyzed ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-345.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles 8th HUPO World Congress: The Human Disease Glycomics/Proteomics Initiative (HGPI) Session 26 September 2009, Toronto, Canada. Proteomics. 2010 May;10(10):1899-902 Authors: Narimatsu H The Human Disease Glycomics/Proteomics Initiative (HGPI) Session at the HUPO World Congress was held in Toronto on 26 September 2009. In this report, we summarize the presentation of the HGPI workshop as follows: (i) The results of the past HGPI pilot studies (first and second) in which we analyzed N- and O-linked glycans using standard glycoproteins (i.e. first: N-linked glycan analysis of transferrin and IgG; second: O-linked glycan analysis of IgA). (ii) The recent progresses of the current HGPI third pilot study. The third analytical pilot study is in progress to perform the two tasks, which are glycan structural analysis and identification of proteins which carry specific carbohydrate antigen (Lewis X antigen) using cancer cells (i.e. L428, U937, and SK-N-SH), under the theme of "Glyco-Biomarker Discovery". Finally, recently advanced glycomic and glycoproteomic analyses were also reported. PMID: 20623475 [PubMed - in process]（【斜め読み用】機械翻訳：関連の記事第8 HUPOの世界議会: 人間の病気Glycomics/Proteomicsの初めの(HGPI)会議2009年9月26日、トロント、カナダ。 Proteomics。 5月2010日; 10 (10): 1899-902書く: Narimatsu Hは2009年9月26日にトロントでHUPOの世界議会の人間の病気Glycomics/Proteomicsの初めの(HGPI)会議保持された。 このレポートでは、私達は次の通りHGPIの研修会の提示を要約する: (i)私達がN-を分析し、標準的な糖蛋白質を使用してglycansをOつないだ過去HGPIのパイロット・スタディの結果(第1および二番目に) (すなわち最初に: transferrinおよびIgGのNつながれたglycan分析; 二番目に: IgAのOつながれたglycan分析)。 (ii)最近は現在のHGPI第3パイロット・スタディの進歩する。 第3分析的なパイロット・スタディは進行中癌細胞(すなわちL428、U937およびSK-N-SH)を使用して特定の炭水化物の抗原(ルイスXの抗原)を運ぶ蛋白質のglycan構造解析そして同一証明の「Glyco-Biomarker発見」のの主題の下で2つの仕事を行うためにである。 最後に、最近高度のglycomicおよびglycoproteomic分析はまた報告された。 PMID: 20623475 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Towards Functional Glycomics by Lectin Histochemistry: Strategic Probe Selection to Monitor Core and Branch-end Substitutions and Detection of Cell-type and Regional Selectivity in Adult Mouse Testis and Epididymis.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-346.html</link>
      <description>Towards Functional Glycomics by Lectin Histochemistry: Strategic Probe Selection to Monitor Core and Branch-end Substitutions and Detection of Cell-type and Regional Selectivity in Adult Mouse Testis and Epididymis. Anat Histol Embryol. 2010 Jul 7; Authors: Lohr M, Kaltner H, Schwartz-Albiez R, Sinowatz F, Gabius HJ With 2 figures and 3 tables Summary The emerging insights into glycan functionality direct increasing attention to monitor core modifications of N-glycans and branch-end structures.  ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-346.html</guid>
        
      <content:encoded> <![CDATA[
    Towards Functional Glycomics by Lectin Histochemistry: Strategic Probe Selection to Monitor Core and Branch-end Substitutions and Detection of Cell-type and Regional Selectivity in Adult Mouse Testis and Epididymis. Anat Histol Embryol. 2010 Jul 7; Authors: Lohr M, Kaltner H, Schwartz-Albiez R, Sinowatz F, Gabius HJ With 2 figures and 3 tables Summary The emerging insights into glycan functionality direct increasing attention to monitor core modifications of N-glycans and branch-end structures. To address this issue in histochemistry, a panel of lectins with respective specificities was devised. The selection of probes with overlapping specificities facilitated to relate staining profiles to likely target structures. The experiments on fixed sections of adult murine testis and epididymis were carried out at non-saturating lectin concentrations to visualize high-affinity sites with optimal signal-to-background ratio. They revealed selectivity in lectin reactivity for distinct cell types and segment-dependent staining in the epididymis. Leydig cells, for instance, were reactive with the Sambucus nigra agglutinin and human siglec-2 (CD22), two lectins also separating principal from basal and apical cells in the caput segments I-III of the epididymis. Apical cells were reactive with the Maackia amurensis agglutinin-I, and basal cells with the erythroagglutinin of Phaseolus vulgaris. The reported differences support the concept of lectin staining as cell marker. They thus intimate to study glycogene (genes for glycosyltransferases and lectins) expression and cellular reactivity with tissue lectins. These investigations will be instrumental to assign a role as biochemical signals to the detected staining properties. PMID: 20624157 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： Lectin Histochemistry著機能Glycomicsの方: 大人のマウスの睾丸および副睾丸炎の細胞タイプそして地方選択率の中心および枝終りの取り替えそして検出を監視する戦略的な調査の選択。 Anat Histol Embryol。 7月2010日7日; 著者: Lohr M、Kaltner H、Schwartz-Albiez R、Sinowatz F、2つの図とのGabius HJおよび3つのテーブルの概要はglycan機能性への出現の洞察力N-glycansおよび枝終りの構造のモニターの中心の修正への増加する注意を指示する。 組織化学のこの問題を扱うためには、それぞれの特定性のlectinsのパネルは案出された。 プロフィールを本当らしいターゲット構造に汚すことを関連付けるために促進される重複の特定性の調査の選択。 大人のネズミ科の睾丸および副睾丸炎の固定セクションの実験は非飽和のlectinの集中で最適の信号に背景の比率の高類縁の場所を視覚化するために遂行された。 それらは明瞭な細胞のタイプのためのlectinの反応の選択率および副睾丸炎の区分依存した汚損を明らかにした。 例えばLeydigの細胞はSambucusのnigraの凝集素と反応であり、人間siglec-2 (CD22)、また頭の基底および頂点の細胞から校長を分ける2つのlectinsは副睾丸炎のI-IIIを区分する。 頂点の細胞はvulgaris Phaseolusのerythroagglutininが付いているMaackiaのamurensisの凝集素私および基底細胞と反応だった。 報告された相違サポート細胞のマーカーとして汚れるlectinの概念。 それらはこうしてティッシュのlectinsとのglycogene (glycosyltransferasesおよびlectinsのための遺伝子)の表現そして細胞反応を調査するために暗示する。 これらの調査は器械検出された汚損の特性に生化学的な信号として役割を割り当てるためにである。 PMID: -出版業者によって供給される… 20624157 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The impact of CpG island on defining transcriptional activation of the mouse L1 retrotransposable elements.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-365.html</link>
      <description> Related Articles The impact of CpG island on defining transcriptional activation of the mouse L1 retrotransposable elements. PLoS One. 2010;5(6):e11353 Authors: Lee SH, Cho SY, Shannon MF, Fan J, Rangasamy D BACKGROUND: L1 retrotransposable elements are potent insertional mutagens responsible for the generation of genomic variation and diversification of mammalian genomes, but reliable estimates of the numbers of actively transposing L1 elements are mostly nonexistent. While the human and mouse ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-365.html</guid>
        
      <content:encoded> <![CDATA[
    
  Related Articles
        The impact of CpG island on defining transcriptional activation of the mouse L1 retrotransposable elements.
        PLoS One. 2010;5(6):e11353
        Authors:  Lee SH, Cho SY, Shannon MF, Fan J, Rangasamy D
        BACKGROUND: L1 retrotransposable elements are potent insertional mutagens responsible for the generation of genomic variation and diversification of mammalian genomes, but reliable estimates of the numbers of actively transposing L1 elements are mostly nonexistent. While the human and mouse genomes contain comparable numbers of L1 elements, several phylogenetic and L1Xplore analyses in the mouse genome suggest that 1,500-3,000 active L1 elements currently exist and that they are still expanding in the genome. Conversely, the human genome contains only 150 active L1 elements. In addition, there is a discrepancy among the nature and number of mouse L1 elements in L1Xplore and the mouse genome browser at the UCSC and in the literature. To date, the reason why a high copy number of active L1 elements exist in the mouse genome but not in the human genome is unknown, as are the potential mechanisms that are responsible for transcriptional activation of mouse L1 elements. METHODOLOGY/PRINCIPAL FINDINGS: We analyzed the promoter sequences of the 1,501 potentially active mouse L1 elements retrieved from the GenBank and L1Xplore databases and evaluated their transcription factors binding sites and CpG content. To this end, we found that a substantial number of mouse L1 elements contain altered transcription factor YY1 binding sites on their promoter sequences that are required for transcriptional initiation, suggesting that only a half of L1 elements are capable of being transcriptionally active. Furthermore, we present experimental evidence that previously unreported CpG islands exist in the promoters of the most active T(F) family of mouse L1 elements. The presence of sequence variations and polymorphisms in CpG islands of L1 promoters that arise from transition mutations indicates that CpG methylation could play a significant role in determining the activity of L1 elements in the mouse genome. CONCLUSIONS: A comprehensive analysis of mouse L1 promoters suggests that the number of transcriptionally active elements is significantly lower than the total number of full-length copies from the three active mouse L1 families. Like human L1 elements, the CpG islands and potentially the transcription factor YY1 binding sites are likely to be required for transcriptional initiation of mouse L1 elements.
        PMID: 20613872 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Mapping candidate regions and genes for congenital anomalies of the kidneys and urinary tract (CAKUT) by array-based comparative genomic hybridization.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-361.html</link>
      <description>Related Articles Mapping candidate regions and genes for congenital anomalies of the kidneys and urinary tract (CAKUT) by array-based comparative genomic hybridization. Nephrol Dial Transplant. 2010 Jul 5; Authors: Weber S, Landwehr C, Renkert M, Hoischen A, WÃ?hl E, Denecke J, Radlwimmer B, Haffner D, Schaefer F, Weber RG BACKGROUND: Congenital anomalies of the kidneys and urinary tract (CAKUT) are frequently associated with malformations of other organs. METHODS: In order to explore the role ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-361.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Mapping candidate regions and genes for congenital anomalies of the kidneys and urinary tract (CAKUT) by array-based comparative genomic hybridization.
        Nephrol Dial Transplant. 2010 Jul 5;
        Authors:  Weber S, Landwehr C, Renkert M, Hoischen A, WÃ?hl E, Denecke J, Radlwimmer B, Haffner D, Schaefer F, Weber RG
        BACKGROUND: Congenital anomalies of the kidneys and urinary tract (CAKUT) are frequently associated with malformations of other organs. METHODS: In order to explore the role of DNA microimbalances in syndromal CAKUT, we applied genome-wide array-based comparative genomic hybridization (array-CGH) in 30 children with various CAKUT phenotypes and at least one additional extrarenal symptom. RESULTS: In three patients, causal imbalances were detected: In one patient with duplex kidney and vesico-ureteral reflux associated with extrarenal stigmata, a terminal 9.52 Mb gain in chromosomal band 2q37.1-q37.3 and a terminal 5.65 Mb loss in 7q36.2-q36.3 were detected, which were due to an unbalanced 2;7-translocation according to FISH analysis. A balanced 2;7-translocation was present in the unaffected mother. In another patient presenting with renal hypoplasia and proximal ureteric stenosis combined with mental retardation, macrocephaly and ear anomalies, a duplication of 2.73 Mb was detected in 1q21.1. The unaffected father had a 1.3 Mb gain in 1q21.1-q21.2 involving the distal part of the patient's gain, for which benign copy number variation was described. A third patient affected by dysplastic kidney with a strongly dilated ureter and extrarenal abnormalities exhibited a de novo loss of 13.38 Mb in 3q23-q25.1 including the AGTR1 gene. However, no AGTR1 mutations were identified in the remaining allele of this case or in 108 patients with isolated renal dysplasia/hypoplasia. CONCLUSIONS: In this study, 10% of patients with syndromic CAKUT were shown to carry DNA microimbalances, and four chromosomal regions presumably associated with the CAKUT phenotype were identified: 1q21.1, 2q37.1-q37.3, 3q23-q25.1 and 7q36.2-q36.3.
        PMID: 20605837 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Insights into the Role of Fc Gamma Receptors (FcgammaRs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-358.html</link>
      <description>Related Articles Insights into the Role of Fc Gamma Receptors (FcgammaRs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy. Recent Pat Anticancer Drug Discov. 2010 Apr 30; Authors: Concetti F, Napolioni V Recently, the field of oncology has witnessed the introduction of several effective chemotherapeutic agents. Still, not all cancers respond to the use of conventional chemotherapy and thus combination therapy is an emerging weapon in the battle against cancer. There is emergi ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-358.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Insights into the Role of Fc Gamma Receptors (FcgammaRs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy.
        Recent Pat Anticancer Drug Discov. 2010 Apr 30;
        Authors:  Concetti F, Napolioni V
        Recently, the field of oncology has witnessed the introduction of several effective chemotherapeutic agents. Still, not all cancers respond to the use of conventional chemotherapy and thus combination therapy is an emerging weapon in the battle against cancer. There is emerging evidence in support of the use of Monoclonal antibodies (MoAbs) in cancer therapy. The mechanisms behind their efficacy are multi-faceted; they can kill tumor cells through antibody-dependent cell-mediated cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and apoptosis as well as target ligands or growth factor receptors favoring tumor growth. The interaction of the Fc domains of antibodies with the Fcgamma (gamma) receptors is an essential checkpoint in ADCC. This interaction is strongly regulated and is largely dependent upon receptor conformation and number. It is accepted that germ-line single nucleotide polymorphisms (SNPs) and copy number variations (CNVs) have the potential to predict the outcome of therapy. The possibility of predicting patients response to monoclonal antibody therapy is of particular importance, as response rates are moderate, with the risk of serious side effects all at a high financial cost. This patent review provides an insight into the role of Fcgamma receptors (FcgammaRs) genetic variation in Monoclonal Antibody-based anti-cancer therapy.
        PMID: 20594185 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>CNVineta: A data mining tool for large case-control copy number variation data sets.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-362.html</link>
      <description> Related Articles CNVineta: A data mining tool for large case-control copy number variation data sets. Bioinformatics. 2010 Jul 6; Authors: Wittig M, Helbig I, Schreiber S, Franke A MOTIVATION: Copy number variation (CNV), a major contributor to human genetic variation, comprises 1 kb or longer genomic deletions and insertions. Yet, the identification of CNVs from microarray data is still hampered by high false negative and positive prediction rates due to the noisy nature of the raw data. Here, ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-362.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        CNVineta: A data mining tool for large case-control copy number variation data sets.
        Bioinformatics. 2010 Jul 6;
        Authors:  Wittig M, Helbig I, Schreiber S, Franke A
        MOTIVATION: Copy number variation (CNV), a major contributor to human genetic variation, comprises 1 kb or longer genomic deletions and insertions. Yet, the identification of CNVs from microarray data is still hampered by high false negative and positive prediction rates due to the noisy nature of the raw data. Here, we present CNVineta, an R package for rapid data mining and visualization of CNVs in large case-control data sets genotyped with single-nucleotide polymorphism oligonucleotide arrays. CNVineta is compatible with various established CNV prediction algorithms, can be used for genome-wide association analysis of rare and common CNVs and enables rapid and serial display of log2 of raw data ratios as well as B-allele frequencies for visual quality inspection. In summary, CNVineta aides in the interpretation of large-scale CNV data sets and prioritization of target regions for follow-up experiments. Availability and Implementation: CNVineta is available as an R package and can be downloaded from http://www.ikmb.uni-kiel.de/CNVineta/; the package contains a tutorial outlining a typical workflow. The CNVineta compatible HapMap (International HapMap Consortium 2003) data set can also be downloaded from the link above. CONTACT: m.wittig@mucosa.de.
        PMID: 20605930 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A de novo 4q34 interstitial deletion of at least 9.3 Mb with no discernible phenotypic effect.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-353.html</link>
      <description> Related Articles A de novo 4q34 interstitial deletion of at least 9.3 Mb with no discernible phenotypic effect. Am J Med Genet A. 2010 Jul;152A(7):1764-9 Authors: Bateman MS, Mehta SG, Willatt L, Selkirk E, Bedwell C, Zwolinski S, Sparnon L, Simonic I, Abbott K, Barber JC Cytogenetically visible imbalances without phenotypic effect are still rare despite the extent of large-scale copy number variation in the normal population revealed by array CGH. Here we report on a phenotypically normal 30-y ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-353.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        A de novo 4q34 interstitial deletion of at least 9.3 Mb with no discernible phenotypic effect.
        Am J Med Genet A. 2010 Jul;152A(7):1764-9
        Authors:  Bateman MS, Mehta SG, Willatt L, Selkirk E, Bedwell C, Zwolinski S, Sparnon L, Simonic I, Abbott K, Barber JC
        Cytogenetically visible imbalances without phenotypic effect are still rare despite the extent of large-scale copy number variation in the normal population revealed by array CGH. Here we report on a phenotypically normal 30-year-old female with a de novo, cytogenetically visible, interstitial deletion of band 4q34. She was referred following three successive miscarriages, one of which was an intra-uterine death with subendocardial fibroelastosis and dilated cardiomyopathy. There was no other notable medical or family history, she was of normal intelligence and had no dysmorphic features. FISH and Array CGH with a customized 1 Mb BAC array showed that the deletion is a minimum of 9.3 and a maximum of 10.7 Mb in size, between approximately 173 Mb in 4q34.1 and approximately 182 Mb in 4q34.3. The deletion contains only 23 known coding genes giving a low average gene density of approximately 2 genes/Mb. This case further illustrates that (1) sizeable imbalances can be associated with apparent phenotypic normality, (2) gene density is a better guide to possible phenotypic consequences than aberration size, and (3) it is not always safe to assume that de novo imbalances will be causal.
        PMID: 20583179 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Genetic variation of copia suppression in Drosophila melanogaster.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-363.html</link>
      <description> Related Articles Genetic variation of copia suppression in Drosophila melanogaster. Heredity. 2010 Jul 7; Authors: Vu W, Nuzhdin S Transposable elements (TEs) are genomic parasites that propagate by exploiting its host reproductive machinery. However, some hosts have evolved the ability to silence TE activity, whereas others have not. We are investigating the population dynamics of TE host-silencing pathways, particularly copia long terminal repeat retrotransposon in Drosophila melanogaster. He ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-363.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Genetic variation of copia suppression in Drosophila melanogaster.
        Heredity. 2010 Jul 7;
        Authors:  Vu W, Nuzhdin S
        Transposable elements (TEs) are genomic parasites that propagate by exploiting its host reproductive machinery. However, some hosts have evolved the ability to silence TE activity, whereas others have not. We are investigating the population dynamics of TE host-silencing pathways, particularly copia long terminal repeat retrotransposon in Drosophila melanogaster. Here, we identify large effect genes involved in copia suppression by using a semi-quantitative analysis to assay levels of copia plasmids (believed to be an intermediate of transposition) in 98 recombinant inbred lines constructed from a line exhibiting high copia transpositions and a line exhibiting no transpositions. The results revealed that the influence of copia copy number and transcription level on copia plasmid concentrations are weak and that genomic factors, presumably encoded by the host, have stronger effects on transposition rates. We mapped a QTL affecting copia plasmid concentration within the 33A-43E cytological region of the second chromosome and applied a quantitative deficiency complementation analysis on this chromosomal region. One out of the two large effect deficiencies on copia plasmid concentrations corresponded to the vasa gene, an important component of the nuage-piwi RNA TE-silencing machinery. We hypothesize that copia suppression occurs by the joint action of several post-transcriptional mechanisms with at least one of the blocks taking place in the nuage.Heredity advance online publication, 7 July 2010; doi:10.1038/hdy.2010.41.
        PMID: 20606692 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Gene copy-number polymorphism in nature.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-357.html</link>
      <description> Related Articles Gene copy-number polymorphism in nature. Proc Biol Sci. 2010 Jun 30; Authors: Schrider DR, Hahn MW Differences between individuals in the copy-number of whole genes have been found in every multicellular species examined thus far. Such differences result in unique complements of protein-coding genes in all individuals, and have been shown to underlie adaptive phenotypic differences. Here, we review the evidence for copy-number variants (CNVs), focusing on the methods used to de ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-357.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Gene copy-number polymorphism in nature.
        Proc Biol Sci. 2010 Jun 30;
        Authors:  Schrider DR, Hahn MW
        Differences between individuals in the copy-number of whole genes have been found in every multicellular species examined thus far. Such differences result in unique complements of protein-coding genes in all individuals, and have been shown to underlie adaptive phenotypic differences. Here, we review the evidence for copy-number variants (CNVs), focusing on the methods used to detect them and the molecular mechanisms responsible for generating this type of variation. Although there are multiple technical and computational challenges inherent to these experimental methods, next-generation sequencing technologies are making such experiments accessible in any system with a sequenced genome. We further discuss the connection between copy-number variation within species and copy-number divergence between species, showing that these values are exactly what one would expect from similar comparisons of nucleotide polymorphism and divergence. We conclude by reviewing the growing body of evidence for natural selection on copy-number variants. While it appears that most genic CNVs-especially deletions-are quickly eliminated by selection, there are now multiple studies demonstrating a strong link between copy-number differences at specific genes and phenotypic differences in adaptive traits. We argue that a complete understanding of the molecular basis for adaptive natural selection necessarily includes the study of copy-number variation.
        PMID: 20591863 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A novel microdeletion/microduplication syndrome of 19p13.13.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-364.html</link>
      <description>Related Articles A novel microdeletion/microduplication syndrome of 19p13.13. Genet Med. 2010 Jul 6; Authors: Dolan M, Mendelsohn NJ, Pierpont ME, Schimmenti LA, Berry SA, Hirsch B PURPOSE:: Whole genome interrogation by array-based comparative genomic hybridization has led to a rapidly increasing number of discoveries of novel microdeletion and/or microduplication syndromes. We here describe the clinical and cytogenomic correlates of a novel microdeletion/microduplication of 19p13.13. METHODS:: ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-364.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        A novel microdeletion/microduplication syndrome of 19p13.13.
        Genet Med. 2010 Jul 6;
        Authors:  Dolan M, Mendelsohn NJ, Pierpont ME, Schimmenti LA, Berry SA, Hirsch B
        PURPOSE:: Whole genome interrogation by array-based comparative genomic hybridization has led to a rapidly increasing number of discoveries of novel microdeletion and/or microduplication syndromes. We here describe the clinical and cytogenomic correlates of a novel microdeletion/microduplication of 19p13.13. METHODS:: Among patients referred to the Cytogenetics laboratory for array-based comparative genomic hybridization analysis, we identified four with a deletion and one with a duplication within 19p13.13. Confirmatory fluorescence in situ hybridization and parental studies were performed. Detailed clinical findings and array profiles were reviewed and compared. RESULTS:: Patients with deletions of 19p13.13 share a unique constellation of phenotypic abnormalities. In addition to developmental disabilities, the microdeletion manifested in overgrowth, macrocephaly, and ophthalmologic and gastrointestinal findings; in contrast, the single microduplication manifested in growth delay and microcephaly. CONCLUSION:: The consistent constellation of clinical findings associated with copy number variation of this region warrants the designation of microdeletion/microduplication syndrome of 19p13.13. An approximately 311-340 Kb smallest region of overlap encompassing 16 genes was identified. Candidate genes include MAST1, NFIX, and CALR. Identification of this syndrome has led to recommendations for diagnostic work-up and follow-up of patients with this copy number variant. Integration of detailed clinical and array data is critical for advancing both patient care and human genomic research.
        PMID: 20613546 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Copy number variation and transposable elements feature in recent, ongoing adaptation at the Cyp6g1 locus.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-355.html</link>
      <description> Related Articles Copy number variation and transposable elements feature in recent, ongoing adaptation at the Cyp6g1 locus. PLoS Genet. 2010;6(6):e1000998 Authors: Schmidt JM, Good RT, Appleton B, Sherrard J, Raymant GC, Bogwitz MR, Martin J, Daborn PJ, Goddard ME, Batterham P, Robin C The increased transcription of the Cyp6g1 gene of Drosophila melanogaster, and consequent resistance to insecticides such as DDT, is a widely cited example of adaptation mediated by cis-regulatory change. A fragm ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-355.html</guid>
        
      <content:encoded> <![CDATA[
    
  Related Articles
        Copy number variation and transposable elements feature in recent, ongoing adaptation at the Cyp6g1 locus.
        PLoS Genet. 2010;6(6):e1000998
        Authors:  Schmidt JM, Good RT, Appleton B, Sherrard J, Raymant GC, Bogwitz MR, Martin J, Daborn PJ, Goddard ME, Batterham P, Robin C
        The increased transcription of the Cyp6g1 gene of Drosophila melanogaster, and consequent resistance to insecticides such as DDT, is a widely cited example of adaptation mediated by cis-regulatory change. A fragment of an Accord transposable element inserted upstream of the Cyp6g1 gene is causally associated with resistance and has spread to high frequencies in populations around the world since the 1940s. Here we report the existence of a natural allelic series at this locus of D. melanogaster, involving copy number variation of Cyp6g1, and two additional transposable element insertions (a P and an HMS-Beagle). We provide evidence that this genetic variation underpins phenotypic variation, as the more derived the allele, the greater the level of DDT resistance. Tracking the spatial and temporal patterns of allele frequency changes indicates that the multiple steps of the allelic series are adaptive. Further, a DDT association study shows that the most resistant allele, Cyp6g1-[BP], is greatly enriched in the top 5% of the phenotypic distribution and accounts for approximately 16% of the underlying phenotypic variation in resistance to DDT. In contrast, copy number variation for another candidate resistance gene, Cyp12d1, is not associated with resistance. Thus the Cyp6g1 locus is a major contributor to DDT resistance in field populations, and evolution at this locus features multiple adaptive steps occurring in rapid succession.
        PMID: 20585622 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-359.html</link>
      <description> Related Articles Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome. Am J Hum Genet. 2010 Jul 9;87(1):129-38 Authors: RodrÃ?guez-Santiago B, Malats N, Rothman N, Armengol L, Garcia-Closas M, Kogevinas M, Villa O, Hutchinson A, Earl J, Marenne G, Jacobs K, Rico D, TardÃ?n A, Carrato A, Thomas G, Valencia A, Silverman D, Real FX, Chanock SJ, PÃ©rez-Jurado LA Mosaicism is defined as the coexistence of cells with different genetic composition withi ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-359.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome.
        Am J Hum Genet. 2010 Jul 9;87(1):129-38
        Authors:  RodrÃ?guez-Santiago B, Malats N, Rothman N, Armengol L, Garcia-Closas M, Kogevinas M, Villa O, Hutchinson A, Earl J, Marenne G, Jacobs K, Rico D, TardÃ?n A, Carrato A, Thomas G, Valencia A, Silverman D, Real FX, Chanock SJ, PÃ©rez-Jurado LA
        Mosaicism is defined as the coexistence of cells with different genetic composition within an individual, caused by postzygotic somatic mutation. Although somatic mosaicism for chromosomal abnormalities is a well-established cause of developmental and somatic disorders and has also been detected in different tissues, its frequency and extent in the adult normal population are still unknown. We provide here a genome-wide survey of mosaic genomic variation obtained by analyzing Illumina 1M SNP array data from blood or buccal DNA samples of 1991 adult individuals from the Spanish Bladder Cancer/EPICURO genome-wide association study. We found mosaic abnormalities in autosomes in 1.7% of samples, including 23 segmental uniparental disomies, 8 complete trisomies, and 11 large (1.5-37 Mb) copy-number variants. Alterations were observed across the different autosomes with recurrent events in chromosomes 9 and 20. No case-control differences were found in the frequency of events or the percentage of cells affected, thus indicating that most rearrangements found are not central to the development of bladder cancer. However, five out of six events tested were detected in both blood and bladder tissue from the same individual, indicating an early developmental origin. The high cellular frequency of the anomalies detected and their presence in normal adult individuals suggest that this type of mosaicism is a widespread phenomenon in the human genome. Somatic mosaicism should be considered in the expanding repertoire of inter- and intraindividual genetic variation, some of which may cause somatic human diseases but also contribute to modifying inherited disorders and/or late-onset multifactorial traits.
        PMID: 20598279 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[The screening and identification of Apolipoprotein A-II from serum differential proteins in hepatocellular carcinoma patients.]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-212.html</link>
      <description>Related Articles [The screening and identification of Apolipoprotein A-II from serum differential proteins in hepatocellular carcinoma patients.] Zhonghua Gan Zang Bing Za Zhi. 2010 Jun;18(6):445-9 Authors: Jiang ZH, Zhang ZY, He M, Qin J, Wang Q, Wei X, Nong BJ, Liu F To screen differential proteins in serum from hepatocellular carcinoma (HCC) patients by Proteomic Technology and to purify and identify them. Surface enhanced laser desorption Ionization time of flight-mass spectrum (SELDI-TOF-MS ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-212.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [The screening and identification of Apolipoprotein A-II from serum differential proteins in hepatocellular carcinoma patients.] Zhonghua Gan Zang Bing Za Zhi. 2010 Jun;18(6):445-9 Authors: Jiang ZH, Zhang ZY, He M, Qin J, Wang Q, Wei X, Nong BJ, Liu F To screen differential proteins in serum from hepatocellular carcinoma (HCC) patients by Proteomic Technology and to purify and identify them. Surface enhanced laser desorption Ionization time of flight-mass spectrum (SELDI-TOF-MS) was employed to screen differential proteins in serum from 33 HCC patients and 33 control cases, and then to purify and identify them using isoelectric precipitation, Tricine sodium dodecyl sulphate ployacrylamide gel electrophoresis (Tricine-SDS-PAGE) and high performance liquid chromatography tandem Mass Spectrum (HPLC-MS). 65 protein peaks in the range of relative molecular weight from 2000 to 10 000 were found significant difference (P less than 0.05) between the patient group and control group. Based on these differential protein peaks, diagnostic model for HCC detection was established and its sensitivity and specificity were 100% and 96.97% respectively. Proteins with 8706.5 and 8579.2 relative molecular weights (the t value was 2.562 and 2.783 respectively, and P value was 0.013 and 0.015 respectively) out of the 65 differential proteins were purified and identified, and then recognized as Apolipoprotein AII (Apo AII). Apo AII is probably a differential protein of HCC and maybe related to the pathogenesis of HCC. PMID: 20587316 [PubMed - in process]（【斜め読み用】機械翻訳：関連の記事[hepatocellular癌腫の患者の血清の差動蛋白質からのApolipoprotein A-IIのスクリーニングそして同一証明。] Zhonghua Gan ZangビングZa Zhi。 6月2010日; 18 (6): 445-9書く: 江ZH、チャンZY、彼M、Qin J、Wang Q、魏X、Nong BJ、hepatocellular癌腫(HCC)の患者からの血清の差動蛋白質をProteomic Technology著選別し、浄化し、識別する劉F。 次に飛行固まりスペクトル(SELDI-TOF-MS)の表面によって高められたレーザーの脱着のイオン化時間は33人のHCCの患者および33の制御場合からの血清の差動蛋白質を選別し、等電の沈殿物、Tricineナトリウムdodecyl硫酸塩のployacrylamideのゲルの電気泳動(Tricine SDSページ)および高性能の液体クロマトグラフィーのタンデム多くスペクトル(HPLC-MS)を使用して浄化し、識別するために用いられた。 2000年から10 000まで相対的な分子量の範囲の65の蛋白質のピークは忍耐強いグループ間の見つけられた重要な相違(Pより少なくより0.05)および制御グループだった。 これらの差動蛋白質のピークに基づいて、HCCの検出のための診断モデルは確立され、感受性および特定性は100%年およびそれぞれ96.97%だった。 65の差動蛋白質からの8706.5そして8579.2相対的な分子量の蛋白質は(tの価値は2.562およびそれぞれ2.783であり、Pの価値は0.013およびそれぞれ0.015だった) Apolipoprotein AII (Apo AII)として浄化され、識別され、そして次に確認された。 Apo AIIはおそらく差動蛋白質HCCのそして多分関連するHCCの病因にである。 PMID: 20587316 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Detection of pancreatic adenocarcinoma using circulating fragments of fibrinogen.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-209.html</link>
      <description>Related Articles Detection of pancreatic adenocarcinoma using circulating fragments of fibrinogen. Eur J Gastroenterol Hepatol. 2010 Jun 15; Authors: Ward DG, Wei W, Buckels J, Taha AM, Hegab B, Tariciotti L, Salih R, Qi YQ, Martin A, Johnson PJ BACKGROUND: There is an urgent need for biomarkers to detect pancreatic cancer in the early, potentially curable, stages. METHODS: We have used SELDI profiling to analyze serum from 75 patients with pancreatic cancer and 61 patients with nonmalignant pan ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-209.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Detection of pancreatic adenocarcinoma using circulating fragments of fibrinogen. Eur J Gastroenterol Hepatol. 2010 Jun 15; Authors: Ward DG, Wei W, Buckels J, Taha AM, Hegab B, Tariciotti L, Salih R, Qi YQ, Martin A, Johnson PJ BACKGROUND: There is an urgent need for biomarkers to detect pancreatic cancer in the early, potentially curable, stages. METHODS: We have used SELDI profiling to analyze serum from 75 patients with pancreatic cancer and 61 patients with nonmalignant pancreaticobiliary diseases. RESULTS: A peak in the SELDI spectra corresponding to a 53 residue fragment of the alpha-chain of fibrinogen is remarkably elevated in approximately 50% of the cancer patients. In addition, fibrinogen degradation products were measured using the DR-70 assay. The areas under the receiver operating characteristic curves for the SELDI-detected fibrinogen fragment, DR-70 and CA19-9 were 0.65, 0.75 and 0.86, respectively. Class prediction models using combinations of these markers did not increase the area under the receiver operating characteristic curve compared with CA19-9. The novel fibrinogen fragment was not elevated to the same extent in other malignancies but was elevated in some patients with benign pancreatic disease. CONCLUSION: Both the SELDI-detected fragment of fibrinogen and DR-70 are significantly elevated in the serum of pancreatic cancer patients. However, they do not seem to improve pancreatic cancer detection over CA19-9 alone. PMID: 20555269 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：フィブリノゲンの循環の片を使用して膵臓の腺癌の関連の記事の検出。 Eur J Gastroenterol Hepatol。 6月2010日15日; 著者: 区DG、魏W、Buckels J、タハAM、Hegab B、Tariciotti L、Salih R、チーYQ、マーティンAのジョンソンPJの背景: 早いのの膵臓癌を、可能性としては検出する治療が可能なbiomarkersのための急務段階がある。 方法: 私達は膵臓癌を持つ75人の患者およびnonmalignant pancreaticobiliary病気の61人の患者からの血清を分析するために側面図を描くSELDIを使用した。 結果: フィブリノゲンのアルファ鎖の53残余の片に相当するSELDIスペクトルのピークは癌患者のおよそ50%で非常に上がる。 さらに、フィブリノゲンの低下プロダクトはDR-70試金を使用して測定された。 SELDI検出されたフィブリノゲンの片、DR-70およびCA19-9のための受信者特性曲線の下の区域は0.65、0.75および0.86、それぞれだった。 これらのマーカーの組合せを使用してクラスの予言モデルはCA19-9と比較された受信者特性曲線の下で区域を高めなかった。 新しいフィブリノゲンの片は他の敵意の同じ範囲に上がらなかったが、温和な膵臓の病気の何人かの患者で上がった。 結論: フィブリノゲンのSELDI検出された片およびDR-70は両方膵臓癌の患者の血清でかなり上がる。 但し、それらは単独でCA19-9上の膵臓癌の検出を改善しないようではない。 PMID: -出版業者によって供給される… 20555269 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-213.html</link>
      <description> Related Articles Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis. Br J Cancer. 2010 Jun 29; Authors: Xue A, Scarlett CJ, Chung L, Butturini G, Scarpa A, Gandy R, Wilson SR, Baxter RC, Smith RC Background and aims:The serum/plasma proteome was explored for biomarkers to improve the diagnostic ability of CA19-9 in pancreatic adenocarcinoma (PC).Methods:A Training Set of serum samples from 20 resectable and 18 stage IV PC patients, 54 disease controls (DCs) and ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-213.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis. Br J Cancer. 2010 Jun 29; Authors: Xue A, Scarlett CJ, Chung L, Butturini G, Scarpa A, Gandy R, Wilson SR, Baxter RC, Smith RC Background and aims:The serum/plasma proteome was explored for biomarkers to improve the diagnostic ability of CA19-9 in pancreatic adenocarcinoma (PC).Methods:A Training Set of serum samples from 20 resectable and 18 stage IV PC patients, 54 disease controls (DCs) and 68 healthy volunteers (HVs) were analysed by surface-enhanced laser desorption and ionisation time-of-flight mass spectrometry (SELDI-TOF MS). The resulting protein panel was validated on 40 resectable PC, 21 DC and 19 HV plasma samples (Validation-1 Set) and further by ELISA on 33 resectable PC, 28 DC and 18 HV serum samples (Validation-2 Set). Diagnostic panels were derived using binary logistic regression incorporating internal cross-validation followed by receiver operating characteristic (ROC) analysis.Results:A seven-protein panel from the training set PC vs DC and from PC vs HV samples gave the ROC area under the curve (AUC) of 0.90 and 0.90 compared with 0.87 and 0.91 for CA19-9. The AUC was greater (0.97 and 0.99, P<0.05) when CA19-9 was added to the panels and confirmed on the validation-1 samples. A simplified panel of apolipoprotein C-I (ApoC-I), apolipoprotein A-II (ApoA-II) and CA19-9 was tested on the validation-2 set by ELISA, in which the ROC AUC was greater than that of CA19-9 alone for PC vs DC (0.90 vs 0.84) and for PC vs HV (0.96 vs 0.90).Conclusions:A simplified diagnostic panel of CA19-9, ApoC-I and ApoA-II improves the diagnostic ability of CA19-9 alone and may have clinical utility.British Journal of Cancer advance online publication, 29 June 2010; doi:10.1038/sj.bjc.6605764. PMID: 20588270 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： proteomic分析を使用して膵臓の腺癌のための血清のbiomarkersの関連の記事の発見。 Br Jの蟹座。 6月2010日29日; 著者: Xue A、Scarlett CJ、チョンL、Butturini G、Scarpa A、Gandy R、ウイルソンSR、バックスターRC、スミスRC背景および目標: 血清または血しょうproteomeはbiomarkersが膵臓の腺癌(PC)のCA19-9の診断能力を改善することができるように探検された。方法: 訓練の一組の20人のresectableおよび18人の段階IVのPCの患者からの血清のサンプル、54の病害対策(DCs)および68人の健康なボランティア(HVs)は表面高められたレーザーの脱着およびイオン化時間の飛行質量分析(SELDI-TOF MS)によって分析された。 生じる蛋白質のパネルは40のresectable PC、21のDCおよび19のHV血しょうサンプル(置かれる確認1)で33のresectable PC、28のDCおよび18のHVの血清のサンプル(置かれる確認2)のELISAによっておよびそれ以上認可された。 診断パネルは受信機のオペレーティング特性(ROC)の分析に先行している内部クロス確認を組み込む二進記号論理学退化を使用して得られた。結果: 訓練の一定のPC対DCとPCからの7蛋白質のパネルは対HVのサンプルCA19-9のための0.87そして0.91と比較された0.90および0.90のカーブ(AUC)の下でROC区域を与えた。 AUCはより大きかった(0.97および0.99、P< 0.05) CA19-9がパネルに加えられ、確認1のサンプルで確認された時。 apolipoprotein CI (ApoC-I)、apolipoprotein A-II (ApoA-II)およびCA19-9の簡単だったパネルはROCがAUC PC対DC (0.84対0.90)とPCのための単独でCA19-9のそれより大きかった対HV (0.90対0.96) ELISAによって置かれた確認2でテストされた。結論: CA19-9、ApoC-IおよびApoA-IIの簡単だった診断パネルは単独でCA19-9の診断能力を改善し、臨床実用性を持つかもしれない。蟹座の前進オンライン書、2010年6月29日のイギリスジャーナル; doi: 10.1038/sj.bjc.6605764. PMID: -出版業者によって供給される… 20588270 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Characterization of a diverse secretome generated by the mouse preimplantation embryo in vitro.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-211.html</link>
      <description> Related Articles Characterization of a diverse secretome generated by the mouse preimplantation embryo in vitro. Reprod Biol Endocrinol. 2010;8:71 Authors: Beardsley AJ, Li Y, O&apos;Neill C ABSTRACT: This study investigates the suitability of surface-enhanced laser desorption and ionization time-of-flight (SELDI-TOF) and electrospray ionization (ESI) mass spectrometry for analysis of the proteins released by the mouse preimplantation embryo in vitro. SELDI-TOF analysis with CM10 or IMAC30 (but not  ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-211.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Characterization of a diverse secretome generated by the mouse preimplantation embryo in vitro. Reprod Biol Endocrinol. 2010;8:71 Authors: Beardsley AJ, Li Y, O'Neill C ABSTRACT: This study investigates the suitability of surface-enhanced laser desorption and ionization time-of-flight (SELDI-TOF) and electrospray ionization (ESI) mass spectrometry for analysis of the proteins released by the mouse preimplantation embryo in vitro. SELDI-TOF analysis with CM10 or IMAC30 (but not Q10) protein chips detected a protein peak at m/z ~8570 released by both C57BL6 and hybrid embryos. No other peaks unique to the presence of the embryo were identified with this method. ESI mass spectrometry of tryptic digests of embryo-conditioned media identified a total of 20 proteins released during development from the zygote to blastocyst stage. Four proteins were expressed in at least 7 out of 8 cultures tested, one of these (lactate dehydrogenase B) was in all cultures. A further five proteins were in at least half of the cultures and 11 more proteins were in at least one culture. The expression of two of these proteins is essential for preimplantation embryo development (NLR family, pyrin domain containing 5 and peptidyl arginine deiminase, type VI). A further four proteins detected have roles in redox regulation of cells, and three others are capable of inducing post-translational modifications of proteins. This study shows the feasibility of ESI mass spectrometry for identifying the proteins secreted by the preimplantation embryo in vitro. This analysis identifies a range of targets that now require detailed functional analysis to assess whether their release by the embryo is an important property of early embryo development. PMID: 20569467 [PubMed - in process]（【斜め読み用】機械翻訳：  マウスのpreimplantationの胚が生体外で発生させる多様なsecretomeの関連の記事の性格描写。 Reprod Biol Endocrinol。 2010年; 8: 71人の著者: 、李Y AJのBeardsleyオーニールCの概要: この調査は表面高められたレーザーの脱着およびイオン化時間の飛行(SELDI-TOF)の適合性およびマウスのpreimplantationの胚が生体外で解放する蛋白質の分析のためのelectrosprayイオン化(ESI)質量分析を調査する。 CM10またはIMAC30 (しかしないQ10)のSELDI-TOFの分析はC57BL6および雑種の胚が両方解放したm/z ~8570で蛋白質の破片蛋白質のピークを検出した。 他はこの方法と胚の存在に独特識別された最高にしない。 胚調節された媒体のtrypticダイジェストのESIの質量分析は合計zygoteからblastocystの段階に開発の間に解放された20の蛋白質を識別した。 4つの蛋白質はテストされた8つの文化から少なくとも7つこれらの1に表現された(乳酸塩のデヒドロゲナーゼB)はすべての文化にあった。 それ以上の5つの蛋白質は文化の少なくとも半分にあり、11のより多くの蛋白質は少なくとも1つの文化にあった。 これらの蛋白質の2の表現はpreimplantationの胚の開発(NLR家族、pyrinの範囲5つを含んでいるおよびpeptidylアルギニンdeiminase、タイプVI)のために必要である。 検出されるそれ以上の4つの蛋白質に細胞のレドックスの規則に於いての役割があり、3他は蛋白質のポスト翻訳の修正を引き起こすことができる。 この調査はpreimplantationの胚が生体外で分泌する蛋白質を識別するためのESIの質量分析の可能性を示す。 この分析は今詳しい機能分析が胚による解放は早い胚の開発の重要な特性であるかどうか査定するように要求するターゲットの範囲を識別する。 PMID: 20569467 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Probing the dynamic nature of signalling pathways by IMAC and SELDI-tof MS.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-214.html</link>
      <description> Related Articles Probing the dynamic nature of signalling pathways by IMAC and SELDI-tof MS. Arch Physiol Biochem. 2010 Jun 30; Authors: Foucher AL, SpÃ¤th GF, Pemberton IK One major obstacle to the analysis of signalling pathways is the dynamic nature of signalling response to environmental stimuli. To overcome this limitation we applied immobilized metal affinity chromatography (IMAC) in combination with SELDI-tof MS to investigate the temporal variation of protein phosphorylation. We ana ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-214.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Probing the dynamic nature of signalling pathways by IMAC and SELDI-tof MS. Arch Physiol Biochem. 2010 Jun 30; Authors: Foucher AL, SpÃ¤th GF, Pemberton IK One major obstacle to the analysis of signalling pathways is the dynamic nature of signalling response to environmental stimuli. To overcome this limitation we applied immobilized metal affinity chromatography (IMAC) in combination with SELDI-tof MS to investigate the temporal variation of protein phosphorylation. We analysed the phospho-proteome variations in our model organism, Leishmania donovani, in response to changes in pH and temperature, which induce differentiation from promastigotes to amastigotes. Investigation of total cell extracts did not allow promastigote and amastigote life cycle stages to be distinguished. However, using IMAC enriched samples, the pattern and intensity of phospho-proteins analysed distinguished both stages reproducibly. Approximately 61% of the phospho-proteins analysed were significantly different in abundance (p<0.02). Of these 61%, 73% showed an increased phosphorylation in promastigotes while 27% showed an increase phosphorylation in amastigotes. The workflow developed is currently being applied to the temporal analysis of environmental stimuli. PMID: 20590411 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： IMACおよびSELDI-tof氏によって細道に信号を送ることの動的性質を厳密に調べる関連の記事はPhysiol Biochemをアーチ形にする。 6月2010日30日; 著者: FoucherのAL、SpÃ¤th GFの細道に信号を送ることの分析へのPemberton IK 1の主要な障害は環境の刺激への応答に信号を送ることの動的性質である。 この限定を克服するためには私達はSELDI-tof MSを伴って蛋白質のリン酸化の一時的な変化を調査するように固定された金属のアフィニティー・クロマトグラフィー(IMAC)を適用した。 私達はpromastigotesからのamastigotesに微分を引き起こすpHおよび温度の変更に応じて私達のモデル有機体、Leishmaniaのdonovaniのphospho-proteomeの変化を、分析した。 総細胞のエキスの調査は区別されるべきpromastigoteおよびamastigoteのライフサイクルの段階を可能にしなかった。 但し、IMACを使用してサンプルを、パターン富ませ、リン蛋白質の強度は再生可能に区別した両方の段階を分析した。 分析されたリン蛋白質のおよそ61%は豊富(p&ltでかなり違った; 0.02)。 この61%の、73%はpromastigotesで27%がamastigotesで増加のリン酸化を示す間、高められたリン酸化を示した。 開発されるワークフローは環境の刺激の一時的な分析に現在適用されている。 PMID: -出版業者によって供給される… 20590411 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of a 17-protein signature in the serum of lung cancer patients.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-208.html</link>
      <description>Related Articles Identification of a 17-protein signature in the serum of lung cancer patients. Oncol Rep. 2010 Jul;24(1):263-70 Authors: Sreseli RT, Binder H, Kuhn M, Digel W, Veelken H, Sienel W, Passlick B, Schumacher M, Martens UM, Zimmermann S Early detection of lung cancer may potentially help to improve the outcome of this fatal disease. Currently, no satisfactory laboratory tests are available to screen for this type of cancer. The aim of this study was to improve diagnostic procedures f ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-208.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Identification of a 17-protein signature in the serum of lung cancer patients. Oncol Rep. 2010 Jul;24(1):263-70 Authors: Sreseli RT, Binder H, Kuhn M, Digel W, Veelken H, Sienel W, Passlick B, Schumacher M, Martens UM, Zimmermann S Early detection of lung cancer may potentially help to improve the outcome of this fatal disease. Currently, no satisfactory laboratory tests are available to screen for this type of cancer. The aim of this study was to improve diagnostic procedures for lung cancer through the discovery of serum biomarkers using SELDI-TOF MS (surface-enhanced laser desorption/ionization time-of-flight mass spectrometry). Mass spectrometric profiling was applied to the serum of a total of 139 lung cancer patients and 158 healthy individuals for developing a prognostic signature. For validation, two separate groups were employed, comprising of 126 and 50 individuals, respectively. Informative regions of mass spectra were identified by forming protein mass clusters and identifying predictive clusters in a logistic regression model. A total of 17 differential predictive protein mass clusters were identified in patients with metastatic lung cancer disease compared to healthy individuals. These clusters provide for a robust risk prediction model. The sensitivity and specificity of this model was estimated to be 87.3 and 81.9%, respectively, for the first validation set, and 96.0 and 66.7%, respectively, for a second validation set of patients with early disease (stages I and II). A differential 11.5/11.7 kDa double-peak could be identified as serum amyloid alpha (SAA) by peptide mapping. Our data suggest that the SELDI-TOF MS technology in combination with a careful statistical analysis appears to be a useful experimental platform which delivers a rapid insight into the proteome of body fluids and may guide to identify novel biomarkers for lung cancer disease. PMID: 20514471 [PubMed - in process]（【斜め読み用】機械翻訳：肺癌の患者の血清の17蛋白質の署名の関連の記事の同一証明。 Oncol Rep。 7月2010日; 24 (1): 263-70書く: Sreseli RTのつなぎH、Kuhn M、Digel W、Veelken H、Sienel W、Passlick B、Schumacher MのテンUMのZimmermann Sの肺癌の早期発見は可能性としてはこの致命的な病気の結果の改善を助けるかもしれない。 現在、満足な実験室試験はこのタイプの癌のために選別して利用できない。 この調査の目標はSELDI-TOF MSを使用して血清のbiomarkersの発見によって肺癌の診断手順を改善することだった(表面高められたレーザーの脱着またはイオン化時間の飛行質量分析)。 多くに分光に側面図を描くことは予想署名を開発するための139人の肺癌の患者そして158人の健康な個人の合計の血清に適用された。 確認のために、126人そして50人の個人で構成している2つの別々のグループはそれぞれ雇われた。 多くスペクトルの報知的な地域は蛋白質の多くの集りを形作り、記号論理学の回帰モデルの予言する集りを識別することによって識別された。 17の差動予言する蛋白質の固まりの集りの合計は健康な個人と比較されたmetastatic肺癌の病気の患者で識別された。 これらの集りは強い危険の予言モデルを提供する。 このモデルの感受性そして特定性は、および第2確認の一組の早い病気(段階であるためにIおよびII)の患者のための96.0および66.7%置かれた、最初の確認のための87.3そして81.9%、それぞれ、それぞれ、推定された。 差動11.5/11.7 kDaの二重ピークは血清のアミロイドのアルファ(SAA)としてペプチッド地図を描くことによって識別できる。 私達のデータは注意深い統計分析を伴うSELDI-TOF MSの技術が肺癌の病気のための新しいbiomarkersを識別するために体液のproteomeに急速な洞察力を提供し、導くかもしれない有用な実験プラットホームのようであることを提案する。 PMID: 20514471 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteomic investigations of the ventriculo-lumbar gradient in human CSF.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-215.html</link>
      <description> Related Articles Proteomic investigations of the ventriculo-lumbar gradient in human CSF. J Neurosci Methods. 2010 Jun 25; Authors: Simonsen AH, Bech S, Laursen I, Salvesen L, Winge K, Waldemar G, Werdelin L, Nielsen JE, McGuire JN, Hjermind LE Cerebrospinal fluid (CSF) is an ideal biological material in which to search for new biomarkers for improved diagnosis of neurological diseases. During a lumbar puncture between 5 and 15mL of CSF are obtained. Previous studies have assessed the ventricul ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-215.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Proteomic investigations of the ventriculo-lumbar gradient in human CSF. J Neurosci Methods. 2010 Jun 25; Authors: Simonsen AH, Bech S, Laursen I, Salvesen L, Winge K, Waldemar G, Werdelin L, Nielsen JE, McGuire JN, Hjermind LE Cerebrospinal fluid (CSF) is an ideal biological material in which to search for new biomarkers for improved diagnosis of neurological diseases. During a lumbar puncture between 5 and 15mL of CSF are obtained. Previous studies have assessed the ventriculo-lumbar concentration gradient of a number of specific proteins. In the present study we took a proteomics approach to investigate the possible concentration gradient of a panel of proteins and peptides in the CSF of 16 patients with neurodegenerative diseases. Using two different mass spectrometry techniques, matrix assisted laser desorption ionization time of flight (MALDI-TOF) and surface enhanced laser desorption ionization time of flight (SELDI-TOF), we found that only one of the investigated proteins, apolipoprotein CI, was significantly decreased between the 1st and the 10th mL of CSF. Furthermore, we confirmed previous results showing a significant decrease in albumin concentration from the first to the last CSF aliquots. In conclusion, we found a significant gradient effect for only two of the measured proteins. However, a standardized procedure for CSF collection for diagnostic and research purposes is crucial to allow comparisons of results between patients groups and between laboratories. This is especially important since CSF is usually collected at several centres and variation in sampled CSF due to pre-analytical factors could complicate the interpretation of the results. PMID: 20599557 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 人間CSFのventriculo腰神経の勾配の記事のProteomicの関連の調査。 J Neurosci方法。 6月2010日25日; 著者: Simonsenはああ、Bech S、Laursen I、Salvesen L、Winge K、Waldemar G、Werdelin L、ニールセンJE、McGuire JNのHjermind LEの脳脊髄液体(CSF)神経疾患の改善された診断のための新しいbiomarkersを捜す理想的な生物的材料である。 CSFの5と15mL間の腰神経穿刺の間に得られる。 前の調査はいくつかの特定の蛋白質のventriculo腰神経の濃度勾配を査定した。 現在の調査で私達はneurodegenerative病気の16人の患者のCSFの蛋白質そしてペプチッドのパネルの可能な濃度勾配を調査するためにproteomicsのアプローチを取った。 2つの質量分析の技術を使用して、マトリックスは(MALDI-TOF)レーザーの脱着のイオン化経過時間を助け、調査された蛋白質の1つだけが、apolipoprotein CI CSFの第1そして第10 mLの間で、かなり減ったことが表面は(SELDI-TOF)レーザーの脱着のイオン化経過時間を、私達分った高めた。 なお、私達は初めから最後のCSFの因数にアルブミンの集中の重要な減少を示す前の結果を確認した。 結論として、私達は測定された蛋白質の2だけのための重要な勾配の効果を見つけた。 但し、診断および研究の目的のCSFのコレクションの標準化されたプロシージャは患者グループと実験室間の結果の比較を許可して重大である。 これはCSFが通常複数の中心で集められ、前分析的な要因による見本抽出されたCSFの変化が結果の解釈を複雑にすることができるので特に重要である。 PMID: -出版業者によって供給される… 20599557 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of a beta-casein-like peptide in breast nipple aspirate fluid that is associated with breast cancer.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-206.html</link>
      <description>Related Articles Identification of a beta-casein-like peptide in breast nipple aspirate fluid that is associated with breast cancer. Biomark Med. 2009 Oct;3(5):577-88 Authors: Sauter ER, Davis W, Qin W, Scanlon S, Mooney B, Bromert K, Folk WR AIMS: Nipple aspirate fluid was collected prospectively from women scheduled for diagnostic breast surgery in order to determine protein masses associated with breast cancer, subsets of women with a unique proteomic profile and a breast cancer predictive mo ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-206.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Identification of a beta-casein-like peptide in breast nipple aspirate fluid that is associated with breast cancer. Biomark Med. 2009 Oct;3(5):577-88 Authors: Sauter ER, Davis W, Qin W, Scanlon S, Mooney B, Bromert K, Folk WR AIMS: Nipple aspirate fluid was collected prospectively from women scheduled for diagnostic breast surgery in order to determine protein masses associated with breast cancer, subsets of women with a unique proteomic profile and a breast cancer predictive model. MATERIALS &amp; METHODS: Breast nipple aspirate fluid was collected preoperatively in 163 breasts from 125 women and analyzed for changes in cell morphology and by SELDI-TOF mass spectrometry over approximately a 44 kDa range (1.5-45 kDa) using IMAC30, CM10 and Q10 ProteinChips. RESULTS: Considering all samples, 16 protein masses were associated with the presence of cancer, the most discriminating being 3592, 6570/6580 and 15870 Da. Excluding women with pathologic nipple discharge or those with a papilloma identified an additional protein of 6383 Da. The best cancer detection models included Breast Imaging Reporting and Data System, age, and either the 4262 (best sensitivity: >87%) or 3592 (best specificity: >94%) peak. MALDI-TOF mass spectrometry demonstrated the 3592 peak, which was most discriminating in many of our cancer prediction models, to be a beta-casein-like peptide. CONCLUSION: Differential nipple aspirate fluid proteomic expression exists between women with/without breast cancer. The most discriminating protein identified is a beta-casein-like peptide not previously described. Combining proteomic and clinical information, which are available before surgery, optimizes the prediction of which women have breast cancer. PMID: 20477526 [PubMed]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-216.html</link>
      <description> Related Articles Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer. J Cancer Res Clin Oncol. 2010 Jul 4; Authors: Enkelmann A, Heinzelmann J, von Eggeling F, Walter M, Berndt A, Wunderlich H, Junker K PURPOSE: Tumour development and progression are strongly affected by interaction of tumour cells and tumour stroma. Different tumour models demonstrate a supportive effect of tumour-associated fibroblasts (TAF) on the tumour genesis. Aims of the prese ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-216.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer. J Cancer Res Clin Oncol. 2010 Jul 4; Authors: Enkelmann A, Heinzelmann J, von Eggeling F, Walter M, Berndt A, Wunderlich H, Junker K PURPOSE: Tumour development and progression are strongly affected by interaction of tumour cells and tumour stroma. Different tumour models demonstrate a supportive effect of tumour-associated fibroblasts (TAF) on the tumour genesis. Aims of the present study are the isolation of TAF from primary urinary bladder tumour specimens and the proteomic and epigenetic characterisation. METHODS: TAF were isolated from cultured urinary bladder tumour specimens. Therefore, primary tumour material was treated with EDTA followed by two separated detachment steps. Non-tumour fibroblasts were isolated from foreskin and normal bladder tissues. Proteins and total RNA were isolated from cultured fibroblasts. Protein pattern analyses were carried out by SELDI-TOF-MS. The miRNA expression profile was analysed by miRNA microarray. RESULTS: By optimising cell culture routines, we achieved to isolate and subsequently cultivate TAF from primary tumour material of the urinary bladder. SELDI-TOF-MS measurements reveal distinct differences in the proteomic patterns of TAF and non-tumour fibroblasts. Microarray analyses indicate specific expression of several miRNAs in TAF and non-tumour fibroblasts. CONCLUSION: In summary, we determined proteomic and epigenetic differences between non-tumour fibroblasts and TAF of urinary bladder carcinoma and identified specific protein expression patterns as well as miRNA profiles of TAF in comparison with non-tumour fibroblasts. These findings provide more insights into the complex tumour network and a good starting point for the identification of markers for the prediction of tumour development and progression based on specific TAF expression patterns. PMID: 20607552 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 関連の記事の特定の蛋白質およびmiRNAパターンはぼうこう癌の腫瘍準の繊維芽細胞を特徴付ける。 Jの蟹座Res Clin Oncol。 7月2010日4日; 著者: Enkelmann A、Heinzelmann J、フォンEggeling F、ウォルターM、Berndt A、Wunderlich Hのぽんこつ自動車Kの目的: 腫瘍の開発および進行は腫瘍の細胞および腫瘍のstromaの相互作用によって強く影響される。 異なった腫瘍モデルは腫瘍の起源に対する腫瘍準の繊維芽細胞(TAF)の支える効果を示す。 現在の調査の目標は第一次尿ぼうこうの腫瘍の標本からのTAFの分離およびproteomicおよび後成の性格描写である。 方法: TAFは培養された尿ぼうこうの腫瘍の標本から隔離された。 従って、第一次腫瘍材料は2つの分けられた取り外しのステップに先行しているEDTAと扱われた。 非腫瘍の繊維芽細胞はforeskinおよび正常なぼうこうのティッシュから隔離された。 蛋白質および総RNAは培養された繊維芽細胞から隔離された。 蛋白質のパターン解析はSELDI-TOF-MSによって遂行された。 miRNAの表現のプロフィールはmiRNAのマイクロアレイによって分析された。 結果: 細胞培養ルーチンを最大限に活用することによって尿ぼうこうの第一次腫瘍材料からのTAFを隔離し、続いて耕すために、私達は達成した。 SELDI-TOF-MSの測定はTAFおよび非腫瘍の繊維芽細胞のproteomicパターンの明瞭な相違を明らかにする。 マイクロアレイの分析はTAFおよび非腫瘍の繊維芽細胞の複数のmiRNAsの特定の表現を示す。 結論: 要約すると、私達は尿ぼうこうの癌腫の非腫瘍の繊維芽細胞とTAFのproteomicおよび後成の違いを定め、TAFのmiRNAのプロフィールと同様、非腫瘍の繊維芽細胞と比べて特定の蛋白質の表現パターンを識別した。 これらの調査結果は特定のTAFの表現パターンに基づいて腫瘍の開発および進行の予言にマーカーの同一証明に複雑な腫瘍ネットワークおよびよい出発点により多くの洞察力を提供する。 PMID: -出版業者によって供給される… 20607552 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Isolation and characterization of pigment-protein complexes from Rhodobacter azotoformans]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-210.html</link>
      <description>Related Articles [Isolation and characterization of pigment-protein complexes from Rhodobacter azotoformans] Wei Sheng Wu Xue Bao. 2010 Apr 4;50(4):500-5 Authors: Zhao G, Yang S, Qu Y, Jiao N OBJECTIVE: In order to reveal the relationships of compositions and content of pigment in pigment-protein complexes (PPC) and hydrogen photoevolution from anoxygenic phototrophic bacteria. METHODS: We isolated and identified pigment-protein complexes using a separation strategy of subsequent fractionated am ...</description>
        <pubDate>Thu, 15 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-210.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Isolation and characterization of pigment-protein complexes from Rhodobacter azotoformans] Wei Sheng Wu Xue Bao. 2010 Apr 4;50(4):500-5 Authors: Zhao G, Yang S, Qu Y, Jiao N OBJECTIVE: In order to reveal the relationships of compositions and content of pigment in pigment-protein complexes (PPC) and hydrogen photoevolution from anoxygenic phototrophic bacteria. METHODS: We isolated and identified pigment-protein complexes using a separation strategy of subsequent fractionated ammonium-sulfate precipitation, ion exchange column chromatography, absorption spectra and sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) from hydrogen-producing Rhodobacter azotoformans R7. We investigated the characterizations of the peripheral light-harvesting complex (LH2) with an unusual absorption spectrum by surface enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS), high performance liquid chromatography-mass spectrometry (HPLC-MS) and fluorescence spectra. RESULTS: We acquired three types of PPC, the reaction center and core light-harvesting complex (RC-LH1) and two kinds of LH2, from strain R7 incubated anaerobically in the light. The two LH2 showed the different absorption spectra, one of them displayed unusual absorption spectrum with the maximum absorption band at 423 nm. The unusual LH2 consisted of two kinds of protein subunits with the molecular weight of 5556.8 Da and 5697.8 Da and carotenoid of spheroidene series with the molecular weight of 562 Da. It was also capable of transferring energy from carotenoid to bacterialcholorophyll and from B800 bacterialcholorophyll to B850 bacterialcholorophyll. CONCLUSIONS: Rhodobacter azotoformans R7 with hydrogen-producing capacity could photosynthesize two types of LH2 under anaerobically in the light, one of them presented novel spectral property. PMID: 20560353 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：関連の記事[Rhodobacterのazotoformansからの顔料蛋白質の複合体の分離そして性格描写]魏ShengウーXue Bao。 4月2010日4日; 50 (4): 500-5書く: 肇G、ヤンS、Qu YのJiao Nの目的: 顔料蛋白質の複合体(PPC)の顔料の構成そして内容の関係およびanoxygenic phototrophic細菌からの水素のphotoevolutionを明らかにするため。 方法: 私達はRhodobacterの水素作成のazotoformans R7からのそれに続く分別されたアンモニウム硫酸塩の沈殿物、イオン交換カラム・クロマトグラフィ、吸収スペクトルおよびナトリウムのdodecylsulfateのポリアクリルアミドゲルの電気泳動(SDS-PAGE)の分離の作戦を使用して顔料蛋白質の複合体を隔離し、識別した。 私達は質量分析(SELDI-TOF-MS)、高性能の液体のクロマトグラフィー固まりの分光測定(HPLC-MS)および蛍光性スペクトル表面によって高められたレーザーの脱着またはイオン化経過時間までに珍しい吸収スペクトルのペリフェラルライト収穫の複合体(LH2)の性格描写を調査した。 結果: 私達はPPC、反作用の中心および中心のライト収穫の複合体(RC-LH1)およびライトで嫌気性に孵化した2種類の緊張R7からのLH2の3つのタイプを、得た。 2 LH2は423 nmで異なった吸収スペクトル、それらの1を表示した最高の吸収バンドとの珍しい吸収スペクトルを示した。 珍しいLH2は2種類の5556.8 Daおよび562 Daの分子量とのspheroideneシリーズの5697.8 Daおよびカロチノイドの分子量が付いている蛋白質の亜単位から成っていた。 それはカロチノイドbacterialcholorophyllへとB800のbacterialcholorophyllからB850 bacterialcholorophyllへエネルギーを移すまたことができた。 結論: R7がライト、それらの1で水素作成容量と2つのタイプのLH2を嫌気性にphotosynthesizeできたRhodobacterのazotoformansは新しい分光特性を示した。 PMID: 20560353 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Bone morphogenetic protein regulation of enteric neuronal phenotypic diversity: relationship to timing of cell cycle exit.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-114.html</link>
      <description> Related Articles Bone morphogenetic protein regulation of enteric neuronal phenotypic diversity: relationship to timing of cell cycle exit. J Comp Neurol. 2008 Aug 10;509(5):474-92 Authors: Chalazonitis A, Pham TD, Li Z, Roman D, Guha U, Gomes W, Kan L, Kessler JA, Gershon MD The effects of bone morphogenetic protein (BMP) signaling on enteric neuron development were examined in transgenic mice overexpressing either the BMP inhibitor, noggin, or BMP4 under control of the neuron specific enolase ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-114.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Bone morphogenetic protein regulation of enteric neuronal phenotypic diversity: relationship to timing of cell cycle exit. J Comp Neurol. 2008 Aug 10;509(5):474-92 Authors: Chalazonitis A, Pham TD, Li Z, Roman D, Guha U, Gomes W, Kan L, Kessler JA, Gershon MD The effects of bone morphogenetic protein (BMP) signaling on enteric neuron development were examined in transgenic mice overexpressing either the BMP inhibitor, noggin, or BMP4 under control of the neuron specific enolase (NSE) promoter. Noggin antagonism of BMP signaling increased total numbers of enteric neurons and those of subpopulations derived from precursors that exit the cell cycle early in neurogenesis (serotonin, calretinin, calbindin). In contrast, noggin overexpression decreased numbers of neurons derived from precursors that exit the cell cycle late (gamma-aminobutyric acid, tyrosine hydroxylase [TH], dopamine transporter, calcitonin gene-related peptide, TrkC). The numbers of TH- and TrkC-expressing neurons were increased by overexpression of BMP4. These observations are consistent with the idea that phenotypic expression in the enteric nervous system (ENS) is determined, in part, by the number of proliferative divisions neuronal precursors undergo before their terminal mitosis. BMP signaling may thus regulate enteric neuronal phenotypic diversity by promoting the exit of precursors from the cell cycle. BMP2 increased the numbers of TH- and TrkC-expressing neurons developing in vitro from immunoselected enteric crest-derived precursors; BMP signaling may thus also specify or promote the development of dopaminergic TrkC/NT-3-dependent neurons. The developmental defects in the ENS of noggin-overexpressing mice caused a relatively mild disturbance of motility (irregular rapid transit and increased stool frequency, weight, and water content). Although the function of the gut thus displays a remarkable tolerance for ENS defects, subtle functional abnormalities in motility or secretion may arise when ENS defects short of aganglionosis occur during development. PMID: 18537141 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of oxytetracycline as a chondrogenic compound using a cell-based screening system.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-196.html</link>
      <description> Related Articles Identification of oxytetracycline as a chondrogenic compound using a cell-based screening system. J Bone Miner Metab. 2010 Apr 8; Authors: Hojo H, Yano F, Ohba S, Igawa K, Nakajima K, Komiyama Y, Kan A, Ikeda T, Yonezawa T, Woo JT, Takato T, Nakamura K, Kawaguchi H, Chung UI To effectively treat degenerative joint diseases including osteoarthritis (OA), small chemical compounds need to be developed that can potently induce chondrogenic differentiation without promoting terminal ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-196.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Identification of oxytetracycline as a chondrogenic compound using a cell-based screening system. J Bone Miner Metab. 2010 Apr 8; Authors: Hojo H, Yano F, Ohba S, Igawa K, Nakajima K, Komiyama Y, Kan A, Ikeda T, Yonezawa T, Woo JT, Takato T, Nakamura K, Kawaguchi H, Chung UI To effectively treat degenerative joint diseases including osteoarthritis (OA), small chemical compounds need to be developed that can potently induce chondrogenic differentiation without promoting terminal differentiation. For this purpose, we screened natural and synthetic compound libraries using a Col2GFP-ATDC5 system and identified oxytetracycline (Oxy) as a chondrogenic compound. Oxy induced cartilaginous matrix synthesis and mRNA expressions of chondrocyte markers in ATDC5 cells. In addition, Oxy suppressed mineralization and mRNA expressions of terminal chondrocyte differentiation markers in ATDC5 cells, primary chondrocytes, and cultured metatarsal bones. Oxy's induction of Col2 mRNA expression was decreased by the addition of Noggin and was increased by the addition of BMP2. Furthermore, Oxy increased mRNA expression of Id1, Bmp2, Bmp4, and Bmp6. These data suggest that Oxy induces chondrogenic differentiation in a BMP-dependent manner and suppresses terminal differentiation. Oxy may be useful for treatment of OA and also for regeneration of cartilage tissue. PMID: 20376510 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 細胞に基づくスクリーニングシステムを使用してchondrogenic混合物としてオキシテトラサイクリンの関連の記事の同一証明。 Jは抗夫の骨を抜くMetab。 4月2010日8日; 著者: Hojo H、Yano F、Ohba S、Igawa K、Nakajima K、Komiyama Y、Kan A、Ikeda T、Yonezawa Tは、効果的に骨関節炎(OA)を含む退化的な接合箇所病気を扱うためにJT、Takato T、Nakamura K、Kawaguchi H、チョンUIに末端の微分を促進しないで有効にchondrogenic微分を引き起こすことができる小さい化合物成長する必要がある懇願する。 このため、私達はCol2GFP-ATDC5システムを使用して自然で、総合的な混合の図書館を選別し、chondrogenic混合物としてオキシテトラサイクリン(Oxy)を識別した。 OxyはATDC5細胞のchondrocyteのマーカーの軟骨性のマトリックスの統合そしてmRNAの表現を引き起こした。 さらに、OxyはATDC5細胞の末端のchondrocyteの微分のマーカーの鉱化そしてmRNAの表現を、第一次chondrocytes抑制し、metatarsalの骨を培養した。 OxyのCol2 mRNAの表現の誘導はNogginの付加によって減り、BMP2の付加によって高められた。 なお、OxyはId1、Bmp2、Bmp4およびBmp6のmRNAの表現を高めた。 これらのデータはOxyがBMP依存した方法のchondrogenic微分を引き起こし、末端の微分を抑制することを提案する。 OxyはOAの処置とまた軟骨のティッシュの再生のために有用かもしれない。 PMID: -出版業者によって供給される… 20376510 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-130.html</link>
      <description> Related Articles Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness. Blood. 2009 Jan 15;113(3):688-95 Authors: Truksa J, Lee P, Beutler E Hepcidin plays a major role in the regulation of iron homeostasis. Several bone morphogenetic proteins (BMPs) are strong inducers of hepcidin (Hamp1, HAMP) expression. Hemojuvelin, a protein critical for maintaining appropriate levels of hepcidin, acts as a coreceptor for B ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-130.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness. Blood. 2009 Jan 15;113(3):688-95 Authors: Truksa J, Lee P, Beutler E Hepcidin plays a major role in the regulation of iron homeostasis. Several bone morphogenetic proteins (BMPs) are strong inducers of hepcidin (Hamp1, HAMP) expression. Hemojuvelin, a protein critical for maintaining appropriate levels of hepcidin, acts as a coreceptor for BMP2 and BMP4, thereby providing a link between iron homeostasis and the BMP-signaling pathway. We show that a robust BMP, hemojuvelin, and SMAD1 response by murine Hamp1 is dependent on a distal BMP responsive element (BMP-RE2), the adjacent bZIP, HNF4alpha/COUP binding sites, and plus or minus 50 bp of the flanking area within -1.6 to -1.7 kb of the Hamp1 promoter. Furthermore, the STAT site and the BMP responsive element (BMP-RE1) located in the proximal 260-bp region of the Hamp1 promoter are also indispensable for maximal activation of hepcidin transcription. The homologous motifs in the distal and proximal regions of the human HAMP promoter act in a manner similar to the murine Hamp1 promoter. Therefore, we propose that the regulation of hepcidin by the BMP pathway involves the formation of a complex of liver-specific and response-specific transcription factors bound to the distal BMP-RE2 /bZIP/HNF4alpha/COUP region and to the proximal BMP-RE1/STAT region possibly by physical association of the 2 regions. PMID: 18997172 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：  関連の記事はhepcidinの促進者の2つのBMPの敏感な要素、STATおよびbZIP/HNF4/COUPのモチーフBMP、SMAD1およびHJVの敏感さのために重大である。 血。 1月2009日15日; 113 (3): 688-95書く: Truksa J、リーP、Beutler E Hepcidinは鉄ホメオスタティスの規則の大きな役割を担う。 複数はmorphogenetic蛋白質(BMPs)のであるhepcidin (Hamp1、HAMP)の表現の強い誘因物骨を抜く。 Hemojuvelinのhepcidinの適切なレベルを維持するためにそれにより鉄ホメオスタティスとBMPシグナリング細道間のリンクを提供するBMP2およびBMP4のためのcoreceptorとして重大な蛋白質は、機能する。 私達はネズミ科Hamp1による強いBMP、hemojuvelinおよびSMAD1応答が遠位BMPの敏感な要素(BMP-RE2)、隣接したbZIP、HNF4alpha/COUPの結合場所に、そしてHamp1促進者の-1.6から-1.7 kb内の並ぶ区域の50 bp前後依存していることを示す。 なお、Hamp1促進者の近位260bp地域で取付けられるSTATの場所およびBMPの敏感な要素(BMP-RE1)はまたhepcidinのトランスクリプションの最高の活発化のための不可欠なものである。 人間HAMPの促進者の遠位および近位地域の一致するモチーフはネズミ科Hamp1促進者にある意味では類似している機能する。 従って、私達はBMPの細道によるhepcidinの規則が2つの地域の物理的な連合によって遠位BMP-RE2 /bZIP/HNF4alpha/COUPの地域と近位BMP-RE1/STATの地域に多分区切られるレバー特定および応答特定のトランスクリプション要因の複合体の形成を含むことを提案する。 PMID: 18997172 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The expression of twisted gastrulation in postnatal mouse brain and functional implications.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-197.html</link>
      <description> Related Articles The expression of twisted gastrulation in postnatal mouse brain and functional implications. Neuroscience. 2010 May 21; Authors: Sun M, Forsman C, Sergi C, Gopalakrishnan R, O&apos;Connor MB, Petryk A Twisted gastrulation (TWSG1), an extracellular regulator of bone morphogenetic protein (BMP) signaling, is critical for embryonic brain development. Mice deficient in TWSG1 have abnormal forebrain development manifesting as holoprosencephaly. The expression and potential roles of TWSG1 ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-197.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The expression of twisted gastrulation in postnatal mouse brain and functional implications. Neuroscience. 2010 May 21; Authors: Sun M, Forsman C, Sergi C, Gopalakrishnan R, O'Connor MB, Petryk A Twisted gastrulation (TWSG1), an extracellular regulator of bone morphogenetic protein (BMP) signaling, is critical for embryonic brain development. Mice deficient in TWSG1 have abnormal forebrain development manifesting as holoprosencephaly. The expression and potential roles of TWSG1 in postnatal brain development are less well understood. We show that Twsg1 is expressed in the adult mouse brain in the choroid plexus (CP), hippocampus, and other regions, with the strongest expression observed in CP. TWSG1 was also detected in a human fetal brain at mid-gestation, with highest levels in the epithelium of CP. Bmp1, Bmp2, Bmp4-Bmp7 as well as BmprIA and BmprII, but not BmprIB, were expressed in CP. BMP antagonists Chordin (Chrd) and Noggin were not detected in CP, however Chrd-like 1 and brain-specific Chrd-like (Brorin) were expressed. Electrophysiological study of synaptic plasticity revealed normal paired-pulse facilitation and long-term potentiation in the CA1 region of hippocampus in Twsg1-/- mice. Among the homozygous mutants that survive beyond the first 2 weeks, the prevalence of hydrocephalus is 4.3%, compared to 1.5% in a wild type colony (P=0.0133) between 3 and 10 weeks of life. We detected a high level of BMP signaling in CP in wild type adult mice that was 17-fold higher than in the hippocampus (P=0.005). In contrast, transforming growth factor beta (TGFbeta) signaling was predominant in the hippocampus. Both BMP signaling and the expression of BMP downstream targets Msx1 and Msx2 were reduced in CP in Twsg1-/- mice. In summary, we show that Twsg1 is expressed in the adult mouse and human fetal CP. We also show that BMP is a branch of TGFbeta superfamily that is dominant in CP. This presents an interesting avenue for future research in light of the novel roles of CP in neural progenitor differentiation and neuronal repair, especially since TWSG1 appears to be the main regulator of BMP present in CP. PMID: 20493240 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Daily low-intensity pulsed ultrasound stimulates production of bone morphogenetic protein in ROS 17/2.8 cells.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-146.html</link>
      <description> Related Articles Daily low-intensity pulsed ultrasound stimulates production of bone morphogenetic protein in ROS 17/2.8 cells. J Oral Sci. 2009 Mar;51(1):29-36 Authors: Suzuki A, Takayama T, Suzuki N, Kojima T, Ota N, Asano S, Ito K Although daily low-intensity pulsed ultrasound (LIPUS) can accelerate osteogenic differentiation of the rat clonal cell line ROS 17/2.8, the molecular mechanism that underlies this phenomenon is unclear. The purpose of this study was to determine which molecules ex ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-146.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Daily low-intensity pulsed ultrasound stimulates production of bone morphogenetic protein in ROS 17/2.8 cells. J Oral Sci. 2009 Mar;51(1):29-36 Authors: Suzuki A, Takayama T, Suzuki N, Kojima T, Ota N, Asano S, Ito K Although daily low-intensity pulsed ultrasound (LIPUS) can accelerate osteogenic differentiation of the rat clonal cell line ROS 17/2.8, the molecular mechanism that underlies this phenomenon is unclear. The purpose of this study was to determine which molecules exposed to daily LIPUS treatment stimulate osteogenic differentiation. The cells were cultured in the presence and absence (control) of LIPUS stimulation. LIPUS treatments consisted of 1.5-MHz ultrasound administered at an intensity of 30 mW/cm(2), 20 min daily for 7 days. The expression of bone morphogenetic proteins (BMPs) and their receptors involved in osteogenesis were measured using real-time PCR and/or Western blot analysis. Phosphorylation of the mothers against decapentaplegic 1 (Smad1) protein was determined by Western blotting. Daily LIPUS treatment significantly increased the expression of BMP-2, -4, and -7 and their receptors, and also phosphorylation of Smad1. Noggin markedly inhibited the daily LIPUS-induced phosphorylation of Smad1. Our findings demonstrate that the osteogenic activity of daily LIPUS may be mediated by BMPs in ROS 17/2.8 cells. PMID: 19325197 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事の毎日の低強度は超音波刺激するROS 17/2.8の細胞の骨のmorphogenetic蛋白質の生産を脈打った。 J口頭Sci。 3月2009日; 51 (1): 29-36書く: 毎日の低強度が超音波(LIPUS)脈打ったが鈴木A、Takayama T、鈴木N、小島T、Ota N、Asano S、Ito Kはこの現象の下にある分子メカニズム明白でないラットの栄養系細胞ラインROS 17/2.8のosteogenic微分を加速できる。 この調査の目的はどの分子が毎日LIPUSの処置に刺激するosteogenic微分を露出したか定めることだった。 細胞はLIPUSの刺激の存在そして不在(制御)で培養された。 LIPUSの処置は30 mW/cm (2)の7日の強度で間20分の日刊新聞管理された1.5MHz超音波から成っていた。 骨のmorphogenetic蛋白質(BMPs)の表現およびosteogenesisにかかわった受容器は実時間PCRや西部のしみの分析を使用して測定された。 decapentaplegic (Smad1)蛋白質1つに対する母のリン酸化は西部にしみが付くことによって定められた。 毎日LIPUSの処置はかなりSmad1のBMP-2の表現を、-4、および-7および受容器およびまたリン酸化高めた。 Nogginは著しくSmad1の毎日LIPUS引き起こされたリン酸化を禁じた。 私達の調査結果は毎日LIPUSのosteogenic活動がROS 17/2.8の細胞のBMPsによって仲介されるかもしれないことを示す。 PMID: 19325197 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Agrin binds BMP2, BMP4 and TGFbeta1.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-198.html</link>
      <description> Related Articles Agrin binds BMP2, BMP4 and TGFbeta1. PLoS One. 2010;5(5):e10758 Authors: BÃ¡nyai L, Sonderegger P, Patthy L The C-terminal 95 kDa fragment of some isoforms of vertebrate agrins is sufficient to induce clustering of acetylcholine receptors but despite two decades of intense agrin research very little is known about the function of the other isoforms and the function of the larger, N-terminal part of agrins that is common to all isoforms. Since the N-terminal part of agrins c ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-198.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Agrin binds BMP2, BMP4 and TGFbeta1. PLoS One. 2010;5(5):e10758 Authors: BÃ¡nyai L, Sonderegger P, Patthy L The C-terminal 95 kDa fragment of some isoforms of vertebrate agrins is sufficient to induce clustering of acetylcholine receptors but despite two decades of intense agrin research very little is known about the function of the other isoforms and the function of the larger, N-terminal part of agrins that is common to all isoforms. Since the N-terminal part of agrins contains several follistatin-domains, a domain type that is frequently implicated in binding TGFbetas, we have explored the interaction of the N-terminal part of rat agrin (Agrin-Nterm) with members of the TGFbeta family using surface plasmon resonance spectroscopy and reporter assays. Here we show that agrin binds BMP2, BMP4 and TGFbeta1 with relatively high affinity, the K(D) values of the interactions calculated from SPR experiments fall in the 10(-8) M-10(-7) M range. In reporter assays Agrin-Nterm inhibited the activities of BMP2 and BMP4, half maximal inhibition being achieved at approximately 5x10(-7) M. Paradoxically, in the case of TGFbeta1 Agrin N-term caused a slight increase in activity in reporter assays. Our finding that agrin binds members of the TGFbeta family may have important implications for the role of these growth factors in the regulation of synaptogenesis as well as for the role of agrin isoforms that are unable to induce clustering of acetylcholine receptors. We suggest that binding of these TGFbeta family members to agrin may have a dual function: agrin may serve as a reservoir for these growth factors and may also inhibit their growth promoting activity. Based on analysis of the evolutionary history of agrin we suggest that agrin's growth factor binding function is more ancient than its involvement in acetylcholine receptor clustering. PMID: 20505824 [PubMed - in process]（【斜め読み用】機械翻訳：  関連の記事AgrinはBMP2、BMP4およびTGFbeta1を結合する。 PLoS 1。 2010年; 5 (5): e10758は書く: BÃの¡のnyai L、Sonderegger P、Patthy Lは脊椎動物のagrinsのあるisoformsのCターミナル95 kDaの片アセチルコリンの受容器の群がを引き起こして十分であるが、強いagrinの研究の二十年にもかかわらず少しだけ他のisoformsの機能およびより大きいのの機能、すべてのisoformsに共通であるagrinsのNターミナル部品について知られている。 agrinsのNターミナル部品が複数のfollistatin範囲を含んでいるので、TGFbetasを不良部分で頻繁に関係する範囲のタイプ、私達は表面のプラズモン共鳴分光学およびレポーターの試金を使用してTGFbeta家族のメンバーとのラットのagrin (Agrin-Nterm)のNターミナル部品の相互作用を探検した。 ここに私達はagrinが比較的高い類縁のBMP2、BMP4およびTGFbeta1を結合することを、K示す(D)相互作用の価値は10 (- 8) M-10 (- 7) Mの範囲でSPRの実験から下る計算した。 レポーターの試金ではAgrin-NtermはBMP2およびBMP4のレポーターの試金で活動のわずかな増加を引き起こされたTGFbeta1 AgrinのN言葉の場合にはおよそ5x10 (- 7)逆説的のM.で、達成される半分の最高の阻止の活動を禁じた。 私達のTGFbeta家族のagrinの縛りのメンバーにアセチルコリンの受容器の群がを引き起こしてないagrinのisoformsの役割のためのと同様、synaptogenesisの規則に於いてのこれらの成長因子の役割のための重要な含意があるかもしれないことが分ること。 私達はagrinへのこれらのTGFbetaの家族の不良部分に二重機能があるかもしれないことを提案する: agrinはこれらの成長因子のための貯蔵所として役立ち、また活動を促進する成長を禁じるかもしれない。 agrinの発展の歴史の分析に基づいて私達はagrinの成長因子の結合機能がアセチルコリンの受容器の群がることことをの介入より古代であることを提案する。 PMID: 20505824 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Msx1 and Msx2 are required for endothelial-mesenchymal transformation of the atrioventricular cushions and patterning of the atrioventricular myocardium.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-122.html</link>
      <description> Related Articles Msx1 and Msx2 are required for endothelial-mesenchymal transformation of the atrioventricular cushions and patterning of the atrioventricular myocardium. BMC Dev Biol. 2008;8:75 Authors: Chen YH, Ishii M, Sucov HM, Maxson RE BACKGROUND: Msx1 and Msx2, which belong to the highly conserved Nk family of homeobox genes, display overlapping expression patterns and redundant functions in multiple tissues and organs during vertebrate development. Msx1 and Msx2 have well-documented rol ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-122.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Msx1 and Msx2 are required for endothelial-mesenchymal transformation of the atrioventricular cushions and patterning of the atrioventricular myocardium. BMC Dev Biol. 2008;8:75 Authors: Chen YH, Ishii M, Sucov HM, Maxson RE BACKGROUND: Msx1 and Msx2, which belong to the highly conserved Nk family of homeobox genes, display overlapping expression patterns and redundant functions in multiple tissues and organs during vertebrate development. Msx1 and Msx2 have well-documented roles in mediating epithelial-mesenchymal interactions during organogenesis. Given that both Msx1 and Msx2 are crucial downstream effectors of Bmp signaling, we investigated whether Msx1 and Msx2 are required for the Bmp-induced endothelial-mesenchymal transformation (EMT) during atrioventricular (AV) valve formation. RESULTS: While both Msx1-/- and Msx2-/- single homozygous mutant mice exhibited normal valve formation, we observed hypoplastic AV cushions and malformed AV valves in Msx1-/-; Msx2-/- mutants, indicating redundant functions of Msx1 and Msx2 during AV valve morphogenesis. In Msx1/2 null mutant AV cushions, we found decreased Bmp2/4 and Notch1 signaling as well as reduced expression of Has2, NFATc1 and Notch1, demonstrating impaired endocardial activation and EMT. Moreover, perturbed expression of chamber-specific genes Anf, Tbx2, Hand1 and Hand2 reveals mispatterning of the Msx1/2 double mutant myocardium and suggests functions of Msx1 and Msx2 in regulating myocardial signals required for remodelling AV valves and maintaining an undifferentiated state of the AV myocardium. CONCLUSION: Our findings demonstrate redundant roles of Msx1 and Msx2 in regulating signals required for development of the AV myocardium and formation of the AV valves. PMID: 18667074 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：  関連の記事Msx1およびMsx2は房室の心筋層の房室のクッションそして模造のendothelialmesenchymal変形に要求される。 BMC Dev Biol. 2008年; 8: 75人の著者: 陳YH、Ishii Mの、SucovのHM背景に関してMaxson: 多数のティッシュのhomeoboxの遺伝子、表示重複の表現パターンおよび余分な機能および脊椎動物の開発の間に器官のNkの非常に節約された系列に属するMsx2、およびMsx1。 Msx1におよびMsx2に器官形成の間に上皮性mesenchymal相互作用を仲介することに於いてのよくとり上げられる役割がある。 Msx1およびMsx2が両方Bmpシグナリングの重大な下流の作動体であること与えられて、私達はMsx1およびMsx2がBmp引き起こされたendothelialmesenchymal変形(EMT)に房室の(AV)弁の形成の間に要求されるかどうか調査した。 結果: Msx1-/-およびMsx2-/-が両方選抜する間、homozygous突然変異体のマウスは正常な弁の形成を表わした、私達はMsx1-/-のhypoplastic AVのクッションそして奇形AV弁を観察した; Msx2-/-の突然変異体、Msx1およびMsx2の余分な機能をAV弁の形態形成の間に示す。 Msx1/2ブランクの突然変異体AVのクッションでは、私達はHas2、NFATc1およびNotch1の減らされた表現と同様、減らされたBmp2/4およびNotch1シグナリングを見つけ、損なわれたendocardial活発化およびEMTを示す。 さらに、部屋特定の遺伝子Anf、Tbx2、Hand1およびHand2の混乱させた表現はMsx1/2二重突然変異体の心筋層のmispatterningを明らかにし、AV弁を改造し、AVの心筋層の画一的な状態を維持するために必要な心筋信号の調整のMsx1そしてMsx2の機能を提案する。 結論: 私達の調査結果はAV弁のAVの心筋層そして形成の開発に必要な調整信号に於いてのMsx1およびMsx2の余分な役割を示す。 PMID: 18667074 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>BMP Signalling in the Human Fetal Ovary is Developmentally-regulated and Promotes Primordial Germ Cell Apoptosis.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-199.html</link>
      <description> Related Articles BMP Signalling in the Human Fetal Ovary is Developmentally-regulated and Promotes Primordial Germ Cell Apoptosis. Stem Cells. 2010 May 6; Authors: Childs AJ, Kinnell HL, Collins CS, Hogg K, Bayne RA, Green SJ, McNeilly AS, Anderson RA Primordial Germ Cells (PGCs) are the embryonic precursors of gametes in the adult organism, and their development, differentiation and survival is regulated by a combination of growth factors collectively known as the germ cell niche. Although man ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-199.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles BMP Signalling in the Human Fetal Ovary is Developmentally-regulated and Promotes Primordial Germ Cell Apoptosis. Stem Cells. 2010 May 6; Authors: Childs AJ, Kinnell HL, Collins CS, Hogg K, Bayne RA, Green SJ, McNeilly AS, Anderson RA Primordial Germ Cells (PGCs) are the embryonic precursors of gametes in the adult organism, and their development, differentiation and survival is regulated by a combination of growth factors collectively known as the germ cell niche. Although many candidate niche components have been identified through studies on mouse PGCs, the growth factor composition of the human primordial germ cell niche has not been studied extensively. Here we report a detailed analysis of the expression of components of the BMP signalling apparatus in the human fetal ovary, from post-migratory PGC proliferation to the onset of primordial follicle formation. We find developmentally-regulated and reciprocal patterns of expression of BMP2 and BMP4, and identify germ cells to be the exclusive targets of ovarian BMP signalling. By establishing long term cultures of human fetal ovaries in which PGCs are retained within their physiological niche, we find that BMP4 negatively regulates post-migratory PGC numbers in the human fetal ovary by promoting PGC apoptosis. Finally, we report expression of both MSX1 and MSX2 in the human fetal ovary, and reveal a selective up-regulation of MSX2 expression in human fetal ovary in response to BMP4, suggesting this gene may act as a downstream effector of BMP-induced apoptosis in the ovary, as in other systems. These data reveal for the first time growth factor regulation of human PGC development in a physiologically relevant context, and have significant implications for the development of cultures systems for the in vitro maturation of germ cells, and their derivation from pluripotent stem cells. PMID: 20506112 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 人間の胎児の卵巣で信号を送る関連の記事BMPは進化調整され、原始の細菌細胞Apoptosisを促進する。 幹細胞。 5月2010日6日; 著者: 、KinnellのHL AJ、Childs CollinsのCS、Hogg KのBayneのRA、緑SJ、McNeillyは一まとめに細菌細胞のニッチとして知られている成長因子を組み合わせてように、原始の細菌細胞(PGCs)が大人の有機体のgametesの萌芽期の前駆物質、および開発、微分および存続であるアンダーソンのRA調整される。 多くの候補者のニッチの部品がマウスPGCsの調査によって識別されたが、人間の原始の細菌細胞のニッチの成長因子の構成は広く調査されなかった。 ここで私達はポスト移住性PGC拡散信号を送るBMPの部品の表現の詳細解析をからの原始の小胞の形成の手始めに人間の胎児の卵巣の器具に、報告する。 私達はBMP2およびBMP4の表現の進化調整された相互パターンを見つけ、卵巣にBMPの信号を送ることの排他的なターゲットであるために細菌細胞を識別する。 PGCsが生理学的なニッチの内で保たれる人間の胎児の卵巣の長期文化の確立によって、私達はBMP4がPGCのapoptosisのことを促進によって否定的に人間の胎児の卵巣のポスト移住性PGC数を調整することが分る。 最後に、私達は人間の胎児の卵巣のMSX1そしてMSX2両方の表現を報告し、BMP4に応じてこの遺伝子が他のシステムのように卵巣のBMP引き起こされたapoptosisの下流の作動体として、機能するかもしれないことを提案する人間の胎児の卵巣のMSX2表現の選択的な規則を明らかにする。 これらのデータに生理学的に関連した文脈の人間PGCの開発の成長因子の規則をはじめて明らかにし、細菌細胞の生体外の成熟のための文化システムの開発のための重要な含意、およびpluripotent幹細胞からの派生がある。 PMID: -出版業者によって供給される… 20506112 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A distinct cohort of the TGFbeta superfamily members expressed in human endometrium regulate decidualization.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-106.html</link>
      <description> Related Articles A distinct cohort of the TGFbeta superfamily members expressed in human endometrium regulate decidualization. Hum Reprod. 2008 Jun;23(6):1447-56 Authors: Stoikos CJ, Harrison CA, Salamonsen LA, Dimitriadis E BACKGROUND: Successful blastocyst implantation requires the differentiation of human endometrial stromal cells (HESC), a process known as decidualization. Activin A, a transforming growth factor beta (TGFbeta) superfamily member, enhances HESC decidualization and localizes  ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-106.html</guid>
        
      <content:encoded> <![CDATA[
       Related Articles A distinct cohort of the TGFbeta superfamily members expressed in human endometrium regulate decidualization. Hum Reprod. 2008 Jun;23(6):1447-56 Authors: Stoikos CJ, Harrison CA, Salamonsen LA, Dimitriadis E BACKGROUND: Successful blastocyst implantation requires the differentiation of human endometrial stromal cells (HESC), a process known as decidualization. Activin A, a transforming growth factor beta (TGFbeta) superfamily member, enhances HESC decidualization and localizes to decidual cells in human endometrium. Other TGFbeta superfamily members, including BMP2, BMP4, BMP7, GDF5, GDF8, GDF11, TGFbetas and Nodal, may also play a role during decidualization. This study aimed to identify these TGFbeta family members in human endometrium, and to determine whether they are involved in human decidualization. METHODS: Protein localization of TGFbeta family members was examined in secretory phase human endometrium and first trimester decidua by immunohistochemistry. mRNA expression was examined in HESC. Activin inhibitors (Activin-M108A/SB431542) with differing specificities for the other TGFbeta members under consideration were applied during HESC decidualization in vitro. The secretion levels of potential TGFbeta superfamily members were measured during decidualization, and recombinant proteins added to examine their effect. RESULTS: This study has identified BMP2, BMP4, BMP7, GDF5, GDF8 and GDF11 but not Nodal in secretory phase human endometrium, but only BMP2, GDF5 and TGFbeta1 protein were detected in decidual cells. All ligands except Nodal were expressed by cultured HESC. Both inhibitors significantly reduced decidualization validating the role of activin, but potentially also other TGFbeta members, during decidualization. BMP2 and TGFbeta1 secretion increased during HESC decidualisation and exogenous administration of these proteins significantly enhanced decidualization in vitro. CONCLUSIONS: Like activin, BMP2 and TGFbeta1 are likely to be involved in HESC decidualization. This is the first study to identify and localize BMP4, BMP7, GDF5, GDF8 and GDF11 in secretory phase human endometrium. Understanding the factors critical for the implantation process is needed for improving fertility and pregnancy outcomes. PMID: 18434375 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism.</title>
  <link>http://biomarket.jp/modules/pubmed_bmp/article-138.html</link>
      <description> Related Articles BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009 Apr;41(4):482-7 Authors: Andriopoulos B, Corradini E, Xia Y, Faasse SA, Chen S, Grgurevic L, Knutson MD, Pietrangelo A, Vukicevic S, Lin HY, Babitt JL Juvenile hemochromatosis is an iron-overload disorder caused by mutations in the genes encoding the major iron regulatory hormone hepcidin (HAMP) and hemojuvelin (HFE2). We have previously shown that hemojuvelin is a co-receptor for bon ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_bmp/article-138.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009 Apr;41(4):482-7 Authors: Andriopoulos B, Corradini E, Xia Y, Faasse SA, Chen S, Grgurevic L, Knutson MD, Pietrangelo A, Vukicevic S, Lin HY, Babitt JL Juvenile hemochromatosis is an iron-overload disorder caused by mutations in the genes encoding the major iron regulatory hormone hepcidin (HAMP) and hemojuvelin (HFE2). We have previously shown that hemojuvelin is a co-receptor for bone morphogenetic proteins (BMPs) and that BMP signals regulate hepcidin expression and iron metabolism. However, the endogenous BMP regulator(s) of hepcidin in vivo is unknown. Here we show that compared with soluble hemojuvelin (HJV.Fc), the homologous DRAGON.Fc is a more potent inhibitor of BMP2 or BMP4 but a less potent inhibitor of BMP6 in vitro. In vivo, HJV.Fc or a neutralizing antibody to BMP6 inhibits hepcidin expression and increases serum iron, whereas DRAGON.Fc has no effect. Notably, Bmp6-null mice have a phenotype resembling hereditary hemochromatosis, with reduced hepcidin expression and tissue iron overload. Finally, we demonstrate a physical interaction between HJV.Fc and BMP6, and we show that BMP6 increases hepcidin expression and reduces serum iron in mice. These data support a key role for BMP6 as a ligand for hemojuvelin and an endogenous regulator of hepcidin expression and iron metabolism in vivo. PMID: 19252486 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：  関連の記事BMP6はhepcidinの表現および鉄新陳代謝の主内生調整装置である。 Nat. Genet。 4月2009日; 41 (4): 482-7書く: Andriopoulos B、Corradini E、Xia YのFaasse SA、陳S、Grgurevic L、Knutson MD、Pietrangelo A、Vukicevic S、林HYのBabitt JLの年少のhemochromatosis主要な鉄の規定するホルモンのhepcidin (HAMP)およびhemojuvelin (HFE2)を符号化する遺伝子で突然変異によって引き起こされる鉄積み過ぎの無秩序である。 私達は前にこと、そしてBMP信号がhepcidinの表現および鉄新陳代謝を調整することをhemojuvelinが骨のmorphogenetic蛋白質(BMPs)のためのco受容器である示してしまった。 但し、hepcidinの内生BMPの調整装置は生体内で未知である。 ここに私達は溶けるhemojuvelin (HJV.Fc)と比較されるそれを一致するDRAGON.FcでありBMP2またはBMP4のより有効な抑制剤BMP6の生体外でより少なく有効な抑制剤示すではない。 DRAGON.Fcが効果をもたらさない一方、生体内で、BMP6へのHJV.Fcか中和の抗体はhepcidinの表現を禁じ、血清鉄を増加する。 特に、Bmp6ブランクのマウスに減らされたhepcidinの表現およびティッシュの鉄の積み過ぎの表現型の類似している遺伝性のhemochromatosisが、ある。 最後に、私達はHJV.FcとBMP6間の物理的な相互作用を示し、BMP6がhepcidinの表現を高め、マウスの血清鉄を減らすことを示す。 これらのデータはhemojuvelinのためのligandおよびhepcidinの表現および鉄新陳代謝の内生調整装置としてBMP6のための重要な役割を生体内で支える。 PMID: 19252486 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Detection of increased amounts of cell-free fetal DNA with short PCR amplicons.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-308.html</link>
      <description> Related Articles Detection of increased amounts of cell-free fetal DNA with short PCR amplicons. Clin Chem. 2010 Jan;56(1):136-8 Authors: Sikora A, Zimmermann BG, Rusterholz C, Birri D, Kolla V, Lapaire O, Hoesli I, Kiefer V, Jackson L, Hahn S AIM: A digital PCR approach has recently been suggested to detect greater amounts of cell-free fetal DNA in maternal plasma than conventional real-time quantitative PCR (qPCR). Because the digital qPCR approach uses shorter PCR amplicons than the real-tim ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-308.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Detection of increased amounts of cell-free fetal DNA with short PCR amplicons. Clin Chem. 2010 Jan;56(1):136-8 Authors: Sikora A, Zimmermann BG, Rusterholz C, Birri D, Kolla V, Lapaire O, Hoesli I, Kiefer V, Jackson L, Hahn S AIM: A digital PCR approach has recently been suggested to detect greater amounts of cell-free fetal DNA in maternal plasma than conventional real-time quantitative PCR (qPCR). Because the digital qPCR approach uses shorter PCR amplicons than the real-time qPCR assay, we investigated whether a real-time qPCR assay appropriately modified for such short amplicons would improve the detection of cell-free fetal DNA. METHOD: We developed a novel universal-template (UT) real-time qPCR assay that was specific for the DYS14 sequence on Y chromosome and had a short amplicon size of 50 bp. We examined this "short" assay with 50 maternal plasma samples and compared the results with those for a conventional real-time qPCR assay of the same locus but with a longer amplicon (84 bp). RESULTS: Qualitatively, both assays detected male cell-free fetal DNA with the same specificity and detection capability. Quantitatively, however, the new UT real-time qPCR assay for shorter amplicons detected, on average, almost 1.6-fold more cell-free fetal DNA than the conventional real-time qPCR assay with longer amplicons. CONCLUSIONS: The use of short PCR amplicons improves the detection of cell-free fetal DNA. This feature may prove useful in attempts to detect cell-free fetal DNA under conditions in which the amount of template is low, such as in samples obtained early in pregnancy. PMID: 19884486 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 短いPCRのampliconsが付いているcell-free胎児DNAの増加された量の関連の記事の検出。 Clin Chem。 1月2010日; 56 (1): 136-8書く: Sikora A、Zimmermann BG、Rusterholz C、Birri D、Kolla V、Lapaire O、Hoesli I、Kiefer V、ジャクソンLのHahn Sの目標: デジタルPCRのアプローチは最近慣習的な実時間量的なPCR (qPCR)より母性的な血しょうのcell-free胎児DNAのすばらしい量を検出するために提案されてしまった。 デジタルqPCRのアプローチが実時間qPCRの試金より短いPCRのampliconsを使用するので、私達は適切にそのような短いampliconsのために変更された実時間qPCRの試金がcell-free胎児DNAの検出を改善するかどうか調査した。 方法: 私達はY染色体のDYS14順序のために特定、50 bpの短いampliconのサイズがあった新しい普遍的型板(UT)の実時間qPCRの試金を開発した。 私達は50の母性的な血しょうサンプルとのこの「短い」試金を検査し、同じ位置の慣習的な実時間qPCRの試金のためのそれらとより長いamplicon (84 bp)と結果を比較した。 結果: 質的に、試金は両方とも同じ特定性および検出の機能の男性のcell-free胎児DNAを検出した。 しかし量的に、平均すると検出される、短いampliconsのための新しいUTの実時間qPCRの試金はほとんどより長いampliconsとの慣習的な実時間qPCRの試金よりcell-free胎児DNAを1.6折る。 結論: 短いPCRのampliconsの使用はcell-free胎児DNAの検出を改善する。 この特徴は型板の量が低い妊娠で早く得られるサンプルののような条件の下でcell-free胎児DNAを検出する試みに有用証明するかもしれない。 PMID: 19884486 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>PCA3: a new tool to diagnose prostate cancer (PCa) and a guidance in biopsy decisions. Preliminary report of the UrOP study.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-343.html</link>
      <description>Related Articles PCA3: a new tool to diagnose prostate cancer (PCa) and a guidance in biopsy decisions. Preliminary report of the UrOP study. Arch Ital Urol Androl. 2010 Mar;82(1):5-9 Authors: Galasso F, Giannella R, Bruni P, Giulivo R, Barbini VR, Disanto V, Leonardi R, Pansadoro V, Sepe G OBJECTIVES: PCA3 is a prostate specific non-coding mRNA that is significantly overexpressed in prostate cancer tissue. Urinary PCA3 levels have been associated with prostate cancer grade suggesting a signific ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-343.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles PCA3: a new tool to diagnose prostate cancer (PCa) and a guidance in biopsy decisions. Preliminary report of the UrOP study. Arch Ital Urol Androl. 2010 Mar;82(1):5-9 Authors: Galasso F, Giannella R, Bruni P, Giulivo R, Barbini VR, Disanto V, Leonardi R, Pansadoro V, Sepe G OBJECTIVES: PCA3 is a prostate specific non-coding mRNA that is significantly overexpressed in prostate cancer tissue. Urinary PCA3 levels have been associated with prostate cancer grade suggesting a significant role in the diagnosis of prostate cancer. We measured urinary PCA3 score in 925 subjects from several areas of Italy assessing in 114 the association of urinary PCA3 score with the results of prostate biopsy. MATERIAL AND METHODS: First-catch urine samples were collected after digital rectal examination (DRE). PCA3 and PSA mRNA levels were measured using Trascription-mediated PCR amplification. The PCA3 score was calculated as the ratio of PCA3 and PSA mRNA (PCA3 mRNA/PSA mRNA x 1000) and the cut off was set at 35. RESULTS: A total of 925 PCA3 tests were performed from December 2008 to January 2010. The rate of informative PCA3 test was 99%, with 915 subjects showing a valid PCA3 score value: 443 patients (48.42%) presented a PCA3 score >/= 35 (cut-off) whereas the remaining 472 patients (51.58%) presented a PCA3 score lower the cut-off limit (< 35). Of the 443 patients with PCA3 score >/= 35, 105 (23.70%) underwent biopsy or rebiopsy. We found that 27 patients (25.71%) had no tumour at biopsy, 37 (35.24%) had HGPIN or ASAP and 41 (39.05%) had a cancer. Moreover, including the additonal 9 patients with PCA3 < 35, who underwent biopsy post PCA3 results, our data indicate that patients with negative biopsy (n = 31) show lower PCA3 score (mean = 54.9) compared with patients with positive biopsy (n = 45) (mean = 141.6) (p = 0.000183; two-tailed t-student test). The mean PCA3 score (79.6)for the patients diagnosed with HGPIN/ASAP at biopsy (n = 38) was intermediate between patients with negative and positive biopsy. Conclusions: Our results indicate that the PCA3 score is a valid tool for prostate cancer detection and its role in making better biopsy decisions. This marker consents to discriminate patients who have to undergo biopsy from patients who only need be actively surveilled: Quantitative PCA3 score is correlated with the probability of a positive result at biopsy. PMID: 20593708 [PubMed - in process]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Noninvasive prenatal diagnosis of single gene disorders through cell-free fetal DNA in maternal blood]</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-314.html</link>
      <description>Related Articles [Noninvasive prenatal diagnosis of single gene disorders through cell-free fetal DNA in maternal blood] Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Aug;26(4):410-3 Authors: Guo QW, Zhou YL The discovery of cell-free fetal DNA (cff-DNA) in maternal plasma offered a new way to noninvasive prenatal diagnosis for single gene disorders. In the past decade, many techniques such as real-time PCR, pyrophosphorolysis-activated polymerization, mass spectrum and digital PCR have been develop ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-314.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Noninvasive prenatal diagnosis of single gene disorders through cell-free fetal DNA in maternal blood] Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Aug;26(4):410-3 Authors: Guo QW, Zhou YL The discovery of cell-free fetal DNA (cff-DNA) in maternal plasma offered a new way to noninvasive prenatal diagnosis for single gene disorders. In the past decade, many techniques such as real-time PCR, pyrophosphorolysis-activated polymerization, mass spectrum and digital PCR have been developed for noninvasive prenatal diagnosis. In this review, the author discuss the principles, applications, advantages and disadvantages of these techniques. PMID: 20017305 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：関連の記事[母性的な血のcell-free胎児DNAを通した単一の遺伝子の無秩序の非侵襲的な出生前の診断] ZhonghuaイXueイChuan Xue Za Zhi。 8月2009日; 26 (4): 410-3書く: 郡野QW、Zhou YLは単一の遺伝子の無秩序のための非侵襲的な出生前の診断に母性的な血しょうのcell-free胎児DNA (CFFDNA)の発見新しい方法を提供した。 過去10年間に、実時間PCRのような多くの技術、非侵襲的な出生前の診断のためのpyrophosphorolysis活動化させた重合、多くスペクトルおよびデジタルPCRは開発された。 この検討では、著者はこれらの技術の原則、適用、利点および不利な点を論議する。 PMID: 20017305 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Digital PCR on a SlipChip.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-344.html</link>
      <description>Related Articles Digital PCR on a SlipChip. Lab Chip. 2010 Jul 1; Authors: Shen F, Du W, Kreutz JE, Fok A, Ismagilov RF This paper describes a SlipChip to perform digital PCR in a very simple and inexpensive format. The fluidic path for introducing the sample combined with the PCR mixture was formed using elongated wells in the two plates of the SlipChip designed to overlap during sample loading. This fluidic path was broken up by simple slipping of the two plates that removed the overlap among  ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-344.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Digital PCR on a SlipChip. Lab Chip. 2010 Jul 1; Authors: Shen F, Du W, Kreutz JE, Fok A, Ismagilov RF This paper describes a SlipChip to perform digital PCR in a very simple and inexpensive format. The fluidic path for introducing the sample combined with the PCR mixture was formed using elongated wells in the two plates of the SlipChip designed to overlap during sample loading. This fluidic path was broken up by simple slipping of the two plates that removed the overlap among wells and brought each well in contact with a reservoir preloaded with oil to generate 1280 reaction compartments (2.6 nL each) simultaneously. After thermal cycling, end-point fluorescence intensity was used to detect the presence of nucleic acid. Digital PCR on the SlipChip was tested quantitatively by using Staphylococcus aureus genomic DNA. As the concentration of the template DNA in the reaction mixture was diluted, the fraction of positive wells decreased as expected from the statistical analysis. No cross-contamination was observed during the experiments. At the extremes of the dynamic range of digital PCR the standard confidence interval determined using a normal approximation of the binomial distribution is not satisfactory. Therefore, statistical analysis based on the score method was used to establish these confidence intervals. The SlipChip provides a simple strategy to count nucleic acids by using PCR. It may find applications in research applications such as single cell analysis, prenatal diagnostics, and point-of-care diagnostics. SlipChip would become valuable for diagnostics, including applications in resource-limited areas after integration with isothermal nucleic acid amplification technologies and visual readout. PMID: 20596567 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：SlipChipの記事のデジタル関連のPCR。 実験室の破片。 7月2010日1日; 著者: センF、Du W、Kreutz JE、Fok AのIsmagilov RFのこのペーパーは非常に簡単で、安価なフォーマットでデジタルPCRを行うためにSlipChipを記述する。 PCRの混合物と結合されたサンプルローディングの間に重複するように設計されているSlipChipの2つの版の細長い井戸を使用してサンプルを導入するための流体道は形作られた。 この流体道は井戸間の重複を取除き、1280年の反作用コンパートメントを(2.6 nLそれぞれ)同時に発生させるためにオイルと前もって積まれた貯蔵所と接触してそれぞれをよく持って来た2つの版の簡単な入れることによって壊れていた。 熱循環の後で核酸の存在を検出するのに、終点の蛍光性の強度が使用された。 SlipChipのデジタルPCRは黄色ブドウ球菌genomic DNAの使用によって量的にテストされた。 反応混合物の型板DNAの集中として、統計分析から期待どおりに減った肯定的な井戸の一部分薄くされた。 クロス汚染は実験の間に観察されなかった。 デジタルPCRのダイナミックレンジの極端で二項分布の正常な近似を使用して定められる標準的な信頼区間は満足ではない。 従ってこれらの信頼区間を確立するのに、スコア方法に基づく統計分析が使用された。 SlipChipはPCRの使用によって核酸を数えるために簡単な作戦を提供する。 それは単一セルの分析、出生前の診断およびポイントの心配の診断のような研究の適用の適用を見つけるかもしれない。 SlipChipは等温の核酸の拡大の技術およびカウンター読取表示機構との統合の後で資源限られた区域の適用を含む診断のために貴重に、なる。 PMID: -出版業者によって供給される… 20596567 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>High-throughput quantitative polymerase chain reaction in picoliter droplets.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-296.html</link>
      <description> Related Articles High-throughput quantitative polymerase chain reaction in picoliter droplets. Anal Chem. 2008 Dec 1;80(23):8975-81 Authors: Kiss MM, Ortoleva-Donnelly L, Beer NR, Warner J, Bailey CG, Colston BW, Rothberg JM, Link DR, Leamon JH Limiting dilution PCR has become an increasingly useful technique for the detection and quantification of rare species in a population, but the limit of detection and accuracy of quantification are largely determined by the number of reactions that can b ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-296.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles High-throughput quantitative polymerase chain reaction in picoliter droplets. Anal Chem. 2008 Dec 1;80(23):8975-81 Authors: Kiss MM, Ortoleva-Donnelly L, Beer NR, Warner J, Bailey CG, Colston BW, Rothberg JM, Link DR, Leamon JH Limiting dilution PCR has become an increasingly useful technique for the detection and quantification of rare species in a population, but the limit of detection and accuracy of quantification are largely determined by the number of reactions that can be analyzed. Increased throughput may be achieved by reducing the reaction volume and increasing processivity. We have designed a high-throughput microfluidic chip that encapsulates PCR reagents in millions of picoliter droplets in a continuous oil flow. The oil stream conducts the droplets through alternating denaturation and annealing zones, resulting in rapid (55-s cycles) and efficient PCR amplification. Inclusion of fluorescent probes in the PCR reaction mix permits the amplification process to be monitored within individual droplets at specific locations within the microfluidic chip. We show that amplification of a 245-bp adenovirus product can be detected and quantified in 35 min at starting template concentrations as low as 1 template molecule/167 droplets (0.003 pg/microL). The frequencies of positive reactions over a range of template concentrations agree closely with the frequencies predicted by Poisson statistics, demonstrating both the accuracy and sensitivity of this platform for limiting dilution and digital PCR applications. PMID: 19551929 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事の高効率のpicoliterのしぶきの量的なポリメラーゼの連鎖反応。 肛門のChem。 12月2008日1日; 80 (23): 8975-81書く: 接吻MM、Ortoleva-Donnelly LのビールNR、ワーナーJ、ベイリーCG、Colston BW、Rothberg JMのリンクDR、希薄PCRを限るLeamon JHは人口のまれな種の検出そして定量化のためのますます有用な技術になったが、検出の限界および定量化の正確さは分析することができる反作用の数によって主として定められる。 増加された効率は反作用の容積を減らし、processivityを増加することによって達成することができる。 私達は何百万の連続的なオイルの流れのpicoliterのしぶきのPCRの試薬を内部に閉じ込める高効率のmicrofluidic破片を設計した。 オイルの流れは急速で、(55-s周期)有効なPCRの拡大に終って交互になる変性および焼きなましの地帯によってしぶきを、行なう。 PCRの反作用の組合せの蛍光調査の包含は拡大プロセスがmicrofluidic破片内の特定の位置で個々のしぶきの内で監視されるようにする。 私達は245bpアデノウィルスプロダクトの拡大が1型板molecule/167のしぶき(0.003 pg/microL)低い型板の集中の開始の35分に検出され、量を示すことができることを示す。 型板の集中の範囲上の肯定的な反作用の頻度はポアソンの統計量によって予測される頻度と密接に一致し希薄およびデジタルPCRの適用を限るためのこのプラットホームの正確さそして感受性を両方示す。 PMID: 19551929 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-345.html</link>
      <description>Related Articles Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood. Int J Oncol. 2010 Aug;37(2):519-525 Authors: Lauriola M, Ugolini G, Rosati G, Zanotti S, Montroni I, Manaresi A, Zattoni D, Rivetti S, Mattei G, Coppola D, Strippoli P, Taffurelli M, Solmi R Evidence from the literature widely supports the efficacy of screening for colorectal cancer (CRC) in reducing mortality. A blood- ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-345.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood. Int J Oncol. 2010 Aug;37(2):519-525 Authors: Lauriola M, Ugolini G, Rosati G, Zanotti S, Montroni I, Manaresi A, Zattoni D, Rivetti S, Mattei G, Coppola D, Strippoli P, Taffurelli M, Solmi R Evidence from the literature widely supports the efficacy of screening for colorectal cancer (CRC) in reducing mortality. A blood-based assay, potentially, represents a more accessible early detection tool for the identification of circulating tumour cells originating from a primary tumour site in the body. The present work aimed at identifying a set of specific mRNAs expressed in colon tissue but not in blood cells. These mRNAs may represent useful markers for early detection of circulating colon cancer cells by a simple, qualitative RT-PCR assay, following RNA extraction from peripheral blood samples. Using a data-mining tool called cDNA digital gene expression displayer (DGED), based on serial analysis of gene expression (SAGE) from the Cancer Genome Anatomy Project (CGAP) database, 4-colon and 14-blood cDNA libraries were analyzed. We selected 7 genes expressed in colon tissue but not in blood and were able to test 6 of them by RT-PCR in peripheral blood of CRC patients and healthy controls. We present a relatively easy and highly reproducible technique for the detection of mRNA expression of genes as candidate markers of malignancy in blood samples of patients with colon cancer. SAGE DGED provided a list of the best candidate mRNAs predicted to detect colon cells in the blood, namely those encoding the following proteins: hypothetical protein LOC644844 (LOC644844, whose cDNA was not amplifiable), fatty acid binding protein 1 (FABP1), carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5), mucin 13 cell surface associated (MUC13), guanylate cyclase activator 2A (GUCA2A), amiloride binding protein 1 (ABP1), galactoside-binding, solute carrier family 26, member 3 (SLC26A3). The mRNA expression of these genes was evaluated in 8 samples from subjects diagnosed with CRC and 9 from healthy controls. We observed the expression of 2 of the 6 investigated genes in the blood samples of the vast majority of patients considered, but also in a subset of the controls. Our data confirm the extreme sensitivity of RT-PCR, making this technique able to detect minimal amounts of mRNA expressed in a non-tissue-specific manner. Moreover, DGED remains a powerful tool to identify candidate epithelial markers in blood, such as colon related mRNAs. However, to date, none of these qualified as tumour markers. PMID: 20596680 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-318.html</link>
      <description> Related Articles Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma. Neoplasia. 2010 Jan;12(1):20-7 Authors: Nakahara Y, Northcott PA, Li M, Kongkham PN, Smith C, Yan H, Croul S, Ra YS, Eberhart C, Huang A, Bigner D, Grajkowska W, Van Meter T, Rutka JT, Taylor MD Although medulloblastoma is the most common pediatric malignant brain tumor, its molecular underpinnings are largely unknown. We have identified rare, recurrent homozygous deletions of Kruppel-like Factor 4 ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-318.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma. Neoplasia. 2010 Jan;12(1):20-7 Authors: Nakahara Y, Northcott PA, Li M, Kongkham PN, Smith C, Yan H, Croul S, Ra YS, Eberhart C, Huang A, Bigner D, Grajkowska W, Van Meter T, Rutka JT, Taylor MD Although medulloblastoma is the most common pediatric malignant brain tumor, its molecular underpinnings are largely unknown. We have identified rare, recurrent homozygous deletions of Kruppel-like Factor 4 (KLF4) in medulloblastoma using high-resolution single nucleotide polymorphism arrays, digital karyotyping, and genomic real-time polymerase chain reaction (PCR). Furthermore, we show that there is loss of physiological KLF4 expression in more than 40% of primary medulloblastomas both at the RNA and protein levels. Medulloblastoma cell lines drastically increase the expression of KLF4 in response to the demethylating agent 5-azacytidine and demonstrate dense methylation of the promoter CpG island by bisulfite sequencing. Methylation-specific PCR targeting the KLF4 promoter demonstrates CpG methylation in approximately 16% of primary medulloblastomas. Reexpression of KLF4 in the D283 medulloblastoma cell line results in significant growth suppression both in vitro and in vivo. We conclude that KLF4 is inactivated by either genetic or epigenetic mechanisms in a large subset of medulloblastomas and that it likely functions as a tumor suppressor gene in the pathogenesis of medulloblastoma. PMID: 20072650 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-304.html</link>
      <description>Related Articles Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies. Expert Rev Mol Diagn. 2009 Sep;9(6):613-21 Authors: Hahn S, Jackson LG, Kolla V, Mahyuddin AP, Choolani M The application of recent technical developments, such as digital PCR or shot-gun sequencing, for the analysis of cell-free fetal DNA, have indicated that the long-sought goal of the noninvasive detection of Down syndrome may finally be attained. Although these methods ar ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-304.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies. Expert Rev Mol Diagn. 2009 Sep;9(6):613-21 Authors: Hahn S, Jackson LG, Kolla V, Mahyuddin AP, Choolani M The application of recent technical developments, such as digital PCR or shot-gun sequencing, for the analysis of cell-free fetal DNA, have indicated that the long-sought goal of the noninvasive detection of Down syndrome may finally be attained. Although these methods are still cumbersome and not high throughput, they provide a paradigm shift in prenatal diagnosis, as they could effectively pronounce the end of invasive procedures, such as amniocentesis or chorionic villous sampling for the detection of such fetal anomalies. However, it remains to be determined how suitable these approaches are for the detection of more subtle fetal genetic alterations, such as those involved in hereditary Mendelian disorders (e.g., thalassemia and cystic fibrosis). New technical developments, such as microfluidics and reliable automated scanning microscopes, have indicated that it may be possible to efficiently retrieve and examine circulating fetal cells. As these contain the entire genomic complement of the fetus, future developments may include the noninvasive determination of the fetal karyotype. PMID: 19732005 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：胎児の異数性およびMendelian無秩序の関連の記事の非侵襲的な出生前の診断: 新しく革新的な作戦。 巧妙なRev. Mol Diagn。 9月2009日; 9 (6): 613-21書く: ダウン症の非侵襲的な検出の念願の目的が最終的に達成されるかもしれないことをHahn S、ジャクソンLG、Kolla V、Mahyuddin AP、Choolani Mはcell-free胎児DNAの分析のために、配列するデジタルPCRまたは散弾銃のような最近の技術的な開発の適用、示した。 これらの方法がまだ扱いにくく、高くない効率であるが、効果的にそのような胎児の変則の検出のための羊水穿刺またはchorionic villous見本抽出のような侵略的なプロシージャの終わりを、発音できるので、出生前の診断の範例の転位を提供する。 但し、それは適したこれらのアプローチが遺伝性のMendelian無秩序(例えば、サラセミアおよび嚢胞性線維症)にかかわるそれらのようなより微妙な胎児の遺伝の変化の検出のため、いかにであるか定められることを残る。 新しい技術的な開発は、microfluidicsおよび信頼できる自動化されたスキャン顕微鏡のような、効率的に循環の胎児細胞を取り出し、検査することは可能かもしれないことを示した。 ことして胎児の全体のgenomic補足物を、未来の開発胎児のkaryotypeの非侵襲的な決定を含むかもしれない含みなさい。 PMID: 19732005 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Development of unigene-derived SSR markers in cowpea (Vigna unguiculata) and their transferability to other Vigna species.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-347.html</link>
      <description>Related Articles Development of unigene-derived SSR markers in cowpea (Vigna unguiculata) and their transferability to other Vigna species. Genome. 2010 Jul;53(7):508-23 Authors: Gupta SK, Gopalakrishna T Unigene sequences available in public databases provide a cost-effective and valuable source for the development of molecular markers. In this study, the identification and development of unigene-based SSR markers in cowpea (Vigna unguiculata (L.) Walp.) is presented. A total of 1071 SSRs were  ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-347.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Development of unigene-derived SSR markers in cowpea (Vigna unguiculata) and their transferability to other Vigna species. Genome. 2010 Jul;53(7):508-23 Authors: Gupta SK, Gopalakrishna T Unigene sequences available in public databases provide a cost-effective and valuable source for the development of molecular markers. In this study, the identification and development of unigene-based SSR markers in cowpea (Vigna unguiculata (L.) Walp.) is presented. A total of 1071 SSRs were identified in 15 740 cowpea unigene sequences downloaded from the National Center for Biotechnology Information. The most frequent SSR motifs present in the unigenes were trinucleotides (59.7%), followed by dinucleotides (34.8%), pentanucleotides (4%), and tetranucleotides (1.5%). The copy number varied from 6 to 33 for dinucleotide, 5 to 29 for trinucleotide, 5 to 7 for tetranucleotide, and 4 to 6 for pentanucleotide repeats. Primer pairs were successfully designed for 803 SSR motifs and 102 SSR markers were finally characterized and validated. Putative function was assigned to 64.7% of the unigene SSR markers based on significant homology to reported proteins. About 31.7% of the SSRs were present in coding sequences and 68.3% in untranslated regions of the genes. About 87% of the SSRs located in the coding sequences were trinucleotide repeats. Allelic variation at 32 SSR loci produced 98 alleles in 20 cowpea genotypes. The polymorphic information content for the SSR markers varied from 0.10 to 0.83 with an average of 0.53. These unigene SSR markers showed a high rate of transferability (88%) across other Vigna species, thereby expanding their utility. Alignment of unigene sequences with soybean genomic sequences revealed the presence of introns in amplified products of some of the SSR markers. This study presents the distribution of SSRs in the expressed portion of the cowpea genome and is the first report of the development of functional unigene-based SSR markers in cowpea. These SSR markers would play an important role in molecular mapping, comparative genomics, and marker-assisted selection strategies in cowpea and other Vigna species. PMID: 20616873 [PubMed - in process]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Copy number variation of the SELENBP1 gene in schizophrenia.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-346.html</link>
      <description>Related Articles Copy number variation of the SELENBP1 gene in schizophrenia. Behav Brain Funct. 2010 Jul 8;6(1):40 Authors: Amar S, Ovadia O, Maier W, Ebstein R, Belmaker RH, Mishmar D, Agam G ABSTRACT: BACKGROUND: Schizophrenia is associated with rare copy-number (CN) mutations. Screening for such alleles genome-wide, though comprehensive, cannot study in-depth the causality of particular loci, therefore cannot provide the functional interpretation for the disease etiology. We hypothesized tha ...</description>
        <pubDate>Wed, 14 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-346.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Copy number variation of the SELENBP1 gene in schizophrenia. Behav Brain Funct. 2010 Jul 8;6(1):40 Authors: Amar S, Ovadia O, Maier W, Ebstein R, Belmaker RH, Mishmar D, Agam G ABSTRACT: BACKGROUND: Schizophrenia is associated with rare copy-number (CN) mutations. Screening for such alleles genome-wide, though comprehensive, cannot study in-depth the causality of particular loci, therefore cannot provide the functional interpretation for the disease etiology. We hypothesized that CN mutations in the SELENBP1 locus could associate with the disorder and that these mutations could alter the gene product's activity in patients. METHODS: We analyzed SELENBP1 CN variation (CNV) in blood DNA from 49 schizophrenia patients and 49 controls (cohort A). Since CN of genes may vary among tissues, we investigated SELENBP1 CN in age- sex- and postmortem interval-matched cerebellar DNA samples from 14 patients and 14 controls (cohort B). Since CNV may either be de-novo or inherited we analyzed CNV of the SELENBP1 locus in blood DNA from 26 trios of schizophrenia probands and their healthy parents (cohort C). SELENBP1 mRNA levels were measured by real-time PCR. RESULTS: In cohort A reduced CN of the SELENBP1 locus was found in four patients but in none of the controls. In cohort B we found reduced CN of the SELENBP1 locus in two patients but in none of the controls. In cohort C three patients exhibited drastic CN reduction, not present in their parents, indicating de-novo mutation. A reduction in SELENBP1 mRNA levels in the postmortem cerebellar samples of schizophrenia patients was found. CONCLUSIONS: We report a focused study of CN mutations in the selenium binding-protein1 (SELENBP1) locus previously linked with schizophrenia. We provide evidence for recurrence of decreased CN of the SELENBP1 locus in three unrelated patients' cohorts but not in controls, raising the possibility of functional involvement of these mutations in the etiology of the disease. PMID: 20615253 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Chiral-auxiliary-mediated 1,2-cis-glycosylations for the solid-supported synthesis of a biologically important branched alpha-glucan.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-328.html</link>
      <description>Related Articles Chiral-auxiliary-mediated 1,2-cis-glycosylations for the solid-supported synthesis of a biologically important branched alpha-glucan. Nat Chem. 2010 Jul;2(7):552-7 Authors: Boltje TJ, Kim JH, Park J, Boons GJ Solid-phase oligosaccharide synthesis offers the promise of providing libraries of oligosaccharides for glycomics research. A major stumbling block to solid-phase oligosaccharide synthesis has been a lack of general methods for the stereoselective installation of 1,2-cis-gl ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-328.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Chiral-auxiliary-mediated 1,2-cis-glycosylations for the solid-supported synthesis of a biologically important branched alpha-glucan. Nat Chem. 2010 Jul;2(7):552-7 Authors: Boltje TJ, Kim JH, Park J, Boons GJ Solid-phase oligosaccharide synthesis offers the promise of providing libraries of oligosaccharides for glycomics research. A major stumbling block to solid-phase oligosaccharide synthesis has been a lack of general methods for the stereoselective installation of 1,2-cis-glycosides, and intractable mixtures of compounds are obtained if several such glycosides need to be installed. We have prepared on-resin a biologically important glucoside containing multiple 1,2-cis-glycosidic linkages with complete anomeric control by using glycosyl donors having a participating (S)-(phenylthiomethyl)benzyl chiral auxiliary at C2. A branching point could be installed by using 9-fluorenylmethyloxycarbonyl (Fmoc) and allyloxycarbonyl (Alloc) as a versatile set of orthogonal protecting groups. The synthetic strategy made it possible to achieve partial on-resin deprotection of the completed oligosaccharide, thereby increasing the overall efficiency of the synthesis. The combination of classical and auxiliary-mediated neighbouring-group participation for controlling anomeric selectivity is bringing the promise of routine automated solid-supported oligosaccharide synthesis closer. PMID: 20571573 [PubMed - in process]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Central Role of Manganese in Regulation of Stress Responses, Physiology and Metabolism in Streptococcus pneumoniae.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-329.html</link>
      <description>Related Articles Central Role of Manganese in Regulation of Stress Responses, Physiology and Metabolism in Streptococcus pneumoniae. J Bacteriol. 2010 Jul 2; Authors: Ogunniyi AD, Mahdi LK, Jennings MP, McEwan AG, McDevitt CA, Van der Hoek MB, Bagley CJ, Hoffmann P, Gould KA, Paton JC The importance of Mn(2+) for pneumococcal physiology and virulence has been studied extensively. However, the specific cellular role(s) for which Mn(2+) is required are yet to be fully elucidated. Here, we analyzed ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-329.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Central Role of Manganese in Regulation of Stress Responses, Physiology and Metabolism in Streptococcus pneumoniae. J Bacteriol. 2010 Jul 2; Authors: Ogunniyi AD, Mahdi LK, Jennings MP, McEwan AG, McDevitt CA, Van der Hoek MB, Bagley CJ, Hoffmann P, Gould KA, Paton JC The importance of Mn(2+) for pneumococcal physiology and virulence has been studied extensively. However, the specific cellular role(s) for which Mn(2+) is required are yet to be fully elucidated. Here, we analyzed the effect of Mn(2+) limitation on the transcriptome and proteome of Streptococcus pneumoniae D39. This was carried out by comparing a deletion mutant lacking the solute binding protein of the high-affinity Mn(2+) transporter, pneumococcal surface antigen A (PsaA) with its isogenic wild-type counterpart. We provide clear evidence for the Mn(2+)-dependent regulation of expression of oxidative stress-response enzymes SpxB and Mn(2+)-SodA, and of virulence-associated genes pcpA and prtA. We also demonstrate the upregulation of at least one oxidative and nitrosative stress-response gene cluster, comprising adhC, nmlRsp and czcD, in response to Mn(2+) stress. A significant increase in 6-phosphogluconate dehydrogenase activity in the psaA mutant grown under Mn(2+)-replete conditions, and upregulation of an oligopeptide ABC permease (AppDCBA), was also observed. Together, transcriptomic and proteomic analyses provided evidence for Mn(2+) having a central role in activating or stimulating enzymes involved in central carbon and general metabolism. Our results also highlight the importance of high-affinity Mn(2+) transport by PsaA in pneumococcal competence, physiology and metabolism, and elucidate mechanisms underlying the response to Mn(2+) stress. PMID: 20601473 [PubMed - as supplied by publisher]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Lectin Glycoarrays technologies for Nanoscale Biomedical Detection.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-326.html</link>
      <description>Related Articles Lectin Glycoarrays technologies for Nanoscale Biomedical Detection. Protein Pept Lett. 2010 Jun 3; Authors: Chan K, Ng TB Microarray technologies have begun to feature widely in biomedical science. These techniques, allow for high throughput and quantitative analysis of protein-carbohydrate interactions. Lectin and antibody have been evaluated with these new techniques which extend to the detection of viruses and bacteria. This review outlines some of the basic principles of &apos;gl ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-326.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Lectin Glycoarrays technologies for Nanoscale Biomedical Detection. Protein Pept Lett. 2010 Jun 3; Authors: Chan K, Ng TB Microarray technologies have begun to feature widely in biomedical science. These techniques, allow for high throughput and quantitative analysis of protein-carbohydrate interactions. Lectin and antibody have been evaluated with these new techniques which extend to the detection of viruses and bacteria. This review outlines some of the basic principles of 'glycoarrays' and illustrates their recent applications. Moreover, the review also gives an overview about a recently launched powerful detection platform using lectin microarrays with a potential to revolutionize the use of lectins in biomedical diagnosis and glycomics in general. In addition, two analytical techniques including mass spectrometry and glycan microarrays expected to play important role to characterize binding profile of new lectins are described in brief. Finally, strong and weak points of lectins as biorecognition molecules currently used in biomedical diagnosis are shown with conclusions drawn from molecular modelling of biorecognition events. PMID: 20518732 [PubMed - as supplied by publisher]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Site-mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-324.html</link>
      <description>Related Articles Site-mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle. J Biol Chem. 2010 May 27; Authors: Stalnaker SH, Hashmi S, Lim JM, Aoki K, Porterfield M, Gutierrez-Sanchez G, Wheeler J, Ervasti JM, Bergmann C, Tiemeyer M, Wells L The main extracellular matrix binding component of the dystrophin-glycoprotein complex (DGC), alpha-dystroglycan (alpha-DG), which was originally isolated from rabbit skeletal muscle, is an extensivel ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-324.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Site-mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle. J Biol Chem. 2010 May 27; Authors: Stalnaker SH, Hashmi S, Lim JM, Aoki K, Porterfield M, Gutierrez-Sanchez G, Wheeler J, Ervasti JM, Bergmann C, Tiemeyer M, Wells L The main extracellular matrix binding component of the dystrophin-glycoprotein complex (DGC), alpha-dystroglycan (alpha-DG), which was originally isolated from rabbit skeletal muscle, is an extensively O-glycosylated protein. Previous studies have shown alpha-DG to be modified by both O-GalNAc and O-mannose initiated glycan structures. O-mannosylation while accounting for up to 30% of the reported O-linked structures in certain tissues, has been rarely observed on mammalian proteins. Mutations in multiple genes encoding defined or putative glycosyltransferases involved in O-mannosylation are causal for various forms of Congenital Muscular Dystrophy. Here we explore the glycosylation of purified rabbit skeletal muscle alpha-DG in detail. Using tandem mass spectrometry approaches, we identify 4 O-mannose initiated and 17 O-GalNAc initiated structures on alpha-DG isolated from rabbit skeletal muscle. Additionally, we demonstrate the use of tandem mass spectrometry-based workflows to directly analyze glycopeptides generated from the purified protein. By combining glycomics and tandem mass spectrometry analysis of 91 glycopeptides from alpha-DG, we are able to assign 21 different residues as being modified by O-glycosylation with differing degrees of microheterogeneity; 9 sites of O-mannosylation and 14 sites of O-GalNAcylation are observed with only two sites definitively exhibiting occupancy by either type of glycan. The distribution of identified sites of O-mannosylation suggests a limited role for local primary sequence in dictating sites of attachment. PMID: 20507986 [PubMed - as supplied by publisher]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-325.html</link>
      <description> Related Articles Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell. 2010 May 28;141(5):897-907 Authors: Zielinska DF, Gnad F, Wi</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-325.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell. 2010 May 28;141(5):897-907 Authors: Zielinska DF, Gnad F, Wi
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-323.html</link>
      <description> Related Articles Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. Anal Chem. 2010 Jun 15;82(12):5095-106 Authors: Alley WR, Madera M, Mechref Y, Novotny MV The study of protein glycosylation in biological fluids and tissues has substantial medical importance, as changes in glycan structures have now been associated with a number of diseases. Quantification of glycomic-profile changes is b ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-323.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. Anal Chem. 2010 Jun 15;82(12):5095-106 Authors: Alley WR, Madera M, Mechref Y, Novotny MV The study of protein glycosylation in biological fluids and tissues has substantial medical importance, as changes in glycan structures have now been associated with a number of diseases. Quantification of glycomic-profile changes is becoming increasingly important in the search for disease biomarkers. Here, we report a highly reproducible combination of a glycomic sample preparation/solid-phase derivatization of glycoprotein-derived N-linked glycans with their subsequent microchip-based separation and mass-spectrometric (MS) measurements. Following our previously described reductive beta-elimination for O-linked glycans with ammonia-borane complex to reduce N-linked structures, the N-linked alditol structures are effectively methylated in dimethylformamide medium to avoid artefacts in MS measurements. Reversed-phase microfluidic liquid chromatography (LC) of methylated N-linked oligosaccharide alditols resolved some closely related structures into regular retention increments, aiding in their structural assignments. Optimized LC gradients, together with nanospray MS, have been applied here in the quantitative measurements of N-linked glycans in blood serum, distinguishing breast cancer patients from control individuals. PMID: 20491449 [PubMed - in process]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Preparation of regioselectively feruloylated p-nitrophenyl alpha-L-arabinofuranosides and beta-D-xylopyranosides-convenient substrates for study of feruloyl esterase specificity.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-321.html</link>
      <description> Related Articles Preparation of regioselectively feruloylated p-nitrophenyl alpha-L-arabinofuranosides and beta-D-xylopyranosides-convenient substrates for study of feruloyl esterase specificity. Carbohydr Res. 2010 Jun 16;345(9):1094-8 Authors: Mastihubov</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-321.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Preparation of regioselectively feruloylated p-nitrophenyl alpha-L-arabinofuranosides and beta-D-xylopyranosides-convenient substrates for study of feruloyl esterase specificity. Carbohydr Res. 2010 Jun 16;345(9):1094-8 Authors: Mastihubov
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Platform technology to identify potential disease markers and establish heritability and environmental determinants of the human serum N-glycome.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-319.html</link>
      <description> Related Articles Platform technology to identify potential disease markers and establish heritability and environmental determinants of the human serum N-glycome. Carbohydr Res. 2010 Apr 18; Authors: Tharmalingam T, Mari</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-319.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Platform technology to identify potential disease markers and establish heritability and environmental determinants of the human serum N-glycome. Carbohydr Res. 2010 Apr 18; Authors: Tharmalingam T, Mari
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Enzymatic synthesis of new oligosaccharides using mannosyltransferases from Candida species and their NMR assignments.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-322.html</link>
      <description> Related Articles Enzymatic synthesis of new oligosaccharides using mannosyltransferases from Candida species and their NMR assignments. Biol Pharm Bull. 2010;33(5):895-9 Authors: Shibata N, Okawa Y The outer layer of the cell wall of pathogenic fungi, Candida species, consists of mannan, which plays an important role in infection. In this study, we synthesized several oligosaccharides using mannosyltransferases obtained from Candida parapsilosis and Candida albicans. Namely, we synthesized mann ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-322.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Enzymatic synthesis of new oligosaccharides using mannosyltransferases from Candida species and their NMR assignments. Biol Pharm Bull. 2010;33(5):895-9 Authors: Shibata N, Okawa Y The outer layer of the cell wall of pathogenic fungi, Candida species, consists of mannan, which plays an important role in infection. In this study, we synthesized several oligosaccharides using mannosyltransferases obtained from Candida parapsilosis and Candida albicans. Namely, we synthesized mannotetraoses [Manalpha1--> 2Manalpha1-->3Manalpha1-->2Man and Manalpha1-->3(Manalpha1-->6)Manalpha1-->2Man] from mannotriose, Manalpha1-->3Manalpha1--> 2Man, and mannohexaoses [Manalpha1-->2Manalpha1-->3Manalpha1-->3Manalpha1-->2Manalpha1-->2Man and Manalpha1-->3(Manalpha1-->6)Manalpha1-->3Manalpha1-->2Manalpha1-->2Man] from mannopentaose, Manalpha1-->3Manalpha1-->3Manalpha1-->2Manalpha1-->2Man. The linkage sequence of these oligosaccharides was identified by a sequential (1)H-NMR assignment method combined with rotating frame nuclear Overhauser enhancement spectroscopy and relayed coherence transfer spectroscopy. The steric effect by the alpha-1,6-linked branching mannose residue to the H-1 proton chemical shift of the neighboring 3-O-substituted mannose residue was different from that of the 2-O-substituted mannose residue. These oligosaccharides having novel structures seem to be useful as the substrate or ligand for glycomics. PMID: 20460773 [PubMed - in process]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Mass Spectrometry and Glycomics.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-318.html</link>
      <description>Related Articles Mass Spectrometry and Glycomics. OMICS. 2010 May 5; Authors: Zaia J Abstract Glycosylation defines the adhesive properties of animal cell surfaces and the surrounding extracellular environments. Because cells respond to stimuli by altering glycan expression, glycan structures vary according to spatial location in tissue and temporal factors. These dynamic structural expression patterns, combined with the essential roles glycans play in physiology, drive the need for analytical m ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-318.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Mass Spectrometry and Glycomics. OMICS. 2010 May 5; Authors: Zaia J Abstract Glycosylation defines the adhesive properties of animal cell surfaces and the surrounding extracellular environments. Because cells respond to stimuli by altering glycan expression, glycan structures vary according to spatial location in tissue and temporal factors. These dynamic structural expression patterns, combined with the essential roles glycans play in physiology, drive the need for analytical methods for glycoconjugates. In addition, recombinant glycoprotein drug products represent a multibillion dollar market. Effective analytical methods are needed to speed the identification of new targets and the development of industrial glycoprotein products, both new and biosimilar. Mass spectrometry is an enabling technology in glycomics. This review summarizes mass spectrometry of glycoconjugate glycans. The intent is to summarize appropriate methods for glycans given their chemical properties as distinct from those of proteins, lipids, and small molecule metabolites. Special attention is given to the uses of mass spectral profiling for glycomics with respect to the N-linked, O-linked, ganglioside, and glycosaminoglycan compound classes. Next, the uses of tandem mass spectrometry of glycans are summarized. The review finishes with an update on mass spectral glycoproteomics. PMID: 20443730 [PubMed - as supplied by publisher]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteoglycomics: Recent Progress and Future Challenges.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-320.html</link>
      <description>Related Articles Proteoglycomics: Recent Progress and Future Challenges. OMICS. 2010 May 7; Authors: Ly M, Laremore TN, Linhardt RJ Abstract Proteoglycomics is a systematic study of structure, expression, and function of proteoglycans, a posttranslationally modified subset of a proteome. Although relying on the established technologies of proteomics and glycomics, proteoglycomics research requires unique approaches for elucidating structure-function relationships of both proteoglycan components, ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-320.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Proteoglycomics: Recent Progress and Future Challenges. OMICS. 2010 May 7; Authors: Ly M, Laremore TN, Linhardt RJ Abstract Proteoglycomics is a systematic study of structure, expression, and function of proteoglycans, a posttranslationally modified subset of a proteome. Although relying on the established technologies of proteomics and glycomics, proteoglycomics research requires unique approaches for elucidating structure-function relationships of both proteoglycan components, glycosaminoglycan chain, and core protein. This review discusses our current understanding of structure and function of proteoglycans, major players in the development, normal physiology, and disease. A brief outline of the proteoglycomic sample preparation and analysis is provided along with examples of several recent proteoglycomic studies. Unique challenges in the characterization of glycosaminoglycan component of proteoglycans are discussed, with emphasis on the many analytical tools used and the types of information they provide. PMID: 20450439 [PubMed - as supplied by publisher]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glycopeptidome of a heavily N-glycosylated cell surface glycoprotein of Dictyostelium implicated in cell adhesion.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-317.html</link>
      <description> Related Articles Glycopeptidome of a heavily N-glycosylated cell surface glycoprotein of Dictyostelium implicated in cell adhesion. J Proteome Res. 2010 Jul 2;9(7):3495-510 Authors: Feasley CL, Johnson JM, West CM, Chia CP Genetic analysis has implicated the cell surface glycoprotein gp130 in cell interactions of the social amoeba Dictyostelium, and information about the utilization of the 18 N-glycosylation sequons present in gp130 is needed to identify critical molecular determinants of its a ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-317.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Glycopeptidome of a heavily N-glycosylated cell surface glycoprotein of Dictyostelium implicated in cell adhesion. J Proteome Res. 2010 Jul 2;9(7):3495-510 Authors: Feasley CL, Johnson JM, West CM, Chia CP Genetic analysis has implicated the cell surface glycoprotein gp130 in cell interactions of the social amoeba Dictyostelium, and information about the utilization of the 18 N-glycosylation sequons present in gp130 is needed to identify critical molecular determinants of its activity. Various glycomics strategies, including mass spectrometry of native and derivatized glycans, monosaccharide analysis, exoglycosidase digestion, and antibody binding, were applied to characterize a nonanchored version secreted from Dictyostelium. s-gp130 is modified by a predominant Man(8)GlcNAc(4) species containing bisecting and intersecting GlcNAc residues and additional high-mannose N-glycans substituted with sulfate, methyl-phosphate, and/or core alpha 3-fucose. Site mapping confirmed the occupancy of 15 sequons, some variably, and glycopeptide analysis confirmed 14 sites and revealed extensive heterogeneity at most sites. Glycopeptide glycoforms ranged from Man(6) to Man(9), GlcNAc(0-2) (peripheral), Fuc(0-2) (including core alpha 3 and peripheral), (SO(4))(0-1), and (MePO(4))(0-1), which represented elements of virtually the entire known cellular N-glycome as inferred from prior metabolic labeling and mass spectrometry studies. gp130, and a family of 14 related predicted glycoproteins whose polypeptide sequences are rapidly diverging in the Dictyostelium lineage, may contribute a functionally important shroud of high-mannose N-glycans at the interface of the amoebae with each other, their predators and prey, and the soil environment. PMID: 20443635 [PubMed - in process]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Rescue of Drosophila Melanogaster l(2)35Aa lethality is only mediated by polypeptide GalNAc-transferase pgant35A, but not by the evolutionary conserved human ortholog GalNAc-transferase-T11.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-315.html</link>
      <description> Related Articles Rescue of Drosophila Melanogaster l(2)35Aa lethality is only mediated by polypeptide GalNAc-transferase pgant35A, but not by the evolutionary conserved human ortholog GalNAc-transferase-T11. Glycoconj J. 2010 May;27(4):435-44 Authors: Bennett EP, Chen YW, Schwientek T, Mandel U, Schjoldager KB, Cohen SM, Clausen H The Drosophila l(2)35Aa gene encodes a UDP-N-acetylgalactosamine: Polypeptide N-acetylgalactosaminyltransferase, essential for embryogenesis and development (J. Biol. ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-315.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Rescue of Drosophila Melanogaster l(2)35Aa lethality is only mediated by polypeptide GalNAc-transferase pgant35A, but not by the evolutionary conserved human ortholog GalNAc-transferase-T11. Glycoconj J. 2010 May;27(4):435-44 Authors: Bennett EP, Chen YW, Schwientek T, Mandel U, Schjoldager KB, Cohen SM, Clausen H The Drosophila l(2)35Aa gene encodes a UDP-N-acetylgalactosamine: Polypeptide N-acetylgalactosaminyltransferase, essential for embryogenesis and development (J. Biol. Chem. 277, 22623-22638; J. Biol. Chem. 277, 22616-22). l(2)35Aa, also known as pgant35A, is a member of a large evolutionarily conserved family of genes encoding polypeptide GalNAc-transferases. Phylogenetic and functional analyses have proposed that subfamilies of orthologous GalNAc-transferase genes are conserved in species, suggesting that they serve distinct functions in vivo. Based on sequence alignments, pgant35A and human GALNT11 are thought to belong to a distinct subfamily. Recent in vitro studies have shown that pgant35A and pgant7, encoding enzymes from different subfamilies, prefer different acceptor substrates, whereas the orthologous pgant35A and human GALNT11 gene products possess, 1) conserved substrate preferences and 2) similar acceptor site preferences in vitro. In line with the in vitro pgant7 studies, we show that l(2)35Aa lethality is not rescued by ectopic pgant7 expression. Remarkably and in contrast to this observation, the human pgant35A ortholog, GALNT11, was shown not to support rescue of the l(2)35Aa lethality. By use of genetic "domain swapping" experiments we demonstrate, that lack of rescue was not caused by inappropriate sub-cellular targeting of functionally active GalNAc-T11. Collectively our results show, that fly embryogenesis specifically requires functional pgant35A, and that the presence of this gene product during fly embryogenesis is functionally distinct from other Drosophila GalNAc-transferase isoforms and from the proposed human ortholog GALNT11. PMID: 20422447 [PubMed - in process]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Generating heparan sulfate saccharide libraries for glycomics applications.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-310.html</link>
      <description> Related Articles Generating heparan sulfate saccharide libraries for glycomics applications. Nat Protoc. 2010;5(5):821-33 Authors: Powell AK, Ahmed YA, Yates EA, Turnbull JE Natural and semi-synthetic heparan sulfate (HS) saccharide libraries are a valuable resource for investigating HS structure-function relationships, enabling high-throughput glycomics studies. Owing to the difficulty of chemical or in vitro enzymatic synthesis of HS saccharides, the structural diversity displayed in sacchari ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-310.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Generating heparan sulfate saccharide libraries for glycomics applications. Nat Protoc. 2010;5(5):821-33 Authors: Powell AK, Ahmed YA, Yates EA, Turnbull JE Natural and semi-synthetic heparan sulfate (HS) saccharide libraries are a valuable resource for investigating HS structure-function relationships, enabling high-throughput glycomics studies. Owing to the difficulty of chemical or in vitro enzymatic synthesis of HS saccharides, the structural diversity displayed in saccharides from tissue or cell sources cannot be readily accessed. In contrast, saccharide libraries can be generated by partial digestion of tissue-derived HS polysaccharide chains and chromatographic fractionation of the resulting saccharide mixtures. Fractionation is initially on the basis of hydrodynamic volume, using size exclusion chromatography. Further fractionation, on the basis of charge using strong anion exchange, can subsequently be applied. Desalting and sample concentration follows each fractionation step. Chromatographic fractions are generated that contain purified, or partially purified, saccharides. Here we describe a comprehensive protocol for generation of structurally diverse natural saccharide libraries from HS variants that is fast (approximately 3 weeks) and reproducible. PMID: 20379137 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Developing high-affinity boron-based receptors for cell-surface carbohydrates.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-313.html</link>
      <description> Related Articles Developing high-affinity boron-based receptors for cell-surface carbohydrates. Chembiochem. 2010 May 3;11(7):954-7 Authors: Houston TA PMID: 20391454 [PubMed - in process]</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-313.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Developing high-affinity boron-based receptors for cell-surface carbohydrates. Chembiochem. 2010 May 3;11(7):954-7 Authors: Houston TA  PMID: 20391454 [PubMed - in process]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Simultaneous determination of nucleotide sugars with ion-pair reversed-phase HPLC.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-309.html</link>
      <description> Related Articles Simultaneous determination of nucleotide sugars with ion-pair reversed-phase HPLC. Glycobiology. 2010 Jul;20(7):865-71 Authors: Nakajima K, Kitazume S, Angata T, Fujinawa R, Ohtsubo K, Miyoshi E, Taniguchi N Nucleotide sugars are important in determining cell surface glycoprotein glycosylation, which can modulate cellular properties such as growth and arrest. We have developed a conventional HPLC method for simultaneous determination of nucleotide sugars. A mixture of nucleotid ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-309.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Simultaneous determination of nucleotide sugars with ion-pair reversed-phase HPLC. Glycobiology. 2010 Jul;20(7):865-71 Authors: Nakajima K, Kitazume S, Angata T, Fujinawa R, Ohtsubo K, Miyoshi E, Taniguchi N Nucleotide sugars are important in determining cell surface glycoprotein glycosylation, which can modulate cellular properties such as growth and arrest. We have developed a conventional HPLC method for simultaneous determination of nucleotide sugars. A mixture of nucleotide sugars (CMP-NeuAc, UDP-Gal, UDP-Glc, UDP-GalNAc, UDP-GlcNAc, GDP-Man, GDP-Fuc and UDP-GlcUA) and relevant nucleotides were perfectly separated in an optimized ion-pair reversed-phase mode using Inertsil ODS-4 and ODS-3 columns. The newly developed method enabled us to determine the nucleotide sugars in cellular extracts from 1 x 10(6) cells in a single run. We applied this method to characterize nucleotide sugar levels in breast and pancreatic cancer cell lines and revealed that the abundance of UDP-GlcNAc, UDP-GalNAc, UDP-GlcUA and GDP-Fuc were a cell-type-specific feature. To determine the physiological significance of changes in nucleotide sugar levels, we analyzed their changes by glucose deprivation and found that the determination of nucleotide sugar levels provided us with valuable information with respect to studying the overview of cellular glycosylation status. PMID: 20371511 [PubMed - in process]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Chemical approaches to glycobiology.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-311.html</link>
      <description> Related Articles Chemical approaches to glycobiology. Annu Rev Biochem. 2010;79:619-53 Authors: Kiessling LL, Splain RA Glycans are ubiquitous components of all organisms. Efforts to elucidate glycan function and to understand how they are assembled and disassembled can reap benefits in fields ranging from bioenergy to human medicine. Significant advances in our knowledge of glycan biosynthesis and function are emerging, and chemical biology approaches are accelerating the pace of discovery. No ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:18 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-311.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Chemical approaches to glycobiology. Annu Rev Biochem. 2010;79:619-53 Authors: Kiessling LL, Splain RA Glycans are ubiquitous components of all organisms. Efforts to elucidate glycan function and to understand how they are assembled and disassembled can reap benefits in fields ranging from bioenergy to human medicine. Significant advances in our knowledge of glycan biosynthesis and function are emerging, and chemical biology approaches are accelerating the pace of discovery. Novel strategies for assembling oligosaccharides, glycoproteins, and other glycoconjugates are providing access to critical materials for interrogating glycan function. Chemoselective reactions that facilitate the synthesis of glycan-substituted imaging agents, arrays, and materials are yielding compounds to interrogate and perturb glycan function and dysfunction. To complement these advances, small molecules are being generated that inhibit key glycan-binding proteins or biosynthetic enzymes. These examples illustrate how chemical glycobiology is providing new insight into the functional roles of glycans and new opportunities to interfere with or exploit these roles. PMID: 20380561 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Synthesis of alkyl and cycloalkyl alpha-d-mannopyranosides and derivatives thereof and their evaluation in the mycobacterial mannosyltransferase assay.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-308.html</link>
      <description> Related Articles Synthesis of alkyl and cycloalkyl alpha-d-mannopyranosides and derivatives thereof and their evaluation in the mycobacterial mannosyltransferase assay. Carbohydr Res. 2010 Mar 15; Authors: Pol</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-308.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Synthesis of alkyl and cycloalkyl alpha-d-mannopyranosides and derivatives thereof and their evaluation in the mycobacterial mannosyltransferase assay. Carbohydr Res. 2010 Mar 15; Authors: Pol
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Comparative glycomic profiling in esophageal adenocarcinoma.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-314.html</link>
      <description> Related Articles Comparative glycomic profiling in esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2010 May;139(5):1216-23 Authors: Hammoud ZT, Mechref Y, Hussein A, Bekesova S, Zhang M, Kesler KA, Novotny MV OBJECTIVE: Aberrant glycosylation has been implicated in various types of cancers. Cancerous cells with altered glycosylation of their surface proteins shed such proteins into the circulating fluids. Glycomic profiling of such fluids shows the altered glycosylation. We performed glyco ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-314.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Comparative glycomic profiling in esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2010 May;139(5):1216-23 Authors: Hammoud ZT, Mechref Y, Hussein A, Bekesova S, Zhang M, Kesler KA, Novotny MV OBJECTIVE: Aberrant glycosylation has been implicated in various types of cancers. Cancerous cells with altered glycosylation of their surface proteins shed such proteins into the circulating fluids. Glycomic profiling of such fluids shows the altered glycosylation. We performed glycomic profiling of serum from patients with no known disease, Barrett's without dysplasia, with high-grade dysplasia, and with esophageal adenocarcinoma in an attempt to delineate distinct differences in glycosylation among these groups. METHODS: Serum samples from patients with Barrett's metaplasia (N = 5), high-grade dysplasia (N = 11), and esophageal adenocarcinoma (N = 50) were collected; samples from 18 healthy volunteers were used as control. Serum N-glycans were enzymatically released and then applied to both C18 Sep-Pak (Waters, Milford, MA) cartridges and activated charcoal cartridges. N-glycans were permethylated and then spotted directly onto a matrix-assisted laser desorption ionization plate. Mass spectra were acquired using the Applied Biosystems 4800 MALDI TOF/TOF Analyzer (Applied Biosystems Inc, Framingham, Mass). The obtained matrix-assisted laser desorption ionization-mass spectrometry data were processed using DataExplorer files (Applied Biosystems Inc) listing m/z values and intensities. RESULTS: The intensities of 98 glycans were significantly different among the 3 groups; 26 of these corresponded to known glycan structures. Pairwise comparisons showed that 8 glycans were significantly different in all 3 pairwise comparisons. CONCLUSION: We demonstrated that comparative glycomic profiling of esophageal adenocarcinoma reveals a subset of glycans that can be selected as candidate biomarkers. These markers can differentiate normal from high-grade dysplasia, normal from esophageal adenocarcinoma, and high-grade dysplasia from esophageal adenocarcinoma. Further validation will be necessary to determine the clinical utility of these glycan biomarkers. PMID: 20412957 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Carbohydrate vaccines: developing sweet solutions to sticky situations?</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-307.html</link>
      <description> Related Articles Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat Rev Drug Discov. 2010 Apr;9(4):308-24 Authors: Astronomo RD, Burton DR Recent technological advances in glycobiology and glycochemistry are paving the way for a new era in carbohydrate vaccine design. This is enabling greater efficiency in the identification, synthesis and evaluation of unique glycan epitopes found on a plethora of pathogens and malignant cells. Here, we review the progress being made i ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-307.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat Rev Drug Discov. 2010 Apr;9(4):308-24 Authors: Astronomo RD, Burton DR Recent technological advances in glycobiology and glycochemistry are paving the way for a new era in carbohydrate vaccine design. This is enabling greater efficiency in the identification, synthesis and evaluation of unique glycan epitopes found on a plethora of pathogens and malignant cells. Here, we review the progress being made in addressing challenges posed by targeting the surface carbohydrates of bacteria, protozoa, helminths, viruses, fungi and cancer cells for vaccine purposes. PMID: 20357803 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Altered Serum Glycomics in Alzheimer Disease: A Potential Blood Biomarker?</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-316.html</link>
      <description>Related Articles Altered Serum Glycomics in Alzheimer Disease: A Potential Blood Biomarker? Rejuvenation Res. 2010 Apr 28; Authors: Chen CC, Engelborghs S, Dewaele S, Le Bastard N, Martin JJ, Vanhooren V, Libert C, De Deyn PP Abstract We investigated whether blood N-glycan changes can be used as a diagnostic biomarker for Alzheimer disease (AD). We used DNA sequencer-assisted, fluorophore-assisted carbohydrate electrophoresis (DSA-FACE) technology to assay N-glycans in sera from 79 autopsy-confi ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-316.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Altered Serum Glycomics in Alzheimer Disease: A Potential Blood Biomarker? Rejuvenation Res. 2010 Apr 28; Authors: Chen CC, Engelborghs S, Dewaele S, Le Bastard N, Martin JJ, Vanhooren V, Libert C, De Deyn PP Abstract We investigated whether blood N-glycan changes can be used as a diagnostic biomarker for Alzheimer disease (AD). We used DNA sequencer-assisted, fluorophore-assisted carbohydrate electrophoresis (DSA-FACE) technology to assay N-glycans in sera from 79 autopsy-confirmed dementia patients and 149 healthy controls. One N-glycan (NA2F) was substantially decreased in AD patients but not in controls. Use of NA2F for discriminating AD between dementia patients and healthy controls showed a diagnostic accuracy of 85.7% +/- 2.8% with 92% specificity and 70% sensitivity. The decrease in the level of NA2F in AD patients compared to non-AD patients was more pronounced in females (p < 0.0001) than in males (p < 0.014). Use of NA2F to differentiate female AD from female non-AD patients reached a diagnostic accuracy of 90.7% +/- 4.8 %. Pearson correlation analysis showed that in female dementia patients, serum NA2F levels were significantly correlated with the cerebrospinal fluid (CSF) beta-amyloid peptide of 42 amino acids (Abeta(1-42)) and tau phosphorylated at threonine 181 (P-tau(181P)) levels, whereas in male dementia patients serum NA2F levels were significantly correlated only with CSF total tau protein (T-tau) level. Thus, we suggest that the serum N-glycan marker might be suitable for longitudinal and follow-up studies. PMID: 20426627 [PubMed - as supplied by publisher]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glycomic Analysis of Sialic Acid Linkages in Glycans Derived from Blood Serum Glycoproteins.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-306.html</link>
      <description> Related Articles Glycomic Analysis of Sialic Acid Linkages in Glycans Derived from Blood Serum Glycoproteins. J Proteome Res. 2010 May 5; Authors: Alley WR, Novotny MV A number of alterations to the normal glycomic profile have been previously described for a number of diseases and disorders, thus underscoring the medical importance of studying the glycans associated with proteins present in biological samples. An important alteration in cancer progression is an increased level of alpha2,6-sial ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-306.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Glycomic Analysis of Sialic Acid Linkages in Glycans Derived from Blood Serum Glycoproteins. J Proteome Res. 2010 May 5; Authors: Alley WR, Novotny MV A number of alterations to the normal glycomic profile have been previously described for a number of diseases and disorders, thus underscoring the medical importance of studying the glycans associated with proteins present in biological samples. An important alteration in cancer progression is an increased level of alpha2,6-sialylation, which aids in increasing the metastatic potential of tumor cells. Here we report a glycomic method that selectively amidates alpha2,6-linked sialic acids, while those that are alpha2,3-linked undergo spontaneous lactonization. Following subsequent permethylation, MALDI-TOF MS analysis revealed that many sialylated glycans present on glycoproteins found in blood serum featured increased levels of alpha2,6-sialylation in breast cancer samples. On the basis of the altered ratios of alpha2,3-linked to alpha2,6-linked sialic acids, many of these glycans became diagnostically relevant when they did not act as such indicators when based on traditional glycomic profiling alone. PMID: 20345175 [PubMed - as supplied by publisher]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Marine glycobiology: current status and future perspectives.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-312.html</link>
      <description> Related Articles Marine glycobiology: current status and future perspectives. Mar Biotechnol (NY). 2010 Jun;12(3):241-52 Authors: Caldwell GS, Pagett HE Glycobiology, which is the study of the structure and function of carbohydrates and carbohydrate containing molecules, is fundamental to all biological systems.Progress in glycobiology has shed light on a range of complex biological processes associated with, for example,disease and immunology, molecular and cellular communication,and developme ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-312.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Marine glycobiology: current status and future perspectives. Mar Biotechnol (NY). 2010 Jun;12(3):241-52 Authors: Caldwell GS, Pagett HE Glycobiology, which is the study of the structure and function of carbohydrates and carbohydrate containing molecules, is fundamental to all biological systems.Progress in glycobiology has shed light on a range of complex biological processes associated with, for example,disease and immunology, molecular and cellular communication,and developmental biology. There is an established,if rather modest, tradition of glycobiology research in marine systems that has primarily focused on reproduction,biofouling, and chemical communication. The current status of marine glycobiology research is primarily descriptive with very limited progress on structural elucidation and the subsequent definition of precise functional roles beyond a small number of classical examples, e.g., induction of the acrosome reaction in echinoderms. However, with recent advances in analytical instrumentation, there is now the capacity to begin to characterize marine glycoconjugates,many of which will have potential biomedical and biotechnological applications. The analytical approach to glycoscience has developed to such an extent that it has acquired its own "-omics" identity. Glycomics is the quest to decipher the complex information conveyed by carbohydrate molecules--the carbohydrate code or glycocode. Due to the paucity of structural information available, this article will highlight the fundamental importance of glycobiology for many biological processes in marine organisms and will draw upon the best defined systems. These systems therefore may prove genuine candidates for full carbohydrate characterization. PMID: 20390314 [PubMed - in process]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Enzymatic Oxidation and Separation of Various Saccharides with Immobilized Glucose Oxidase.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-305.html</link>
      <description> Related Articles Enzymatic Oxidation and Separation of Various Saccharides with Immobilized Glucose Oxidase. Appl Biochem Biotechnol. 2010 Mar 27; Authors: Mislovi</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-305.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Enzymatic Oxidation and Separation of Various Saccharides with Immobilized Glucose Oxidase. Appl Biochem Biotechnol. 2010 Mar 27; Authors: Mislovi
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Coencapsulation of oxygen carriers and glucose oxidase in polyelectrolyte complex capsules for the enhancement of D-gluconic acid and delta-gluconolactone production.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-303.html</link>
      <description> Related Articles Coencapsulation of oxygen carriers and glucose oxidase in polyelectrolyte complex capsules for the enhancement of D-gluconic acid and delta-gluconolactone production. Artif Cells Blood Substit Immobil Biotechnol. 2010 Apr;38(2):90-8 Authors: Bucko M, Gemeiner P, Vikartovsk</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-303.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Coencapsulation of oxygen carriers and glucose oxidase in polyelectrolyte complex capsules for the enhancement of D-gluconic acid and delta-gluconolactone production. Artif Cells Blood Substit Immobil Biotechnol. 2010 Apr;38(2):90-8 Authors: Bucko M, Gemeiner P, Vikartovsk
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glycome profiling using modern glycomics technology: technical aspects and applications.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-292.html</link>
      <description>Related Articles Glycome profiling using modern glycomics technology: technical aspects and applications. Biol Chem. 2010 Feb-Mar;391(2-3):149-61 Authors: Vanderschaeghe D, Festjens N, Delanghe J, Callewaert N Glycomics research has become indispensable in many research fields such as immunity, signal transduction and development. Moreover, changes in the glycosylation of proteins and lipids have been reported in several diseases including cancer. The analysis of a complex post-translational mod ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-292.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Glycome profiling using modern glycomics technology: technical aspects and applications. Biol Chem. 2010 Feb-Mar;391(2-3):149-61 Authors: Vanderschaeghe D, Festjens N, Delanghe J, Callewaert N Glycomics research has become indispensable in many research fields such as immunity, signal transduction and development. Moreover, changes in the glycosylation of proteins and lipids have been reported in several diseases including cancer. The analysis of a complex post-translational modification such as glycosylation depends on the availability or development of appropriate analytical technologies. The research goal determines the sensitivity, resolution and throughput requirements and guides the choice of a particular technology. This review highlights the evolution of glycan profiling tools in the past 5 years. We focus on capillary electrophoresis, liquid chromatography, mass spectrometry and lectin microarrays. PMID: 20128687 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Comprehensive analysis of N-linked oligosaccharides from eggs of the family Phasianidae.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-301.html</link>
      <description> Related Articles Comprehensive analysis of N-linked oligosaccharides from eggs of the family Phasianidae. Biosci Biotechnol Biochem. 2010 Mar 23;74(3):606-13 Authors: Sumiyoshi W, Nakakita S, Hasehira K, Miyanishi N, Kubo Y, Kita T, Hirabayashi J We have reported a strategic procedure for the preparation of human-type N-linked oligosaccharides targeting hen egg white and yolk. To determine whether the technique is applicable to other avian species, we performed comparative analysis of N-linked  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-301.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Comprehensive analysis of N-linked oligosaccharides from eggs of the family Phasianidae. Biosci Biotechnol Biochem. 2010 Mar 23;74(3):606-13 Authors: Sumiyoshi W, Nakakita S, Hasehira K, Miyanishi N, Kubo Y, Kita T, Hirabayashi J We have reported a strategic procedure for the preparation of human-type N-linked oligosaccharides targeting hen egg white and yolk. To determine whether the technique is applicable to other avian species, we performed comparative analysis of N-linked oligosaccharides derived from eggs of other pheasant species. Our investigation of the principal oligosaccharides resulted in several major findings: (i) Glycan profiles as well as total yields were different between species and tissues (egg white and yolk). (ii) A common feature of egg white glycans is agalactosylated, hybrid-type, and complex-type oligosaccharides containing bisecting GlcNAc as major components. (iii) Egg yolk of pheasant species contained alpha2-6sialylated, biantennary complex-type oligosaccharides as major components. (iv) Egg yolk of Japanese pheasant and golden pheasant contained unusual persialylated oligosaccharides. Our results suggest that pheasant egg glycomes are significantly different from other avian species, although some common features are present. PMID: 20208342 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-291.html</link>
      <description> Related Articles Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res. 2010 Feb 15;70(4):1306-13 Authors: Wandall HH, Blixt O, Tarp MA, Pedersen JW, Bennett EP, Mandel U, Ragupathi G, Livingston PO, Hollingsworth MA, Taylor-Papadimitriou J, Burchell J, Clausen H Autoantibodies to cancer antigens hold promise as biomarkers for early detection of cancer. Proteins that are aberrantly processed in cancer cells are likely to present autoantibody target ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-291.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res. 2010 Feb 15;70(4):1306-13 Authors: Wandall HH, Blixt O, Tarp MA, Pedersen JW, Bennett EP, Mandel U, Ragupathi G, Livingston PO, Hollingsworth MA, Taylor-Papadimitriou J, Burchell J, Clausen H Autoantibodies to cancer antigens hold promise as biomarkers for early detection of cancer. Proteins that are aberrantly processed in cancer cells are likely to present autoantibody targets. The extracellular mucin MUC1 is overexpressed and aberrantly glycosylated in many cancers; thus, we evaluated whether autoantibodies generated to aberrant O-glycoforms of MUC1 might serve as sensitive diagnostic biomarkers for cancer. Using an antibody-based glycoprofiling ELISA assay, we documented that aberrant truncated glycoforms were not detected in sera of cancer patients. An O-glycopeptide microarray was developed that detected IgG antibodies to aberrant O-glycopeptide epitopes in patients vaccinated with a keyhole limpet hemocyanin-conjugated truncated MUC1 peptide. We detected cancer-associated IgG autoantibodies in sera from breast, ovarian, and prostate cancer patients against different aberrent O-glycopeptide epitopes derived from MUC1. These autoantibodies represent a previously unaddressed source of sensitive biomarkers for early detection of cancer. The methods we have developed for chemoenzymatic synthesis of O-glycopeptides on microarrays may allow for broader mining of the entire cancer O-glycopeptidome. PMID: 20124478 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Special Issue on Carbohydrate Recognition and Applications. Preface.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-299.html</link>
      <description> Related Articles Special Issue on Carbohydrate Recognition and Applications. Preface. Med Res Rev. 2010 Mar;30(2):169-70 Authors: Sun XL PMID: 20175191 [PubMed - indexed for MEDLINE]</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-299.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Special Issue on Carbohydrate Recognition and Applications. Preface. Med Res Rev. 2010 Mar;30(2):169-70 Authors: Sun XL  PMID: 20175191 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glyco-Forum section Obituary: Alan D. Elbein (1933-2009).</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-290.html</link>
      <description> Related Articles Glyco-Forum section Obituary: Alan D. Elbein (1933-2009). Glycobiology. 2010 Jan;20(4):404-5 Authors: Drake RR PMID: 20124191 [PubMed - indexed for MEDLINE]</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-290.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Glyco-Forum section Obituary: Alan D. Elbein (1933-2009). Glycobiology. 2010 Jan;20(4):404-5 Authors: Drake RR  PMID: 20124191 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Xyloglucan endotransglycosylases (XETs) from germinating nasturtium (Tropaeolum majus) seeds: isolation and characterization of the major form.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-297.html</link>
      <description> Related Articles Xyloglucan endotransglycosylases (XETs) from germinating nasturtium (Tropaeolum majus) seeds: isolation and characterization of the major form. Plant Physiol Biochem. 2010 Apr;48(4):207-15 Authors: Stratilov</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-297.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Xyloglucan endotransglycosylases (XETs) from germinating nasturtium (Tropaeolum majus) seeds: isolation and characterization of the major form. Plant Physiol Biochem. 2010 Apr;48(4):207-15 Authors: Stratilov
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Antibody-lectin sandwich arrays for biomarker and glycobiology studies.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-289.html</link>
      <description> Related Articles Antibody-lectin sandwich arrays for biomarker and glycobiology studies. Expert Rev Proteomics. 2010 Feb;7(1):9-11 Authors: Haab BB PMID: 20121469 [PubMed - indexed for MEDLINE]</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-289.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Antibody-lectin sandwich arrays for biomarker and glycobiology studies. Expert Rev Proteomics. 2010 Feb;7(1):9-11 Authors: Haab BB  PMID: 20121469 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>GlycoExtractor: a web-based interface for high throughput processing of HPLC-glycan data.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-295.html</link>
      <description> Related Articles GlycoExtractor: a web-based interface for high throughput processing of HPLC-glycan data. J Proteome Res. 2010 Apr 5;9(4):2037-41 Authors: Artemenko NV, Campbell MP, Rudd PM Recently, an automated high-throughput HPLC platform has been developed that can be used to fully sequence and quantify low concentrations of N-linked sugars released from glycoproteins, supported by an experimental database (GlycoBase) and analytical tools (autoGU). However, commercial packages that suppor ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-295.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles GlycoExtractor: a web-based interface for high throughput processing of HPLC-glycan data. J Proteome Res. 2010 Apr 5;9(4):2037-41 Authors: Artemenko NV, Campbell MP, Rudd PM Recently, an automated high-throughput HPLC platform has been developed that can be used to fully sequence and quantify low concentrations of N-linked sugars released from glycoproteins, supported by an experimental database (GlycoBase) and analytical tools (autoGU). However, commercial packages that support the operation of HPLC instruments and data storage lack platforms for the extraction of large volumes of data. The lack of resources and agreed formats in glycomics is now a major limiting factor that restricts the development of bioinformatic tools and automated workflows for high-throughput HPLC data analysis. GlycoExtractor is a web-based tool that interfaces with a commercial HPLC database/software solution to facilitate the extraction of large volumes of processed glycan profile data (peak number, peak areas, and glucose unit values). The tool allows the user to export a series of sample sets to a set of file formats (XML, JSON, and CSV) rather than a collection of disconnected files. This approach not only reduces the amount of manual refinement required to export data into a suitable format for data analysis but also opens the field to new approaches for high-throughput data interpretation and storage, including biomarker discovery and validation and monitoring of online bioprocessing conditions for next generation biotherapeutics. PMID: 20143869 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glycan and lectin microarrays for glycomics and medicinal applications.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-288.html</link>
      <description> Related Articles Glycan and lectin microarrays for glycomics and medicinal applications. Med Res Rev. 2010 Mar;30(2):394-418 Authors: Katrl</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-288.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Glycan and lectin microarrays for glycomics and medicinal applications. Med Res Rev. 2010 Mar;30(2):394-418 Authors: Katrl
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The phasevarion: phase variation of type III DNA methyltransferases controls coordinated switching in multiple genes.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-293.html</link>
      <description> Related Articles The phasevarion: phase variation of type III DNA methyltransferases controls coordinated switching in multiple genes. Nat Rev Microbiol. 2010 Mar;8(3):196-206 Authors: Srikhanta YN, Fox KL, Jennings MP In several host-adapted pathogens, phase variation has been found to occur in genes that encode methyltransferases associated with type III restriction-modification systems. It was recently shown that in the human pathogens Haemophilus influenzae, Neisseria gonorrhoeae and Neisse ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-293.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The phasevarion: phase variation of type III DNA methyltransferases controls coordinated switching in multiple genes. Nat Rev Microbiol. 2010 Mar;8(3):196-206 Authors: Srikhanta YN, Fox KL, Jennings MP In several host-adapted pathogens, phase variation has been found to occur in genes that encode methyltransferases associated with type III restriction-modification systems. It was recently shown that in the human pathogens Haemophilus influenzae, Neisseria gonorrhoeae and Neisseria meningitidis phase variation of a type III DNA methyltransferase, encoded by members of the mod gene family, regulates the expression of multiple genes. This novel genetic system has been termed the 'phasevarion' (phase-variable regulon). The wide distribution of phase-variable mod family genes indicates that this may be a common strategy used by host-adapted bacterial pathogens to randomly switch between distinct cell types. PMID: 20140025 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>N-glycomic changes in human breast carcinoma MCF-7 and T-lymphoblastoid cells after treatment with herceptin and herceptin/Lipoplex.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-287.html</link>
      <description> Related Articles N-glycomic changes in human breast carcinoma MCF-7 and T-lymphoblastoid cells after treatment with herceptin and herceptin/Lipoplex. J Proteome Res. 2010 Mar 5;9(3):1533-40 Authors: Lattov</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-287.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles N-glycomic changes in human breast carcinoma MCF-7 and T-lymphoblastoid cells after treatment with herceptin and herceptin/Lipoplex. J Proteome Res. 2010 Mar 5;9(3):1533-40 Authors: Lattov
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Software utilities for the interpretation of mass spectrometric data of glycoconjugates: application to glycosphingolipids of human serum.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-302.html</link>
      <description> Related Articles Software utilities for the interpretation of mass spectrometric data of glycoconjugates: application to glycosphingolipids of human serum. Rapid Commun Mass Spectrom. 2010 Apr 15;24(7):1039-48 Authors: Souady J, Dadimov D, Kirsch S, Bindila L, Peter-Katalini</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-302.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Software utilities for the interpretation of mass spectrometric data of glycoconjugates: application to glycosphingolipids of human serum. Rapid Commun Mass Spectrom. 2010 Apr 15;24(7):1039-48 Authors: Souady J, Dadimov D, Kirsch S, Bindila L, Peter-Katalini
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Akira Kobata: a man who established the structural basis for glycobiology of N-linked sugar chains.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-286.html</link>
      <description> Related Articles Akira Kobata: a man who established the structural basis for glycobiology of N-linked sugar chains. J Biochem. 2010 Jan;147(1):9-17 Authors: Endo T Akira Kobata is a pioneer of the glycobiology of N-linked sugar chains. He established the basis of glycobiology by developing a series of reliable methods to analyse the structures of N-linked sugar chains. The sensitive methods established by him greatly contributed to our understanding of the structural characteristics of the sug ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-286.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Akira Kobata: a man who established the structural basis for glycobiology of N-linked sugar chains. J Biochem. 2010 Jan;147(1):9-17 Authors: Endo T Akira Kobata is a pioneer of the glycobiology of N-linked sugar chains. He established the basis of glycobiology by developing a series of reliable methods to analyse the structures of N-linked sugar chains. The sensitive methods established by him greatly contributed to our understanding of the structural characteristics of the sugar chains and the biosynthetic mechanisms responsible for the production of such characteristics. He also provided new aspects that the sugar chains of glycoproteins play an important role in cell-to-cell recognition, and that the structures of sugar chains are altered under physiological and pathological conditions, including many tumours and diseases on a structural basis. In this article, the author would like to sketch out Kobata's main contributions to glycobiology for the sake of young scientists, who are planning to enter this scientific field in the future. PMID: 20051389 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Biochemical analysis of Lgt3, a glycosyltransferase of the bacterium Moraxella catarrhalis.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-298.html</link>
      <description> Related Articles Biochemical analysis of Lgt3, a glycosyltransferase of the bacterium Moraxella catarrhalis. Biochem Biophys Res Commun. 2010 Mar 19;393(4):609-13 Authors: Faglin I, Tiralongo J, Wilson JC, Collins PM, Peak IR The lipooligosaccharide (LOS) of Moraxella catarrhalis is unusual in that it lacks heptose. The sugar linking oligosaccharide to Lipid A is a trisubstituted glucose. A single enzyme, Lgt3, is suggested to trisubstitute this core sugar. The lgt3 gene encodes two distinct do ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-298.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Biochemical analysis of Lgt3, a glycosyltransferase of the bacterium Moraxella catarrhalis. Biochem Biophys Res Commun. 2010 Mar 19;393(4):609-13 Authors: Faglin I, Tiralongo J, Wilson JC, Collins PM, Peak IR The lipooligosaccharide (LOS) of Moraxella catarrhalis is unusual in that it lacks heptose. The sugar linking oligosaccharide to Lipid A is a trisubstituted glucose. A single enzyme, Lgt3, is suggested to trisubstitute this core sugar. The lgt3 gene encodes two distinct domains with high similarity to glucosyltransferases of the GT-A superfamily, thus encoding a bidomain, multifunctional glucosyltransferase. To characterise Lgt3, the gene was amplified from M. catarrhalis, expressed in Escherichia coli, and purified. Analysis of its glycosyltransferase catalytic activity ascertained the pH and temperature optima for Lgt3. The donor specificity and acceptor specificity were examined. This study confirms that Lgt3 is a glucosyltransferase which catalyses addition of glucose to its cognate receptor, a terminal glucose presented as the core region of LOS. PMID: 20153730 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-285.html</link>
      <description> Related Articles Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling. J Biol Chem. 2010 Feb 26;285(9):6515-21 Authors: Kitazume S, Imamaki R, Ogawa K, Komi Y, Futakawa S, Kojima S, Hashimoto Y, Marth JD, Paulson JC, Taniguchi N Antiangiogenesis therapies are now part of the standard repertoire of cancer therapies, but the mechanisms for the proliferation and survival of endothelial cells are not ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-285.html</guid>
        
      <content:encoded> <![CDATA[
       Related Articles Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling. J Biol Chem. 2010 Feb 26;285(9):6515-21 Authors: Kitazume S, Imamaki R, Ogawa K, Komi Y, Futakawa S, Kojima S, Hashimoto Y, Marth JD, Paulson JC, Taniguchi N Antiangiogenesis therapies are now part of the standard repertoire of cancer therapies, but the mechanisms for the proliferation and survival of endothelial cells are not fully understood. Although endothelial cells are covered with a glycocalyx, little is known about how endothelial glycosylation regulates endothelial functions. Here, we show that alpha2,6-sialic acid is necessary for the cell-surface residency of platelet endothelial cell adhesion molecule (PECAM), a member of the immunoglobulin superfamily that plays multiple roles in cell adhesion, mechanical stress sensing, antiapoptosis, and angiogenesis. As a possible underlying mechanism, we found that the homophilic interactions of PECAM in endothelial cells were dependent on alpha2,6-sialic acid. We also found that the absence of alpha2,6-sialic acid down-regulated the tyrosine phosphorylation of PECAM and recruitment of Src homology 2 domain-containing protein-tyrosine phosphatase 2 and rendered the cells more prone to mitochondrion-dependent apoptosis, as evaluated using PECAM- deficient endothelial cells. The present findings open up a new possibility that modulation of glycosylation could be one of the promising strategies for regulating angiogenesis. PMID: 20048157 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The promise of glycomics, glycan arrays and carbohydrate-based vaccines.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-294.html</link>
      <description> Related Articles The promise of glycomics, glycan arrays and carbohydrate-based vaccines. Immunopharmacol Immunotoxicol. 2010 Jun;32(2):196-207 Authors: Lepenies B, Seeberger PH Carbohydrates and glycoconjugates are involved in a number of biological processes including host-pathogen interactions, cell communication, proliferation and differentiation as well as the initiation of immune responses. However, access to synthetic oligosaccharide structures has been limited for long time since no sta ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-294.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The promise of glycomics, glycan arrays and carbohydrate-based vaccines. Immunopharmacol Immunotoxicol. 2010 Jun;32(2):196-207 Authors: Lepenies B, Seeberger PH Carbohydrates and glycoconjugates are involved in a number of biological processes including host-pathogen interactions, cell communication, proliferation and differentiation as well as the initiation of immune responses. However, access to synthetic oligosaccharide structures has been limited for long time since no standardized protocols for the synthesis of complex oligosaccharides from monomeric building block existed. Recent advances in glycochemistry and glycobiology have helped elucidate biological functions of carbohydrates. Novel methods such as automated synthesis of vaccine candidates and immunologically relevant carbohydrates have contributed to this success as well as high-throughput methods such as glycan arrays. This review illustrates the impact of carbohydrate synthesis on the design of efficient carbohydrate-based antimicrobial and anticancer vaccines. Furthermore, this review focuses on how immunological research can benefit from these novel tools provided by glycochemistry. PMID: 20141495 [PubMed - in process]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Isolation of bioactive compounds that relate to the anti-platelet activity of Cymbopogon ambiguus.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-284.html</link>
      <description> Related Articles Isolation of bioactive compounds that relate to the anti-platelet activity of Cymbopogon ambiguus. Evid Based Complement Alternat Med. 2010 Jan 4; Authors: Grice ID, Rogers KL, Griffiths LR Infusions and decoctions of Cymbopogon ambiguus have been used traditionally in Australia for the treatment of headache, chest infections and muscle cramps. The aim of the present study was to screen and identify bioactive compounds from C. ambiguus that could explain this plant&apos;s anti-heada ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-284.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Isolation of bioactive compounds that relate to the anti-platelet activity of Cymbopogon ambiguus. Evid Based Complement Alternat Med. 2010 Jan 4; Authors: Grice ID, Rogers KL, Griffiths LR Infusions and decoctions of Cymbopogon ambiguus have been used traditionally in Australia for the treatment of headache, chest infections and muscle cramps. The aim of the present study was to screen and identify bioactive compounds from C. ambiguus that could explain this plant's anti-headache activity. A dichloromethane extract of C. ambiguus was identified as having activity in adenosine-diphosphate-induced human platelet aggregation and serotonin-release inhibition bioassays. Subsequent fractionation of this extract led to the isolation of four phenylpropenoids, eugenol, elemicin, eugenol methylether and trans-isoelemicin. While both eugenol and elemicin exhibited dose-dependent inhibition of ADP-induced human platelet serotonin release, only eugenol displayed potent inhibitory activity with an IC(50) value of 46.6 microM, in comparison to aspirin, with an IC(50) value of 46.1 microM. These findings provide evidence to support the therapeutic efficacy of C. ambiguus in the non-conventional treatment of headache and inflammatory conditions. PMID: 20047890 [PubMed - as supplied by publisher]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A weighted q-gram method for glycan structure classification.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-300.html</link>
      <description> Related Articles A weighted q-gram method for glycan structure classification. BMC Bioinformatics. 2010;11 Suppl 1:S33 Authors: Li L, Ching WK, Yamaguchi T, Aoki-Kinoshita KF BACKGROUND: Glycobiology pertains to the study of carbohydrate sugar chains, or glycans, in a particular cell or organism. Many computational approaches have been proposed for analyzing these complex glycan structures, which are chains of monosaccharides. The monosaccharides are linked to one another by glycosidic bonds, w ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-300.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles A weighted q-gram method for glycan structure classification. BMC Bioinformatics. 2010;11 Suppl 1:S33 Authors: Li L, Ching WK, Yamaguchi T, Aoki-Kinoshita KF BACKGROUND: Glycobiology pertains to the study of carbohydrate sugar chains, or glycans, in a particular cell or organism. Many computational approaches have been proposed for analyzing these complex glycan structures, which are chains of monosaccharides. The monosaccharides are linked to one another by glycosidic bonds, which can take on a variety of comformations, thus forming branches and resulting in complex tree structures. The q-gram method is one of these recent methods used to understand glycan function based on the classification of their tree structures. This q-gram method assumes that for a certain q, different q-grams share no similarity among themselves. That is, that if two structures have completely different components, then they are completely different. However, from a biological standpoint, this is not the case. In this paper, we propose a weighted q-gram method to measure the similarity among glycans by incorporating the similarity of the geometric structures, monosaccharides and glycosidic bonds among q-grams. In contrast to the traditional q-gram method, our weighted q-gram method admits similarity among q-grams for a certain q. Thus our new kernels for glycan structure were developed and then applied in SVMs to classify glycans. RESULTS: Two glycan datasets were used to compare the weighted q-gram method and the original q-gram method. The results show that the incorporation of q-gram similarity improves the classification performance for all of the important glycan classes tested. CONCLUSION: The results in this paper indicate that similarity among q-grams obtained from geometric structure, monosaccharides and glycosidic linkage contributes to the glycan function classification. This is a big step towards the understanding of glycan function based on their complex structures. PMID: 20122206 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>N-Glycosylation profiling of turtle egg yolk: expression of galabiose structure.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-283.html</link>
      <description> Related Articles N-Glycosylation profiling of turtle egg yolk: expression of galabiose structure. Carbohydr Res. 2010 Feb 11;345(3):442-8 Authors: Yagi H, Yamamoto M, Yu SY, Takahashi N, Khoo KH, Lee YC, Kato K To understand the roles of species-specific carbohydrates, systematic studies of interspecific glycan analyses are imperative. An extensive series of glycomics studies on approximately 180 kinds of bird eggs have demonstrated that 60-70% of the birds, which are closely related in phyloge ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-283.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles N-Glycosylation profiling of turtle egg yolk: expression of galabiose structure. Carbohydr Res. 2010 Feb 11;345(3):442-8 Authors: Yagi H, Yamamoto M, Yu SY, Takahashi N, Khoo KH, Lee YC, Kato K To understand the roles of species-specific carbohydrates, systematic studies of interspecific glycan analyses are imperative. An extensive series of glycomics studies on approximately 180 kinds of bird eggs have demonstrated that 60-70% of the birds, which are closely related in phylogeny, express the alpha-Galp-(1-->4)-Galp structure on their egg glycoproteins. This prompted us to investigate the glycosylation profiles of eggs from an evolutionarily related organism, a sea turtle (reptilian). We performed N-glycosylation profiling of turtle egg yolk by using HPLC mapping in conjunction with mass spectrometric methods and thereby demonstrated that the alpha-Galp-(1-->4)-Galp groups are displayed on approximately 38% of total N-glycans. Our findings suggest that the ability to express the galabiose structure was acquired at an early stage of diversification in amniotes. PMID: 20044081 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Comparative glycomics using a tetraplex stable-isotope coded tag.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-304.html</link>
      <description> Related Articles Comparative glycomics using a tetraplex stable-isotope coded tag. Anal Chem. 2010 Apr 1;82(7):3023-31 Authors: Bowman MJ, Zaia J This study illustrates the utility of tetraplex stable isotope coded tags in mass spectrometric glycomics using three carbohydrate classes. The teteraplex tags allow for the direct comparison of glycan compositions within four samples using capillary scale hydrophilic interaction chromatography with online mass spectrometry. In addition, the ability t ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-304.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Comparative glycomics using a tetraplex stable-isotope coded tag. Anal Chem. 2010 Apr 1;82(7):3023-31 Authors: Bowman MJ, Zaia J This study illustrates the utility of tetraplex stable isotope coded tags in mass spectrometric glycomics using three carbohydrate classes. The teteraplex tags allow for the direct comparison of glycan compositions within four samples using capillary scale hydrophilic interaction chromatography with online mass spectrometry. In addition, the ability to discern glycan structural isomers is shown based on the tandem mass spectra of each composition using nanospray ionization. Results are shown for chondroitin sulfate proteoglycans, low molecular weight heparins, full length heparins, and N-glycans from alpha-1-acid glycoproteins from four mammalian species. The data demonstrate the value of the tetraplex stable isotope tagging approach for producing high-quality glycomics compositional profiling and fine structural analysis. PMID: 20230064 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-282.html</link>
      <description> Related Articles Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics. 2010 Apr;9(4):719-27 Authors: Wada Y, Dell A, Haslam SM, Tissot B, Canis K, Azadi P, B</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-282.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics. 2010 Apr;9(4):719-27 Authors: Wada Y, Dell A, Haslam SM, Tissot B, Canis K, Azadi P, B
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Never take candy from a stranger: the role of the bacterial glycome in host-pathogen interactions.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-296.html</link>
      <description>Related Articles Never take candy from a stranger: the role of the bacterial glycome in host-pathogen interactions. Future Microbiol. 2010 Feb;5(2):267-88 Authors: Reid CW, Fulton KM, Twine SM With the comprehensive study and complete sequencing of the Haemophilus influenzae genome in 1995 came the term &apos;genomics&apos; and the beginning of the &apos;omics&apos; era. Since this time, several analogous fields, such as transcriptomics and proteomics, have emerged. While growth and advancement in these fields have ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-296.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Never take candy from a stranger: the role of the bacterial glycome in host-pathogen interactions. Future Microbiol. 2010 Feb;5(2):267-88 Authors: Reid CW, Fulton KM, Twine SM With the comprehensive study and complete sequencing of the Haemophilus influenzae genome in 1995 came the term 'genomics' and the beginning of the 'omics' era. Since this time, several analogous fields, such as transcriptomics and proteomics, have emerged. While growth and advancement in these fields have increased understanding of microbial virulence, the study of bacterial glycomes is still in its infancy and little is known concerning their role in host-pathogen interactions. Bacterial glycomics is challenging owing to the diversity of glyco-conjugate molecules, vast array of unusual sugars and limited number of analytical approaches available. However, recent advances in glycomics technologies offer the potential for exploration and characterization of both the structures and functions of components of bacterial glycomes in a systematic manner. Such characterization is a prerequisite for discerning the role of bacterial glycans in the interaction between host defences and bacterial virulence factors. PMID: 20143949 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification and characterization of the aspartate chemosensory receptor of Campylobacter jejuni.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-281.html</link>
      <description> Related Articles Identification and characterization of the aspartate chemosensory receptor of Campylobacter jejuni. Mol Microbiol. 2010 Feb;75(3):710-30 Authors: Hartley-Tassell LE, Shewell LK, Day CJ, Wilson JC, Sandhu R, Ketley JM, Korolik V Campylobacter jejuni is a highly motile bacterium that responds via chemotaxis to environmental stimuli to migrate towards favourable conditions. Previous in silico analysis of the C. jejuni strain NCTC11168 genome sequence identified 10 open reading fra ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-281.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Identification and characterization of the aspartate chemosensory receptor of Campylobacter jejuni. Mol Microbiol. 2010 Feb;75(3):710-30 Authors: Hartley-Tassell LE, Shewell LK, Day CJ, Wilson JC, Sandhu R, Ketley JM, Korolik V Campylobacter jejuni is a highly motile bacterium that responds via chemotaxis to environmental stimuli to migrate towards favourable conditions. Previous in silico analysis of the C. jejuni strain NCTC11168 genome sequence identified 10 open reading frames, tlp1-10, that encode putative chemosensory receptors. We describe the characterization of the role and specificity of the Tlp1 chemoreceptor (Cj1506c). In vitro and in vivo models were used to determine if Tlp1 had a role in host colonization. The tlp1(-) isogenic mutant was more adherent in cell culture, however, showed reduced colonization ability in chickens. Specific interactions between the purified sensory domain of Tlp1 and l-aspartate were identified using an amino acid array and saturation transfer difference nuclear magnetic resonance spectroscopy. Chemotaxis assays showed differences between migration of wild-type C. jejuni cells and that of a tlp1(-) isogenic mutant, specifically towards aspartate. Furthermore, using yeast two-hybrid and three-hybrid systems for analysis of protein-protein interactions, the cytoplasmic signalling domain of Tlp1 was found to preferentially interact with CheV, rather than the CheW homologue of the chemotaxis signalling pathway; this interaction was confirmed using immune precipitation assays. This is the first identification of an aspartate receptor in bacteria other than Escherichia coli and Salmonella enterica serovar Typhimurium. PMID: 20025667 [PubMed - in process]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Sequential enrichment of sulfated glycans by strong anion-exchange chromatography prior to mass spectrometric measurements.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-279.html</link>
      <description> Related Articles Sequential enrichment of sulfated glycans by strong anion-exchange chromatography prior to mass spectrometric measurements. J Am Soc Mass Spectrom. 2010 Mar;21(3):348-57 Authors: Lei M, Novotny MV, Mechref Y Structural characterization of sulfated glycans through mass spectrometry (MS) has been often limited by their low abundance in biological materials and inefficient ionization in the positive-ion mode. Here, we describe a microscale method for sequentially enriching sulfate ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-279.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Sequential enrichment of sulfated glycans by strong anion-exchange chromatography prior to mass spectrometric measurements. J Am Soc Mass Spectrom. 2010 Mar;21(3):348-57 Authors: Lei M, Novotny MV, Mechref Y Structural characterization of sulfated glycans through mass spectrometry (MS) has been often limited by their low abundance in biological materials and inefficient ionization in the positive-ion mode. Here, we describe a microscale method for sequentially enriching sulfated glycans according to their degree of sulfation. This method is based on modifying the binding ability of strong anion-exchange material through the use of different sodium acetate concentrations, thus enabling fairly selective binding and a subsequent elution of different glycans according to their degree of sulfation. Before this enrichment, the negative charge on the sialic acid, which is commonly associated with such glycans, was eliminated through permethylation that is used to enhance the positive-ion mode matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-MS) signal for all glycans. This enrichment approach minimizes competitive ionization between sulfated and neutral glycans, as well as that between sulfated species with a different degree of sulfation. The described method was initially optimized using sulfated oligosaccharide standards, while its potential has been verified for the sulfated N-glycans originated from the bovine thyroid-stimulating hormone (bTSH), a glycoprotein possessing mono- and disulfated N-glycans. This enhancement of the MALDI-MS signal facilitates analysis of some otherwise undetected components. PMID: 20022260 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Profiling LPS glycoforms of non-typeable Haemophilus influenzae by multiple-stage tandem mass spectrometry.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-255.html</link>
      <description> Related Articles Profiling LPS glycoforms of non-typeable Haemophilus influenzae by multiple-stage tandem mass spectrometry. Methods Mol Biol. 2010;600:79-92 Authors: Schweda EK, Richards JC Non-typeable (acapsular) Haemophilus influenzae (NTHi) is a major cause of otitis media accounting for 25-30% of all cases of the disease. Lipopolysaccharide (LPS) is an essential and exposed component of the H. influenzae cell wall. A characteristic feature of H. influenzae LPS is the extensive inter-strai ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:17 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-255.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Profiling LPS glycoforms of non-typeable Haemophilus influenzae by multiple-stage tandem mass spectrometry. Methods Mol Biol. 2010;600:79-92 Authors: Schweda EK, Richards JC Non-typeable (acapsular) Haemophilus influenzae (NTHi) is a major cause of otitis media accounting for 25-30% of all cases of the disease. Lipopolysaccharide (LPS) is an essential and exposed component of the H. influenzae cell wall. A characteristic feature of H. influenzae LPS is the extensive inter-strain and intra-strain heterogeneity of glycoform structure which is key to the role of the molecule in both commensal and disease-causing behavior of the bacterium. However, to characterize LPS structure unambiguously is a major challenge due to the extreme heterogeneity of glycoforms that certain strains express. A powerful tool for obtaining sequence and branching information is multiple-stage tandem ESI-MS (ESI-MS( n )) performed on dephosphorylated and permethylated oligosaccharide material using an ESI-quadrupole ion trap mass spectrometer. In general, permethylation increases the MS response by several orders of magnitude and sequence information is readily obtained since methyl tagging allows the distinction between fragment ions generated by cleavage of a single glycosidic bond and inner fragments resulting from the rupture of two glycosidic linkages. Using this approach we are now able to identify all isomeric glycoforms in very heterogeneous LPS preparations. PMID: 19882122 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Threshold in stage-specific embryonic glycotypes uncovered by a full portrait of dynamic N-glycan expression during cell differentiation.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-277.html</link>
      <description> Related Articles Threshold in stage-specific embryonic glycotypes uncovered by a full portrait of dynamic N-glycan expression during cell differentiation. Mol Cell Proteomics. 2010 Mar;9(3):523-37 Authors: Amano M, Yamaguchi M, Takegawa Y, Yamashita T, Terashima M, Furukawa J, Miura Y, Shinohara Y, Iwasaki N, Minami A, Nishimura S Although various glycoforms appear to participate independently in multiple molecular interactions in cellular adhesion that contribute to embryogenesis and organogen ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-277.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Threshold in stage-specific embryonic glycotypes uncovered by a full portrait of dynamic N-glycan expression during cell differentiation. Mol Cell Proteomics. 2010 Mar;9(3):523-37 Authors: Amano M, Yamaguchi M, Takegawa Y, Yamashita T, Terashima M, Furukawa J, Miura Y, Shinohara Y, Iwasaki N, Minami A, Nishimura S Although various glycoforms appear to participate independently in multiple molecular interactions in cellular adhesion that contribute to embryogenesis and organogenesis, a full portrait of the glycome diversity and the effect of the structural variations of cellular glycoforms on individual cell stages in proliferation and differentiation remain unclear. Here we describe a novel concept for the characterization of dynamic glycoform alteration during cell differentiation by means of "glycoblotting-based cellular glycomics," the only method allowing for rapid and quantitative glycan analysis. We demonstrated that processes of dynamic cellular differentiation of mouse embryonic carcinoma cells, P19CL6 and P19C6, and mouse embryonic stem cells into cardiomyocytes or neural cells can be monitored and characterized quantitatively by profiling entire N-glycan structures of total cell glycoproteins. Whole N-glycans enriched and identified by the glycoblotting method (67 glycans for P19CL6, 75 glycans for P19C6, and 72 glycans for embryonic stem cells) were profiled and bar-coded quantitatively with respect to the ratio of subgroups composed of characteristic glycoforms, namely glycotypes. PMID: 20008832 [PubMed - in process]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Quantitative glycomics.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-254.html</link>
      <description> Related Articles Quantitative glycomics. Methods Mol Biol. 2010;600:31-49 Authors: Orlando R The ability to quantitatively determine changes is an essential component of comparative glycomics. Multiple strategies are available by which this can be accomplished. These include label-free approaches and strategies where an isotopic label is incorporated into the glycans prior to analysis. The focus of this chapter is to describe each of these approaches while providing insight into their strengths ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-254.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Quantitative glycomics. Methods Mol Biol. 2010;600:31-49 Authors: Orlando R The ability to quantitatively determine changes is an essential component of comparative glycomics. Multiple strategies are available by which this can be accomplished. These include label-free approaches and strategies where an isotopic label is incorporated into the glycans prior to analysis. The focus of this chapter is to describe each of these approaches while providing insight into their strengths and weaknesses, so that glycomic investigators can make an educated choice of the strategy that is best suited for their particular application. PMID: 19882119 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Neisseria meningitidis serogroup B polysialyltransferase: insights into substrate binding.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-275.html</link>
      <description> Related Articles Neisseria meningitidis serogroup B polysialyltransferase: insights into substrate binding. Chembiochem. 2010 Jan 25;11(2):170-4 Authors: B</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-275.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Neisseria meningitidis serogroup B polysialyltransferase: insights into substrate binding. Chembiochem. 2010 Jan 25;11(2):170-4 Authors: B
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Historical overview of glycoanalysis.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-253.html</link>
      <description> Related Articles Historical overview of glycoanalysis. Methods Mol Biol. 2010;600:9-30 Authors: Bielik AM, Zaia J More than half of all human proteins are glycosylated. Glycosylation defines the adhesive properties of glycoconjugates and it is largely through glycan-protein interactions that cell-cell and cell-pathogen contacts occur. Not surprisingly, considering the central role they play in molecular encounters, glycoprotein and carbohydrate-based drugs and therapeutics represent a greater t ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-253.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Historical overview of glycoanalysis. Methods Mol Biol. 2010;600:9-30 Authors: Bielik AM, Zaia J More than half of all human proteins are glycosylated. Glycosylation defines the adhesive properties of glycoconjugates and it is largely through glycan-protein interactions that cell-cell and cell-pathogen contacts occur. Not surprisingly, considering the central role they play in molecular encounters, glycoprotein and carbohydrate-based drugs and therapeutics represent a greater than $20 billion market. Glycomics, the study of glycan expression in biological systems, relies on effective analytical techniques for correlation of glycan structure with function. This overview summarizes techniques developed historically for glycan characterization as well as recent trends. Derivatization methods key to both traditional and modern approaches for glycoanalysis are described. Monosaccharide compositional analysis is fundamental to any effort to understand glycan structure-function relationships. Chromatographic and electrophoretic separations are key parts of any glycoanalytical workflow. Mass spectrometry and nuclear magnetic resonance are complementary instrumental techniques for glycan analysis. Finally, microarrays are emerging as powerful new tools for dynamic analysis of glycan expression. PMID: 19882118 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glycomics profiling of Chinese hamster ovary cell glycosylation mutants reveals N-glycans of a novel size and complexity.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-273.html</link>
      <description> Related Articles Glycomics profiling of Chinese hamster ovary cell glycosylation mutants reveals N-glycans of a novel size and complexity. J Biol Chem. 2010 Feb 19;285(8):5759-75 Authors: North SJ, Huang HH, Sundaram S, Jang-Lee J, Etienne AT, Trollope A, Chalabi S, Dell A, Stanley P, Haslam SM Identifying biological roles for mammalian glycans and the pathways by which they are synthesized has been greatly facilitated by investigations of glycosylation mutants of cultured cell lines and model  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-273.html</guid>
        
      <content:encoded> <![CDATA[
       Related Articles Glycomics profiling of Chinese hamster ovary cell glycosylation mutants reveals N-glycans of a novel size and complexity. J Biol Chem. 2010 Feb 19;285(8):5759-75 Authors: North SJ, Huang HH, Sundaram S, Jang-Lee J, Etienne AT, Trollope A, Chalabi S, Dell A, Stanley P, Haslam SM Identifying biological roles for mammalian glycans and the pathways by which they are synthesized has been greatly facilitated by investigations of glycosylation mutants of cultured cell lines and model organisms. Chinese hamster ovary (CHO) glycosylation mutants isolated on the basis of their lectin resistance have been particularly useful for glycosylation engineering of recombinant glycoproteins. To further enhance the application of these mutants, and to obtain insights into the effects of altering one specific glycosyltransferase or glycosylation activity on the overall expression of cellular glycans, an analysis of the N-glycans and major O-glycans of a panel of CHO mutants was performed using glycomic analyses anchored by matrix-assisted laser desorption ionization-time of flight/time of flight mass spectrometry. We report here the complement of the major N-glycans and O-glycans present in nine distinct CHO glycosylation mutants. Parent CHO cells grown in monolayer versus suspension culture had similar profiles of N- and O-GalNAc glycans, although the profiles of glycosylation mutants Lec1, Lec2, Lec3.2.8.1, Lec4, LEC10, LEC11, LEC12, Lec13, and LEC30 were consistent with available genetic and biochemical data. However, the complexity of the range of N-glycans observed was unexpected. Several of the complex N-glycan profiles contained structures of m/z approximately 13,000 representing complex N-glycans with a total of 26 N-acetyllactosamine (Gal beta1-4GlcNAc)(n) units. Importantly, the LEC11, LEC12, and LEC30 CHO mutants exhibited unique complements of fucosylated complex N-glycans terminating in Lewis(x) and sialyl-Lewis(x) determinants. This analysis reveals the larger-than-expected complexity of N-glycans in CHO cell mutants that may be used in a broad variety of functional glycomics studies and for making recombinant glycoproteins. PMID: 19951948 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Functional glycomics and glycobiology: an overview.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-252.html</link>
      <description> Related Articles Functional glycomics and glycobiology: an overview. Methods Mol Biol. 2010;600:1-8 Authors: Li J, Richards JC Glycomics is the study of the biological role of glycans and glycoconjugates, including glycoproteins, glycolipids, proteoglycans, and of protein-glycan interactions. This chapter outlines the scope of functional glycomics, from biological/biomedical significance to technology development. PMID: 19882117 [PubMed - indexed for MEDLINE]</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-252.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Functional glycomics and glycobiology: an overview. Methods Mol Biol. 2010;600:1-8 Authors: Li J, Richards JC Glycomics is the study of the biological role of glycans and glycoconjugates, including glycoproteins, glycolipids, proteoglycans, and of protein-glycan interactions. This chapter outlines the scope of functional glycomics, from biological/biomedical significance to technology development. PMID: 19882117 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A comprehensive HPLC analytical system for the identification and quantification of hexoses that employs 2-aminobenzamide coupling.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-271.html</link>
      <description> Related Articles A comprehensive HPLC analytical system for the identification and quantification of hexoses that employs 2-aminobenzamide coupling. J Biochem. 2010 Apr;147(4):501-9 Authors: Hasehira K, Nakakita S, Miyanishi N, Sumiyoshi W, Hayashi S, Takegawa K, Hirabayashi J Rare sugars are defined as monosaccharides with extremely low natural abundances. Their natural distributions and biological functions remain to be clarified. To establish a robust analytical system that can separate, ide ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-271.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles A comprehensive HPLC analytical system for the identification and quantification of hexoses that employs 2-aminobenzamide coupling. J Biochem. 2010 Apr;147(4):501-9 Authors: Hasehira K, Nakakita S, Miyanishi N, Sumiyoshi W, Hayashi S, Takegawa K, Hirabayashi J Rare sugars are defined as monosaccharides with extremely low natural abundances. Their natural distributions and biological functions remain to be clarified. To establish a robust analytical system that can separate, identify and quantify rare sugars, 12 d-hexoses-including five rare aldohexoses and three rare ketohexoses-were labelled with 2-aminobenzamide (2-AB), and the fluorescently tagged monosaccharides were separated by high-performance liquid chromatography (HPLC). Because the ketohexoses were much less reactive than were the aldohexoses, the reaction conditions were optimized to achieve the maximum yields (>75%) for both aldohexoses and ketohexoses. The calibration curve determined for the rare ketohexose, d-psicose (Psi), was linear between 1 pmol and 1 micromol and had a correlation coefficient of 0.9999. Using the developed method, the psicose content in a leaf of Itea virginica, in which the presence of psicose has previously been reported, was found to be 2.7 mg psicose/g leaf. The result proved feasibility of the method even for natural products. Because the system is a comprehensive tool, it should help answer questions concerning the biosyntheses and functions of rare hexose sugars. PMID: 19948774 [PubMed - in process]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-251.html</link>
      <description> Related Articles The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs. J Thromb Haemost. 2010 Jan;8(1):137-45 Authors: Canis K, McKinnon TA, Nowak A, Panico M, Morris HR, Laffan M, Dell A BACKGROUND: von Willebrand factor (VWF) is a key component for maintenance of normal hemostasis. Its glycan moieties, accounting for about 20% of its molecular weight, have been shown to affect many of its properties. Previous stud ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-251.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs. J Thromb Haemost. 2010 Jan;8(1):137-45 Authors: Canis K, McKinnon TA, Nowak A, Panico M, Morris HR, Laffan M, Dell A BACKGROUND: von Willebrand factor (VWF) is a key component for maintenance of normal hemostasis. Its glycan moieties, accounting for about 20% of its molecular weight, have been shown to affect many of its properties. Previous studies reported correlations between VWF secretion, half-life and the nature or presence of its N-glycans, and more importantly between VWF plasma level and the type of N-linked ABH antigens. Despite the presence of 10 predicted O-glycosylation sites, the O-glycome remains poorly characterized, impairing the complete elucidation of its influence on VWF functions. So far only a single glycan structure, a disialyl core 1 glycan, has been identified. OBJECTIVES: To define an exhaustive profile of the VWF O-glycan structures to help the understanding of their role in VWF regulation and properties. METHODS: Plasma-derived VWF O-linked sugars were isolated and analyzed using state-of-the-art mass spectrometry methodologies. RESULTS AND CONCLUSIONS: We provide here a detailed analysis of the human plasma-derived VWF O-glycome. Eighteen O-glycan structures including both core 1 and core 2 structures are now demonstrated to be present on VWF. Amongst the newly determined structures are unusual tetra-sialylated core 1 O-glycans and ABH antigen-containing core 2 O-glycans. In conjunction with current models explaining VWF activity, knowledge of the complete O-glycome will facilitate research aimed at providing a better understanding of the influence of glycosylation on VWF functions. PMID: 19874459 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Chemo-enzymatic synthesis and functional analysis of natural and modified glycostructures.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-269.html</link>
      <description> Related Articles Chemo-enzymatic synthesis and functional analysis of natural and modified glycostructures. Nat Prod Rep. 2009 Dec;26(12):1555-71 Authors: Homann A, Seibel J The advancing field of glycomics is driven by the development of new analysis and synthesis techniques and novel strategies such as metabolic glyco-labeling. In this review we will present strategies for tailoring chemo-enzymatic glycosyltransfer reactions, screening methods such as carbohydrate-based micro-arrays, and meta ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-269.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Chemo-enzymatic synthesis and functional analysis of natural and modified glycostructures. Nat Prod Rep. 2009 Dec;26(12):1555-71 Authors: Homann A, Seibel J The advancing field of glycomics is driven by the development of new analysis and synthesis techniques and novel strategies such as metabolic glyco-labeling. In this review we will present strategies for tailoring chemo-enzymatic glycosyltransfer reactions, screening methods such as carbohydrate-based micro-arrays, and metabolic glyco-engineering as a strategy to visualize biological recognition processes for the development of carbohydrate-based vaccines. PMID: 19936386 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Phenylenediamine-based bivalent glycocyclophanes: synthesis and analysis of the influence of scaffold rigidity and ligand spacing on lectin binding in cell systems with different glycomic profiles.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-250.html</link>
      <description> Related Articles Phenylenediamine-based bivalent glycocyclophanes: synthesis and analysis of the influence of scaffold rigidity and ligand spacing on lectin binding in cell systems with different glycomic profiles. Org Biomol Chem. 2009 Nov 21;7(22):4715-25 Authors: Andr</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-250.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Phenylenediamine-based bivalent glycocyclophanes: synthesis and analysis of the influence of scaffold rigidity and ligand spacing on lectin binding in cell systems with different glycomic profiles. Org Biomol Chem. 2009 Nov 21;7(22):4715-25 Authors: Andr
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-267.html</link>
      <description> Related Articles A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics. FEBS J. 2010 Jan;277(1):95-105 Authors: Narimatsu H, Sawaki H, Kuno A, Kaji H, Ito H, Ikehara Y Detection of cancer at early stages that can be treated through surgery is a difficult task. One methodology for cancer biomarker discovery exploits the fact that glycoproteins produced by cancer cells have altered glycan structures, although the proteins themselves ar ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-267.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics. FEBS J. 2010 Jan;277(1):95-105 Authors: Narimatsu H, Sawaki H, Kuno A, Kaji H, Ito H, Ikehara Y Detection of cancer at early stages that can be treated through surgery is a difficult task. One methodology for cancer biomarker discovery exploits the fact that glycoproteins produced by cancer cells have altered glycan structures, although the proteins themselves are common, ubiquitous, abundant, and familiar. However, as cancer tissue at the early stage probably constitutes less than 1% of the normal tissue in the relevant organ, only 1% of the relevant glycoproteins in the serum should have altered glycan structures. Here, we describe our strategy to approach the detection of these low-level glycoproteins: (a) a quantitative real-time PCR array for glycogenes to predict the glycan structures of secreted glycoproteins; (b) analysis by lectin microarray to select lectins that distinguish cancer-related glycan structures on secreted glycoproteins; and (c) an isotope-coded glycosylation site-specific tagging high-throughput method to identify carrier proteins with the specific lectin epitope. Using this strategy, we have identified many glycoproteins containing glycan structures that are altered in cancer cells. These candidate glycoproteins were immunoprecipitated from serum using commercially available antibodies, and their glycan alteration was examined by a lectin microarray. Finally, they were analyzed by multistage tandem MS. PMID: 19919546 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Characterisation of oxidized recombinant human galectin-1.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-249.html</link>
      <description>Related Articles Characterisation of oxidized recombinant human galectin-1. Protein Pept Lett. 2009;16(10):1249-55 Authors: Scott SA, Bugarcic A, Blanchard H Oxidized human galectin-1 plays a role in the immune response to injured axons. Over-expression of galectin-1 by cancer, in combination with cancer associated oxidative stress suggests oxidized human galectin-1 may also play a role(s) in tumourigenesis. Here we generate milligram quantities of oxidized human galectin-1 and undertake biophys ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-249.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Characterisation of oxidized recombinant human galectin-1. Protein Pept Lett. 2009;16(10):1249-55 Authors: Scott SA, Bugarcic A, Blanchard H Oxidized human galectin-1 plays a role in the immune response to injured axons. Over-expression of galectin-1 by cancer, in combination with cancer associated oxidative stress suggests oxidized human galectin-1 may also play a role(s) in tumourigenesis. Here we generate milligram quantities of oxidized human galectin-1 and undertake biophysical characterization. The protein adopts a number of different states. Two separable oxidized forms are identified that exist as largely mono-disperse solutions at higher milligram/ml concentrations. The presence of disulphide bonds is confirmed for these two protein forms, as is their change in overall shape and loss of lectin activity. Our studies lead to production of a particular mono-disperse oxidized human galectin-1 species that is anticipated most optimal for investigations requiring milligram/ml concentrations such as X-ray crystallography. PMID: 19860718 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Photoimmobilization of unmodified carbohydrates on activated surface.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-265.html</link>
      <description> Related Articles Photoimmobilization of unmodified carbohydrates on activated surface. J Colloid Interface Sci. 2010 Feb 1;342(1):202-4 Authors: Sharma P, Basir SF, Nahar P Herein, we demonstrate a simple, versatile and efficient method for immobilization of unmodified carbohydrates onto a solid surface. The method employs a photoreactive-cellulose membrane which is prepared by the introduction of a photoreactive group to a cellulose membrane through 1-fluoro-2-nitro-4-azidobenzene (FNAB). Upon ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-265.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Photoimmobilization of unmodified carbohydrates on activated surface. J Colloid Interface Sci. 2010 Feb 1;342(1):202-4 Authors: Sharma P, Basir SF, Nahar P Herein, we demonstrate a simple, versatile and efficient method for immobilization of unmodified carbohydrates onto a solid surface. The method employs a photoreactive-cellulose membrane which is prepared by the introduction of a photoreactive group to a cellulose membrane through 1-fluoro-2-nitro-4-azidobenzene (FNAB). Upon exposure to UV light photo-reactive azido group of the activated cellulose membrane transforms itself into highly reactive nitrene which covalently binds to underivatized carbohydrates through an insertion reaction. Maximum immobilization of carbohydrate is achieved at the UV exposure time of 60min and carbohydrate concentration of 100microg/disk. The immobilized carbohydrate is assayed by affinity binding of biotin-labeled lectins. The amount of Con A required for detecting immobilized carbohydrate ranges from 4-10microg/ml. The binding affinities of the lectin to the immobilized carbohydrates are analyzed by calculating their IC(50) values. Overall, the present work demonstrates an efficient immobilization of underivatized carbohydrate onto cellulose surface and has the potential to be applied to other surfaces. PMID: 19914627 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glycome and transcriptome regulation of vasculogenesis.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-248.html</link>
      <description> Related Articles Glycome and transcriptome regulation of vasculogenesis. Circulation. 2009 Nov 10;120(19):1883-92 Authors: Harfouche R, Hentschel DM, Piecewicz S, Basu S, Print C, Eavarone D, Kiziltepe T, Sasisekharan R, Sengupta S BACKGROUND: Therapeutic vasculogenesis is an emerging concept that can potentially be harnessed for the management of ischemic pathologies. The present study elucidates the potential coregulation of vasculogenesis by the heparan sulfate glycosaminoglycan-rich cell-su ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-248.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Glycome and transcriptome regulation of vasculogenesis. Circulation. 2009 Nov 10;120(19):1883-92 Authors: Harfouche R, Hentschel DM, Piecewicz S, Basu S, Print C, Eavarone D, Kiziltepe T, Sasisekharan R, Sengupta S BACKGROUND: Therapeutic vasculogenesis is an emerging concept that can potentially be harnessed for the management of ischemic pathologies. The present study elucidates the potential coregulation of vasculogenesis by the heparan sulfate glycosaminoglycan-rich cell-surface glycome and the transcriptome. METHODS AND RESULTS: Differentiation of embryonic stem cells into endothelial cells in an in vitro embryoid body is paralleled by an amplification of heparan sulfate glycosaminoglycan sulfation, which correlates with the levels of the enzyme N-deacetylase/N-sulfotransferase 1 (NDST1). Small hairpin RNA-mediated knockdown of NDST1 or modification of heparan sulfate glycosaminoglycans in embryonic stem cells with heparinases or sodium chlorate inhibited differentiation of embryonic stem cells into endothelial cells. This was translated to an in vivo zebrafish embryo model, in which the genetic knockdown of NDST1 resulted in impaired vascularization characterized by a concentration-dependent decrease in intersegmental vessel lumen and a large tail-vessel configuration, which could be rescued by use of exogenous sulfated heparan sulfate glycosaminoglycans. To explore the cross talk between the glycome and the transcriptome during vasculogenesis, we identified by microarray and then validated wild-type and NDST1 knockdown-associated gene-expression patterns in zebrafish embryos. Temporal analysis at 3 developmental stages critical for vasculogenesis revealed a cascade of pathways that may mediate glycocalyx regulation of vasculogenesis. These pathways were intimately connected to cell signaling, cell survival, and cell fate determination. Specifically, we demonstrated that forkhead box O3A/5 proteins and insulin-like growth factor were key downstream signals in this process. CONCLUSIONS: The present study for the first time implicates interplay between the glycome and the transcriptome during vasculogenesis, revealing the possibility of harnessing specific cellular glyco-microenvironments for therapeutic vascularization. PMID: 19858418 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Fungal glucuronoyl esterases and substrate uronic acid recognition.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-263.html</link>
      <description> Related Articles Fungal glucuronoyl esterases and substrate uronic acid recognition. Biosci Biotechnol Biochem. 2009 Nov;73(11):2483-7 Authors: Duranov</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-263.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Fungal glucuronoyl esterases and substrate uronic acid recognition. Biosci Biotechnol Biochem. 2009 Nov;73(11):2483-7 Authors: Duranov
    ]]> </content:encoded>
                                </item>
  <item>
  <title>From the gamma-glutamyl cycle to the glycan cycle: a road with many turns and pleasant surprises.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-247.html</link>
      <description> Related Articles From the gamma-glutamyl cycle to the glycan cycle: a road with many turns and pleasant surprises. J Biol Chem. 2009 Dec 11;284(50):34469-78 Authors: Taniguchi N PMID: 19840938 [PubMed - indexed for MEDLINE]</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-247.html</guid>
        
      <content:encoded> <![CDATA[
       Related Articles From the gamma-glutamyl cycle to the glycan cycle: a road with many turns and pleasant surprises. J Biol Chem. 2009 Dec 11;284(50):34469-78 Authors: Taniguchi N  PMID: 19840938 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Bioinformatics in glycomics: glycan characterization with mass spectrometric data using SimGlycan.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-261.html</link>
      <description> Related Articles Bioinformatics in glycomics: glycan characterization with mass spectrometric data using SimGlycan. Methods Mol Biol. 2010;600:269-81 Authors: Apte A, Meitei NS Mass spectrometry (MS), with its low sample requirement and high sensitivity, has been the predominantly used methodology for characterization and elucidation of glycan structures. However, manual interpretation of MS data is complex and tedious due to large number of product ions observed and also due to the variation i ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-261.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Bioinformatics in glycomics: glycan characterization with mass spectrometric data using SimGlycan. Methods Mol Biol. 2010;600:269-81 Authors: Apte A, Meitei NS Mass spectrometry (MS), with its low sample requirement and high sensitivity, has been the predominantly used methodology for characterization and elucidation of glycan structures. However, manual interpretation of MS data is complex and tedious due to large number of product ions observed and also due to the variation in their m/z values under various experimental conditions. We present an automated tool, SimGlycan, for this purpose, which accepts raw/standard MS data files as input and characterizes the associated glycan structure with high accuracy using database searching and scoring techniques. Not only does it predict the glycan structure using an MS/MS database searching technique, but it also facilitates predicting novel glycans by drawing a glycan and mapping it onto an experimental spectrum to check the degree of proximity between the theoretical and the experimental glycans. It serves as a platform for developing advanced tools that may be used for glycopeptide identification using MS data and 3D structural analysis of glycans with a few improvements in the existing features. PMID: 19882135 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The glycobiology of brain tumors: disease relevance and therapeutic potential.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-246.html</link>
      <description>Related Articles The glycobiology of brain tumors: disease relevance and therapeutic potential. Expert Rev Neurother. 2009 Oct;9(10):1529-45 Authors: Moskal JR, Kroes RA, Dawson G The oligosaccharides that decorate cell surface glycoconjugates play important roles in intercellular recognition and cell-extracellular matrix interactions, and thus the regulation of cellular migration, metastasis and invasivity. Virtually all tumor cells display aberrant cell-surface glycosylation patterns brought a ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-246.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles The glycobiology of brain tumors: disease relevance and therapeutic potential. Expert Rev Neurother. 2009 Oct;9(10):1529-45 Authors: Moskal JR, Kroes RA, Dawson G The oligosaccharides that decorate cell surface glycoconjugates play important roles in intercellular recognition and cell-extracellular matrix interactions, and thus the regulation of cellular migration, metastasis and invasivity. Virtually all tumor cells display aberrant cell-surface glycosylation patterns brought about by alterations in their biosynthetic machinery. This holds true for highly invasive, malignant brain tumors as well as tumor cells that metastasize to the brain. The field of glycobiology is well established with essentially all of the biochemical pathways for oligosaccharide metabolism characterized and all of the 'glycogenes' involved in these pathways cloned. Yet there has been a paucity of progress toward the development of therapeutics. However, recent studies aimed at controlled glycosylation of therapeutic antibodies and mucins with anticancer vaccine potential, the emergence of new and highly sensitive tools for the identification of tumor-associated biomarkers and the manipulation of the expression of glycogenes that inhibit brain tumor invasivity have emerged. The opportunity now exists to answer questions as to how glycogenes are regulated at the genomic and transcriptomic level and how altered glycogene expression patterns lead to altered cell surface glycoconjugates. These studies should lead to the development of ways to directly regulate tumor cell glycogene expression, which should have significant therapeutic potential. PMID: 19831842 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A glycomics approach to the discovery of potential cancer biomarkers.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-259.html</link>
      <description> Related Articles A glycomics approach to the discovery of potential cancer biomarkers. Methods Mol Biol. 2010;600:199-213 Authors: An HJ, Lebrilla CB Glycosylation is highly sensitive to the biochemical environment and plays a key role in development and disease manifestation. Moreover, glycan biosynthesis depends on several highly competitive processes; thus, variations in the concentration of specific glycosyltransferases produce different products. For this reason, monitoring changes in glyc ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-259.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles A glycomics approach to the discovery of potential cancer biomarkers. Methods Mol Biol. 2010;600:199-213 Authors: An HJ, Lebrilla CB Glycosylation is highly sensitive to the biochemical environment and plays a key role in development and disease manifestation. Moreover, glycan biosynthesis depends on several highly competitive processes; thus, variations in the concentration of specific glycosyltransferases produce different products. For this reason, monitoring changes in glycosylation may be a more specific and sensitive approach to biomarker discovery and possibly disease diagnosis. Glycans in serum are of particular interest as approximately half of all proteins are glycosylated. We have developed the methods for profiling the glycans in human serum to identify glycan biomarker. Global release methods were used including chemical and enzymatic to access O-linked and N-linked glycans, respectively. Glycans were released from the culture medium of various cancer cell lines, in control sera, and in cancer patients and isolated using solid phase extraction (SPE) with a porous graphitized carbon. The SPE fractions were analyzed by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry (MALDI FTICR MS). Glycan compositions were determined based on accurate masses and tandem mass spectrometry. Glycosylation changes between control and patient group were monitored. Several glycans were identified as potential markers for ovarian, breast, and prostate cancer. In short, direct glycan analysis of human serum without any protein identification represents a new and innovative approach to disease marker discovery. PMID: 19882130 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Determination of sulfation pattern in brain glycosaminoglycans by chip-based electrospray ionization ion trap mass spectrometry.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-245.html</link>
      <description> Related Articles Determination of sulfation pattern in brain glycosaminoglycans by chip-based electrospray ionization ion trap mass spectrometry. Anal Bioanal Chem. 2009 Dec;395(8):2489-98 Authors: Flangea C, Schiopu C, Sisu E, Serb A, Przybylski M, Seidler DG, Zamfir AD Chondroitin sulfate (CS) and dermatan sulfate (DS) glycosaminoglycans display variability of sulfation in their constituent disaccharide repeats during chain elongation. Since a large proportion of the extracellular matrix of t ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-245.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Determination of sulfation pattern in brain glycosaminoglycans by chip-based electrospray ionization ion trap mass spectrometry. Anal Bioanal Chem. 2009 Dec;395(8):2489-98 Authors: Flangea C, Schiopu C, Sisu E, Serb A, Przybylski M, Seidler DG, Zamfir AD Chondroitin sulfate (CS) and dermatan sulfate (DS) glycosaminoglycans display variability of sulfation in their constituent disaccharide repeats during chain elongation. Since a large proportion of the extracellular matrix of the central nervous system (CNS) is composed of proteoglycans, CS/DS disaccharide degree and profile of sulfation play important roles in the functional diversity of neurons, brain development, and some of its pathological states. To investigate the sulfation pattern of CS/DS structures expressed in CNS, we introduced here a novel method based on an advanced system encompassing fully automated chip nanoelectrospray ionization (nanoESI) in the negative ion mode and high capacity ion trap multistage mass spectrometry (MS(2)-MS(3)) by collision-induced dissociation (CID). This method, introduced here for the first time in glycomics of brain glycosaminoglycans, was particularly applied to structural investigation of disaccharides obtained by beta-elimination and digestion with chondroitin B and AC I lyase of hybrid CS/DS chains from wild-type mouse brain. Screening in the chip-MS mode of DS disaccharide fraction resulting after depolymerization with chondroitin B lyase revealed molecular ions assigned to monosulfated disaccharide species having a composition of 4,5-Delta-[IdoA-GalNAc]. By optimized CID MS(2)-MS(3), fragment ions supporting the localization of sulfate ester group at C4 within GalNAc were produced. Chip ESI MS profiling of CS disaccharide fraction obtained by depolymerization of the same CS/DS chain using chondroitin AC I lyase indicated the occurrence of mono- and bisulfated 4,5-Delta-[GlcA-GalNAc]. The site of oversulfation was determined by MS(2)-MS(3), which provided sequence patterns consistent with a rare GlcA-3-sulfate-GalNAc-6-sulfate structural motif. Figure Mouse brain GlcA-3-sulfate-GalNAc-6-sulfate structural motif. PMID: 19826794 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Metabolomics in glycomics.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-257.html</link>
      <description> Related Articles Metabolomics in glycomics. Methods Mol Biol. 2010;600:175-86 Authors: Soo EC, Hui JP Metabolomics is essentially the study of all low molecular weight molecules in a biological system under defined conditions. In glycomics, there is much potential to gain insight into the biosynthesis of novel glycoconjugate structures by probing the metabolome for substrates that are suspected, or known, to be involved in the biosynthetic processes. Recently, we employed the use of hydrophilic ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-257.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Metabolomics in glycomics. Methods Mol Biol. 2010;600:175-86 Authors: Soo EC, Hui JP Metabolomics is essentially the study of all low molecular weight molecules in a biological system under defined conditions. In glycomics, there is much potential to gain insight into the biosynthesis of novel glycoconjugate structures by probing the metabolome for substrates that are suspected, or known, to be involved in the biosynthetic processes. Recently, we employed the use of hydrophilic interaction liquid chromatography-mass spectrometry (HILIC-MS) in a focused metabolomic study of sugar-nucleotides relevant to the biosynthesis of highly novel carbohydrate modifications on the flagellin of Campylobacter sp. We exploited the unique selectivity of the HILIC-MS method for discriminating between closely related sugar-nucleotide intermediates and allowed their subsequent structural identification using a combination of high-resolution mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy. In addition, the HILIC-MS method permitted screening of selected isogenic mutants for sugar-nucleotide intermediates to determine a role for the corresponding genes on the flagellin glycosylation locus in the biosynthesis of the novel carbohydrate modifications. PMID: 19882128 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glycans on influenza hemagglutinin affect receptor binding and immune response.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-244.html</link>
      <description> Related Articles Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18137-42 Authors: Wang CC, Chen JR, Tseng YC, Hsu CH, Hung YF, Chen SW, Chen CM, Khoo KH, Cheng TJ, Cheng YS, Jan JT, Wu CY, Ma C, Wong CH Recent cases of avian influenza H5N1 and the swine-origin 2009 H1N1 have caused a great concern that a global disaster like the 1918 influenza pandemic may occur again. Viral transmission begins with a critical intera ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-244.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18137-42 Authors: Wang CC, Chen JR, Tseng YC, Hsu CH, Hung YF, Chen SW, Chen CM, Khoo KH, Cheng TJ, Cheng YS, Jan JT, Wu CY, Ma C, Wong CH Recent cases of avian influenza H5N1 and the swine-origin 2009 H1N1 have caused a great concern that a global disaster like the 1918 influenza pandemic may occur again. Viral transmission begins with a critical interaction between hemagglutinin (HA) glycoprotein, which is on the viral coat of influenza, and sialic acid (SA) containing glycans, which are on the host cell surface. To elucidate the role of HA glycosylation in this important interaction, various defined HA glycoforms were prepared, and their binding affinity and specificity were studied by using a synthetic SA microarray. Truncation of the N-glycan structures on HA increased SA binding affinities while decreasing specificity toward disparate SA ligands. The contribution of each monosaccharide and sulfate group within SA ligand structures to HA binding energy was quantitatively dissected. It was found that the sulfate group adds nearly 100-fold (2.04 kcal/mol) in binding energy to fully glycosylated HA, and so does the biantennary glycan to the monoglycosylated HA glycoform. Antibodies raised against HA protein bearing only a single N-linked GlcNAc at each glycosylation site showed better binding affinity and neutralization activity against influenza subtypes than the fully glycosylated HAs elicited. Thus, removal of structurally nonessential glycans on viral surface glycoproteins may be a very effective and general approach for vaccine design against influenza and other human viruses. PMID: 19822741 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Alteration of N-glycome in diethylnitrosamine-induced hepatocellular carcinoma mice: a non-invasive monitoring tool for liver cancer.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-327.html</link>
      <description> Related Articles Alteration of N-glycome in diethylnitrosamine-induced hepatocellular carcinoma mice: a non-invasive monitoring tool for liver cancer. Liver Int. 2010 May 26; Authors: Liu XE, Dewaele S, Vanhooren V, Fan YD, Wang L, Van Huysse J, Zhuang H, Contreras R, Libert C, Chen CC Abstract Background and aims: There is a demand for serum markers that can routinely assess the progression of liver cancer. DENA (diethylnitrosamine), a hepatocarcinogen, is commonly used in an experimental mous ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-327.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Alteration of N-glycome in diethylnitrosamine-induced hepatocellular carcinoma mice: a non-invasive monitoring tool for liver cancer. Liver Int. 2010 May 26; Authors: Liu XE, Dewaele S, Vanhooren V, Fan YD, Wang L, Van Huysse J, Zhuang H, Contreras R, Libert C, Chen CC Abstract Background and aims: There is a demand for serum markers that can routinely assess the progression of liver cancer. DENA (diethylnitrosamine), a hepatocarcinogen, is commonly used in an experimental mouse model to induce liver cancer that closely mimics a subclass of human hepatocellular carcinoma (HCC). However, blood monitoring of the progression of HCC in mouse model has not yet been achieved. In this report, we studied glycomics during the development of mouse HCC induced by DENA. Methods: Mouse HCC was induced by DENA. Serum N-glycans were profiled using the sequencer assisted-Fluorophore-assisted carbohydrate electrophoresis technique developed in our laboratory. Possible alteration in the transcription of genes relevant to the synthesis of the changed glycans was analysed by real-time polymerase chain reaction. Results: In comparison with the control mice that received the same volume of saline, a tri-antennary glycan (peak 8) and a biantennary glycan (peak 4) in serum total glycans of DENA mice increased gradually but significantly during progression of liver cancer, whereas a core-fucosylated biantennary glycan (peak 6) decreased. Expression of alpha-1,6-fucosyltransferase 8 (Fut8), which is responsible for core fucosylation, decreased in the liver of DENA mice compared with that of age-matched control mice. Likewise, the expression level of Mgat4a, which is responsible for tri-antennary, significantly increased in the liver of DENA mice (P<0.001). Conclusions: The changes of N-glycan levels in the serum could be used as a biomarker to monitor the progress of HCC and to follow up the treatment of liver tumours in this DENA mouse model. PMID: 20524982 [PubMed - as supplied by publisher]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Vibrio cholerae O1 Ogawa detoxified lipopolysaccharide structures as inducers of cytokines and oxidative species in macrophages.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-243.html</link>
      <description> Related Articles Vibrio cholerae O1 Ogawa detoxified lipopolysaccharide structures as inducers of cytokines and oxidative species in macrophages. J Med Microbiol. 2010 Feb;59(Pt 2):158-64 Authors: Paulovicov</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-243.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Vibrio cholerae O1 Ogawa detoxified lipopolysaccharide structures as inducers of cytokines and oxidative species in macrophages. J Med Microbiol. 2010 Feb;59(Pt 2):158-64 Authors: Paulovicov
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Improved hydrophilic interaction chromatography LC/MS of heparinoids using a chip with postcolumn makeup flow.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-276.html</link>
      <description> Related Articles Improved hydrophilic interaction chromatography LC/MS of heparinoids using a chip with postcolumn makeup flow. Anal Chem. 2010 Jan 15;82(2):516-22 Authors: Staples GO, Naimy H, Yin H, Kileen K, Kraiczek K, Costello CE, Zaia J Heparan sulfate (HS) and heparin are linear, heterogeneous carbohydrates of the glycosaminoglycan (GAG) family that are modified by N-acetylation, N-sulfation, O-sulfation, and uronic acid epimerization. HS interacts with growth factors in the extracellula ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-276.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Improved hydrophilic interaction chromatography LC/MS of heparinoids using a chip with postcolumn makeup flow. Anal Chem. 2010 Jan 15;82(2):516-22 Authors: Staples GO, Naimy H, Yin H, Kileen K, Kraiczek K, Costello CE, Zaia J Heparan sulfate (HS) and heparin are linear, heterogeneous carbohydrates of the glycosaminoglycan (GAG) family that are modified by N-acetylation, N-sulfation, O-sulfation, and uronic acid epimerization. HS interacts with growth factors in the extracellular matrix, thereby modulating signaling pathways that govern cell growth, development, differentiation, proliferation, and adhesion. High-performance liquid chromatography (HPLC)-chip-based hydrophilic interaction liquid chromatography/mass spectrometry has emerged as a method for analyzing the domain structure of GAGs. However, analysis of highly sulfated GAG structures decasaccharide or larger in size has been limited by spray instability in the negative-ion mode. This report demonstrates that addition of postcolumn makeup flow to the amide-HPLC-chip configuration permits robust and reproducible analysis of extended GAG domains (up to degree of polymerization 18) from HS and heparin. This platform provides quantitative information regarding the oligosaccharide profile, degree of sulfation, and nonreducing chain termini. It is expected that this technology will enable quantitative, comparative glycomics profiling of extended GAG oligosaccharide domains of functional interest. PMID: 20000724 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>OMICS-rooted studies of milk proteins, oligosaccharides and lipids.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-242.html</link>
      <description> Related Articles OMICS-rooted studies of milk proteins, oligosaccharides and lipids. J Proteomics. 2009 Dec 1;73(2):196-208 Authors: Casado B, Affolter M, Kussmann M Milk has co-evolved with mammals and mankind to nourish their offspring and is a biological fluid of unique complexity and richness. It contains all necessary nutrients for the growth and development of the newborn. Structure and function of biomolecules in milk such as the macronutrients (glyco-) proteins, lipids, and oligosacchar ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-242.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles OMICS-rooted studies of milk proteins, oligosaccharides and lipids. J Proteomics. 2009 Dec 1;73(2):196-208 Authors: Casado B, Affolter M, Kussmann M Milk has co-evolved with mammals and mankind to nourish their offspring and is a biological fluid of unique complexity and richness. It contains all necessary nutrients for the growth and development of the newborn. Structure and function of biomolecules in milk such as the macronutrients (glyco-) proteins, lipids, and oligosaccharides are central topics in nutritional research. Omics disciplines such as proteomics, glycomics, glycoproteomics, and lipidomics enable comprehensive analysis of these biomolecule components in food science and industry. Mass spectrometry has largely expanded our knowledge on these milk bioactives as it enables identification, quantification and characterization of milk proteins, carbohydrates, and lipids. In this article, we describe the biological importance of milk macronutrients and review the application of proteomics, glycomics, glycoproteomics, and lipidomics to the analysis of milk. Proteomics is a central platform among the Omics tools that have more recently been adapted and applied to nutrition and health research in order to deliver biomarkers for health and comfort as well as to discover beneficial food bioactives. PMID: 19793547 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Altered serum N-glycomics in chronic hepatitis B patients.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-272.html</link>
      <description> Related Articles Altered serum N-glycomics in chronic hepatitis B patients. Liver Int. 2010 Feb;30(2):259-67 Authors: Gui HL, Gao CF, Wang H, Liu XE, Xie Q, Dewaele S, Wang L, Zhuang H, Contreras R, Libert C, Chen C BACKGROUND: We previously reported on serum N-glycans as markers for the diagnosis of cirrhosis in patients with chronic hepatitis C infection. Our present study aimed to evaluate the use of serum glycan markers for the diagnosis of liver fibrosis in patients with chronic hepatitis  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-272.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Altered serum N-glycomics in chronic hepatitis B patients. Liver Int. 2010 Feb;30(2):259-67 Authors: Gui HL, Gao CF, Wang H, Liu XE, Xie Q, Dewaele S, Wang L, Zhuang H, Contreras R, Libert C, Chen C BACKGROUND: We previously reported on serum N-glycans as markers for the diagnosis of cirrhosis in patients with chronic hepatitis C infection. Our present study aimed to evaluate the use of serum glycan markers for the diagnosis of liver fibrosis in patients with chronic hepatitis B infection. METHODS: Patients with hepatitis B virus (HBV) infection (n=173) were diagnosed by clinical laboratory analysis and histological examination. Liver fibrosis was staged using Ishak score. N-glycan profiles of serum proteins were determined by DNA sequencer-based carbohydrate analytical profiling. RESULTS: We found that in HBV patients, like in hepatitis C virus patients, several serum N-glycans were altered during the development of liver fibrosis. We found higher levels of total agalactosylated biantennary glycans in fibrosis patients with HBV infection than in healthy controls. The biantennary (NA2) and the triantennary (NA3) N-glycans decreased significantly (P<0.001) with increased severity of fibrosis. The diagnostic power of serum glycan marker (GlycoFibroTest) [area under the curve (AUC)=0.735) was similar to that of FibroTest (AUC=0.740) for discriminating between moderate and advanced fibrosis (F3-F6) from non- or mild fibrosis (F0-F2). However, GlycoFibroTest (AUC=0.740) was slightly better than FibroTest (AUC=0.696) for distinguishing fibrotic patients (F1 or more) from non-fibrotic patients (F0). CONCLUSIONS: The assay for serum glycan profiling showed satisfactory reproducibility and is a non-invasive blood test for the diagnosis of liver fibrosis. The changes of N-glycan level in serum can be used to monitor or follow-up the progress of fibrosis using specific N-glycan markers. PMID: 19951379 [PubMed - in process]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Carbohydrate cluster microarrays fabricated on three-dimensional dendrimeric platforms for functional glycomics exploration.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-241.html</link>
      <description> Related Articles Carbohydrate cluster microarrays fabricated on three-dimensional dendrimeric platforms for functional glycomics exploration. J Proteome Res. 2009 Nov;8(11):5031-40 Authors: Zhou X, Turchi C, Wang D We reported here a novel, ready-to-use bioarray platform and methodology for construction of sensitive carbohydrate cluster microarrays. This technology utilizes a three-dimensional (3-D) poly(amidoamine) starburst dendrimer monolayer assembled on glass surface, which is functionaliz ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-241.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Carbohydrate cluster microarrays fabricated on three-dimensional dendrimeric platforms for functional glycomics exploration. J Proteome Res. 2009 Nov;8(11):5031-40 Authors: Zhou X, Turchi C, Wang D We reported here a novel, ready-to-use bioarray platform and methodology for construction of sensitive carbohydrate cluster microarrays. This technology utilizes a three-dimensional (3-D) poly(amidoamine) starburst dendrimer monolayer assembled on glass surface, which is functionalized with terminal aminooxy and hydrazide groups for site-specific coupling of carbohydrates. A wide range of saccharides, including monosaccharides, oligosaccharides and polysaccharides of diverse structures, are applicable for the 3-D bioarray platform without prior chemical derivatization. The process of carbohydrate coupling is effectively accelerated by microwave radiation energy. The carbohydrate concentration required for microarray fabrication is substantially reduced using this technology. Importantly, this bioarray platform presents sugar chains in defined orientation and cluster configurations. It is, thus, uniquely useful for exploration of the structural and conformational diversities of glyco-epitope and their functional properties. PMID: 19791771 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glycan array: a powerful tool for glycomics studies.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-268.html</link>
      <description>Related Articles Glycan array: a powerful tool for glycomics studies. Expert Rev Proteomics. 2009 Dec;6(6):631-45 Authors: Liang CH, Wu CY Glycan arrays have become a powerful tool for the high-throughput elucidation of interactions of different carbohydrate structures with a wide variety of biological targets, including antibodies, proteins, viruses and cells. This technique is especially suitable for glycomics studies, because arrays present carbohydrate ligands in a manner that mimics interac ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-268.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Glycan array: a powerful tool for glycomics studies. Expert Rev Proteomics. 2009 Dec;6(6):631-45 Authors: Liang CH, Wu CY Glycan arrays have become a powerful tool for the high-throughput elucidation of interactions of different carbohydrate structures with a wide variety of biological targets, including antibodies, proteins, viruses and cells. This technique is especially suitable for glycomics studies, because arrays present carbohydrate ligands in a manner that mimics interactions at cell-cell interfaces. This review assesses the recent advances involving glycan arrays, including new methods for glycan-array fabrication, new platforms for novel biological information, and new perceptions of glycomics for improving the understanding of disease-related glycobiology. Furthermore, this review attempts to forecast trends in the development of glycan arrays and possible solutions for some remaining challenges to improve this new technology. PMID: 19929609 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Mechanistic investigation of the endo-alpha-N-acetylgalactosaminidase from Streptococcus pneumoniae R6.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-240.html</link>
      <description> Related Articles Mechanistic investigation of the endo-alpha-N-acetylgalactosaminidase from Streptococcus pneumoniae R6. Biochemistry. 2009 Nov 3;48(43):10334-41 Authors: Willis LM, Zhang R, Reid A, Withers SG, Wakarchuk WW The large (1767-amino acid) endo-alpha-N-acetylgalactosaminidase from Streptococcus pneumoniae (SpGH101) specifically removes an O-linked disaccharide Gal-beta-1,3-GalNAc-alpha from glycoproteins. While the enzyme from natural sources has been used as a reagent for many year ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-240.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Mechanistic investigation of the endo-alpha-N-acetylgalactosaminidase from Streptococcus pneumoniae R6. Biochemistry. 2009 Nov 3;48(43):10334-41 Authors: Willis LM, Zhang R, Reid A, Withers SG, Wakarchuk WW The large (1767-amino acid) endo-alpha-N-acetylgalactosaminidase from Streptococcus pneumoniae (SpGH101) specifically removes an O-linked disaccharide Gal-beta-1,3-GalNAc-alpha from glycoproteins. While the enzyme from natural sources has been used as a reagent for many years, very few mechanistic studies have been performed. Using the recently determined three-dimensional structure of the recombinant protein as a background, we report here a mechanistic investigation of the SpGH101 retaining alpha-glycoside hydrolase using a combination of synthetic and natural substrates. On the basis of a model of the substrate complex of SpGH101, we propose D764 and E796 as the nucleophile and general acid-base residues, respectively. These roles were confirmed by kinetic and mechanistic analysis of mutants at those positions using synthetic substrates and anion rescue experiments. pK(a) values of 5.3 and 7.2 were assigned to D764 and E796 on the basis of the pK(a) values derived from the bell-shaped dependence of k(cat)/K(m) upon pH. The enzyme contains several putative carbohydrate binding modules whose glycan binding specificities were probed using the printed glycan array of the Consortium for Functional Glycomics using the inactive D764A and D764F mutants that had been labeled with Alexafluor 488. These studies revealed binding to galacto-N-biose, consistent with a role for these domains in localizing the enzyme near its substrates. PMID: 19788271 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Symbol nomenclature for glycan representation.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-264.html</link>
      <description> Related Articles Symbol nomenclature for glycan representation. Proteomics. 2009 Dec;9(24):5398-9 Authors: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Marth JD, Bertozzi CR, Hart GW, Etzler ME The glycan symbol nomenclature proposed by Harvey et al. in these pages has relative advantages and disadvantages. The use of symbols to depict glycans originated from Kornfeld in 1978, was systematized in the First Edition of &quot;Essentials of Glycobiology&quot; and updated for the second edition, with  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-264.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Symbol nomenclature for glycan representation. Proteomics. 2009 Dec;9(24):5398-9 Authors: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Marth JD, Bertozzi CR, Hart GW, Etzler ME The glycan symbol nomenclature proposed by Harvey et al. in these pages has relative advantages and disadvantages. The use of symbols to depict glycans originated from Kornfeld in 1978, was systematized in the First Edition of "Essentials of Glycobiology" and updated for the second edition, with input from relevant organizations such as the Consortium for Functional Glycomics. We also note that >200 illustrations in the second edition have already been published using our nomenclature and are available for download at PubMed. PMID: 19902428 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glycomics and disease markers.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-239.html</link>
      <description> Related Articles Glycomics and disease markers. Curr Opin Chem Biol. 2009 Dec;13(5-6):601-7 Authors: An HJ, Kronewitter SR, de Leoz ML, Lebrilla CB Glycomics is the comprehensive study of all glycans expressed in biological systems. The biosynthesis of glycan relies on a number of highly competitive processes involving glycosyl transferases. Glycosylation is therefore highly sensitive to the biochemical environment and has been implicated in many diseases including cancer. Recently, interest in ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-239.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Glycomics and disease markers. Curr Opin Chem Biol. 2009 Dec;13(5-6):601-7 Authors: An HJ, Kronewitter SR, de Leoz ML, Lebrilla CB Glycomics is the comprehensive study of all glycans expressed in biological systems. The biosynthesis of glycan relies on a number of highly competitive processes involving glycosyl transferases. Glycosylation is therefore highly sensitive to the biochemical environment and has been implicated in many diseases including cancer. Recently, interest in profiling the glycome has increased owing to the potential of glycans for disease markers. In this regard, mass spectrometry is emerging as a powerful technique for profiling the glycome. Global glycan profiling of human serum based on mass spectrometry has already led to several potentially promising markers for several types of cancer and diseases. PMID: 19775929 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>N-linked protein glycosylation in a bacterial system.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-260.html</link>
      <description> Related Articles N-linked protein glycosylation in a bacterial system. Methods Mol Biol. 2010;600:227-43 Authors: Nothaft H, Liu X, McNally DJ, Szymanski CM N-Linked protein glycosylation is conserved throughout the three domains of life and influences protein function, stability, and protein complex formation. N-Linked glycosylation is an essential process in Eukaryotes; however, although N-glycosylation affects multiple cellular processes in Archaea and Bacteria, it is not needed for cell sur ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-260.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles N-linked protein glycosylation in a bacterial system. Methods Mol Biol. 2010;600:227-43 Authors: Nothaft H, Liu X, McNally DJ, Szymanski CM N-Linked protein glycosylation is conserved throughout the three domains of life and influences protein function, stability, and protein complex formation. N-Linked glycosylation is an essential process in Eukaryotes; however, although N-glycosylation affects multiple cellular processes in Archaea and Bacteria, it is not needed for cell survival. Methods for the analyses of N-glycosylation in eukaryotes are well established, but comparable techniques for the analyses of the pathways in Bacteria and Archaea are needed. In this chapter we describe new methods for the detection and analyses of N-linked, and the recently discovered free oligosaccharides (fOS), from whole cell lysates of Campylobacter jejuni using non-specific pronase E digestion and permethylation followed by mass spectrometry. We also describe the expression and immunodetection of the model N-glycoprotein, AcrA, fused to a hexa-histidine tag to follow protein glycosylation in C. jejuni. This chapter concludes with the recent demonstration that high-resolution magic angle spinning NMR of intact bacterial cells provides a rapid, non-invasive method for analyzing fOS in C. jejuni in vivo. This combination of techniques provides a powerful tool for the exploration, quantification, and structural analyses of N-linked and free oligosaccharides in the bacterial system. PMID: 19882132 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Analysis of bacterial lipid-linked oligosaccharide intermediates using porous graphitic carbon liquid chromatography-electrospray ionization mass spectrometry: heterogeneity in the polyisoprenyl carrier revealed.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-238.html</link>
      <description> Related Articles Analysis of bacterial lipid-linked oligosaccharide intermediates using porous graphitic carbon liquid chromatography-electrospray ionization mass spectrometry: heterogeneity in the polyisoprenyl carrier revealed. Anal Chem. 2009 Oct 15;81(20):8472-8 Authors: Reid CW, Stupak J, Szymanski CM, Li J N-glycosylation of proteins is recognized as one of the most common post-translational modifications. It was believed that N-glycosylation occurred exclusively in eukaryotes until the r ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-238.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Analysis of bacterial lipid-linked oligosaccharide intermediates using porous graphitic carbon liquid chromatography-electrospray ionization mass spectrometry: heterogeneity in the polyisoprenyl carrier revealed. Anal Chem. 2009 Oct 15;81(20):8472-8 Authors: Reid CW, Stupak J, Szymanski CM, Li J N-glycosylation of proteins is recognized as one of the most common post-translational modifications. It was believed that N-glycosylation occurred exclusively in eukaryotes until the recent discovery of the general protein glycosylation pathway (Pgl) in Campylobacter jejuni, which has similarities to the eukaryotic system and adds proteins en bloc from a lipid carrier to a protein acceptor. In addition to N-linked glycans, a number of pathogenic bacteria such as Pseudomonas aeruginosa and Neisseria species have been shown to O-glycosylate their proteins through polyisoprene-linked intermediates. To date, most techniques to analyze lipid-linked oligosaccharides (LLOs) of these pathways involve the use of radiolabels and chromatographic separation. With the increasing frequency of reports of bacterial protein glycosylation that proceed through lipid-mediated steps, there is a need for technologies capable of characterizing these newly described bacterial systems as well as eukaryotic pathways from biologically relevant samples in an accurate, rapid, and cost-effective manner. In this paper, a new glycomics strategy based on porous graphite carbon (PGC) liquid chromatography mass spectrometry (LC-MS) was devised and validated on the C. jejuni N-glycan pathway. Lipid-linked oligosaccharide intermediates of the Pgl pathway from crude lipid extracts were separated using online chromatography on a capillary PGC column with a chloroform gradient. By exploiting the retention properties of hydrophobic and polar analytes on PGC, baseline separation of LLOs with minor changes in oligosaccharide structure and polyisoprene chain length was obtained. This method is capable of analyzing low levels of LLOs (from approximately 10(6) bacterial cells) and distinguishing the LLOs that differ by as little as one monosaccharide or polyisoprene unit. Furthermore, we have demonstrated for the first time that oligosaccharides of the C. jejuni Pgl pathway are assembled on different polyisoprenes, e. g. C(45), C(60), and apparent hydroxylated forms, in addition to those previously reported (i.e., C(50) and C(55)). The hydroxylated forms of the LLOs are believed to be an intermediate in the degradation of accumulated LLOs for polyisoprene carrier recycling. PMID: 19772334 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The application of NMR spectroscopy to functional glycomics.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-256.html</link>
      <description> Related Articles The application of NMR spectroscopy to functional glycomics. Methods Mol Biol. 2010;600:155-73 Authors: Brisson JR, Vinogradov E, McNally DJ, Khieu NH, Schoenhofen IC, Logan SM, Jarrell H Glycomics which is the study of saccharides and genes responsible for their formation requires the continuous development of rapid and sensitive methods for the identification of glycan structures. It involves glycoanalysis which relies upon the development of methods for determining the struc ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-256.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The application of NMR spectroscopy to functional glycomics. Methods Mol Biol. 2010;600:155-73 Authors: Brisson JR, Vinogradov E, McNally DJ, Khieu NH, Schoenhofen IC, Logan SM, Jarrell H Glycomics which is the study of saccharides and genes responsible for their formation requires the continuous development of rapid and sensitive methods for the identification of glycan structures. It involves glycoanalysis which relies upon the development of methods for determining the structure and interactions of carbohydrates. For the application of functional glycomics to microbial virulence, carbohydrates and their associated metabolic and carbohydrate processing enzymes and respective genes can be identified and exploited as targets for drug discovery, glyco-engineering, vaccine design, and detection and diagnosis of diseases. Glycomics also encompasses the detailed understanding of carbohydrate-protein interactions and this knowledge can be applied to research efforts focused toward the development of vaccines and immunological therapies to alleviate infectious diseases. PMID: 19882127 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Iodine-promoted ribosylation leads to a facile acetonide-forming reaction.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-237.html</link>
      <description> Related Articles Iodine-promoted ribosylation leads to a facile acetonide-forming reaction. Carbohydr Res. 2009 Nov 2;344(16):2240-4 Authors: Houston TA, Koreeda M Iodine not only promotes smooth beta-selective glycosylation of ribose tetra-acetate under exceptionally mild conditions, it also catalyzes an expedient acetonide-forming reaction in this system when dry acetone is used as a solvent. PMID: 19765691 [PubMed - indexed for MEDLINE]</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-237.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Iodine-promoted ribosylation leads to a facile acetonide-forming reaction. Carbohydr Res. 2009 Nov 2;344(16):2240-4 Authors: Houston TA, Koreeda M Iodine not only promotes smooth beta-selective glycosylation of ribose tetra-acetate under exceptionally mild conditions, it also catalyzes an expedient acetonide-forming reaction in this system when dry acetone is used as a solvent. PMID: 19765691 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Polysaccharide microarrays for high-throughput screening of transglycosylase activities in plant extracts.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-274.html</link>
      <description> Related Articles Polysaccharide microarrays for high-throughput screening of transglycosylase activities in plant extracts. Glycoconj J. 2010 Jan;27(1):79-87 Authors: Kos</description>
        <pubDate>Tue, 13 Jul 2010 01:01:16 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-274.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Polysaccharide microarrays for high-throughput screening of transglycosylase activities in plant extracts. Glycoconj J. 2010 Jan;27(1):79-87 Authors: Kos
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Fluorescent glycan derivatives: their use for natural glycan microarrays.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-236.html</link>
      <description> Related Articles Fluorescent glycan derivatives: their use for natural glycan microarrays. ACS Chem Biol. 2009 Sep 18;4(9):699-701 Authors: Park S, Sung JW, Shin I Glycan microarrays have become powerful tools in the investigation of biological systems because they enable fast, quantitative, and simultaneous analysis of glycan-protein interactions with small quantities of samples. One hurdle in the construction of glycan microarrays is to obtain a diverse set of glycans for immobilization on su ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:15 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-236.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Fluorescent glycan derivatives: their use for natural glycan microarrays. ACS Chem Biol. 2009 Sep 18;4(9):699-701 Authors: Park S, Sung JW, Shin I Glycan microarrays have become powerful tools in the investigation of biological systems because they enable fast, quantitative, and simultaneous analysis of glycan-protein interactions with small quantities of samples. One hurdle in the construction of glycan microarrays is to obtain a diverse set of glycans for immobilization on surfaces. An article in this issue of ACS Chemical Biology describes the microscale preparation of fluorescently labeled reactive glycans in a cyclic form of the reducing sugar, from natural sources, that can be utilized directly to create natural glycan microarrays for use in functional glycomics. PMID: 19761252 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Chemoenzymatic synthesis and lectin array characterization of a class of N-glycan clusters.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-266.html</link>
      <description>Related Articles Chemoenzymatic synthesis and lectin array characterization of a class of N-glycan clusters. J Am Chem Soc. 2009 Dec 16;131(49):17963-71 Authors: Huang W, Wang D, Yamada M, Wang LX N-Glycans are major components of many glycoproteins. These sugar moieties are frequently involved in important physiological and disease processes via their interactions with a variety of glycan-binding proteins (GBP). Clustering effect is an important feature in many glycan-lectin interactions. We de ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:15 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-266.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Chemoenzymatic synthesis and lectin array characterization of a class of N-glycan clusters. J Am Chem Soc. 2009 Dec 16;131(49):17963-71 Authors: Huang W, Wang D, Yamada M, Wang LX N-Glycans are major components of many glycoproteins. These sugar moieties are frequently involved in important physiological and disease processes via their interactions with a variety of glycan-binding proteins (GBP). Clustering effect is an important feature in many glycan-lectin interactions. We describe in this paper a chemoenzymatic synthesis of novel N-glycan clusters using a tandem endoglycosidase-catalyzed transglycosylation. It was found that the internal beta-1,2-linked GlcNAc moieties in the N-glycan core, once exposed in the nonreducing terminus, was able to serve as acceptors for transglycosylation catalyzed by Endo-A and EndoM-N175A. This efficient chemoenzymatic method allows a quick extension of the sugar chains to form a class of glycan clusters in which sugar residues are all connected by native glycosidic linkages found in natural N-glycans. In addition, a discriminative enzymatic reaction at the two GlcNAc residues could be fulfilled to afford novel hybrid clusters. Lectin microarray studies revealed unusual properties in glyco-epitope expression by this panel of structurally well-defined synthetic N-glycans. These new compounds are likely valuable for functional glycomics studies to unveil new functions of both glycans and carbohydrate-binding proteins. PMID: 19916512 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A Glyco-mix of Approaches To Studying Carbohydrates.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-235.html</link>
      <description> Related Articles A Glyco-mix of Approaches To Studying Carbohydrates. ACS Chem Biol. 2009 Sep 18;4(9):685-6 Authors: Martens E PMID: 19761247 [PubMed - indexed for MEDLINE]</description>
        <pubDate>Tue, 13 Jul 2010 01:01:15 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-235.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles A Glyco-mix of Approaches To Studying Carbohydrates. ACS Chem Biol. 2009 Sep 18;4(9):685-6 Authors: Martens E  PMID: 19761247 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Characterization of lipid-linked oligosaccharides by mass spectrometry.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-258.html</link>
      <description> Related Articles Characterization of lipid-linked oligosaccharides by mass spectrometry. Methods Mol Biol. 2010;600:187-97 Authors: Reid CW, Stupak J, Szymanski CM N- Glycosylation of proteins is recognized as one of the most common post-translational modifications. Until recently it was believed that N-glycosylation occurred exclusively in eukaryotes until the discovery of the general protein glycosylation pathway (Pgl) in Campylobacter jejuni. We have developed a new glycomics strategy based  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:15 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-258.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Characterization of lipid-linked oligosaccharides by mass spectrometry. Methods Mol Biol. 2010;600:187-97 Authors: Reid CW, Stupak J, Szymanski CM N- Glycosylation of proteins is recognized as one of the most common post-translational modifications. Until recently it was believed that N-glycosylation occurred exclusively in eukaryotes until the discovery of the general protein glycosylation pathway (Pgl) in Campylobacter jejuni. We have developed a new glycomics strategy based on lectin-affinity capture of lipid-linked oligosaccharides (LLOs) coupled to capillary electrophoresis mass spectrometry. The LLO intermediates of the C. jejuni Pgl pathway were used to validate the methodology and to better characterize the bacterial model system for protein N-glycosylation. This method provides a rapid, non-radioactive approach for the characterization of intermediates in polysaccharide biosynthesis and is a useful tool for glycoengineering efforts in bacteria. PMID: 19882129 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glycome-DB.org: a portal for querying across the digital world of carbohydrate sequences.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-234.html</link>
      <description> Related Articles Glycome-DB.org: a portal for querying across the digital world of carbohydrate sequences. Glycobiology. 2009 Dec;19(12):1563-7 Authors: Ranzinger R, Frank M, von der Lieth CW, Herget S Despite ongoing harmonization efforts, the major carbohydrate sequence databases following the first initiative in this field, CarbBank, are still isolated islands, with mechanisms for automatic structure exchange and comparison largely missing. This unfavorable situation has been overcome with a ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:15 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-234.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Glycome-DB.org: a portal for querying across the digital world of carbohydrate sequences. Glycobiology. 2009 Dec;19(12):1563-7 Authors: Ranzinger R, Frank M, von der Lieth CW, Herget S Despite ongoing harmonization efforts, the major carbohydrate sequence databases following the first initiative in this field, CarbBank, are still isolated islands, with mechanisms for automatic structure exchange and comparison largely missing. This unfavorable situation has been overcome with a systematic data integration effort, resulting in the GlycomeDB, a meta-database for public carbohydrate sequences. It contains at present 35,056 unique structures in GlycoCT encoding, referencing more than 100,000 external records from 1845 different taxonomic sources. We have created a user-friendly, web-based graphical interface which allows taxonomic and structural data to be entered and searched for. The structural search possibilities include substructure search, similarity search, and maximum common substructure. A novel search refinement mechanism allows the assembly of complex queries. With GlycomeDB (www.glycome-db.org), it is now possible to use a single portal to access all digitally encoded, public structural data in glycomics and to perform complex queries with the help of a web-based user interface. PMID: 19759275 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Preparation of synthetic polyoxazoline based carrier and Vibrio cholerae O-specific polysaccharide conjugate vaccine.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-270.html</link>
      <description> Related Articles Preparation of synthetic polyoxazoline based carrier and Vibrio cholerae O-specific polysaccharide conjugate vaccine. Eur J Med Chem. 2010 Feb;45(2):795-9 Authors: Farkas P, Korcov</description>
        <pubDate>Tue, 13 Jul 2010 01:01:15 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-270.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Preparation of synthetic polyoxazoline based carrier and Vibrio cholerae O-specific polysaccharide conjugate vaccine. Eur J Med Chem. 2010 Feb;45(2):795-9 Authors: Farkas P, Korcov
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The repertoire of glycan determinants in the human glycome.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-233.html</link>
      <description> Related Articles The repertoire of glycan determinants in the human glycome. Mol Biosyst. 2009 Oct;5(10):1087-104 Authors: Cummings RD The number of glycan determinants that comprise the human glycome is not known. This uncertainty arises from limited knowledge of the total number of distinct glycans and glycan structures in the human glycome, as well as limited information about the glycan determinants recognized by glycan-binding proteins (GBPs), which include lectins, receptors, toxins, micr ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:15 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-233.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The repertoire of glycan determinants in the human glycome. Mol Biosyst. 2009 Oct;5(10):1087-104 Authors: Cummings RD The number of glycan determinants that comprise the human glycome is not known. This uncertainty arises from limited knowledge of the total number of distinct glycans and glycan structures in the human glycome, as well as limited information about the glycan determinants recognized by glycan-binding proteins (GBPs), which include lectins, receptors, toxins, microbial adhesins, antibodies, and enzymes. Available evidence indicates that GBP binding sites may accommodate glycan determinants made up of 2 to 6 linear monosaccharides, together with their potential side chains containing other sugars and modifications, such as sulfation, phosphorylation, and acetylation. Glycosaminoglycans, including heparin and heparan sulfate, comprise repeating disaccharide motifs, where a linear sequence of 5 to 6 monosaccharides may be required for recognition. Based on our current knowledge of the composition of the glycome and the size of GBP binding sites, glycoproteins and glycolipids may contain approximately 3000 glycan determinants with an additional approximately 4000 theoretical pentasaccharide sequences in glycosaminoglycans. These numbers provide an achievable target for new chemical and/or enzymatic syntheses, and raise new challenges for defining the total glycome and the determinants recognized by GBPs. PMID: 19756298 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-278.html</link>
      <description> Related Articles Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice. Glycobiology. 2010 Jan;20(4):485-97 Authors: Takamatsu S, Antonopoulos A, Ohtsubo K, Ditto D, Chiba Y, Le DT, Morris HR, Haslam SM, Dell A, Marth JD, Taniguchi N N-Acetylglucosaminyltransferase-IV (GnT-IV) has two isoenzymes, GnT-IVa and GnT-IVb, which initiate the GlcNAcbeta1-4 branch synthesis on the Manalpha1-3 arm of the N-glycan core thereby increasing N-glyca ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:15 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-278.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice. Glycobiology. 2010 Jan;20(4):485-97 Authors: Takamatsu S, Antonopoulos A, Ohtsubo K, Ditto D, Chiba Y, Le DT, Morris HR, Haslam SM, Dell A, Marth JD, Taniguchi N N-Acetylglucosaminyltransferase-IV (GnT-IV) has two isoenzymes, GnT-IVa and GnT-IVb, which initiate the GlcNAcbeta1-4 branch synthesis on the Manalpha1-3 arm of the N-glycan core thereby increasing N-glycan branch complexity and conferring endogenous lectin binding epitopes. To elucidate the physiological significance of GnT-IV, we engineered and characterized GnT-IVb-deficient mice and further generated GnT-IVa/-IVb double deficient mice. In wild-type mice, GnT-IVa expression is restricted to gastrointestinal tissues, whereas GnT-IVb is broadly expressed among organs. GnT-IVb deficiency induced aberrant GnT-IVa expression corresponding to the GnT-IVb distribution pattern that might be attributed to increased Ets-1, which conceivably activates the Mgat4a promoter, and thereafter preserved apparent GnT-IV activity. The compensative GnT-IVa expression might contribute to amelioration of the GnT-IVb-deficient phenotype. GnT-IVb deficiency showed mild phenotypic alterations in hematopoietic cell populations and hemostasis. GnT-IVa/-IVb double deficiency completely abolished GnT-IV activity that resulted in the disappearance of the GlcNAcbeta1-4 branch on the Manalpha1-3 arm that was confirmed by MALDI-TOF MS and GC-MS linkage analyses. Comprehensive glycomic analyses revealed that the abundance of terminal moieties was preserved in GnT-IVa/-IVb double deficiency that was due to the elevated expression of glycosyltransferases regarding synthesis of terminal moieties. Thereby, this may maintain the expression of glycan ligands for endogenous lectins and prevent cellular dysfunctions. The fact that the phenotype of GnT-IVa/-IVb double deficiency largely overlapped that of GnT-IVa single deficiency can be attributed to the induced glycomic compensation. This is the first report that mammalian organs have highly organized glycomic compensation systems to preserve N-glycan branch complexity. PMID: 20015870 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>How does a medical doctor become a glycobiologist.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-262.html</link>
      <description>Related Articles How does a medical doctor become a glycobiologist. Biochim Biophys Acta. 2009 Sep;1792(9):824 Authors: Hennet T PMID: 19894337 [PubMed - indexed for MEDLINE]</description>
        <pubDate>Tue, 13 Jul 2010 01:01:15 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-262.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles How does a medical doctor become a glycobiologist. Biochim Biophys Acta. 2009 Sep;1792(9):824 Authors: Hennet T  PMID: 19894337 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Programmable nano-bio-chips: multifunctional clinical tools for use at the point-of-care.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-280.html</link>
      <description>Related Articles Programmable nano-bio-chips: multifunctional clinical tools for use at the point-of-care. Nanomedicine (Lond). 2010 Jan;5(1):143-55 Authors: Jokerst JV, McDevitt JT A new generation of programmable diagnostic devices is needed to take advantage of information generated from the study of genomics, proteomics, metabolomics and glycomics. This report describes the &apos;programmable nano-bio-chip&apos; with potential to bridge the significant scientific, technology and clinical gaps through  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:15 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-280.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Programmable nano-bio-chips: multifunctional clinical tools for use at the point-of-care. Nanomedicine (Lond). 2010 Jan;5(1):143-55 Authors: Jokerst JV, McDevitt JT A new generation of programmable diagnostic devices is needed to take advantage of information generated from the study of genomics, proteomics, metabolomics and glycomics. This report describes the 'programmable nano-bio-chip' with potential to bridge the significant scientific, technology and clinical gaps through the creation of a diagnostic platform to measure the molecules of life. This approach, with results at the point-of-care, possesses capabilities for measuring such diverse analyte classes as cells, proteins, DNA and small molecules in the same compact device. Applications such as disease diagnosis and prognosis for areas including cancer, heart disease and HIV are described. New diagnostic panels are inserted as 'plug and play' elements into the modular platform with universal assay operating systems and standard read out sequences. The nano-bio-chip ensemble exhibits excellent analytical performance and cost-effectiveness with extensive validation versus standard reference methods (R(2) = 0.95-0.99). This report describes the construction and use of two major classes of nano-bio-chip designs that serve as cellular and chemical processing units, and provides perspective on future growth in this newly emerging field of programmable nano-bio-chip sensor systems. PMID: 20025471 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Quantitative glycomics from fluidic glycan microarrays.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-232.html</link>
      <description>Related Articles Quantitative glycomics from fluidic glycan microarrays. J Am Chem Soc. 2009 Sep 30;131(38):13646-50 Authors: Zhu XY, Holtz B, Wang Y, Wang LX, Orndorff PE, Guo A A hallmark of cell-surface processes involving glycans is their multivalent interaction with glycan binding proteins (GBPs). Such a multivalent interaction depends critically on the mobility and density of signaling molecules on the membrane surface. While glycan microarrays have been used in exploring multivalent inter ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:15 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-232.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Quantitative glycomics from fluidic glycan microarrays. J Am Chem Soc. 2009 Sep 30;131(38):13646-50 Authors: Zhu XY, Holtz B, Wang Y, Wang LX, Orndorff PE, Guo A A hallmark of cell-surface processes involving glycans is their multivalent interaction with glycan binding proteins (GBPs). Such a multivalent interaction depends critically on the mobility and density of signaling molecules on the membrane surface. While glycan microarrays have been used in exploring multivalent interactions, the lack of mobility and the difficulty in controlling surface density both limit their quantitative applications. Here we apply a fluidic glycan microarray, with glycan density varying for orders of magnitude, to profile cell surface interaction using a model system, the adhesion of Escherichia coli to mannose. We show the quantitative determination of monovalent and multivalent adhesion channels; the latter can be inhibited by nanopartices presenting a high density of mannosyl groups. These results reveal a new E. coli adhesion mechanism: the switching in the FimH adhesion protein avidity from monovalent to multivalent as the density of mobile mannosyl groups increases; such avidity switching enhances binding affinity and triggers multiple fimbriae anchoring. Affinity enhancement toward FimH has only been observed before for oligo-mannose due to the turn on of secondary interactions outside the mannose binding pocket. We suggest that the new mechanism revealed by the fluidic microarray is of general significance to cell surface interactions: the dynamic clustering of simple sugar groups (homogeneous or heterogeneous) on the fluidic membrane surface may simulate the functions of complex glycan molecules. PMID: 19731906 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Development of a microtiter plate-based glycosaminoglycan array for the investigation of glycosaminoglycan-protein interactions.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-231.html</link>
      <description> Related Articles Development of a microtiter plate-based glycosaminoglycan array for the investigation of glycosaminoglycan-protein interactions. Glycobiology. 2009 Dec;19(12):1537-46 Authors: Marson A, Robinson DE, Brookes PN, Mulloy B, Wiles M, Clark SJ, Fielder HL, Collinson LJ, Cain SA, Kielty CM, McArthur S, Buttle DJ, Short RD, Whittle JD, Day AJ The interactions of glycosaminoglycans (GAGs) with proteins underlie a wide range of important biological processes. However, the study of such  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:01:15 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-231.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Development of a microtiter plate-based glycosaminoglycan array for the investigation of glycosaminoglycan-protein interactions. Glycobiology. 2009 Dec;19(12):1537-46 Authors: Marson A, Robinson DE, Brookes PN, Mulloy B, Wiles M, Clark SJ, Fielder HL, Collinson LJ, Cain SA, Kielty CM, McArthur S, Buttle DJ, Short RD, Whittle JD, Day AJ The interactions of glycosaminoglycans (GAGs) with proteins underlie a wide range of important biological processes. However, the study of such binding reactions has been hampered by the lack of a simple frontline analysis technique. Previously, we have reported that cold plasma polymerization can be used to coat microtiter plate surfaces with allyl amine to which GAGs (e.g., heparin) can be noncovalently immobilized retaining their ability to interact with proteins. Here, we have assessed the capabilities of surface coats derived from different ratios of allyl amine and octadiene (100:0 to 0:100) to support the binding of diverse GAGs (e.g., chondroitin-4-sulfate, dermatan sulfate, heparin preparations, and hyaluronan) in a functionally active state. The Link module from TSG-6 was used as a probe to determine the level of functional binding because of its broad (and unique) specificity for both sulfated and nonsulfated GAGs. All of the GAGs tested could bind this domain following their immobilization, although there were clear differences in their protein-binding activities depending on the surface chemistry to which they were adsorbed. On the basis of these experiments, 100% allyl amine was chosen for the generation of a microtiter plate-based "sugar array"; X-ray photoelectron spectroscopy revealed that similar relative amounts of chondroitin-4-sulfate, dermatan sulfate, and heparin (including two selectively de-sulfated derivatives) were immobilized onto this surface. Analysis of four unrelated proteins (i.e., TSG-6, complement factor H, fibrillin-1, and versican) illustrated the utility of this array to determine the GAG-binding profile and specificity for a particular target protein. PMID: 19729381 [PubMed - indexed for MEDLINE]
    ]]> </content:encoded>
                                </item>
  <item>
  <title>SELDI-TOF serum proteomics and colorectal cancer: A current overview.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-105.html</link>
      <description>Related Articles SELDI-TOF serum proteomics and colorectal cancer: A current overview. Arch Physiol Biochem. 2010 Jul 8; Authors: Gemoll T, Roblick UJ, Auer G, JÃ¶rnvall H, Habermann JK Surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) is a widely used technology platform for diagnostic biomarker discovery in tissue, plasma and serum. High-throughput and simplicity of experimental procedures have allowed this technology to become an important researc ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-105.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles SELDI-TOF serum proteomics and colorectal cancer: A current overview. Arch Physiol Biochem. 2010 Jul 8; Authors: Gemoll T, Roblick UJ, Auer G, JÃ¶rnvall H, Habermann JK Surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) is a widely used technology platform for diagnostic biomarker discovery in tissue, plasma and serum. High-throughput and simplicity of experimental procedures have allowed this technology to become an important research tool for biomarker discovery during the last years. This review provides an overview of SELDI-TOF functionality, its advantages and drawbacks and gives a current literature overview of colorectal cancer based serum biomarker detection. Further improvements in instrumentation sensitivity and labelling chemistries will enable detection of novel, tissue-leakage biomarkers in serum. However, major emphasis should be given on subsequent identification of differentially observed protein peaks detected by SELDI-TOF. Clinical validation in large patient cohorts will then allow transferring novel biomarkers into clinical use. PMID: 20615064 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：関連の記事SELDI-TOFの血清のproteomicsおよびcolorectal癌: 現在の概観。 アーチのPhysiol Biochem。 7月2010日8日; 著者: Gemoll T、Roblick UJ、Auer G、JÃ¶rnvall H、Habermann JKは高められたレーザーの脱着浮上するまたはイオン化時間の飛行質量分析(SELDI-TOF-MS)はティッシュ、血しょうおよび血清の診断biomarkerの発見のための広く利用された技術のプラットホームである。 実験プロシージャの高効率そして簡易性はこの技術が最後の年の間にbiomarkerの発見のための重要な研究用具になるようにした。 この検討はSELDI-TOFの機能性、利点および欠点の概観を提供し、colorectal癌によって基づく血清のbiomarkerの検出の現在の文献の概観を与える。 器械使用の感受性のそれ以上の改善および分類化学は小説、血清のティッシュ漏出biomarkersの検出を可能にする。 但し、SELDI-TOFによって検出される特異的に観察された蛋白質のピークのそれに続く同一証明の主な重点は与えられるべきである。 大きく忍耐強いグループの臨床確認はそれから臨床使用に新しいbiomarkersを移すことを割り当てる。 PMID: -出版業者によって供給される… 20615064 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Discovery and identification of potential biomarkers of papillary thyroid carcinoma.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-155.html</link>
      <description> Related Articles Discovery and identification of potential biomarkers of papillary thyroid carcinoma. Mol Cancer. 2009;8:79 Authors: Fan Y, Shi L, Liu Q, Dong R, Zhang Q, Yang S, Fan Y, Yang H, Wu P, Yu J, Zheng S, Yang F, Wang J ABSTRACT: BACKGROUND: Thyroid carcinoma is the most common endocrine malignancy and a common cancer among the malignancies of head and neck. Noninvasive and convenient biomarkers for diagnosis of papillary thyroid carcinoma (PTC) as early as possible remain an urgent n ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-155.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Discovery and identification of potential biomarkers of papillary thyroid carcinoma. Mol Cancer. 2009;8:79 Authors: Fan Y, Shi L, Liu Q, Dong R, Zhang Q, Yang S, Fan Y, Yang H, Wu P, Yu J, Zheng S, Yang F, Wang J ABSTRACT: BACKGROUND: Thyroid carcinoma is the most common endocrine malignancy and a common cancer among the malignancies of head and neck. Noninvasive and convenient biomarkers for diagnosis of papillary thyroid carcinoma (PTC) as early as possible remain an urgent need. The aim of this study was to discover and identify potential protein biomarkers for PTC specifically. METHODS: Two hundred and twenty four (224) serum samples with 108 PTC and 116 controls were randomly divided into a training set and a blind testing set. Serum proteomic profiles were analyzed using SELDI-TOF-MS. Candidate biomarkers were purified by HPLC, identified by LC-MS/MS and validated using ProteinChip immunoassays. RESULTS: A total of 3 peaks (m/z with 9190, 6631 and 8697 Da) were screened out by support vector machine (SVM) to construct the classification model with high discriminatory power in the training set. The sensitivity and specificity of the model were 95.15% and 93.97% respectively in the blind testing set. The candidate biomarker with m/z of 9190 Da was found to be up-regulated in PTC patients, and was identified as haptoglobin alpha-1 chain. Another two candidate biomarkers (6631, 8697 Da) were found down-regulated in PTC and identified as apolipoprotein C-I and apolipoprotein C-III, respectively. In addition, the level of haptoglobin alpha-1 chain (9190 Da) progressively increased with the clinical stage I, II, III and IV, and the expression of apolipoprotein C-I and apolipoprotein C-III (6631, 8697 Da) gradually decreased in higher stages. CONCLUSION: We have identified a set of biomarkers that could discriminate PTC from non-cancer controls. An efficient strategy, including SELDI-TOF-MS analysis, HPLC purification, MALDI-TOF-MS trace and LC-MS/MS identification, has been proved successful. PMID: 19785722 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-107.html</link>
      <description> Related Articles Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays. Proteomics. 2009 Apr;9(8):2182-92 Authors: Ueda K, Fukase Y, Katagiri T, Ishikawa N, Irie S, Sato TA, Ito H, Nakayama H, Miyagi Y, Tsuchiya E, Kohno N, Shiwa M, Nakamura Y, Daigo Y To screen for glycoproteins showing aberrant sialylation patterns in sera of cancer patients and apply such information for biomarker identification, we performe ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-107.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays. Proteomics. 2009 Apr;9(8):2182-92 Authors: Ueda K, Fukase Y, Katagiri T, Ishikawa N, Irie S, Sato TA, Ito H, Nakayama H, Miyagi Y, Tsuchiya E, Kohno N, Shiwa M, Nakamura Y, Daigo Y To screen for glycoproteins showing aberrant sialylation patterns in sera of cancer patients and apply such information for biomarker identification, we performed SELDI-TOF MS analysis coupled with lectin-coupled ProteinChip arrays (Jacalin or SNA) using sera obtained from lung cancer patients and control individuals. Our approach consisted of three processes (i) removal of 14 abundant proteins in serum, (ii) enrichment of glycoproteins with lectin-coupled ProteinChip arrays, and (iii) SELDI-TOF MS analysis with acidic glycoprotein-compatible matrix. We identified 41 protein peaks showing significant differences (p<0.05) in the peak levels between the cancer and control groups using the Jacalin- and SNA-ProteinChips. Among them, we identified loss of Neu5Ac (alpha2,6) Gal/GalNAc structure in apolipoprotein C-III (apoC-III) in cancer patients through subsequent MALDI-QIT-TOF MS/MS. Furthermore, subsequent validation experiments using an additional set of 60 lung adenocarcinoma patients and 30 normal controls demonstrated that there is a higher frequency of serum apoC-III with loss of alpha2,6-linkage Neu5Ac residues in lung cancer patients compared to controls. Our results have demonstrated that lectin-coupled ProteinChip technology allows the high-throughput and specific recognition of cancer-associated aberrant glycosylations, and implied a possibility of its applicability to studies on other diseases. PMID: 19322776 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の肺ProteinChipのlectinつながれた配列を使用して癌準のglycosylationの無秩序の発見のための記事によって目標とされる血清のglycoproteomics。 Proteomics。 4月2009日; 9 (8): 2182-92書く: Ueda K、Fukase Y、Katagiri T、石川N、Irie S、佐藤TA、Ito H、Nakayama H、宮城Y、Tsuchiya E、Kohno N、Shiwa M、Nakamura Y、癌患者の血清で異常なsialylationパターンを示す糖蛋白質のためのスクリーンへのDaigo Yはbiomarkerの同一証明のためのそのような情報を適用し、私達はProteinChipのlectinつながれた配列と肺癌の患者および制御個人から得られた血清を使用して(JacalinかSNA)つながれたSELDI-TOF MSの分析を行った。 私達のアプローチは血清の14の豊富な蛋白質の3つのプロセス(i)取り外しから、(ii) ProteinChipのlectinつながれた配列を用いる糖蛋白質の強化、および(iii)酸性糖蛋白質互換性があるマトリックスとのSELDI-TOF MSの分析成っていた。 私達は重要な相違(p&ltを示す41の蛋白質のピークを識別した; Jacalin-およびSNAProteinChipsを使用して癌と制御グループ間のピークレベルの0.05)。 その中で、私達はそれに続くMALDI-QIT-TOF MS/MS.によってNeu5Ac (alpha2,6)の損失を癌患者のapolipoprotein C-III (apoC-III)のGalまたはGalNAcの構造識別した。 なお、付加的な一組の60人の肺腺癌の患者および30の正常な制御を使用してそれに続く確認の実験は制御と比較される肺癌の患者のalpha2,6連結Neu5Ac残余の損失の血清のapoC-IIIのより高い頻度があることを示した。 私達の結果はProteinChipのlectinつながれた技術が癌準の異常なglycosylationsの高効率そして特定の認識を可能にし、他の病気の調査に適用の可能性の可能性を意味したことを示した。 PMID: 19322776 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-156.html</link>
      <description>Related Articles Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling. Int J Biol Markers. 2009 Jul-Sep;24(3):130-41 Authors: Gast MC, van Dulken EJ, van Loenen TK, Kingma-Vegter F, Westerga J, Flohil CC, Knol JC, Jimenez CR, van Gils CH, Wessels LF, Schellens JH, Beijnen JH AIM: Novel diagnostic breast cancer markers have been extensively searched for in the proteome, using, among others, surface-enhanced  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-156.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling. Int J Biol Markers. 2009 Jul-Sep;24(3):130-41 Authors: Gast MC, van Dulken EJ, van Loenen TK, Kingma-Vegter F, Westerga J, Flohil CC, Knol JC, Jimenez CR, van Gils CH, Wessels LF, Schellens JH, Beijnen JH AIM: Novel diagnostic breast cancer markers have been extensively searched for in the proteome, using, among others, surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS). Thus far, the majority of SELDI-TOF MS studies have investigated samples originating from biorepositories, which hampers biomarker discovery as they likely suffer from variable adherence to collection protocols. MATERIAL AND METHODS: We investigated breast cancer (n=75) and control (n=26) serum and tissue samples, collected prospectively by rigorous adherence to a strictly defined protocol. Sera were collected preoperatively and postoperatively, and serum and tissue samples were analyzed by SELDI-TOF MS using the IMAC30 Ni and Q10 pH 8 array. RESULTS: Three serum peaks were significantly associated with breast cancer, while in tissue, 27 discriminative peaks were detected. Several peak clusters gradually increased or decreased in intensity from healthy to benign to cancer, or with increasing cancer stage. The constructed classification trees had a tenfold cross-validated performance of 67% to 87%. Two tissue peaks were identified as N-terminal albumin fragments. These are likely to have been generated by (breast) cancer-specific proteolytic activity in the tumor microenvironment. CONCLUSIONS: These albumin fragment scan potentially provide insights into the pathophysiological mechanisms associated with, or underlying, breast cancer, and aid in improving breast cancer diagnosis. PMID: 19787623 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：表面高められたレーザーの脱着またはイオン化時間の飛行質量分析のティッシュおよび血清蛋白質の側面図を描くことによる乳癌の関連の記事の検出。 Int J Biolのマーカー。 2009日7月9月; 24 (3): 130-41書く: Gast MC、van Dulken EJ、van Loenen TK、Kingma-Vegter F、Westerga J、Flohil CC、Knol JCのヒメネスのCR、van Gils CH、Wessels LF、Schellens JHのBeijnen JHの目標: 新しい診断乳癌のマーカーは他、表面高められたレーザーの脱着またはイオン化時間の飛行質量分析(SELDI-TOF MS)の中のproteomeをで広く、を使用して、捜された。 これまで、biomarkerの発見を妨げる可変的な付着にコレクションの議定書への多分苦しむと同時にSELDI-TOF MSの調査の大半はbiorepositoriesから起きるサンプルを調査した。 材料および方法: 私達は乳癌(n=75)および制御(n=26)血清および厳しく定義された議定書への厳密な付着によって将来集められた組織サンプルを調査した。 血清はpreoperativelyそしてpostoperatively集められ、血清および組織サンプルはIMAC30 NIおよびQ10 pH 8の配列を使用しているSELDI-TOF MSによって分析された。 結果: 3つの血清のピークは乳癌とかなり、がティッシュで、27の区別的なピーク検出された関連付けられた。 複数のピークの集りは癌、または増加する癌の段階とにに強度で次第に健康からの温和増加するか、または減った。 組み立てられた分類の木に67%から87%の10倍の十字認可された性能があった。 2つのティッシュのピークはNターミナルアルブミンの片として識別された。 これらは本当らしい(胸)腫瘍の小生息区の癌特定の蛋白質分解活動によって発生するために。 結論: これらのアルブミンの片スキャンはと関連付けられか、または乳癌の診断の改善の下にあり、乳癌そして援助病態生理学的なメカニズムに可能性としては洞察力を提供する。 PMID: 19787623 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Evaluation of two different albumin depletion strategies for improved analysis of human CSF by SELDI-TOF-MS.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-109.html</link>
      <description> Related Articles Evaluation of two different albumin depletion strategies for improved analysis of human CSF by SELDI-TOF-MS. Clin Biochem. 2009 Jul;42(10-11):1136-43 Authors: Siegmund R, Kiehntopf M, Deufel T OBJECTIVES: Two different depletion strategies for removing albumin from human cerebrospinal fluid (CSF), Microcon Centrifugal Filter vs. Montage Albumin Deplete kit, were evaluated for improving protein profiling pattern and reproducibility in SELDI analysis. DESIGN AND METHODS: Pooled C ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-109.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Evaluation of two different albumin depletion strategies for improved analysis of human CSF by SELDI-TOF-MS. Clin Biochem. 2009 Jul;42(10-11):1136-43 Authors: Siegmund R, Kiehntopf M, Deufel T OBJECTIVES: Two different depletion strategies for removing albumin from human cerebrospinal fluid (CSF), Microcon Centrifugal Filter vs. Montage Albumin Deplete kit, were evaluated for improving protein profiling pattern and reproducibility in SELDI analysis. DESIGN AND METHODS: Pooled CSF was divided into 20 aliquots and these aliquots were subjected to SELDI analysis either after albumin depletion or without preprocessing. Protein profiles were obtained by using CM10, Q10 and IMAC chips. RESULTS: Both strategies resulted in reliable albumin depletion (<6.2 mg/L, filter; 8.1 mg/L, depletion kit). Investigated methods of albumin depletion showed no significant differences in coefficients of variation (CVs) of peak intensities compared to unprocessed CSF on almost all chip types. Peak intensities were significantly higher after albumin depletion compared to CSF without preprocessing on Q10 and on CM10 chips. Nevertheless, the two strategies of albumin depletion led to a decrease in the number of detected peaks on all chip types compared to unprocessed CSF, but several additional peaks, not detected in unprocessed CSF, occurred. CONCLUSIONS: This study demonstrates that reduction of sample complexity by albumin depletion of CSF can be performed without CV impairment. However, the significance of this strategy needs to be evaluated separately for each individual biomarker discovery study. PMID: 19327347 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： SELDI-TOF-MSによる人間CSFの改善された分析のための2つのアルブミンの枯渇の作戦の関連の記事の評価。 Clin Biochem。 7月2009日; 42 (10-11): 1136-43書く: Siegmund R、Kiehntopf MのDeufel Tの目的: 人間の脳脊髄液体(CSF)からアルブミンを、Microconの遠心フィルター対モンタージュのアルブミン取除くための2つの枯渇の作戦はキットを減らしたり、SELDIの分析のパターンそして再現性の側面図を描く蛋白質を改良するために評価された。 設計および方法: 分かち合われたCSFは20の因数に分けられ、これらの因数はアルブミンの枯渇の後でまたは前処理なしでSELDIの分析に服従した。 蛋白質のプロフィールはCM10、Q10およびIMACの破片の使用によって得られた。 結果: 作戦は両方とも信頼できるアルブミンの枯渇(&ltで起因した; 6.2 mg/Lのフィルター; 8.1 mg/Lの枯渇のキット)。 アルブミンの枯渇の調査された方法はほとんどすべての破片のタイプの加工されていないCSFと比較されたピーク強度の変化(CVs)の係数で重要な相違を示さなかった。 ピーク強度はアルブミンの枯渇がCSFとQ10とCM10破片で調査分析しないで比較した後かなりより高かった。 それにもかかわらず、すべての破片のタイプの検出されたピークの数の減少に導かれたアルブミンの枯渇の2つの作戦は加工されていないCSF、起こった加工されていないCSFで検出されなかった複数の付加的なピークと、比較した。 結論: この調査はCSFのアルブミンの枯渇によるサンプル複雑さの減少がCVの減損なしで行うことができることを示す。 但し、この作戦の重大さは各々の個々のbiomarkerの発見の調査のために別に評価される必要がある。 PMID: 19327347 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-157.html</link>
      <description> Related Articles Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions. Toxicol Appl Pharmacol. 2010 Jan 1;242(1):47-55 Authors: Kakehashi A, Kato A, Inoue M, Ishii N, Okazaki E, Wei M, Tachibana T, Wanibuchi H To search for a reliable biomarker of preneoplastic lesions arising early in mouse hepatocarcinogenesis the proteomes of microdissected basophilic foci, hepatocellular adenomas (HCAs), carcinomas (HCCs) and normal-appearing liver of B6C3F1 mice initiated with diethylnitro ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-157.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions. Toxicol Appl Pharmacol. 2010 Jan 1;242(1):47-55 Authors: Kakehashi A, Kato A, Inoue M, Ishii N, Okazaki E, Wei M, Tachibana T, Wanibuchi H To search for a reliable biomarker of preneoplastic lesions arising early in mouse hepatocarcinogenesis the proteomes of microdissected basophilic foci, hepatocellular adenomas (HCAs), carcinomas (HCCs) and normal-appearing liver of B6C3F1 mice initiated with diethylnitrosamine (DEN) were analysed on anionic (Q10) surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) ProteinChip arrays. Significant overexpression of cytokeratin 8 (CK8; m/z 54, 565), cytokeratin 18 (CK18; m/z 47,538) proteins was found in basophilic foci as well as in HCAs and HCCs. Furthermore, immunohistochemistry demonstrated profound overexpression of CK8 and CK18 proteins (CK8/18) in all basophilic foci, mixed cell type foci, HCAs and HCCs in B6C3F1 and C57BL/6J mice initiated with DEN. A strong correlation between CK8/18-positive foci development and multiplicity of liver tumors in B6C3F1 and C57Bl/6J mice was further observed. Moreover, formation of CK8 and CK18 complexes due to CK8 phosphorylation at Ser73 and Ser431 was found to be strongly associated with neoplastic transformation of mice liver basophilic foci. Elevation of CK8/18 was strongly correlated with induction of cell proliferation in basophilic foci and tumors. In conclusion, our data imply that CK8/18 is a novel reliable marker of preneoplastic lesions arising during mouse hepatocarcinogenesis which might be used for prediction of tumor development and evaluation of environmental agents as well as drugs and food additives using mouse liver tests. PMID: 19796649 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： マウスのレバーpreneoplastic損害の新しいマーカーとして関連の記事Cytokeratin 8/18。 Toxicol Appl Pharmacol。 1月2010日1日; 242 (1): 47-55書く: Kakehashi A、Kato A、Inoue M、Ishii N、岡崎E、魏M、マウスのhepatocarcinogenesisで早く起こるpreneoplastic損害の信頼できるbiomarkerを捜すTachibana T、Wanibuchi H microdissected basophilic焦点のproteomesを、hepatocellularアデノーマ(HCAs)、癌腫(HCCs)およびdiethylnitrosamine (洞穴)と始められた質量分析(SELDI-TOF-MS) ProteinChipが配列する陰イオンの(Q10)表面高められたレーザーの脱着またはイオン化時間の飛行でB6C3F1マウスの正常出現のレバーは分析された。 cytokeratin 8 (CK8の重要なoverexpression; m/z 54、565)、cytokeratin 18 (CK18; m/z 47,538)蛋白質はおよびHCCsと同様、HCAsのbasophilic焦点で見つけられた。 なお、洞穴と始められるB6C3F1およびC57BL/6Jのマウスのすべてのbasophilic焦点、混合された細胞のタイプ焦点、HCAsおよびHCCsのCK8およびCK18蛋白質のimmunohistochemistry示された深遠なoverexpression (CK8/18)。 B6C3F1およびC57Bl/6Jのマウスのレバー腫瘍のCK8/18肯定的な焦点の開発と多様性間の強い相関関係は更に観察された。 さらに、Ser73およびSer431でCK8リン酸化によるCK8およびCK18複合体の形成は強くマウスのレバーbasophilic焦点のneoplastic変形と関連付けられると見つけられた。 CK8/18の高度はbasophilic焦点および腫瘍の細胞増殖の誘導に強く関連した。 結論として、私達のデータはCK8/18が腫瘍の開発の予言および薬剤および食品添加物と同様、マウスのレバーテストを使用して環境の代理店の評価に使用するかもしれないマウスのhepatocarcinogenesisの間に起こるpreneoplastic損害の新しい信頼できるマーカーであることを意味する。 PMID: 19796649 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of biomarkers for risk stratification of cardiovascular events using genetic algorithm with recursive local floating search.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-111.html</link>
      <description> Related Articles Identification of biomarkers for risk stratification of cardiovascular events using genetic algorithm with recursive local floating search. Proteomics. 2009 Apr;9(8):2286-94 Authors: Zhou X, Wang H, Wang J, Wang Y, Hoehn G, Azok J, Brennan ML, Hazen SL, Li K, Chang SF, Wong ST Conventional biomarker discovery focuses mostly on the identification of single markers and thus often has limited success in disease diagnosis and prognosis. This study proposes a method to identify an o ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-111.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Identification of biomarkers for risk stratification of cardiovascular events using genetic algorithm with recursive local floating search. Proteomics. 2009 Apr;9(8):2286-94 Authors: Zhou X, Wang H, Wang J, Wang Y, Hoehn G, Azok J, Brennan ML, Hazen SL, Li K, Chang SF, Wong ST Conventional biomarker discovery focuses mostly on the identification of single markers and thus often has limited success in disease diagnosis and prognosis. This study proposes a method to identify an optimized protein biomarker panel based on MS studies for predicting the risk of major adverse cardiac events (MACE) in patients. Since the simplicity and concision requirement for the development of immunoassays can only tolerate the complexity of the prediction model with a very few selected discriminative biomarkers, established optimization methods, such as conventional genetic algorithm (GA), thus fails in the high-dimensional space. In this paper, we present a novel variant of GA that embeds the recursive local floating enhancement technique to discover a panel of protein biomarkers with far better prognostic value for prediction of MACE than existing methods, including the one approved recently by FDA (Food and Drug Administration). The new pragmatic method applies the constraints of MACE relevance and biomarker redundancy to shrink the local searching space in order to avoid heavy computation penalty resulted from the local floating optimization. The proposed method is compared with standard GA and other variable selection approaches based on the MACE prediction experiments. Two powerful classification techniques, partial least squares logistic regression (PLS-LR) and support vector machine classifier (SVMC), are deployed as the MACE predictors owing to their ability in dealing with small scale and binary response data. New preprocessing algorithms, such as low-level signal processing, duplicated spectra elimination, and outliner patient's samples removal, are also included in the proposed method. The experimental results show that an optimized panel of seven selected biomarkers can provide more than 77.1% MACE prediction accuracy using SVMC. The experimental results empirically demonstrate that the new GA algorithm with local floating enhancement (GA-LFE) can achieve the better MACE prediction performance comparing with the existing techniques. The method has been applied to SELDI/MALDI MS datasets to discover an optimized panel of protein biomarkers to distinguish disease from control. PMID: 19337989 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Serum proteomics of glioma: methods and applications.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-158.html</link>
      <description>Related Articles Serum proteomics of glioma: methods and applications. Expert Rev Mol Diagn. 2009 Oct;9(7):695-707 Authors: Somasundaram K, Nijaguna MB, Kumar DM The prognosis of patients with glioblastoma, the most malignant adult glial brain tumor, remains poor in spite of advances in treatment procedures, including surgical resection, irradiation and chemotherapy. Genetic heterogeneity of glioblastoma warrants extensive studies in order to gain a thorough understanding of the biology of this  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-158.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Serum proteomics of glioma: methods and applications. Expert Rev Mol Diagn. 2009 Oct;9(7):695-707 Authors: Somasundaram K, Nijaguna MB, Kumar DM The prognosis of patients with glioblastoma, the most malignant adult glial brain tumor, remains poor in spite of advances in treatment procedures, including surgical resection, irradiation and chemotherapy. Genetic heterogeneity of glioblastoma warrants extensive studies in order to gain a thorough understanding of the biology of this tumor. While there have been several studies of global transcript profiling of glioma with the identification of gene signatures for diagnosis and disease management, translation into clinics is yet to happen. Serum biomarkers have the potential to revolutionize the process of cancer diagnosis, grading, prognostication and treatment response monitoring. Besides having the advantage that serum can be obtained through a less invasive procedure, it contains molecules at an extraordinary dynamic range of ten orders of magnitude in terms of their concentrations. While the conventional methods, such as 2DE, have been in use for many years, the ability to identify the proteins through mass spectrometry techniques such as MALDI-TOF led to an explosion of interest in proteomics. Relatively new high-throughput proteomics methods such as SELDI-TOF and protein microarrays are expected to hasten the process of serum biomarker discovery. This review will highlight the recent advances in the proteomics platform in discovering serum biomarkers and the current status of glioma serum markers. We aim to provide the principles and potential of the latest proteomic approaches and their applications in the biomarker discovery process. Besides providing a comprehensive list of available serum biomarkers of glioma, we will also propose how these markers will revolutionize the clinical management of glioma patients. PMID: 19817554 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：gliomaの関連の記事の血清のproteomics: 方法および適用。 巧妙なRev. Mol Diagn。 10月2009日; 9 (7): 695-707書く: Somasundaram K、Nijaguna MB、Kumar DMは外科切除、照射および化学療法を含む処置のプロシージャにglioblastomaの患者の予想、悪性の大人のglial脳腫瘍、前進にもかかわらず粗末に、残る。 glioblastomaの遺伝の不均質はこの腫瘍の生物学の完全な理解を得るために広範な調査を保証する。 診断および病気管理のための遺伝子の署名の同一証明が付いているgliomaの全体的なコピーの側面図を描くことの複数の調査の間、医院への翻訳はまだ起こることである。 血清のbiomarkersに癌の診断、等級分け、予言および処置の応答の監視のプロセスを革命化する潜在性がある。 利点を持っていることのほかに血清がより少なく侵略的なプロシージャによって得ることができることそれは集中の点では10の一桁の異常なダイナミックレンジで分子を含んでいる。 従来の方法が、2DEのような、多くの年の間使用中の間、MALDI-TOFのような質量分析の技術によって蛋白質を識別する機能はproteomicsの興味の爆発をもたらした。 SELDI-TOFおよび蛋白質のマイクロアレイのような比較的新しい高効率のproteomics方法は血清のbiomarkerの発見のプロセスを急がせると期待される。 この検討はgliomaの血清のマーカーの血清のbiomarkersそして現状の発見のproteomicsのプラットホームの最近の前進を強調する。 私達はbiomarkerの発見のプロセスの最も最近のproteomicアプローチそして適用の原則そして潜在性を提供することを向ける。 gliomaの利用できる血清のbiomarkersの広範囲のリストの提供のほかに、私達はまたこれらのマーカーがgliomaの患者の臨床管理をいかに革命化するか提案する。 PMID: 19817554 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Analysis of serum proteome profiles of non-Hodgkin lymphoma for biomarker identification.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-113.html</link>
      <description> Related Articles Analysis of serum proteome profiles of non-Hodgkin lymphoma for biomarker identification. J Proteomics. 2009 Aug 20;72(6):952-9 Authors: Zhang MZ, Sun ZC, Fu XR, Nan FF, Fan QX, Wu XA, Geng L, Ma W, Wang RL Serum samples from non-Hodgkin lymphoma (NHL) patients who had not undergone chemotherapy, lymphnoditis patients, and healthy adults were analyzed using surface-enhanced laser desorption-ionization time-of-flight mass spectrometry (SELDI-TOF MS) to detect the differentially  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-113.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Analysis of serum proteome profiles of non-Hodgkin lymphoma for biomarker identification. J Proteomics. 2009 Aug 20;72(6):952-9 Authors: Zhang MZ, Sun ZC, Fu XR, Nan FF, Fan QX, Wu XA, Geng L, Ma W, Wang RL Serum samples from non-Hodgkin lymphoma (NHL) patients who had not undergone chemotherapy, lymphnoditis patients, and healthy adults were analyzed using surface-enhanced laser desorption-ionization time-of-flight mass spectrometry (SELDI-TOF MS) to detect the differentially expressed serum proteins. Models were developed to distinguish between the healthy adult group and the NHL group, with a sensitivity of 69% and specificity of 90%, and between the lymphnoditis group and the NHL group with a sensitivity of 74% and specificity of 84%. A protein with the m/z of M10 197.91 u was expressed at a significantly higher level in the NHL group, compared to the other groups. Furthermore, differences were also significant among different stages of NHL and among samples with different International Prognosis Index (IPI) scores or lactase dehydrogenase (LDH) levels. The three identified proteins may offer a new serological approach for early diagnosis, differential diagnosis, and pathogenic investigation of NHL. And the protein with the m/z of M10 197.91 u may be a new serological biomarker for monitoring treatment response and evaluating the prognosis of patients with NHL. PMID: 19361584 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： biomarkerの同一証明のためのnon-Hodgkinリンパ腫の血清のproteomeのプロフィールの関連の記事の分析。 J Proteomics。 8月2009日20日; 72 (6): 952-9書く: チャンMZ、日曜日ZC、Fu XR、ナンFFのファンQX、ウーXA、化学療法を経なかったnon-Hodgkinリンパ腫(NHL)の患者からのGeng L、Ma W、Wang RLの血清のサンプル、lymphnoditisの患者および健康な大人は表面高められたレーザーの脱着イオン化時間の飛行質量分析(SELDI-TOF MS)を使用して特異的に表現された血清蛋白質を検出するために分析された。 モデルは健康な大人のグループとNHLのグループの間で、69%の感受性および90%の特定性と、そして74%の感受性のlymphnoditisのグループおよびNHLのグループおよび84%の特定性の間で区別するために開発された。 M10 197.91 uのm/zの蛋白質は他のグループと比較されたNHLのグループにかなり高レベルに表現された。 なお、相違はNHLの異なった段階と異なった国際的な予想の索引(IPI)のスコアまたはラクターゼのデヒドロゲナーゼ(LDH)のレベルが付いているサンプル間でまた重要だった。 3つの識別された蛋白質はNHLの早い診断、差動診断および病原性のある調査のための新しい血清学のアプローチを提供するかもしれない。 そしてM10 197.91 uのm/zの蛋白質は監視の処置の応答およびNHLを持つ患者の予想を評価するための新しい血清学のbiomarkerであるかもしれない。 PMID: 19361584 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Classification and diagnostic prediction of colorectal cancer using protein profiling of serum and bioinformatics]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-159.html</link>
      <description>Related Articles [Classification and diagnostic prediction of colorectal cancer using protein profiling of serum and bioinformatics] Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009 Sep;38(5):470-7 Authors: Chen YD, Xie PP, Yu JW, Zhou J, Zheng S OBJECTIVE: To develop a bioinformatic tool and to use it to identify proteomic patterns in serum, distinguishing colorectal cancer from colorectal adenoma and healthy individuals. METHODS: 182 serum samples including 55 colorectal cancer patients, 35 colorectal ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-159.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Classification and diagnostic prediction of colorectal cancer using protein profiling of serum and bioinformatics] Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009 Sep;38(5):470-7 Authors: Chen YD, Xie PP, Yu JW, Zhou J, Zheng S OBJECTIVE: To develop a bioinformatic tool and to use it to identify proteomic patterns in serum, distinguishing colorectal cancer from colorectal adenoma and healthy individuals. METHODS: 182 serum samples including 55 colorectal cancer patients, 35 colorectal adenoma and 92 healthy individuals were subjected to analysis by surface-enhanced laser desorption/ionization (SELDI) mass spectrometry. RESULT: The diagnostic pattern combined of 4 candidate biomarkers (M/Z 5911, 8922, 8 944, and 8817) could separate colorectal patients from healthy control with a specificity of 93.3%, sensitivity of 90.9%, and Youden index value of 0.84242. The diagnostic pattern combined of 7 candidate biomarkers (M/Z 17247, 18420 ,5911, 9294, 4654, 21694, and 21742) could separate colorectal cancer patients from colorectal adenoma patients with a specificity of 83.2%, sensitivity of 89.3%, and Youden index value of 0.72484. CONCLUSION: Combination of SELDI with bioinformatics tool can identify some new biomarkers from the sera of colorectal cancer patients, which has a high sensitivity and specificity to distinguish colorectal cancer patients from healthy control. PMID: 19830859 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：記事の[血清および生物情報学の蛋白質の側面図を描くことを使用してcolorectal癌の分類および診断の予言]浙江関連のDa Xue Xue BaoイXueの禁止。 9月2009日; 38 (5): 470-7書く: 陳YD、Xie PP、Yu JW、Zhou JのZheng Sの目的: bioinformatic用具を発達させ、colorectalアデノーマおよび健康な個人とcolorectal癌を区別する血清のproteomicパターンを識別するのに使用するため。 方法: 55人のcolorectal癌患者、35人のcolorectalアデノーマおよび92人の健康な個人を含む182の血清のサンプルは表面高められたレーザーの脱着またはイオン化(SELDI)質量分析によって分析に服従した。 結果: 4候補者のbiomarkers (M/Z 5911、8922の、8 944および8817)の結合された診断パターンは93.3%の特定性の健康な制御、90.9%の感受性、および0.84242のYoudenのからインデックス値colorectal患者を分けることができる。 7候補者のbiomarkers (M/Z 17247、18420、5911、9294、4654、21694、および21742)の結合された診断パターンは83.2%の特定性、89.3%の感受性、および0.72484のYoudenのインデックス値のcolorectalアデノーマの患者からcolorectal癌患者を分けることができる。 結論: 高い感受性および特定性が健康な制御とcolorectal癌患者を区別するある生物情報学用具とのSELDIの組合せはcolorectal癌患者の血清からのある新しいbiomarkersを識別できる。 PMID: 19830859 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Can serum apolipoprotein C-I demonstrate metabolic abnormality early in women with polycystic ovary syndrome?</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-115.html</link>
      <description> Related Articles Can serum apolipoprotein C-I demonstrate metabolic abnormality early in women with polycystic ovary syndrome? Fertil Steril. 2010 Jun;94(1):205-10 Authors: Huang S, Qiao J, Li R, Wang L, Li M OBJECTIVE: To evaluate the role of apolipoprotein C-I (apoC-I) levels and assess relationships between apoC-I and clinical features in women with polycystic ovary syndrome (PCOS). DESIGN: Prospective study. SETTING: Reproductive Center of Peking University Third Hospital. PATIENT(S): Thirt ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-115.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Can serum apolipoprotein C-I demonstrate metabolic abnormality early in women with polycystic ovary syndrome? Fertil Steril. 2010 Jun;94(1):205-10 Authors: Huang S, Qiao J, Li R, Wang L, Li M OBJECTIVE: To evaluate the role of apolipoprotein C-I (apoC-I) levels and assess relationships between apoC-I and clinical features in women with polycystic ovary syndrome (PCOS). DESIGN: Prospective study. SETTING: Reproductive Center of Peking University Third Hospital. PATIENT(S): Thirty patients with PCOS with insulin resistance, 30 patients with PCOS without insulin resistance, and 30 control individuals. INTERVENTION(S): Fasting serum samples. MAIN OUTCOME MEASURE(S): Measures of serum apoC-I, androgens, total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apoA1, apoB, heat-shock C-reactive protein, glucose, and homeostasis model assessment of insulin resistance (HOMA-IR). RESULT(S): We found differentially expressed proteins by use of the surface-enhanced laser adsorption/ionization (SELDI) protein chip in the serum of women with PCOS and controls. Of these, apoC-I, was highly up-regulated. ApoC-I is associated with glycometabolism and lipid metabolism, but its role in PCOS has been unknown. The serum levels of apoC-I in the patients with PCOS were statistically significantly elevated compared with those of controls, especially in women with insulin resistance. The lean PCOS women had higher apoC-I levels than controls. In patients with PCOS and without any abnormal serum lipid index, apoC-I levels were still higher than in controls. Analysis showed that apoC-I correlated with body mass index, triglycerides, high-density lipoprotein cholesterol, apoA1, and HOMA-IR. CONCLUSION(S): ApoC-I may have an important role in glucose and lipid metabolism, and may be useful for early demonstration of metabolic abnormality in women with PCOS. PMID: 19368908 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事は血清のapolipoprotein CIを示すpolycystic卵巣シンドロームの女性の新陳代謝の異常を早く缶詰にするか。 Fertil Steril。 6月2010日; 94 (1): 205-10書く: 黄S、Qiao J、李R、Wang Lの李Mの目的: apolipoprotein CI (apoC-I)のレベルの役割を評価し、polycystic卵巣シンドローム(PCOS)の女性に於いてのapoC-Iと臨床特徴間の関係を査定するため。 設計: 前向き研究。 設定: 北京大学の第3病院の生殖中心。 患者: インシュリン抵抗性のPCOSの30人の患者、インシュリン抵抗性のないPCOSの30人の患者、および30人の制御個人。 介在: 絶食の血清のサンプル。 主要な結果の手段: 血清のapoC-Iの手段、男性ホルモン、総コレステロール、トリグリセリド、高密度脂蛋白質のコレステロール、低密度脂蛋白質のコレステロール、apoA1のapoBは、インシュリン抵抗性(HOMA-IR)のC反応蛋白質、ブドウ糖およびホメオスタティスモデル査定に熱衝撃を与える。 結果: 私達はPCOSおよび制御を用いる女性の血清の表面高められたレーザーの吸着またはイオン化(SELDI)蛋白質の破片を用いて特異的に表現された蛋白質を見つけた。 これらの、apoC-Iは、非常に調整された。 ApoC-Iはglycometabolismおよび脂質新陳代謝と関連付けられるが、ずっとPCOSに於いての役割は未知である。 PCOSの患者のapoC-Iの血清のレベルは統計的にかなり、特にインシュリン抵抗性の女性の制御のそれらと比較されて上がった。 細いPCOSの女性に制御より高いapoC-Iのレベルがあった。 PCOSのそして異常な血清の脂質の索引のない患者では、apoC-Iのレベルは制御でよりまだ高かった。 分析はapoC-Iが体格指数、トリグリセリド、高密度脂蛋白質のコレステロール、apoA1およびHOMA-IRに関連したことを示した。 結論: ApoC-Iにブドウ糖および脂質新陳代謝に於いての重要な役割がありPCOSの女性に新陳代謝の異常の早いデモンストレーションのために有用かもしれない。 PMID: 19368908 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunction.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-160.html</link>
      <description> Related Articles Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunction. Proteomics. 2009 Nov;9(22):5175-87 Authors: Zimmermann S, Biniossek ML, Maurer C, MÃ?nzer P, Pantic M, Veelken H, Martens UM Telomere dysfunction is evoking a DNA damage response which leads to replicative senescence or apoptosis. Tumor cells feature telomerase, a ribonucleoprotein complex counteracting telomere shortening a ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-160.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunction. Proteomics. 2009 Nov;9(22):5175-87 Authors: Zimmermann S, Biniossek ML, Maurer C, MÃ?nzer P, Pantic M, Veelken H, Martens UM Telomere dysfunction is evoking a DNA damage response which leads to replicative senescence or apoptosis. Tumor cells feature telomerase, a ribonucleoprotein complex counteracting telomere shortening and proliferation limitation as a prerequisite of immortal cell growth. Recently, we demonstrated the effects of telomerase inhibition on the proteome of tumor cell clones in whole cell lysates by SELDI-TOF-MS profiling and MS/MS protein identification (Zimmermann et al., Proteomics 2009, 9, 521-534). We continued proteomic analyses of such clones after telomerase-inhibition using fractionation of cellular compartments. Among the differentially expressed peaks found in different fractions, a cytoplasmic 10.1 kDa protein upregulated in telomerase-inhibited clones (p<0.0001) was identified by nanoflow-HPLC-MS/MS as S100A6. S100A6 upregulation was confirmed by immunoblotting in telomerase-inhibited HCT-116, A-549, and NCI-H460 clones. S100A6 and other proteins involved in telomere dysfunction were further analyzed in derivative p53(-/-) and p21(-/-) HCT-116 cell lines indicating an overall reduced number of significant changes in these lines compared to wild type HCT-116 cells. In addition, post-translational modification of S100A6 was demonstrated with a potential role in mediating the cellular response to telomere dysfunction. In conclusion, proteomic profiling in distinct cellular compartments led to the identification of a novel p53-dependent biomarker of telomere dysfunction, S100A6. PMID: 19834903 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 腫瘍の細胞の明瞭な細胞コンパートメントで側面図を描く関連の記事Proteomicはtelomereの機能障害の誘導にS100A6のp53依存したupregulationを明らかにする。 Proteomics。 11月2009日; 9 (22): 5175-87書く: Zimmermann S、Biniossek ML、マウラーCのMÃの?のnzer P、Pantic M、Veelken HのテンUM Telomereの機能障害はreplicative老衰かapoptosisに導くDNAの損傷の応答を換起している。 腫瘍の細胞は不滅の細胞の成長の前提条件としてtelomerase、リボ核タンパク質の複雑な妨害のtelomereの短縮および拡散の限定を特色にする。 最近、私達は側面図を描くSELDI-TOF-MSおよびMS/MS蛋白質の同一証明(Zimmermann等、Proteomics 2009年、9、521-534)によって全細胞のlysatesの腫瘍の細胞のクローンのproteomeに対するtelomeraseの阻止の効果を示した。 私達は細胞コンパートメントの分別を使用してtelomerase阻止の後でそのようなクローンのproteomic分析を続けた。 異なった一部分で見つけられる特異的に表現されたピークの間telomerase禁じられたクローン(p&ltでupregulated細胞質10.1のkDa蛋白質; 0.0001はS100A6としてnanoflow高性能液体クロマトクラフィーMS/MSによって)識別された。 S100A6 upregulationはtelomerase禁じられたHCT-116、A-549およびNCI-H460クローンのimmunoblottingによって確認された。 S100A6および他蛋白質含まれてでtelomere機能障害あった更に分析されるで派生物p53 (- /-)およびこれらのラインの重要な変更の全面的な減らされた数を示すp21 (- /-) HCT-116細胞ラインは野生のタイプHCT-116の細胞と比較した。 さらに、S100A6のポスト翻訳の修正はtelomereの機能障害への細胞応答を仲介することに於いての潜在的な役割と示された。 結論として、明瞭な細胞コンパートメントでproteomic側面図を描くことはtelomereの機能障害、S100A6の新しいp53依存したbiomarkerの同一証明をもたらした。 PMID: 19834903 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>SELDI-TOF MS detection of urinary hepcidin.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-117.html</link>
      <description> Related Articles SELDI-TOF MS detection of urinary hepcidin. Biochimie. 2009 Oct;91(10):1335-8 Authors: Altamura S, Kiss J, Blattmann C, Gilles W, Muckenthaler MU Hepcidin is a 25-residue hepatic peptide that regulates iron absorption from the diet and tissue iron distribution. Inappropriately low Hepcidin expression is implicated in the pathogenesis of hereditary hemochromatosis and iron-loading anemias, like the thalassemias. Increased hepcidin expression mediates iron retention in the anemia ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-117.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles SELDI-TOF MS detection of urinary hepcidin. Biochimie. 2009 Oct;91(10):1335-8 Authors: Altamura S, Kiss J, Blattmann C, Gilles W, Muckenthaler MU Hepcidin is a 25-residue hepatic peptide that regulates iron absorption from the diet and tissue iron distribution. Inappropriately low Hepcidin expression is implicated in the pathogenesis of hereditary hemochromatosis and iron-loading anemias, like the thalassemias. Increased hepcidin expression mediates iron retention in the anemias of inflammation and plays a pathogenic role in iron-refractory iron-deficiency anemia (IRIDA). Because of its clinical importance, Hepcidin is expected to be a useful biomarker for diagnosis and management of iron-related disorders. So far an ELISA for human hepcidin and SELDI-TOF-MS based approaches have been applied to monitor urinary and/or serum hepcidin levels. Here we report a modified protocol for SELDI-TOF based detection of human, urinary hepcidin. We show that CM10 Proteinchips are superior to NP20 Proteinchips commonly used in previously reported protocols to sensitively and accurately detect urinary hepcidin. Application of this modified hepcidin assay accurately detects increased hepcidin levels in the urine of sepsis patients. PMID: 19393287 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 尿のhepcidinの関連の記事SELDI-TOF MSの検出。 Biochimie。 10月2009日; 91 (10): 1335-8書く: Altamura Sの接吻J、Blattmann C、ギレスW、Muckenthaler MU Hepcidinは食事療法およびティッシュの鉄の配分からの鉄の吸収を調整する25残余の肝臓のペプチッドである。 不適当にHepcidinの低い表現はthalassemiasのような遺伝性のhemochromatosisおよび鉄ローディングの貧血症の病因で、関係する。 高められたhepcidinの表現は発火の貧血症の鉄の保持を仲介し、鉄処理し難い鉄不足の貧血症(IRIDA)の病原性のある役割を担う。 臨床重要性のために、Hepcidinは鉄関係した無秩序の診断そして管理のための有用なbiomarkerであると期待される。 これまでは人間のhepcidinおよびSELDI-TOF-MSによって基づくアプローチのためのELISAは尿モニターおよび/または血清のhepcidinのレベルに適用された。 ここで私達は人間の、尿のhepcidinのSELDI-TOFによって基づく検出のための変更された議定書を報告する。 私達はCM10 Proteinchipsが敏感に前に報告された議定書でそしてであることを正確に一般的なNP20 Proteinchipsより優秀検出する尿のhepcidinを示す。 この変更されたhepcidinの試金の適用は正確にsepsisの患者の尿の増加されたhepcidinのレベルを検出する。 PMID: 19393287 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-161.html</link>
      <description> Related Articles SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease. Clin Biochem. 2010 Jan;43(1-2):168-77 Authors: Gomes-Alves P, Imrie M, Gray RD, Nogueira P, Ciordia S, Pacheco P, Azevedo P, Lopes C, de Almeida AB, Guardiano M, Porteous DJ, Albar JP, Boyd AC, Penque D OBJECTIVES: The aim of this work was to establish protein profiles in serum and nasal epithelial cells of cystic fibrosis individuals in comparison with controls, asthma and chr ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-161.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease. Clin Biochem. 2010 Jan;43(1-2):168-77 Authors: Gomes-Alves P, Imrie M, Gray RD, Nogueira P, Ciordia S, Pacheco P, Azevedo P, Lopes C, de Almeida AB, Guardiano M, Porteous DJ, Albar JP, Boyd AC, Penque D OBJECTIVES: The aim of this work was to establish protein profiles in serum and nasal epithelial cells of cystic fibrosis individuals in comparison with controls, asthma and chronic obstructive pulmonary disease patients for specific biomarker signatures identification. DESIGN AND METHODS: Protein extracts were analyzed by Surface Enhanced Laser Desorption/Ionization Time-Of-Flight Mass-Spectrometry (SELDI-TOF-MS). RESULTS: The mass spectra revealed a set of peaks with differential expression in serum and nasal cells among the different groups studied, resulting into peak signatures representative/specific of each pathology. Logistic regressions were applied to those peaks; sensitivity, specificity, Youden's indexes and area under the curve (AUC) of the respective receiver operating characteristic (ROC) curves were compared. DISCUSSION: Multivariate analysis demonstrated that combination of peaks has a better predictive value than the individual ones. These protein signatures may serve as diagnostic/prognostic markers for the studied diseases with common clinical features, or as follow-up assessment markers of therapeutic interventions. PMID: 19850022 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 嚢胞性線維症、喘息および慢性閉塞性肺疾患のための関連の記事SELDI-TOFのbiomarkerの署名。 Clin Biochem。 1月2010日; 43 (1-2): 168-77書く: Gomes-Alves P、Imrie M、灰色RD、Nogueira P、Ciordia S、Pacheco P、Azevedo Pは、C、de Almeida AB、Guardiano M、Porteous DJ、Albar JP、Boyd ACのPenque Dの目的を軽やかに駆けさせる: この仕事の目標は特定のbiomarkerの署名の同一証明のための制御、喘息および慢性閉塞性肺疾患の患者と比べて嚢胞性線維症の個人の血清そして鼻の上皮細胞に蛋白質のプロフィールを確立することだった。 設計および方法: 蛋白質のエキスはSurface Enhancedレーザーの脱着またはイオン化時間の飛行固まり分光測定(SELDI-TOF-MS)によって分析された。 結果: 多くスペクトルは一組の血清の差動表現のピークを明らかにし、異なったグループ間の鼻の細胞は調査し、各病理学のピーク署名の代表か細目に起因する。 記号論理学退化はそれらのピークに適用された; それぞれの受信機のオペレーティング特性(ROC)のカーブのカーブ(AUC)の下の感受性、特定性、Youdenの索引および区域は比較された。 議論: 多変量解析はピークの組合せに個々の物よりよい予言する価値があることを示した。 これらの蛋白質の署名は共通の臨床特徴との調査された病気のための診断か予想マーカー、または治療上の介在のフォローアップの査定のマーカーとして役立つかもしれない。 PMID: 19850022 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-119.html</link>
      <description> Related Articles The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles. Anticancer Res. 2009 Apr;29(4):1039-45 Authors: Cadron I, Van Gorp T, Amant F, Vergote I, Moerman P, Waelkens E, Daemen A, Van De Plas R, De Moor B, Zeillinger R BACKGROUND: There is a strong need for prognostic biomarkers in ovarian cancer patients due to the heterogeneous responses on current treatment modalities. MATERIALS AND METHODS: This study investigates the feasibil ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-119.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles. Anticancer Res. 2009 Apr;29(4):1039-45 Authors: Cadron I, Van Gorp T, Amant F, Vergote I, Moerman P, Waelkens E, Daemen A, Van De Plas R, De Moor B, Zeillinger R BACKGROUND: There is a strong need for prognostic biomarkers in ovarian cancer patients due to the heterogeneous responses on current treatment modalities. MATERIALS AND METHODS: This study investigates the feasibility of combining laser microdissection (LMD) and surface enhanced laser desorption ionization-time of flight mass spectrometry (SELDI-TOF MS) in ovarian cancer tissue to obtain protein profiles. RESULTS: Ideal conditions for preparing a protein lysate were determined and subsequently analysed on SELDI-TOF MS. Applying these protocols on tissue of 9 ovarian cancer patients showed different protein profiles between platinum sensitive and resistant patients. CONCLUSION: This shows that combining optimised protocols for LMD with SELDI-TOF MS can be used to obtain discriminatory protein profiles. However, studies with large patient numbers and validation sets are essential to identify reliable biomarkers using this approach. PMID: 19414343 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事蛋白質のプロフィールを識別する卵巣癌のティッシュのレーザーのmicrodissectionそしてSELDI-TOF MSの使用。 抗癌性Res。 4月2009日; 29 (4): 1039-45書く: Cadron I、ヴァンGorp T、Amant F、Vergote I、Moerman P、Waelkens E、Daemen A、ヴァンDe Plas R、De Moor BのZeillinger Rの背景: 現在の処置の様相の異質応答による卵巣癌の患者の予想biomarkersのための強い必要性がある。 材料および方法: この調査はレーザーのmicrodissection (LMD)および卵巣癌のティッシュの飛行質量分析(SELDI-TOF MS)の表面によって高められるレーザーの脱着のイオン化時間を結合する可能性を蛋白質のプロフィールを得る調査する。 結果: 蛋白質のlysateを準備するための理想的な条件はプラチナ敏感な、抵抗力がある患者間の異なった蛋白質のプロフィールを示されている9人の卵巣癌の患者のティッシュのこれらの議定書を適用しているSELDI-TOF氏で断固とした、続いて分析されて。 結論: これはSELDI-TOF MSとLMDのための最大限に活用された議定書を差別的な蛋白質のプロフィールを得るのに結合することが使用することができることを示す。 但し、大きく忍耐強い数および確認セットとの調査はこのアプローチを使用して信頼できるbiomarkersを識別して必要である。 PMID: 19414343 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-162.html</link>
      <description> Related Articles Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease. Proteomics. 2010 Jan;10(1):81-9 Authors: Steinacker P, Rist W, Swiatek-de-Lange M, Lehnert S, Jesse S, Pabst A, Tumani H, von Arnim CA, Mitrova E, Kretzschmar HA, Lenter M, Wiltfang J, Otto M Until today, a definite diagnosis of Creutzfeldt-Jakob disease (CJD) can only be made neuropathologically. At lifetime the early and differential diagnosis is often a problem. With SELDI we analyzed cerebrospin ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-162.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease. Proteomics. 2010 Jan;10(1):81-9 Authors: Steinacker P, Rist W, Swiatek-de-Lange M, Lehnert S, Jesse S, Pabst A, Tumani H, von Arnim CA, Mitrova E, Kretzschmar HA, Lenter M, Wiltfang J, Otto M Until today, a definite diagnosis of Creutzfeldt-Jakob disease (CJD) can only be made neuropathologically. At lifetime the early and differential diagnosis is often a problem. With SELDI we analyzed cerebrospinal fluid (CSF) from 32 CJD patients, 32 patients having other dementive diseases and 31 non-demented control subjects for diagnosis-dependent protein pattern differences. In a screening set of patients, peaks that discriminate best between groups were identified. These peaks were subsequently analyzed using an independent validation set of patients. Diagnostic accuracies were compared with established markers like tau protein and 14-3-3-protein. Potential marker proteins were purified and identified by LC-MS/MS. In the validation set only one peak of 8.6 kDa out of ten in the screening set could be confirmed. This protein was identified to be ubiquitin and increased levels in CSF (but not in serum) of CJD patients were confirmed by Western blot. Ubiquitin allows the correct diagnoses of that CJD cases missed by tau protein or 14-3-3-protein. We conclude that ubiquitin is a promising additional CSF biomarker for diagnosis of CJD, especially in differential diagnostically difficult cases. The selective increase of ubiquitin in CSF of CJD patients might point to an involvement of ubiquitin in pathophysiological process. PMID: 19882659 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： クロイツフェルト・ヤコブ病の潜在的な脳脊髄液体マーカーとして関連の記事Ubiquitin。 Proteomics。 1月2010日; 10 (1): 81-9書く: Steinacker P、Rist W、SwiatekdeLange M、Lehnert S、Jesse S、Pabst A、Tumani H、フォンArnim CA、Mitrova E、Kretzschmar HA、Lenter M、Wiltfang J、今日までのオットーMは、クロイツフェルト・ヤコブ病(CJD)の明確な診断ただneuropathologically作ることができる。 寿命で早く、差動診断は頻繁に問題である。 SELDIを使うと私達は32人のCJDの患者、他のdementive病気を持っている32人の患者からの脳脊髄液体(CSF)を分析し、診断依存した蛋白質のための31の非気違いじみた制御主題は相違を模造する。 スクリーニングの一組の患者では、グループの間で最もよく区別するピークは識別された。 これらのピークは独立した確認の一組の患者を使用して続いて分析された。 診断正確さはtau蛋白質および14 3 3蛋白質のような確立されたマーカーと比較された。 潜在的なマーカー蛋白質はLC-MS/MS.によって浄化され、識別された。 スクリーニングセットの10から8.6 kDaの1つのただピーク置かれた確認で確認できる。 この蛋白質はubiquitinであるために識別され、CJDの患者のCSFの増加されたレベルは(しかしない血清で)西部のしみによって確認された。 Ubiquitinはそれの正しい診断にtau蛋白質か14 3 3蛋白質によって逃されるCJDの場合を与える。 私達はubiquitinがCJDの診断のための有望で付加的なCSFのbiomarkerであることを、特に結論を出す差動診断によって困難な場合で。 CJDの患者のCSFのubiquitinの選択的な増加は病態生理学的なプロセスのubiquitinの介入を指すかもしれない。 PMID: 19882659 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Evaluation of relaxin&apos;s antifibrotic action by SELDI-TOF mass spectrometry-based profiling of relaxin knockout mice, a model of progressive fibrosis.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-121.html</link>
      <description> Related Articles Evaluation of relaxin&apos;s antifibrotic action by SELDI-TOF mass spectrometry-based profiling of relaxin knockout mice, a model of progressive fibrosis. Ann N Y Acad Sci. 2009 Apr;1160:350-2 Authors: Giannakis E, Macris M, Chan L, Tregear GW, Samuel CS, Wade JD Surface-enhanced laser desorption ionization-time-of-flight mass spectrometry was employed to identify potential biomarkers for early-onset fibrosis. These biomarkers were then used to evaluate the efficacy of relaxin to re ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-121.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Evaluation of relaxin's antifibrotic action by SELDI-TOF mass spectrometry-based profiling of relaxin knockout mice, a model of progressive fibrosis. Ann N Y Acad Sci. 2009 Apr;1160:350-2 Authors: Giannakis E, Macris M, Chan L, Tregear GW, Samuel CS, Wade JD Surface-enhanced laser desorption ionization-time-of-flight mass spectrometry was employed to identify potential biomarkers for early-onset fibrosis. These biomarkers were then used to evaluate the efficacy of relaxin to reverse or ameliorate the development of the condition. PMID: 19416218 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： SELDI-TOFによるrelaxinのantifibrotic行為の関連の記事の評価はrelaxinのノックアウトのマウスの分光測定基づかせていた側面図を描を、進歩的な線維症のモデル集中する。 アンN Y Acad Sci。 4月2009日; 1160年: 350-2書く: Giannakis E、Macris M、Chan L、TregearギガワットのサミュエルのCS、ウェードJDによって表面高められたレーザーの脱着イオン化時間の飛行質量分析は早手始めの線維症のための潜在的なbiomarkersを識別するために用いられた。 これらのbiomarkersがそれから条件の開発を逆転させるか、または改善するためにrelaxinの効力を評価するのに使用された。 PMID: 19416218 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-163.html</link>
      <description>Related Articles [Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study] Klin Onkol. 2009;22(5):228-32 Authors: LakomÃ? R, GreplovÃ¡ K, PilnÃ? R, BudinskÃ¡ E, ValÃ?k D, Poprach A, Nemecek R, Vyzula R BACKGROUNDS: Recently, research at genetic and molecular levels has extensively accelerated due to advances in new technologies. Since the mid-90s, a relatively new discipline--cl ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-163.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study] Klin Onkol. 2009;22(5):228-32 Authors: LakomÃ? R, GreplovÃ¡ K, PilnÃ? R, BudinskÃ¡ E, ValÃ?k D, Poprach A, Nemecek R, Vyzula R BACKGROUNDS: Recently, research at genetic and molecular levels has extensively accelerated due to advances in new technologies. Since the mid-90s, a relatively new discipline--clinical proteomics, has evolved, which focuses on studying gene products--proteins. The evaluation of protein profiles may contribute to the more accurate stratification of patients in the future, in terms of both prediction of treatment results and prognosis. In pursuing this objective, proteomic approaches are currently used for the identification of new biomarkers. This is also the case with malignant melanoma, a disease without typical serum marker possessing high sensitivity and high specificity. METHODS: We analyzed human blood serum samples from 25 patients with metastatic malignant melanoma treated with palliative chemotherapy at the Masaryk Memorial Cancer Institute, Brno, in 2004-2006. The analysis was performed by Surface Enhanced Laser Desorption/lonisation Time of Flight Mass Spectrometry (SELDI-TOF-MS). Our patients were divided into two subgroups: a group relatively resistant to chemotherapy--14 patients--and a group with certain clinical benefit from the treatment (complete and partial remission, stabilized disease)--11 patients. We were searching for a new biomarker or typical protein profile in the selected two subgroups. Then, we recategorized our patients into three groups according to the similarity of their protein profiles regardless of sensitivity to chemotherapy. Finally, we evaluated differences in laboratory and clinical parameters, between both the groups of chemo-resistant and chemo-sensitive patients, and newly defined subgroups with similar protein profiles. CONCLUSION: We did not identify any significant differences in protein profiles or laboratory parameters in the predefined chemo-sensitive or chemo-resistant groups of patients. However, with regard to the new groups with similar protein profiles, we identified a subgroup of patients with different laboratory and clinical parameters. The results are very interesting and merit further research. PMID: 19886361 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>SELDI protein chip technology for the detection of serum biomarkers for liver disease.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-123.html</link>
      <description>Related Articles SELDI protein chip technology for the detection of serum biomarkers for liver disease. Protein Pept Lett. 2009;16(5):467-72 Authors: Chen L, Fatima S, Peng J, Leng X The need to identify disease biomarkers is critical to ensure fast diagnosis and timely treatment. Surface enhanced laser desorption/ionization time-of-fight mass spectrometry (SELDI-TOF-MS) is a widely used technology platform for diagnostic biomarker discovery. This short review provides an overview of how it func ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-123.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles SELDI protein chip technology for the detection of serum biomarkers for liver disease. Protein Pept Lett. 2009;16(5):467-72 Authors: Chen L, Fatima S, Peng J, Leng X The need to identify disease biomarkers is critical to ensure fast diagnosis and timely treatment. Surface enhanced laser desorption/ionization time-of-fight mass spectrometry (SELDI-TOF-MS) is a widely used technology platform for diagnostic biomarker discovery. This short review provides an overview of how it functions and also describes its advantages and drawbacks. PMID: 19442224 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：肝臓病のための血清のbiomarkersの検出のための関連の記事SELDI蛋白質の破片の技術。 蛋白質Pept Lett。 2009年; 16 (5): 467-72書く: 陳L、ファティマS、ポンJ、Leng Xは病気のbiomarkersを識別する必要性速い診断および時機を得た処置を保障して重大である。 質量分析(SELDI-TOF-MS)が表面によって高められるレーザーの脱着によってかイオン化はである診断biomarkerの発見のための広く利用された技術のプラットホーム時間の戦う。 この短い検討はいかにの作用し、また利点および欠点を記述するか概観を提供する。 PMID: 19442224 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Protein biomarker analysis of primary Peyronie&apos;s disease cells.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-164.html</link>
      <description> Related Articles Protein biomarker analysis of primary Peyronie&apos;s disease cells. J Sex Med. 2010 Jan;7(1 Pt 1):99-106 Authors: De Young LX, Bella AJ, O&apos;Gorman DB, Gan BS, Lim KB, Brock GB INTRODUCTION: The molecular pathogenesis of Peyronie&apos;s Disease (PD) remains unclear more than 250 years after its initial description. Because of this, no test is currently available to accurately predict PD progression among those affected. AIM: To investigate the expression of wound healing and fibrosis-asso ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-164.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Protein biomarker analysis of primary Peyronie's disease cells. J Sex Med. 2010 Jan;7(1 Pt 1):99-106 Authors: De Young LX, Bella AJ, O'Gorman DB, Gan BS, Lim KB, Brock GB INTRODUCTION: The molecular pathogenesis of Peyronie's Disease (PD) remains unclear more than 250 years after its initial description. Because of this, no test is currently available to accurately predict PD progression among those affected. AIM: To investigate the expression of wound healing and fibrosis-associated proteins in primary cell cultures of PD fibroblasts to determine whether altered protein expression patterns can be used as predictors of clinical course and natural history. METHODS: Primary cell cultures derived from normal Tunica albuginea tissue and PD plaque tissue were examined by immuno-cytochemistry. Protein expression profiles were analyzed by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (SELDI-TOF-MS) and Western immunoblotting. MAIN OUTCOME MEASURES: Expression of wound healing and fibrosis-associated proteins and protein expression patterns were assessed. RESULTS: Statistically significant increases in smooth muscle alpha-actin, beta-catenin, and Heat shock proteins (Hsp47) were identified in cells derived from PD relative to cells derived from normal Tunica albuginea tissue. Changes in TGFbeta-1 receptor and Fibronectin were also observed. In addition, altered expression of additional as yet unidentified proteins at 4.7, 8.9, 10.8, 16.8, and 76.8 kDa were detected by complementary SELDI-TOF-MS approaches. CONCLUSIONS: Primary cells derived from PD plaques display up-regulated expression of several proteins that are established components of fibrosis and wound healing. In addition, changes in other, as yet unidentified proteins were measured. It will be of interest to conduct further studies to see whether these dysregulated protein peaks represent potential biological markers of disease progression. PMID: 19889147 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>SELDI-TOF-MS-based serum proteomic screening in combination with CT scan distinguishes renal cell carcinoma from benign renal tumors and healthy persons.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-125.html</link>
      <description>Related Articles SELDI-TOF-MS-based serum proteomic screening in combination with CT scan distinguishes renal cell carcinoma from benign renal tumors and healthy persons. Technol Cancer Res Treat. 2009 Jun;8(3):225-30 Authors: Xu G, Xiang CQ, Lu Y, Wang WJ, Kang XN, Liao P, Ding Q, Zhang YF In order to identify the proteomic differences between renal cell carcinoma (RCC) and benign renal tumors, we analyzed 168 serum samples from 65 RCC patients, 34 patients with benign renal tumors, and 69 heal ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-125.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles SELDI-TOF-MS-based serum proteomic screening in combination with CT scan distinguishes renal cell carcinoma from benign renal tumors and healthy persons. Technol Cancer Res Treat. 2009 Jun;8(3):225-30 Authors: Xu G, Xiang CQ, Lu Y, Wang WJ, Kang XN, Liao P, Ding Q, Zhang YF In order to identify the proteomic differences between renal cell carcinoma (RCC) and benign renal tumors, we analyzed 168 serum samples from 65 RCC patients, 34 patients with benign renal tumors, and 69 healthy persons using the IMAC-Cu2+ ProteinChip system by surface enhanced laser desorption/ionization mass spectrometry technology. Two decision trees were generated by Biomarker Pattern software to distinguish between RCC versus healthy and RCC versus patients with benign tumors, respectively. Although the sensitivity and specificity of the RCC vs. healthy decision tree were 97.6% and 95.7%, respectively, it could not be used to distinguish RCC from benign renal tumors. The sensitivity of a blind test process using RCC, benign tumors and healthy persons were 92%. The specificity of the test process was 35.3% for benign tumors and 95.5% for healthy persons. The sensitivity and specificity of the RCC-Benign tumors decision tree were 85.7% and 95.5%, respectively. The blind test process using RCC, benign tumors and healthy persons also showed significant results. The sensitivity was 90.0%. The specificity was 95.7% for healthy persons and 90.0% for benign tumors. Combining these data with the results of CT scanning, the sensitivity can be improved over the use of either CT and decision tree analysis and the specificity may reach 100%. Two peaks with molecular masses of 3887.11 Da and 11079.8 Da were detected that are potentially useful for the diagnosis or screening of RCC. It was found that these two peaks can be used, not only to distinguish the RCC vs. healthy cases, but also to distinguish RCC from benign renal tumors. In combination with CT scanning, the sensitivity and specificity of the diagnosis of renal tumors can be improved. However, the decision tree constructed for RCC and healthy persons may not present good specificity for use in distinguishing malignant from benign renal tumors. PMID: 19445540 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-165.html</link>
      <description> Related Articles Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform. Int J Oral Maxillofac Surg. 2010 Jan;39(1):68-74 Authors: Shintani S, Hamakawa H, Ueyama Y, Hatori M, Toyoshima T New and more consistent biomarkers of oral squamous cell carcinoma (OSCC) are needed to improve early detection of the disease and to monitor patient management. The aim of this study was to detect new OSCC tumor markers in saliva. ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-165.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform. Int J Oral Maxillofac Surg. 2010 Jan;39(1):68-74 Authors: Shintani S, Hamakawa H, Ueyama Y, Hatori M, Toyoshima T New and more consistent biomarkers of oral squamous cell carcinoma (OSCC) are needed to improve early detection of the disease and to monitor patient management. The aim of this study was to detect new OSCC tumor markers in saliva. Unstimulated saliva, collected from patients with primary stage I OSCC as matched pre-and post-treatment samples, was used in the analysis. A surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF) ProteinChip system was used to screen for differentially expressed proteins in the saliva samples. This analysis revealed 26 proteins with significantly different expression levels in the pre-and post-treatment samples (P<0.05). A 14 kDa protein detected in pre-treatment saliva from the OSCC patients was identified as a truncated cystatin SA-I, with deletion of three amino acids from the N-terminus. The authors propose that ProteinChip analysis may provide a reliable screening test for early diagnosis of OSCC and that truncated cystatin SA-I might be a useful tumor biomarker for OSCC. PMID: 19896329 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： SELDI ProteinChipのプラットホームを使用して口頭squamous細胞癌腫のための唾液のbiomarkerとして省略されたcystatin SA-Iの関連の記事の同一証明。 Int J口頭Maxillofac Surg。 1月2010日; 39 (1): 68-74書く: Shintani S、Hamakawa H、Ueyama Y、Hatori M、Toyoshima口頭squamous細胞癌腫(OSCC)のTは新しく、より一貫したbiomarkers必要病気の早期発見を改善し、忍耐強い管理を監視するためにである。 この調査の目標は唾液の新しいOSCCの腫瘍のマーカーを検出することだった。 一致させた前および治療後のサンプルとして第一次段階I OSCCを持つ患者から集められた刺激されない唾液は分析で使用された。 唾液のサンプルの特異的に表現された蛋白質のために選別するのにレーザーの脱着またはイオン化時間の飛行質量分析(SELDI-TOF)のProteinChip表面高められたシステムが使用された。 この分析は前および治療後のサンプル(P&ltのかなり違う表現のレベルが付いている26の蛋白質を明らかにした; 0.05)。 OSCCの患者からの前処理の唾液で検出された14 kDa蛋白質はN終点からの3アミノ酸の削除を用いる省略されたcystatin SA-Iとして、識別された。 著者はProteinChipの分析がOSCCの早い診断に信頼できるスクリーンテストを提供するかもしれないこと、そして省略されたcystatin SA-IがOSCCのための有用な腫瘍のbiomarkerであるかもしれないことを提案する。 PMID: 19896329 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Surface-enhanced Laser Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer Markers in Tears and Serum.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-127.html</link>
      <description> Related Articles Surface-enhanced Laser Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer Markers in Tears and Serum. Cancer Genomics Proteomics. 2009 Mar-Apr;6(2):75-83 Authors: Lebrecht A, Boehm D, Schmidt M, Koelbl H, Grus FH BACKGROUND: New biomarkers are needed to improve the early detection of breast cancer. This study describes the use of surface-enhanced laser desorption/ionisation time-of-flight mass spectroscopy (SELDI-TOF-MS) in serum and tear fluid. MATE ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-127.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Surface-enhanced Laser Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer Markers in Tears and Serum. Cancer Genomics Proteomics. 2009 Mar-Apr;6(2):75-83 Authors: Lebrecht A, Boehm D, Schmidt M, Koelbl H, Grus FH BACKGROUND: New biomarkers are needed to improve the early detection of breast cancer. This study describes the use of surface-enhanced laser desorption/ionisation time-of-flight mass spectroscopy (SELDI-TOF-MS) in serum and tear fluid. MATERIALS AND METHODS: Blood and tear fluid of 10 women with breast cancer and 10 healthy age-matched women were screened for potential biomarkers. Blood samples and tear fluid were drawn prior to surgery. SELDI-TOF-MS were used for protein profiling with three different active surfaces of the protein chips. The data were analyzed by multivariate statistical techniques and artificial neural networks. RESULTS: Complex protein and peptide patterns were found on all three surfaces. We identified the main proteins in tear fluid. Statistically significant differences in the protein pattern (p<0.001) were found between breast cancer patients and healthy controls. The diagnostic pattern differentiated cancer patients from controls with a specificity and sensitivity of approximately 90% in serum and tear fluid. CONCLUSION: Protein chip technology facilitates the discovery of new and better biomarkers in breast cancer. It is a promising approach to analyse a large number of patients with high sensitivity and specificity. Analysing tear fluid could show some advantages. PMID: 19451091 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事は乳癌のマーカーおよび血清を泣検出するためにレーザーの脱着またはイオン化時間の飛行質量分析表面高めた。 蟹座のゲノミクスProteomics。 2009日3月4月; 6 (2): 75-83書く: Lebrecht A、Boehm D、シュミツトM、Koelbl HのGrus FHの背景: 新しいbiomarkersは必要乳癌の早期発見を改善するためにである。 この調査は血清および破損液体で表面高められたレーザーの脱着またはイオン化時間の飛行多く分光学(SELDI-TOF-MS)の使用を記述する。 材料および方法: 乳癌を持つ10人の女性および10人の健康なage-matched女性の血そして破損液体は潜在的なbiomarkersのために選別された。 血液サンプルおよび破損液体は外科前に引かれた。 SELDI-TOF-MSは蛋白質の破片の3つの活動的な表面と側面図を描く蛋白質のために使用された。 データは多変数の統計的な技術および人工の神経ネットワークによって分析された。 結果: 複雑な蛋白質およびペプチッドパターンはすべての3つの表面で見つけられた。 私達は破損液体の主要な蛋白質を識別した。 蛋白質パターン(p&ltの統計的に重要な相違; 0.001は乳癌患者と健康な制御の間で)見つけられた。 診断パターンは血清および破損液体のおよそ90%の特定性そして感受性の制御からの癌患者を区別した。 結論: 蛋白質の破片の技術は乳癌の新しく、よりよいbiomarkersの発見を促進する。 それは高い感受性および特定性の多数の患者を分析する有望なアプローチである。 破損液体を分析することはある利点を示すことができる。 PMID: 19451091 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A computational platform for MALDI-TOF mass spectrometry data: application to serum and plasma samples.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-166.html</link>
      <description> Related Articles A computational platform for MALDI-TOF mass spectrometry data: application to serum and plasma samples. J Proteomics. 2010 Jan 3;73(3):562-70 Authors: Mantini D, Petrucci F, Pieragostino D, Del Boccio P, Sacchetta P, Candiano G, Ghiggeri GM, Lugaresi A, Federici G, Di Ilio C, Urbani A BACKGROUND: Mass spectrometry (MS) is becoming the gold standard for biomarker discovery. Several MS-based bioinformatics methods have been proposed for this application, but the divergence of the ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-166.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles A computational platform for MALDI-TOF mass spectrometry data: application to serum and plasma samples. J Proteomics. 2010 Jan 3;73(3):562-70 Authors: Mantini D, Petrucci F, Pieragostino D, Del Boccio P, Sacchetta P, Candiano G, Ghiggeri GM, Lugaresi A, Federici G, Di Ilio C, Urbani A BACKGROUND: Mass spectrometry (MS) is becoming the gold standard for biomarker discovery. Several MS-based bioinformatics methods have been proposed for this application, but the divergence of the findings by different research groups on the same MS data suggests that the definition of a reliable method has not been achieved yet. In this work, we propose an integrated software platform, MASCAP, intended for comparative biomarker detection from MALDI-TOF MS data. RESULTS: MASCAP integrates denoising and feature extraction algorithms, which have already shown to provide consistent peaks across mass spectra; furthermore, it relies on statistical analysis and graphical tools to compare the results between groups. The effectiveness in mass spectrum processing is demonstrated using MALDI-TOF data, as well as SELDI-TOF data. The usefulness in detecting potential protein biomarkers is shown comparing MALDI-TOF mass spectra collected from serum and plasma samples belonging to the same clinical population. CONCLUSIONS: The analysis approach implemented in MASCAP may simplify biomarker detection, by assisting the recognition of proteomic expression signatures of the disease. A MATLAB implementation of the software and the data used for its validation are available at http://www.unich.it/proteomica/bioinf. PMID: 19914411 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： MALDI-TOFの質量分析データのための関連の記事Aの計算のプラットホーム: 血清および血しょうサンプルへの適用。 J Proteomics。 1月2010日3日; 73 (3): 562-70書く: Mantini D、Petrucci F、Pieragostino D、Del Boccio P、Sacchetta P、Candiano G、Ghiggeri GM、Lugaresi A、Federici G、Di Ilio C、Urbani背景: 質量分析(MS)はbiomarkerの発見のための金本位になっている。 複数の氏基づかせていた生物情報学方法はこの適用のために提案されたが、確かな方法の定義がまだ達成されていないことを同じMSデータの異なった研究グループによる調査結果の発散は提案する。 この仕事では、私達は統合ソフトのプラットホーム提案する、MALDI-TOF MSデータからの比較biomarkerの検出のために意図されているMASCAPを。 結果: 多くスペクトルを渡る一貫したピークを提供するために既に示してしまったMASCAPはdenoisingおよび特徴抽出のアルゴリズムを統合する、; グループ間の結果を比較するためになお、それは統計分析および写実的な用具に頼る。 多くスペクトルの処理の有効性はSELDI-TOFデータと同様、MALDI-TOFデータを使用して、示される。 同じ臨床人口に属する血清および血しょうサンプルから集められるMALDI-TOFの多くスペクトルを比較する潜在的な蛋白質のbiomarkersの検出の実用性は示されている。 結論: MASCAPで実行される分析のアプローチは病気のproteomic表現の署名の認識の援助によってbiomarkerの検出を、簡単にすることができる。 ソフトウェアのMATLABの実施および確認に使用するデータはhttp://www.unich.it/proteomica/bioinfで利用できる。 PMID: 19914411 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Detection of growth hormone responsive proteins using SELDI-TOF mass spectrometry.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-129.html</link>
      <description> Related Articles Detection of growth hormone responsive proteins using SELDI-TOF mass spectrometry. Growth Horm IGF Res. 2009 Aug;19(4):383-7 Authors: Chung L, Baxter RC The detection of growth hormone (GH) doping is a significant problem in elite sports. GH is secreted in a pulsatile pattern from the anterior pituitary, influenced by a variety of normal and pathophysiological conditions. Exogenous recombinant hGH is virtually indistinguishable from the predominant naturally occurring isoform a ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-129.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Detection of growth hormone responsive proteins using SELDI-TOF mass spectrometry. Growth Horm IGF Res. 2009 Aug;19(4):383-7 Authors: Chung L, Baxter RC The detection of growth hormone (GH) doping is a significant problem in elite sports. GH is secreted in a pulsatile pattern from the anterior pituitary, influenced by a variety of normal and pathophysiological conditions. Exogenous recombinant hGH is virtually indistinguishable from the predominant naturally occurring isoform and is cleared from the body within 24h. Although GH is on the World Anti-doping Agency list of banned substances, the detection of GH abuse remains challenging. This article gives an overview of the potential application of surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry to examine proteomic changes following GH administration, using both serum and white blood cell extracts as samples for analysis. Results to date indicate that proteomic changes observed following GH administration have the potential to yield novel biomarker sets for the detection of GH abuse. PMID: 19467616 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： SELDI-TOFの質量分析を使用して成長ホルモンの敏感な蛋白質の関連の記事の検出。 成長Horm IGF Res。 8月2009日; 19 (4): 383-7書く: チョンL、バックスターRCは添加する成長ホルモン(GH)の検出エリートのスポーツの重要な問題である。 GHはいろいろ正常な、病態生理学的な条件によって影響を及ぼされる前方pituitaryからのpulsatileパターンで分泌する。 外因性の組換えのhGHは優勢な自然発生するisoformから事実上識別不可能、24h内のボディから取り除かれる。 GHが禁止された物質の世界のアンチドーピング代理店のリストにあるが、GHの乱用の検出は挑戦的に残る。 この記事は分析のためのサンプルとして血清および白血球の両方エキスを使用してGHの管理の後のproteomic変更を、検査するために表面高められたレーザーの脱着またはイオン化時間の飛行(SELDI-TOF)質量分析の潜在的な適用の概観を与える。 結果は今までにGHの管理の後で観察されるproteomic変更にGHの乱用の検出のための新しいbiomarkerセットをもたらす潜在性があることを示す。 PMID: 19467616 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Detection and identification of potential biomarkers of non-small cell lung cancer.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-167.html</link>
      <description>Related Articles Detection and identification of potential biomarkers of non-small cell lung cancer. Technol Cancer Res Treat. 2009 Dec;8(6):455-66 Authors: Yang Y, Zhao S, Fan Y, Zhao F, Liu Q, Hu W, Liu D, Fan K, Wang J, Wang J The aim of this study was to discover and identify potential protein biomarkers specific for non-small cell lung cancer (NSCLC). Two hundred and thirty five (235) Serum samples with 112 NSCLC and 123 controls were randomly divided into a training set and a blind testing ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-167.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Detection and identification of potential biomarkers of non-small cell lung cancer. Technol Cancer Res Treat. 2009 Dec;8(6):455-66 Authors: Yang Y, Zhao S, Fan Y, Zhao F, Liu Q, Hu W, Liu D, Fan K, Wang J, Wang J The aim of this study was to discover and identify potential protein biomarkers specific for non-small cell lung cancer (NSCLC). Two hundred and thirty five (235) Serum samples with 112 NSCLC and 123 controls were randomly divided into a training set and a blind testing set. Serum proteomic profiles were analyzed using surface-enhanced laser desorption/ionization time-of-flight mass spectroscopy (SELDI-TOF-MS). Candidate protein biomarkers were purified by high Performance Liquid Chromatography (HPLC) and identified by liquid chromatography tandem mass spectrometry (LC-MS/MS) and validated using ProteinChip immunoassays. A total of 3 peaks (m/z with 6628, 9191 and 11412 Da) were screened out by SVM to construct the classification model with the high discriminatory power in the training set. The sensitivity and specificity of the model were 96.56% and 94.79% respectively in the blind testing set. The candidate biomarker with m/z of 6628 Da was found down-regulated in NSCLC patients, and identified as apolipoprotein C-I. Another two candidate biomarkers (9191 and 11412 Da) were found up-regulated in serum of NSCLC patients and identified as haptoglobin alpha-1 chain and S100A4, respectively. We have identified a set of biomarkers that could discriminate NSCLC from non-cancer controls. An efficient strategy, including SELDI-TOF-MS analysis, HPLC purification, MALDI-TOF-MS trace and LC-MS/MS identification, has been proved successfully. PMID: 19925029 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：非小さい細胞の肺癌の潜在的なbiomarkersの関連の記事検出および同一証明。 Technolの蟹座Resの御馳走。 12月2009日; 8 (6): 455-66書く: ヤンY、肇SのファンY、肇F、劉Q、Hu W、劉DのファンK、Wang J、Wang Jはこの調査の目標非小さい細胞の肺癌(NSCLC)のために特定の潜在的な蛋白質のbiomarkersを発見し、識別するべきだった。 112 NSCLCおよび123の制御を用いる200そして35の(235の)血清のサンプルは置かれた訓練に任意に分けられ、盲目のテストは置いた。 血清のproteomicプロフィールは表面高められたレーザーの脱着またはイオン化時間の飛行多く分光学(SELDI-TOF-MS)を使用して分析された。 候補者蛋白質のbiomarkersは高性能の液体クロマトグラフィー(高性能液体クロマトグラフィー)によって浄化され、液体クロマトグラフィーのタンデム質量分析(LC-MS/MS)によって識別され、そしてProteinChipのimmunoassaysを使用して認可された。 合計3つのピーク(6628、9191および11412 Daのm/z)はSVMによって訓練セットの高く差別的な力の分類モデルを組み立てるために選別された。 モデルの感受性そして特定性は96.56%であり、盲目のテストの94.79%はそれぞれ置いた。 6628 Daのm/zの候補者のbiomarkerはNSCLCの患者で調整され、apolipoprotein CIとして識別されて見つけられた。 もう2人の候補者のbiomarkersは(9191および11412 Da) NSCLCの患者の血清で調整され、haptoglobinのアルファ1の鎖およびS100A4として識別されて、それぞれ見つけられた。 私達はnon-cancer制御からのNSCLCを区別できる一組のbiomarkersを識別した。 有効な作戦は、SELDI-TOF-MSの分析を含んで、高性能液体クロマトグラフィーの浄化、MALDI-TOF-MSの跡およびLC-MS/MSの同一証明、首尾よく証明された。 PMID: 19925029 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteomic analysis of archival breast cancer serum.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-131.html</link>
      <description> Related Articles Proteomic analysis of archival breast cancer serum. Cancer Genomics Proteomics. 2009 May-Jun;6(3):141-7 Authors: Zeidan BA, Cutress RI, Murray N, Coulton GR, Hastie C, Packham G, Townsend PA Large cohorts of archival samples are stored in tissue banks worldwide yet their contribution to biomarker discovery is limited. Proteomic profiling technologies have potential for early screening and diagnosis of cancer, and data from such samples can be the answer for many clinical questi ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-131.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Proteomic analysis of archival breast cancer serum. Cancer Genomics Proteomics. 2009 May-Jun;6(3):141-7 Authors: Zeidan BA, Cutress RI, Murray N, Coulton GR, Hastie C, Packham G, Townsend PA Large cohorts of archival samples are stored in tissue banks worldwide yet their contribution to biomarker discovery is limited. Proteomic profiling technologies have potential for early screening and diagnosis of cancer, and data from such samples can be the answer for many clinical questions. Here we introduce the notion of archival samples proteomics. Using SELDI-TOF MS analysis, we compared 30-year-old archival serum samples of healthy volunteers and patients diagnosed with non metastatic breast cancer. To validate the reproducibility of our results, analysis of the same samples was repeated in a different centre under standardised settings. Plausible differentially expressed protein peaks between the breast cancer and control groups were repeatedly detected. Our pilot study showed highly reproducible and concordant results between two independent analyses conducted in different centres. The feasibility and reliability of profiling serum archives of women with breast cancer was tested in this pilot study. Our results imply that proteomic profiling of serum may have an important role in biomarkers discovery regardless of the storage period. Clearly, multicentre validation of larger archival cohorts is vital. PMID: 19487543 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 記録保管乳癌の血清の記事のProteomicの関連の分析。 蟹座のゲノミクスProteomics。 2009日5月6月; 6 (3): 141-7書く: ZeidanのBA、Cutress RI、マレーN、Coulton GR、Hastie C、Packham GのTownsend PAの記録保管サンプルの大きいグループはティッシュ銀行で世界的に貯えられるけれどもbiomarkerの発見への貢献は限られている。 技術の側面図を描くProteomicに癌の早いスクリーニングそして診断のための潜在性があり、そのようなサンプルからのデータは多くの臨床質問のための答えである場合もある。 ここに私達は記録保管サンプルproteomicsの概念をもたらす。 SELDI-TOF MSの分析を使用して、私達は非metastatic乳癌と診断された健康なボランティアおよび患者の30歳の記録保管血清のサンプルを比較した。 私達の結果の再現性を認可するためには、同じサンプルの分析は標準化された設定の下の別の中心で繰り返された。 乳癌と制御グループ間のもっともらしい特異的に表現された蛋白質のピークは繰り返し検出された。 私達のパイロット・スタディは異なった中心で行なわれた2つの独立した分析間の非常に再生可能な、一致した結果を示した。 乳癌を持つ女性の血清のアーカイブの側面図を描くことの可能性そして信頼性はこのパイロット・スタディでテストされた。 私達の結果は血清のproteomic側面図を描くことに貯蔵期間にもかかわらずbiomarkersの発見に於いての重要な役割があるかもしれないことを意味する。 明らかに、より大きい記録保管グループのmulticentre確認は重大である。 PMID: 19487543 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Differential protein profiling as a potential multi-marker approach for TSE diagnosis.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-168.html</link>
      <description> Related Articles Differential protein profiling as a potential multi-marker approach for TSE diagnosis. BMC Infect Dis. 2009;9:188 Authors: Barr JB, Watson M, Head MW, Ironside JW, Harris N, Hogarth C, Fraser JR, Barron R BACKGROUND: Transmissible spongiform encephalopathy describes a family of diseases affecting both man and animals. Current tests for the diagnosis of these diseases are based on the detection of an abnormal misfolded form of the host protein PrP which is found within the centr ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-168.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Differential protein profiling as a potential multi-marker approach for TSE diagnosis. BMC Infect Dis. 2009;9:188 Authors: Barr JB, Watson M, Head MW, Ironside JW, Harris N, Hogarth C, Fraser JR, Barron R BACKGROUND: Transmissible spongiform encephalopathy describes a family of diseases affecting both man and animals. Current tests for the diagnosis of these diseases are based on the detection of an abnormal misfolded form of the host protein PrP which is found within the central nervous and lymphoreticular systems of affected animals. Recently, concern that this marker may not be as reliable as previously thought, coupled with an urgentneed for a pre-clinical live animal test, has led to the search for alternative assays for the detection of TSE disease. METHODS: This "proof of concept" study, examines the use of differential protein expression profiling using surface enhanced laser desorption and ionisationtime of flight mass spectrometry (SELDI-TOF) for the diagnosis of TSE disease. Spectral output from all proteins selectively captured from individual murine brain homogenate samples, are compared as "profiles" in groups of infected and non-infected animals. Differential protein expression between groups is thus highlighted and statistically significant protein "peaks" used to construct a panel of disease specific markers.Studies at both terminal stages of disease and throughout the time course of disease have shown a disease specific protein profile or "disease fingerprint" which could be used to distinguish between groups of TSE infected and uninfected animals at an early time point of disease. RESULTS: Our results show many differentially expressed proteins in diseased and control animals, some at early stages of disease. Three proteins identified by SELDI-TOF analysis were verified by immunohistochemistry in brain tissue sections. We demonstrate that by combining the most statistically significant changes in expression, a panel of markers can be constructed that can distinguish between TSE diseased and normal animals. CONCLUSION: Differential protein expression profiling has the potential to be used for the detection of disease in TSE infected animals. Having established that a "training set" of potential markers can be constructed, more work would be required to further test the specificity and sensitivity of the assay in a "testing set". Based on these promising results, further studies are being performed using blood samples from infected sheep to assess the potential use of SELDI-TOF as a pre-mortem blood based diagnostic. PMID: 19943924 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteomic profiling of growth hormone-responsive proteins in human peripheral blood leukocytes.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-133.html</link>
      <description> Related Articles Proteomic profiling of growth hormone-responsive proteins in human peripheral blood leukocytes. J Clin Endocrinol Metab. 2009 Aug;94(8):3038-43 Authors: Chung L, Nelson AE, Ho KK, Baxter RC CONTEXT: GH is a known modulator of the immune system, but the effect of exogenous GH administration on white blood cell proteins has not been investigated. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) is a powerful platform for the study of GH ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-133.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Proteomic profiling of growth hormone-responsive proteins in human peripheral blood leukocytes. J Clin Endocrinol Metab. 2009 Aug;94(8):3038-43 Authors: Chung L, Nelson AE, Ho KK, Baxter RC CONTEXT: GH is a known modulator of the immune system, but the effect of exogenous GH administration on white blood cell proteins has not been investigated. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) is a powerful platform for the study of GH effects on immune system proteins. OBJECTIVE: Our objective was to explore a novel approach for the detection of GH-responsive proteins in human leukocytes by proteomic analysis using SELDI-TOF MS. DESIGN: We conducted a randomized double-blind, placebo-controlled GH administration study of 8 wk treatment followed by 6 wk washout. Pre- and posttreatment samples from 30 subjects were used for biomarker discovery. SETTING: The study was performed at a clinical research facility. PARTICIPANTS: We studied 30 recreationally trained healthy athletes. INTERVENTION: Subjects received either recombinant human GH (2 mg/d sc; n = 22) or placebo (n = 8) for 8 wk. MAIN OUTCOME MEASURES: Proteomic profiles were determined using CM10 weak cation-exchange protein chips, and some GH-regulated proteins were purified and identified by mass spectrometry and/or immunoblotting. RESULTS: SELDI-TOF analysis revealed a number of GH-regulated peptides/proteins in the 3- to 22-kDa range that are either up- or down-regulated by GH. Several of these may be useful as biomarkers of GH action. The calcium-binding, proinflammatory calgranulins S100A8, S100A9, and S100A12 were all significantly down-regulated in response to GH treatment. CONCLUSION: This study illustrates the novel use of human leukocyte proteomic profiling by SELDI-TOF MS and reveals the negative regulation of proinflammatory S100 proteins by GH in human white blood cells. PMID: 19491220 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 人間の周辺血の白血球の成長のホルモン敏感な蛋白質の記事のProteomicの関連に側面図を描くこと。 J Clin Endocrinol Metab。 8月2009日; 94 (8): 3038-43書く: チョンL、ネルソンAE、Ho KKのバックスターRCの文脈: GHは免疫組織の知られていた変調器であるが、白血球蛋白質に対する外因性GHの管理の効果は調査されなかった。 表面高められたレーザーの脱着またはイオン化時間の飛行質量分析(SELDI-TOF MS)は免疫組織蛋白質に対するGHの効果の調査のための強力なプラットホームである。 目的: 私達の目的はSELDI-TOF氏を使用してDESIGN proteomic分析によって人間の白血球のGH敏感な蛋白質の検出のための目新しい取り組み方を探検することだった: 私達は6週の流出に先行している8週の処置のランダム化されたdouble-blind、偽薬管理されたGHの管理の調査を行なった。 30の主題からの前および治療後のサンプルはbiomarkerの発見のために使用された。 設定: 調査は臨床研究所で行われた。 関係者: 私達は30人の娯楽に訓練された健康な運動選手を調査した。 介在: 主題は組換えの人間GH (2 mg/d scを受け取った; n = 22)または偽薬(n = 8週の間8)。 主要な結果は測定する: ProteomicのプロフィールはCM10弱いcation-exchange蛋白質の破片を使用して断固としたであり、あるGH調整された蛋白質は質量分析および/またはimmunoblottingによって浄化され、識別された。 結果: SELDI-TOFの分析は-またはGHによって調整されてある22-kDa範囲に… 3のいくつかのGH調整されたペプチッドか蛋白質を明らかにした。 これらの複数はGHの行為のbiomarkersとして有用かもしれない。 カルシウム結合、proinflammatory calgranulins S100A8、S100A9およびS100A12はかなりGHの処置に応じて調整されたすべてだった。 結論: この調査はSELDI-TOF MSによって人間の白血球のproteomic側面図を描く新しい使用を説明し、人間の白血球のGHによってproinflammatory S100蛋白質の否定的な規則を明らかにする。 PMID: 19491220 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Feature selection and machine learning with mass spectrometry data.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-169.html</link>
      <description> Related Articles Feature selection and machine learning with mass spectrometry data. Methods Mol Biol. 2010;593:205-29 Authors: Datta S, Pihur V Mass spectrometry has been used in biochemical research for a long time. However, its potential for discovering proteomic biomarkers using protein mass spectra has aroused tremendous interest in the last few years. In spite of its potential for biomarker discovery, it is recognized that the identification of meaningful proteomic features from mass spec ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-169.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Feature selection and machine learning with mass spectrometry data. Methods Mol Biol. 2010;593:205-29 Authors: Datta S, Pihur V Mass spectrometry has been used in biochemical research for a long time. However, its potential for discovering proteomic biomarkers using protein mass spectra has aroused tremendous interest in the last few years. In spite of its potential for biomarker discovery, it is recognized that the identification of meaningful proteomic features from mass spectra needs careful evaluation. Hence, extracting meaningful features and discriminating the samples based on these features are still open areas of research. Several research groups are actively involved in making the process as perfect as possible. In this chapter, we provide a review of major contributions toward feature selection and classification of proteomic mass spectra involving MALDI-TOF and SELDI-TOF technology. PMID: 19957152 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 質量分析データとの関連の記事の特徴選択そして機械学習。 方法Mol Biol. 2010年; 593: 205-29書く: Datta SのPihur Vの質量分析は生化学的な研究で長い間使用されてしまった。 但し、蛋白質の多くスペクトルを使用してproteomic biomarkersを発見するための潜在性はここ数年間の途方もない興味を覚醒させた。 biomarkerの発見のための潜在性にもかかわらず、多くスペクトルからの意味を持ったproteomic特徴の同一証明が注意深い評価を必要とすることが確認される。 それ故に、意味を持った特徴を得、これらの特徴に基づいてサンプルを区別することは今でも開いた研究分野である。 何人かの研究グループはプロセスをできるだけ完全にさせることに積極的にかかわる。 この章では、私達はMALDI-TOFおよびSELDI-TOFの技術を含むproteomic多くスペクトルの特徴選択そして分類の方に多大な貢献の検討を提供する。 PMID: 19957152 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: serum protein profiling in seminoma patients.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-135.html</link>
      <description> Related Articles Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: serum protein profiling in seminoma patients. World J Urol. 2010 Apr;28(2):193-7 Authors: Strenziok R, Hinz S, Wolf C, Conrad T, Krause H, Miller K, Schrader M PURPOSE: Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) allows rapid protein profiling of complex biological mixtures. We analyzed testicular germ cell cancer serum samples to differentiate between ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-135.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: serum protein profiling in seminoma patients. World J Urol. 2010 Apr;28(2):193-7 Authors: Strenziok R, Hinz S, Wolf C, Conrad T, Krause H, Miller K, Schrader M PURPOSE: Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) allows rapid protein profiling of complex biological mixtures. We analyzed testicular germ cell cancer serum samples to differentiate between cancer and controls with a special focus on beta-hCG-negative seminomas. METHODS: Proteomic spectra were generated by the ProteinChip system and analyzed by the proteomic platform "proteomic.net". For statistical analysis, an artificial intelligence learning algorithm was used. RESULTS: The classification algorithm correctly identified the pattern in 90.4% of the patients. Decision trees predicted seminomas with 91.5% sensitivity and 89.4% specificity. Seminoma patients with normal beta-hCG serum level were correctly predicted with 80% sensitivity and 70% specificity. CONCLUSIONS: Our study demonstrates protein profiles of testicular germ cell cancer patients that differ in a highly significant degree from normal controls. Validation of these findings may enable proteomic profiling to become a valuable tool, especially for aftercare. PMID: 19529944 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事はレーザーの脱着またはイオン化時間の飛行質量分析を表面高めた: seminomaの患者で側面図を描く血清蛋白質。 世界J Urol。 4月2010日; 28 (2): 193-7書く: Strenziok R、Hinz SのオオカミC、コンラッドT、Krause H、ミラーKのSchrader Mの目的: 表面高められたレーザーの脱着のイオン化時間の飛行質量分析(SELDI-TOF MS)は複雑な生物的混合物の急速な蛋白質の側面図を描を可能にする。 私達はベータhCG否定的なseminomasの特別な焦点との癌と制御を区別するために精巣の細菌細胞癌の血清のサンプルを分析した。 方法: ProteomicスペクトルはProteinChipシステムによって発生し、proteomicプラットホーム「proteomic.netによって」分析された。 統計分析のために、人工知能の学習アルゴリズムは使用された。 結果: 分類のアルゴリズムは正しく患者の90.4%のパターンを識別した。 決定ツリーは91.5%感受性のseminomasをおよび89.4%特定性予測した。 正常なベータhCG血清のレベルを持つSeminomaの患者は80%の感受性および70%の特定性と正しく予測された。 結論: 私達の調査は正常な制御と非常に重要な程度で異なる精巣の細菌細胞の癌患者の蛋白質のプロフィールを示す。 これらの調査結果の確認はアフターケアのための貴重な用具に、特になるproteomic側面図を描を可能にするかもしれない。 PMID: 19529944 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Inflammatory biomarker profiling in elderly patients with acute hip fracture treated with heparins.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-170.html</link>
      <description>Related Articles Inflammatory biomarker profiling in elderly patients with acute hip fracture treated with heparins. Clin Appl Thromb Hemost. 2010 Feb;16(1):42-50 Authors: Knesek MJ, Litinas E, Adiguzel C, Hopkinson W, Hoppensteadt D, Lassen M, Fareed J Hip fracture is common in the elderly patients with associated high risk of venous thromboembolic complications. Pathogenic activation results in the generation of various surrogate markers in plasma. This study is designed to identify unique bio ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-170.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Inflammatory biomarker profiling in elderly patients with acute hip fracture treated with heparins. Clin Appl Thromb Hemost. 2010 Feb;16(1):42-50 Authors: Knesek MJ, Litinas E, Adiguzel C, Hopkinson W, Hoppensteadt D, Lassen M, Fareed J Hip fracture is common in the elderly patients with associated high risk of venous thromboembolic complications. Pathogenic activation results in the generation of various surrogate markers in plasma. This study is designed to identify unique biomarkers in elderly patients with hip fracture using protein chip array enzyme-linked immunosorbent assay (ELISA) methods. Plasma from a randomized hip fracture study (PK-532; n = 341) treated with either enoxaparin (40 mg once daily) or unfractionated heparin (UFH; 5000 IU twice daily) were collected prior to and at 1, 3, 5, and 7 days. A total of 52 samples were analyzed using proteomic surface-enhanced laser desorption/ ionization-time of flight (SELDI-TOF) mass spectrometry to identify unique biomarkers in the molecular weight range of 0 to 150 kd. Twenty-nine healthy volunteer's and pooled plasma from total hip replacement/total knee replacement patients with a unique biomarker at 11.9 kd were used as quality controls. In the 29 healthy individuals, the biomarker profile did not reveal the presence of any unique peak in comparison to the reference normal human plasma (NHP). Plasma obtained prior to surgery exhibits unique biomarkers in 4 of 52 (7.6%) of the samples. On day 1 postoperatively, 41 of 51 (80.3%) showed a distinct peak at 11.9 kd. On day 3, 43 of 49 (87.8%) patients showed the presence of this biomarker most often at its strongest intensity. In all, 22 of 44 (50%) showed this biomarker on day 5 and 4 of 23 (17.9%) on day 7. C-reactive protein (CRP), tumor necrosis factor alpha (TNF-alpha), and serum amyloid A were also increased after surgery. Tissue factor pathway inhibitor (TFPI) antigen levels were increased due to the treatment modalities. PMID: 19959493 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Applications of Surface-Enhanced Laser Desorption/Ionization Time-Of-Flight (SELDI-TOF) Mass Spectrometry in Defining Salivary Proteomic Profiles.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-137.html</link>
      <description> Related Articles Applications of Surface-Enhanced Laser Desorption/Ionization Time-Of-Flight (SELDI-TOF) Mass Spectrometry in Defining Salivary Proteomic Profiles. Open Dent J. 2009;3:74-79 Authors: Al-Tarawneh SK, Bencharit S Recent advancement in mass spectrometry leads us to a new era of proteomic analysis. Human saliva can be easily collected; however, the complexity of the salivary proteome in the past prevented the use of saliva for proteomic analysis. Here we review the development of pr ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-137.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Applications of Surface-Enhanced Laser Desorption/Ionization Time-Of-Flight (SELDI-TOF) Mass Spectrometry in Defining Salivary Proteomic Profiles. Open Dent J. 2009;3:74-79 Authors: Al-Tarawneh SK, Bencharit S Recent advancement in mass spectrometry leads us to a new era of proteomic analysis. Human saliva can be easily collected; however, the complexity of the salivary proteome in the past prevented the use of saliva for proteomic analysis. Here we review the development of proteomic analyses for human saliva and focus on the use of a new mass spectrometric technology known as surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF). SELDI-TOF, a modification of matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF), combines the precision of mass spectrometry and the high-through-put nature of protein arrays known as Protein Chips. This technology shows a promising future for salivary proteomic analysis in monitoring treatments and diseases, as well as novel biomarker discovery. PMID: 19543543 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： Proteomicの唾液プロフィールの定義の表面高められたレーザーの脱着またはイオン化時間の飛行(SELDI-TOF)質量分析の関連の記事の塗布。 凹みJ. 2009年を開けなさい; 3: 74-79書く: AlTarawneh SKの質量分析のBencharit Sの最近の進歩はproteomic分析の新しい時代に私達を導く。 人間の唾液は容易に集めることができる; 但し、以前唾液proteomeの複雑さはproteomic分析のための唾液の使用を防いだ。 ここに私達は人間の唾液のためのproteomic分析の開発を見直し、表面高められたレーザーの脱着またはイオン化時間の飛行質量分析(SELDI-TOF)として知られている新しい多くの分光技術の使用に焦点を合わせる。 マトリックス助けられたレーザーの脱着またはイオン化質量分析(MALDI-TOF)のSELDI-TOF、修正、コンバインは質量分析の精密および蛋白質の破片として知られていた蛋白質の配列の性質を高によ置いた。 この技術は新しいbiomarkerの発見と同様、監視の処置および病気で唾液proteomic分析のための有望な未来を、示す。 PMID: -出版業者によって供給される… 19543543 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Establishment of endometriosis diagnostic model using plasma protein profiling]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-171.html</link>
      <description>Related Articles [Establishment of endometriosis diagnostic model using plasma protein profiling] Zhonghua Fu Chan Ke Za Zhi. 2009 Aug;44(8):601-4 Authors: Liu HY, Zheng YH, Zhang JZ, Leng JH, Sun DW, Liu ZF, Zhu L, Lang JH OBJECTIVE: To establish the diagnostic model for endometriosis by screening the plasma biomarkers of endometriosis using surface enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS)coupled with bioinformatics. METHODS: Plasma samples from 36 pa ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-171.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Establishment of endometriosis diagnostic model using plasma protein profiling] Zhonghua Fu Chan Ke Za Zhi. 2009 Aug;44(8):601-4 Authors: Liu HY, Zheng YH, Zhang JZ, Leng JH, Sun DW, Liu ZF, Zhu L, Lang JH OBJECTIVE: To establish the diagnostic model for endometriosis by screening the plasma biomarkers of endometriosis using surface enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS)coupled with bioinformatics. METHODS: Plasma samples from 36 patients with endometriosis (endometriosis group) matched with 35 patients with infertility or benign ovarian tumors (control group) before laparoscopy were collected at Peking Union Medical College Hospital from January to October 2007. Plasma protein profiling were detected using SELDI-TOF-MS and protein chip and peak intensities were compared between the two groups. Biomarker Discovery Software was used for data analysis and model was build by classification and regression tree software (CART), sensitivity and specificity of the diagnostic model were verified. RESULTS: There were 14 protein peaks abnormally expressed in endometriosis group compared with those of control group (P < 0.01). The diagnostic model composed of three protein peaks with the molecular weight of 3,956,000, 11,710,000 and 6,986,000 showed a sensitivity of 92% and specificity of 83%. In the blind test the model showed a sensitivity of 88% and specificity of 80%. CONCLUSIONS: SELDI-TOF-MS is a new approach for screening markers of endometriosis. Its clinical value deserves further investigation. PMID: 20003789 [PubMed - in process]（【斜め読み用】機械翻訳：関連の記事[側面図を描く血しょう蛋白質を使用してendometriosisの診断モデルの確立] Zhonghua Fu Chan Ke Za Zhi。 8月2009日; 44 (8): 601-4書く: 劉HY、Zheng YH、チャンJZ、Leng JH、日曜日DW、劉ZF、朱LのLang JHの目的: endometriosisのための診断モデルを生物情報学とつながれる質量分析(SELDI-TOF-MS)表面によって高められるレーザーの脱着またはイオン化経過時間を使用してendometriosisの血しょうbiomarkersの選別によって確立するため。 方法: endometriosis (endometriosisのグループ)の36人の患者からの血しょうサンプルは不妊または温和な卵巣の腫瘍(制御グループ)を持つ35人の患者とlaparoscopyが1月から2007年10月への北京連合医学の大学病院で集められた前に一致した。 血しょう蛋白質の側面図を描くことはSELDI-TOF-MSを使用して検出され、蛋白質の破片およびピーク強度は2グループの間で比較された。 Biomarkerの発見ソフトウェアはデータ解析のために使用され、モデルは分類によって造り行い、退化の木ソフトウェア(カート)、診断モデルの感受性および特定性は確認された。 結果: 異常に制御グループ(Pの&ltのそれらと比較されたendometriosisのグループに表現された14の蛋白質のピークがあった; 0.01)。 3,956,000、11,710,000および6,986,000の分子量が付いている3つの蛋白質のピークで構成された診断モデルは92%の感受性および83%の特定性を示した。 盲目テストでモデルは88%の感受性および80%の特定性を示した。 結論: SELDI-TOF-MSはendometriosisのスクリーニングのマーカーのための新しいアプローチである。 その臨床価値はより詳しい調査に値する。 PMID: 20003789 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-139.html</link>
      <description> Related Articles Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer. Br J Cancer. 2009 Jul 21;101(2):295-302 Authors: Mohri Y, Mohri T, Wei W, Qi YJ, Martin A, Miki C, Kusunoki M, Ward DG, Johnson PJ BACKGROUND: Proteomic methods have the potential to meet the urgent need for better cancer biomarkers. We have used a range of proteomic analyses of serum and tissue from gastric cancer patients and relevant controls ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-139.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer. Br J Cancer. 2009 Jul 21;101(2):295-302 Authors: Mohri Y, Mohri T, Wei W, Qi YJ, Martin A, Miki C, Kusunoki M, Ward DG, Johnson PJ BACKGROUND: Proteomic methods have the potential to meet the urgent need for better cancer biomarkers. We have used a range of proteomic analyses of serum and tissue from gastric cancer patients and relevant controls to discover biomarkers for gastric cancer. METHODS: Surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI) and antibody arrays were used to compare protein expression in 21 pairs of gastric cancer tissue and adjacent normal mucosa and serum from 51 gastric cancer patients and 29 patients with benign gastric diseases. Expression differences were confirmed by enzyme-linked immunosorbent assay. RESULTS: Tissue analysis shows human neutrophil peptides 1-3 (HNPs 1-3) elevated 10-fold (P=0.001) in gastric cancer relative to adjacent normal mucosa. Macrophage migration inhibitory factor (MIF) was increased five-fold (P=1.84 x 10(-7)) in the serum of gastric cancer patients relative to individuals with benign gastric disease. The large increase in MIF concentration in serum gives an area under the receiver operating characteristic curve of 0.85. CONCLUSIONS: Proteomic analyses of serum and tissue indicate that HNPs 1-3 and MIF have potential as biomarkers for gastric cancer. In particular MIF may be useful, either alone or in combination with other markers, for diagnosing and monitoring gastric cancer. PMID: 19550422 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 大食細胞移動の抑制的な要因および人間の好中球のペプチッドの関連の記事の同一証明胃癌のための潜在的なbiomarkersとして1-3。 Br Jの蟹座。 7月2009日21日; 101 (2): 295-302書く: Mohri Y、Mohri T、魏W、チーYJ、マーティンA、Miki C、Kusunoki M、区DGのジョンソンPJの背景: Proteomic方法によりよい癌のbiomarkersのための急務を満たす潜在性がある。 私達は胃癌のためのbiomarkersを発見するのに胃の癌患者からの血清そしてティッシュのproteomic分析および関連した制御の範囲を使用した。 方法: 表面高められたレーザーの脱着またはイオン化時間の飛行質量分析(SELDI)温和な胃の病気と21組の51人の胃の癌患者および29人の患者からの胃癌のティッシュの蛋白質の表現をおよび隣接した正常な粘膜および血清比較するのにおよび抗体の配列が使用された。 表現の相違は酵素つながれたimmunosorbentの試金によって確認された。 結果: ティッシュの分析は胃癌の相関的な隣接した正常な粘膜で人間の好中球のペプチッドに十倍に上がる1-3 (HNPs 1-3)を(P=0.001)示す。 大食細胞移動の抑制的な要因(MIF)は増加された5重だった(P=1.84 X 10 (- 7つ)) 温和な胃の病気の胃の癌患者の相関的な個人の血清。 血清のMIFの集中の大きい増加は0.85の受信者特性曲線の下で区域を与える。 結論: 血清およびティッシュのProteomicの分析はHNPs 1-3およびMIFに胃癌のためのbiomarkersとして潜在性があることを示す。 特にMIFは単独でまたは胃癌を診断し、監視するための他のマーカーを伴って有用、かもしれない。 PMID: 19550422 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Serum protein profiling of smear-positive and smear-negative pulmonary tuberculosis using SELDI-TOF mass spectrometry.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-172.html</link>
      <description> Related Articles Serum protein profiling of smear-positive and smear-negative pulmonary tuberculosis using SELDI-TOF mass spectrometry. Lung. 2010 Jan-Feb;188(1):15-23 Authors: Liu Q, Chen X, Hu C, Zhang R, Yue J, Wu G, Li X, Wu Y, Wen F The focus of this study was to detect novel sera biomarkers for smear-positive and smear-negative pulmonary tuberculosis and to establish respective diagnostic models using the surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-172.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Serum protein profiling of smear-positive and smear-negative pulmonary tuberculosis using SELDI-TOF mass spectrometry. Lung. 2010 Jan-Feb;188(1):15-23 Authors: Liu Q, Chen X, Hu C, Zhang R, Yue J, Wu G, Li X, Wu Y, Wen F The focus of this study was to detect novel sera biomarkers for smear-positive and smear-negative pulmonary tuberculosis and to establish respective diagnostic models using the surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) technique. A total of 155 sera samples from smear-positive pulmonary tuberculosis (SPPTB) and smear-negative pulmonary tuberculosis (SNPTB) patients and non-tuberculosis (non-TB) controls were analyzed with SELDI-TOF MS. The study was divided into a preliminary training set and a blinded testing set. A classification tree of spectra derived from 31 SPPTB patients, 22 SNPTB patients, and 42 non-TB controls were used to develop an optimal classification tree that discriminated them respectively in the training set. Then, the validity of the classification tree was challenged with another independent blinded testing set, which included 20 SPPTB patients, 14 SNPTB patients, and 26 non-TB controls. SNPTB patients and non-TB controls also were analyzed alone using the same method. The optimal decision tree model with a panel of nine biomarkers with mass:charge ratios (m/z) of 4821.45, 3443.22, 9284.93, 4473.86, 4702.84, 3443.22, 5343.26, 3398.27, and 3193.61 determined in the training set could detect 93.55%, 95.46%, and 88.09% accuracy for classifying SPPTB patients, SNPTB patients, and non-TB controls specimens, respectively. Validation of an independent, blinded testing set gave an accuracy of 80.77% for controls, 75.00% for SPPTB, and 71.43% for SNPTB samples using the same classification tree. With the peaks displaying differences between SNPTB patients and non-TB controls, a simplified dendrogram (m/z 4821.45, 4792.74) demonstrated classification efficacy of 85.94% (sensitivity 86.36% and specificity 85.71%) for distinguishing SNPTB patients from non-TB controls. The independent blinded testing set containing 14 SNPTB patients and 26 non-TB controls gained an accuracy of 81.59% (sensitivity 78.57% and specificity 84.62%) for diagnosing SNPTB. Special proteins/peptides may change in SPPTB and SNPTB patients and those changes may be used to distinguish them with the proper discriminant analytical method and to pursue and identify some involved proteins underlying the biological process of tuberculosis. PMID: 20012079 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of two new serum protein profiles for renal cell carcinoma.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-141.html</link>
      <description>Related Articles Identification of two new serum protein profiles for renal cell carcinoma. Oncol Rep. 2009 Aug;22(2):401-8 Authors: Engwegen JY, Mehra N, Haanen JB, Schellens JH, Voest EE, Beijnen JH Renal cell carcinoma (RCC) is the most lethal urological cancer, and survival greatly depends on early diagnosis. Therefore, reliable, new biomarkers for detection of RCC are required. We assessed serum protein profiles of samples from two institutes with SELDI-TOF MS in duplicate on CM10 chips at  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-141.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Identification of two new serum protein profiles for renal cell carcinoma. Oncol Rep. 2009 Aug;22(2):401-8 Authors: Engwegen JY, Mehra N, Haanen JB, Schellens JH, Voest EE, Beijnen JH Renal cell carcinoma (RCC) is the most lethal urological cancer, and survival greatly depends on early diagnosis. Therefore, reliable, new biomarkers for detection of RCC are required. We assessed serum protein profiles of samples from two institutes with SELDI-TOF MS in duplicate on CM10 chips at pH 6.0 (set 1: 37 RCC + 32 healthy controls (HC), set 2: 20 RCC + 25 HC). Mean peak intensities of detected proteins were compared between RCC and HC with non-parametric testing. Classification trees were built with discriminating peaks using one sample set as training set and the other as independent validation set. We found 15 peaks significantly different (p<0.01) between RCC and HC. Two classification trees could be built with these peaks. Tree A achieved 75% sensitivity and 85% specificity for cross-validation and 76 and 65% for independent validation. Tree B had 71 and 62% sensitivity and specificity for cross-validation and 83 and 82% for independent validation. Although two serum protein profiles comprising 5 protein peaks were found that could separate RCC from HC, the sensitivity and specificity is not sufficient to recommend large scale use. Upon structural identification and quantitative validation, however, these proteins might prove suitable markers in the follow up of RCC patients. PMID: 19578783 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：腎臓の細胞の癌腫のための2つの新しい血清蛋白質のプロフィールの関連の記事の同一証明。 Oncol Rep。 8月2009日; 22 (2): 401-8書く: Engwegen JY、Mehra N、Haanen JB、Schellens JH、Voest EE、腎臓の細胞の癌腫(RCC)が最も致命的な泌尿器科癌および存続であるBeijnen JHは早い診断によって非常に決まる。 従って、RCCの検出のための信頼できる、新しいbiomarkersは要求される。 私達はpH 6.0でCM10破片のSELDI-TOF MSを持つ2人の協会からのサンプルの血清蛋白質のプロフィールを正副2通りに査定した(1:37をRCC + 32の健康な制御(HC)、置く2:20をRCC + 25 HC置きなさい)。 検出された蛋白質の中間のピーク強度はノンパラメトリックのテストとRCCとHCの間で比較された。 分類の木は置かれた訓練として置かれた1つのサンプルおよび他を使用して識別力があるピークとように独立した確認セット造られた。 私達は15のピークをかなり違う見つけた(p< RCCとHCの間の0.01)。 2本の分類の木はこれらのピークと造ることができる。 木Aは独立した確認のためのクロス確認のための75%の感受性そして85%の特定性および76および65%達成した。 木Bに独立した確認のためのクロス確認のための71そして62%の感受性そして特定性がおよび83そして82%あった。 HCからRCCを分けることができる5つの蛋白質のピークから成り立つ2つの血清蛋白質のプロフィールが見つけられたが感受性および特定性は大規模の使用を推薦して十分ではない。 しかし構造同一証明および量的な確認にこれらの蛋白質はRCCの患者のフォローアップの適したマーカーを証明するかもしれない。 PMID: 19578783 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-173.html</link>
      <description> Related Articles The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. J Gastroenterol. 2010 Apr;45(4):459-67 Authors: Kanmura S, Uto H, Sato Y, Kumagai K, Sasaki F, Moriuchi A, Oketani M, Ido A, Nagata K, Hayashi K, Stuver SO, Tsubouchi H BACKGROUND: Hepatocellular carcinoma (HCC) has a high mortality rate, and early detection of HCC improves patient survival. However, the molecular diagnostic markers for early HCC have not been  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-173.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. J Gastroenterol. 2010 Apr;45(4):459-67 Authors: Kanmura S, Uto H, Sato Y, Kumagai K, Sasaki F, Moriuchi A, Oketani M, Ido A, Nagata K, Hayashi K, Stuver SO, Tsubouchi H BACKGROUND: Hepatocellular carcinoma (HCC) has a high mortality rate, and early detection of HCC improves patient survival. However, the molecular diagnostic markers for early HCC have not been fully elucidated. The aim of this study was to identify novel diagnostic markers for HCC. METHODS: Serum protein profiles of 45 hepatitis C virus infection (HCV)-related HCC patients (HCV-HCC) were compared to 42 HCV-related chronic liver disease patients without HCC (HCV-CLD) and 21 healthy volunteers using the ProteinChip SELDI system. One of the identified proteins was evaluated as a diagnostic marker for HCC in patients with HCV. RESULTS: Five protein peaks (4067, 4470, 7564, 7929, and 8130 m/z) had p-values less than 1 x 10(-7) and were significantly increased in the sera of HCV-HCC patients compared to HCV-CLD patients and healthy volunteers. Among these proteins, an 8130 m/z peak was the most differentially expressed and identified as the complement component 3a (C3a) fragment. For HCV-HCC and HCV-CLD, the relative intensity of this C3a fragment had the best area under the ROC curve [0.70], followed by des-gamma-carboxy prothrombin (DCP) [0.68], lectin-bound alpha fetoprotein (AFP-L3) [0.58] and AFP [0.53] for HCC. A combined analysis of the C3a fragment, AFP and DCP led to a 98% positive identification rate. In addition, the measurable C3a fragment in some HCC patients was not only significantly higher in the year of HCC onset compared to the pre-onset year, but also decreased after treatment. CONCLUSIONS: The 8130 m/z C3a fragment is a potential marker for the early detection of HCV-related HCC. PMID: 20012107 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事は補足物構成C3aの片肝炎のウイルス関係したhepatocellular癌腫のための潜在的なbiomarkerである。 J Gastroenterol。 4月2010日; 45 (4): 459-67書く: Kanmura S、Uto H、佐藤Y、Kumagai K、Sasaki F、Moriuchi A、Oketani M、Ido A、Nagata K、Hayashi K、そうStuver、Tsubouchi Hの背景: Hepatocellular癌腫(HCC)にHCCの高い死亡率および早期発見が改善する忍耐強い存続をある。 但し、早いHCCのための分子診断マーカーは十分に明瞭にならなかった。 この調査の目標はHCCのための新しい診断マーカーを識別することだった。 方法: 45人の肝炎のウイルスの伝染(HCV)関連のHCCの患者(HCV-HCC)の血清蛋白質のプロフィールはHCC (HCV-CLD)なしで42人のHCV関係した慢性の肝臓病の患者およびProteinChip SELDIシステムを使用している21人の健康なボランティアと比較された。 識別された蛋白質の1つはHCVの患者のHCCのための診断マーカーとして評価された。 結果: 5蛋白質のピークの(4067に、4470、7564、7929、および8130にm/z) p価値がより少なくより1 x 10 (- 7)あり、HCV-CLDの患者および健康なボランティアと比較されたHCV-HCCの患者の血清でかなり増加した。 これらの蛋白質の間で、8130 m/zのピークは最も特異的に表現されて補足物の部品3a (C3a)の片として識別されて。 HCV-HCCおよびHCV-CLDのために、このC3aの片の相対的な強度にdesガンマcarboxyプロトロムビン(DCP) [0.68]に先行しているROCのカーブ[0.70]の下で最もよい区域がlectin区切るアルファfetoprotein (AFP-L3) [0.58]およびHCCのためのAFP [0.53]あった。 C3aの片、AFPおよびDCPの結合された分析は98%の確実な識別率をもたらした。 さらに、HCCの患者の測定可能なC3aの片は前手始め年と比較された、しかしまた処置の後で減ったHCCの手始めの年にかなりより高かったただ。 結論: 8130 m/z C3aの片はHCV関係したHCCの早期発見のための潜在的なマーカーである。 PMID: 20012107 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Study for drug-resistance of epithelial ovarian cancer by serum protein profiling]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-143.html</link>
      <description>Related Articles [Study for drug-resistance of epithelial ovarian cancer by serum protein profiling] Zhonghua Yi Xue Za Zhi. 2009 May 19;89(19):1326-9 Authors: Zhang WY, Zhu LR, Zheng YH, Zhou L, Zhang JZ, Wu JH, Liao QP OBJECTIVE: To develop the rationales for ovarian cancer-specific protein profiles in serum and to analyze the protein profiles of multidrug resistance P-glucoprotein (MDR1) and multidrug resistance-associated protein (MRP) positive and negative expression sets for a rapid and se ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-143.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Study for drug-resistance of epithelial ovarian cancer by serum protein profiling] Zhonghua Yi Xue Za Zhi. 2009 May 19;89(19):1326-9 Authors: Zhang WY, Zhu LR, Zheng YH, Zhou L, Zhang JZ, Wu JH, Liao QP OBJECTIVE: To develop the rationales for ovarian cancer-specific protein profiles in serum and to analyze the protein profiles of multidrug resistance P-glucoprotein (MDR1) and multidrug resistance-associated protein (MRP) positive and negative expression sets for a rapid and sensitive serum protein pattern. METHOD: Serum protein profiles from 36 epithelial ovarian cancer cases were compared with 30 healthy controls using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (DELDI-TOF-MS). Blinded test was conducted subsequently for identification of the protein pattern. Expression of MDR and MRP were detected in set of training cases by immunohistochemistry. The spectra were analyzed statistically between positive and negative groups. RESULTS: Twenty-nine peaks were significantly different between ovarian cancer and healthy controls (P < 0.01, 15 peaks up-regulated and 14 down-regulated). A set of three peaks, at 5 486, 6 463 and 8 575 m/z respectively, were selected from 29 sense peaks as an ovarian cancer biomarker. The sensitivity was 100% and specificity 93.33%. Identification by blinded validation indicated a positive predictive value of 90%. MDR1 expression in ovarian cancer was 69.4 %. Twenty peaks were significantly different between positive and negative sets (P < 0.01). MRP expression in ovarian cancer was 63.8%. But one peak was detected (P < 0.01). CONCLUSION: It was an ideal pattern for employing the SELDI mass spectrum approach to diagnose ovarian cancer and select the multidrug resistance cases. Serum biomarkers for detecting drug resistance in ovarian cancer can be established on the basis of MDR1 immunohistochemistry. PMID: 19615186 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：関連の記事[側面図を描く血清蛋白質による上皮性の卵巣癌の薬剤抵抗のための調査] ZhonghuaイXue Za Zhi。 5月2009日19日; 89 (19): 1326-9書く: チャンWY、朱LR、Zheng YH、Zhou L、チャンJZ、ウーJHのLiao QPの目的: 血清の卵巣の癌特定の蛋白質のプロフィールのための理論的根拠を開発し、multidrugの抵抗P-glucoprotein (MDR1)、multidrugの抵抗準蛋白質(MRP)の肯定的で、否定的な表現の蛋白質のプロフィールを分析し急速で、敏感な血清蛋白質パターンのために置く。 方法: 36の上皮性の卵巣癌の場合からの血清蛋白質のプロフィールは表面高められたレーザーの脱着またはイオン化時間の飛行質量分析(DELDI-TOF-MS)を使用して30の健康な制御と比較された。 盲目にされたテストは蛋白質パターンの同一証明のために続いて行なわれた。 MDRの表現およびMRPはimmunohistochemistryによってトレインケースのセットで検出された。 スペクトルは肯定的で、否定的なグループの間で統計的に分析された。 結果: 29のピークは卵巣癌と健康な制御(Pの&lt間でかなり違った; 調整される0.01、15のピークおよび調整される14)。 一組の3つのピークは、5 486で、それぞれ6 463そして8 575 m/z、卵巣癌のbiomarkerとして29の感覚のピークから選ばれた。 感受性は100%年および特定性93.33%だった。 盲目にされた確認による同一証明は90%という肯定的な予言する値を示した。 卵巣癌のMDR1表現は69.4%だった。 20のピークは陽性間でかなり違い、陰性は置く(Pの< 0.01)。 卵巣癌のMRPの表現は63.8%だった。 しかし1つのピークは検出された(Pの< 0.01)。 結論: それは卵巣癌を診断し、multidrugの抵抗の例を選ぶためにSELDIの多くスペクトルのアプローチを用いるための理想的なパターンだった。 卵巣癌の薬剤抵抗を検出するための血清のbiomarkersはimmunohistochemistry MDR1に基づいて確立することができる。 PMID: 19615186 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteomic profiling of the rat cerebral cortex in sleep and waking.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-174.html</link>
      <description>Related Articles Proteomic profiling of the rat cerebral cortex in sleep and waking. Arch Ital Biol. 2009 Sep;147(3):59-68 Authors: Cirelli C, Pfister-Genskow M, McCarthy D, Woodbury R, Tononi G Transcriptomic studies have shown that hundreds of genes change their expression levels across the sleep/waking cycle, and found that waking-related and sleep-related mRNAs belong to different functional categories. Proteins, however, rather than DNA or RNA, carry out most of the cellular functions, and  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-174.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Proteomic profiling of the rat cerebral cortex in sleep and waking. Arch Ital Biol. 2009 Sep;147(3):59-68 Authors: Cirelli C, Pfister-Genskow M, McCarthy D, Woodbury R, Tononi G Transcriptomic studies have shown that hundreds of genes change their expression levels across the sleep/waking cycle, and found that waking-related and sleep-related mRNAs belong to different functional categories. Proteins, however, rather than DNA or RNA, carry out most of the cellular functions, and direct measurements of protein levels and activity are required to assess the effects of behavioral states on the overall functional state of the cell. Here we used surface-enhanced laser desorption-ionization (SELDI), followed by time-of-flight mass spectrometry, to obtain a large-scale profiling of the proteins in the rat cerebral cortex whose expression is affected by sleep, spontaneous waking, short (6 hours) and long (7 days) sleep deprivation. Each of the 94 cortical samples was profiled in duplicate on 4 different ProteinChip Array surfaces using 2 different matrix molecules. Overall, 1055 protein peaks were consistently detected in cortical samples and 15 candidate biomarkers were selected for identification based on significant changes in multiple conditions (conjunction analysis): 8 "sleep" peaks, 4 "waking" peaks, and 4 "long sleep deprivation" peaks. Four candidate biomarkers were purified and positively identified. The 3353 Da candidate sleep marker was identified as the 30 amino acid C-terminal fragment of rat histone H4. This region encompasses the osteogenic growth peptide, but a possible link between sleep and this peptide remains highly speculative. Two peaks associated with short and long sleep deprivation were identified as hemoglobin alpha1/2 and beta, respectively, while another peak associated with long sleep deprivation was identified as cytochrome C. The upregulation of hemoglobins and cytochrome C may be part of a cellular stress response triggered by even short periods of sleep loss. PMID: 20014652 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Profiling MS proteomics data using smoothed non-linear energy operator and Bayesian additive regression trees.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-145.html</link>
      <description> Related Articles Profiling MS proteomics data using smoothed non-linear energy operator and Bayesian additive regression trees. Proteomics. 2009 Sep;9(17):4176-91 Authors: He S, Li X, Viant MR, Yao X This paper proposes a novel profiling method for SELDI-TOF and MALDI-TOF MS data that integrates a novel peak detection method based on modified smoothed non-linear energy operator, correlation-based peak selection and Bayesian additive regression trees. The peak detection and classification perfor ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-145.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Profiling MS proteomics data using smoothed non-linear energy operator and Bayesian additive regression trees. Proteomics. 2009 Sep;9(17):4176-91 Authors: He S, Li X, Viant MR, Yao X This paper proposes a novel profiling method for SELDI-TOF and MALDI-TOF MS data that integrates a novel peak detection method based on modified smoothed non-linear energy operator, correlation-based peak selection and Bayesian additive regression trees. The peak detection and classification performance of the proposed approach is validated on two publicly available MS data sets, namely MALDI-TOF simulation data and high-resolution SELDI-TOF ovarian cancer data. The results compared favorably with three state-of-the-art peak detection algorithms and four machine-learning algorithms. For the high-resolution ovarian cancer data set, seven biomarkers (m/z windows) were found by our method, which achieved 97.30 and 99.10% accuracy at 25th and 75th percentiles, respectively, from 50 independent cross-validation samples, which is significantly better than other profiling and dimensional reduction methods. The results show that the method is capable of finding parsimonious sets of biologically meaningful biomarkers with better accuracy than existing methods. Supporting Information material and MATLAB/R scripts to implement the methods described in the article are available at: http://www.cs.bham.ac.uk/szh/SourceCode-for-Proteomics.zip. PMID: 19722190 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 滑らかにされた非線形エネルギーオペレータおよびベイズの付加的な退化の木を使用してMSのproteomicsデータの側面図を描く関連の記事。 Proteomics。 9月2009日; 9 (17): 4176-91書く: 彼はS、李Xの矢尾、Viantの氏Xこのペーパー変更された滑らかにされた非線形エネルギーオペレータ、相関関係基づかせていたピーク選択およびベイズの付加的な退化の木に基づいて新しいピーク検出方法を統合するSELDI-TOFおよびMALDI-TOF MSデータのための新しい側面図を描く方法を提案する。 提案されたアプローチのピーク検出および分類の性能は2つの一般公開されたMSのデータセット、即ちMALDI-TOFのシミュレーションデータおよび高解像SELDI-TOFの卵巣癌データで認可される。 結果は3つの最新式のピーク検出のアルゴリズムおよび4つの機械学習のアルゴリズムと好意的に比較した。 高解像の卵巣癌のデータセットのために、7 biomarkers (m/zの窓)は第25そして第75百分位数で97.30および99.10%正確さを達成した私達の方法によって、50の独立したクロス確認のサンプルからそれぞれ見つけられた、他の側面図を描くことおよび次元の減少方法よりかなりよい。 結果は方法が既存の方法よりよい正確さの生物学的に意味を持ったbiomarkersのparsimoniousセットを見つけることができることを示す。 支持情報材料および記事で記述されている方法を実行するMATLAB/Rの原稿は利用できるで: http://www.cs.bham.ac.uk/szh/SourceCode-for-Proteomics.zip。 PMID: 19722190 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Regulation of CXCR/IL-8 in human airway epithelial cells.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-175.html</link>
      <description> Related Articles Regulation of CXCR/IL-8 in human airway epithelial cells. Int Arch Allergy Immunol. 2010;152(2):140-50 Authors: Gras D, Tiers L, Vachier I, de Senneville LD, Bourdin A, Godard P, Lehman S, Chanez P BACKGROUND: Severe asthma is characterized by neutrophilic inflammation and high levels of interleukin (IL)-8. Airway epithelial cells play a pivotal role in the pathogenesis and chronicity of asthma. The objective of this work was to determine whether CXC receptors were involved in  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-175.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Regulation of CXCR/IL-8 in human airway epithelial cells. Int Arch Allergy Immunol. 2010;152(2):140-50 Authors: Gras D, Tiers L, Vachier I, de Senneville LD, Bourdin A, Godard P, Lehman S, Chanez P BACKGROUND: Severe asthma is characterized by neutrophilic inflammation and high levels of interleukin (IL)-8. Airway epithelial cells play a pivotal role in the pathogenesis and chronicity of asthma. The objective of this work was to determine whether CXC receptors were involved in human small airway epithelial cell (SAEC) activity by incubating them with IL-8; the investigation also included a proteomic approach. METHODS: IL-6 and intercellular adhesion molecule-1 (ICAM-1) were assessed by ELISA and flow cytometry, respectively. CXCR-1 and CXCR-2 receptor mRNA and protein expressions were analyzed by RT-PCR, immunocytochemistry and flow cytometry. Cells were incubated with different concentrations (0-100 ng/ml) of IL-8. The involvement of both receptors was assessed using specific antibodies. RESULTS: Only the CXCR-1 receptor was expressed in SAECs. IL-8 (50 ng/ml, 12 h) induced the release of IL-6 and had no effect on ICAM-1. Supernatants analyzed by surface enhanced laser desorption ionization time of flight mass spectrometry (SELDI-TOF MS) showed very weak differences in peptide profiles. Interestingly, 4,820-m/z peptide release was detected in the presence of IL-8 and abolished by CXCR-1 antibody. DISCUSSION: The present study illustrated the fact that IL-8 mediated by CXCR-1 increased IL-6. We also highlight the usefulness of SELDI ProteinChip technology to confirm the potential variation of peptide profile. Moreover, we were able to detect the 4,820-m/z peptide secreted in vitro by human airway epithelial cells induced by IL-8 via CXCR-1 receptor. Determination of the protein secretion profile in response to inflammatory stimuli could be an important therapeutic strategy in severe asthma. PMID: 20016196 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 人間の航空路の上皮細胞のCXCR/IL-8の関連の記事の規則。 IntはアレルギーImmunolをアーチ形にする。 2010年; 152 (2): 140-50書く: Gras Dの層L、Vachier I、de Senneville LD、Bourdin A、Godard P、Lehman SのChanez Pの背景: 厳しい喘息はinterleukin (IL)のneutrophilic発火そしてハイレベル- 8によって特徴付けられる。 航空路の上皮細胞は喘息の病因そしてchronicityの極めて重要な役割を担う。 この仕事の目的はCXC受容器が人間の小さい航空路の上皮細胞(SAEC)の活動にIL-8ことをとそれらの孵化によってかかわったかどうか定めることだった; 調査はまたproteomicアプローチを含んでいた。 方法: IL-6および細胞間付着の分子1 (ICAM-1)はELISAによって査定され、cytometry、それぞれ流れる。 CXCR-1およびCXCR-2受容器mRNAはおよび蛋白質のcytometry RT-PCR、immunocytochemistryおよび流れによって表現分析された。 細胞はIL-8の異なった集中(0-100 ng/ml)と孵化した。 両方の受容器の介入は特定の抗体を使用して査定された。 結果: CXCR-1受容器だけSAECsに表現された。 IL-8 (50 ng/ml、h) 12はIL-6の解放を引き起こし、ICAM-1に対する効果をもたらした。 Supernatantsはペプチッドプロフィールの質量分析(SELDI-TOF MS)の示されていた非常に弱い相違表面によって高められたレーザーの脱着のイオン化経過時間までに分析した。 興味深いことに、4,820-m/zペプチッド解放はIL-8の前で検出され、CXCR-1抗体によって廃止された。 議論: 現在の調査はIL-8がCXCR-1によって増加されたIL-6によって仲介した事実を説明した。 私達はまたペプチッドプロフィールの潜在的な変化を確認するためにSELDI ProteinChipの技術の実用性を強調する。 さらに、私達はCXCR-1受容器でIL-8によって引き起こされた人間の航空路の上皮細胞によって生体外で分泌した4,820-m/zペプチッドを検出できた。 炎症性刺激に応じての蛋白質の分泌のプロフィールの決定は厳しい喘息の重要な治療上の作戦であることができる。 PMID: 20016196 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-147.html</link>
      <description> Related Articles Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK. Artif Cells Blood Substit Immobil Biotechnol. 2009;37(5):208-13 Authors: He H, Sun G, Ping F To find new biomarkers and establish histopathology protein fingerprint models for early detection of oral squamous cell carcinoma (OSCC), laser capture microdissection (LCM) technology was utilized in 21 OSCC tissues and 7 oral leukoplaque (OLK) tissues as well as their adjacent normal tissues ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-147.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK. Artif Cells Blood Substit Immobil Biotechnol. 2009;37(5):208-13 Authors: He H, Sun G, Ping F To find new biomarkers and establish histopathology protein fingerprint models for early detection of oral squamous cell carcinoma (OSCC), laser capture microdissection (LCM) technology was utilized in 21 OSCC tissues and 7 oral leukoplaque (OLK) tissues as well as their adjacent normal tissues. Each sample was then detected by SELDI-TOF-MS technology and CM10 protein chip as well as bioinformatics tools. Three proteomic biomarker patterns were identified. Pattern 1 distinguishes patients with OLK from healthy individuals. Pattern 2 distinguishes patients with OSCC from healthy individuals. Pattern 3 distinguishes patients with OSCC from patients with OLK. The analysis yielded both a specificity and a sensitivity of 90.48% for pattern 1, a specificity of 100.00% and a sensitivity of 85.71% for pattern 2, and a specificity of 100.00% and a sensitivity of 85.71% for pattern 3. Proteome mass/charge 3714, 3515, and 4944 built the distinguished protein peaks between the OSCC tumor and adjacent normal tissues. The accuracy of the blind prediction was 90.48% (38/42). M/Z 15122 and 7569 built the distinguished protein peaks between the OLK and adjacent normal tissues. M/Z 3738 and 11366 built the distinguished protein peaks between the OSCC and the OLK. By employing LCM technology combined with SELDI-TOF-MS technology and bioinformatics approaches, histopathology would not only facilitate the discovery of better biomarkers for OSCC and OLK, but also provide a useful tool for molecular diagnosis by potential biomarker. PMID: 19735007 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事はOSCCおよびOLKの蛋白質の指紋のためのmicrodissectionおよび蛋白質の抽出をレーザー捕獲する。 Artifの血球Substit Immobil Biotechnol。 2009年; 37 (5): 208-13書く: 彼は口頭squamous細胞癌腫(OSCC)の早期発見のために21のOSCCのティッシュおよび7つの口頭leukoplaque (OLK)のティッシュで隣接した正常なティッシュと同様、H、日曜日Gの新しいbiomarkersを見つけ、組織病理学蛋白質の指紋を確立するポーンF、レーザーの捕獲のmicrodissection (LCM)の技術利用された模倣する。 各サンプルは生物情報学用具と同様、SELDI-TOF-MSの技術およびCM10蛋白質の破片によってそれから検出された。 3つのproteomic biomarkerパターンは識別された。 パターン1は健康な個人とOLKの患者を区別する。 パターン2は健康な個人とOSCCの患者を区別する。 パターン3はOLKの患者とOSCCの患者を区別する。 分析はパターン1、100.00%の特定性およびパターン2のための85.71%の感受性のための90.48%の特定性そして感受性を両方もたらし、100.00%の特定性およびパターン3. Proteomeの固まりか充満3714、3515、および4944のための85.71%の感受性はOSCCの腫瘍と隣接した正常なティッシュ間の顕著な蛋白質のピークを造った。 盲目の予言の正確さは90.48%だった(38/42)。 M/Z 15122および7569はOLKと隣接した正常なティッシュ間の顕著な蛋白質のピークを造った。 M/Z 3738および11366はOSCCとOLK間の顕著な蛋白質のピークを造った。 SELDI-TOF-MSの技術および生物情報学のアプローチと結合されたLCMの技術を用いることによって組織病理学はOSCCおよびOLKのためのよりよいbiomarkersの発見しか促進しなかったが、また潜在的なbiomarkerによって分子診断のための役に立つツールを提供する。 PMID: 19735007 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-176.html</link>
      <description> Related Articles Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J Biomed Biotechnol. 2010;2010:906082 Authors: De Bock M, de Seny D, Meuwis MA, Chapelle JP, Louis E, Malaise M, Merville MP, Fillet M Protein profiling using SELDI-TOF-MS has gained over the past few years an increasing interest in the field of biomarker discovery. The technology presents great potential if some parameters, such as sample handling, SELDI settings, and data analysis, are strictly controlled.  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-176.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J Biomed Biotechnol. 2010;2010:906082 Authors: De Bock M, de Seny D, Meuwis MA, Chapelle JP, Louis E, Malaise M, Merville MP, Fillet M Protein profiling using SELDI-TOF-MS has gained over the past few years an increasing interest in the field of biomarker discovery. The technology presents great potential if some parameters, such as sample handling, SELDI settings, and data analysis, are strictly controlled. Practical considerations to set up a robust and sensitive strategy for biomarker discovery are presented. This paper also reviews biological fluids generally available including a description of their peculiar properties and the preanalytical challenges inherent to sample collection and storage. Finally, some new insights for biomarker identification and validation challenges are provided. PMID: 20029632 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：  SELDI-TOF-MSを使用して体液のbiomarkerの発見のための関連の記事の挑戦。 J Biomed Biotechnol。 2010年; 2010年: 906082人の著者: De Bock M、de Seny D、Meuwis MA、Chapelle JP、ルイEのけん怠感M、Merville MPのSELDI-TOF-MSを使用して側面図を描く肉付けM蛋白質はbiomarkerの発見の分野の増加する興味をここ数年間得た。 技術は、SELDIの設定扱うサンプルのようなある変数が、およびデータ解析、厳しく制御されれば大きい潜在性を示す。 biomarkerの発見のための強く、敏感な作戦をセットアップする実用的な考察は示される。 このペーパーはまた一般に利用可能な生物的液体を見直しコレクションおよび貯蔵を見本抽出するために独特な特性および固有preanalytical挑戦の記述を含んでいる。 最後に、biomarkerの同一証明のためのある新しい洞察力および確認の挑戦は提供される。 PMID: 20029632 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-149.html</link>
      <description>Related Articles Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS. Technol Cancer Res Treat. 2009 Oct;8(5):323-32 Authors: Hegmans JP, Veltman JD, Fung ET, Verch T, Glover C, Zhang F, Allard WJ, T&apos;Jampens D, Hoogsteden HC, Lambrecht BN, Aerts J Diagnosis of malignant pleural mesothelioma (MM) is limited. Novel proteomic techno_logies can be utilized to discover changes in expression of pleural proteins that might have diagnostic value. The obje ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-149.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS. Technol Cancer Res Treat. 2009 Oct;8(5):323-32 Authors: Hegmans JP, Veltman JD, Fung ET, Verch T, Glover C, Zhang F, Allard WJ, T'Jampens D, Hoogsteden HC, Lambrecht BN, Aerts J Diagnosis of malignant pleural mesothelioma (MM) is limited. Novel proteomic techno_logies can be utilized to discover changes in expression of pleural proteins that might have diagnostic value. The objective of this study was to detect protein profiles that could be used to identify malignant pleural mesothelioma with surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry (MS). Pleural effusions were collected from patients with confirmed mesothelioma (n = 41) and from patients with effusions due to other causes ([n = 48] cancerous and non-cancerous). Samples were fractionated using anion exchange chromatography and bound to different types of ProteinChip array surfaces. All samples were also subjected to other commercially available immunoassays (human epididymes protein 4 [HE4], osteopontin [OPN], soluble mesothelin-related proteins [SMRP], and the cytokeratin 19 fragment [CYFRA 21-1]). Peak intensity data obtained by SELDI-TOF were subjected to classification algorithms in order to identify potential classifier peaks. A protein peak at m/z 6614 was characterized as apolipoprotein (Apo) CI. In this setting, the sensitivity and specificity of this potential biomarker was 76 % and 69 %, respectively. The area under the receiver operating characteristic curve (AUC) for Apo CI was 0.755, thereby outperforming OPN, HE4, and CYFRA 21-1. SMRP performed best with an AUC of 0.860 with a sensitivity of 83% and specificity of 74%. Our study validates the use of SMRP as a diagnostic marker for pleural mesothelioma and furthermore suggests that Apo CI levels could be used in the future to discriminate pleural mesothelioma from other causes of exudates. PMID: 19754208 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification biomarkers of eutopic endometrium in endometriosis using artificial neural networks and protein fingerprinting.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-177.html</link>
      <description> Related Articles Identification biomarkers of eutopic endometrium in endometriosis using artificial neural networks and protein fingerprinting. Fertil Steril. 2010 May 1;93(7):2460-2 Authors: Wang L, Zheng W, Ding XY, Yu JK, Jiang WZ, Zhang SZ Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) protein chip array technology was used to detect biomarkers of eutopic endometrium in endometriosis patients. Five potential biomarkers (6,898 m/z, 5,891 m/z, 5,3 ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-177.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Identification biomarkers of eutopic endometrium in endometriosis using artificial neural networks and protein fingerprinting. Fertil Steril. 2010 May 1;93(7):2460-2 Authors: Wang L, Zheng W, Ding XY, Yu JK, Jiang WZ, Zhang SZ Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) protein chip array technology was used to detect biomarkers of eutopic endometrium in endometriosis patients. Five potential biomarkers (6,898 m/z, 5,891 m/z, 5,385 m/z, 6,448 m/z, and 5,425 m/z) were found. PMID: 20045516 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 人工の神経ネットワークおよび蛋白質の指紋採取を使用してendometriosisのeutopic endometriumの関連の記事の同一証明のbiomarkers。 Fertil Steril。 5月2010日1日; 93 (7): 2460-2書く: WangがL、Yu JK X-Y、Zheng W、丁江WZ、チャンSZによって表面高められたレーザーの脱着またはイオン化時間の飛行質量分析(SELDI-TOF-MS)蛋白質の破片の配列の技術はendometriosisの患者のeutopic endometriumのbiomarkersを検出するのに使用された。 5潜在的なbiomarkers (6,898 m/z、5,891 m/z、5,385 m/z、6,448 m/z、および5,425 m/z)は見つけられた。 PMID: 20045516 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-151.html</link>
      <description> Related Articles Identification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment. J Surg Res. 2010 Mar;159(1):474-81 Authors: Li Y, Liu B, Dillon ST, Fukudome EY, Kheirbek T, Sailhamer EA, Velmahos G, deMoya M, Libermann TA, Alam HB BACKGROUND: The initial management of a poly-trauma patient requires evaluation for potential hemorrhage and ongoing monitoring to assess the efficacy of treatment and avoid complications related to massive blood loss. Certa ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-151.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Identification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment. J Surg Res. 2010 Mar;159(1):474-81 Authors: Li Y, Liu B, Dillon ST, Fukudome EY, Kheirbek T, Sailhamer EA, Velmahos G, deMoya M, Libermann TA, Alam HB BACKGROUND: The initial management of a poly-trauma patient requires evaluation for potential hemorrhage and ongoing monitoring to assess the efficacy of treatment and avoid complications related to massive blood loss. Certain serum protein levels may be altered in response to hemorrhagic shock, and may serve as useful biomarkers to guide diagnosis, prognosis, and therapeutics in traumatic hemorrhagic shock (HS). Treatment with valproic acid (VPA) has been shown to up-regulate various survival pathways and improve outcome. Here we determine whether these changes would result in altered serum biomarkers. METHODS: Wistar-Kyoto rats underwent hemorrhagic shock (60% blood loss) followed by treatment with or without VPA (300 mg/kg). Using surface enhanced laser desorption-time of flight mass spectrometry (SELDI or SELDI-TOF MS) technology, we screened serum samples obtained from five rats at different time points (baseline, post-hemorrhagic shock, and post-VPA treatment) in a lethal model of hemorrhagic shock (HS). Additionally, we used isobaric tag labeling for relative quantitation (iTRAQ) to identify potential biomarkers in the serum. Western blots were performed to validate iTRAQ-identified biomarker from independent serum samples, and to analyze protein biomarker levels in the intestine during hemorrhagic shock and treatment. RESULTS: HS and treatment with VPA affected serum levels of many proteins. One such protein with a mass spectrum around 22.7 kDa was detected in all five rats. The same serum samples subjected to iTRAQ resulted in our identification of claudin-3, a 23 kDa tight junction protein. HS elevated serum claudin-3 protein levels, which was reversed by VPA treatment in a pattern similar to the SELDI-TOF MS studies. Further validation with independent serum and intestine samples from individual rats by Western blots confirmed that HS increased the protein level of claudin-3 in serum and decreased its level in the intestine. Treatment with VPA reversed the hemorrhagic shock-induced alteration in claudin-3 to sham levels. CONCLUSIONS: HS causes an acute rise in serum claudin-3 protein levels and a concurrent decrease in intestinal claudin-3 protein expression. VPA treatment attenuates these alterations and stabilizes intestinal claudin-3 levels. Our results demonstrate for the first time that claudin-3 is a potential biomarker in HS and treatment. PMID: 19765733 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Application of saliva protein fingerprints in the diagnosis of oral squamous cell cancer by surface enhanced laser desorption ionization time of flight mass.]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-178.html</link>
      <description>Related Articles [Application of saliva protein fingerprints in the diagnosis of oral squamous cell cancer by surface enhanced laser desorption ionization time of flight mass.] Zhonghua Kou Qiang Yi Xue Za Zhi. 2009 Nov;44(11):664-7 Authors: Sun G, Ping FY OBJECTIVE: To screen proteomic markers of oral precancerous lesion, local and metastatic squamous cell cancer from human saliva. METHODS: Seventeen patients with oral squamous cell carcinoma, six cases with leukoplakia, seven cases with local  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-178.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Application of saliva protein fingerprints in the diagnosis of oral squamous cell cancer by surface enhanced laser desorption ionization time of flight mass.] Zhonghua Kou Qiang Yi Xue Za Zhi. 2009 Nov;44(11):664-7 Authors: Sun G, Ping FY OBJECTIVE: To screen proteomic markers of oral precancerous lesion, local and metastatic squamous cell cancer from human saliva. METHODS: Seventeen patients with oral squamous cell carcinoma, six cases with leukoplakia, seven cases with local metastasis and 15 healthy subjects were selected. All patients were diagnosed of T(1)N(0)M(0) and did not accept any preoperative treatment. Saliva samples were collected preoperatively, combined in the chips (CM-10) for two copies, and tested by surface enhanced laser desorption/ionization (SELDI) mass spectrometry respectively. Chips were detected by the PBS-II plus mass spectrometer reader. Mass accuracy was calibrated by the all-in-one peptide molecular mass standard (ciphergen ciosystems). RESULTS: The differentiated pattern between oral squamous cell carcinoma and healthy people consisted of four biomarker peaks of 5797, 2902, 3883, 4951 (mass/charge) with the sensitivity of 88.24% and specificity of 93.33%. The differentiated pattern between oral squamous cell carcinoma and leukoplakia consisted of three biomarker peaks of 5818, 4617 and 3884 with the sensitivity of 100.00% and specificity of 100.00%. The differentiated pattern between oral squamous cell carcinoma and oral cancer with local metastatic consisted of three biomarker peaks of 55 809 and 5383 (mass/charge) with the sensitivity of 94.12% and specificity of 85.71%. CONCLUSIONS: The biomarkers selected by SELDI could help in the adjuvant early diagnosis of oral cancer and forecasting the transformation from leukoplakia to oral cancer and metastasis. PMID: 20079267 [PubMed - in process]（【斜め読み用】機械翻訳：関連の記事[唾液蛋白質の適用は固まり表面によって高められるレーザーの脱着のイオン化経過時間までに口頭squamous細胞癌の診断で指紋をとる。] Zhonghua Kou QiangイXue Za Zhi。 11月2009日; 44 (11): 664-7書く: 日曜日GのポーンFYの目的: 人間の唾液からの口頭前癌性の損害の、ローカルおよびmetastatic squamous細胞癌のproteomicマーカーを選別するため。 方法: 口頭squamous細胞癌腫の17人の患者、leukoplakiaの6つの場合、ローカル転移との7つの場合および15人の健常者は選ばれた。 すべての患者はT (1つの) N (0の) M (0)の診断され、術前の処置を受け入れなかった。 唾液のサンプルは、2枚のコピーのための破片(CM-10)で結合されてpreoperatively集められ、表面によってテストされてそれぞれレーザーの脱着またはイオン化(SELDI)質量分析を高めた。 破片は質量分析計の読者とPBS-IIによって検出された。 多くの正確さはオールインワンペプチッド分子多く標準(ciphergenのciosystems)によって目盛りが付いていた。 結果: 口頭squamous細胞癌腫と健康な人々間の区別されたパターンは88.24%の感受性との5797、2902、3883、4951 (固まりか充満)および93.33%の特定性の4つのbiomarkerのピークから成っていた。 口頭squamous細胞癌腫とleukoplakia間の区別されたパターンは100.00%の感受性および100.00%の特定性との5818、4617および3884の3つのbiomarkerのピークから成っていた。 94.12%の感受性および85.71%の特定性との55 809そして5383の3つのbiomarkerのピークから(固まりか充満)成っているローカルmetastaticの口頭squamous細胞癌腫と口頭癌間の区別されたパターン。 結論: SELDIによって選ばれたbiomarkersは口頭癌および予測のアジェバント早い診断でleukoplakiaからの口頭癌および転移に変形助けることができる。 PMID: 20079267 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-153.html</link>
      <description> Related Articles Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis. Cancer Sci. 2009 Dec;100(12):2292-301 Authors: Guo J, Wang W, Liao P, Lou W, Ji Y, Zhang C, Wu J, Zhang S Diagnosis of pancreatic adenocarcinoma (PaCa) at an early stage is important for successful treatment and improving the prognosis of patients. Serum samples were applied to strong anionic exchange chromatography (SAX) protein chips for protein profiling by surface enhanced laser desorpti ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-153.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis. Cancer Sci. 2009 Dec;100(12):2292-301 Authors: Guo J, Wang W, Liao P, Lou W, Ji Y, Zhang C, Wu J, Zhang S Diagnosis of pancreatic adenocarcinoma (PaCa) at an early stage is important for successful treatment and improving the prognosis of patients. Serum samples were applied to strong anionic exchange chromatography (SAX) protein chips for protein profiling by surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) to distinguish PaCa from noncancer. The Wilcoxon rank-sum test, decision tree algorithm, and logistic regression were used to statistically analyze the multiple protein peaks. Sixty-one protein peaks between 2000 and 30,000 m/z ratios were detected to establish multiple decision classification trees for differentiating the known disease states. A sensitivity of 0.833 and a specificity of 1.000 were obtained in distinguishing PaCa from healthy controls and benign pancreatic diseases. Six protein biomarkers related to different PaCa TNM stages were detected (P < 0.01). One protein biomarker (m/z 4016) rich in PaCa had a down-regulated trend when preoperative and postoperative samples (P < 0.05) were compared. Three protein biomarkers (m/z 4155, 4791, and 28,068) were detected in the differential diagnosis of the three test groups (P < 0.05). A peak m/z 28 068 was identified as C14orf16 using ProteinChip immunoassay. C14orf166 levels were significantly higher in the serum of patients with PaCa compared with the control group using a sandwich immunoenzymatic system. Immunolabeling of tissue sections revealed that the C14orf166 protein was strongly expressed in tumor cells. The results suggest that SELDI-TOF-MS serum profiling is helpful for the diagnostic, prognostic or therapeutic effects of PaCa, which is superior to CA 19-9. The identified protein biomarker C14orf166 is a potential biomarker of PaCa. PMID: 19775290 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Proteomics studies on arthritis by SELDI-TOF-MS: identification of the S100 proteins family as proteins of interest]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-179.html</link>
      <description>Related Articles [Proteomics studies on arthritis by SELDI-TOF-MS: identification of the S100 proteins family as proteins of interest] Rev Med Liege. 2009;64 Spec No:29-35 Authors: De Seny D, Ribbens C, Cobraiville G, Meuwis MA, MarÃ©e R, Geurts P, Wehenkel L, Louis E, Merville MP, Fillet M, Malaise MG Clinical proteomics is a technical approach studying the entire proteome expressed by cells, tissues or organs. It describes the dynamics of cell regulation by detecting molecular events relat ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-179.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Proteomics studies on arthritis by SELDI-TOF-MS: identification of the S100 proteins family as proteins of interest] Rev Med Liege. 2009;64 Spec No:29-35 Authors: De Seny D, Ribbens C, Cobraiville G, Meuwis MA, MarÃ©e R, Geurts P, Wehenkel L, Louis E, Merville MP, Fillet M, Malaise MG Clinical proteomics is a technical approach studying the entire proteome expressed by cells, tissues or organs. It describes the dynamics of cell regulation by detecting molecular events related to diseases development. Proteomic techniques focus mainly on identification of new biomarkers or new therapeutic targets. It is a multidisciplinary approach using medical, biological, bioanalytical and bioinformatics knowledges. A strong collaboration between these fields allowed SELDI-TOF-MS proteomics studies to be performed at the CHU and the University of LiÃ¨ge, in GIGA-Research facilities. The aim of these studies was driven along three main axes of research related to the identification of biomarkers specific to a studied pathology, to a common biological pathway and, finally, to a treatment response. This work was presented in the setting of the "SynthÃ¨se CHU 2009" meeting. PMID: 20085013 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：関連の記事[ProteomicsはSELDI-TOF-MSによって関節炎で調査する: 興味の] Rev. Medリエージュの蛋白質としてS100蛋白質家族の同一証明。 2009年; 64のSpecのNO: 29-35書く: De Seny D、Ribbens C、Cobraiville G、Meuwis MA、MarÃ©e R、Geurts P、Wehenkel L、ルイE、細胞、ティッシュまたは器官によって表現される全体のproteomeを調査しているMerville MPの肉付けMのけん怠感MGの臨床proteomicsは技術アプローチである。 それは病気の開発と関連している分子でき事の検出によって細胞の規則の原動力を記述する。 Proteomicの技術は新しいbiomarkersまたは新しい治療上のターゲットの同一証明に主に焦点を合わせる。 それは医学、生物的、bioanalyticalおよび生物情報学の知識を使用して学際的なアプローチである。 SELDI-TOF-MSのproteomicsを与えられるこれらの分野間の強い共同はGIGA研究設備でLiÃ¨geの儲そして大学で、行われるために調査する。 これらの目標は調査された病理学、共通の生物的細道および、最終的に、処置の応答に特定のbiomarkersの同一証明と関連している研究の3本の主要な斧に沿って運転された調査する。 この仕事は「SynthÃ¨se儲2009年」の会合の設定で示された。 PMID: 20085013 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteomic Identification of Early Biomarkers of Acute Kidney Injury After Cardiac Surgery in Children.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-204.html</link>
      <description> Related Articles Proteomic Identification of Early Biomarkers of Acute Kidney Injury After Cardiac Surgery in Children. Am J Kidney Dis. 2010 Jul 2; Authors: Devarajan P, Krawczeski CD, Nguyen MT, Kathman T, Wang Z, Parikh CR BACKGROUND: Serum creatinine is a delayed marker of acute kidney injury (AKI). Our purpose is to discover and validate novel early urinary biomarkers of AKI after cardiac surgery. STUDY DESIGN: Diagnostic test study. SETTING &amp;amp; PARTICIPANTS: Children undergoing cardiopu ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-204.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Proteomic Identification of Early Biomarkers of Acute Kidney Injury After Cardiac Surgery in Children. Am J Kidney Dis. 2010 Jul 2; Authors: Devarajan P, Krawczeski CD, Nguyen MT, Kathman T, Wang Z, Parikh CR BACKGROUND: Serum creatinine is a delayed marker of acute kidney injury (AKI). Our purpose is to discover and validate novel early urinary biomarkers of AKI after cardiac surgery. STUDY DESIGN: Diagnostic test study. SETTING &amp; PARTICIPANTS: Children undergoing cardiopulmonary bypass surgery. The test set included 15 participants with AKI and 15 matched controls (median age, 1.5 year) of 45 participants without AKI. The validation set included 365 children (median age, 1.9 year). INDEX TESTS: Biomarkers identified using proteomic profiling: alpha(1)-microglobulin, alpha(1)-acid glycoprotein, and albumin. REFERENCE TEST: AKI, defined as >/=50% increase in serum creatinine level from baseline within 3 days of surgery. RESULTS: Proteomic profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) showed 3 protein peaks that appeared consistently within 2 hours in children who developed AKI after cardiopulmonary bypass surgery. The proteins were identified as alpha(1)-microglobulin, alpha(1)-acid glycoprotein, and albumin. Using clinical assays, results were confirmed in a test set and validated in an independent prospective cohort. In the validation set, 135 (37%) developed AKI, in whom there was a progressive increase in urinary biomarker concentrations with severity of AKI. Areas under the curve for urinary alpha(1)-microglobulin, alpha(1)-acid glycoprotein, and albumin at 6 hours after cardiac surgery were 0.84 (95% CI, 0.79-0.89), 0.87 (95% CI, 0.83-0.91), and 0.76 (95% CI, 0.71-0.81), respectively. Participants with increasing quartiles of biomarkers showed increasing lengths of hospital stays and durations of AKI (P < 0.001). LIMITATIONS: Single-center study of children with normal kidney function at recruitment. The SELDI-TOF MS technique has limited sensitivity for the detection of proteins greater than the 20-kDa range. CONCLUSIONS: Urinary alpha(1)-microglobulin, alpha(1)-acid glycoprotein, and albumin represent early, accurate, inexpensive, and widely available biomarkers of AKI after cardiac surgery. They also offer prognostic information about the duration of AKI and length of hospitalization after cardiac surgery. PMID: 20599305 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-180.html</link>
      <description> Related Articles Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer. Jpn J Clin Oncol. 2010 Apr;40(4):336-42 Authors: Lu HB, Zhou JH, Ma YY, Lu HL, Tang YL, Zhang QY, Zhao CH OBJECTIVE: The aims of this study were to detect serum proteomic patterns in gastric cancer serum samples using Surface-enhanced Laser Desorption/ionization-Time-of-flight-Mass Spectrometry ProteinChip array technology, to screen biomarker candidates, to build diagnostic models and  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-180.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer. Jpn J Clin Oncol. 2010 Apr;40(4):336-42 Authors: Lu HB, Zhou JH, Ma YY, Lu HL, Tang YL, Zhang QY, Zhao CH OBJECTIVE: The aims of this study were to detect serum proteomic patterns in gastric cancer serum samples using Surface-enhanced Laser Desorption/ionization-Time-of-flight-Mass Spectrometry ProteinChip array technology, to screen biomarker candidates, to build diagnostic models and to evaluate their clinical significance. METHODS: Serum samples from patients with gastric cancer and normal healthy control subjects (n = 125) were analysed using surface-enhanced laser desorption/ionization technology. The spectra were generated on weak cation exchange (WCX2) chips, and protein peak clustering and classification analyses were established using Ciphergen Biomarker Wizard and Biomarker Pattern software, respectively. The diagnostic models were developed and validated by discriminant analysis. In addition, the results of the surface-enhanced laser desorption/ionization model were compared with the biomarkers carcinoembryonic antigen and carbohydrate antigen 199 in a subset of samples using a microparticle enzyme immunoassay. RESULTS: Five protein peaks at 2046, 3179, 1817, 1725 and 1929 m/z were automatically chosen as components of the best biomarker pattern for diagnosis of gastric cancer. In addition, we identified a single protein peak at 4665 m/z, which could distinguish between stage I/II and stage III/IV gastric cancer with a specificity and sensitivity of 91.6% (11/12) and 95.4% (21/22), respectively. When this biomarker was validated in the second set of samples, the specificity and sensitivity were 91.7% (11/12) and 86.3% (19/22), respectively. CONCLUSIONS: The present results suggest that serum surface-enhanced laser desorption/ionization protein profiling can distinguish patients with gastric cancer, and in particular stage I/II patients, from normal subjects with a relatively high sensitivity and specificity. Surface-enhanced Laser Desorption/ionization-Time-of-flight-Mass Spectrometry is a potential new diagnostic tool for the screening of gastric cancer. PMID: 20089528 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Biomarker discovery in asthma-related inflammation and remodeling.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-108.html</link>
      <description> Related Articles Biomarker discovery in asthma-related inflammation and remodeling. Proteomics. 2009 Apr;9(8):2163-70 Authors: Calvo FQ, Fillet M, de Seny D, Meuwis MA, Maree R, Crahay C, Paulissen G, Rocks N, Gueders M, Wehenkel L, Merville MP, Louis R, Foidart JM, NoÃ?l A, Cataldo D Asthma is a complex inflammatory disease of airways. A network of reciprocal interactions between inflammatory cells, peptidic mediators, extracellular matrix components, and proteases is thought to be involved  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-108.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Biomarker discovery in asthma-related inflammation and remodeling. Proteomics. 2009 Apr;9(8):2163-70 Authors: Calvo FQ, Fillet M, de Seny D, Meuwis MA, Maree R, Crahay C, Paulissen G, Rocks N, Gueders M, Wehenkel L, Merville MP, Louis R, Foidart JM, NoÃ?l A, Cataldo D Asthma is a complex inflammatory disease of airways. A network of reciprocal interactions between inflammatory cells, peptidic mediators, extracellular matrix components, and proteases is thought to be involved in the installation and maintenance of asthma-related airway inflammation and remodeling. To date, new proteic mediators displaying significant activity in the pathophysiology of asthma are still to be unveiled. The main objective of this study was to uncover potential target proteins by using surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS) on lung samples from mouse models of allergen-induced airway inflammation and remodeling. In this model, we pointed out several protein or peptide peaks that were preferentially expressed in diseased mice as compared to controls. We report the identification of different five proteins: found inflammatory zone 1 or RELM alpha (FIZZ-1), calcyclin (S100A6), clara cell secretory protein 10 (CC10), Ubiquitin, and Histone H4. PMID: 19322781 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 喘息関係した発火および改造の記事のBiomarkerの関連の発見。 Proteomics。 4月2009日; 9 (8): 2163-70書く: Calvo FQの肉付けM、de Seny D、Meuwis MA、Maree R、Crahay C、Paulissen Gの石N、Gueders M、Wehenkel L、Merville MP、ルイR、Foidart JM、NoÃ 「l AのCataldo Dの喘息は航空路の複雑な炎症性病気である。 炎症性細胞、peptidic仲介人、細胞外のマトリックスの部品およびプロテアーゼ間の相互相互作用のネットワークは喘息関係した航空路の発火および改造の取付けそして維持にかかわると考えられる。 今まで、喘息のpathophysiologyの重要な活動を表示している新しいproteic仲介人はまだベールを取られるべきである。 この調査の主要な目的はアレルゲン引き起こされた航空路の発火のマウスモデルからの肺サンプルの飛行固まりの分光測定(SELDI-TOF-MS)の表面高められたレーザーの脱着かイオン化時間を使用し、改造によって潜在的なターゲット蛋白質の覆いを取ることだった。 このモデルでは、私達は複数制御と比べて病気にかかったマウスに優先的に表現された蛋白質またはペプチッドピークを指摘した。 私達は異なった蛋白質5つの同一証明を報告する: 炎症性地帯1かRELMのアルファ(FIZZ-1)、calcyclin (S100A6)、クララの細胞の分泌蛋白質10 (CC10)、UbiquitinおよびヒストンH4見つけた。 PMID: 19322781 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Comparison of normalization methods for the identification of biomarkers using MALDI-TOF and SELDI-TOF mass spectra.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-181.html</link>
      <description>Related Articles Comparison of normalization methods for the identification of biomarkers using MALDI-TOF and SELDI-TOF mass spectra. OMICS. 2010 Feb;14(1):115-26 Authors: Borgaonkar SP, Hocker H, Shin H, Markey MK Proteomic profiling by mass spectrometry has tremendous potential for identifying disease biomarkers. A key limitation of mass spectrometry is that the information provided on the abundance of the various peptides is only relative. Thus, normalization is typically employed. Several no ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-181.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Comparison of normalization methods for the identification of biomarkers using MALDI-TOF and SELDI-TOF mass spectra. OMICS. 2010 Feb;14(1):115-26 Authors: Borgaonkar SP, Hocker H, Shin H, Markey MK Proteomic profiling by mass spectrometry has tremendous potential for identifying disease biomarkers. A key limitation of mass spectrometry is that the information provided on the abundance of the various peptides is only relative. Thus, normalization is typically employed. Several normalization methods have been proposed and implemented in the literature. However, it is not clear if there is any reason to prefer one method over another. The goal of this study was to investigate the effect of normalization strategy on the identification of putative biomarkers from MALDI-TOF and SELDI-TOF mass spectra. Our results demonstrate that many of the putative biomarkers identified by mass spectrometry will be the same regardless of which data normalization scheme is applied. However, there can be substantial differences in the m/z values identified as being most discriminatory based on choice of normalization method. As there is no consistent pattern as to which normalization method yields the most promising targets for follow up study, we recommend that investigators routinely repeat their analysis with multiple normalization methods and consider the top several candidates identified in each case. PMID: 20141334 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：MALDI-TOFおよびSELDI-TOFの多くを使用してbiomarkersの同一証明のための標準化方法の関連の記事の比較スペクトル。 OMICS. 2月2010日; 14 (1): 115-26書く: Borgaonkar SP、Hocker Hの向こうずねH、質量分析によって側面図を描くMarkey MK Proteomicに病気のbiomarkersを識別するための途方もない潜在性がある。 質量分析の主限定は多量のさまざまなペプチッドで提供される情報がただ相対的であることである。 従って、標準化は普通用いられる。 複数の標準化方法は文献で提案され、実行された。 但し、それは別のもの上の1つの方法を好む理由があれば明確ではない。 この調査の目的はスペクトルMALDI-TOFおよびSELDI-TOFの多くからの推定のbiomarkersの同一証明に対する標準化の作戦の効果を調査することだった。 私達の結果は質量分析によって識別された推定のbiomarkersの多数がデータ標準化の機構が応用である同じであることを示す。 但し、場合もあり標準化方法の選択に基づく最も差別的があるとして識別されるm/zの価値に相当な相違がある。 標準化方法がフォローアップのための最も有望なターゲットをもたらす一貫したパターンがないので、私達は調査官が定期的に多数の標準化方法の彼らの分析を繰り返す推薦し、上を何人かの候補者と各場合で識別されたとことを考慮する。 PMID: 20141334 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteomic analysis of human papillomavirus-related oral squamous cell carcinoma: identification of thioredoxin and epidermal-fatty acid binding protein as upregulated protein markers in microdissected tumor tissue.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-112.html</link>
      <description> Related Articles Proteomic analysis of human papillomavirus-related oral squamous cell carcinoma: identification of thioredoxin and epidermal-fatty acid binding protein as upregulated protein markers in microdissected tumor tissue. Proteomics. 2009 Apr;9(8):2193-201 Authors: Melle C, Ernst G, Winkler R, Schimmel B, Klussmann JP, Wittekindt C, Guntinas-Lichius O, von Eggeling F Human papillomavirus (HPV) infection has been identified as an etiologic agent for a subset of oral squamous cell carci ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-112.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Proteomic analysis of human papillomavirus-related oral squamous cell carcinoma: identification of thioredoxin and epidermal-fatty acid binding protein as upregulated protein markers in microdissected tumor tissue. Proteomics. 2009 Apr;9(8):2193-201 Authors: Melle C, Ernst G, Winkler R, Schimmel B, Klussmann JP, Wittekindt C, Guntinas-Lichius O, von Eggeling F Human papillomavirus (HPV) infection has been identified as an etiologic agent for a subset of oral squamous cell carcinoma (OSCC) with increasing incidence. HPV DNA-positivity may confer better prognosis but the related oncogenic mechanisms are unknown. For the identification of HPV relevant proteins, we analyzed microdissected cells from HPV DNA-positive (n = 17) and HPV DNA-negative (n = 7) OSCC tissue samples. We identified 18 proteins from tumor tissues by peptide fingerprint mapping and SELDI MS that were separated using 2-DE. Among a number of signals that were detected as significantly different in the protein profiling analysis, we identified thioredoxin (TRX) and epidermal-fatty acid binding protein as upregulated in HPV related tumor tissue. This study, investigating for the first time proteomic changes in microdissected HPV infected tumor tissue, provides an indication on the oncogenic potential of viruses. PMID: 19337991 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 人間のpapillomavirus関係した口頭squamous細胞癌腫の記事のProteomicの関連の分析: microdissected腫瘍のティッシュのupregulated蛋白質のマーカーとしてthioredoxinそして表皮脂肪質の酸の結合蛋白質の同一証明。 Proteomics。 4月2009日; 9 (8): 2193-201書く: Melle C、エルンストG、Winkler R、Schimmel B、Klussmann JP、Wittekindt C、Guntinas-Lichius OのフォンEggeling Fの人間のpapillomavirus (HPV)の伝染は増加する発生の口頭squamous細胞癌腫(OSCC)のサブセットのための病因学的な代理店として識別された。 HPVのDNA相談するよりよい予想関連のoncogenicメカニズムは未知である。 HPVの関連した蛋白質の同一証明のために、私達はDNA肯定的なDNA否定的なHPV (n = 17)およびHPVからのmicrodissected細胞を分析した(n = 7) OSCCの組織サンプル。 地図を描いている私達2DEを使用して分かれていた腫瘍のティッシュからの18の蛋白質をおよびSELDI MSはペプチッド指紋によって識別した。 分析の側面図を描く蛋白質でかなり違うように検出されたいくつかの信号の間でHPVでupregulated腫瘍のティッシュを関連付けたように私達はthioredoxin (TRX)および表皮脂肪質の酸の結合蛋白質を識別した。 microdissected HPVによって感染させる腫瘍のティッシュのproteomic変更をはじめて調査するこの調査はウイルスのoncogenic潜在性で徴候を提供する。 PMID: 19337991 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Use of SELDI MS to discover and identify potential biomarkers of toxicity in InnoMed PredTox: a multi-site, multi-compound study.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-182.html</link>
      <description> Related Articles Use of SELDI MS to discover and identify potential biomarkers of toxicity in InnoMed PredTox: a multi-site, multi-compound study. Proteomics. 2010 Apr;10(8):1592-608 Authors: Collins BC, Sposny A, McCarthy D, Brandenburg A, Woodbury R, Pennington SR, Gautier JC, Hewitt P, Gallagher WM A serious bottleneck in the drug development pipeline is the inability of current pre-clinical toxicology evaluation methods to predict early on, and with good accuracy, that a drug candidate will ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-182.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Use of SELDI MS to discover and identify potential biomarkers of toxicity in InnoMed PredTox: a multi-site, multi-compound study. Proteomics. 2010 Apr;10(8):1592-608 Authors: Collins BC, Sposny A, McCarthy D, Brandenburg A, Woodbury R, Pennington SR, Gautier JC, Hewitt P, Gallagher WM A serious bottleneck in the drug development pipeline is the inability of current pre-clinical toxicology evaluation methods to predict early on, and with good accuracy, that a drug candidate will have to be removed from development due to toxicology/safety issues. The InnoMed PredTox consortium attempted to address this issue by assessing the value of using molecular profiling techniques (proteomics, transcriptomics, and metabonomics), in combination with conventional toxicology measurements, on decision making earlier in pre-clinical safety evaluation. In this study, we report on the SELDI-TOF-MS proteomics component of the InnoMed PredTox project. In this large scale, multi-site, multi-compound study, tissue and plasma samples from 14-day in vivo rat experiments conducted for 16 hepato- and nephro-toxicants with known toxicology endpoints (including 14 proprietary compounds and 2 reference compounds) were analyzed by SELDI-TOF-MS. We have identified seven plasma proteins and four liver proteins which were shown to be modulated by treatment, and correlated with histopathological evaluations and can be considered potential biomarker candidates for the given toxicology endpoints. In addition, we report on the intra- and inter-site variations observed based on measurements from a reference sample, and steps that can be taken to minimize this variation. PMID: 20162557 [PubMed - in process]（【斜め読み用】機械翻訳： InnoMed PredToxの毒性の潜在的なbiomarkersを発見し、識別するSELDI MSの関連の記事の使用: multi-site、多混合の調査。 Proteomics。 4月2010日; 10 (8): 1592-608書く: 紀元前のCollinsは、Sposny A、McCarthy D、ブランデンブルクA、Woodbury RのPenningtonのSR、Gautier JC、Hewitt Pの薬剤の開発のパイプラインのGallagher WM Aの深刻なネック薬剤の候補者が毒物学か安全問題による開発から取除かれなければならないこと、そしてよい正確さ前もって予測するであるの無力現在のpre-clinical毒物学の評価方法の。 InnoMed PredToxの借款団は先に使用すること査定によってこの問題をの価値のpre-clinical安全評価で分子側面図を描く技術(proteomics、transcriptomicsおよび、意志決定の慣習的な毒物学の測定を伴って、metabonomics)を扱うように試みた。 この調査では、私達はInnoMed PredToxのプロジェクトのSELDI-TOF-MSのproteomicsの部品で報告する。 この大規模では、知られていた毒物学の終点の16 hepato-そしてnephro毒物のために行なわれたSELDI-TOF-MSによって14日間の生体内のラットの実験からのmulti-site、多混合の調査、ティッシュおよび血しょうサンプルは(を含む14の専有混合物および2つの参照の混合物)分析された。 私達は処置によって調整され、病理組織学的な評価に関連するために示され、ある特定の毒物学の終点のための潜在的なbiomarkerの候補者として考慮することができる7つの血しょう蛋白質をおよび4つのレバー蛋白質を識別した。 さらに、私達は観察される参照サンプルからの測定に基づいてこの変化を最小にするために踏むことができる内部および内側場所の変化でおよびステップ報告する。 PMID: 20162557 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteomic toolbox for autoimmunity research.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-116.html</link>
      <description> Related Articles Proteomic toolbox for autoimmunity research. Autoimmun Rev. 2009 Jun;8(7):595-8 Authors: Wu T, Mohan C Autoimmune diseases are genetically complex and poorly understood, and may lead to clinically severe consequences including end-organ damage. Given this scenario, early biomarker discovery is becoming increasingly important for early diagnosis and treatment in these diseases. Among the different approaches tried, the application of proteomic analysis of body fluids has great p ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-116.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Proteomic toolbox for autoimmunity research. Autoimmun Rev. 2009 Jun;8(7):595-8 Authors: Wu T, Mohan C Autoimmune diseases are genetically complex and poorly understood, and may lead to clinically severe consequences including end-organ damage. Given this scenario, early biomarker discovery is becoming increasingly important for early diagnosis and treatment in these diseases. Among the different approaches tried, the application of proteomic analysis of body fluids has great potential as a non-invasive tool for early diagnosis in many different disease settings. During the past 10 years, proteomics-based approaches have made steady inroads into the study of various autoimmune diseases. In this review, we summarize the highlights of various traditional as well as novel proteomic methods, including 2D-MS/MS, multi-dimensional HPLC-MS/MS, CE-MS/MS, SELDI-TOF-MS/MS, iTRAQ and a variety of targeted antibody-based protein arrays, which have been particularly informative in the field of autoimmunity. PMID: 19393208 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 自己免疫の研究のための記事のProteomicの関連の道具箱。 AutoimmunのRev. 6月2009日; 8 (7): 595-8書く: ウーTのMohan Cの自己免疫疾患は遺伝的に複雑、十分理解されていなく、終り器官の損傷を含む臨床的に厳しい結果に導くかもしれない。 このシナリオを与えられて、早いbiomarkerの発見はこれらの病気の早い診断そして処置のためにますます重要になっている。 試みられる異なったアプローチの間で体液のproteomic分析の適用に多くの異なった病気の設定で早い診断のための非侵襲的な用具として大きい潜在性がある。 過去の10年の間に、proteomics基づかせていたアプローチはさまざまな自己免疫疾患の調査に安定した侵害をした。 この検討では、私達は新しいproteomic方法、またさまざまな従来のハイライトを、ずっと自己免疫の分野で特に報知的である第2MS/MS、多次元HPLC-MS/MS、CE-MS/MS、SELDI-TOF-MS/MS、iTRAQおよびいろいろ目標とされた抗体基づかせていた蛋白質の配列を含んで要約する。 PMID: 19393208 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Culture of human cells and synthesis of extracellular matrix on materials compatible with direct analysis by mass spectrometry.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-183.html</link>
      <description> Related Articles Culture of human cells and synthesis of extracellular matrix on materials compatible with direct analysis by mass spectrometry. Analyst. 2010 Mar;135(3):503-11 Authors: Lavigne D, Guerrier L, Gueguen V, Michel JB, Boschetti E, Meilhac O, Letourneur D The extracellular matrix (ECM) is a complex three-dimensional network of macromolecules synthesized by cells and is essential for the structure and the function of a tissue. The aim of our approach was to propose a surface allowing ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-183.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Culture of human cells and synthesis of extracellular matrix on materials compatible with direct analysis by mass spectrometry. Analyst. 2010 Mar;135(3):503-11 Authors: Lavigne D, Guerrier L, Gueguen V, Michel JB, Boschetti E, Meilhac O, Letourneur D The extracellular matrix (ECM) is a complex three-dimensional network of macromolecules synthesized by cells and is essential for the structure and the function of a tissue. The aim of our approach was to propose a surface allowing cell culture and subsequent analysis of ECM produced by cells directly on materials compatible with Surface Enhanced Laser Desorption Ionization-Time Of Flight (SELDI-TOF) mass spectrometry on a 96-well format. Surfaces were made of aluminium and spots of 2 mm in diameter were covered with specific chemical groups (silica, C(6) and C(12) alkyl groups, carboxyl, quaternary amine, or nitrilotriacetic acid groups). We found that among the chemically modified aluminium spots, only silica groups allowed the culture of human vascular cells. The wettability was an essential parameter for cell culture on the surfaces. Indeed, cells could only be cultured on surfaces presenting a moderate wettability with water contact angles of ca. 60 degrees. Then, by treatment of confluent cells with detergents (Triton X100 and deoxycholate), we were able to obtain ECM on the surfaces that were subsequently analyzed using a mass spectrometer, which is currently impossible with any type of cell culture system. As an example, the analysis of ECM from human vascular smooth muscle cells (hVSMCs) and human umbilical vein endothelial cells (HUVECs) appeared to be reproducible and evidenced different ECM patterns from the two cell types. Applications based on these materials can be proposed for biomarker discovery or characterization of cells for biomedical/diagnostic purposes. PMID: 20174702 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： ヒト細胞の関連の記事文化および質量分析によって直接分析と互換性がある材料の細胞外のマトリックスの統合。 分析者。 3月2010日; 135 (3): 503-11書く: Lavigne D、Guerrier L、Gueguen V、マイケルJB、Boschetti E、Meilhac O、Letourneur Dは細胞外のマトリックス(ECM)細胞によって総合される高分子の複雑な三次元ネットワーク、ティッシュの構造そして機能のために必要である。 私達のアプローチの目標は表面が表面と互換性がある材料の細胞によって直接作り出されたECMの細胞培養そしてそれに続く分析を許可して96-wellフォーマットの飛行(SELDI-TOF)質量分析のレーザーの脱着のイオン化時間を高めたことを提案することだった。 表面はアルミニウムから成り、直径の2つのmmの点は特定の化学グループ(無水ケイ酸、でC覆われた(6)およびCの(12の)アルキルグループ、carboxyl、四基から成るアミン、またはアンモニア三酢酸のグループ)。 私達は無水ケイ酸のグループだけが人間の管の細胞の文化を可能にした、化学的に変更されたアルミニウム点間のそれを見つけた。 湿潤性は表面の細胞培養のための必要な変数だった。 実際に、細胞はca.の水接触角の適当な湿潤性に60度を示す表面だけで培養できる。 それから、洗剤(トリトンX100およびdeoxycholate)が付いている合流する細胞の処置によって、私達はあらゆるタイプの細胞培養システムと現在不可能の、質量分析計を使用して続いて分析された表面のECMを得られた。 一例として、人間の管の滑らかな筋肉細胞(hVSMCs)および人間の臍静脈のendothelial細胞(HUVECs)からのECMの分析は再生可能ようで、2つの細胞のタイプからの異なったECMパターンを立証した。 これらの材料に基づく適用は生物医学的なか診断目的のための細胞のbiomarkerの発見か性格描写のために提案することができる。 PMID: 20174702 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-120.html</link>
      <description>Related Articles Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS). Clin Chem Lab Med. 2009;47(6):694-705 Authors: Gast MC, van Gils CH, Wessels LF, Harris N, Bonfrer JM, Rutgers EJ, Schellens JH, Beijnen JH BACKGROUND: Issues have been raised concerning the robustness and validity of alleged serum markers discovered by surface-enhanced laser desorption/ionisation time-of-flight  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-120.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS). Clin Chem Lab Med. 2009;47(6):694-705 Authors: Gast MC, van Gils CH, Wessels LF, Harris N, Bonfrer JM, Rutgers EJ, Schellens JH, Beijnen JH BACKGROUND: Issues have been raised concerning the robustness and validity of alleged serum markers discovered by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS). Pre-analytical variables have been shown to exert a profound effect on protein profiles, irrespective of true biological variation. However, little is known about the possible effects of sample storage duration on protein profiles. We, therefore, aimed to investigate the effects of extended storage duration on the serum protein profile. METHODS: Archival sera from 140 breast cancer patients, stored at -30 degrees C for 1-11 years, were profiled by SELDI-TOF MS using immobilised metal affinity capture (IMAC) arrays, a condition applied in the majority of breast cancer biomarker discovery studies. RESULTS: Fourteen peak clusters, structurally identified as C3a des-arginine anaphylatoxin and multiple fragments of albumin and fibrinogen, were found to be significantly associated with sample storage duration by five distinct patterns. These proteins have been described previously as potential cancer markers, rendering them specific to both disease and sample handling issues. CONCLUSIONS: To prevent experimental variation being interpreted erroneously as disease associated variation, assessment of potential confounding pre-analytical parameters is a pre-requisite in biomarker discovery and validation studies. In addition, with respect to the different (non-)linear patterns observed in the current study, simply performing linear corrections to account for sample storage duration will not necessarily suffice. PMID: 19416081 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Ovarian cancer classification based on dimensionality reduction for SELDI-TOF data.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-184.html</link>
      <description> Related Articles Ovarian cancer classification based on dimensionality reduction for SELDI-TOF data. BMC Bioinformatics. 2010;11:109 Authors: Tang KL, Li TH, Xiong WW, Chen K BACKGROUND: Recent advances in proteomics technologies such as SELDI-TOF mass spectrometry has shown promise in the detection of early stage cancers. However, dimensionality reduction and classification are considerable challenges in statistical machine learning. We therefore propose a novel approach for dimensionality red ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-184.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Ovarian cancer classification based on dimensionality reduction for SELDI-TOF data. BMC Bioinformatics. 2010;11:109 Authors: Tang KL, Li TH, Xiong WW, Chen K BACKGROUND: Recent advances in proteomics technologies such as SELDI-TOF mass spectrometry has shown promise in the detection of early stage cancers. However, dimensionality reduction and classification are considerable challenges in statistical machine learning. We therefore propose a novel approach for dimensionality reduction and tested it using published high-resolution SELDI-TOF data for ovarian cancer. RESULTS: We propose a method based on statistical moments to reduce feature dimensions. After refining and t-testing, SELDI-TOF data are divided into several intervals. Four statistical moments (mean, variance, skewness and kurtosis) are calculated for each interval and are used as representative variables. The high dimensionality of the data can thus be rapidly reduced. To improve efficiency and classification performance, the data are further used in kernel PLS models. The method achieved average sensitivity of 0.9950, specificity of 0.9916, accuracy of 0.9935 and a correlation coefficient of 0.9869 for 100 five-fold cross validations. Furthermore, only one control was misclassified in leave-one-out cross validation. CONCLUSION: The proposed method is suitable for analyzing high-throughput proteomics data. PMID: 20187963 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：  SELDI-TOFデータのための次元の数の減少に基づく関連の記事の卵巣癌の分類。 BMCの生物情報学。 2010年; 11: 109人の著者: 独特の味KLの李のTH、Xiong WWの陳Kの背景: SELDI-TOFの質量分析のようなproteomicsの技術の最近の前進は初期癌の検出で約束を示した。 但し、次元の数の減少および分類は統計的な機械学習のかなりの挑戦である。 従って私達は目新しい取り組み方を次元の数の減少のためのそしてテストされる卵巣癌のために出版された高解像SELDI-TOFデータを使用してそれ提案する。 結果: 私達は特徴次元を減らすために統計的な時に基づいて方法を提案する。 精錬およびtテストの後で、SELDI-TOFデータは複数の間隔に分けられる。 4統計的な時(平均、変動、ひずみおよび尖度)は各間隔のために計算され、代表的な変数として使用される。 データの高い次元の数はこうして急速に減らすことができる。 効率および分類の性能を改善するためには、データは穀粒PLSモデルで更に使用される。 方法は0.9950の平均感受性、0.9916の特定性、0.9935の正確さおよび100つの5重のクロス確認のための0.9869の相関係数を達成した。 なお、1つの制御だけで去る1クロス確認を誤って分類された。 結論: 提案された方法は高効率のproteomicsデータを分析するために適している。 PMID: 20187963 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteomic identification of serum biomarkers for head and neck cancer surveillance.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-124.html</link>
      <description> Related Articles Proteomic identification of serum biomarkers for head and neck cancer surveillance. Laryngoscope. 2009 Jul;119(7):1291-302 Authors: Gourin CG, Zhi W, Adam BL OBJECTIVES/HYPOTHESIS: Serum protein profiling by SELDI-TOF-MS distinguishes pretreatment and post-treatment samples from patients with head and neck squamous cell cancer (HNSCC) by disease status (disease-free or recurrence) with a high degree of sensitivity and specificity. We sought to identify biomarkers for recurrence ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-124.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Proteomic identification of serum biomarkers for head and neck cancer surveillance. Laryngoscope. 2009 Jul;119(7):1291-302 Authors: Gourin CG, Zhi W, Adam BL OBJECTIVES/HYPOTHESIS: Serum protein profiling by SELDI-TOF-MS distinguishes pretreatment and post-treatment samples from patients with head and neck squamous cell cancer (HNSCC) by disease status (disease-free or recurrence) with a high degree of sensitivity and specificity. We sought to identify biomarkers for recurrence with potential utility for surveillance and incorporated 2-D DIGE and MALDI-TOF-MS techniques to overcome the limitations of SELDI-TOF-MS in determining biomarker identity. METHODS: Serum samples were collected prospectively from 143 HNSCC patients and analyzed based on disease status following treatment. RESULTS: Recurrent HNSCC occurred in 46 patients. MALDI-TOF-MS following immunodepletion of major plasma proteins followed by 2-D DIGE identified 181 proteins with differential expression between pretreatment and post-treatment samples collected 6 months or more following treatment. Classification by disease status revealed significant differential expression of 16 proteins, with recurrent HNSCC associated with underexpression of kininogen and serine protease inhibitors C-1 inhibitor, kininogen, angiotensinogen, serine/cysteine proteinase inhibitor clade G member 1, and overexpression of thiol-specific antioxidant proteins (TSA), apolipoprotein A1 and proapolipoprotein, and epidermal cytokeratin 2. CONCLUSIONS: Serum protein profiling using 2D DIGE/MALDI-TOF-MS identifies proteins with significant differential expression in HNSCC based on disease status. Recurrent HNSCC was associated with underexpression of several protease inhibitors and kininogen, which has antiangiogenic properties, and overexpression of TSA, which is a free radical scavenger, as well as several forms of apolipoprotein A1 that may serve as a carrier molecule but may also indirectly promote tumor survival through kinase activation. This profile is consistent with a more aggressive disease variant and warrants further investigation. PMID: 19444892 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Application of serum protein profiling in diagnosis, prognosis and evaluation of curative effect of pancreatic adenocarcinoma]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-185.html</link>
      <description>Related Articles [Application of serum protein profiling in diagnosis, prognosis and evaluation of curative effect of pancreatic adenocarcinoma] Zhonghua Zhong Liu Za Zhi. 2010 Jan;32(1):33-6 Authors: Guo JH, Wang WJ, Liao P, Zhang CY, Jin DY, Lou WH, Zhang SC OBJECTIVE: To establish decision tree and logistic regression classification models for diagnosing pancreatic adenocarcinoma (PaCa) and for screening serum biomarkers related to evaluation of different stages and curative effects. METHODS: ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-185.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Application of serum protein profiling in diagnosis, prognosis and evaluation of curative effect of pancreatic adenocarcinoma] Zhonghua Zhong Liu Za Zhi. 2010 Jan;32(1):33-6 Authors: Guo JH, Wang WJ, Liao P, Zhang CY, Jin DY, Lou WH, Zhang SC OBJECTIVE: To establish decision tree and logistic regression classification models for diagnosing pancreatic adenocarcinoma (PaCa) and for screening serum biomarkers related to evaluation of different stages and curative effects. METHODS: Serum samples obtained from subjects with pancreatic adenocarcinoma (n = 58) and normal pancreas (n = 51) were applied to strong anion exchange chromatography (SAX2) chips for protein profiling by SELDI-TOF-MS to screen multiple serum biomarkers. Biomarker Wizard software and several statistical methods including algorithm of decision tree, logistic regression and ROC curves were used to construct the decision tree or logistic regression classification models. RESULTS: Average of 61 mass peaks were detected at the molecular range of 2000-30,000, ten decision trees with the highest cross validation rate were chosen to construct the classification models, which can differentiate PaCa from normal pancreas with a sensitivity of 83.3% and a specificity of 100%. Logistic regression was used to achieve the AUC (0.976 +/- 0.011, P < 0.001) with a sensitivity of 77.6% - 91.4% and a specificity of 92.2% - 100%. Six mass peaks were combined by logistic regression to achieve the AUC 0.897 +/- 0.054, 0.978 +/- 0.021 and 0.792 +/- 0.107 (P < 0.05) in the three groups (patients at stage I and II, stage II and III, stage III and IV). One mass peak (M/Z 4,016) was screened (P < 0.05) significantly between the preoperative and postoperative PaCa samples and the intensity decreased weeks after operation. CONCLUSION: Decision tree and logistic regression classification models of the mass peaks screened by SELDI-TOF-MS serum profiling can be used to differentiate pancreatic adenocarcinoma from normal pancreas, and is superior to CA 199. The detected mass peaks are helpful for the evaluation of curative effect and prognosis of pancreatic adenocarcinoma. PMID: 20211064 [PubMed - in process]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Detection of differentially expressed proteins in the semen of oligospermia patients by SELDI-TOF-MS technology]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-128.html</link>
      <description>Related Articles [Detection of differentially expressed proteins in the semen of oligospermia patients by SELDI-TOF-MS technology] Zhonghua Nan Ke Xue. 2009 Mar;15(3):232-6 Authors: Liu CB, Liang Y, Pan CQ, Zhang J OBJECTIVE: To analyze the spectrometric semen protein profiling of oligospermia patients and healthy controls by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS), and to establish a semen marker pattern for the diagnosis of oligospermia. MET ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-128.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Detection of differentially expressed proteins in the semen of oligospermia patients by SELDI-TOF-MS technology] Zhonghua Nan Ke Xue. 2009 Mar;15(3):232-6 Authors: Liu CB, Liang Y, Pan CQ, Zhang J OBJECTIVE: To analyze the spectrometric semen protein profiling of oligospermia patients and healthy controls by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS), and to establish a semen marker pattern for the diagnosis of oligospermia. METHODS: Semen samples of 33 oligospermia patients and 31 healthy controls were collected on the CM01O proteinchip. The spectrometric protein profiling was detected by SELDI-TOF-MS and the data analyzed by Biomarker Pattern Software provided by Ciphergen Corp. A primary diagnostic model of oligospermia was established and evaluated by blind test with the 33 patients and 31 healthy controls. RESULTS: A total of 185 protein peaks were detected at the molecular range of 2000-20,000, among which 23 showed significant differences between oligospermia patients and healthy controls (P < 0.05). The diagnostic model consisted of 3 protein peaks, with a sensitivity of 90.9% (30/33) and a specificity of 93.6% (29/31). And the double-blind test generated a sensitivity of 87.8% (29/33) and a specificity of 90.3% (28/31). CONCLUSION: The diagnostic model was successfully established by SELDI-TOF-MS, which could be applied to the differentiation of the spectrometric protein profiling patterns of oligospermia patients and healthy controls. PMID: 19452695 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：関連の記事[SELDI-TOF-MSの技術によるoligospermiaの患者の精液の特異的に表現された蛋白質の検出] ZhonghuaナンKe Xue。 3月2009日; 15 (3): 232-6書く: 劉のCB、梁Y、鍋CQのチャンJの目的: oligospermiaの患者および健康な制御の分光に精液蛋白質の側面図を描を表面高められたレーザーの脱着またはイオン化時間の飛行質量分析(SELDI-TOF-MS)によって分析し、oligospermiaの診断のための精液のマーカーパターンを確立するため。 方法: 33人のoligospermiaの患者および31の健康な制御の精液のサンプルはCM01Oのproteinchipで集められた。 分光に蛋白質の側面図を描くことはSELDI-TOF-MSによって検出され、データはCiphergen Corp.によって提供されたBiomarker Patternソフトウェアによって分析された。 oligospermiaの第一次診断モデルは33人の患者および31の健康な制御を用いる盲目テストによって確立され、評価された。 結果: 185の蛋白質のピークの合計は23がoligospermiaの患者と健康な制御(Pの&ltの重要な違いを示した2000-20,000の分子範囲で検出された; 0.05)。 診断モデルは90.9%の感受性(30/33)および93.6%の特定性の3つの蛋白質のピークから、成っていた(29/31)。 そしてdouble-blindテストは87.8%の感受性(29/33)および90.3%の特定性を発生させた(28/31)。 結論: 診断モデルはoligospermiaの患者および健康な制御のパターンの側面図を描く分光蛋白質の微分に適用できるSELDI-TOF-MSによって首尾よく確立された。 PMID: 19452695 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-186.html</link>
      <description> Related Articles Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study. Anesthesiology. 2010 Apr;112(4):926-35 Authors: Paugam-Burtz C, Albuquerque M, Baron G, Bert F, Voitot H, Delefosse D, Dondero F, Sommacale D, Francoz C, Hanna N, Belghiti J, Ravaud P, Bedossa P, Mantz J, Paradis V BACKGROUND: While outcome continuously improves after liver transplantation, sepsis remains the leading cause of early postoperative mortalit ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-186.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study. Anesthesiology. 2010 Apr;112(4):926-35 Authors: Paugam-Burtz C, Albuquerque M, Baron G, Bert F, Voitot H, Delefosse D, Dondero F, Sommacale D, Francoz C, Hanna N, Belghiti J, Ravaud P, Bedossa P, Mantz J, Paradis V BACKGROUND: While outcome continuously improves after liver transplantation, sepsis remains the leading cause of early postoperative mortality. Diagnosis of infections remains particularly difficult in these patients. This study used plasma profiling coupling Proteinchip array with surface-enhanced laser desorption ionization time-of-fly mass spectrometry to search for biomarkers of postoperative sepsis in patients who underwent liver transplantation. METHODS: Diagnosis of sepsis at day 5 relied on widely accepted clinical signs and positive culture of microbiologic samples. Profiles of day 5 plasma were obtained from SELDI-TOF CM10 chip (BioRad, Marnes-la-Coquette, France) analysis. Mean peak intensity of proteins was compared between septic and nonseptic plasma by U test followed by analysis of the area under the receiver-operating characteristic for the significant peaks. Diagnostic performance of significant proteins was established in a derivation set and in a validation set. RESULTS: In the derivation set of 31 patients with and 30 without infection, 23 plasma protein peaks were differentially expressed between patients with and without sepsis. Combination of five peaks allowed sepsis diagnosis with a positive likelihood ratio of 12.5 and a C-statistics of 0.72, 95% CI 0.57-0.85. In the validation set of 31 patients with infection and 34 without infection, the five peaks were differentially expressed as well and allowed day 5 sepsis diagnosis with a positive likelihood ratio of 5.1 and C-statistics of 0.74 (0.58-0.85). CONCLUSION: A combination of five plasma protein peaks may provide material for useful diagnostic biomarkers of postoperative sepsis in patients undergoing liver transplantation. However, these proteins remain to be identified. PMID: 20216396 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Detection of tissue protein biomarkers by surface enhanced laser desorption/ionization-time of flight-mass spectrometry in patients with mycosis fungoides]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-132.html</link>
      <description>Related Articles [Detection of tissue protein biomarkers by surface enhanced laser desorption/ionization-time of flight-mass spectrometry in patients with mycosis fungoides] Zhonghua Yi Xue Za Zhi. 2009 Jan 13;89(2):100-4 Authors: Liu J, Zheng YH, Zhou YF, Zhang JZ, Wang BX OBJECTIVE: To search the tissue biomarker in mycosis fungoides (MF) patients by surface enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS). METHODS: Skin specimens were collected from 12 MF p ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-132.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Detection of tissue protein biomarkers by surface enhanced laser desorption/ionization-time of flight-mass spectrometry in patients with mycosis fungoides] Zhonghua Yi Xue Za Zhi. 2009 Jan 13;89(2):100-4 Authors: Liu J, Zheng YH, Zhou YF, Zhang JZ, Wang BX OBJECTIVE: To search the tissue biomarker in mycosis fungoides (MF) patients by surface enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS). METHODS: Skin specimens were collected from 12 MF patients and 15 normal controls to prepare solution of protein. CM10 Proteinchip was used to detect the biomarkers for MF. Differentially expressed protein was identified by immuno capturing. RESULTS: The expression intensity levels of 24 proteins were different between the MF patients and controls. By searching in SWISS-PRO database and literature, the 3498 and 10 837 peaks were found to accord with HNP3 and S100A8 proteins respectively. By immuno capturing, 10 837 could be identified as S100A8 with a special antibody against S100A8. CONCLUSION: A quick, easy, and high throughout proteome analytic method, SELDI-TOF-MS can identify the differential expressed proteins from MF tissue, thus offering a unique platform for biomarker detection of MF. PMID: 19489271 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：関連の記事[検出か真菌症のfungoidesを持つ患者の飛行固まりの分光測定の表面によって高められるレーザーの脱着によるティッシュ蛋白質のbiomarkersのイオン化時間] ZhonghuaイXue Za Zhi。 1月2009日13日; 89 (2): 100-4書く: 劉J、Zheng YH、Zhou YF、チャンJZのWang BXの目的: 表面によって真菌症のfungoides (MF)の患者のティッシュのbiomarkerを捜すことは飛行固まりの分光測定(SELDI-TOF-MS)のレーザーの脱着かイオン化時間を高めた。 方法: 皮の標本は12人のMFの患者および15の正常な制御から蛋白質の解決を準備するために集められた。 CM10 ProteinchipがMFのためのbiomarkersを検出するのに使用された。 特異的に表現された蛋白質は免疫の捕獲によって識別された。 結果: 24の蛋白質の表現の強さのレベルはMFの患者と制御間で異なっていた。 SWISS-PROのデータベースおよび文献の捜索によって、3498そして10の837のピークはそれぞれHNP3およびS100A8蛋白質と一致すると見つけられた。 免疫の捕獲によって、10 837はS100A8に対する特別な抗体とのS100A8として識別できる。 結論: 従ってproteomeの分析的な方法中の速くの、容易の、および高く、SELDI-TOF-MS MFのティッシュからの差動表現された蛋白質を識別できMFのbiomarkerの検出のための独特なプラットホームを提供する。 PMID: 19489271 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Detection and identification of potential biomarkers of breast cancer.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-187.html</link>
      <description> Related Articles Detection and identification of potential biomarkers of breast cancer. J Cancer Res Clin Oncol. 2010 Aug;136(8):1243-54 Authors: Fan Y, Wang J, Yang Y, Liu Q, Fan Y, Yu J, Zheng S, Li M, Wang J PURPOSE: Noninvasive and convenient biomarkers for early diagnosis of breast cancer remain an urgent need. The aim of this study was to discover and identify potential protein biomarkers specific for breast cancer. METHODS: Two hundred and eighty-two (282) serum samples with 124 breast c ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-187.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Detection and identification of potential biomarkers of breast cancer. J Cancer Res Clin Oncol. 2010 Aug;136(8):1243-54 Authors: Fan Y, Wang J, Yang Y, Liu Q, Fan Y, Yu J, Zheng S, Li M, Wang J PURPOSE: Noninvasive and convenient biomarkers for early diagnosis of breast cancer remain an urgent need. The aim of this study was to discover and identify potential protein biomarkers specific for breast cancer. METHODS: Two hundred and eighty-two (282) serum samples with 124 breast cancer and 158 controls were randomly divided into a training set and a blind-testing set. Serum proteomic profiles were analyzed using SELDI-TOF-MS. Candidate biomarkers were purified by HPLC, identified by LC-MS/MS and validated using ProteinChip immunoassays and western blot technique. RESULTS: A total of 3 peaks (m/z with 6,630, 8,139 and 8,942 Da) were screened out by support vector machine to construct the classification model with high discriminatory power in the training set. The sensitivity and specificity of the model were 96.45 and 94.87%, respectively, in the blind-testing set. The candidate biomarker with m/z of 6,630 Da was found to be down-regulated in breast cancer patients, and was identified as apolipoprotein C-I. Another two candidate biomarkers (8,139, 8,942 Da) were found up-regulated in breast cancer and identified as C-terminal-truncated form of C3a and complement component C3a, respectively. In addition, the level of apolipoprotein C-I progressively decreased with the clinical stages I, II, III and IV, and the expression of C-terminal-truncated form of C3a and complement component C3a gradually increased in higher stages. CONCLUSIONS: We have identified a set of biomarkers that could discriminate breast cancer from non-cancer controls. An efficient strategy, including SELDI-TOF-MS analysis, HPLC purification, MALDI-TOF-MS trace and LC-MS/MS identification, has been proved very successful. PMID: 20237941 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 乳癌の潜在的なbiomarkersの関連の記事検出および同一証明。 Jの蟹座Res Clin Oncol。 8月2010日; 136 (8): 1243-54書く: ファンY、Wang J、ヤンY、劉QのファンY、Yu J、Zheng S、李MのWang Jの目的: 乳癌の早い診断のための非侵襲的で、便利なbiomarkersは急務に残る。 この調査の目標は乳癌のために特定の潜在的な蛋白質のbiomarkersを発見し、識別することだった。 方法: 124の乳癌が付いている200そして82の(282の)血清のサンプルおよび158の制御は置かれた訓練セットおよび盲目テストに任意に分けられた。 血清のproteomicプロフィールはSELDI-TOF-MSを使用して分析された。 候補者のbiomarkersはHPLCによって浄化され、LC-MS/MSによって識別され、そしてProteinChipのimmunoassaysおよび西部のしみの技術を使用して認可された。 結果: 合計3つのピーク(6,630、8,139および8,942 Daのm/z)はサポートベクトル機械によって訓練セットの高く差別的な力の分類モデルを組み立てるために選別された。 モデルの感受性そして特定性は置かれた盲目テストの96.45そして94.87%、それぞれ、だった。 6,630 Daのm/zの候補者のbiomarkerは乳癌患者で調整されると見つけられapolipoprotein CIとして識別された。 もう2人の候補者のbiomarkers (8,139、8,942 Da)は乳癌で調整され、識別されてようにC3aおよび補足物の部品C3aのCターミナル省略された形態、それぞれ見つけられた。 さらに、apolipoprotein CIのレベルは臨床段階と漸進的に次第により高い段階で高められたC3aおよび補足物の部品C3aのCターミナル省略された形態のIつ、II、IIIおよびIV、および表現減らした。 結論: 私達はnon-cancer制御からの乳癌を区別できる一組のbiomarkersを識別した。 有効な作戦は、SELDI-TOF-MSの分析を含んで、高性能液体クロマトグラフィーの浄化、MALDI-TOF-MSの跡およびLC-MS/MSの同一証明、ずっと証明された非常に成功している。 PMID: 20237941 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-136.html</link>
      <description> Related Articles SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2009;28:85 Authors: Huang YJ, Xuan C, Zhang BB, Liao M, Deng KF, He M, Zhao JM BACKGROUND: No satisfactory biomarkers are currently available to screen for nasopharyngeal carcinoma (NPC). We have developed and evaluated surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for detection and analysis of multiple proteins for distinguishing indi ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-136.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2009;28:85 Authors: Huang YJ, Xuan C, Zhang BB, Liao M, Deng KF, He M, Zhao JM BACKGROUND: No satisfactory biomarkers are currently available to screen for nasopharyngeal carcinoma (NPC). We have developed and evaluated surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for detection and analysis of multiple proteins for distinguishing individuals with NPC from control individuals. METHODS: A preliminary learning set and a classification tree of spectra derived from 24 patients with NPC and a group of 24 noncancer controls were used to develop a proteomic model that discriminated cancer from noncancer effectively. Then, the validity of the classification tree was challenged with a blind test set, which included another 20 patients with NPC and 12 noncancer controls. RESULTS: A panel of 3 biomarkers ranging m/z 3-20 k was selected to establish Decision Tree model by BPS with sensitivity of 91.66% and specificity of 95.83%. The ability to detect NPC patients was evaluated, a sensitivity of 95.0% and specificity of 83.33% were validated in blind testing set. CONCLUSION: This high-flux proteomic classification system will provide a highly accurate and innovative approach for the detection/diagnosis of NPC. PMID: 19534814 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：  nasopharyngeal癌腫の検出のための血清の関連に記事SELDI-TOF MSの側面図を描くこと。 J Exp. Clinの蟹座Res。 2009年; 28: 85人の著者: 黄YJ、Xuan CのチャンのBB、Liao M、Deng KF、彼Mの肇JMの背景: 満足なbiomarkersはnasopharyngeal癌腫(NPC)のために選別するために現在利用できない。 私達は制御個人とNPCの個人を区別するための多数蛋白質の検出そして分析のための評価された表面高められたレーザーの脱着またはイオン化時間の飛行質量分析(SELDI-TOF MS)成長し。 方法: セットを学ぶ予備がおよびNPCの24人の患者から得られたスペクトルおよび24のnoncancer制御のグループの分類の木はnoncancerからの癌を効果的に区別したproteomicモデルを開発するのに使用された。 それから、分類の木の妥当性はNPCおよび12のnoncancer制御を用いるもう一人の20人の患者を含んでいた盲目テストセットと挑戦された。 結果: 3 biomarkers及ぶm/z 3-20 kのパネルは91.66%の感受性および95.83%の特定性のビット/秒決定ツリーモデルを確立するために選ばれた。 NPCの患者を検出する機能は、95.0%の感受性評価され、83.33%の特定性は置かれた盲目のテストで認可された。 結論: この高変化proteomic分類体系はNPCの検出か診断に極めて正確で、革新的なアプローチを提供する。 PMID: 19534814 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[A diagnostic model of cerebrospinal protein fingerprint pattern for brain metastases of non-small cell lung cancer]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-188.html</link>
      <description>Related Articles [A diagnostic model of cerebrospinal protein fingerprint pattern for brain metastases of non-small cell lung cancer] Nan Fang Yi Ke Da Xue Xue Bao. 2010 Mar;30(3):498-501 Authors: Xie SX, Li WX, Huang YJ, Chen JG, Wu YL OBJECTIVE: To establish a diagnostic model of protein fingerprint pattern in the cerebrospinal fluid (CSF) for non-small-cell lung cancer (NSCLC) patients with brain metastases. METHODS: The CSF samples were obtained from 29 NSCLC patients with brain metastasis,  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-188.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [A diagnostic model of cerebrospinal protein fingerprint pattern for brain metastases of non-small cell lung cancer] Nan Fang Yi Ke Da Xue Xue Bao. 2010 Mar;30(3):498-501 Authors: Xie SX, Li WX, Huang YJ, Chen JG, Wu YL OBJECTIVE: To establish a diagnostic model of protein fingerprint pattern in the cerebrospinal fluid (CSF) for non-small-cell lung cancer (NSCLC) patients with brain metastases. METHODS: The CSF samples were obtained from 29 NSCLC patients with brain metastasis, 23 non-tumor patients and 10 early-stage NSCLC patients without brain metastases for analysis of the protein expression profiles using surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS). The data were then analyzed by Biomarker Wizard software, and the tree analysis patterns were generated using the decision-tree model in Biomarker Patterns software. The diagnostic model was tested for its clinical application. RESULTS: Five protein peaks were identified showing differential expression between patients with brain metastases and those without brain metastases. Combination of the 3 protein peaks (m/z: 8698.00, 1215.32 and 1245.70) could discriminate these two samples with a sensitivity of 100.00% (29/29) and a specificity of 100.00% (23/23). Five proteins were differentially expressed between the NSCLC patients with brain metastases and the non-tumor patients. With one protein peak (m/z: 6050.00), these two samples could be discriminated with a sensitivity of 90.00% (9/10) and a specificity of 78.26% (18/23). CONCLUSION: The established diagnostic model of CSF protein fingerprint pattern provides high sensitivity and specificity in the diagnosis of NSCLC with brain metastasis. PMID: 20335119 [PubMed - in process]（【斜め読み用】機械翻訳：記事[Aの非小さい細胞の肺癌の頭脳の転移のための脳脊髄蛋白質の指紋パターンの診断モデル]ナンの関連の牙イKe Da Xue Xue Bao。 3月2010日; 30 (3): 498-501書く: Xie SX、李WX、黄YJ、陳JGのウーYLの目的: 蛋白質の指紋パターンの診断モデルを頭脳の転移を持つ非小さ細胞の肺癌(NSCLC)の患者のための脳脊髄液体(CSF)に確立するため。 方法: CSFのサンプルは表面高められたレーザーの脱着を使用して蛋白質の表現のプロフィールの分析または飛行固まりの分光測定(SELDI-TOF-MS)のイオン化時間の頭脳の転移なしで頭脳の転移を持つ29人のNSCLCの患者、23人の非腫瘍の患者および10人の早段階NSCLCの患者から得られた。 データはBiomarker Wizardソフトウェアによってそれから分析され、木の分析パターンはBiomarkerパターンソフトウェアの決定木モデルを使用して発生した。 診断モデルは臨床応用のためにテストされた。 結果: 頭脳の転移を持つ患者と頭脳の転移なしの患者間の差動表現を示す5つの蛋白質のピークは識別された。 3つの蛋白質のピーク(m/zの組合せ: 8698.00、1215.32および1245.70は) 100.00%の感受性(29/29)および100.00%の特定性のこれら二つのサンプルを区別できる(23/23)。 5つの蛋白質は頭脳の転移を持つNSCLCの患者と非腫瘍の患者の間に特異的に表現された。 ピーク1つの蛋白質を使って(m/z: 6050.00は90.00%の感受性と)、これら二つのサンプル区別できる(78.26%の9/10)そして特定性(18/23)。 結論: CSF蛋白質の指紋パターンの確立された診断モデルは頭脳の転移をNSCLCの診断の高い感受性そして特定性に与える。 PMID: 20335119 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-140.html</link>
      <description> Related Articles New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma. Biomarkers. 2009 Aug;14(5):340-6 Authors: Xu SY, Liu Z, Ma WJ, Sheyhidin I, Zheng ST, Lu XM OBJECTIVE: To analyse the alterations of serum proteins in cases of esophageal squamous cell carcinoma (ESCC) in order to screen and validate serum marker patterns for the diagnosis of ESCC in the high-risk populations of Xinjiang, China. METHODS: The serum proteomic patterns of 188 cases, including 139 pati ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-140.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma. Biomarkers. 2009 Aug;14(5):340-6 Authors: Xu SY, Liu Z, Ma WJ, Sheyhidin I, Zheng ST, Lu XM OBJECTIVE: To analyse the alterations of serum proteins in cases of esophageal squamous cell carcinoma (ESCC) in order to screen and validate serum marker patterns for the diagnosis of ESCC in the high-risk populations of Xinjiang, China. METHODS: The serum proteomic patterns of 188 cases, including 139 patients with ESCC (54 Uygur, 45 Kazakh and 40 Han subjects) and 49 sex- and age-matched healthy controls, were detected using the SELDI-TOF-MS (surface-enhanced laser desorption/ionization-time of flight-mass spectrometry) technology with the CM10 ProteinChip. Differences in protein peaks between patients with ESCC and controls were analysed using the Biomarker Pattern Software, and a primary diagnosis model of ESCC was developed and validated with SVM (support vector machines). This model was further evaluated by a large-scale blind test. RESULTS: Two hundred and eighty-three protein peaks were detected within the molecular range of 0-20 kDa, among which, 140 peaks were significantly different between ESCC cases and controls (p < 0.05). A diagnostic pattern consisting of six protein peaks (m/z 5667, 5709, 5876, 5979, 6043 and 6102) was established with a sensitivity of 97.12% and a specificity of 83.87%. The large-scale blind test generated a sensitivity of 91.43% and a specificity of 88.89%. CONCLUSIONS: The differential protein peaks analysed by SELDI-TOF-MS may contain promising serum biomarkers for screening ESCC. The diagnostic model which combined only six protein peaks had a satisfactory discriminatory power. The model should be further evaluated in other populations of ESCC patients and tested against controls. The nature and function of the discriminating proteins have yet to be elucidated. PMID: 19552569 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 食道のsquamous細胞癌腫の診断の関連の記事の新しく潜在的なbiomarkers。 Biomarkers。 8月2009日; 14 (5): 340-6書く: Xu SY、劉Z、Ma WJ、Sheyhidin I、Zheng STのLu XMの目的: 食道のsquamous細胞癌腫(ESCC)の場合の血清蛋白質の変化を新彊の危険度が高い人口のESCCの診断のための血清のマーカーパターンを選別し、認可するために分析するため中国。 方法: ESCC (Uygur、45のカザフスタン人および40のハンの54の主題)および飛行固まりの分光測定の49性およびage-matched健康な制御、CM10 ProteinChipのSELDI-TOF-MSの(表面高められたレーザーの脱着またはイオン化時間)の139人の患者を含む188の場合の血清proteomicパターンは、を使用して技術検出された。 ESCCの患者と制御間の蛋白質のピークの相違はBiomarkerパターンソフトウェアを使用して分析され、ESCCの第一次診断モデルはSVM (サポートベクトル機械)と開発され、認可された。 このモデルは大規模な盲目テストによって更に評価された。 結果: 200そして八十三の蛋白質のピークは、140のピークがESCCの場合と制御(pの&lt間でかなり違った0-20 kDaの分子範囲の内で検出された; 0.05)。 6つの蛋白質のピーク(m/z 5667、5709、5876、5979、6043および6102)から成っている診断パターンは97.12%の感受性および83.87%の特定性と確立された。 大規模な盲目テストは91.43%の感受性および88.89%の特定性を発生させた。 結論: SELDI-TOF-MSによって分析される差動蛋白質のピークはスクリーニングESCCのための有望な血清のbiomarkersを含むかもしれない。 6つの蛋白質のピークだけ結合した診断モデルに満足で差別的な力があった。 モデルはESCCの患者の他の人口で更に評価され、制御に対してテストされるべきである。 識別力がある蛋白質の性質そして機能はまだ明瞭になることを持っている。 PMID: 19552569 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-189.html</link>
      <description> Related Articles Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis. Cancer Genomics Proteomics. 2010 Mar-Apr;7(2):93-103 Authors: Al-Ruwaili JA, Larkin SE, Zeidan BA, Taylor MG, Adra CN, Aukim-Hastie CL, Townsend PA BACKGROUND: The incidence of prostate cancer (PCa) has increased in recent years due to the aging of the population and increased testing; however, mortality rates have remained largely unchanged. Studies have shown deficiencies in predictin ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-189.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis. Cancer Genomics Proteomics. 2010 Mar-Apr;7(2):93-103 Authors: Al-Ruwaili JA, Larkin SE, Zeidan BA, Taylor MG, Adra CN, Aukim-Hastie CL, Townsend PA BACKGROUND: The incidence of prostate cancer (PCa) has increased in recent years due to the aging of the population and increased testing; however, mortality rates have remained largely unchanged. Studies have shown deficiencies in predicting patient outcome for both of the major PCa diagnostic tools, namely prostate specific antigen (PSA) and transrectal ultrasound-guided biopsy. Therefore, serum biomarkers are needed that accurately predict prognosis of PCa (indolent vs. aggressive) and can thus inform clinical management. Aim: This study uses surface enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS) mass spectrometry analysis to identify differential serum protein expression between PCa patients with indolent vs. aggressive disease categorised by Gleason grade and biochemical recurrence. MATERIALS AND METHODS: A total of 99 serum samples were selected for analysis. According to Gleason score, indolent (45 samples) and aggressive (54) forms of PCa were compared using univariate analysis. The same samples were then separated into groups of different recurrence status (10 metastatic, 15 biochemical recurrences and 70 non-recurrences) and subjected to univariate analysis in the same way. The data from Gleason score and recurrence groups were then analysed using multivariate statistical analysis to improve PCa biomarker classification. RESULTS: The comparison between serum protein spectra from indolent and aggressive samples resulted in the identification of twenty-six differentially expressed protein peaks (p<0.05), of which twenty proteins were found with 99% confidence. A total of 18 differentially expressed proteins (p<0.05) were found to distinguish between recurrence groups; three of these were robust with p<0.01. Sensitivity and specificity within the Gleason score group was 73.3% and 60% respectively and for the recurrence group 70% and 62.5%. CONCLUSION: SELDI-TOF-MS technology has facilitated the discovery of prognostic biomarkers in serum that can successfully discriminate aggressive from indolent PCa and also differentiate between recurrence groups. PMID: 20335524 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-144.html</link>
      <description> Related Articles Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer. BMC Cancer. 2009;9:287 Authors: Wang Q, Shen J, Li ZF, Jie JZ, Wang WY, Wang J, Zhang ZT, Li ZX, Yan L, Gu J BACKGROUND: Surface enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF-MS) analysis on serum samples was reported to be able to detect colorectal cancer (CRC) from normal or control patients. We carried out a validation ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-144.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer. BMC Cancer. 2009;9:287 Authors: Wang Q, Shen J, Li ZF, Jie JZ, Wang WY, Wang J, Zhang ZT, Li ZX, Yan L, Gu J BACKGROUND: Surface enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF-MS) analysis on serum samples was reported to be able to detect colorectal cancer (CRC) from normal or control patients. We carried out a validation study of a SELDI-TOF MS approach with IMAC surface sample processing to identify CRC. METHODS: A retrospective cohort of 338 serum samples including 154 CRCs, 67 control cancers and 117 non-cancerous conditions was profiled using SELDI-TOF-MS. RESULTS: No CRC "specific" classifier was found. However, a classifier consisting of two protein peaks separates cancer from non-cancerous conditions with high accuracy. CONCLUSION: In this study, the SELDI-TOF-MS-based protein expression profiling approach did not perform to identify CRC. However, this technique is promising in distinguishing patients with cancer from a non-cancerous population; it may be useful for monitoring recurrence of CRC after treatment. PMID: 19689818 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：  とりわけcolorectal癌を検出するIMACの表面とSELDI-TOF MSの全血清のproteomic側面図を描くことの関連の記事の限定。 BMCの蟹座。 2009年; 9: 287人の著者: Wang Q、センJ、李ZF、Jie JZ、Wang WY、Wang J、チャンZT、李ZX、沿LのグウJの背景: 表面はレーザーの脱着を高め、血清のサンプルのイオン化時間の飛行質量分析(SELDI-TOF-MS)の分析は常態からのcolorectal癌(CRC)を検出してまたは患者を制御できるために報告された。 私達はCRCを識別するために処理するIMACの表面のサンプルとのSELDI-TOF MSのアプローチの確認の調査を遂行した。 方法: 154のCRCs、67を含む338の血清のサンプルの回顧のグループは癌を制御し、117のnon-cancerous条件はSELDI-TOF-MSを使用して側面図を描かれた。 結果: CRCの「特定の」助数詞は見つけられなかった。 但し、2つの蛋白質のピークから成っている助数詞は高精度のnon-cancerous条件から癌を分ける。 結論: この調査ではCRCを識別するために、アプローチの側面図を描くSELDI TOF MS基づかせていた蛋白質の表現は行わなかった。 但し、この技術はnon-cancerous人口と癌を持つ患者を区別することで有望である; それは処置の後でCRCの監視の再発のために有用かもしれない。 PMID: 19689818 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-190.html</link>
      <description>Related Articles Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer. Clin Chem Lab Med. 2010 Jun;48(6):863-7 Authors: Han M, Liu Q, Yu J, Zheng S BACKGROUND: Empirical chemotherapy for patients with non-small cell lung cancer (NSCLC) is recommended, even without knowledge of the tumor&apos;s specific biological characteristics, and many patients may not benefit. The goal of this study was to identify potential serum biomarkers that influence ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-190.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer. Clin Chem Lab Med. 2010 Jun;48(6):863-7 Authors: Han M, Liu Q, Yu J, Zheng S BACKGROUND: Empirical chemotherapy for patients with non-small cell lung cancer (NSCLC) is recommended, even without knowledge of the tumor's specific biological characteristics, and many patients may not benefit. The goal of this study was to identify potential serum biomarkers that influence resistance to chemotherapy, and to build a model that could be used to predict resistance to chemotherapy of patients with advanced NSCLC. METHODS: A total of 97 NSCLC patients were classified as stage IIIB and stage IV. The chemotherapy regimen was cisplatin plus docetaxel. All patients received two cycles of chemotherapy. Serum protein profiles were detected using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) and the spectra were analyzed with a support vector machine (SVM). RESULTS: For the 93 eligible patients, 22 patients had a partial response (23.7%); 27 patients had stable disease (29.0%) and 44 (47.3%) had progressive disease. One hundred and twenty-eight mass peaks were detected from the chemotherapy sensitive group and the chemotherapy resistant group by receiver operator characteristic curve. The top 10 peaks with the highest area under the curve values were selected, randomly combined, and fed into the SVM. The SVM model with the highest accuracy was used as the diagnostic model. The model constructed using five protein peaks with mass/charge ratios of 3955 Da, 6207 Da, 7992 Da, 9214 Da, and 15,086 Da separated the chemotherapy resistant group from the chemotherapy sensitive group with a sensitivity of 83.3% and specificity of 85.7%. CONCLUSIONS: SELDI-TOF MS may provide a useful means in the search for serum biomarkers for predicting chemotherapy resistance in patients with advanced NSCLC. PMID: 20345233 [PubMed - in process]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Mining novel biomarkers for prognosis of gastric cancer with serum proteomics.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-148.html</link>
      <description> Related Articles Mining novel biomarkers for prognosis of gastric cancer with serum proteomics. J Exp Clin Cancer Res. 2009;28:126 Authors: Qiu FM, Yu JK, Chen YD, Jin QF, Sui MH, Huang J BACKGROUND: Although gastric cancer (GC) remains the second cause of cancer-related death, useful biomarkers for prognosis are still unavailable. We present here the attempt of mining novel biomarkers for GC prognosis by using serum proteomics. METHODS: Sera from 43 GC patients and 41 controls with gastritis a ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-148.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles Mining novel biomarkers for prognosis of gastric cancer with serum proteomics. J Exp Clin Cancer Res. 2009;28:126 Authors: Qiu FM, Yu JK, Chen YD, Jin QF, Sui MH, Huang J BACKGROUND: Although gastric cancer (GC) remains the second cause of cancer-related death, useful biomarkers for prognosis are still unavailable. We present here the attempt of mining novel biomarkers for GC prognosis by using serum proteomics. METHODS: Sera from 43 GC patients and 41 controls with gastritis as Group 1 and 11 GC patients as Group 2 was successively detected by Surface Enhanced Laser Desorption/ionization Time of Flight Mass Spectrometry (SELDI-TOF-MS) with Q10 chip. Peaks were acquired by Ciphergen ProteinChip Software 3.2.0 and analyzed by Zhejiang University-ProteinChip Data Analysis System (ZJU-PDAS). CEA level were evaluated by chemiluminescence immunoassay. RESULTS: After median follow-up periods of 33 months, Group 1 with 4 GC patients lost was divided into 20 good-prognosis GC patients (overall survival more than 24 months) and 19 poor-prognosis GC patients (no more than 24 months). The established prognosis pattern consisted of 5 novel prognosis biomarkers with 84.2% sensitivity and 85.0% specificity, which were significantly higher than those of carcinoembryonic antigen (CEA) and TNM stage. We also tested prognosis pattern blindly in Group 2 with 66.7% sensitivity and 80.0% specificity. Moreover, we found that 4474-Da peak elevated significantly in GC and was associated with advanced stage (III+IV) and short survival (p < 0.03). CONCLUSION: We have identified a number of novel biomarkers for prognosis prediction of GC by using SELDI-TOF-MS combined with sophisticated bioinformatics. Particularly, elevated expression of 4474-Da peak showed very promising to be developed into a novel biomarker associated with biologically aggressive features of GC. PMID: 19740432 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：  血清のproteomicsの胃癌の予想のために新しいbiomarkersを採鉱する関連の記事。 J Exp. Clinの蟹座Res。 2009年; 28: 126人の著者: Qiu FM、Yu JK、陳YD、ジンQF、隋MHの黄Jの背景: 胃癌(GC)が癌関係した死の第2原因に残るが、予想のための有用なbiomarkersはまだ利用できない。 私達は血清のproteomicsの使用によってGCの予想のための鉱山の新しいbiomarkersの試みをここに示す。 方法: グループ2としてグループ1および11のGCの患者として胃炎の43人のGCの患者そして41の制御からの血清はQ10破片との質量分析(SELDI-TOF-MS) Surface Enhancedレーザーの脱着またはイオン化経過時間までに引き続いて検出された。 ピークはCiphergen ProteinChipソフトウェア3.2.0によって得られ、浙江大学ProteinChipデータ解析システム(ZJU-PDAS)によって分析された。 CEAのレベルは化学ルミネセンスのimmunoassayによって評価された。 結果: 33か月の中央のフォローアップの期間後で、失われる4人のGCの患者との1つを分けられた20人のよ予想のGCの患者(全面的な存続以上24か月)および19人の貧し予想のGCの患者(これ以上より24か月)に分けなさい。 確立された予想パターンは84.2%感受性の5新しい予想のbiomarkersからおよびcarcinoembryonic抗原(CEA)およびTNMの段階のそれらよりかなり高かった85.0%特定性成っていた。 私達はまた66.7%感受性のグループ2で予想パターンをおよび80.0%特定性盲目的にテストした。 さらに、GCでかなり上がった私達はことが4474Daピーク分り、高度の段階(III+IV)および短いと存続(pの&lt関連付けられた; 0.03)。 結論: 私達は洗練された生物情報学と結合されるSELDI-TOF-MSの使用によってGCの予想の予言のためのいくつかの新しいbiomarkersを識別した。 特に、4474Daピークの高い表現は非常に有望GCの生物学的に積極的な特徴と関連付けられた新しいbiomarkerに開発されるために示した。 PMID: 19740432 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-191.html</link>
      <description> Related Articles Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker. Ann Surg Oncol. 2010 Mar 31; Authors: Chen L, Ho DW, Lee NP, Sun S, Lam B, Wong KF, Yi X, Lau GK, Ng EW, Poon TC, Lai PB, Cai Z, Peng J, Leng X, Poon RT, Luk JM BACKGROUND: Biomarkers for accurate diagnosis of early hepatocellular carcinoma (HCC) are limited in number and clinical validation. We applied SELDI-TOF-MS ProteinChip technology to identi ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-191.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker. Ann Surg Oncol. 2010 Mar 31; Authors: Chen L, Ho DW, Lee NP, Sun S, Lam B, Wong KF, Yi X, Lau GK, Ng EW, Poon TC, Lai PB, Cai Z, Peng J, Leng X, Poon RT, Luk JM BACKGROUND: Biomarkers for accurate diagnosis of early hepatocellular carcinoma (HCC) are limited in number and clinical validation. We applied SELDI-TOF-MS ProteinChip technology to identify serum profile for distinguishing HCC and liver cirrhosis (LC) and to compare the accuracy of SELDI-TOF-MS profile and alpha-fetoprotein (AFP) level in HCC diagnosis. PATIENTS AND METHODS: Serum samples were obtained from 120 HCC and 120 LC patients for biomarker discovery and validation studies. ProteinChip technology was employed for generating SELDI-TOF proteomic features and analyzing serum proteins/peptides. RESULTS: A diagnostic model was established by CART algorithm, which is based on 5 proteomic peaks with m/z values at 3324, 3994, 4665, 4795, and 5152. In the training set, the CART algorithm could differentiate HCC from LC subjects with a sensitivity and specificity of 98% and 95%, respectively. The results were assessed in blind validation using separate cohorts of 60 HCC and 60 LC patients, with an accuracy of 83% for HCC and 92% for LC patients. The diagnostic odd ratio (DOR) indicated that SELDI-TOF proteomic signature could achieve better diagnostic performance than serum AFP level at a cutoff of 20 ng/mL (AFP(20)) (92.72 vs 9.11), particularly superior for early-stage HCC (87% vs 54%). Importantly, a combined use of both tests could enhance the detection of HCC (sensitivity, 95%; specificity, 98%; DOR, 931). CONCLUSION: Serum SELDI-TOF proteomic signature, alone or in combination with AFP marker, promises to be a good tool for early diagnosis and/screening of HCC in at-risk population with liver cirrhosis. PMID: 20354800 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 関連の記事はアルファFetoproteinのマーカーと結合されたSerum SELDI-TOF Proteomicの署名によって早いHepatocellular癌腫の検出を高めた。 アンSurg Oncol。 3月2010日31日; 著者: 陳L、Ho DW、リーNP、日曜日Sの逃亡B、Wong KF、イX、Lau GK、NG EW、Poon TCのLaiのPB、CAI Z、ポンJ、Leng X、Poon RTのLuk JMの背景: 早いhepatocellular癌腫(HCC)の正確な診断のためのBiomarkersは臨床確認総計で限られ。 私達はHCCおよび肝硬変(LC)を区別するための血清のプロフィールを識別し、SELDI-TOF-MSのプロフィールの正確さおよびHCCの診断のアルファfetoprotein (AFP)のレベルを比較するためにSELDI-TOF-MS ProteinChipの技術を適用した。 患者および方法: 血清のサンプルはbiomarkerの発見および確認の調査のための120 HCCそして120人のLCの患者から得られた。 ProteinChipの技術はSELDI-TOFのproteomic特徴を発生させ、血清の蛋白質かペプチッドを分析するために用いられた。 結果: 診断モデルは3324、3994、4665、4795、および5152のm/zの価値の5つのproteomicピークに基づいているCARTのアルゴリズムによって確立された。 訓練セットでは、カートのアルゴリズムはそれぞれ98%および95%の感受性そして特定性のLCの主題からのHCCを区別できる。 結果は60 HCCの別のグループおよびHCCのための83%およびLCの患者のための92%の正確さの60人のLCの患者を使用して盲目の確認で、査定された。 SELDI-TOFのproteomic署名が20 ng/mL (の締切りで血清AFPのレベルよりよい診断性能をAFP (20)実現)できることを診断異様な比率(DOR)は示した (9.11対92.72)、早段階HCC (54%対87%)のための特に目上の人。 重要なのは、両方のテストの結合された使用はHCC (感受性、95%の検出を高めることができる; 特定性、98%; DOR、931)。 結論: 単独でまたはAFPのマーカー、肝硬変の危険の人口のHCCの早い診断そしてまたはスクリーニングのためのよい用具がある約束を伴う血清SELDI-TOFのproteomic署名。 PMID: -出版業者によって供給される… 20354800 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Serum protein profiles in myasthenia gravis.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-152.html</link>
      <description> Related Articles Serum protein profiles in myasthenia gravis. Ann Thorac Surg. 2009 Oct;88(4):1118-23 Authors: Cheng C, Wu G, Yeung SC, Li R, Bella AE, Pang J, Zhong FT, Luo H, Jin Y, Pan J BACKGROUND: The diagnosis of myasthenia gravis (MG) remains challenging. We performed a proteome-wide search for potential serum protein diagnostic markers for MG using surface-enhanced laser desorption/ionization (SELDI) time-of-flight mass spectrometry (TOFMS). METHODS: Proteomic spectra from 80 MG patient ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-152.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Serum protein profiles in myasthenia gravis. Ann Thorac Surg. 2009 Oct;88(4):1118-23 Authors: Cheng C, Wu G, Yeung SC, Li R, Bella AE, Pang J, Zhong FT, Luo H, Jin Y, Pan J BACKGROUND: The diagnosis of myasthenia gravis (MG) remains challenging. We performed a proteome-wide search for potential serum protein diagnostic markers for MG using surface-enhanced laser desorption/ionization (SELDI) time-of-flight mass spectrometry (TOFMS). METHODS: Proteomic spectra from 80 MG patients and 80 healthy individuals were generated by SELDI. Samples from 56 MG patients and 56 healthy individuals in the training set were analyzed to set up the decision tree. Samples from 24 MG patients and 24 healthy individuals were used for cross-validation testing. RESULTS: The SELDI TOFMS analysis generated 101 peaks, representing differentially expressed proteins between 1000 and 20000 Da. Among them, 9 peaks were down-regulated and 30 others were up-regulated in the MG sera compared with the controls. The decision tree used the peak at M4168.94 Da and M1122.57 Da as splitters in the classification process. In the training set, 112 samples were classified as MG or control group, with a sensitivity of 100% and specificity of 89.3%; the 10-fold cross-validated analysis identified the optimal decision tree with the lowest relative cross-validated cost of 0.080. In the test set, the decision tree generated was able to identify 20 of 24 MG patients and 21 of 24 healthy individuals with a sensitivity of 83.3% and a specificity of 87.5%. CONCLUSIONS: SELDI TOFMS is a useful tool for the detection and identification of potential serum biomarkers that can diagnose MG with high sensitivity and specificity. PMID: 19766792 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： myastheniaのgravisの関連の記事の血清蛋白質のプロフィール。 アンThorac Surg。 10月2009日; 88 (4): 1118-23書く: チェンC、ウーG、Yeung SC、李R、Bella AEの激痛J、Zhong FT、ルオH、ジンYの鍋Jの背景: myastheniaのgravis (MG)の診断は挑戦的に残る。 私達は表面高められたレーザーの脱着またはイオン化(SELDI)時間の飛行質量分析(TOFMS)を使用してMGの潜在的な血清蛋白質の診断マーカーのproteome広い調査を行った。 方法: 80人のMGの患者および80人の健康な個人からのProteomicスペクトルはSELDIによって発生した。 訓練セットの56人のMGの患者そして56人の健康な個人からのサンプルは決定ツリーをセットアップするために分析された。 24人のMGの患者および24人の健康な個人からのサンプルはクロス確認のテストのために使用された。 結果: SELDI TOFMSの分析は1000年と20000 Da間の特異的に表現された蛋白質を表す101のピークを発生させた。 その中で、9つのピークは調整され、30他は制御と比較されたMGの血清で調整された。 決定ツリーは分類プロセスでM4168.94 DaおよびM1122.57 Daでピークをようにディバイダー使用した。 訓練セットでは、112のサンプルは100%年の感受性および89.3%の特定性のMGか制御グループとして、分類された; 十倍の十字認可された分析は0.080の最も低く相対的な十字認可された費用の最適決定の木を識別した。 テストセットでは、発生した決定ツリーは24人のMGの患者の20および83.3%の感受性および87.5%の特定性の24人の健康な個人の21を識別できた。 結論: SELDI TOFMSは高い感受性および特定性のMGを診断できる潜在的な血清のbiomarkersの検出そして同一証明のための役に立つツールである。 PMID: 19766792 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Analysis of proteomic spectra in serum from patients with laryngeal carcinoma by SELDI-TOF-MS technology]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-192.html</link>
      <description>Related Articles [Analysis of proteomic spectra in serum from patients with laryngeal carcinoma by SELDI-TOF-MS technology] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Dec;23(24):1116-9 Authors: Xu Y, Qiao S, Huangfu H, Wang B OBJECTIVE: To screen the tumor markers of laryngeal carcinoma and to investigate their expression in preoperative and postoperative serum. METHOD: The distinct protein in serum was detected in 32 cases of laryngeal carcinoma and 38 healthy people by IMAC-Cu protei ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-192.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Analysis of proteomic spectra in serum from patients with laryngeal carcinoma by SELDI-TOF-MS technology] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Dec;23(24):1116-9 Authors: Xu Y, Qiao S, Huangfu H, Wang B OBJECTIVE: To screen the tumor markers of laryngeal carcinoma and to investigate their expression in preoperative and postoperative serum. METHOD: The distinct protein in serum was detected in 32 cases of laryngeal carcinoma and 38 healthy people by IMAC-Cu proteinchip array and surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS). The distinct proteins in serum were detected in 32 cases of laryngeal carcinoma preoperation and within 10 days 15 cases of laryngeal carcinoma postoperation with the same methods. The discriminatory profiling between preoperative and postoperative patients was analyzed by Biomarker Wizard software and Biomarker Pattern software. RESULT: The results showed that fifteen differentially expressed proteins in serum were screened by analysis of protemic spectra of preoprative patients and normal subjects. Seventeen kinds of protein differentially expressed in serum were screened by analysis of protemic spectra of preoperative and postoperative patients. Six kinds of protein (2958.52, 3796.89, 5148.86, 6115.57, 4052.18, and 7770.76) were obtained for making up patterns that was able to class the preoperative-team and postoperative-team. Corresponding correct ratio were 84.38% (27/32) and 73.33% (11/15). CONCLUSION: The preliminary results suggest that classification system will provide a highly accurate and innovative approach for the early dioagnosis of laryngeal carcinoma and judgement of prognosis. SELDI-TOF-MS technology is a useful tool for a high throughput screening of large-sized serum samples to discover potential biomarkers for laryngeal carcinoma. PMID: 20359086 [PubMed - in process]（【斜め読み用】機械翻訳：記事[SELDI-TOF-MSの技術によるlaryngeal癌腫の患者からの血清のproteomicスペクトルの分析]林関連のチョンのえーBi沿Hou Tou Jing Wai Ke Za Zhi。 12月2009日; 23 (24): 1116-9書く: Xu Y、Qiao S、Huangfu HのWang Bの目的: laryngeal癌腫の腫瘍のマーカーを選別し、術前およびpostoperative血清の表現を調査するため。 方法: 血清の明瞭な蛋白質はlaryngeal癌腫の32の場合で検出され、IMACCUのproteinchipによる38人の健康な人々はレーザーの脱着またはイオン化時間の飛行質量分析(SELDI-TOF-MS)を配列し、表面高めた。 血清の明瞭な蛋白質はlaryngeal癌腫のpreoperationのそして10日以内の32の場合で同じ方法のlaryngeal癌腫のpostoperationの15の場合検出された。 術前およびpostoperative患者の間で差別的な側面図を描くことはBiomarker WizardソフトウェアおよびBiomarkerパターンソフトウェアによって分析された。 結果: 結果は血清の15の特異的に表現された蛋白質がpreoprative患者および正常な主題のprotemicスペクトルの分析によって選別されたことを示した。 特異的に血清に表現された17種類の蛋白質は術前およびpostoperative患者のprotemicスペクトルの分析によって選別された。 6種類の蛋白質(2958.52、3796.89、5148.86、6115.57、4052.18、および7770.76)はパターンを術前チームおよびpostoperativeチームを分類できた構成するために得られた。 対応する正しい比率は84.38% (27/32)および73.33%だった(11/15)。 結論: 予備の結果は分類体系がlaryngeal癌腫の早いdioagnosisおよび予想の判断に極めて正確で、革新的なアプローチを提供することを提案する。 SELDI-TOF-MSの技術はlaryngeal癌腫のための潜在的なbiomarkersを発見する大型の血清のサンプルの高い効率のスクリーニングのための役に立つツールである。 PMID: 20359086 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Screening of serum protein biomarkers by surface-enhanced laser desorption and ionization with time-of-flight detection mass spectrometry in patients with mycosis fungoides]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-106.html</link>
      <description>Related Articles [Screening of serum protein biomarkers by surface-enhanced laser desorption and ionization with time-of-flight detection mass spectrometry in patients with mycosis fungoides] Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009 Feb;31(1):13-6 Authors: Liu J, Zheng YH, Zhang JZ, Wang BX OBJECTIVE: To screen serum biomarkers in patients with mycosis fungoides (MF) using surface-enhanced laser desorption and ionization with time-of-flight detection mass spectrometry (SELDI-TOF-MS) technique.  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-106.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Screening of serum protein biomarkers by surface-enhanced laser desorption and ionization with time-of-flight detection mass spectrometry in patients with mycosis fungoides] Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009 Feb;31(1):13-6 Authors: Liu J, Zheng YH, Zhang JZ, Wang BX OBJECTIVE: To screen serum biomarkers in patients with mycosis fungoides (MF) using surface-enhanced laser desorption and ionization with time-of-flight detection mass spectrometry (SELDI-TOF-MS) technique. METHODS: Serum was analyzed from 14 patients with MF and 17 controls using CM10 Protein-chip to capture serum proteins, followed by Biomarker Wizard software analysis. RESULTS: In all specimens, about 131 protein peaks could be detected when the relative molecular weight ranged from 0 to 50 000. When comparing the protein fingerprint between these two groups, 14 differentially expressed protein peaks were found. By searching SWISS-PRO database, we found 7 670Da peaks accord with C-C motif chemokine 22. CONCLUSION: SELDI-TOF-MS technique can be used for screening serum protein biomarkers in patients with MF. PMID: 19317049 [PubMed - in process]（【斜め読み用】機械翻訳：関連の記事[真菌症のfungoidesを持つ患者の時間の飛行検出の質量分析の表面高められたレーザーの脱着そしてイオン化による血清蛋白質のbiomarkersのスクリーニング] ZhongguoイXue Ke Xue元Xue Bao。 2月2009日; 31 (1): 13-6書く: 劉J、Zheng YH、チャンJZのWang BXの目的: 真菌症のfungoides (MF)を持つ患者の血清のbiomarkersを時間の飛行検出の質量分析(SELDI-TOF-MS)の技術の表面高められたレーザーの脱着そしてイオン化を使用して選別するため。 方法: 血清はCM10蛋白質破片を使用してMFおよび17の制御を用いる14人の患者からBiomarker Wizardソフトウェア分析に先行している血清蛋白質を捕獲するために分析された。 結果: すべての標本では、約131の蛋白質のピークは相対的な分子量が0から50 000まで及んだときに検出できる。 これら二つのグループ間の蛋白質の指紋を比較するとき、14の特異的に表現された蛋白質のピークは見つけられた。 SWISS-PROのデータベースの捜索によって、私達は7つの670DaピークがC-Cのモチーフのchemokine 22と一致することを見つけた。 結論: SELDI-TOF-MSの技術はMFの患者でスクリーニングの血清蛋白質のbiomarkersに使用することができる。 PMID: 19317049 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Serum proteomic profiling analysis of chronic arsenic exposure by using SELDI-TOF-MS technology.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-193.html</link>
      <description> Related Articles Serum proteomic profiling analysis of chronic arsenic exposure by using SELDI-TOF-MS technology. Toxicol Lett. 2010 Jun 2;195(2-3):155-60 Authors: Zhao L, Gao Y, Yang Y, Wei Y, Li Y, Feng H, Wei W, Ding Y, Sun D This study was to investigate the differences in serum proteomic profiling among subjects exposed to different levels of arsenic in drinking water and to identify proteins related to arsenicosis. A total of 148 subjects from endemic regions of China were selected and di ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-193.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Serum proteomic profiling analysis of chronic arsenic exposure by using SELDI-TOF-MS technology. Toxicol Lett. 2010 Jun 2;195(2-3):155-60 Authors: Zhao L, Gao Y, Yang Y, Wei Y, Li Y, Feng H, Wei W, Ding Y, Sun D This study was to investigate the differences in serum proteomic profiling among subjects exposed to different levels of arsenic in drinking water and to identify proteins related to arsenicosis. A total of 148 subjects from endemic regions of China were selected and divided into low (0-8.30 microg/L), medium (16.30-37.60 microg/L) and high (140.88-273.67 microg/L) exposure groups. High exposure group consisted of subjects with and without skin lesions. Serum proteomic profiling was analyzed by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technology. Twenty proteins were found significantly different among three groups. Further multivariate logistic regression revealed that no different proteins existed in medium versus low exposure group. A panel of five proteins, including m/z of 15167.7, 7783.1, 7580.7, 2952.6 and 2237.4, was seen in high versus low exposure group, with a sensitivity of 93.0% and specificity of 87.5%. The same panel was found in high versus a combination of low and medium exposure groups but with somewhat lower predicting power. Only one protein was significantly different between high exposure group with and without skin lesions. The results indicate that high levels of arsenic exposure could significantly change human serum proteomic profiling, which can be detected before skin lesions occur. PMID: 20362649 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： SELDI-TOF-MSの技術の使用による慢性のヒ素の露出の関連の記事の血清のproteomic側面図を描く分析。 Toxicol Lett。 6月2010日2日; 195 (2-3): 155-60書く: 肇L、高Y、ヤンY、魏Y、李Y、Feng H、魏W、丁Yの日曜日Dのこの調査は飲料水のヒ素の異なったレベル--にさらされた主題間で血清のproteomic側面図を描くことの相違を調査するべきで、蛋白質を識別することはarsenicosisに関連していた。 合計中国の風土性の地域からの148の主題は低速(0-8.30 microg/L)のに媒体選ばれ、分けられた(16.30-37.60 microg/L)および最高(140.88-273.67のmicrog/L)露出のグループ。 高い露出のグループは皮膚損傷の有無にかかわらず主題から成っていた。 血清のproteomic側面図を描くことは表面高められたレーザーの脱着またはイオン化時間の飛行質量分析(SELDI-TOF-MS)の技術によって分析された。 20の蛋白質は3グループ間でかなり違う見つけられた。 それ以上の多変数の記号論理学退化は異なった蛋白質が媒体に対低い露出のグループなかったことを明らかにした。 15167.7のm/zを含む5つの蛋白質のパネルは、7783.1、最高で7580.7、2952.6および2237.4、対93.0%の感受性および87.5%の特定性の低い露出のグループ、見られた。 同じパネルは最高で対低く、中型の露出のグループの幾分より低い予測力との組合せ見つけられた。 1つの蛋白質だけ皮膚損傷の有無にかかわらず高い露出のグループ間でかなり違った。 結果はヒ素の露出のハイレベルがかなり皮膚損傷が起こる前に検出することができる人間の血清のproteomic側面図を描くことを変えることができることを示す。 PMID: 20362649 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-114.html</link>
      <description> Related Articles Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma. Cancer Lett. 2009 Sep 18;282(2):205-13 Authors: Xu G, Xiang CQ, Lu Y, Kang XN, Liao P, Ding Q, Zhang YF PURPOSE: Early diagnosis is critical for improving the outcome of patients with renal cell carcinoma (RCC). In this study, we applied a proteomic approach to identify serum biomarkers associated with different stages of renal tumor development. MATERIALS AND METHODS: The protein expression prof ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-114.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma. Cancer Lett. 2009 Sep 18;282(2):205-13 Authors: Xu G, Xiang CQ, Lu Y, Kang XN, Liao P, Ding Q, Zhang YF PURPOSE: Early diagnosis is critical for improving the outcome of patients with renal cell carcinoma (RCC). In this study, we applied a proteomic approach to identify serum biomarkers associated with different stages of renal tumor development. MATERIALS AND METHODS: The protein expression profiles in patient serum samples were analyzed using surface enhanced laser desorption/ionization time-of-flight mass spectroscopy (SELDI-TOF-MS). The subjects included 65 patients with renal cell carcinomas, 34 with benign renal tumors, and 69 normal controls. A diagnostic decision tree was developed and validated based on the differentially expressed proteins between the serum of patients with small (<or=3 cm) RCC tumors and normal controls. RESULTS: The numbers of proteins differentially expressed in the serum samples were 29 between the patients with RCC and normal controls, 18 between patients with RCC and benign renal tumors, and 35 between patients with small RCC tumors and normal controls, respectively. The diagnostic decision tree generated from the differentially expressed proteins between patients with small RCC tumors and normal controls proved efficient in the early diagnosis of renal cell carcinoma, with a sensitivity of 81.8% and specificity of 100%. The eukaryotic initiation factor 2B delta subunit (eIF2B-delta) was identified as the most highly up-regulated protein in the serum of patients with RCC. CONCLUSIONS: SELDI-TOF-MS is a simple, sensitive and highly reproducible technique that can be used to identify serum biomarkers. The serum biomarkers identified by this study may facilitate early diagnosis of RCC and offer new targets for mechanistic understanding and clinical therapy of this disease. PMID: 19362769 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 腎臓の細胞の癌腫のための血清のbiomarkersを識別するSELDI-TOF-MSの関連の記事の塗布。 蟹座Lett。 9月2009日18日; 282 (2): 205-13書く: Xu G、Xiang CQ、Lu Y、Kang XN、Liao P、丁QのチャンYFの目的: 早い診断は腎臓の細胞の癌腫(RCC)の患者の結果を改善するために重大である。 この調査では、私達は腎臓の腫瘍の開発の異なった段階と関連付けられた血清のbiomarkersを識別するためにproteomicアプローチを適用した。 材料および方法: 蛋白質の表現のプロフィールの入院患者の血清のサンプルは表面によって高められたレーザーの脱着またはイオン化時間の飛行多く分光学(SELDI-TOF-MS)を使用して分析された。 主題は腎臓の細胞の癌腫の65人の患者、温和な腎臓の腫瘍との34、および69の正常な制御を含んでいた。 診断決定の木は小さいの患者の血清間の特異的に表現された蛋白質に基づいて開発され、認可した(< or=3 cm) RCCの腫瘍および正常な制御。 結果: 特異的に血清のサンプルに表現された蛋白質の数はRCCの患者と正常な制御の間の29、RCCの患者と温和な腎臓の腫瘍の間の18、と小さいRCCの腫瘍を持つ患者と正常な制御の間の35、それぞれだった。 小さいRCCの腫瘍を持つ患者と正常な制御間の特異的に表現された蛋白質から発生した診断決定の木は81.8%の感受性および100%年の特定性の腎臓の細胞の癌腫の早い診断の有効、証明した。 eukaryotic開始要因2Bデルタの亜単位(eIF2Bデルタ)はRCCの患者の血清の最も非常に調整された蛋白質として識別された。 結論: SELDI-TOF-MSは血清のbiomarkersを識別するのに使用することができる簡単で、敏感で非常に再生可能な技術である。 この調査によって識別される血清のbiomarkersはおよびこの病気の臨床療法をRCCの早い診断促進し、機械論的な理解のための新しいターゲットを提供するかもしれない。 PMID: 19362769 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-194.html</link>
      <description>Related Articles Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis. Oncol Rep. 2010 May;23(5):1325-30 Authors: Saito Y, Oba N, Nishinakagawa S, Mizuguchi Y, Kojima T, Nomura K, Nakatsura T Glypican-3 (GPC3) is overexpressed in hepatocellular carcinoma (HCC) but not in chronic hepatitis (CH) and liver cirrhosis (LC). We have reported the possibility of GPC3-specific cytotoxic T lymphocytes (CTLs) s ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-194.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis. Oncol Rep. 2010 May;23(5):1325-30 Authors: Saito Y, Oba N, Nishinakagawa S, Mizuguchi Y, Kojima T, Nomura K, Nakatsura T Glypican-3 (GPC3) is overexpressed in hepatocellular carcinoma (HCC) but not in chronic hepatitis (CH) and liver cirrhosis (LC). We have reported the possibility of GPC3-specific cytotoxic T lymphocytes (CTLs) serving as a marker for the early diagnosis of imaging invisible HCC. In this study, to identify new early diagnostic biomarker of imaging invisible HCC, we analyzed plasma of healthy donors and patients with CH, LC and HCC using surface-enhanced laser desorption-ionaization time-of-flight mass spectrometry (SELDI-TOF-MS). The intensities of four peaks were significantly increased in HCC patients compared with healthy donors. Two of these four peaks were significantly higher in CH and LC patients with GPC3-specific CTLs than in those without. One peak (11.7 kDa) was predicted to be beta2-microglobulin (beta2-MG) by molecular mass. There was a correlation between concentration of beta2-MG by latex agglutination immunoassay in plasma and peak intensity using SELDI-TOF-MS. The 11.7 kDa protein was fractionated by gel filtration and was identified as beta2-MG by Western blot analysis. These results suggest that the level of beta2-MG in plasma from patients with CH and LC could be a useful marker for the early diagnosis of imaging invisible HCC, however further investigation is needed. PMID: 20372847 [PubMed - in process]（【斜め読み用】機械翻訳：肝硬変のイメージ投射見えないhepatocellular癌腫の入院患者の早い診断のための候補者としてbeta2-microgloblinの関連の記事の同一証明。 Oncol Rep。 5月2010日; 23 (5): 1325-30書く: Saito Y、Oba N、Nishinakagawa S、Mizuguchi Y、小島T、Nomura K、Nakatsura T Glypican-3 (GPC3)はhepatocellular癌腫(HCC)でない慢性の肝炎(CH)および肝硬変(LC)でoverexpressed。 私達はイメージ投射見えないHCCの早い診断のためのマーカーとして役立っているGPC3特定の細胞毒素Tのリンパ球(CTLs)の可能性を報告した。 この調査では、イメージ投射見えないHCCの新しく早い診断biomarkerを識別するために、私達は表面高められたレーザーの脱着ionaization時間の飛行質量分析(SELDI-TOF-MS)を使用してCH、LCおよびHCCの健康な提供者そして患者の血しょうを分析した。 4つのピークの強度は健康な提供者と比較されたHCCの患者でかなり増加した。 この4つのピークの2つは外によりそれらのGPC3特定のCTLsのCHおよびLCの患者でかなり高かった。 1つのピークは(11.7のkDa)分子固まりによってbeta2-microglobulin (beta2MG)であるために予測された。 血しょうの乳液の膠着のimmunoassayによるbeta2MGの集中とSELDI-TOF-MSを使用してピーク強度間に相関関係があった。 11.7のkDa蛋白質はゲル濾過によって分別され、beta2MGとして西部のしみの分析によって識別された。 これらの結果はより詳しい調査が必要であるどんなにCHおよびLCの患者からの血しょうのbeta2MGのレベルがイメージ投射見えないHCCの早い診断のための有用なマーカーであることができることを提案する。 PMID: 20372847 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-122.html</link>
      <description>Related Articles Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry. Clin Chem Lab Med. 2009;47(6):713-23 Authors: Navaglia F, Fogar P, Basso D, Greco E, Padoan A, Tonidandel L, Fadi E, Zambon CF, Bozzato D, Moz S, Seraglia R, Pedrazzoli S, Plebani M BACKGROUND: Surface-enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF/MS), a laboratory-friendly technique, is used to identify biomarkers fo ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-122.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry. Clin Chem Lab Med. 2009;47(6):713-23 Authors: Navaglia F, Fogar P, Basso D, Greco E, Padoan A, Tonidandel L, Fadi E, Zambon CF, Bozzato D, Moz S, Seraglia R, Pedrazzoli S, Plebani M BACKGROUND: Surface-enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF/MS), a laboratory-friendly technique, is used to identify biomarkers for cancer. The aim of the present study was to explore the application of SELDI proteomic patterns in serum for distinguishing between cases of pancreatic cancer, chronic pancreatitis, type 2 diabetes mellitus and healthy controls. METHODS: Sera from 12 healthy controls, 24 patients with type 2 diabetes mellitus, 126 with pancreatic cancer, including 84 with diabetes, and 61 with chronic pancreatitis, 32 of which were diabetics, were analyzed using SELDI-TOF/MS. Spectra (IMAC-30) were clustered and classified using Biomarker Wizard and Biomarker Pattern software. RESULTS: Two decision tree classification algorithms, one with and one without CA 19-9, were constructed. In the absence of CA 19-9, the splitting protein peaks were: m/z 1526, 1211, and 3519; when CA 19-9 was used in the analysis, it replaced the m/z 3519 splitter. The two algorithms performed equally for classifying patients. A classification tree that considered diabetic patients only was constructed; the main splitters were: 1211, CA 19-9, 7903, 3359, 1802. With this algorithm, 100% of patients with type 2 diabetes mellitus, 97% with chronic pancreatitis and 77% of patients with pancreatic cancer were correctly classified. SELDI-TOF/MS features improved the diagnostic accuracy of CA 19-9 (AUC = 0.883 for CA 19-9; AUC = 0.935 for CA 19-9 and SELDI-TOF/MS features combined). CONCLUSIONS: SELDI-TOF/MS allows identification of new peptides which, in addition to CA 19-9, enable the correct classification of the vast majority of patients with pancreatic cancer, which can be distinguished from patients with chronic pancreatitis or type 2 diabetes mellitus. PMID: 19426140 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The promise of bone cancer proteomics.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-195.html</link>
      <description> Related Articles The promise of bone cancer proteomics. Ann N Y Acad Sci. 2010 Mar;1192(1):222-9 Authors: Byrum S, Montgomery CO, Nicholas RW, Suva LJ Mass spectrometric analysis of the low-molecular-weight (LMW) range of the serum/plasma proteome is revealing the existence of large numbers of previously unknown peptides and protein fragments, predicted to be derived from circulating low-abundance proteins. While genomics and proteomics are the primary discovery research tool, recent innovation ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-195.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The promise of bone cancer proteomics. Ann N Y Acad Sci. 2010 Mar;1192(1):222-9 Authors: Byrum S, Montgomery CO, Nicholas RW, Suva LJ Mass spectrometric analysis of the low-molecular-weight (LMW) range of the serum/plasma proteome is revealing the existence of large numbers of previously unknown peptides and protein fragments, predicted to be derived from circulating low-abundance proteins. While genomics and proteomics are the primary discovery research tool, recent innovations in high-throughput proteomics are now standard practice for biomarker and target discovery. Surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry (MS) is the current mainstay for serum or plasma analysis, although other methods are emerging as alternative high-throughput approaches. From a proteomics perspective, the bone cancers, such as myeloma, breast and prostate cancer bony metastases, and osteosarcoma, are likely among the least studied. As recent advances in proteomic technology have thrust the bone cancer field into the era of proteomics, a review of the current status of the proteome as it relates to the skeletal consequences of malignancy seems reasonable. PMID: 20392240 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事骨肉腫のproteomicsの約束。 アンN Y Acad Sci。 3月2010日; 1192年(1): 222-9書く: Byrum S、モントゴメリーCO、ニコラス血清または血しょうproteomeの低分子量の(LMW)範囲のRW、スバLJの多くの分光分析循環の低豊富蛋白質から得られるために予測される多数の前に未知のペプチッドおよび蛋白質の片の存在を明らかにしている。 今ではゲノミクスおよびproteomicsが第一次発見の研究用具の間、高効率のproteomicsの最近の革新はbiomarkerおよびターゲット発見のための標準的技法である。 代わりとなる高効率が近づくと同時に他の方法が現れているが、表面高められたレーザーの脱着またはイオン化時間の飛行(SELDI-TOF)質量分析(MS)は血清または血しょう分析のための現在の支柱である。 proteomicsの見通しから、骨肉腫は、骨髄種のような、胸および前立腺癌の骨の多い転移およびosteosarcoma、最も少なく調査されるの中で本当らしい。 proteomic技術の最近の前進がproteomicsの時代に骨肉腫分野を押し出したので、敵意の骨格結果に関連していると同時にproteomeの現状の検討は適度なようである。 PMID: 20392240 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Characterization of apolipoprotein A-I as a potential biomarker for cholangiocarcinoma.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-130.html</link>
      <description> Related Articles Characterization of apolipoprotein A-I as a potential biomarker for cholangiocarcinoma. Eur J Cancer Care (Engl). 2009 Nov;18(6):625-35 Authors: Wang X, Dai S, Zhang Z, Liu L, Wang J, Xiao X, He D, Liu B Serum samples from 60 cholangiocarcinoma (CC), 60 benign diseases of hepatobiliary and 53 normal individuals were analysed by SELDI-TOF-MS (Surface Enhanced Laser Desorption/Ionization Time of Flight Mass Spectrometry). It was found that a 28 k m/z peak was significantly decrea ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-130.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Characterization of apolipoprotein A-I as a potential biomarker for cholangiocarcinoma. Eur J Cancer Care (Engl). 2009 Nov;18(6):625-35 Authors: Wang X, Dai S, Zhang Z, Liu L, Wang J, Xiao X, He D, Liu B Serum samples from 60 cholangiocarcinoma (CC), 60 benign diseases of hepatobiliary and 53 normal individuals were analysed by SELDI-TOF-MS (Surface Enhanced Laser Desorption/Ionization Time of Flight Mass Spectrometry). It was found that a 28 k m/z peak was significantly decreased in CC and retained discriminatory value between CC and normal group, also between CC and benign groups. Then 1-D, 2-D gel electrophoresis and tandem mass spectroscopy were employed to isolate and identify the protein that correlates with observed SELDI-TOF-MS (m/z) value. The results demonstrated that 28 k m/z peak was apolipoprotein A-I (ApoA-I) and its identity was further validated by immunodepletion and Western blotting analysis. Subsequently, it was inspiring found that the decreased level of ApoA-I analysed by enzyme linked immunosorbent assay was consistent with SELDI-TOF-MS analysis. Therefore, it suggested that ApoA-I could be a potential useful biomarker for CC. PMID: 19486127 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： cholangiocarcinomaのための潜在的なbiomarkerとしてapolipoprotein A-Iの関連の記事の性格描写。 Eur Jの蟹座の心配(イギリス)。 11月2009日; 18 (6): 625-35書く: Wang X、戴S、チャンZ、劉L、Wang J、シャオX、彼D、60 cholangiocarcinomaからの劉Bの血清のサンプル(CC)、hepatobiliaryおよび正常な個人53人の60の温和な病気はSELDI-TOF-MSによって分析された(質量分析表面によって高められるレーザーの脱着またはイオン化経過時間)。 28 k m/zのピークがCCでかなり減り、CCと温和なグループ間のCCと正常なグループ間の差別的な価値を、また保ったことが分られた。 それから1-D、第2ゲルの電気泳動およびタンデム多く分光学は観察されたSELDI-TOF-MSに関連する蛋白質を隔離し、識別するために用いられた(m/z)価値。 結果は28 k m/zのピークがapolipoprotein A-I (ApoA-I)であり、ことを示したアイデンティティはimmunodepletionおよび西部のしみが付く分析によって更に認可された。 続いて、それは酵素によってつながれたimmunosorbentの試金によって分析されたApoA-Iの減らされたレベルがSELDI-TOF-MSの分析に一貫していたことが分られた促すことだった。 従ってApoA-IがCCのための潜在的で有用なbiomarkerであることができることを、提案した。 PMID: 19486127 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A review of experimental design best practices for proteomics based biomarker discovery: focus on SELDI-TOF.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-196.html</link>
      <description> Related Articles A review of experimental design best practices for proteomics based biomarker discovery: focus on SELDI-TOF. Methods Mol Biol. 2010;641:167-83 Authors: Caffrey RE Surface Enhanced Laser/Desorption Ionization-time of flight (SELDI-TOF) mass spectrometry is a technique uniquely suited to the study of the urine proteome due to its salt tolerance, high-throughput, and small sample requirements. However, due to the extreme sensitivity of the technique, sample collection and storage  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-196.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles A review of experimental design best practices for proteomics based biomarker discovery: focus on SELDI-TOF. Methods Mol Biol. 2010;641:167-83 Authors: Caffrey RE Surface Enhanced Laser/Desorption Ionization-time of flight (SELDI-TOF) mass spectrometry is a technique uniquely suited to the study of the urine proteome due to its salt tolerance, high-throughput, and small sample requirements. However, due to the extreme sensitivity of the technique, sample collection and storage conditions, as well as instrument protocols and analysis conditions, must be rigorously controlled to ensure that data generated and collected is accurate and free from artifacts. Robust and reproducible data sets can be generated and compared between clinical sites when experimental protocols are carefully standardized. This chapter aims to review known factors that cause irreproducible results so that the experiments may be designed with appropriate sample and process controls for successful biomarker discovery. A suggested protocol follows the review. A number of issues for study design are discussed and these are generally applicable to biomarker discovery experiments. PMID: 20407947 [PubMed - in process]（【斜め読み用】機械翻訳： proteomicsのための実験設計最良の方法の関連の記事Aの検討はbiomarkerの発見を基づかせていた: SELDI-TOFの焦点。 方法Mol Biol. 2010年; 641: 167-83書く: 表面に関してCaffreyはレーザーを高めたまたは飛行(SELDI-TOF)質量分析の脱着のイオン化時間は独特に塩の許容、高効率および小さいサンプル条件による尿のproteomeの調査に適する技術である。 但し、器械の議定書および分析の状態、また技術、サンプルコレクションおよび貯蔵条件の極度な感受性が原因で、厳格に発生し、集められるデータが人工物から正確、自由であることを確認するために制御されなければならない。 強く、再生可能なデータセットは臨床場所の間で実験議定書が注意深く標準化されるとき発生し、比較することができる。 この章は実験が巧妙なbiomarkerの発見のための適切なサンプルそしてプロセス制御と設計されているように再現不可能な結果を引き起こす知られていた要因を見直すことを向ける。 提案された議定書は検討に続く。 調査の設計のためのいくつかの問題は論議され、これらはbiomarkerの発見の実験にふつうは適用できる。 PMID: 20407947 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The isolation and identification of a secreted biomarker associated with cell stress in serum-free CHO cell culture.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-138.html</link>
      <description> Related Articles The isolation and identification of a secreted biomarker associated with cell stress in serum-free CHO cell culture. Biotechnol Bioeng. 2009 Oct 15;104(3):590-600 Authors: Woolley JF, Al-Rubeai M One approach to improving mammalian culture productivity has been to reduce cell stress and cell death in the bioreactor, thus enhancing productivity through a longer phase of viability. Here we describe the isolation and identification of a biomarker for stress and viability loss in C ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-138.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The isolation and identification of a secreted biomarker associated with cell stress in serum-free CHO cell culture. Biotechnol Bioeng. 2009 Oct 15;104(3):590-600 Authors: Woolley JF, Al-Rubeai M One approach to improving mammalian culture productivity has been to reduce cell stress and cell death in the bioreactor, thus enhancing productivity through a longer phase of viability. Here we describe the isolation and identification of a biomarker for stress and viability loss in CHO culture. Using SELDI-TOF mass spectrometry to profile the protein component of supernatant culture media we have identified a peak at 7.7 kDa that was associated with loss of viability toward the end of the culture and simulated stress from both toxic metabolite accumulation and nutrient depletion. The relative intensity (signal/noise ratio) of the peak increased rapidly at the onset of dropping viability toward the end of the growth phase. Also, the peak height was seen to increase significantly when cells were grown under conditions emulating ammonia accumulation and glutamine deprivation. The species has been identified as a fragment of Galectin-1 (Gal-1) via MS/MS fingerprinting. We propose that this peak could be utilized as a marker for early onset of stress in cell culture. This work demonstrates the efficacy of SELDI technology to identify biomarkers in mammalian cell culture and highlights its value as a tool for the monitoring and improvement of culture processes. PMID: 19544303 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事はserum-free CHOの細胞培養の細胞の圧力と分泌されたbiomarkerの分離そして同一証明関連付けた。 Biotechnol Bioeng。 10月2009日15日; 104 (3): 590-600書く: 従ってWoolley JFの哺乳類文化生産性の改善へのAlRubeai M 1のアプローチは生物反応炉の細胞の圧力そして細胞死を減らすことであり実行可能性のより長い段階によって生産性を高める。 ここに私達はCHO文化で圧力および実行可能性の損失のためのbiomarkerの分離そして同一証明を記述する。 上澄みの培養基の蛋白質部品の側面図を描くSELDI-TOFの質量分析を使用して私達は有毒な代謝物質の蓄積および栄養素の枯渇両方からの文化そして模倣された圧力の終わりの方の実行可能性の損失と関連付けられた7.7 kDaでピークを識別した。 ピークの相対的な強度は(信号または騒音の比率)成長段階の終わりの方に低下の実行可能性の手始めで急速に増加した。 また、ピーク高さは細胞がアンモナル蓄積およびグルタミンの剥奪を競争する条件の下で育ったときにかなり増加するために見られた。 種はGalectin-1 (Gal1)の片としてMS/MSの指紋採取によって識別された。 私達はこのピークが細胞培養の圧力の早い手始めのためにマーカーとして利用できることを提案する。 この仕事は哺乳類の細胞培養のbiomarkersを識別するためにSELDIの技術の効力を示し、文化プロセスの監視そして改善のための用具として価値を強調する。 PMID: 19544303 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Changes in protein expression profiles between a low phytic acid rice ( Oryza sativa L. Ssp. japonica) line and its parental line: a proteomic and bioinformatic approach.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-197.html</link>
      <description> Related Articles Changes in protein expression profiles between a low phytic acid rice ( Oryza sativa L. Ssp. japonica) line and its parental line: a proteomic and bioinformatic approach. J Agric Food Chem. 2010 Jun 9;58(11):6912-22 Authors: Emami K, Morris NJ, Cockell SJ, Golebiowska G, Shu QY, Gatehouse AM The seed proteome of a low phytic acid (lpa) rice line (Os-lpa-XS110-1), developed as a novel food source, was compared to that of its parental line, Xiushui 110 (XS-110). Analysis by surfa ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-197.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Changes in protein expression profiles between a low phytic acid rice ( Oryza sativa L. Ssp. japonica) line and its parental line: a proteomic and bioinformatic approach. J Agric Food Chem. 2010 Jun 9;58(11):6912-22 Authors: Emami K, Morris NJ, Cockell SJ, Golebiowska G, Shu QY, Gatehouse AM The seed proteome of a low phytic acid (lpa) rice line (Os-lpa-XS110-1), developed as a novel food source, was compared to that of its parental line, Xiushui 110 (XS-110). Analysis by surfaced enhanced laser desorption ionization-time-of-flight mass spectrometry (SELDI-TOF MS) and two-dimensional gel electrophoresis (2-DE) allowed the detection of a potential low molecular weight biomarker and identification of 23 differentially expressed proteins that include stress-related proteins, storage proteins, and potential allergens. Bioinformatic analyses revealed that triose phosphate isomerase (TPI) and fructose bisphosphatealdolase (FBA), two major differentially expressed proteins, are involved in myo-inositol metabolism. Accumulation of globulin was also significantly decreased in the lpa line. This study demonstrates the potential of proteomic and bioinformatic profiling techniques for safety assessment of novel foods. Furthermore, these techniques provide powerful tools for studying functional genomics due to the possibility of identifying genes related to the mutated traits. PMID: 20441221 [PubMed - in process]（【斜め読み用】機械翻訳： 関連の記事は低いphytic酸の米(Oryza sativa L. Ssp.のjaponica)ラインと親ライン間の蛋白質の表現のプロフィールで変わる: proteomicおよびbioinformaticアプローチ。 J Agricの食糧Chem。 6月2010日9日; 58 (11): 6912-22書く: Emami K、Morris NJ、Cockell SJ、Golebiowska G、Shu QYのGatehouse AMは親ラインのそれ、Xiushui 110 (XS-110)と新しい食糧源として開発された低いphytic酸(lpa)の米ライン(OslpaXS110 1)の種のproteome比較された。 浮上した高められたレーザーの脱着イオン化時間の飛行質量分析(SELDI-TOF MS)および二次元のゲルの電気泳動(2DE)による分析は潜在的な低分子量のbiomarkerの検出および重点を置関係した蛋白質、貯蔵蛋白質および潜在的なアレルゲンを含んでいる23の特異的に表現された蛋白質の同一証明を可能にした。 Bioinformaticの分析はその三炭糖の隣酸塩イソメラーゼ(TPI)を明らかにし、フルクトースのbisphosphatealdolase (FBA)、2つの主要な特異的に表現された蛋白質はmyoイノシトールの新陳代謝に、かかわる。 グロブリンの蓄積はまたlpaラインでかなり減った。 この調査は新しい食糧の安全性評価のためのproteomicおよびbioinformatic側面図を描く技術の潜在性を示す。 なお、これらの技術は変異する特性と関連している遺伝子を識別する可能性による機能ゲノミクスを調査するための強力な用具を提供する。 PMID: 20441221 [PubMed -プロセスの…）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapy.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-146.html</link>
      <description>Related Articles Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapy. Int J Oncol. 2009 Oct;35(4):683-92 Authors: He J, Shen D, Chung DU, Saxton RE, Whitelegge JP, Faull KF, Chang HR Chemotherapy is often used for breast cancer treatment, but individual outcome varies widely. We hypothesized that tumor proteomic profiles obtained prior to chemotherapy may predict the individual tumor response to treatment. The goal of our study was to explore feasibility of usi ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-146.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapy. Int J Oncol. 2009 Oct;35(4):683-92 Authors: He J, Shen D, Chung DU, Saxton RE, Whitelegge JP, Faull KF, Chang HR Chemotherapy is often used for breast cancer treatment, but individual outcome varies widely. We hypothesized that tumor proteomic profiles obtained prior to chemotherapy may predict the individual tumor response to treatment. The goal of our study was to explore feasibility of using proteomic profiling to preselect patients for an effective chemotherapeutic regimen. Tumors from 52 patients with T2-T4 breast cancer were prospectively collected before neoadjuvant chemotherapy, and were analyzed using surface-enhanced laser desorption ionization/time of flight (SELDI) mass spectrometry. Mass spectral profiles were obtained from tumors with various sensitivities to chemotherapy. Both non-supervised hierarchical clustering and supervised neural network-based classification approaches were employed to compare the profiles. The first two thirds of the enrolled cases (35) were allocated to a training set to select peaks characteristic of resistant tumors. The candidate peaks were used to develop a predicting rule to evaluate the remaining 17 specimens in the validation set. In the training set, the most prominent differences were found between drug resistant and drug susceptible tumors by non-supervised hierarchical clustering. In the validation set, the supervised classification with the K nearest neighbor (KNN) model correctly classified most tumor responses with an accuracy rate of 92.3% [100% of resistant tumors (4/4), and 84.6% of the tumors with favorable response (11/13)]. In the entire group, a single peak at m/z 16,906 correctly separated 88.9% of the tumors with pathologically complete response, and 91.7% of the resistant tumors. The data suggest that breast cancer protein biomarkers may be used to pre-select patients for optimal chemotherapeutic treatment. PMID: 19724903 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer&apos;s disease.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-198.html</link>
      <description> Related Articles Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer&apos;s disease. J Neurosci. 2010 May 5;30(18):6315-22 Authors: Villemagne VL, Perez KA, Pike KE, Kok WM, Rowe CC, White AR, Bourgeat P, Salvado O, Bedo J, Hutton CA, Faux NG, Masters CL, Barnham KJ Alzheimer&apos;s disease (AD) is the most common age-related dementia. Unfortunately due to a lack of validated biomarkers definitive diagnosis relies on the histological demonstration of amyloid-beta (Abeta) plaques  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-198.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease. J Neurosci. 2010 May 5;30(18):6315-22 Authors: Villemagne VL, Perez KA, Pike KE, Kok WM, Rowe CC, White AR, Bourgeat P, Salvado O, Bedo J, Hutton CA, Faux NG, Masters CL, Barnham KJ Alzheimer's disease (AD) is the most common age-related dementia. Unfortunately due to a lack of validated biomarkers definitive diagnosis relies on the histological demonstration of amyloid-beta (Abeta) plaques and tau neurofibrillary tangles. Abeta processing is implicated in AD progression and many therapeutic strategies target various aspects of this biology. While Abeta deposition is the most prominent feature of AD, oligomeric forms of Abeta have been implicated as the toxic species inducing the neuronal dysfunction. Currently there are no methods allowing routine monitoring of levels of such species in living populations. We have used surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry incorporating antibody capture to investigate whether the cellular membrane-containing fraction of blood provides a new source of biomarkers. There are significant differences in the mass spectra profiles of AD compared with HC subjects, with significantly higher levels of Abeta monomer and dimer in the blood of AD subjects. Furthermore, levels of these species correlated with clinical markers of AD including brain Abeta burden, cognitive impairment and brain atrophy. These results indicate that fundamental biochemical events relevant to AD can be monitored in blood, and that the species detected may be useful clinical biomarkers for AD. PMID: 20445057 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 関連の記事によって血耐えられるアミロイドベータ二量体はアルツハイマー病の臨床マーカーに関連する。 J Neurosci。 5月2010日5日; 30 (18): 6315-22書く: Villemagne VLのペレーズのKA、パイクKE、Kok WM、Rowe CC、白人AR、Bourgeat P、Salvado O、Bedo J、Huttonカリフォルニア、のどNGのマスターのCL、Barnham KJアルツハイマー病(広告)は共通の年齢関連の痴呆である。 残念ながら認可されたbiomarkersの限定的な診断の欠乏が原因で(Abetaの)アミロイドベータプラクおよびtauのneurofibrillaryもつれの組織学的なデモンストレーションに頼る。 Abetaの処理は広告の進行で関係し、多くの治療上の作戦はこの生物学のさまざまな面を目標とする。 Abetaの沈殿が広告の最も顕著な特徴の間、Abetaのoligomeric形態は神経の機能障害を引き起こす有毒な種として関係した。 現在方法があり生きている人口のそのような種のレベルの定期的な監視を許可する。 私達は血の細胞膜含んでいる一部分がbiomarkersの新しい源を提供するかどうか調査する(SELDI-TOF)質量分析の組み込む抗体の捕獲表面によって高められるレーザーの脱着のイオン化経過時間を使用した。 広告の主題の血のAbetaの単量体そして二量体のかなりハイレベルが付いているHCの主題と、比較される広告の多くスペクトルのプロフィールに重要な相違がある。 なお、これらの種のレベルは頭脳のAbetaの重荷、認識減損および頭脳の萎縮を含む広告の臨床マーカーに関連した。 これらの結果は広告に関連した基本的で生化学的なでき事が血で監視することができること、そして検出される種が広告のための有用な臨床biomarkersであるかもしれないことを示す。 PMID: 20445057 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Cancer-specific MALDI-TOF profiles of blood serum and plasma: biological meaning and perspectives.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-154.html</link>
      <description> Related Articles Cancer-specific MALDI-TOF profiles of blood serum and plasma: biological meaning and perspectives. J Proteomics. 2010 Jan 3;73(3):537-51 Authors: Karpova MA, Moshkovskii SA, Toropygin IY, Archakov AI MALDI-TOF mass-spectrometry has become a popular tool of cancer research during the last decade. High throughput and relative simplicity of this technology have made it attractive for biomarker discovery and validation across various platforms in blood serum/plasma. Many technical  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-154.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Cancer-specific MALDI-TOF profiles of blood serum and plasma: biological meaning and perspectives. J Proteomics. 2010 Jan 3;73(3):537-51 Authors: Karpova MA, Moshkovskii SA, Toropygin IY, Archakov AI MALDI-TOF mass-spectrometry has become a popular tool of cancer research during the last decade. High throughput and relative simplicity of this technology have made it attractive for biomarker discovery and validation across various platforms in blood serum/plasma. Many technical approaches have been developed for plasma/serum profiling including protein-chip based SELDI-TOF mass-spectrometry, purification of serum on magnetic beads, analysis of carrier-associated fraction and mass-spectrometric immunoassays. Extensive data about the identity of differential features detected on mass-spectra up to now makes it possible to draw conclusions about potency and perspectives of MALDI-TOF mass-spectrometry in this field. A great majority of identified differentially expressed proteins are either house-keeping or inflammatory proteins as well as their modifications or fragments. Discriminating ability of mass-spectra is likely to be based on differential modification and fragmentation patterns of abundant serum proteins reflecting activity of enzymes including proteases and their inhibitors. PMID: 19782778 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 血血清および血しょうの関連の記事蟹座特定のMALDI-TOFのプロフィール: 生物的意味および見通し。 J Proteomics。 1月2010日3日; 73 (3): 537-51書く: Karpova MAのMoshkovskii SA、Toropygin IYのArchakov AI MALDI-TOFの固まり分光測定最後の十年の間に癌研究の普及した用具になった。 この技術の高い効率そして相対的な簡易性はそれを血血清または血しょうのさまざまなプラットホームを渡るbiomarkerの発見そして確認のために魅力的にさせた。 多くの技術アプローチは磁気ビードの血清の蛋白質破片によって基づくSELDI-TOFの固まり分光測定、浄化、キャリア準の一部分の分析およびmass-spectrometric immunoassaysを含んで側面図を描く血しょうか血清のために開発された。 固まりスペクトルで検出される差動特徴のアイデンティティについての広範なデータは今まで潜在的能力についての結論およびこの分野のMALDI-TOFの固まり分光測定の見通しを引くことを可能にする。 識別された特異的に表現された蛋白質の大多数は修正と同様、家計または炎症性蛋白質または片である。 固まりスペクトルの識別力がある能力は本当らしいプロテアーゼおよび抑制剤を含む酵素の活動を反映する豊富な血清蛋白質の差動修正および分裂パターンに基づいているために。 PMID: 19782778 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Effect of amygdlin on serum proteinic biomarker in pulmonary fibrosis of bleomycin-induced rat]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-199.html</link>
      <description>Related Articles [Effect of amygdlin on serum proteinic biomarker in pulmonary fibrosis of bleomycin-induced rat] Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2010 Apr;28(4):260-3 Authors: Du HK, Song FC, Zhou X, Li H, Zhang JP OBJECTIVE: To evaluate effect of amygdlin on expression of four biomarkers in the animal model of pulmonary fibrosis induced by bleomycin. METHODS: Rats were given one dose (5 mg/kg) of bleomycin in bleomycin-treated groups, amygdlin-treated groups and saline in contro ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-199.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Effect of amygdlin on serum proteinic biomarker in pulmonary fibrosis of bleomycin-induced rat] Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2010 Apr;28(4):260-3 Authors: Du HK, Song FC, Zhou X, Li H, Zhang JP OBJECTIVE: To evaluate effect of amygdlin on expression of four biomarkers in the animal model of pulmonary fibrosis induced by bleomycin. METHODS: Rats were given one dose (5 mg/kg) of bleomycin in bleomycin-treated groups, amygdlin-treated groups and saline in controls by intratracheal instillation exposed surgically. The amygdlin-treated groups rats were treated with intraperitoneal injection of amygdlin (15 mg x kg(-1) x day(-1)). The rats were sacrificed 7, 14 and 28 days after bleomycin administration. Polarized light microscopy and Image-Pro Plus detected I and III collagen expressed in Paraffin-embedded lung sections stained with Sirius red. Surface-enhanced laser desorption-ionization time-of-flight mass spectrometry (SELDI-TOF MS) with weak cationic proteinchip (CM10) detected differentially expressed proteins in the pooled serum samples of all groups. RESULTS: Consistent fibrotic responses were found in all bleomycin and amygdlin-tread groups. On the 7th, 14th and 28th day after bleomycin or saline instillation, four differentially expressed proteins were detected in the pooled serum of all groups rats, consisting of 4 proteins with mass/charge ratio of 3530.7, 7043.5, 8332.6 and 9068.0, respectively. Compared with control groups, protein peaks intensity ratio with mass/charge ratio of 3530.7 on 7, 28 d and 7043.5, 8332.6 and 9068.0 on 7, 14 and 28 d was > 2 in bleomycin-treated groups. Compared with amygdlin-treated groups, protein peaks intensity with mass/charge ratio of 3530.7 at 7, 14, 28 d had no change almost, but protein peaks intensity ratio with mass/charge ratio of 7043.5 at 7 d, 8332.6 on 28 d and 9068.0 on 14 d was > 2 in bleomycin-tread groups. All the four protein peaks intensity had no change almost at other point. CONCLUSION: Amygdlin may reduce the bleomycin-induced increase of differentially expressed protein peak intensities in rat serum. PMID: 20465950 [PubMed - in process]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Detection of elevated proteins in peritoneal dissemination of gastric cancer by analyzing mass spectra data of serum proteins.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-118.html</link>
      <description> Related Articles Detection of elevated proteins in peritoneal dissemination of gastric cancer by analyzing mass spectra data of serum proteins. J Surg Res. 2009 Jul;155(1):13-7 Authors: Kojima T, Yoshikawa K, Saga S, Yamada T, Kure S, Matsui T, Uemura T, Fujimitsu Y, Sakakibara M, Kodera Y, Kojima H BACKGROUND: Recently, several authors reported on the Protein Chip approach to analyze serum. They used SELDI-TOF-MS (surface enhanced laser desorption/ionization-time of flight-mass spectrometry) t ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-118.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Detection of elevated proteins in peritoneal dissemination of gastric cancer by analyzing mass spectra data of serum proteins. J Surg Res. 2009 Jul;155(1):13-7 Authors: Kojima T, Yoshikawa K, Saga S, Yamada T, Kure S, Matsui T, Uemura T, Fujimitsu Y, Sakakibara M, Kodera Y, Kojima H BACKGROUND: Recently, several authors reported on the Protein Chip approach to analyze serum. They used SELDI-TOF-MS (surface enhanced laser desorption/ionization-time of flight-mass spectrometry) to identify patients with cancers of various origins in a highly sensitive and specific manner. In the current study, a similar approach was employed to analyze the serum of patients with various stages of gastric cancer. METHODS: Control serum specimens from patients with gastritis (n = 19) and those with gastric cancer (Stage I: n = 6, Stage II or III: n = 6, Stage IV: n = 6, total: n = 18) were collected and analyzed by the Protein Chip biomarker system (Bio-Rad, Japan), a platform for SELDI-TOF-MS, and protein profiles were obtained and compared. The cation exchange chip (CM10) and the anion exchange chip (Q10) were used for processing before TOF-MS. RESULTS: nine proteins were significantly over-expressed (P < 0.05, Student t-test) in patients with gastric cancer compared to patients with gastritis. Among them, four protein masses with 2929 m/z, 3293 m/z, 3371 m/z, and 4213 m/z were found to be differentially expressed solely in patients suffering from peritoneal dissemination. All peaks were processed on CM10 chips. Employing one data mining method, CART (classification and regression trees), gastric cancer patients with peritoneal dissemination were successfully separated from those who had no peritoneal seeding. CONCLUSION: A validation study with a larger number of samples is mandatory; however, the detected peaks here might be candidates for biomarkers of peritoneal dissemination and/or gastric cancer. Moreover, further analysis of these four proteins might be helpful in revealing the mechanism of peritoneal dissemination, which at present has no cure. PMID: 19394641 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The Lucid Proteomics System for top-down biomarker research.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-200.html</link>
      <description> Related Articles The Lucid Proteomics System for top-down biomarker research. Arch Physiol Biochem. 2010 May 28; Authors: Jourdain S, Bulman A, Dalmasso E Advances have been made in recent years for both &quot;top-down&quot; and &quot;bottom-up&quot; profiling approaches to biomarker discovery. Top-down protein profiling via SELDI-TOF mass spectrometry has been used by researchers in many fields of study to discover native protein biomarker candidates from a variety of sample types, but has been limited without a  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-200.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles The Lucid Proteomics System for top-down biomarker research. Arch Physiol Biochem. 2010 May 28; Authors: Jourdain S, Bulman A, Dalmasso E Advances have been made in recent years for both "top-down" and "bottom-up" profiling approaches to biomarker discovery. Top-down protein profiling via SELDI-TOF mass spectrometry has been used by researchers in many fields of study to discover native protein biomarker candidates from a variety of sample types, but has been limited without a means for straightforward identification of these candidates. Bio-Rad has recently partnered with Bruker Daltonics to create the Lucid Proteomics System, a complete SELDI-based research workflow - system qualification, biomarker discovery, data analysis, and biomarker purification/identification - using Bruker's flex series of TOF and TOF/TOF mass spectrometers, which have long provided consistent performance and high value data for MALDI applications. This collaboration enables both top-down and bottom-up proteomics approaches on a single high performance MALDI-TOF MS platform for maximum coverage of the proteome - allowing greater flexibility with experimental design and accelerating biomarker research programmes. PMID: 20507259 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳： 関連の記事トップダウンのbiomarkerの研究のためのProteomics透明なシステム。 アーチのPhysiol Biochem。 5月2010日28日; 著者: Jourdain S、Bulman AのDalmasso Eの前進は「トップダウン」および「上昇形」のために近年作られbiomarkerの発見へのアプローチの側面図を描く。 SELDI-TOFの質量分析によって側面図を描くトップダウン蛋白質が多くの研究分野で研究者によっていろいろなサンプルタイプからの原産蛋白質のbiomarkerの候補者を発見するのに使用されていたがなしでこれらの候補者の簡単な同一証明のための手段限られた。 生物ラドはBruker Daltonicsと-をBrukerのMALDIの適用に長く堅実なパーフォーマンスおよび高い値データを提供してしまった屈曲の一連のTOFおよびTOF/TOFの質量分析計を使用して…最近Proteomics透明なシステム、完全なSELDI基づかせていた研究のワークフロー-システム資格、biomarkerの発見、データ解析およびbiomarkerの浄化または同一証明作成するために組んでしまった。 この共同はproteomeの最高の適用範囲-実験設計のより大きい柔軟性を許可し、biomarkerの研究計画を加速することのための単一の高性能MALDI-TOF MSのプラットホームのトップダウンおよび上昇形proteomicsのアプローチを可能にする。 PMID: -出版業者によって供給される… 20507259 [PubMed）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-134.html</link>
      <description>Related Articles Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS. Oncol Rep. 2009 Jul;22(1):205-13 Authors: Gast MC, Van Gils CH, Wessels LF, Harris N, Bonfrer JM, Rutgers EJ, Schellens JH, Beijnen JH In search for novel markers for breast cancer, we aimed to identify and validate novel serum protein profiles specific for breast cancer, and assess the influence of clinical (subjects age) and pre-analytical (sample storage duration) variables on the constructed classifie ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-134.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS. Oncol Rep. 2009 Jul;22(1):205-13 Authors: Gast MC, Van Gils CH, Wessels LF, Harris N, Bonfrer JM, Rutgers EJ, Schellens JH, Beijnen JH In search for novel markers for breast cancer, we aimed to identify and validate novel serum protein profiles specific for breast cancer, and assess the influence of clinical (subjects age) and pre-analytical (sample storage duration) variables on the constructed classifiers. To this end, sera of breast cancer patients (n=152) and healthy controls (n=129), randomly divided into a training and test set, were analysed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS). In the training set, 14 peak clusters were found to differ significantly in expression between cases and controls. None of the peak clusters were influenced by subjects age and sample storage duration. Ten peak clusters were also found significantly discriminative in the test set. Peak clusters were structurally identified as C3a des-arginine anaphylatoxin, (tentative) inter-alpha-trypsin inhibitor heavy chain 4 fragments and a fibrinogen fragment. Logistic regression analyses on the training set yielded a classification model with a moderate performance on the test set, corresponding to those reported in previously performed validation studies. Most likely originating from the highly heterogeneous nature of breast cancer, selection of breast cancer subgroups for comparison with healthy controls is expected to improve results of future diagnostic SELDI-TOF MS studies. PMID: 19513525 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：SELDI-TOF氏Repを使用してOncol乳癌の診断のために側面図を描く関連の記事の血清蛋白質。 7月2009日; 22 (1): 205-13書く: Gast MC、ヴァンGils CH、Wessels LF、ハリスN、Bonfrer JM、Rutgers EJ、Schellens JH、乳癌の新しいマーカーの調査のBeijnen JH、私達は乳癌のために特定の新しい血清蛋白質のプロフィールを識別し、認可することを向け組み立てられた助数詞の臨床(主題の年齢)および前分析的な(サンプル貯蔵の持続期間の)変数の影響を査定する。 これを受けて、乳癌患者(n=152)および任意に訓練およびテストセットに分けられた表面高められたレーザーの脱着またはイオン化時間の飛行質量分析(SELDI-TOF MS)によって健康な制御(n=129)の血清は、分析された。 訓練セットでは、14のピーク集りは場合と制御間の表現でかなり異なると見つけられた。 ピーク集りのどれも主題によって老化し、見本抽出する貯蔵の持続期間を影響を及ぼされなかった。 10のピーク集りはまたテストセットでかなり区別的見つけられた。 ピーク集りはC3aのdesアルギニンanaphylatoxinとして構造的に、(一時的な)内側アルファトリプシンの抑制剤の重鎖4の片およびフィブリノゲンの片識別された。 訓練セットの記号論理学の回帰分析は前に行われた確認の調査で報告されたそれらに相当してテストセットの適当な性能の分類モデルを、もたらした。 たぶん乳癌の非常に異質性質から起きて、健康な制御を用いる比較のための乳癌小群の選択は未来の診断SELDI-TOF MSの調査の結果を改善すると期待される。 PMID: 19513525 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-201.html</link>
      <description>Related Articles Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry. Oncol Rep. 2010 Jul;24(1):57-64 Authors: Helgason HH, Engwegen JY, Zapatka M, Vincent A, Cats A, Boot H, Beijnen JH, Schellens JH Colorectal cancer (CRC) is the second most common cause of cancer related death. Prognosis is highly dependent on stage at diagnosis making early detection mandatory. This study ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-201.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry. Oncol Rep. 2010 Jul;24(1):57-64 Authors: Helgason HH, Engwegen JY, Zapatka M, Vincent A, Cats A, Boot H, Beijnen JH, Schellens JH Colorectal cancer (CRC) is the second most common cause of cancer related death. Prognosis is highly dependent on stage at diagnosis making early detection mandatory. This study aimed to identify novel disease specific biomarkers of CRC, validate our previously identified biomarkers of CRC and identify serum biomarkers predicting treatment response and for monitoring. Serum of patients with metastatic CRC was collected, according to a predefined schedule, prior to start of standard first-line chemotherapy with oxaliplatin and capecitabine and serially before each 3 weekly treatment cycle and analyzed for proteomic profile by standardized SELDI-TOF MS. Serum proteomic mass spectrometry data of all subjects were processed using the tbimass R-package and proteomic profiles of CRC patients were compared with those of matched normal control subjects. Furthermore, changes in proteomic profiles during the course of chemotherapy were recorded according to treatment response. In total, 42 patients with advanced CRC were treated and mean follow-up was 13.5 months. The response rate was 50% and the median overall survival 19.5 months (95% CI: 16-23). By comparing CRC patients and healthy controls we identified 13 potential biomarkers of CRC (m/z 2.0-31.9 kDa) whereas two proteins, m/z 14060 and 28100 Da (apolipoprotein A-I), were highly significant (p<0.0001). Comparison of responding and non-responding patients identified 6 proteins potentially predicting response, where of m/z 3330 Da was significant (p=0.007). Serial analysis identified 2 proteins, m/z 2022 and 28100 Da, that changed during chemotherapy in accordance with response. We identified 13 m/z values discriminating between CRC patients and healthy controls, including the previously identified apolipoprotein A-I as a candidate biomarker for CRC and treatment monitoring. PMID: 20514444 [PubMed - in process]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Identification of potential serum markers for endometrial cancer using protein expression profiling.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-150.html</link>
      <description> Related Articles Identification of potential serum markers for endometrial cancer using protein expression profiling. J Cancer Res Clin Oncol. 2010 Mar;136(3):475-81 Authors: Takano M, Kikuchi Y, Asakawa T, Goto T, Kita T, Kudoh K, Kigawa J, Sakuragi N, Sakamoto M, Sugiyama T, Yaegashi N, Tsuda H, Seto H, Shiwa M OBJECTIVES: Screening method of endometrial cancer (EC) has not been established yet. Our study was to explore serum biomarkers of EC patients using surface-enhanced laser desorption a ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-150.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Identification of potential serum markers for endometrial cancer using protein expression profiling. J Cancer Res Clin Oncol. 2010 Mar;136(3):475-81 Authors: Takano M, Kikuchi Y, Asakawa T, Goto T, Kita T, Kudoh K, Kigawa J, Sakuragi N, Sakamoto M, Sugiyama T, Yaegashi N, Tsuda H, Seto H, Shiwa M OBJECTIVES: Screening method of endometrial cancer (EC) has not been established yet. Our study was to explore serum biomarkers of EC patients using surface-enhanced laser desorption and ionization-time-of-flight mass spectrometry (SELDI-TOF MS). METHODS: Serum samples from 65 EC patients and 40 controls were analyzed by SELDI-TOF MS (training set). Single- and multi-variant analyses were performed to compare protein profiles in serum of EC patients and healthy controls. Subsequently, blind test set including 40 EC patients and 40 controls were analyzed for validation. RESULTS: A panel of four biomarker candidates were selected in training set analysis. These markers could also distinguish stage I patients from controls. Among them, two biomarkers were purified and identified as apolipoprotein A1 and a modified form of apolipoprotein C1. Screening for blind test set using dual-biomarker analysis yielded a sensitivity of 82% and a specificity of 86%. CONCLUSIONS: Involvement of apolipoproteins with EC is first suggested in this study. In addition to possibility of screening method for EC, findings of these new biomarkers might be related with carcinogenesis or predisposition to EC. PMID: 19756734 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： 蛋白質の表現の側面図を描くことを使用してendometrial癌のための潜在的な血清のマーカーの関連の記事の同一証明。 Jの蟹座Res Clin Oncol。 3月2010日; 136 (3): 475-81書く: Takano M、Kikuchi Y、Asakawa T、主力のT、Kita T、Kudoh K、Kigawa J、Sakuragi N、Sakamoto M、Sugiyama T、Yaegashi N、Tsuda H、Seto HのShiwa Mの目的: endometrial癌(欧州共同体)の選別法はまだ確立されていない。 私達の調査は表面高められたレーザーの脱着およびイオン化時間の飛行質量分析(SELDI-TOF MS)を使用している欧州共同体の患者の血清のbiomarkersを探検することだった。 方法: 65人の欧州共同体の患者および40の制御からの血清のサンプルはSELDI-TOF MS (置かれる訓練)によって分析された。 単一およびmulti-variant分析は欧州共同体の患者および健康な制御の血清の蛋白質のプロフィールを比較するために行われた。 続いて、40人の欧州共同体の患者を含む盲目テストセットおよび40の制御は確認のために分析された。 結果: 4人のbiomarkerの候補者のパネルは訓練の一定の分析で選ばれた。 これらのマーカーはまた制御と段階Iの患者を区別できる。 その中で、2 biomarkersはようにapolipoprotein A1およびapolipoprotein C1の変更された形態浄化され、識別した。 二重biomarker分析を使用して盲目テストセットのためのスクリーニングは82%の感受性および86%の特定性をもたらした。 結論: 欧州共同体を用いるapolipoproteinsの介入はこの調査で最初に提案される。 欧州共同体のための選別法の可能性に加えて、これらの新しいbiomarkersの調査結果は欧州共同体と発癌か性質と関連しているかもしれない。 PMID: 19756734 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-202.html</link>
      <description>Related Articles Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents. Nephrol Dial Transplant. 2010 Jun 10; Authors: Tessitore N, Girelli D, Campostrini N, Bedogna V, Pietro Solero G, Castagna A, Melilli E, Mantovani W, De Matteis G, Olivieri O, Poli A, Lupo A BACKGROUND: It has been suggested that hepcidin may be useful as a tool for managing iron therapy in haemodialysis (HD) patients on erythropoiesis-stimulating agen ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-202.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents. Nephrol Dial Transplant. 2010 Jun 10; Authors: Tessitore N, Girelli D, Campostrini N, Bedogna V, Pietro Solero G, Castagna A, Melilli E, Mantovani W, De Matteis G, Olivieri O, Poli A, Lupo A BACKGROUND: It has been suggested that hepcidin may be useful as a tool for managing iron therapy in haemodialysis (HD) patients on erythropoiesis-stimulating agents (ESA). METHODS: We used SELDI-TOF mass spectrometry assay to measure serum hepcidin-25 (Hep-25) and hepcidin-20 (Hep-20) in 56 adult HD patients on maintenance ESA to assess their ability to predict haemoglobin (Hb) response after 1 g intravenous iron (62.5 mg ferric gluconate at 16 consecutive dialysis sessions) and their relationship with markers of iron status, inflammation and erythropoietic activity. RESULTS: At multivariate analysis (in a model that also included Hb, reticulocyte, ESA dose, HFE genotype, soluble transferrin receptor [sTfR] and C-reactive protein), Hep-25 independently correlated with ferritin (beta = 0.03, P = 0.01) and the percentage of hypochromic red blood cells [%Hypo] (beta = 1.84, P = 0.01), suggesting that Hep-25 may be a useful biomarker for iron stores and bone marrow iron availability. Hep-20 correlated independently with Hep-25 (beta = 0.159, P < 0.001) and ferritin (beta = 0.006, P = 0.05), suggesting that it may be a useful additional biomarker for iron stores. On receiver operating characteristics curve analysis, neither Hep-25 nor Hep-20 significantly predicted who will increase their Hb after iron loading (AUC = 0.52 +/- 0.09 and 0.54 +/- 0.08, P = 0.612), and the same applied to ferritin and transferrin saturation (AUC = 0.55 +/- 0.08 and 0.59 +/- 0.08, P = 0.250), whereas %Hypo and reticulocyte Hb content were significant predictors (AUC = 0.84 +/- 0.05 and 0.70 +/- 0.08, P < 0.01). At multivariate logistic regression analysis, %Hypo was the only biomarker independently associated with iron responsiveness. CONCLUSIONS: Although our study suggests an important role for hepcidin in regulating iron homeostasis in HD patients on ESA, our findings do not support its utility as a predictor of iron needs, offering no advantage over established markers of iron status. PMID: 20538788 [PubMed - as supplied by publisher]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>An integrative multi-platform analysis for discovering biomarkers of osteosarcoma.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-126.html</link>
      <description> Related Articles An integrative multi-platform analysis for discovering biomarkers of osteosarcoma. BMC Cancer. 2009;9:150 Authors: Li G, Zhang W, Zeng H, Chen L, Wang W, Liu J, Zhang Z, Cai Z BACKGROUND: SELDI-TOF-MS (Surface Enhanced Laser Desorption/Ionization-Time of Flight-Mass Spectrometry) has become an attractive approach for cancer biomarker discovery due to its ability to resolve low mass proteins and high-throughput capability. However, the analytes from mass spectrometry are describ ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-126.html</guid>
        
      <content:encoded> <![CDATA[
      Related Articles An integrative multi-platform analysis for discovering biomarkers of osteosarcoma. BMC Cancer. 2009;9:150 Authors: Li G, Zhang W, Zeng H, Chen L, Wang W, Liu J, Zhang Z, Cai Z BACKGROUND: SELDI-TOF-MS (Surface Enhanced Laser Desorption/Ionization-Time of Flight-Mass Spectrometry) has become an attractive approach for cancer biomarker discovery due to its ability to resolve low mass proteins and high-throughput capability. However, the analytes from mass spectrometry are described only by their mass-to-charge ratio (m/z) values without further identification and annotation. To discover potential biomarkers for early diagnosis of osteosarcoma, we designed an integrative workflow combining data sets from both SELDI-TOF-MS and gene microarray analysis. METHODS: After extracting the information for potential biomarkers from SELDI data and microarray analysis, their associations were further inferred by link-test to identify biomarkers that could likely be used for diagnosis. Immuno-blot analysis was then performed to examine whether the expression of the putative biomarkers were indeed altered in serum from patients with osteosarcoma. RESULTS: Six differentially expressed protein peaks with strong statistical significances were detected by SELDI-TOF-MS. Four of the proteins were up-regulated and two of them were down-regulated. Microarray analysis showed that, compared with an osteoblastic cell line, the expression of 653 genes was changed more than 2 folds in three osteosarcoma cell lines. While expression of 310 genes was increased, expression of the other 343 genes was decreased. The two sets of biomarkers candidates were combined by the link-test statistics, indicating that 13 genes were potential biomarkers for early diagnosis of osteosarcoma. Among these genes, cytochrome c1 (CYC-1) was selected for further experimental validation. CONCLUSION: Link-test on datasets from both SELDI-TOF-MS and microarray high-throughput analysis can accelerate the identification of tumor biomarkers. The result confirmed that CYC-1 may be a promising biomarker for early diagnosis of osteosarcoma. PMID: 19445706 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Application of SELDI-TOF-MS in establishing a model for predicting radiotherapy response of hypopharyngeal cancers.]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-203.html</link>
      <description>Related Articles [Application of SELDI-TOF-MS in establishing a model for predicting radiotherapy response of hypopharyngeal cancers.] Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jun;30(6):1282-7 Authors: Tian WD, Zeng ZY, Yu WB, Li XP OBJECTIVE: To detect the serum proteomic fingerprints in patients with hypopharyngeal squamous cell carcinoma (HPSCC) by surface enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS) protein chip array technique. METHODS: The serum samples w ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-203.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Application of SELDI-TOF-MS in establishing a model for predicting radiotherapy response of hypopharyngeal cancers.] Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jun;30(6):1282-7 Authors: Tian WD, Zeng ZY, Yu WB, Li XP OBJECTIVE: To detect the serum proteomic fingerprints in patients with hypopharyngeal squamous cell carcinoma (HPSCC) by surface enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS) protein chip array technique. METHODS: The serum samples were obtained from 58 HPSCC patients for protein expression analysis using SELDI-TOF Protein Chip technique and cation-exchange (CM10) protein array. All the spectra were compared and the qualified mass peaks with mass-to-charge ratios (m/z) between 1 and 70 kD were autotimatically detected. The tree analysis pattern was generated using Biomarker Patterns Software. RESULTS: The protein profiles of HPSCC serum were analyzed according to the clinical and pathological features of the patients and their treatment response. No significant difference was noted in the serum proteins between HPSCC patients with different statuses of cervical lympha node metastasis (P>0.05), and the difference between well differentiated and poorly differentiated HPSCC was only minor. No significant difference was found in the serum proteins between chemotherapy-sensitive patients and the insensitive patients (P>0.05), but 5 proteins were identified to be overexpressed in the sensitive patients (P</=0.05). Radiotherapy-sensitive HPSCC patients were segregated from the insensitive group with a sensitivity of 86.67% and specificity of 100%. CONCLUSION: The serum protein at the m/z value of 6115.74 is overexpressed in radiotherapy-sensitive HPSCC patients. Serum protein profiling allows the prediction of radiotherapy response in HPSCC patients, and the identified proteins may serve as candidate biomarkers for predicting the radiotherapy sensitivity of HPSCC. PMID: 20584658 [PubMed - in process]（【斜め読み用】機械翻訳：）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteomic Helicobacter pylori biomarkers discriminating between duodenal ulcer and gastric cancer.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-110.html</link>
      <description> Related Articles Proteomic Helicobacter pylori biomarkers discriminating between duodenal ulcer and gastric cancer. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 15;877(11-12):1193-9 Authors: Khoder G, Yamaoka Y, FauchÃ¨re JL, Burucoa C, Atanassov C Protein patterns of 129 Helicobacter pylori strains isolated from Korean and Colombian patients suffering from duodenal ulcer or gastric cancer were analyzed by the high-throughput methodology SELDI-TOF-MS. Eighteen statistically signif ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-110.html</guid>
        
      <content:encoded> <![CDATA[
     Related Articles Proteomic Helicobacter pylori biomarkers discriminating between duodenal ulcer and gastric cancer. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 15;877(11-12):1193-9 Authors: Khoder G, Yamaoka Y, FauchÃ¨re JL, Burucoa C, Atanassov C Protein patterns of 129 Helicobacter pylori strains isolated from Korean and Colombian patients suffering from duodenal ulcer or gastric cancer were analyzed by the high-throughput methodology SELDI-TOF-MS. Eighteen statistically significant candidate biomarkers discriminating between the two clinical outcomes were selected by using the Mann-Whitney test. Three biomarker proteins were purified and identified as a neutrophil-activating protein NapA (HU HPAG1_0821), a RNA-binding protein (HPAG1_0813), and a DNA-binding histone-like protein HU, respectively (jhp0228). These novel biomarkers can be used for development of diagnostic assays predicting the evolution to gastric cancer in H. pylori-infected patients. PMID: 19328750 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳： duodenal潰瘍と胃癌の間で区別する関連の記事のProteomic Helicobacterの幽門のbiomarkers。 J Chromatogr B Analyt Technol Biomedの生命Sci。 4月2009日15日; 877 (11-12): 1193-9書く: Khoder G、Yamaoka Y、FauchÃ¨re JL、Burucoa Cのduodenal潰瘍か胃癌に苦しんでいる高効率の方法SELDI-TOF-MSによって韓国およびコロンビアの患者から隔離された129のHelicobacterの幽門の緊張のAtanassov C蛋白質パターンは分析された。 2臨床結果の間で区別する18統計的に重要な候補者のbiomarkersはMann-Whitneyテストの使用によって選ばれた。 3つのbiomarker蛋白質は、それぞれ浄化され、好中球活動化蛋白質NapA (HU HPAG1_0821)、RNA結合蛋白質(HPAG1_0813)、そして蛋白質HUヒストンのようにDNA結合として識別し(jhp0228)。 これらの新しいbiomarkersはH.によって幽門感染させる患者で胃癌への進化を予測する診断試金の開発に使用することができる。 PMID: 19328750 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Screening and identification analysis of serum protein biomarkers in nephroblastoma]</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-142.html</link>
      <description>Related Articles [Screening and identification analysis of serum protein biomarkers in nephroblastoma] Zhonghua Yi Xue Za Zhi. 2009 May 12;89(18):1259-63 Authors: Wang JX, Yang SB, Liu QL, Dong R, Fan YX, Zhang Q, Yang FQ, Wu P, Yu JK, Zheng S OBJECTIVE: To screen and characterize the serum protein biomarkers in nephroblastoma so as to establish the proteins as the specific serum biomarkers for diagnosis and prognosis monitoring. METHODS: The differential protein peaks were located by detecting  ...</description>
        <pubDate>Tue, 13 Jul 2010 01:00:07 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-142.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles [Screening and identification analysis of serum protein biomarkers in nephroblastoma] Zhonghua Yi Xue Za Zhi. 2009 May 12;89(18):1259-63 Authors: Wang JX, Yang SB, Liu QL, Dong R, Fan YX, Zhang Q, Yang FQ, Wu P, Yu JK, Zheng S OBJECTIVE: To screen and characterize the serum protein biomarkers in nephroblastoma so as to establish the proteins as the specific serum biomarkers for diagnosis and prognosis monitoring. METHODS: The differential protein peaks were located by detecting serum samples of preoperative and postoperative patients and normal children using the SELDI-TOF MS technology. After purification, the differential proteins were further analyzed by LC-MS/MS and the protein sequences searched in database. RESULTS: Two peaks with m/z of 6455.5 and 6984.4 were selected as potential biomarkers. They were weakly expressed in nephroblastoma (intensity: 1029 +/- 364, 297 +/- 126) but highly expressed in normal individuals (2108 +/- 837, 753 +/- 226); another peak with m/z of 9190.8 was weakly expressed in preoperative sera (283 +/- 154) but highly expressed in serum samples of postoperative patients and normal children (5974 +/- 657, 6231 +/- 519). The protein at 6455.5 and 9190.8 were identified as apolipoprotein C-III and haptoglobin respectively. CONCLUSION: The detection of differentially expressed apolipoprotein C-III and haptoglobin may have potential utilities for serum diagnosis, malignancy classification and prognosis monitoring of nephroblastoma and is worthy of further studies and applications. PMID: 19595180 [PubMed - indexed for MEDLINE]（【斜め読み用】機械翻訳：関連の記事[nephroblastomaの血清蛋白質のbiomarkersのスクリーニングおよび同一証明の分析] ZhonghuaイXue Za Zhi。 5月2009日12日; 89 (18): 1259-63書く: Wang JXのヤンのSB、劉QL、東RのファンYX、チャンQ、ヤンFQ、ウーP、Yu JKのZheng Sの目的: nephroblastomaの血清蛋白質のbiomarkersを特徴付けるため診断および予想の監視のための特定の血清のbiomarkersとして蛋白質を確立するために選別し。 方法: 差動蛋白質のピークは術前およびpostoperative患者およびSELDI-TOF MSの技術を使用している正常な子供の血清のサンプルの検出によってあった。 浄化の後で、差動蛋白質はLC-MS/MSによって更に分析され、蛋白質順序はデータベースで捜された。 結果: 6455.5および6984.4のm/zの2つのピークは潜在的なbiomarkersとして選ばれた。 それらはnephroblastoma (強度に弱く表現された: 1029年+/- 364、297 +/- 126)しかし正常な個人(2108 +/- 837、753 +/- 226)に非常に表現されて; 9190.8のm/zの別のピークは術前の血清(283 +/- 154)に弱く表現されたりしかしpostoperative患者および正常な子供(5974 +/- 657、6231 +/- 519)の血清のサンプルに非常に表現された。 6455.5の蛋白質および9190.8はそれぞれapolipoprotein C-IIIおよびhaptoglobinとして識別された。 結論: 特異的に表現されたapolipoprotein C-IIIおよびhaptoglobinの検出にnephroblastomaの血清の診断、敵意の分類および予想の監視のための潜在的な実用性があるかもしれ、それ以上の調査および適用の価値がある。 PMID: 19595180 [MEDLINEのために指示されるPubMed -）
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Measurement of waist circumference at four different sites in children, adolescents, and young adults: concordance and correlation with nutritional status as well as cardiometabolic risk factors.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-221.html</link>
      <description> Related Articles Measurement of waist circumference at four different sites in children, adolescents, and young adults: concordance and correlation with nutritional status as well as cardiometabolic risk factors. Obes Facts. 2008;1(5):243-9 Authors: Hitze B, Bosy-Westphal A, Bielfeldt F, Settler U, MÃ¶nig H, MÃ?ller MJ BACKGROUND: This study investigates the concordance of four waist circumference (WC) measurement sites, and examines their relationships with nutritional status and cardiome ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:31 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-221.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Measurement of waist circumference at four different sites in children, adolescents, and young adults: concordance and correlation with nutritional status as well as cardiometabolic risk factors.
        Obes Facts. 2008;1(5):243-9
        Authors:  Hitze B, Bosy-Westphal A, Bielfeldt F, Settler U, MÃ¶nig H, MÃ?ller MJ
        BACKGROUND: This study investigates the concordance of four waist circumference (WC) measurement sites, and examines their relationships with nutritional status and cardiometabolic risk. SUBJECTS AND METHODS: In 91 females / 89 males (6.1-19.9 years; 12.2% overweight), WC was assessed beneath the lowest rib (WCR), 4 cm above the umbilicus (WC4), above the iliac crest (WCC), and midway between WCR/WCC (WCM). 'Overwaist' was defined as a WC > 90th age-/sex-specific percentile. Pubertal stage was assessed according to Tanner. Body composition (air-displacement plethysmography), blood pressure, lipid profile, glucose/insulin levels, and HOMA-IR (homeostasis model assessment of insulin resistance) were measured. RESULTS: Medians of WCs (cm) for females/males were WCR (64.4/69.5) < WC4 (64.6/70.2) < WCM (67.1/71.2) < WCC (71.5/ 74.2). Although closely related to each other (all r > 0.93; p < 0.001), paired comparisons revealed differences between WCs in their magnitudes which was stronger for females than males. Prevalence of 'overwaist' differed according to measurement site in females/males: WCR (13.2/15.7%) < WC4 (14.3/ 19.1%) < WCM (18.7/22.5%) < WCC (37.4/30.3%). After adjusting for age and pubertal status, WCs were closely related to body mass index (BMI) (all r > 0.86; p < 0.001), percent fat mass (%FM; all r > 0.61; p < 0.001), and comparably associated with cardiometabolic risk factors. However, stronger correlations were found for i) WCR vs. WC4 with BMI in males (r = 0.93 vs. 0.91; p < 0.05), ii) WCC vs. WC4 with %FM in females (r = 0.67 vs. 0.61; p < 0.05), iii) WCC vs. WCR with triglycerides in females (r = 0.29 vs. r = 0.22; p < 0.05), and iv) WCC (r = 0.36) vs. other WCs (r = 0.30-0.32) with low-density lipoprotein cholesterol (LDL-C) in males (p < 0.05). CONCLUSION: WCs measured at different sites were closely correlated with BMI and %FM as well as comparably associated with cardiometabolic risk factors. However, different WCs had different magnitudes, which was more obvious in females and led to discordant results with respect to 'overwaist' and risk assessment.
        PMID: 20054185 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Doxorubicin attached to HPMA copolymer via amide bond modifies the glycosylation pattern of EL4 cells.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-226.html</link>
      <description> Related Articles Doxorubicin attached to HPMA copolymer via amide bond modifies the glycosylation pattern of EL4 cells. Tumour Biol. 2010 Aug;31(4):233-42 Authors: Kovar L, Etrych T, Kabesova M, Subr V, Vetvicka D, Hovorka O, Strohalm J, Sklenar J, Chytil P, Ulbrich K, Rihova B To avoid the side effects of the anti-cancer drug doxorubicin (Dox), we conjugated this drug to a N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer backbone. Dox was conjugated via an amide bond (Dox-HPMA(AM), PK1) or a ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:31 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-226.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Doxorubicin attached to HPMA copolymer via amide bond modifies the glycosylation pattern of EL4 cells.
        Tumour Biol. 2010 Aug;31(4):233-42
        Authors:  Kovar L, Etrych T, Kabesova M, Subr V, Vetvicka D, Hovorka O, Strohalm J, Sklenar J, Chytil P, Ulbrich K, Rihova B
        To avoid the side effects of the anti-cancer drug doxorubicin (Dox), we conjugated this drug to a N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer backbone. Dox was conjugated via an amide bond (Dox-HPMA(AM), PK1) or a hydrazone pH-sensitive bond (Dox-HPMA(HYD)). In contrast to Dox and Dox-HPMA(HYD), Dox-HPMA(AM) accumulates within the cell's intracellular membranes, including those of the Golgi complex and endoplasmic reticulum, both involved in protein glycosylation. Flow cytometry was used to determine lectin binding and cell death, immunoblot to characterize the presence of CD7, CD43, CD44, and CD45, and high-performance anion exchange chromatography with pulsed amperometric detector analysis for characterization of plasma membrane saccharide composition. Incubation of EL4 cells with Dox-HPMA(AM) conjugate, in contrast to Dox or Dox-HPMA(HYD), increased the amounts of membrane surface-associated glycoproteins, as well as saccharide moieties recognized by peanut agglutinin, Erythrina cristagalli, or galectin-1 lectins. Only Dox-HPMA(AM) increased expression of the highly glycosylated membrane glycoprotein CD43, while expression of others (CD7, CD44, and CD45) was unaffected. The binding sites for galectin-1 are present on CD43 molecule. Furthermore, we present that EL4 treated with Dox-HPMA(AM) possesses increased sensitivity to galectin-1-induced apoptosis. In this study, we demonstrate that Dox-HPMA(AM) treatment changes glycosylation of the EL4 T cell lymphoma surface and sensitizes the cells to galectin-1-induced apoptosis.
        PMID: 20556593 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Adiposity measures as indicators of metabolic risk factors in adolescents.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-223.html</link>
      <description> Related Articles Adiposity measures as indicators of metabolic risk factors in adolescents. Obes Facts. 2009;2(5):294-301 Authors: Neovius M, Rossner SM, VÃ?gstrand K, von Hausswolff-Juhlin YL, Hoffstedt J, Ekelund U AIM: To examine the relation between adiposity assessment methods (percentage body fat (%BF), BMI, and waist circumference (WC)) and individual metabolic risk factors (f-insulin, HDL cholesterol, triglycerides) and a combined measure of metabolic risk. METHODS: Crosssectional stu ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:31 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-223.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Adiposity measures as indicators of metabolic risk factors in adolescents.
        Obes Facts. 2009;2(5):294-301
        Authors:  Neovius M, Rossner SM, VÃ?gstrand K, von Hausswolff-Juhlin YL, Hoffstedt J, Ekelund U
        AIM: To examine the relation between adiposity assessment methods (percentage body fat (%BF), BMI, and waist circumference (WC)) and individual metabolic risk factors (f-insulin, HDL cholesterol, triglycerides) and a combined measure of metabolic risk. METHODS: Crosssectional study of 300 males (BMI 20.8 +/- 3.0 kg/m(2)) and females (BMI 21.3 +/- 2.9 kg/m(2)) 17 years of age. F-insulin and components of the metabolic syndrome defined by the International Diabetes Federation (IDF) were used as metabolic risk indicators, with samples stratified into BMI, %BF, and WC groups, respectively. Diagnostic accuracy was expressed as the area under the ROC curve (AUC). RESULTS: In males, diagnostic accuracy for HDL and f-insulin was poor to fair for BMI (AUC 0.70, p = 0.001; 0.60, p = 0.22), WC (0.68, p = 0.003; 0.63, p = 0.11), and %BF (0.65, p = 0.009; 0.66, p = 0.04). The diagnostic accuracy for triglycerides was greater for all three measures (BMI 0.92, WC 0.95, %BF 0.87; all p < 0.001). For females, neither test performed better than chance for f-insulin and HDL, and only %BF performed better than chance for triglycerides (0.65, p = 0.08). All three measures exhibited higher accuracy for presence of > or =2 metabolic risk factors (AUCs 0.76-0.91, p < 0.001) in both sexes. CONCLUSION: %BF was not superior to BMI and WC for detecting metabolic risk in the general adolescent population.
        PMID: 20057196 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Co-distribution of glycoconjugates and H(+), K(+)-ATPase in the parietal cells of the greater horseshoe bat, Rhinolophus ferrumequinum (Schreber, 1774).</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-225.html</link>
      <description>Related Articles Co-distribution of glycoconjugates and H(+), K(+)-ATPase in the parietal cells of the greater horseshoe bat, Rhinolophus ferrumequinum (Schreber, 1774). Zoolog Sci. 2010 May;27(5):433-9 Authors: Scillitani G, Mastrodonato M, Liquori GE, Ferri D Histochemical, lectin-histochemical, and immunohistochemical analyses were performed on parietal cells of the greater horseshoe bat, Rhinolophus ferrumequinum, to clarify the composition and distribution of oligosaccharide chains in the b ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:31 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-225.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Co-distribution of glycoconjugates and H(+), K(+)-ATPase in the parietal cells of the greater horseshoe bat, Rhinolophus ferrumequinum (Schreber, 1774).
        Zoolog Sci. 2010 May;27(5):433-9
        Authors:  Scillitani G, Mastrodonato M, Liquori GE, Ferri D
        Histochemical, lectin-histochemical, and immunohistochemical analyses were performed on parietal cells of the greater horseshoe bat, Rhinolophus ferrumequinum, to clarify the composition and distribution of oligosaccharide chains in the beta-subunit of the protonic pump H(+),K(+)-ATPase. PAS, Alcian Blue (pH 2.5) and Alcian Blue (pH 1.0) stainings detected only neutral glycoconjugates. Lectin-binding analyses included LTA, UEA-I, ConA, SBA, BSI-B4, AAA, DBA, PNA, and WGA. WGA-and PNA-bindings were also tested after beta-elimination to detect O-linked glycans. Parietal cells were negative for binding to LTA and UEA-I, and to PNA and WGA after beta-elimination, indicating the lack of (1,2) fucosylated residues and of N-linked glycans, respectively. Immunohistochemical tests with anti-alpha- and anti-beta-H(+),K(+)-ATPase were positive. Two alternative patterns of glycoconjugate distribution were found, i.e. a perinuclear and a diffuse one, indicating localization in the intracellular canaliculus and in the tubulovesicular system of the parietal cells, respectively. Both the subunits of the H(+),K(+)-ATPase and the galactosyl/galactosaminyl residues were co-distributed in both the perinuclear and the diffuse patterns, suggesting that the residues are part of the protonic pump. Glycosyl/glycosaminyl and mannosyl groups were concentrated in the tubulovesicular system, and fucosylated residues were found almost exclusively in the intracellular canaliculi; thus they are probably not included in the oligosaccharide chains of beta-H(+),K(+)-ATPase. These findings indicate that the oligosaccharide chains linked to the beta-H(+),K(+)-ATPase subunit in R. ferrumequinum have distinct features compared to the other mammals studied and confirms the taxon specificity of the chains in the proton pump.
        PMID: 20443691 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Effect of amniotic membrane transplantation on corneal healing and proteoglycan expression in an experimental model of limbal deficiency in rabbits.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-222.html</link>
      <description>Related Articles Effect of amniotic membrane transplantation on corneal healing and proteoglycan expression in an experimental model of limbal deficiency in rabbits. Eur J Ophthalmol. 2010 Mar-Apr;20(2):290-9 Authors: Andrade AL, Campos MQ, Gomes JA, Berto AG, Michelacci YM PURPOSE: Amniotic membrane transplantation (AMT) has been used as a graft or as a dressing in ocular surface reconstruction, facilitating epithelization, maintaining normal epithelial phenotype, and reducing inflammation, vas ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:31 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-222.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Effect of amniotic membrane transplantation on corneal healing and proteoglycan expression in an experimental model of limbal deficiency in rabbits.
        Eur J Ophthalmol. 2010 Mar-Apr;20(2):290-9
        Authors:  Andrade AL, Campos MQ, Gomes JA, Berto AG, Michelacci YM
        PURPOSE: Amniotic membrane transplantation (AMT) has been used as a graft or as a dressing in ocular surface reconstruction, facilitating epithelization, maintaining normal epithelial phenotype, and reducing inflammation, vascularization, and scarring. The corneal transparency is due, at least in part, to the arrangement in orthogonal lamellae of collagen fibrils, surrounded by proteoglycans (PGs). These PGs regulate fibrilogenesis, the matrix assembly, and ultimately the corneal transparency. The purpose of the present study was to investigate the effects of AMT upon the corneal PGs after severe limbal injury. METHODS: Experiments were performed on the right corneas of 22 New Zealand female albino rabbits, and their left corneas were used as matched controls. These animals were divided into 3 groups: G1 (n=10): total peritomy and keratolimbectomy, followed by application of 0.5 M NaOH; G2 (n=10): submitted to the same trauma as G1, and treated by AMT; G3: no trauma, only AMT (n=2). The right corneas of G2 and G3 were covered by DMSO4 cryopreserved human amniotic membrane, fixed by interrupted 9-0 mononylon sutures, with its stromal face toward the ocular surface. After 7 or 30 days, the corneas were removed and PGs were extracted. RESULTS: Normal corneas contained approximately 9 mg of PGs per gram of dry tissue. AMT on intact cornea (G3) did not cause any changes in the concentration of PGs. In contrast, injured corneas contained much less PGs, both on the seventh and on the 30th day posttrauma. The PG concentration was even lower in injured corneas treated by AMT. This decrease was due almost exclusively to dermatan sulfate PGs, and the structure of dermatan sulfate was also modified, indicating changes in the biosynthesis patterns. CONCLUSIONS: Although beneficial effects have been observed on clinical observation and concentration of soluble proteins after AMT, the normal PG composition of cornea was not attained, even 30 days postinjury, indicating that the normal ocular surface reconstruction, if possible, is a long-term process.
        PMID: 19967677 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Phagocytic activity of macrophages against liposomes with conjugates of oxidized dextrans and isonicotinic acid hydrazide during modeling of phagocytosis disturbances in vitro.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-224.html</link>
      <description>Related Articles Phagocytic activity of macrophages against liposomes with conjugates of oxidized dextrans and isonicotinic acid hydrazide during modeling of phagocytosis disturbances in vitro. Bull Exp Biol Med. 2009 Oct;148(4):689-91 Authors: Arkhipov SA, Shkurupy VA, Troitsky AV, Luzgina NG, Ufimceva EG, Zaikovskaja MV, Iljine DA, Akhramenko ES, Gulyaeva EP, Bistrova TN We studied phagocytic activity of macrophages against molecular-liposome hybrid compositions consisting of liposomes (diamet ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:31 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-224.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Phagocytic activity of macrophages against liposomes with conjugates of oxidized dextrans and isonicotinic acid hydrazide during modeling of phagocytosis disturbances in vitro.
        Bull Exp Biol Med. 2009 Oct;148(4):689-91
        Authors:  Arkhipov SA, Shkurupy VA, Troitsky AV, Luzgina NG, Ufimceva EG, Zaikovskaja MV, Iljine DA, Akhramenko ES, Gulyaeva EP, Bistrova TN
        We studied phagocytic activity of macrophages against molecular-liposome hybrid compositions consisting of liposomes (diameter 200-450 nm) containing oxidized dextrans with a molecular weight of 35 or 60 kDa conjugated with the basic antituberculosis preparation isonicotinic acid hydrazide (dextrazides) during modeling of various disturbances of endocytosis function of phagocytic cells in vitro. Preincubation of macrophages with trypsin, colchicine, or sodium azide did not change the parameters of adhesion of molecular-liposome hybrid compositions to macrophages. It was found that preincubation of cells with colchicine or sodium azide reduced parameters of phagocytosis of the molecular-liposome hybrid compositions; this reduction did not depend on the molecular weight of dextrans entering the composition of the molecular-liposome hybrid compositions.
        PMID: 20396771 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Biochemical analysis and quantification of hematopoietic stem cells by infrared spectroscopy.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-230.html</link>
      <description>Related Articles Biochemical analysis and quantification of hematopoietic stem cells by infrared spectroscopy. J Biomed Opt. 2010 May-Jun;15(3):037008 Authors: Zelig U, Dror Z, Iskovich S, Zwielly A, Ben-Harush M, Nathan I, Mordechai S, Kapelushnik J Identification of hematopoietic stem cells (HSCs) in different stages of maturation is one of the major issues in stem cell research and bone marrow (BM) transplantation. Each stage of maturation of HSCs is characterized by a series of distinct glyc ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:31 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-230.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Biochemical analysis and quantification of hematopoietic stem cells by infrared spectroscopy.
        J Biomed Opt. 2010 May-Jun;15(3):037008
        Authors:  Zelig U, Dror Z, Iskovich S, Zwielly A, Ben-Harush M, Nathan I, Mordechai S, Kapelushnik J
        Identification of hematopoietic stem cells (HSCs) in different stages of maturation is one of the major issues in stem cell research and bone marrow (BM) transplantation. Each stage of maturation of HSCs is characterized by a series of distinct glycoproteins present on the cell plasma membrane surface, named a cluster of differentiation (CD). Currently, complicated and expensive procedures based on CD expression are needed for identification and isolation of HSCs. This method is under dispute, since the correct markers' composition is not strictly clear, thus there is need for a better method for stem cell characterization. In the present study, Fourier transform infrared (FTIR) spectroscopy is employed as a novel optical method for identification and characterization of HSCs based on their entire biochemical features. FTIR spectral analysis of isolated mice HSCs reveals several spectral markers related to lipids, nucleic acids, and carbohydrates, which distinguish HSCs from BM cells. The unique "open" conformation of HSC DNA as identified by FTIR is exploited for HSCs quantification in the BM. The proposed method of FTIR spectroscopy for HSC identification and quantification can contribute to stem cell research and BM transplantation.
        PMID: 20615037 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Regulation of growth response to water stress in the soybean primary root. I. Proteomic analysis reveals region-specific regulation of phenylpropanoid metabolism and control of free iron in the elongation zone.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-227.html</link>
      <description> Related Articles Regulation of growth response to water stress in the soybean primary root. I. Proteomic analysis reveals region-specific regulation of phenylpropanoid metabolism and control of free iron in the elongation zone. Plant Cell Environ. 2010 Feb;33(2):223-43 Authors: Yamaguchi M, Valliyodan B, Zhang J, Lenoble ME, Yu O, Rogers EE, Nguyen HT, Sharp RE In water-stressed soybean primary roots, elongation was maintained at well-watered rates in the apical 4 mm (region 1), but was progres ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:31 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-227.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Regulation of growth response to water stress in the soybean primary root. I. Proteomic analysis reveals region-specific regulation of phenylpropanoid metabolism and control of free iron in the elongation zone.
        Plant Cell Environ. 2010 Feb;33(2):223-43
        Authors:  Yamaguchi M, Valliyodan B, Zhang J, Lenoble ME, Yu O, Rogers EE, Nguyen HT, Sharp RE
        In water-stressed soybean primary roots, elongation was maintained at well-watered rates in the apical 4 mm (region 1), but was progressively inhibited in the 4-8 mm region (region 2), which exhibits maximum elongation in well-watered roots. These responses are similar to previous results for the maize primary root. To understand these responses in soybean, spatial profiles of soluble protein composition were analysed. Among the changes, the results indicate that region-specific regulation of phenylpropanoid metabolism may contribute to the distinct growth responses in the different regions. Several enzymes related to isoflavonoid biosynthesis increased in abundance in region 1, correlating with a substantial increase of isoflavonoid content in this region which could contribute to growth maintenance via various potential mechanisms. In contrast, caffeoyl-CoA O-methyltransferase, which is involved in lignin synthesis, was highly up-regulated in region 2. This response was associated with enhanced accumulation of lignin, which may be related to the inhibition of growth in this region. Several proteins that increased in abundance in both regions of water-stressed roots were related to protection from oxidative damage. In particular, an increase in the abundance of ferritin proteins effectively sequestered more iron and prevented excess free iron in the elongation zone under water stress.
        PMID: 19906149 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Increased cell and matrix accumulation during atherogenesis in mice with vessel wall-specific deletion of discoidin domain receptor 1.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-229.html</link>
      <description> Related Articles Increased cell and matrix accumulation during atherogenesis in mice with vessel wall-specific deletion of discoidin domain receptor 1. Circ Res. 2010 Jun 11;106(11):1775-83 Authors: Franco C, Ahmad PJ, Hou G, Wong E, Bendeck MP RATIONALE: Discoidin domain receptor (DDR)1 is a collagen receptor expressed on both smooth muscle cells (SMCs) and macrophages, where it plays important roles regulating cell and matrix accumulation during atherogenesis. Systemic deletion of DDR1 result ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:31 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-229.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Increased cell and matrix accumulation during atherogenesis in mice with vessel wall-specific deletion of discoidin domain receptor 1.
        Circ Res. 2010 Jun 11;106(11):1775-83
        Authors:  Franco C, Ahmad PJ, Hou G, Wong E, Bendeck MP
        RATIONALE: Discoidin domain receptor (DDR)1 is a collagen receptor expressed on both smooth muscle cells (SMCs) and macrophages, where it plays important roles regulating cell and matrix accumulation during atherogenesis. Systemic deletion of DDR1 resulted in attenuated plaque growth but accelerated matrix accumulation in LDLR-deficient mice. Deletion of DDR1 solely on bone marrow-derived cells resulted in decreased macrophage accumulation and plaque growth but no change in matrix accumulation. OBJECTIVE: These findings led us to hypothesize that accelerated matrix accumulation was attributable to the increased synthetic ability of Ddr1(-/-) resident vascular wall SMCs. METHODS AND RESULTS: We used bone marrow transplantation to generate chimeric mice and investigate the role of SMC DDR1 during atherogenesis. Mice with deficiency of DDR1 in vessel wall-derived cells (Ddr1(+/+-->-/-)) or control mice (Ddr1(+/+-->+/+)) were fed an atherogenic diet for 12 weeks. We observed a 3.8-fold increase in the size of aortic sinus plaques in Ddr1(+/+-->-/-) compared to Ddr1(+/+-->+/+) mice. This was attributed to pronounced accumulation of collagen, elastin, proteoglycans, and fibronectin and resulted in a thickened fibrous cap. The enhanced matrix accumulation decreased the proportion of plaque area occupied by cells but was associated with a shift in the cellular composition of the lesions toward increased numbers of vessel wall-derived SMCs compared to bone marrow-derived macrophages. In vitro studies confirmed that Ddr1(-/-) SMCs expressed more matrix, proliferated more, and migrated farther than Ddr1(+/+) SMCs. CONCLUSIONS: DDR1 expression on resident vessel wall SMCs limits proliferation, migration and matrix accumulation during atherogenesis.
        PMID: 20448217 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Impact of acute biochemical castration on insulin sensitivity in healthy adult men.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-228.html</link>
      <description> Related Articles Impact of acute biochemical castration on insulin sensitivity in healthy adult men. Endocr Res. 2010 May;35(2):71-84 Authors: Rabiee A, Dwyer AA, Caronia LM, Hayes FJ, Yialamas MA, Andersen DK, Thomas B, Torriani M, Elahi D INTRODUCTION: Evidence supports an inverse relationship between serum testosterone (T) and insulin resistance in men. However, data with respect to causality are limited. The aim of this study was to explore the impact of acute biochemical castration on insu ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:31 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-228.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Impact of acute biochemical castration on insulin sensitivity in healthy adult men.
        Endocr Res. 2010 May;35(2):71-84
        Authors:  Rabiee A, Dwyer AA, Caronia LM, Hayes FJ, Yialamas MA, Andersen DK, Thomas B, Torriani M, Elahi D
        INTRODUCTION: Evidence supports an inverse relationship between serum testosterone (T) and insulin resistance in men. However, data with respect to causality are limited. The aim of this study was to explore the impact of acute biochemical castration on insulin sensitivity in healthy adult men. METHODS: Ten healthy, adult males (mean age 41.0 +/- 3.9 yr) were studied. Subjects were studied at baseline and after 2 and 4 weeks of biochemical castration. Outpatient hospital research setting. Body composition (dual-energy x-ray absorptiometry), energy expenditure (indirect calorimetry), abdominal and visceral adiposity (MRI), skeletal muscle intramyocellular lipid content ([IMCL] (1)H-MR spectroscopy), and insulin sensitivity (hyperinsulinemic-euglycemic clamp) were assessed before and after 2 and 4 weeks of biochemical castration induced by a GnRH antagonist (acyline 300 mug/kg subcutaneous every 10-14 days). Serum T, insulin and glucose levels, body composition, abdominal visceral fat, IMCL, and glucose disposal rate (M) were measured. RESULTS AND CONCLUSION: Acyline administration suppressed serum T to frankly hypogonadal levels in all subjects for the duration of the study (P <0.009). No significant changes in body composition, energy expenditure, or M were observed at either 2 or 4 weeks of castration. Acyline is an effective GnRH antagonist inducing acute castration in all subjects. ii) Four weeks of biochemical castration has no impact on insulin sensitivity in healthy men likely due to unchanged body composition variables. iii) Insulin resistance associated with chronic low T levels may be largely driven by decreased fat free mass, increased percent body fat, and/or other metabolic regulatory factors.
        PMID: 20408755 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The impact of CpG island on defining transcriptional activation of the mouse l1 retrotransposable elements.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-226.html</link>
      <description>Related Articles The impact of CpG island on defining transcriptional activation of the mouse l1 retrotransposable elements. PLoS One. 2010;5(6):e11353 Authors: Lee SH, Cho SY, Shannon MF, Fan J, Rangasamy D BACKGROUND: L1 retrotransposable elements are potent insertional mutagens responsible for the generation of genomic variation and diversification of mammalian genomes, but reliable estimates of the numbers of actively transposing L1 elements are mostly nonexistent. While the human and mouse  ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:21 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-226.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        The impact of CpG island on defining transcriptional activation of the mouse l1 retrotransposable elements.
        PLoS One. 2010;5(6):e11353
        Authors:  Lee SH, Cho SY, Shannon MF, Fan J, Rangasamy D
        BACKGROUND: L1 retrotransposable elements are potent insertional mutagens responsible for the generation of genomic variation and diversification of mammalian genomes, but reliable estimates of the numbers of actively transposing L1 elements are mostly nonexistent. While the human and mouse genomes contain comparable numbers of L1 elements, several phylogenetic and L1Xplore analyses in the mouse genome suggest that 1,500-3,000 active L1 elements currently exist and that they are still expanding in the genome. Conversely, the human genome contains only 150 active L1 elements. In addition, there is a discrepancy among the nature and number of mouse L1 elements in L1Xplore and the mouse genome browser at the UCSC and in the literature. To date, the reason why a high copy number of active L1 elements exist in the mouse genome but not in the human genome is unknown, as are the potential mechanisms that are responsible for transcriptional activation of mouse L1 elements. METHODOLOGY/PRINCIPAL FINDINGS: We analyzed the promoter sequences of the 1,501 potentially active mouse L1 elements retrieved from the GenBank and L1Xplore databases and evaluated their transcription factors binding sites and CpG content. To this end, we found that a substantial number of mouse L1 elements contain altered transcription factor YY1 binding sites on their promoter sequences that are required for transcriptional initiation, suggesting that only a half of L1 elements are capable of being transcriptionally active. Furthermore, we present experimental evidence that previously unreported CpG islands exist in the promoters of the most active T(F) family of mouse L1 elements. The presence of sequence variations and polymorphisms in CpG islands of L1 promoters that arise from transition mutations indicates that CpG methylation could play a significant role in determining the activity of L1 elements in the mouse genome. CONCLUSIONS: A comprehensive analysis of mouse L1 promoters suggests that the number of transcriptionally active elements is significantly lower than the total number of full-length copies from the three active mouse L1 families. Like human L1 elements, the CpG islands and potentially the transcription factor YY1 binding sites are likely to be required for transcriptional initiation of mouse L1 elements.
        PMID: 20613872 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A novel microdeletion/microduplication syndrome of 19p13.13.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-225.html</link>
      <description>Related Articles A novel microdeletion/microduplication syndrome of 19p13.13. Genet Med. 2010 Jul 6; Authors: Dolan M, Mendelsohn NJ, Pierpont ME, Schimmenti LA, Berry SA, Hirsch B PURPOSE:: Whole genome interrogation by array-based comparative genomic hybridization has led to a rapidly increasing number of discoveries of novel microdeletion and/or microduplication syndromes. We here describe the clinical and cytogenomic correlates of a novel microdeletion/microduplication of 19p13.13. METHODS:: ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:21 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-225.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        A novel microdeletion/microduplication syndrome of 19p13.13.
        Genet Med. 2010 Jul 6;
        Authors:  Dolan M, Mendelsohn NJ, Pierpont ME, Schimmenti LA, Berry SA, Hirsch B
        PURPOSE:: Whole genome interrogation by array-based comparative genomic hybridization has led to a rapidly increasing number of discoveries of novel microdeletion and/or microduplication syndromes. We here describe the clinical and cytogenomic correlates of a novel microdeletion/microduplication of 19p13.13. METHODS:: Among patients referred to the Cytogenetics laboratory for array-based comparative genomic hybridization analysis, we identified four with a deletion and one with a duplication within 19p13.13. Confirmatory fluorescence in situ hybridization and parental studies were performed. Detailed clinical findings and array profiles were reviewed and compared. RESULTS:: Patients with deletions of 19p13.13 share a unique constellation of phenotypic abnormalities. In addition to developmental disabilities, the microdeletion manifested in overgrowth, macrocephaly, and ophthalmologic and gastrointestinal findings; in contrast, the single microduplication manifested in growth delay and microcephaly. CONCLUSION:: The consistent constellation of clinical findings associated with copy number variation of this region warrants the designation of microdeletion/microduplication syndrome of 19p13.13. An approximately 311-340 Kb smallest region of overlap encompassing 16 genes was identified. Candidate genes include MAST1, NFIX, and CALR. Identification of this syndrome has led to recommendations for diagnostic work-up and follow-up of patients with this copy number variant. Integration of detailed clinical and array data is critical for advancing both patient care and human genomic research.
        PMID: 20613546 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Development of unigene-derived SSR markers in cowpea (Vigna unguiculata) and their transferability to other Vigna species.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-228.html</link>
      <description>Related Articles Development of unigene-derived SSR markers in cowpea (Vigna unguiculata) and their transferability to other Vigna species. Genome. 2010 Jul;53(7):508-23 Authors: Gupta SK, Gopalakrishna T Unigene sequences available in public databases provide a cost-effective and valuable source for the development of molecular markers. In this study, the identification and development of unigene-based SSR markers in cowpea (Vigna unguiculata (L.) Walp.) is presented. A total of 1071 SSRs were  ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:21 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-228.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Development of unigene-derived SSR markers in cowpea (Vigna unguiculata) and their transferability to other Vigna species.
        Genome. 2010 Jul;53(7):508-23
        Authors:  Gupta SK, Gopalakrishna T
        Unigene sequences available in public databases provide a cost-effective and valuable source for the development of molecular markers. In this study, the identification and development of unigene-based SSR markers in cowpea (Vigna unguiculata (L.) Walp.) is presented. A total of 1071 SSRs were identified in 15 740 cowpea unigene sequences downloaded from the National Center for Biotechnology Information. The most frequent SSR motifs present in the unigenes were trinucleotides (59.7%), followed by dinucleotides (34.8%), pentanucleotides (4%), and tetranucleotides (1.5%). The copy number varied from 6 to 33 for dinucleotide, 5 to 29 for trinucleotide, 5 to 7 for tetranucleotide, and 4 to 6 for pentanucleotide repeats. Primer pairs were successfully designed for 803 SSR motifs and 102 SSR markers were finally characterized and validated. Putative function was assigned to 64.7% of the unigene SSR markers based on significant homology to reported proteins. About 31.7% of the SSRs were present in coding sequences and 68.3% in untranslated regions of the genes. About 87% of the SSRs located in the coding sequences were trinucleotide repeats. Allelic variation at 32 SSR loci produced 98 alleles in 20 cowpea genotypes. The polymorphic information content for the SSR markers varied from 0.10 to 0.83 with an average of 0.53. These unigene SSR markers showed a high rate of transferability (88%) across other Vigna species, thereby expanding their utility. Alignment of unigene sequences with soybean genomic sequences revealed the presence of introns in amplified products of some of the SSR markers. This study presents the distribution of SSRs in the expressed portion of the cowpea genome and is the first report of the development of functional unigene-based SSR markers in cowpea. These SSR markers would play an important role in molecular mapping, comparative genomics, and marker-assisted selection strategies in cowpea and other Vigna species.
        PMID: 20616873 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Copy number variation of the SELENBP1 gene in schizophrenia.</title>
  <link>http://biomarket.jp/modules/pubmed_fluidigm/article-227.html</link>
      <description>Related Articles Copy number variation of the SELENBP1 gene in schizophrenia. Behav Brain Funct. 2010 Jul 8;6(1):40 Authors: Amar S, Ovadia O, Maier W, Ebstein R, Belmaker RH, Mishmar D, Agam G ABSTRACT: BACKGROUND: Schizophrenia is associated with rare copy-number (CN) mutations. Screening for such alleles genome-wide, though comprehensive, cannot study in-depth the causality of particular loci, therefore cannot provide the functional interpretation for the disease etiology. We hypothesized tha ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:21 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_fluidigm/article-227.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Copy number variation of the SELENBP1 gene in schizophrenia.
        Behav Brain Funct. 2010 Jul 8;6(1):40
        Authors:  Amar S, Ovadia O, Maier W, Ebstein R, Belmaker RH, Mishmar D, Agam G
        ABSTRACT: BACKGROUND: Schizophrenia is associated with rare copy-number (CN) mutations. Screening for such alleles genome-wide, though comprehensive, cannot study in-depth the causality of particular loci, therefore cannot provide the functional interpretation for the disease etiology. We hypothesized that CN mutations in the SELENBP1 locus could associate with the disorder and that these mutations could alter the gene product's activity in patients. METHODS: We analyzed SELENBP1 CN variation (CNV) in blood DNA from 49 schizophrenia patients and 49 controls (cohort A). Since CN of genes may vary among tissues, we investigated SELENBP1 CN in age- sex- and postmortem interval-matched cerebellar DNA samples from 14 patients and 14 controls (cohort B). Since CNV may either be de-novo or inherited we analyzed CNV of the SELENBP1 locus in blood DNA from 26 trios of schizophrenia probands and their healthy parents (cohort C). SELENBP1 mRNA levels were measured by real-time PCR. RESULTS: In cohort A reduced CN of the SELENBP1 locus was found in four patients but in none of the controls. In cohort B we found reduced CN of the SELENBP1 locus in two patients but in none of the controls. In cohort C three patients exhibited drastic CN reduction, not present in their parents, indicating de-novo mutation. A reduction in SELENBP1 mRNA levels in the postmortem cerebellar samples of schizophrenia patients was found. CONCLUSIONS: We report a focused study of CN mutations in the selenium binding-protein1 (SELENBP1) locus previously linked with schizophrenia. We provide evidence for recurrence of decreased CN of the SELENBP1 locus in three unrelated patients' cohorts but not in controls, raising the possibility of functional involvement of these mutations in the etiology of the disease.
        PMID: 20615253 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>SELDI-TOF serum proteomics and colorectal cancer: A current overview.</title>
  <link>http://biomarket.jp/modules/pubmed_seldi/article-104.html</link>
      <description>Related Articles SELDI-TOF serum proteomics and colorectal cancer: A current overview. Arch Physiol Biochem. 2010 Jul 8; Authors: Gemoll T, Roblick UJ, Auer G, JÃ¶rnvall H, Habermann JK Surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) is a widely used technology platform for diagnostic biomarker discovery in tissue, plasma and serum. High-throughput and simplicity of experimental procedures have allowed this technology to become an important researc ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:13 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_seldi/article-104.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        SELDI-TOF serum proteomics and colorectal cancer: A current overview.
        Arch Physiol Biochem. 2010 Jul 8;
        Authors:  Gemoll T, Roblick UJ, Auer G, JÃ¶rnvall H, Habermann JK
        Surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) is a widely used technology platform for diagnostic biomarker discovery in tissue, plasma and serum. High-throughput and simplicity of experimental procedures have allowed this technology to become an important research tool for biomarker discovery during the last years. This review provides an overview of SELDI-TOF functionality, its advantages and drawbacks and gives a current literature overview of colorectal cancer based serum biomarker detection. Further improvements in instrumentation sensitivity and labelling chemistries will enable detection of novel, tissue-leakage biomarkers in serum. However, major emphasis should be given on subsequent identification of differentially observed protein peaks detected by SELDI-TOF. Clinical validation in large patient cohorts will then allow transferring novel biomarkers into clinical use.
        PMID: 20615064 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Plakophilin-1 Localizes to the Nucleus and Interacts with Single-Stranded DNA.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24449.html</link>
      <description> Plakophilin-1 Localizes to the Nucleus and Interacts with Single-Stranded DNA. J Invest Dermatol. 2010 Jul 8; Authors: Sobolik-Delmaire T, Reddy R, Pashaj A, Roberts BJ, Wahl JK Plakophilins (Pkp-1, -2, and -3) comprise a family of armadillo repeat-containing proteins first identified as desmosomal plaque components, in which they link desmoplakin to the desmosomal cadherins. In addition to their role in desmosomal cell-cell adhesion, Pkps also localize to the nucleus, where they perform unknow ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24449.html</guid>
        
      <content:encoded> <![CDATA[
    

        Plakophilin-1 Localizes to the Nucleus and Interacts with Single-Stranded DNA.
        J Invest Dermatol. 2010 Jul 8;
        Authors:  Sobolik-Delmaire T, Reddy R, Pashaj A, Roberts BJ, Wahl JK
        Plakophilins (Pkp-1, -2, and -3) comprise a family of armadillo repeat-containing proteins first identified as desmosomal plaque components, in which they link desmoplakin to the desmosomal cadherins. In addition to their role in desmosomal cell-cell adhesion, Pkps also localize to the nucleus, where they perform unknown functions. Of the three Pkps, Pkp-1 is most readily detected in the nucleus, where it is localized to the nucleoplasm. Pkp chimeras containing the Pkp-1 head domain and Pkp-3 armadillo repeat domain were localized to the nucleus in A431 cells, whereas Pkp chimeras containing the Pkp-3 head domain and Pkp-1 armadillo repeat domain localized to the desmosome and the cytosol. DNAse I digestion of chromatin in cultured cells results in loss of nuclear Pkp-1, suggesting that Pkp-1 associates specifically with nuclear components. In addition, in vitro assays revealed that the amino-terminal head domains of Pkps-1 and -2 were sufficient to bind single-stranded DNA. Induction of DNA damage induced a partial redistribution of Pkp-1 protein to the nucleolus, and depletion of Pkp-1 resulted in increased survival in response to DNA damage. These data suggest that in addition to mediating desmosome assembly, the nuclear pool of Pkp can influence cell survival by interactions with DNA.Journal of Investigative Dermatology advance online publication, 8 July 2010; doi:10.1038/jid.2010.191.
        PMID: 20613778 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>UV-Induced Tolerance to a Contact Allergen Is Impaired in Polymorphic Light Eruption.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24448.html</link>
      <description> UV-Induced Tolerance to a Contact Allergen Is Impaired in Polymorphic Light Eruption. J Invest Dermatol. 2010 Jul 8; Authors: Koulu LM, Laihia JK, Peltoniemi HH, JansÃ©n CT Polymorphic light eruption (PLE) is a common skin disorder provoked by exposure to UVR. Its clinical symptoms resemble those of a contact allergic reaction. PLE is generally considered a T-cell-mediated autoimmune reaction toward a yet unidentified antigen formed in UVR-exposed skin. Predisposition to such an immune reac ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24448.html</guid>
        
      <content:encoded> <![CDATA[
    

        UV-Induced Tolerance to a Contact Allergen Is Impaired in Polymorphic Light Eruption.
        J Invest Dermatol. 2010 Jul 8;
        Authors:  Koulu LM, Laihia JK, Peltoniemi HH, JansÃ©n CT
        Polymorphic light eruption (PLE) is a common skin disorder provoked by exposure to UVR. Its clinical symptoms resemble those of a contact allergic reaction. PLE is generally considered a T-cell-mediated autoimmune reaction toward a yet unidentified antigen formed in UVR-exposed skin. Predisposition to such an immune reaction may result from aberrant epitope formation, increased immune reactivity to a universal epitope, or diminished propensity to UVR-induced immunosuppression or to the induction of tolerance. In a study comprising a total of 24 PLE patients and 24 healthy sex- and age-matched controls, we found that both groups demonstrated similar immunosuppression of contact sensitization to diphenylcyclopropenone by earlier exposure to solar-simulating UVR. However, only 1 out of 13 PLE patients (8%) versus 6 out of 11 controls (55%) that had been immunosuppressed by UVR exhibited a state of immunotolerance toward the same allergen after 10-24 months (P=0.023). We conclude that the impaired propensity to UVR-induced allergen-specific immunotolerance may promote recurrent PLE.Journal of Investigative Dermatology advance online publication, 8 July 2010; doi:10.1038/jid.2010.181.
        PMID: 20613777 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Epigenetic Silencing of Lysyl Oxidase-Like-1 through DNA Hypermethylation in an Autosomal Recessive Cutis Laxa Case.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24450.html</link>
      <description> Epigenetic Silencing of Lysyl Oxidase-Like-1 through DNA Hypermethylation in an Autosomal Recessive Cutis Laxa Case. J Invest Dermatol. 2010 Jul 8; Authors: Debret R, Cenizo V, Aimond G, AndrÃ© V, Devillers M, Rouvet I, MÃ©garbanÃ© A, Damour O, Sommer P We have recently reported a case of cutis laxa caused by a fibulin-5 missense mutation (p.C217R). Skin fibroblasts from this individual showed an abnormal pattern of expression of several genes coding for elastic fiber-related protei ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24450.html</guid>
        
      <content:encoded> <![CDATA[
    

        Epigenetic Silencing of Lysyl Oxidase-Like-1 through DNA Hypermethylation in an Autosomal Recessive Cutis Laxa Case.
        J Invest Dermatol. 2010 Jul 8;
        Authors:  Debret R, Cenizo V, Aimond G, AndrÃ© V, Devillers M, Rouvet I, MÃ©garbanÃ© A, Damour O, Sommer P
        We have recently reported a case of cutis laxa caused by a fibulin-5 missense mutation (p.C217R). Skin fibroblasts from this individual showed an abnormal pattern of expression of several genes coding for elastic fiber-related proteins, including lysyl oxidase-like-1 (LOXL1). In this study we intended to elucidate the mechanism responsible for LOXL1 downregulation in these fibulin-5-mutant cells. We identified a proximal region (-442/-342) of the human LOXL1 promoter in which two binding sites for the transcription factor specific protein 1 (Sp-1) are required for gene activity in normal fibroblasts. Binding of Sp-1 to these sequences was dramatically reduced within cutis laxa cells, although Sp-1 expression was normal. Further analysis of the promoter sequence found increased methylation levels in cutis laxa cells compared with cells from unaffected individuals. When DNA methyltransferase activity was transiently inhibited in cutis laxa cells using the 5-aza-2'-deoxycytidine, we found a significant increase in LOXL1 expression. In conclusion, besides changes caused by the fibulin-5 mutation, LOXL1 gene regulation is affected by an epigenetic mechanism that can be reversed by an inhibitor of DNA methyltransferase activity. It is not yet known whether LOXL1 gene expression is affected in all cases of cutis laxa arising from fibulin-5 mutation.Journal of Investigative Dermatology advance online publication, 8 July 2010; doi:10.1038/jid.2010.186.
        PMID: 20613779 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Dermatology: a multi-faceted field with many chances of expedient interdisciplinary cooperation.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24451.html</link>
      <description> Dermatology: a multi-faceted field with many chances of expedient interdisciplinary cooperation. Dtsch Med Wochenschr. 2010 Jul;135(28/29):1417 Authors: Berking C, Ruzicka T PMID: 20614401 [PubMed - as supplied by publisher] </description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24451.html</guid>
        
      <content:encoded> <![CDATA[
    

        Dermatology: a multi-faceted field with many chances of expedient interdisciplinary cooperation.
        Dtsch Med Wochenschr. 2010 Jul;135(28/29):1417
        Authors:  Berking C, Ruzicka T
        
        PMID: 20614401 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Interventions for melasma.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24452.html</link>
      <description> Interventions for melasma. Cochrane Database Syst Rev. 2010;7:CD003583 Authors: Rajaratnam R, Halpern J, Salim A, Emmett C BACKGROUND: Melasma is an acquired symmetrical pigmentary disorder where confluent grey-brown patches typically appear on the face. Available treatments for melasma are unsatisfactory. OBJECTIVES: To assess interventions used in the management of all types of melasma: epidermal, dermal, and mixed. SEARCH STRATEGY: In May 2010 we searched the Cochrane Skin Group Specialised  ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24452.html</guid>
        
      <content:encoded> <![CDATA[
    

        Interventions for melasma.
        Cochrane Database Syst Rev. 2010;7:CD003583
        Authors:  Rajaratnam R, Halpern J, Salim A, Emmett C
        BACKGROUND: Melasma is an acquired symmetrical pigmentary disorder where confluent grey-brown patches typically appear on the face. Available treatments for melasma are unsatisfactory. OBJECTIVES: To assess interventions used in the management of all types of melasma: epidermal, dermal, and mixed. SEARCH STRATEGY: In May 2010 we searched the Cochrane Skin Group Specialised Register, the Cochrane Central Register of Controlled Trials (Clinical Trials) in The Cochrane Library, MEDLINE, EMBASE, PsycINFO, and LILACS. Reference lists of articles and ongoing trials registries were also searched. SELECTION CRITERIA: Randomised controlled trials that evaluated topical and systemic interventions for melasma. DATA COLLECTION AND ANALYSIS: Study selection, assessment of methodological quality, data extraction, and analysis was carried out by two authors independently. MAIN RESULTS: We included 20 studies with a total of 2125 participants covering 23 different treatments. Statistical pooling of the data was not possible due to the heterogeneity of treatments. Each study involved a different set of interventions. They can be grouped into those including a bleaching agent such as hydroquinone, triple-combination creams (hydroquinone, tretinoin, and fluocinolone acetonide), and combination therapies (hydroquinone cream and glycolic acid peels), as well as less conventional therapies including rucinol, vitamin C iontophoresis, and skin-lightening complexes like Thiospot and Gigawhite.Triple-combination cream was significantly more effective at lightening melasma than hydroquinone alone (RR 1.58, 95% CI 1.26 to 1.97) or when compared to the dual combinations of tretinoin and hydroquinone (RR 2.75, 95% CI 1.59 to 4.74), tretinoin and fluocinolone acetonide (RR 14.00, 95% CI 4.43 to 44.25), or hydroquinone and fluocinolone acetonide (RR 10.50, 95% CI 3.85 to 28.60).Azelaic acid (20%) was significantly more effective than 2% hydroquinone (RR 1.25, 95% CI 1.06 to 1.48) at lightening melasma but not when compared to 4% hydroquinone (RR 1.11, 95% CI 0.94 to 1.32).In two studies where tretinoin was compared to placebo, participants rated their melasma as significantly improved in one (RR 13, 95% CI 1.88 to 89.74) but not the other. In both studies by other objective measures tretinoin treatment significantly reduced the severity of melasma.Thiospot was more effective than placebo (SMD -2.61, 95% CI -3.76 to -1.47).The adverse events most commonly reported were mild and transient such as skin irritation, itching, burning, and stinging. AUTHORS' CONCLUSIONS: The quality of studies evaluating melasma treatments was generally poor and available treatments inadequate. High-quality randomised controlled trials on well-defined participants with long-term outcomes to determine the duration of response are needed.
        PMID: 20614435 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A novel metagenome-derived beta-galactosidase: gene cloning, overexpression, purification and characterization.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24453.html</link>
      <description> A novel metagenome-derived beta-galactosidase: gene cloning, overexpression, purification and characterization. Appl Microbiol Biotechnol. 2010 Jul 8; Authors: Wang K, Li G, Yu SQ, Zhang CT, Liu YH A novel beta-galactosidase gene, zd410, was isolated by screening a soil metagenomic library. Sequence analysis revealed that zd410 encodes a protein of 672 amino acids with a predicted molecular weight of 78.6 kDa. The recombinant ZD410 was expressed and purified in Pichia pastoris, with a yield of  ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24453.html</guid>
        
      <content:encoded> <![CDATA[
    

        A novel metagenome-derived beta-galactosidase: gene cloning, overexpression, purification and characterization.
        Appl Microbiol Biotechnol. 2010 Jul 8;
        Authors:  Wang K, Li G, Yu SQ, Zhang CT, Liu YH
        A novel beta-galactosidase gene, zd410, was isolated by screening a soil metagenomic library. Sequence analysis revealed that zd410 encodes a protein of 672 amino acids with a predicted molecular weight of 78.6 kDa. The recombinant ZD410 was expressed and purified in Pichia pastoris, with a yield of ca. 300 mg from 1 L culture. The purified enzyme displayed optimal activity at 38 degrees C and pH 7.0. Given that the enzyme had 54% of the maximal activity at 20 degrees C and 11% of the maximal activity at close to 0 degrees C, ZD410 was regarded as a cold-adapted beta-galactosidase. ZD410 displays high enzymatic activity for its synthetic substrate-ONPG (o-nitrophenyl-beta-D: -galactopyranoside, 243 U/mg) and its natural substrate-lactose (25.4 U/mg), while its activity was slightly stimulated by addition of Na(+), K(+), or Ca(2+) at low concentrations. ZD410 is a good candidate of beta-galactosidases for food industry after further study.
        PMID: 20614217 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Mechanical Assist Device as a Bridge to Heart Transplantation in Children Less Than 10 Kilograms.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24455.html</link>
      <description>Related Articles Mechanical Assist Device as a Bridge to Heart Transplantation in Children Less Than 10 Kilograms. Ann Thorac Surg. 2010 Jul;90(1):58-62 Authors: Brancaccio G, Amodeo A, Ricci Z, Morelli S, Gagliardi MG, Iacobelli R, Michielon G, Picardo S, Parisi F, Pongiglione G, Di Donato RM BACKGROUND: Despite the remarkable advances with the use of ventricular assist devices (VAD) in adults, pneumatic pulsatile support in children is still limited. We report a retrospective review of our exp ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24455.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Mechanical Assist Device as a Bridge to Heart Transplantation in Children Less Than 10 Kilograms.
        Ann Thorac Surg. 2010 Jul;90(1):58-62
        Authors:  Brancaccio G, Amodeo A, Ricci Z, Morelli S, Gagliardi MG, Iacobelli R, Michielon G, Picardo S, Parisi F, Pongiglione G, Di Donato RM
        BACKGROUND: Despite the remarkable advances with the use of ventricular assist devices (VAD) in adults, pneumatic pulsatile support in children is still limited. We report a retrospective review of our experience in very small children (<10 kg of body weight). METHODS: Ten consecutive children weighing less than 10 kg were offered mechanical support with Berlin Heart (Berlin Heart AG, Berlin, Germany) as a bridge to heart transplant from March 2002 to March 2010. RESULTS: The median patient age was 10.4 months (38 days to 2.2 years). The median patient weight was 6.4 kg (2.9 to 10 kg). Prior to VAD implantation, all children were managed by multiple intravenous inotropes and mechanical ventilation (8) or extracorporeal membrane oxygenation (2). The median pre-VAD pulmonary vascular resistance index was 5.7 Woods units/m(2). Three patients required biventricular mechanical support, but in all other cases a single left VAD proved sufficient. The median duration of VAD support was 61 days (2 to 168 days). Four deaths occurred; from stroke in three and sepsis in one. Five patients were successfully bridged to heart transplantation after a median duration of mechanical support of 89 days (37 to 168 days) and another is still waiting a suitable organ after 77 days of VAD support. There were no complications related to postoperative bleeding. Five patients required at least one pump change. Of 5 patients undergoing heart transplant, 3 developed an extremely elevated (>60%) panel reactive antibody by enzyme-linked immunosorbent assay, confirmed by Luminex (Luminex Corp, Austin, TX). All 3 experienced at least one acute episode of rejection in the first month after heart transplant, needing plasmapheresis. The survival rate after heart transplantation was 100% with a median follow-up of 7.5 months. CONCLUSIONS: Mechanical support in very small children with end-stage heart failure is an effective strategy of bridge to heart transplantation with a reasonable mortality rate. The high rate of complications suggests to optimize indications and timing of VAD implantation.
        PMID: 20609748 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Morphological characteristics of the interface between resin composite and glass-ionomer cement to thin-walled roots: a microscopic investigation.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24454.html</link>
      <description>Related Articles Morphological characteristics of the interface between resin composite and glass-ionomer cement to thin-walled roots: a microscopic investigation. Am J Dent. 2010 Apr;23(2):103-7 Authors: Ayad MF, Bahannan SA, Rosenstiel SF PURPOSE: To identify how different treatments of the root dentin surface affect the microscopic appearance of the resin composite/glass-ionomer cement-to-dentin interface. METHODS: The root canals of 70 extracted human single-rooted teeth were enlarged to red ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24454.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Morphological characteristics of the interface between resin composite and glass-ionomer cement to thin-walled roots: a microscopic investigation.
        Am J Dent. 2010 Apr;23(2):103-7
        Authors:  Ayad MF, Bahannan SA, Rosenstiel SF
        PURPOSE: To identify how different treatments of the root dentin surface affect the microscopic appearance of the resin composite/glass-ionomer cement-to-dentin interface. METHODS: The root canals of 70 extracted human single-rooted teeth were enlarged to reduce dentin wall thicknesses to 0.5 mm. The roots were randomly divided into seven test groups (n=10) according to the canal irrigant used: no irrigant (control), 5% hydrogen peroxide, 5% sodium hypochlorite, a combination of 5% hydrogen peroxide and sodium hypochlorite, 15% ethylenediaminetetraacetic acid (EDTA), 10% lactic acid, or 20% lactic acid. To simulate thin-walled roots, within each group, crowns were sectioned and the entire surface of each root canal space was enlarged with Profile instrument. Half of treated root canals (n=5) were filled with resin composite (PermaFlo) and the other half were filled with glass-ionomer cement (Fuji II LC). A light-transmitting plastic post (Luminex) was used to create space for a fiber-reinforced post and to ensure polymerization of the restorative material. Specimens were critical-point dried and freeze fractured for scanning electron microscope analysis. Three sites along the root were evaluated (cervical, middle, and apical). RESULTS: Scanning electron micrographs showed no differences in the morphology of the resin tags at the cervical, middle or apical levels with any of the irrigants or the restorative materials used. Also, no difference in surface topography was found within individual groups. A resin-dentin interdiffusion zone and resin tags developed after application of resin composite with lactic acid solutions and EDTA but not with the glass-ionomer cement.
        PMID: 20608301 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Tools for analyzing intraflagellar transport in trypanosomes.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24456.html</link>
      <description> Related Articles Tools for analyzing intraflagellar transport in trypanosomes. Methods Cell Biol. 2009;93:59-80 Authors: Julkowska D, Bastin P African trypanosomes are evolutionary-divergent eukaryotes responsible for sleeping sickness. They duplicate their single flagellum while maintaining the old one, providing a unique model to examine mature and elongating flagella in the same cell. Like in most eukaryotes, the trypanosome flagellum is constructed by addition of novel subunits at its dista ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24456.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Tools for analyzing intraflagellar transport in trypanosomes.
        Methods Cell Biol. 2009;93:59-80
        Authors:  Julkowska D, Bastin P
        African trypanosomes are evolutionary-divergent eukaryotes responsible for sleeping sickness. They duplicate their single flagellum while maintaining the old one, providing a unique model to examine mature and elongating flagella in the same cell. Like in most eukaryotes, the trypanosome flagellum is constructed by addition of novel subunits at its distal end via the action of intraflagellar transport (IFT). Almost all genes encoding IFT proteins and motors are conserved in trypanosomes and related species, with only a few exceptions. A dozen of IFT genes have been functionally investigated in this organism, thanks to the potent reverse genetic tools available. Several alternative techniques to trigger RNAi are accessible, either transient RNAi by transfection of long double-stranded RNA or by generation of clonal cell lines able to express long double-stranded RNA under the control of tetracycline-inducible promoters. In addition, we provide a series of techniques to investigate cellular phenotypes in trypanosomes where expression of IFT genes has been silenced. In this chapter, we describe different methods for tagging and expression of IFT proteins in trypanosomes and for visualizing IFT in live cells.
        PMID: 20409811 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24457.html</link>
      <description> Related Articles Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle. J Gen Virol. 2010 Jul;91(Pt 7):1723-7 Authors: Kamrud KI, Alterson K, Custer M, Dudek J, Goodman C, Owens G, Smith JF Alphavirus-based replicon systems are frequently used as preclinical vectors and as antigen discovery tools, and they have recently been assessed in clinical vaccine trials. Typically, alphavirus replicon RNAs are delivered within virus-like replicon  ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24457.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle.
        J Gen Virol. 2010 Jul;91(Pt 7):1723-7
        Authors:  Kamrud KI, Alterson K, Custer M, Dudek J, Goodman C, Owens G, Smith JF
        Alphavirus-based replicon systems are frequently used as preclinical vectors and as antigen discovery tools, and they have recently been assessed in clinical vaccine trials. Typically, alphavirus replicon RNAs are delivered within virus-like replicon particles (VRP) that are produced following transfection of replicon RNA and two helper RNAs into permissive cells in vitro. The non-structural proteins expressed from the replicon RNA amplify the replicon RNA in cis and the helper RNAs in trans, the latter providing the viral structural proteins necessary to package the replicon RNA into VRP. Current helper RNA designs incorporate the alphavirus 26S promoter to direct the transcription of high levels of structural gene mRNAs. We demonstrate here that the 26S promoter is not required on helper RNAs to produce VRP and propose that such promoterless helper RNAs, by design, reduce the probability of generating replication-competent virus that may otherwise result from RNA recombination.
        PMID: 20181749 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Cancer cell specific gene delivery by laminin-derived peptide AG73-labeled liposomes.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24458.html</link>
      <description>Related Articles Cancer cell specific gene delivery by laminin-derived peptide AG73-labeled liposomes. Bioorg Med Chem Lett. 2010 Apr 14; Authors: Iijima H, Negishi Y, Omata D, Nomizu M, Aramaki Y We developed laminin-derived AG73 peptide labeled liposomes for cancer specific gene therapy. AG73 peptide is well known as a ligand for syndecan-2 which is highly expressed in various cancer cells. Liposomes labeled with AG73 showed high efficient transfection efficiency in syndecan-2 overexpressing c ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24458.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Cancer cell specific gene delivery by laminin-derived peptide AG73-labeled liposomes.
        Bioorg Med Chem Lett. 2010 Apr 14;
        Authors:  Iijima H, Negishi Y, Omata D, Nomizu M, Aramaki Y
        We developed laminin-derived AG73 peptide labeled liposomes for cancer specific gene therapy. AG73 peptide is well known as a ligand for syndecan-2 which is highly expressed in various cancer cells. Liposomes labeled with AG73 showed high efficient transfection efficiency in syndecan-2 overexpressing cells, and found that AG73 could be a superior molecule in the development of non-viral vector using liposomes for the gene delivery to syndecan-2 overexpressing cancer cells.
        PMID: 20615691 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Role of Peroxiredoxin-1 and -4 in Protection of RSV-induced Cysteinyl-oxidation of Nuclear Cytoskeletal Proteins.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24464.html</link>
      <description>Related Articles Role of Peroxiredoxin-1 and -4 in Protection of RSV-induced Cysteinyl-oxidation of Nuclear Cytoskeletal Proteins. J Virol. 2010 Jul 7; Authors: Jamaluddin M, Wiktorowicz JE, Soman KV, Boldogh I, Forbus JD, Spratt H, Garofalo RP, Brasier AR The respiratory epithelium plays a central role in innate immunity by secreting networks of inflammatory mediators in response to Respiratory Syncytial Virus (RSV) infection. Previous proteomic studies focusing on the host cellular response to ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24464.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Role of Peroxiredoxin-1 and -4 in Protection of RSV-induced Cysteinyl-oxidation of Nuclear Cytoskeletal Proteins.
        J Virol. 2010 Jul 7;
        Authors:  Jamaluddin M, Wiktorowicz JE, Soman KV, Boldogh I, Forbus JD, Spratt H, Garofalo RP, Brasier AR
        The respiratory epithelium plays a central role in innate immunity by secreting networks of inflammatory mediators in response to Respiratory Syncytial Virus (RSV) infection. Previous proteomic studies focusing on the host cellular response to RSV indicated the existence of a nuclear heat shock response and cytoplasmic depletion of anti-oxidant proteins in model type II-like airway epithelial cells. Here, we increased the depth of nuclear proteomic interrogation by using fluorescence difference labeling followed by liquid isoelectric focusing pre-fractionation/2-D gel electrophoresis (2-DE) to identify an additional 41 proteins affected by RSV infection. Surprisingly, we found inducible oligomers and shifts in isoelectric points for peroxiredoxin (Prdx)-1, -3, and -4 isoforms without changes in their total abundance indicating Prdxs were being oxidized in response to RSV. To address the role of Prdx-1 and -4 in RSV infection, isoforms were selectively knocked down by siRNA transfection. Cells lacking either Prdx-1 or -4 or both showed increased level of ROS formation and a higher level of protein carbonylation in response to RSV infection. Using a novel saturation fluorescence labeling-2-DE analysis, we showed that 15 unique proteins had enhanced oxidative modifications of at least >1.2-fold in the Prdx-knockdowns in response to RSV, including Annexin A2 and desmoplakin. Our results suggest that Prdx-1 and -4 are essential for preventing RSV-induced oxidative damage in a subset of nuclear intermediate filament and actin binding proteins in epithelial cells.
        PMID: 20610706 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24463.html</link>
      <description>Related Articles Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells. Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1223-31 Authors: Gao L, Li F, Dong B, Zhang J, Rao Y, Cong Y, Mao B, Chen X PURPOSE: Constitutively activated signal transducer and activator of transcription 3 (STAT3) and ErbB2 are involved in the pathogenesis of many tumors, including astrocytoma. Inactivation of these molecules is repor ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24463.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells.
        Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1223-31
        Authors:  Gao L, Li F, Dong B, Zhang J, Rao Y, Cong Y, Mao B, Chen X
        PURPOSE: Constitutively activated signal transducer and activator of transcription 3 (STAT3) and ErbB2 are involved in the pathogenesis of many tumors, including astrocytoma. Inactivation of these molecules is reported to result in radiosensitization. The purpose of this study was to investigate whether inhibition of STAT3, ErbB2, or both could enhance radiotherapy in the human glioma model (U251 and U87 cell lines). METHODS AND MATERIALS: The RNAi plasmids targeting STAT3 or ErbB2 were constructed, and their downregulatory effects on target proteins were examined by immunoblotting. After combination treatment of RNAi with or without irradiation, the cell viability was determined using 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and clonogenic assays. The in vivo effect of combined treatment was determined using the U251 xenograft model. The apoptosis caused by the inhibition of STAT3 and ErbB2 was detected, and the mechanism involved in the apoptosis was investigated, including increases in caspase proteins, mitochondrial damage, and the expression of key modulating protein of different apoptosis pathways. RESULTS: Transfection of U251 cells with STAT3 or ErbB2 siRNA plasmids specifically reduced their target gene expressions. Inhibition of STAT3 or ErbB2 greatly decreased glioma cell survival after 2, 4, or 6 Gy irradiation. Inhibition of STAT3 and ErbB2 also enhanced radiation-induced tumor growth inhibition in the U251 xenograft model. Furthermore, the suppression of either STAT3 or ErbB2 could induce U251 cell apoptosis, which was related primarily to the mitochondrial apoptotic pathway. CONCLUSIONS: These results indicated that simultaneous inhibition of STAT3 and ErbB2 expression can promote potent antitumor activity and radiosensitizing activity in human glioma.
        PMID: 20610043 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24461.html</link>
      <description> Related Articles Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation. Circ Res. 2010 Jun 11;106(11):1703-11 Authors: Feaver RE, Gelfand BD, Wang C, Schwartz MA, Blackman BR RATIONALE: The extracellular matrix protein fibronectin (FN) is focally deposited in regions of atherosclerosis, where it contributes to inflammatory signaling. OBJECTIVE: To elucidate the mechanism by which FN deposition is regulated by local shear stre ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24461.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation.
        Circ Res. 2010 Jun 11;106(11):1703-11
        Authors:  Feaver RE, Gelfand BD, Wang C, Schwartz MA, Blackman BR
        RATIONALE: The extracellular matrix protein fibronectin (FN) is focally deposited in regions of atherosclerosis, where it contributes to inflammatory signaling. OBJECTIVE: To elucidate the mechanism by which FN deposition is regulated by local shear stress patterns, its dependence on platelet-endothelial cell adhesion molecule (PECAM)-1 mechanotransduction and the role this pathway plays in sustaining an atheroprone/proinflammatory phenotype. METHODS AND RESULTS: Human endothelial cells were exposed in vitro to atheroprone or atheroprotective shear stress patterns derived from human carotid arteries. Onset of atheroprotective flow induced a transient increase in FN deposition, whereas atheroprone flow caused a steady increase in FN expression and integrin activation over time, leading to a significant and sustained increase in FN deposition relative to atheroprotective conditions. Comparing FN staining in ApoE(-/-) and ApoE(-/-)PECAM(-/-) mice showed that PECAM-1 was essential for FN accumulation in atheroprone regions of the aortic arch. In vitro, small interfering RNA against PECAM-1 blocked the induction of FN and the activation of nuclear factor (NF)-kappaB by atheroprone flow, which was rescued by the addition of exogenous FN. Additionally, blocking NF-kappaB activation attenuated the flow-induced FN expression. Small interfering RNA against FN significantly reduced NF-kappaB activity, which was rescued by the addition of exogenous FN. CONCLUSIONS: These results indicate that FN gene expression and assembly into matrix fibrils is induced by atheroprone fluid shear stress. This effect is mediated at least in part by the transcription factor NF-kappaB. Additionally, because FN promotes activation of NF-kappaB, atheroprone shear stress creates a positive feedback to maintain inflammation.
        PMID: 20378855 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Survivin is a key factor in the differential susceptibility of gastric endothelial and epithelial cells to alcohol-induced injury.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24465.html</link>
      <description>Related Articles Survivin is a key factor in the differential susceptibility of gastric endothelial and epithelial cells to alcohol-induced injury. J Physiol Pharmacol. 2010 Jun;61(3):253-64 Authors: Jones MK, Padilla OR, Zhu E We previously demonstrated that the anti-apoptosis protein, survivin, plays a protective role against alcohol-induced gastric injury. Since the endothelium is a primary target of alcohol-induced gastric damage, we investigated whether survivin expression is a key factor i ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24465.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Survivin is a key factor in the differential susceptibility of gastric endothelial and epithelial cells to alcohol-induced injury.
        J Physiol Pharmacol. 2010 Jun;61(3):253-64
        Authors:  Jones MK, Padilla OR, Zhu E
        We previously demonstrated that the anti-apoptosis protein, survivin, plays a protective role against alcohol-induced gastric injury. Since the endothelium is a primary target of alcohol-induced gastric damage, we investigated whether survivin expression is a key factor in the greater susceptibility of gastric endothelial vs. epithelial cells to alcohol-induced injury. Here, we demonstrate that rat gastric epithelial cells (RGM1 cells, an epithelial cell line derived from normal rat gastric mucosa) expressed 7.5-fold greater survivin protein levels vs. rat gastric endothelial cells. Survivin expression correlated with resistance of gastric epithelial vs. endothelial cells to both alcohol-induced cell damage and alcohol-induced apoptosis. Suppression of survivin protein expression levels using siRNA rendered the gastric epithelial cells as susceptible to both alcohol-induced cell damage and apoptosis as the gastric endothelial cells. Conversely, forced overexpression of survivin by transient transfection rendered gastric endothelial cells as resistant to both alcohol-induced cell damage and apoptosis as mock-transfected gastric epithelial cells. Moreover, overexpression of a threonine-34 to glutamate phosphorylation mimic mutant survivin construct rendered gastric endothelial cells significantly more resistant to alcohol-induced damage and apoptosis vs. mock-transfected gastric epithelial cells. These findings indicate that disparate survivin expression levels can explain the discrepancy between gastric epithelial and endothelial cell susceptibility to alcohol-induced injury; and, that a negative charge at amino acid residue 34 on survivin, such as that which naturally occurs by phosphorylation of threonine-34, enhances its property in conferring gastric mucosal protection.
        PMID: 20610854 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24462.html</link>
      <description>Related Articles Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages. FEBS J. 2010 Jul 1; Authors: Mayi TH, Duhem C, Copin C, Bouhlel MA, Rigamonti E, Pattou F, Staels B, Chinetti-Gbaguidi G Obesity is a low-grade chronic inflammatory disease associated with an increased number of macrophages (adipose tissue macrophages) in adipose tissue. Within the adipose tissue, adipose tissue macrophages are the major source of visfatin/pre-B-cell colony-enhancing fa ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24462.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages.
        FEBS J. 2010 Jul 1;
        Authors:  Mayi TH, Duhem C, Copin C, Bouhlel MA, Rigamonti E, Pattou F, Staels B, Chinetti-Gbaguidi G
        Obesity is a low-grade chronic inflammatory disease associated with an increased number of macrophages (adipose tissue macrophages) in adipose tissue. Within the adipose tissue, adipose tissue macrophages are the major source of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyl transferase. The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) exerts anti-inflammatory effects in macrophages by inhibiting cytokine production and enhancing alternative differentiation. In this study, we investigated whether PPARgamma modulates visfatin expression in murine (bone marrow-derived macrophage) and human (primary human resting macrophage, classical macrophage, alternative macrophage or adipose tissue macrophage) macrophage models and pre-adipocyte-derived adipocytes. We show that synthetic PPARgamma ligands increase visfatin gene expression in a PPARgamma-dependent manner in primary human resting macrophages and in adipose tissue macrophages, but not in adipocytes. The threefold increase of visfatin mRNA was paralleled by an increase of protein expression (30%) and secretion (30%). Electrophoretic mobility shift assay experiments and transient transfection assays indicated that PPARgamma induces visfatin promoter activity in human macrophages by binding to a DR1-PPARgamma response element. Finally, we show that PPARgamma ligands increase NAD(+) production in primary human macrophages and that this regulation is dampened in the presence of visfatin small interfering RNA or by the visfatin-specific inhibitor FK866. Taken together, our results suggest that PPARgamma regulates the expression of visfatin in macrophages, leading to increased levels of NAD(+).
        PMID: 20608974 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Electromagnetic-Guided Dynamic Multileaf Collimator Tracking Enables Motion Management for Intensity-Modulated Arc Therapy.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24467.html</link>
      <description>Related Articles Electromagnetic-Guided Dynamic Multileaf Collimator Tracking Enables Motion Management for Intensity-Modulated Arc Therapy. Int J Radiat Oncol Biol Phys. 2010 Jul 7; Authors: Keall PJ, Sawant A, Cho B, Ruan D, Wu J, Poulsen P, Petersen J, Newell LJ, Cattell H, Korreman S PURPOSE: Intensity-modulated arc therapy (IMAT) is attractive because of high-dose conformality and efficient delivery. However, managing intrafraction motion is challenging for IMAT. The purpose of this researc ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24467.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Electromagnetic-Guided Dynamic Multileaf Collimator Tracking Enables Motion Management for Intensity-Modulated Arc Therapy.
        Int J Radiat Oncol Biol Phys. 2010 Jul 7;
        Authors:  Keall PJ, Sawant A, Cho B, Ruan D, Wu J, Poulsen P, Petersen J, Newell LJ, Cattell H, Korreman S
        PURPOSE: Intensity-modulated arc therapy (IMAT) is attractive because of high-dose conformality and efficient delivery. However, managing intrafraction motion is challenging for IMAT. The purpose of this research was to develop and investigate electromagnetically guided dynamic multileaf collimator (DMLC) tracking as an enabling technology to treat moving targets during IMAT. METHODS AND MATERIALS: A real-time three-dimensional DMLC-based target tracking system was developed and integrated with a linear accelerator. The DMLC tracking software inputs a real-time electromagnetically measured target position and the IMAT plan, and dynamically creates new leaf positions directed at the moving target. Low- and high-modulation IMAT plans were created for lung and prostate cancer cases. The IMAT plans were delivered to a three-axis motion platform programmed with measured patient motion. Dosimetric measurements were acquired by placing an ion chamber array on the moving platform. Measurements were acquired with tracking, without tracking (current clinical practice), and with the phantom in a static position (reference). Analysis of dose distribution differences from the static reference used a gamma-test. RESULTS: On average, 1.6% of dose points for the lung plans and 1.2% of points for the prostate plans failed the 3-mm/3% gamma-test with tracking; without tracking, 34% and 14% (respectively) of points failed the gamma-test. The delivery time was the same with and without tracking. CONCLUSIONS: Electromagnetic-guided DMLC target tracking with IMAT has been investigated for the first time. Dose distributions to moving targets with DMLC tracking were significantly superior to those without tracking. There was no loss of treatment efficiency with DMLC tracking.
        PMID: 20615630 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Small Molecule Inhibitors of Mitochondrial Division: Tools that Translate Basic Biological Research into Medicine.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24466.html</link>
      <description>Related Articles Small Molecule Inhibitors of Mitochondrial Division: Tools that Translate Basic Biological Research into Medicine. Chem Biol. 2010 Jun 25;17(6):578-583 Authors: Lackner LL, Nunnari J Mitochondria do not exist as discrete static entities; rather, mitochondria form a network that continuously moves, divides, and fuses. The structure of this dynamic network is in part maintained by a balance of division and fusion events (Hoppins et al., 2007). The ratio of division to fusion event ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24466.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Small Molecule Inhibitors of Mitochondrial Division: Tools that Translate Basic Biological Research into Medicine.
        Chem Biol. 2010 Jun 25;17(6):578-583
        Authors:  Lackner LL, Nunnari J
        Mitochondria do not exist as discrete static entities; rather, mitochondria form a network that continuously moves, divides, and fuses. The structure of this dynamic network is in part maintained by a balance of division and fusion events (Hoppins et al., 2007). The ratio of division to fusion events that defines a proper balance is not universal but varies with developmental stage, cell type, and biological circumstances. This is evident throughout the cell cycle in higher eukaryotes, where mitochondria elongate during the G1/S transition and fragment at the onset of mitosis, and when mitochondria fragment in response to certain cellular stimuli, such as increases in cytosolic calcium levels (Breckenridge et al., 2003; Cereghetti et al., 2008; Han et al., 2008; Mitra et al., 2009; Taguchi et al., 2007). The functional state and distribution of mitochondria are clearly influenced by its steady-state structure. When the normal balance of division and fusion is disrupted as a consequence of the inappropriate stimulation or inhibition of either process, problems arise at the cellular level that compromises the well-being of the organism as a whole. This is evident by the ever-increasing number of diseases in which abnormal mitochondrial dynamics have been etiologically implicated. In this context, the mitochondrial division and fusion machines are valuable and interesting targets of small molecule effectors, as inhibition or activation of these processes may be able to restore the proper dynamic balance and function. A small molecule inhibitor of mitochondrial division, mdivi-1, has already been identified and characterized (Cassidy-Stone et al., 2008). This inhibitor has provided valuable insight into the mechanism of mitochondrial division and has shown great therapeutic promise in a wide array of disease models. This review will focus on small molecule effectors of mitochondrial division, discussing their value in basic biological research as well as their therapeutic potential.
        PMID: 20609407 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>癌; +960の新しい参照 (cancer; +960 new citations)</title>
  <link>http://biomarket.jp/modules/pubmed/article-24468.html</link>
      <description>960の新しいpubmed参照はあなたの調査のために取り出された。完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:癌これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/10 PubMedの薬の国立図書館のサービスで、含んでいる発生した。これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:960 new pubmed citations were retrieved for your search.Click on the search ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24468.html</guid>
        
      <content:encoded> <![CDATA[
    960の新しいpubmed参照はあなたの調査のために取り出された。
完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:

癌
これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/10 PubMedの薬の国立図書館のサービスで、含んでいる発生した。
これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:960 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

cancer
These pubmed results were generated on 2010/07/10PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.)
    ]]> </content:encoded>
                                </item>
  <item>
  <title>cancer; +960 new citations</title>
  <link>http://biomarket.jp/modules/pubmed/article-24550.html</link>
      <description>960 new pubmed citations were retrieved for your search.Click on the search hyperlink below to display the complete search results:cancerThese pubmed results were generated on 2010/07/10PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950&apos;s.These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.</description>
        <pubDate>Sun, 11 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24550.html</guid>
        
      <content:encoded> <![CDATA[
    
960 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

cancer
These pubmed results were generated on 2010/07/10PubMed, a service of the National Library of Medicine, includes over 15 million 
citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. 
PubMed includes links to many sites providing full text articles and other related resources.

    ]]> </content:encoded>
                                </item>
  <item>
  <title>TNF{alpha}-induced IP3R1 expression through TNFR1/PC-PLC/PKC{alpha} and TNFR2 signalling pathways in human mesangial cell.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24545.html</link>
      <description>Related Articles TNF{alpha}-induced IP3R1 expression through TNFR1/PC-PLC/PKC{alpha} and TNFR2 signalling pathways in human mesangial cell. Nephrol Dial Transplant. 2010 Jul 7; Authors: Wang YR, Li ZG, Fu JL, Wang ZH, Wen Y, Liu P BACKGROUND: Little information is available regarding the mechanisms involved in cytokine-induced type 1 inositol 1,4,5-trisphosphate receptor (IP(3)R1) expression in human mesangial cells (HMCs) in the occurrence of hepatorenal syndrome (HRS). Over-expression of IP(3) ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24545.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        TNF{alpha}-induced IP3R1 expression through TNFR1/PC-PLC/PKC{alpha} and TNFR2 signalling pathways in human mesangial cell.
        Nephrol Dial Transplant. 2010 Jul 7;
        Authors:  Wang YR, Li ZG, Fu JL, Wang ZH, Wen Y, Liu P
        BACKGROUND: Little information is available regarding the mechanisms involved in cytokine-induced type 1 inositol 1,4,5-trisphosphate receptor (IP(3)R1) expression in human mesangial cells (HMCs) in the occurrence of hepatorenal syndrome (HRS). Over-expression of IP(3)R1 would enhance both IP(3)-binding activity and sensitivity. We hypothesize that it is possible that increased IP(3)R1, induced by TNFalpha, would lead to increased IP(3) sensitivity in response to a variety of vasoconstrictors, and promote HMC contraction and thus lead to reduced GFP, promoting HRS occurrence and development. METHODS: Quantitative real-time polymerase chain reaction and immunoblot assay were used to examine the effects of TNFalpha on IP(3)R1 mRNA and protein expression. Several inhibitors of kinases, depletion PKC, over-expression of dominant-negative mutant of PKC and non-radioactive PKC assay were used to examine the mechanism of signal transduction of TNFalpha-regulated IP(3)R1 in HMCs. RESULTS: TNFalpha increased IP(3)R1 mRNA and protein expression in HMCs, an effect that was blocked by prolonged incubated chronic PMA, D609, safingol and also by transfection with domain-negative PKCalpha construct. TNFalpha activated and promoted autophosphorylation of the PKCalpha. In addition, both anti-TNFR1 and anti-TNFR2 antibodies blocked TNFalpha-induced IP(3)R1 protein expression, while only anti-TNFR1 antibodies but not anti-TNFR2 antibodies attenuated TNFalpha-induced PKCalpha activity. Conclusions. TNFalpha increased the expression of IP(3)R1, and this was mediated, at least in part, through the TNFR1/PC-PLC/PKCalpha and TNFR2 signalling pathways in HMCs.
        PMID: 20615908 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Establishment of recombinant cannabinoid receptor assays and characterization of several natural and synthetic ligands.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24549.html</link>
      <description>Related Articles Establishment of recombinant cannabinoid receptor assays and characterization of several natural and synthetic ligands. Naunyn Schmiedebergs Arch Pharmacol. 2010 Jul 9; Authors: Geiger S, Nickl K, Schneider EH, Seifert R, Heilmann J Cannabinoid receptors (CBR) are important drug targets for the treatment of various inflammatory, metabolic and neurological diseases. Therefore, sensitive test systems for the assessment of ligands are needed. In this study, a steady-state GTPase as ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24549.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Establishment of recombinant cannabinoid receptor assays and characterization of several natural and synthetic ligands.
        Naunyn Schmiedebergs Arch Pharmacol. 2010 Jul 9;
        Authors:  Geiger S, Nickl K, Schneider EH, Seifert R, Heilmann J
        Cannabinoid receptors (CBR) are important drug targets for the treatment of various inflammatory, metabolic and neurological diseases. Therefore, sensitive test systems for the assessment of ligands are needed. In this study, a steady-state GTPase assay for human CBR subtypes 1 and 2 was developed to characterize the pharmacological property of ligands at a very proximal point of the signal transduction cascade. Establishing these in vitro test sytems, we studied cell or tissue membranes heterogenously or endogenously expressing CBR, such as CBR-infected Human Embryonic Kidney (HEK) 293 cells, rat cerebellum and spleen cells. The lack of effects in the GTPase assay and in [(35)S]GTPgammaS binding experiments in these expression system, directed us to use Spodoptera frugiperda (Sf9) cells. Co-expressing CBR, different Galpha-subunits, Gbetagamma heterodimer, and RGS (Regulator of G-protein signaling)-proteins in Sf9 cell membranes greatly improved the sensitivity of the assay, with highest GTPase activation in the CBR + Galpha(i2) + Gbeta(1)gamma(2) + RGS4 system. We examined exogenous and endogenous standard ligands as well as secondary metabolites as Delta(9)-tetrahydrocannabinol (Delta(9)-THC), dodeca-2E,4E-dienoic acid isobutylamide, an alkylamide from Echinacea purpurea, and an E. purpurea hexane extract according their agonistic and antagonistic properties. The suitability of the assay for screening procedures was also proven by detecting the activity of Delta(9)-THC in a matrix of other less active compounds (Delta(9)-THC-free Cannabis sativa extract). In conclusion, we have developed highly sensitive test systems for the analysis of CBR ligands.
        PMID: 20617431 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Dramatic Change in Function and Expression Pattern of a Gene Duplicated by Polyploidy Created a Paternal Effect Gene in the Brassicaceae.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24546.html</link>
      <description>Related Articles Dramatic Change in Function and Expression Pattern of a Gene Duplicated by Polyploidy Created a Paternal Effect Gene in the Brassicaceae. Mol Biol Evol. 2010 Jul 8; Authors: Liu SL, Adams KL New gene formation by polyploidy has been an ongoing process during the evolution of various eukaryotes that has contributed greatly to the large number of genes in their genomes. After duplication, some genes that are retained can acquire new functions or expression patterns, or subdivide t ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24546.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Dramatic Change in Function and Expression Pattern of a Gene Duplicated by Polyploidy Created a Paternal Effect Gene in the Brassicaceae.
        Mol Biol Evol. 2010 Jul 8;
        Authors:  Liu SL, Adams KL
        New gene formation by polyploidy has been an ongoing process during the evolution of various eukaryotes that has contributed greatly to the large number of genes in their genomes. After duplication, some genes that are retained can acquire new functions or expression patterns, or subdivide their functions or expression patterns between duplicates. Here we show that SHORT SUSPENSOR (SSP) and Brassinosteroid Kinase 1 (BSK1) are paralogs duplicated by a polyploidy event that occurred in the Brassicaceae family about 23 MYA. SSP is involved in paternal control of zygote elongation in Arabidopsis thaliana by transcription in the sperm cells of pollen and then translation in the zygote, whereas BSK1 is involved in brassinosteroid signal transduction. Comparative analysis of expression in 63 different organs and developmental stages revealed that BSK1 and SSP have opposite expression patterns in pollen compared with all other parts of the plant. We determined that BSK1 retains the ancestral expression pattern and function. Thus SSP has diverged in function after duplication from a component of the brassinosteroid signaling pathway to a paternal regulator of the timing of zygote elongation. The ancestral function of SSP was lost by deletions in the kinase domain. Our sequence rate analysis revealed that SSP, but not BSK1, has experienced a greatly accelerated rate of amino acid sequence changes, and relaxation of purifying selection. In addition, SSP has been duplicated to create a new gene (SSP-like1) with a completely different expression pattern, a shorter coding sequence that has lost a critical functional domain, and a greatly accelerated rate of amino acid sequence evolution along with evidence for positive selection, together indicative of neofunctionalization. This study illustrates two dramatic examples of neofunctionalization following gene duplication by complete changes in expression pattern and function. In addition, our findings indicate that paternal control of zygote elongation by SSP is an evolutionarily recent innovation in the Brassicaceae family.
        PMID: 20616146 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Ontogenomic Study of the Relationship Between Number of Gene Splice Variants and Go Categorization.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24548.html</link>
      <description>Related Articles Ontogenomic Study of the Relationship Between Number of Gene Splice Variants and Go Categorization. Bioinformatics. 2010 Jul 8; Authors: Kahn AB, Zeeberg BR, Ryan MC, Jamison DC, Rockoff DM, Pommier Y, Weinstein JN MOTIVATION: Splice variation plays important roles in evolution and cancer. Different splice variants of a gene may be characteristic of particular cellular processes, subcellular locations, or organs. Although several genomics projects have identified splice variants ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24548.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Ontogenomic Study of the Relationship Between Number of Gene Splice Variants and Go Categorization.
        Bioinformatics. 2010 Jul 8;
        Authors:  Kahn AB, Zeeberg BR, Ryan MC, Jamison DC, Rockoff DM, Pommier Y, Weinstein JN
        MOTIVATION: Splice variation plays important roles in evolution and cancer. Different splice variants of a gene may be characteristic of particular cellular processes, subcellular locations, or organs. Although several genomics projects have identified splice variants, there are no large-scale computational studies of the relationship between number of splice variants and biological function. The Gene Ontology (GO) and tools for leveraging GO, such as GoMiner, now make such a study feasible. RESULTS: We partitioned genes into two groups: those with numbers of splice variants </= b and > b (b = 1,,10). Then we used GoMiner to determine whether any GO categories are enriched in genes with particular numbers of splice variants. Since there was no a priori "appropriate" partition boundary, we studied those "robust" categories whose enrichment did not depend on the selection of a particular partition boundary. Furthermore, because the distribution of splice variant number was a snapshot taken at a particular point in time, we confirmed that those observations were stable across successive versions of the human genome and GenBank. A small number of categories were found for genes in the lower partitions. Those categories were associated exclusively with sensory perception. A larger number of categories were found for genes in the higher partitions. Those categories were largely associated with cell death and signal transduction. Apoptotic genes tended to have a large repertoire of splice variants, and genes with splice variants exhibited a distinctive "apoptotic island" in CIMs.
        PMID: 20616384 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Sumoylation and regulation of cardiac gene expression.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24547.html</link>
      <description>Related Articles Sumoylation and regulation of cardiac gene expression. Circ Res. 2010 Jul 9;107(1):19-29 Authors: Wang J, Schwartz RJ Abstract: Sumoylation is a posttranslational modification process in which SUMO proteins are covalently and reversibly conjugated to their targets via enzymatic cascade reactions. Since the discovery of SUMO-1 in 1996, the SUMO pathway has garnered increased attention due to its role in a number of important biological activities such as cell cycle progression, e ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24547.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Sumoylation and regulation of cardiac gene expression.
        Circ Res. 2010 Jul 9;107(1):19-29
        Authors:  Wang J, Schwartz RJ
        Abstract: Sumoylation is a posttranslational modification process in which SUMO proteins are covalently and reversibly conjugated to their targets via enzymatic cascade reactions. Since the discovery of SUMO-1 in 1996, the SUMO pathway has garnered increased attention due to its role in a number of important biological activities such as cell cycle progression, epigenetic modulation, signal transduction, and DNA replication/repair, as well as its potential implication in human pathogenesis such as in cancer development and metastasis, neurodegenerative disorders and craniofacial defects. The role of the SUMO pathway in regulating cardiogenic gene activity, development and/or disorders is just emerging. Our review is based on recent advances that highlight the regulation of cardiac gene activity in cardiac development and disease by the SUMO conjugation pathway.
        PMID: 20616338 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>biological chemistry; +449 new citations</title>
  <link>http://biomarket.jp/modules/pubmed/article-24551.html</link>
      <description>449 new pubmed citations were retrieved for your search.Click on the search hyperlink below to display the complete search results:biological chemistryThese pubmed results were generated on 2010/07/10PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950&apos;s.These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.</description>
        <pubDate>Sun, 11 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24551.html</guid>
        
      <content:encoded> <![CDATA[
    
449 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

biological chemistry
These pubmed results were generated on 2010/07/10PubMed, a service of the National Library of Medicine, includes over 15 million 
citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. 
PubMed includes links to many sites providing full text articles and other related resources.

    ]]> </content:encoded>
                                </item>
  <item>
  <title>single cell; +160 new citations</title>
  <link>http://biomarket.jp/modules/pubmed/article-24552.html</link>
      <description>160 new pubmed citations were retrieved for your search.Click on the search hyperlink below to display the complete search results:single cellThese pubmed results were generated on 2010/07/10PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950&apos;s.These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.</description>
        <pubDate>Sun, 11 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24552.html</guid>
        
      <content:encoded> <![CDATA[
    
160 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

single cell
These pubmed results were generated on 2010/07/10PubMed, a service of the National Library of Medicine, includes over 15 million 
citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. 
PubMed includes links to many sites providing full text articles and other related resources.

    ]]> </content:encoded>
                                </item>
  <item>
  <title>miR-214 Regulates Lactoferrin Expression and Pro-Apoptotic Function in Mammary Epithelial Cells.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10798.html</link>
      <description>Related Articles miR-214 Regulates Lactoferrin Expression and Pro-Apoptotic Function in Mammary Epithelial Cells. J Nutr. 2010 Jul 7; Authors: Liao Y, Du X, LÃ¶nnerdal B Lactoferrin (Lf) is an abundantly expressed protein in human milk. Lactoferrin exhibits several important biological functions, and its expression is regulated by multiple environmental factors. Cellular endogenous factors, however, have not been extensively studied with regard to lactoferrin gene expression. In this study, w ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10798.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        miR-214 Regulates Lactoferrin Expression and Pro-Apoptotic Function in Mammary Epithelial Cells.
        J Nutr. 2010 Jul 7;
        Authors:  Liao Y, Du X, LÃ¶nnerdal B
        Lactoferrin (Lf) is an abundantly expressed protein in human milk. Lactoferrin exhibits several important biological functions, and its expression is regulated by multiple environmental factors. Cellular endogenous factors, however, have not been extensively studied with regard to lactoferrin gene expression. In this study, we showed that lactoferrin gene expression and function are directly targeted by miR-214 in HC11 and MCF7 cells. In the lactoferrin mRNA 3' untranslated region (UTR) of human, mouse, rat, pig, bovine, camel, and goat species, there is a conserved region that perfectly matches the seed region of miR-214. Transfection of miR-214 mimic in HEK293 cells dose-dependently inhibited the activity of pGL3-control vector containing lactoferrin mRNA 3'UTR downstream of the luciferase gene. In HC11 cells, miR-214 overexpression inhibited the induction of lactoferrin expression by beta-estradiol (E2) and dexamethasone-prolactin-insulin (DPI). Furthermore, in MCF7 cells, overexpression of miR-214 markedly decreased lactoferrin expression (P < 0.05), and inhibition of endogenous miR-214 expression increased lactoferrin expression and cellular apoptotic activities (P < 0.05). In summary, our data showed that miR-214 is directly involved in lactoferrin expression and lactoferrin mediated cancer susceptibility (proapoptotic activities) in mammary epithelial cells.
        PMID: 20610637 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Efficient method for production of high yields of Fab fragments in Drosophila S2 cells.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10795.html</link>
      <description> Related Articles Efficient method for production of high yields of Fab fragments in Drosophila S2 cells. Protein Eng Des Sel. 2010 Apr;23(4):169-74 Authors: Backovic M, Johansson DX, Klupp BG, Mettenleiter TC, Persson MA, Rey FA Fab molecules are used as therapeutic agents, and are invaluable tools in structural biology. We report here a method for production of recombinant Fab in Drosophila S2 cells for use in structural biology. Stably transfected S2 cell lines expressing the Fab were created ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10795.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Efficient method for production of high yields of Fab fragments in Drosophila S2 cells.
        Protein Eng Des Sel. 2010 Apr;23(4):169-74
        Authors:  Backovic M, Johansson DX, Klupp BG, Mettenleiter TC, Persson MA, Rey FA
        Fab molecules are used as therapeutic agents, and are invaluable tools in structural biology. We report here a method for production of recombinant Fab in Drosophila S2 cells for use in structural biology. Stably transfected S2 cell lines expressing the Fab were created within weeks. The recombinant Fab was secreted, and after affinity and size exclusion chromatography, 16 mg of pure protein were obtained from a liter of cell culture. The Fab was functional and formed a complex with its cognate antigen as demonstrated by co-precipitation and size exclusion chromatography. Biochemical characterization indicated that the Fab from S2 cells is less extensively glycosylated than the Fab obtained by digestion of antibody produced in hybridoma cells, a feature that may be advantageous for the purposes of crystallogenesis. Taken together, obtaining recombinant Fab from the S2 cells has been a faster and considerably more cost-effective method compared with the enzymatic digestion of the monoclonal antibody.
        PMID: 20100703 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Single nucleotide polymorphism associated with nonsyndromic cleft palate influences the processing of miR-140.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10797.html</link>
      <description> Related Articles Single nucleotide polymorphism associated with nonsyndromic cleft palate influences the processing of miR-140. Am J Med Genet A. 2010 Apr;152A(4):856-62 Authors: Li L, Meng T, Jia Z, Zhu G, Shi B Nonsyndromic oral cleft is a common developmental malformation of humans. Embryonic development is regulated by microRNAs. MicroRNA-140-5p (miR-140-5p) was found to regulate palatal development. As sequence variants in miRNA genes are likely to affect miRNA expression and/or maturation ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10797.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Single nucleotide polymorphism associated with nonsyndromic cleft palate influences the processing of miR-140.
        Am J Med Genet A. 2010 Apr;152A(4):856-62
        Authors:  Li L, Meng T, Jia Z, Zhu G, Shi B
        Nonsyndromic oral cleft is a common developmental malformation of humans. Embryonic development is regulated by microRNAs. MicroRNA-140-5p (miR-140-5p) was found to regulate palatal development. As sequence variants in miRNA genes are likely to affect miRNA expression and/or maturation, we investigated the miRNA-140 gene and identified a SNP (rs7205289: C>A) located in precursor miRNA-140. We carried out a case-control analysis in 557 patients with nonsyndromic oral clefts and 306 unaffected controls from west China and found that the frequency of minor allele (A allele) was significantly increased (P = 0.003 after Bonferroni correction) in nonsyndromic cleft palate (NSCP) patients in comparison with that in controls. We constructed expression vectors of primary miRNA-140 (pri-miR-140) with the major and minor alleles of rs7205289. The vectors were transfected into HEK293 cells, and the mature forms of miR-140 were detected by Northern blot. Compared to the vector with the C allele, the vector with the A allele was found to influence the miR-140 processing, resulting in a significant decrease of miR-140-5p and an increase of miR-140-3p. These results suggest that the SNP located in pre-miR-140 contributes to NSCP susceptibility by influencing the processing of miR-140.
        PMID: 20358594 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>piggyBac transposon-mediated long-term gene expression in mice.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10796.html</link>
      <description> Related Articles piggyBac transposon-mediated long-term gene expression in mice. Mol Ther. 2010 Apr;18(4):707-14 Authors: Nakanishi H, Higuchi Y, Kawakami S, Yamashita F, Hashida M Transposons are promising systems for somatic gene integration because they can not only integrate exogenous genes efficiently, but also be delivered to a variety of organs using a range of transfection methods. piggyBac (PB) transposon has a high transposability in mammalian cells in vitro, and has been used for gen ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10796.html</guid>
        
      <content:encoded> <![CDATA[
    
  Related Articles
        piggyBac transposon-mediated long-term gene expression in mice.
        Mol Ther. 2010 Apr;18(4):707-14
        Authors:  Nakanishi H, Higuchi Y, Kawakami S, Yamashita F, Hashida M
        Transposons are promising systems for somatic gene integration because they can not only integrate exogenous genes efficiently, but also be delivered to a variety of organs using a range of transfection methods. piggyBac (PB) transposon has a high transposability in mammalian cells in vitro, and has been used for genetic and preclinical studies. However, the transposability of PB in mammalian somatic cells in vivo has not been demonstrated yet. Here, we demonstrated PB-mediated sustained gene expression in adult mice. We constructed PB-based plasmid DNA (pDNA) containing reporter [firefly and Gaussia luciferase (Gluc)] genes. Mice were transfected by injection of these pDNAs using a hydrodynamics-based procedure, and the conditions for high-level sustained gene expression were examined. Consequently, gene expressions were sustained over 2 months. Our results suggest that PB is useful for organ-selective somatic integration and sustained gene expression in mammals, and will contribute to basic genetic studies and gene therapies.
        PMID: 20104210 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Heterodimerization of hypothalamic G-protein-coupled receptors involved in weight regulation.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10794.html</link>
      <description> Related Articles Heterodimerization of hypothalamic G-protein-coupled receptors involved in weight regulation. Obes Facts. 2009;2(2):80-6 Authors: Rediger A, Tarnow P, Bickenbach A, Schaefer M, Krude H, Gruters A, Biebermann H BACKGROUND: Melanocortin 3 and 4 receptors (MC3R and MC4R) are known to play an essential role in hypothalamic weight regulation. In addition to these two G-protein-coupled receptors (GPCRs), a huge number of other GPCRs are expressed in hypothalamic regions, and some of  ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10794.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Heterodimerization of hypothalamic G-protein-coupled receptors involved in weight regulation.
        Obes Facts. 2009;2(2):80-6
        Authors:  Rediger A, Tarnow P, Bickenbach A, Schaefer M, Krude H, Gruters A, Biebermann H
        BACKGROUND: Melanocortin 3 and 4 receptors (MC3R and MC4R) are known to play an essential role in hypothalamic weight regulation. In addition to these two G-protein-coupled receptors (GPCRs), a huge number of other GPCRs are expressed in hypothalamic regions, and some of them are involved in weight regulation. So far, homodimerization was shown for a few of these receptors. Heterodimerization of unrelated receptors may have profound functional consequence but heterodimerization of GPCRs involved in weight regulation was not reported yet. METHODS: A selective number of hypothalamically expressed GPCRs were cloned into a eukaryotic expression vector. Cell surface expression was demonstrated by an ELISA approach. Subcellular distribution was investigated by confocal laser microscopy. A sandwich ELISA and fluorescence resonance energy transfer (FRET) were used to determine protein-protein interaction. RESULTS: Via sandwich ELISA and FRET approach we could demonstrate a robust interaction of the MC4R with GPR7, both of which are expressed in the hypothalamic nucleus paraventricularis. Moreover, we determined a strong interaction of MC3R with the growth hormone secretagogue receptor expressed in the nucleus arcuatus. CONCLUSION: Identification GPCR heterodimerization adds to the understanding of the complexity of weight regulation and may provide important information to develop therapeutic strategies to treat obesity.
        PMID: 20054210 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>5th Annual Conference of the Organisation of Oncology and Translational Research. Foreword.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10807.html</link>
      <description>Related Articles 5th Annual Conference of the Organisation of Oncology and Translational Research. Foreword. Expert Opin Investig Drugs. 2010 Apr;19 Suppl 1:S1-2 Authors: GlÃ?ck S PMID: 20374020 [PubMed - indexed for MEDLINE] </description>
        <pubDate>Sun, 11 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10807.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        5th Annual Conference of the Organisation of Oncology and Translational Research. Foreword.
        Expert Opin Investig Drugs. 2010 Apr;19 Suppl 1:S1-2
        Authors:  GlÃ?ck S
        
        PMID: 20374020 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10809.html</link>
      <description>Related Articles Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP. J Affect Disord. 2010 Jul 5; Authors: Keers R, Uher R, Gupta B, Rietschel M, Schulze TG, Hauser J, Skibinska M, Henigsberg N, Kalember P, Maier W, Zobel A, Mors O, Kristensen AS, Kozel D, Giovannini C, Mendlewicz J, Kumar S, McGuffin P, Farmer AE, Aitchison KJ BACKGROUND: The occurrence of stressful life events (SLEs) has been shown to predict response to antidepressants; however,  ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10809.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.
        J Affect Disord. 2010 Jul 5;
        Authors:  Keers R, Uher R, Gupta B, Rietschel M, Schulze TG, Hauser J, Skibinska M, Henigsberg N, Kalember P, Maier W, Zobel A, Mors O, Kristensen AS, Kozel D, Giovannini C, Mendlewicz J, Kumar S, McGuffin P, Farmer AE, Aitchison KJ
        BACKGROUND: The occurrence of stressful life events (SLEs) has been shown to predict response to antidepressants; however, results are inconsistent. There is some evidence to suggest that SLEs prior to treatment are associated with greater cognitive symptoms at baseline and may therefore predict changes in these symptoms specifically. METHODS: GENDEP, a prospective part-randomised pharmacogenomics trial, collected longitudinal data on the symptoms of patients with major depression treated with either a selective serotonin reuptake inhibitor (SSRI, escitalopram) or a tricyclic antidepressant (TCA, nortriptyline). Data on life events experienced in the 6months preceding treatment measured using the List of Threatening Experiences Questionnaire (LTE-Q) were available for 728 participants. RESULTS: Both the occurrence and number of SLEs were associated with greater cognitive but not mood or neurovegetative symptoms prior to treatment. Those who reported SLEs also experienced a greater decline in cognitive symptoms during treatment with escitalopram, but not with nortriptyline. LIMITATIONS: Life events were measured retrospectively using a self-report checklist and are therefore subject to a number of biases especially in the context of depressive illness. CONCLUSIONS: These findings are in line with cognitive theories of depression and suggest that symptomatic heterogeneity may have contributed to inconsistencies in studies reported to date. Our results also tentatively suggest a clinically relevant drug specific effect of SLEs. Specifically, those reporting stress may benefit more from treatment with SSRIs than TCAs.
        PMID: 20609482 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Pharmacogenetics raises new legal questions.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10811.html</link>
      <description>Related Articles Pharmacogenetics raises new legal questions. Nat Med. 2010 Jul;16(7):729 Authors: Hutson S PMID: 20613735 [PubMed - in process] </description>
        <pubDate>Sun, 11 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10811.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Pharmacogenetics raises new legal questions.
        Nat Med. 2010 Jul;16(7):729
        Authors:  Hutson S
        
        PMID: 20613735 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Cellular Form of Prion Protein Inhibits Reelin-Mediated Shedding of Caspr from the Neuronal Cell Surface to Potentiate Caspr-Mediated Inhibition of Neurite Outgrowth.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10810.html</link>
      <description>Related Articles Cellular Form of Prion Protein Inhibits Reelin-Mediated Shedding of Caspr from the Neuronal Cell Surface to Potentiate Caspr-Mediated Inhibition of Neurite Outgrowth. J Neurosci. 2010 Jul 7;30(27):9292-9305 Authors: Devanathan V, Jakovcevski I, Santuccione A, Li S, Lee HJ, Peles E, Leshchyns&apos;ka I, Sytnyk V, Schachner M Extension of axonal and dendritic processes in the CNS is tightly regulated by outgrowth-promoting and -inhibitory cues to assure precision of synaptic connection ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10810.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Cellular Form of Prion Protein Inhibits Reelin-Mediated Shedding of Caspr from the Neuronal Cell Surface to Potentiate Caspr-Mediated Inhibition of Neurite Outgrowth.
        J Neurosci. 2010 Jul 7;30(27):9292-9305
        Authors:  Devanathan V, Jakovcevski I, Santuccione A, Li S, Lee HJ, Peles E, Leshchyns'ka I, Sytnyk V, Schachner M
        Extension of axonal and dendritic processes in the CNS is tightly regulated by outgrowth-promoting and -inhibitory cues to assure precision of synaptic connections. We identify a novel role for contactin-associated protein (Caspr) as an inhibitory cue that reduces neurite outgrowth from CNS neurons. We show that proteolysis of Caspr at the cell surface is regulated by the cellular form of prion protein (PrP), which directly binds to Caspr. PrP inhibits Reelin-mediated shedding of Caspr from the cell surface, thereby increasing surface levels of Caspr and potentiating the inhibitory effect of Caspr on neurite outgrowth. PrP deficiency results in reduced levels of Caspr at the cell surface, enhanced neurite outgrowth in vitro, and more efficient regeneration of axons in vivo following spinal cord injury. Thus, we reveal a previously unrecognized role for Caspr and PrP in inhibitory modulation of neurite outgrowth in CNS neurons, which is counterbalanced by the proteolytic activity of Reelin.
        PMID: 20610764 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10808.html</link>
      <description>Related Articles Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms. Clin Pharmacokinet. 2010 Aug 1;49(8):549-58 Authors: Sugiyama E, Kaniwa N, Kim SR, Hasegawa R, Saito Y, Ueno H, Okusaka T, Ikeda M, Morizane C, Kondo S, Yamamoto N, Tamura T, Furuse J, Ishii H, Yoshida T, Saijo N, Sawada J Background and Objective: Gemcitabine (2&apos;,2&apos;-difluorodeoxycytidine) is an anticancer drug, which is effective against solid tumours, inc ...</description>
        <pubDate>Sun, 11 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10808.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms.
        Clin Pharmacokinet. 2010 Aug 1;49(8):549-58
        Authors:  Sugiyama E, Kaniwa N, Kim SR, Hasegawa R, Saito Y, Ueno H, Okusaka T, Ikeda M, Morizane C, Kondo S, Yamamoto N, Tamura T, Furuse J, Ishii H, Yoshida T, Saijo N, Sawada J
        Background and Objective: Gemcitabine (2',2'-difluorodeoxycytidine) is an anticancer drug, which is effective against solid tumours, including non-small-cell lung cancer and pancreatic cancer. After gemcitabine is transported into cells by equilibrative and concentrative nucleoside transporters, it is phosphorylated by deoxycytidine kinase (DCK) and further phosphorylated to its active diphosphorylated and triphosphorylated forms. Gemcitabine is rapidly metabolized by cytidine deaminase (CDA) to an inactive metabolite, 2',2'-difluorodeoxyuridine (dFdU), which is excreted into the urine. Toxicities of gemcitabine are generally mild, but unpredictable severe toxicities such as myelosuppression and interstitial pneumonia are occasionally encountered. The aim of this study was to determine the factors, including genetic polymorphisms of CDA, DCK and solute carrier family 29A1 (SLC29A1 [hENT1]), that alter the pharmacokinetics of gemcitabine in Japanese cancer patients. Patients and Methods: 250 Japanese cancer patients who received 30-minute intravenous infusions of gemcitabine at 800 or 1000 mg/m2 in the period between September 2002 and July 2004 were recruited for this study. However, four patients were excluded from the final model built in this study because they showed bimodal concentration-time curves. Two patients who experienced gemcitabine-derived life-threatening toxicities in October 2006 and January 2008 were added to this analysis. One of these patients received 30-minute intravenous infusions of gemcitabine at 454 mg/m2 instead of the usual dose (1000 mg/m2). Plasma concentrations of gemcitabine and dFdU were measured by high-performance liquid chromatography-photodiode array/mass spectrometry. In total, 1973 and 1975 plasma concentrations of gemcitabine and dFdU, respectively, were used to build population pharmacokinetic models using nonlinear mixed-effects modelling software (NONMEM(R) version V level 1.1). Results and Discussion: Two-compartment models fitted well to plasma concentration-time curves for both gemcitabine and dFdU. Major contributing factors for gemcitabine clearance were genetic polymorphisms of CDA, including homozygous CDA*3 [208G>A (Ala70Thr)] (64% decrease), heterozygous *3 (17% decrease) and CDA -31delC (an approximate 7% increase per deletion), which has a strong association with CDA*2 [79A>C (Lys27Gln)], and coadministered S-1, an oral, multicomponent anti-cancer drug mixture consisting of tegafur, gimeracil and oteracil (an approximate 19% increase). The estimated contribution of homozygous CDA*3 to gemcitabine clearance provides an explanation for the life-threatening severe adverse reactions, including grade 4 neutropenia observed in three Japanese patients with homozygous CDA*3. Genetic polymorphisms of DCK and SLC29A1 (hENT1) had no significant correlation with gemcitabine pharmacokinetic parameters. Aging and increased serum creatinine levels correlated with decreased dFdU clearance. Conclusion: A population pharmacokinetic model that included CDA genotypes as a covariate for gemcitabine and dFdU in Japanese cancer patients was successfully constructed. The model confirms the clinical importance of the CDA*3 genotype.
        PMID: 20608756 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>biological chemistry; +290 new citations</title>
  <link>http://biomarket.jp/modules/pubmed/article-23777.html</link>
      <description>290 new pubmed citations were retrieved for your search.Click on the search hyperlink below to display the complete search results:biological chemistryThese pubmed results were generated on 2010/07/06PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950&apos;s.These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.</description>
        <pubDate>Sat, 10 Jul 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23777.html</guid>
        
      <content:encoded> <![CDATA[
    
290 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

biological chemistry
These pubmed results were generated on 2010/07/06PubMed, a service of the National Library of Medicine, includes over 15 million 
citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. 
PubMed includes links to many sites providing full text articles and other related resources.

    ]]> </content:encoded>
                                </item>
  <item>
  <title>生物化学; +290の新しい参照 (biological chemistry; +290 new citations)</title>
  <link>http://biomarket.jp/modules/pubmed/article-23782.html</link>
      <description>290の新しいpubmed参照はあなたの調査のために取り出された。完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:生物化学これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/06 PubMedの薬の国立図書館のサービスで、含んでいる発生した。これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:290 new pubmed citations were retrieved for your search.Click on the  ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23782.html</guid>
        
      <content:encoded> <![CDATA[
    290の新しいpubmed参照はあなたの調査のために取り出された。
完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:

生物化学
これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/06 PubMedの薬の国立図書館のサービスで、含んでいる発生した。
これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:290 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

biological chemistry
These pubmed results were generated on 2010/07/06PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.)
    ]]> </content:encoded>
                                </item>
  <item>
  <title>免疫学; +122の新しい参照 (immulogy; +122 new citations)</title>
  <link>http://biomarket.jp/modules/pubmed/article-23882.html</link>
      <description>122の新しいpubmed参照はあなたの調査のために取り出された。完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:免疫学これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/06 PubMedの薬の国立図書館のサービスで、含んでいる発生した。これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:122 new pubmed citations were retrieved for your search.Click on the se ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23882.html</guid>
        
      <content:encoded> <![CDATA[
    122の新しいpubmed参照はあなたの調査のために取り出された。
完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:

免疫学
これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/06 PubMedの薬の国立図書館のサービスで、含んでいる発生した。
これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:122 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

immunology
These pubmed results were generated on 2010/07/06PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.)
    ]]> </content:encoded>
                                </item>
  <item>
  <title>癌; +498の新しい参照 (cancer; +498 new citations)</title>
  <link>http://biomarket.jp/modules/pubmed/article-23779.html</link>
      <description>498の新しいpubmed参照はあなたの調査のために取り出された。完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:癌これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/06 PubMedの薬の国立図書館のサービスで、含んでいる発生した。これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:498 new pubmed citations were retrieved for your search.Click on the search ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23779.html</guid>
        
      <content:encoded> <![CDATA[
    498の新しいpubmed参照はあなたの調査のために取り出された。
完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:

癌
これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/06 PubMedの薬の国立図書館のサービスで、含んでいる発生した。
これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:498 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

cancer
These pubmed results were generated on 2010/07/06PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.)
    ]]> </content:encoded>
                                </item>
  <item>
  <title>IMRT Implementation and Patient Specific Dose Verification with Film and Ion Chamber Array Detectors.</title>
  <link>http://biomarket.jp/modules/pubmed/article-23781.html</link>
      <description>Related Articles IMRT Implementation and Patient Specific Dose Verification with Film and Ion Chamber Array Detectors. Gulf J Oncolog. 2010 Jul;1(8):20-27 Authors: Sathiyan S, Ravikumar M, Varatharaj C, Supe SS, Keshava SL Implementation of Intensity Modulation Radiotherapy (IMRT) and patient dose verification was carried out with film and I&apos;mariXX using linear accelerator with 120-leaf Millennium dynamic multileaf collimator (dMLC). The basic mechanical and electrical commissioning and quality  ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23781.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        IMRT Implementation and Patient Specific Dose Verification with Film and Ion Chamber Array Detectors.
        Gulf J Oncolog. 2010 Jul;1(8):20-27
        Authors:  Sathiyan S, Ravikumar M, Varatharaj C, Supe SS, Keshava SL
        Implementation of Intensity Modulation Radiotherapy (IMRT) and patient dose verification was carried out with film and I'mariXX using linear accelerator with 120-leaf Millennium dynamic multileaf collimator (dMLC). The basic mechanical and electrical commissioning and quality assurance tests of linear accelerator were carried out. The leaf position accuracy and leaf position repeatability checks were performed for static MLC positions. Picket fence test and garden fence test were performed to check the stability of the dMLC and the reproducibility of the gap between leaves. The radiation checks were performed to verify the position accuracy of MLCs in the collimator system. The dMLC dosimetric checks like output stability, average leaf transmission and dosimetric leaf separation were also investigated. The variation of output with gravitation at different gantry angles was found to be within 0.9 %. The measured average leaf transmission for 6 MV was 1.6 % and 1.8% for 18 MV beam. The dosimetric leaf separation was found to be 2.2 mm and 2.3 mm for 6 MV and 18 MV beams. In order to check the consistency of the stability and the precision of the dMLC, it is necessary to carryout regular weekly and monthly checks. The dynalog files analysis for Garden fence, leaf gap width and step wedge test patterns carried out weekly were in good agreement. Pretreatment verification was performed for 50 patients with ion chamber and I'mariXX device. The variations of calculated absolute dose for all treatment fields with the ion chamber measurement were within the acceptable criterion. Treatment Planning System (TPS) calculated dose distribution pattern was comparable with the I'mariXX measured dose distribution pattern. Out of 50 patients for which the comparison was made, 36 patients were agreed with the gamma pixel match of >95% and 14 patients were with the gamma pixel match of 90-95% with the criteria of 3% delta dose (DD) and 3 mm distance-to-agreement (DTA). Commissioning and quality assurance of dMLC for IMRT application requires considerable time and effort. Many dosimetric characteristics need to be assessed carefully failing which the delivered dose will be significantly different from the planned dose. In addition to the issues discussed above we feel that individual MU check is necessary before the treatment is delivered. Keywords: IMRT, dMLC, Quality Assurance, I'mariXX, DTA, Delta dose.
        PMID: 20601335 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Distinct developmental roles for direct and indirect talin-mediated linkage to actin.</title>
  <link>http://biomarket.jp/modules/pubmed/article-23780.html</link>
      <description>Related Articles Distinct developmental roles for direct and indirect talin-mediated linkage to actin. Dev Biol. 2010 Jun 28; Authors: Franco-Cea A, Ellis SJ, Fairchild MJ, Yuan L, Cheung TY, Tanentzapf G Transmembrane adhesion receptors, such as integrins, mediate cell adhesion by interacting with intracellular proteins that connect to the cytoskeleton. Talin, one such linker protein, is essential to connect extracellular matrix-bound integrins to the cytoskeleton. Talin can connect to the cyto ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23780.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Distinct developmental roles for direct and indirect talin-mediated linkage to actin.
        Dev Biol. 2010 Jun 28;
        Authors:  Franco-Cea A, Ellis SJ, Fairchild MJ, Yuan L, Cheung TY, Tanentzapf G
        Transmembrane adhesion receptors, such as integrins, mediate cell adhesion by interacting with intracellular proteins that connect to the cytoskeleton. Talin, one such linker protein, is essential to connect extracellular matrix-bound integrins to the cytoskeleton. Talin can connect to the cytoskeleton either directly, through its actin-binding motifs, or indirectly, by recruiting other actin-binding proteins. Talin's carboxy-terminal end contains a well-characterized actin-binding domain (ABD). We tested the role of the C-terminal ABD of talin in integrin function in Drosophila. We found that introduction of mutations that reduced actin binding in vitro into the isolated C-terminal Talin-ABD impaired actin binding in vivo. Moreover, when engineered into full-length talin, these mutations disrupted a subset of integrin-mediated adhesion-dependent developmental events. Specifically, morphogenetic processes that involve dynamic, short-term integrin-mediated adhesion were particularly sensitive to impaired function of the C-terminal Talin-ABD. We propose that during development talin connects integrins to the cytoskeleton in distinct ways in different types of integrin-mediated adhesion: directly in transient adhesions and indirectly in stable long-lasting adhesions. Our results provide insight into how a similar array of molecular components can contribute to diverse adhesive processes throughout development.
        PMID: 20599891 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>人間のWhartonのゼリーの幹細胞に人間の萌芽期の幹細胞および他のMesenchymal幹細胞と比較されるTranscriptomeの独特なプロフィールがある。 (Human Wharton&apos;s Jelly Stem Cells Have Unique Transcriptome Profiles Compared to Human Embryonic Stem Cells and Other Mesenchymal Stem Cells.)</title>
  <link>http://biomarket.jp/modules/pubmed/article-23881.html</link>
      <description>Related Articles Human Wharton&apos;s Jelly Stem Cells Have Unique Transcriptome Profiles Compared to Human Embryonic Stem Cells and Other Mesenchymal Stem Cells. Stem Cell Rev. 2010 Jul 3; Authors: Fong CY, Chak LL, Biswas A, Tan JH, Gauthaman K, Chan WK, Bongso A The human umbilical cord that originates from the embryo is an extra-embryonic membrane and the Wharton&apos;s jelly within it is a rich source of stem cells (hWJSCs). It is not definitely known whether these cells behave as human embryonic ste ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23881.html</guid>
        
      <content:encoded> <![CDATA[
    Related Articles Human Wharton's Jelly Stem Cells Have Unique Transcriptome Profiles Compared to Human Embryonic Stem Cells and Other Mesenchymal Stem Cells. Stem Cell Rev. 2010 Jul 3; Authors: Fong CY, Chak LL, Biswas A, Tan JH, Gauthaman K, Chan WK, Bongso A The human umbilical cord that originates from the embryo is an extra-embryonic membrane and the Wharton's jelly within it is a rich source of stem cells (hWJSCs). It is not definitely known whether these cells behave as human embryonic stem cells (hESCs), human mesenchymal stem cells (hMSC) or both. They have the unique properties of high proliferation rates, wide multipotency, hypoimmunogenicity, do not induce teratomas and have anticancer properties. These advantages are important considerations for their use in cell based therapies and treatment of cancers. In a search for properties that confer these advantages we compared a detailed transcriptome profiling of hWJSCs using DNA microarrays with that of a panel of known hESCs, hMSCs and stromal cells. hWJSCs expressed low levels of the pluripotent embryonic stem cell markers including POUF1, NANOG, SOX2 and LIN28, thus explaining why they do not produce teratomas. Several cytokines were significantly upregulated in hWJSCs including IL12A which is associated with the induction of apoptosis, thus explaining their anticancer properties. When GO Biological Process analysis was compared between the various stem cell types, hWJSCs showed an increased expression of genes associated with the immune system, chemotaxis and cell death. The ability to modulate immune responses makes hWJSCs an important compatible stem cell source for transplantation therapy in allogeneic settings without immunorejection. The data in the present study which is the first detailed report on hWJSC transcriptomes provide a foundation for future functional studies where the exact mechanisms of these unique properties of hWJSCs can be confirmed. PMID: 20602182 [PubMed - as supplied by publisher](原文:Related Articles Human Wharton's Jelly Stem Cells Have Unique Transcriptome Profiles Compared to Human Embryonic Stem Cells and Other Mesenchymal Stem Cells. Stem Cell Rev. 2010 Jul 3; Authors: Fong CY, Chak LL, Biswas A, Tan JH, Gauthaman K, Chan WK, Bongso A The human umbilical cord that originates from the embryo is an extra-embryonic membrane and the Wharton's jelly within it is a rich source of stem cells (hWJSCs). It is not definitely known whether these cells behave as human embryonic stem cells (hESCs), human mesenchymal stem cells (hMSC) or both. They have the unique properties of high proliferation rates, wide multipotency, hypoimmunogenicity, do not induce teratomas and have anticancer properties. These advantages are important considerations for their use in cell based therapies and treatment of cancers. In a search for properties that confer these advantages we compared a detailed transcriptome profiling of hWJSCs using DNA microarrays with that of a panel of known hESCs, hMSCs and stromal cells. hWJSCs expressed low levels of the pluripotent embryonic stem cell markers including POUF1, NANOG, SOX2 and LIN28, thus explaining why they do not produce teratomas. Several cytokines were significantly upregulated in hWJSCs including IL12A which is associated with the induction of apoptosis, thus explaining their anticancer properties. When GO Biological Process analysis was compared between the various stem cell types, hWJSCs showed an increased expression of genes associated with the immune system, chemotaxis and cell death. The ability to modulate immune responses makes hWJSCs an important compatible stem cell source for transplantation therapy in allogeneic settings without immunorejection. The data in the present study which is the first detailed report on hWJSC transcriptomes provide a foundation for future functional studies where the exact mechanisms of these unique properties of hWJSCs can be confirmed. PMID: 20602182 [PubMed - as supplied by publisher])
    ]]> </content:encoded>
                                </item>
  <item>
  <title>診断X線検査および高められた染色体の転置: 3つの調査からの証拠。 (Diagstic X-ray examinations and increased chromosome translocations: evidence from three studies.)</title>
  <link>http://biomarket.jp/modules/pubmed/article-23880.html</link>
      <description>関連の記事の診断X線検査および高められた染色体の転置: 3つの調査からの証拠。 RadiatはBiophysを囲む。 7月2010日3日; 著者: Bhatti P、Yong LC、Doody MM、プレストンDL、Kampa DM、Ramsey MJ、区EM、Edwards AA、Ron E、Tucker JDの医学の診断radiologic検査の高められた使用からの潜在的な健康を損う危険性に関するSigurdsonのAJ論争は世間の注目に来た。 私達は染色体の損傷、とりわけ癌の危険性のための可能性としては中間biomarkerである転置が診断X線への露出の後で高められたかどうか、評価したmGyおよそ50のレベルの下で電離放 ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23880.html</guid>
        
      <content:encoded> <![CDATA[
    関連の記事の診断X線検査および高められた染色体の転置: 3つの調査からの証拠。 RadiatはBiophysを囲む。 7月2010日3日; 著者: Bhatti P、Yong LC、Doody MM、プレストンDL、Kampa DM、Ramsey MJ、区EM、Edwards AA、Ron E、Tucker JDの医学の診断radiologic検査の高められた使用からの潜在的な健康を損う危険性に関するSigurdsonのAJ論争は世間の注目に来た。 私達は染色体の損傷、とりわけ癌の危険性のための可能性としては中間biomarkerである転置が診断X線への露出の後で高められたかどうか、評価したmGyおよそ50のレベルの下で電離放射線の用量反応の特別な関心と。 電離放射線の3つの別に行なわれた職業調査からの染色体の転置の頻度データは一緒に分かち合われた。 調査1および2は79人そして150人の医学のradiologic科学技術者を、それぞれ含み、3つを含んでいた83人の航空会社の操縦者および50人の大学教職員(合計を= 155人の女性および207人調査する; 平均年齢= 62年、範囲34-90)。 レントゲン写真の検査のパーソナル・ヒストリーの情報は詳しいアンケートから集められた。 私達はmGy 1単位近似の1と報告されたX線検査の数そしてタイプに基づいて累積赤い骨髄(RBM)の線量のスコアを計算した。 ポアソンの回帰分析は年齢および実験室方法ができるように調節された。 中間RBMの線量のスコアは調査のための49、42、および11 1-3、それぞれだった(全面的な平均= 33.5の範囲0-303)。 かなり増加する線量のスコア(Pの&ltと高められる転置の頻度; 0.001)。 分析を最も低い線量に制限してたくさんの以下50は物質的にこれらの結果を変えなかった。 私達は結論を出し、染色体の損傷が線量を含む診断X線検査からの放射能漏れの低水準と、たくさんのおよそ50およびより低い関連付けられることを長期不利な健康に対する影響の可能性を提案する。 PMID: -出版業者によって供給される… 20602108 [PubMed(原文:Related Articles Diagnostic X-ray examinations and increased chromosome translocations: evidence from three studies. Radiat Environ Biophys. 2010 Jul 3; Authors: Bhatti P, Yong LC, Doody MM, Preston DL, Kampa DM, Ramsey MJ, Ward EM, Edwards AA, Ron E, Tucker JD, Sigurdson AJ Controversy regarding potential health risks from increased use of medical diagnostic radiologic examinations has come to public attention. We evaluated whether chromosome damage, specifically translocations, which are a potentially intermediate biomarker for cancer risk, was increased after exposure to diagnostic X-rays, with particular interest in the ionizing radiation dose-response below the level of approximately 50 mGy. Chromosome translocation frequency data from three separately conducted occupational studies of ionizing radiation were pooled together. Studies 1 and 2 included 79 and 150 medical radiologic technologists, respectively, and study 3 included 83 airline pilots and 50 university faculty members (total = 155 women and 207 men; mean age = 62 years, range 34-90). Information on personal history of radiographic examinations was collected from a detailed questionnaire. We computed a cumulative red bone marrow (RBM) dose score based on the numbers and types of X-ray examinations reported with 1 unit approximating 1 mGy. Poisson regression analyses were adjusted for age and laboratory method. Mean RBM dose scores were 49, 42, and 11 for Studies 1-3, respectively (overall mean = 33.5, range 0-303). Translocation frequencies significantly increased with increasing dose score (P < 0.001). Restricting the analysis to the lowest dose scores of under 50 did not materially change these results. We conclude that chromosome damage is associated with low levels of radiation exposure from diagnostic X-ray examinations, including dose scores of approximately 50 and lower, suggesting the possibility of long-term adverse health effects. PMID: 20602108 [PubMed - as supplied by publisher])
    ]]> </content:encoded>
                                </item>
  <item>
  <title>膵臓の腺癌の処置のための新しい代理店: トンネルの端にライトか。 「2010 ASCO年次総会」のからのハイライト。 シカゴ、IL、米国。 2010年6月4-8日。 (Novel Agents for the Treatment of Pancreatic Adecarcinoma: Any Light at the End of the Tunnel? Highlights from the &quot;2010 ASCO Annual Meeting&quot;. Chicago, IL, USA. June 4-8, </title>
  <link>http://biomarket.jp/modules/pubmed/article-23879.html</link>
      <description>膵臓の腺癌の処置のための関連の記事の新しい代理店: トンネルの端にライトか。 「2010 ASCO年次総会」のからのハイライト。 シカゴ、IL、米国。 2010年6月4-8日。 JOP. 2010年; 11 (4): 324-7書く: Dimouはの、Syrigos KNのSaif MWの膵臓癌陰気な予想の病気であり、処置の選択は限られている。 新しく活動的な混合物の開発は必須である。 腕間の新しい代理店含まれている臨床腫瘍学(ASCO)の年次総会の最近の2010人のアメリカ人の社会で示されたこといくつかの膵臓癌臨床試験。 IGF-1Rの阻止が有効であるかもしれないし、これがそれ以上の ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:11 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23879.html</guid>
        
      <content:encoded> <![CDATA[
    膵臓の腺癌の処置のための関連の記事の新しい代理店: トンネルの端にライトか。 「2010 ASCO年次総会」のからのハイライト。 シカゴ、IL、米国。 2010年6月4-8日。 JOP. 2010年; 11 (4): 324-7書く: Dimouはの、Syrigos KNのSaif MWの膵臓癌陰気な予想の病気であり、処置の選択は限られている。 新しく活動的な混合物の開発は必須である。 腕間の新しい代理店含まれている臨床腫瘍学(ASCO)の年次総会の最近の2010人のアメリカ人の社会で示されたこといくつかの膵臓癌臨床試験。 IGF-1Rの阻止が有効であるかもしれないし、これがそれ以上の試験でテストされるべきであるようである。 EGFRを伴うixabepiloneのMicrotubule安定は予想の有望な改善を反angiogenetic代理店を伴ってある前にテストされない受諾可能な安全プロフィールを示した組合せが捕らえpaclitaxelなさい一方もたらさない。 この組合せは段階II臨床試験でテストする価値があるかもしれない。 大事なことを言い忘れたが、CTLA-4封鎖に受諾可能な毒性のプロフィールがあるが、効力は試験段階IIおよびIIIの偽薬に証明される必要がある。 最後に、腫瘍の生物学の理解および臨床試験からのbiomarkerの分析は保証される。 PMID: 20601803 [PubMed -プロセスの…(原文:Related Articles Novel Agents for the Treatment of Pancreatic Adenocarcinoma: Any Light at the End of the Tunnel? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010. JOP. 2010;11(4):324-7 Authors: Dimou AT, Syrigos KN, Saif MW Pancreatic cancer is a disease with dismal prognosis and treatment options are limited. Development of novel active compounds is mandatory. A number of pancreatic cancer clinical trials that included a novel agent among their arms were presented at the recent 2010 American Society of Clinical Oncology (ASCO) Annual Meeting. It appears that IGF-1R inhibition might be effective and this should be tested in further trials. Microtubule stabilization with ixabepilone in combination with EGFR does not lead to promising improvement in prognosis whereas nab-paclitaxel in combination with anti-angiogenetic agents is a combination not previously tested that showed an acceptable safety profile. This combination might be worth testing in a phase II clinical trial. Last but not least, CTLA-4 blockade has an acceptable toxicity profile but its efficacy needs to be proven over placebo in phase II and III trials. Finally, understanding of the tumor biology and biomarker analysis from the clinical trials is warranted. PMID: 20601803 [PubMed - in process])
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Comparative studies on the extraction of metagenomic DNA from the saline habitats of Coastal Gujarat and Sambhar Lake, Rajasthan (India) in prospect of molecular diversity and search for novel biocatalysts.</title>
  <link>http://biomarket.jp/modules/pubmed/article-23883.html</link>
      <description>Related Articles Comparative studies on the extraction of metagenomic DNA from the saline habitats of Coastal Gujarat and Sambhar Lake, Rajasthan (India) in prospect of molecular diversity and search for novel biocatalysts. Int J Biol Macromol. 2010 Jun 23; Authors: Siddhapura PK, Vanparia S, Purohit MK, Singh SP Extraction of total DNA from a given habitat assumes significance in metagenomics, due to the requirement of inhibitor free and high quality metagenome in good quantity for applications ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23883.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Comparative studies on the extraction of metagenomic DNA from the saline habitats of Coastal Gujarat and Sambhar Lake, Rajasthan (India) in prospect of molecular diversity and search for novel biocatalysts.
        Int J Biol Macromol. 2010 Jun 23;
        Authors:  Siddhapura PK, Vanparia S, Purohit MK, Singh SP
        Extraction of total DNA from a given habitat assumes significance in metagenomics, due to the requirement of inhibitor free and high quality metagenome in good quantity for applications in molecular biology. DNA extraction and its quality assessment for PCR applications from saline soils of Coastal Gujarat and Sambhar Soda Lake, Rajasthan in India is described in a comparative manner. The mechanical and soft lysis methods were simple and efficient for rapid isolation of PCR amplifiable total genomic DNA. The results are significant as only few extreme environments, particularly saline habitats are explored for their metagenomic potential.
        PMID: 20600268 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>HLA-A, -B and DRB1 allele and haplotype frequencies in the Mozambican population: a blood donor based population study.</title>
  <link>http://biomarket.jp/modules/pubmed/article-23921.html</link>
      <description>Related Articles HLA-A, -B and DRB1 allele and haplotype frequencies in the Mozambican population: a blood donor based population study. Hum Immunol. 2010 Jul 2; Authors: Assane AA, Fabricio-Silva GM, Cardoso-Oliveira J, Mabunda NE, Sousa AM, Jani IV, Ferreira OC, Porto LC The human leukocyte antigens (HLA) has been used for several decades as genetic markers for analyzing diversity of gene pool origin, platelet transfusion, tissue transplantation, disease susceptibility or resistance, and foren ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23921.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        HLA-A, -B and DRB1 allele and haplotype frequencies in the Mozambican population: a blood donor based population study.
        Hum Immunol. 2010 Jul 2;
        Authors:  Assane AA, Fabricio-Silva GM, Cardoso-Oliveira J, Mabunda NE, Sousa AM, Jani IV, Ferreira OC, Porto LC
        The human leukocyte antigens (HLA) has been used for several decades as genetic markers for analyzing diversity of gene pool origin, platelet transfusion, tissue transplantation, disease susceptibility or resistance, and forensic and anthropologic studies. In the present study, the allele and haplotype frequencies of HLA-A, -B, and -DRB1 were studied in 250 unrelated Mozambican individuals (black African from south of Mozambique) by using a low-medium resolution polymerase chain reaction-Luminex typing method. A total of 18 A, 25 B, and 13 DRB1 alleles were identified. The most frequent HLA-A, -B, and -DRB1 alleles were HLA-A*30 (23.9%), HLA-B*15 (15.6%), and HLA-DRB1*13 (19.8%), respectively. The most frequent two-locus haplotypes were HLA-A*30-B*42 (7.4%) and HLA-B*42-DRB1*03 (5.4%), and three-locus haplotypes were HLA-A*30-B*42-DRB1*03 (4.9%), and HLA-A*02-B*58-DRB1*11 (4.1%). Allele distribution and haplotype analysis demonstrated that Mozambican population shares HLA patterns with Sub-Saharan populations.
        PMID: 20600444 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Tafazzin knockdown causes hypertrophy of neonatal ventricular myocytes.</title>
  <link>http://biomarket.jp/modules/pubmed/article-23926.html</link>
      <description> Related Articles Tafazzin knockdown causes hypertrophy of neonatal ventricular myocytes. Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H210-6 Authors: He Q Mutation of the mitochondrial protein tafazzin causes dilated cardiomyopathy in Barth syndrome. We employed an adenovirus as a vector to transfer tafazzin small hairpin RNA (shRNA) into neonatal ventricular myocytes (NVMs) to investigate the effects of tafazzin knockdown. The tafazzin shRNA adenovirus consistently knocked down tafazzin mR ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23926.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Tafazzin knockdown causes hypertrophy of neonatal ventricular myocytes.
        Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H210-6
        Authors:  He Q
        Mutation of the mitochondrial protein tafazzin causes dilated cardiomyopathy in Barth syndrome. We employed an adenovirus as a vector to transfer tafazzin small hairpin RNA (shRNA) into neonatal ventricular myocytes (NVMs) to investigate the effects of tafazzin knockdown. The tafazzin shRNA adenovirus consistently knocked down tafazzin mRNA and lowered cardiolipin while significantly decreasing the production of ATP by the mitochondria. The phosphorylation of AMP-activated protein kinase and mitochondrial density were both increased in tafazzin knockdown NVMs compared with scrambled shRNA controls. When we tested whether tafazzin knockdown causes hypertrophy in vitro, we found that the surface area of NVMs infected with tafazzin shRNA adenovirus was significantly increased, as were the protein synthesis and expression of the hypertrophic marker gene, brain natriuretic peptide. Taken together, our data support the concept that a decreased tafazzin expression causes cardiomyocyte hypertrophy in vitro.
        PMID: 20348225 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>癌; +407の新しい参照 (cancer; +407 new citations)</title>
  <link>http://biomarket.jp/modules/pubmed/article-23927.html</link>
      <description>407の新しいpubmed参照はあなたの調査のために取り出された。完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:癌これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/07 PubMedの薬の国立図書館のサービスで、含んでいる発生した。これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:407 new pubmed citations were retrieved for your search.Click on the search ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23927.html</guid>
        
      <content:encoded> <![CDATA[
    407の新しいpubmed参照はあなたの調査のために取り出された。
完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:

癌
これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/07 PubMedの薬の国立図書館のサービスで、含んでいる発生した。
これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:407 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

cancer
These pubmed results were generated on 2010/07/07PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.)
    ]]> </content:encoded>
                                </item>
  <item>
  <title>cancer; +407 new citations</title>
  <link>http://biomarket.jp/modules/pubmed/article-23929.html</link>
      <description>407 new pubmed citations were retrieved for your search.Click on the search hyperlink below to display the complete search results:cancerThese pubmed results were generated on 2010/07/07PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950&apos;s.These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.</description>
        <pubDate>Sat, 10 Jul 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-23929.html</guid>
        
      <content:encoded> <![CDATA[
    
407 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

cancer
These pubmed results were generated on 2010/07/07PubMed, a service of the National Library of Medicine, includes over 15 million 
citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. 
PubMed includes links to many sites providing full text articles and other related resources.

    ]]> </content:encoded>
                                </item>
  <item>
  <title>免疫学; +206の新しい参照 (immulogy; +206 new citations)</title>
  <link>http://biomarket.jp/modules/pubmed/article-24086.html</link>
      <description>206の新しいpubmed参照はあなたの調査のために取り出された。完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:免疫学これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/07 PubMedの薬の国立図書館のサービスで、含んでいる発生した。これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:206 new pubmed citations were retrieved for your search.Click on the se ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:10 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24086.html</guid>
        
      <content:encoded> <![CDATA[
    206の新しいpubmed参照はあなたの調査のために取り出された。
完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:

免疫学
これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/07 PubMedの薬の国立図書館のサービスで、含んでいる発生した。
これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:206 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

immunology
These pubmed results were generated on 2010/07/07PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.)
    ]]> </content:encoded>
                                </item>
  <item>
  <title>biological chemistry; +202 new citations</title>
  <link>http://biomarket.jp/modules/pubmed/article-24165.html</link>
      <description>202 new pubmed citations were retrieved for your search.Click on the search hyperlink below to display the complete search results:biological chemistryThese pubmed results were generated on 2010/07/07PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950&apos;s.These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24165.html</guid>
        
      <content:encoded> <![CDATA[
    
202 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

biological chemistry
These pubmed results were generated on 2010/07/07PubMed, a service of the National Library of Medicine, includes over 15 million 
citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. 
PubMed includes links to many sites providing full text articles and other related resources.

    ]]> </content:encoded>
                                </item>
  <item>
  <title>生物化学; +202の新しい参照 (biological chemistry; +202 new citations)</title>
  <link>http://biomarket.jp/modules/pubmed/article-24084.html</link>
      <description>202の新しいpubmed参照はあなたの調査のために取り出された。完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:生物化学これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/07 PubMedの薬の国立図書館のサービスで、含んでいる発生した。これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:202 new pubmed citations were retrieved for your search.Click on the  ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24084.html</guid>
        
      <content:encoded> <![CDATA[
    202の新しいpubmed参照はあなたの調査のために取り出された。
完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:

生物化学
これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/07 PubMedの薬の国立図書館のサービスで、含んでいる発生した。
これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:202 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

biological chemistry
These pubmed results were generated on 2010/07/07PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.)
    ]]> </content:encoded>
                                </item>
  <item>
  <title>biomarker; +209の新しい参照 (biomarker; +209 new citations)</title>
  <link>http://biomarket.jp/modules/pubmed/article-24085.html</link>
      <description>209の新しいpubmed参照はあなたの調査のために取り出された。完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:biomarkerこれらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/07 PubMedの薬の国立図書館のサービスで、含んでいる発生した。これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:209 new pubmed citations were retrieved for your search.Click on the ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24085.html</guid>
        
      <content:encoded> <![CDATA[
    209の新しいpubmed参照はあなたの調査のために取り出された。
完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:

biomarker
これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/07 PubMedの薬の国立図書館のサービスで、含んでいる発生した。
これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:209 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

biomarker
These pubmed results were generated on 2010/07/07PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.)
    ]]> </content:encoded>
                                </item>
  <item>
  <title>biomarker; +115の新しい参照 (biomarker; +115 new citations)</title>
  <link>http://biomarket.jp/modules/pubmed/article-24235.html</link>
      <description>115の新しいpubmed参照はあなたの調査のために取り出された。完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:biomarkerこれらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/08 PubMedの薬の国立図書館のサービスで、含んでいる発生した。これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:115 new pubmed citations were retrieved for your search.Click on the ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24235.html</guid>
        
      <content:encoded> <![CDATA[
    115の新しいpubmed参照はあなたの調査のために取り出された。
完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:

biomarker
これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/08 PubMedの薬の国立図書館のサービスで、含んでいる発生した。
これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:115 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

biomarker
These pubmed results were generated on 2010/07/08PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.)
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Genome-wide analysis of aminoacylation (charging) levels of tRNA using microarrays.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24162.html</link>
      <description> Related Articles Genome-wide analysis of aminoacylation (charging) levels of tRNA using microarrays. J Vis Exp. 2010;(40): Authors: Zaborske J, Pan T tRNA aminoacylation, or charging, levels can rapidly change within a cell in response to the environment[1]. Changes in tRNA charging levels in both prokaryotic and eukaryotic cells lead to translational regulation which is a major cellular mechanism of stress response. Familiar examples are the stringent response in E. coli and the Gcn2 stress re ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24162.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Genome-wide analysis of aminoacylation (charging) levels of tRNA using microarrays.
        J Vis Exp. 2010;(40):
        Authors:  Zaborske J, Pan T
        tRNA aminoacylation, or charging, levels can rapidly change within a cell in response to the environment[1]. Changes in tRNA charging levels in both prokaryotic and eukaryotic cells lead to translational regulation which is a major cellular mechanism of stress response. Familiar examples are the stringent response in E. coli and the Gcn2 stress response pathway in yeast ([2-6]). Recent work in E. coli and S. cerevisiae have shown that tRNA charging patterns are highly dynamic and depends on the type of stress experienced by cells [1, 6, 7]. The highly dynamic, variable nature of tRNA charging makes it essential to determine changes in tRNA charging levels at the genomic scale, in order to fully elucidate cellular response to environmental variations. In this review we present a method for simultaneously measuring the relative charging levels of all tRNAs in S. cerevisiae . While the protocol presented here is for yeast, this protocol has been successfully applied for determining relative charging levels in a wide variety of organisms including E. coli and human cell cultures[7, 8].
        PMID: 20567214 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>癌; +497の新しい参照 (cancer; +497 new citations)</title>
  <link>http://biomarket.jp/modules/pubmed/article-24163.html</link>
      <description>497の新しいpubmed参照はあなたの調査のために取り出された。完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:癌これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/08 PubMedの薬の国立図書館のサービスで、含んでいる発生した。これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:497 new pubmed citations were retrieved for your search.Click on the search ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24163.html</guid>
        
      <content:encoded> <![CDATA[
    497の新しいpubmed参照はあなたの調査のために取り出された。
完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:

癌
これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/08 PubMedの薬の国立図書館のサービスで、含んでいる発生した。
これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:497 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

cancer
These pubmed results were generated on 2010/07/08PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.)
    ]]> </content:encoded>
                                </item>
  <item>
  <title>cancer; +497 new citations</title>
  <link>http://biomarket.jp/modules/pubmed/article-24164.html</link>
      <description>497 new pubmed citations were retrieved for your search.Click on the search hyperlink below to display the complete search results:cancerThese pubmed results were generated on 2010/07/08PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950&apos;s.These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24164.html</guid>
        
      <content:encoded> <![CDATA[
    
497 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

cancer
These pubmed results were generated on 2010/07/08PubMed, a service of the National Library of Medicine, includes over 15 million 
citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. 
PubMed includes links to many sites providing full text articles and other related resources.

    ]]> </content:encoded>
                                </item>
  <item>
  <title>11q21.1-11q23.3 Is a site of intrinsic genomic instability triggered by irradiation.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24217.html</link>
      <description> 11q21.1-11q23.3 Is a site of intrinsic genomic instability triggered by irradiation. Genes Chromosomes Cancer. 2010 Jun 2;49(9):831-843 Authors: Du N, Baker PM, Do TU, Bien C, Bier-Laning CM, Singh S, Shih SJ, Diaz MO, Vaughan AT The chromosome location, 11q21-23, is linked to loss of heterozygosity (LOH) in multiple tumors including those of breast, lung, and head and neck. To examine the process of LOH induction, the H292 cell line (human muco-epidermoid carcinoma) was irradiated or treated w ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24217.html</guid>
        
      <content:encoded> <![CDATA[
    

        11q21.1-11q23.3 Is a site of intrinsic genomic instability triggered by irradiation.
        Genes Chromosomes Cancer. 2010 Jun 2;49(9):831-843
        Authors:  Du N, Baker PM, Do TU, Bien C, Bier-Laning CM, Singh S, Shih SJ, Diaz MO, Vaughan AT
        The chromosome location, 11q21-23, is linked to loss of heterozygosity (LOH) in multiple tumors including those of breast, lung, and head and neck. To examine the process of LOH induction, the H292 cell line (human muco-epidermoid carcinoma) was irradiated or treated with anti-CD95 antibody, and individual clones isolated through two rounds of cloning. Regions of LOH were determined by screening a suite of eight polymorphic microsatellite markers covering 11p15-11q24 using fluorescent primers and genetic analyzer peak discrimination. LOH induction was observed extending through 11q21.1-11q23.3 in 6/49 of clones surviving 4 Gy and 8/50 after 8 Gy. Analysis of selected clones by Affymetrix 6.0 single nucleotide polymorphism (SNP) arrays confirmed the initial assessment indicating a consistent 27.3-27.7 Mbp deletion in multiple clones. The telomeric border of LOH mapped to a 1 Mbp region of elevated recombination. Whole genome analysis of SNP data indicated that site-restricted LOH also occurred across multiple additional genomic locations. These data indicate that 11q21.1-11q23.3, and potentially other regions of this cell line are sites of intrinsic cell-specific instability leading to LOH after irradiation. Such deletions may subsequently be propagated by genetic selection and clonal expansion. (c) 2010 Wiley-Liss, Inc.
        PMID: 20607707 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Epigenetic pre-patterning and dynamics during initial stages of mammalian preimplantation development.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24219.html</link>
      <description> Epigenetic pre-patterning and dynamics during initial stages of mammalian preimplantation development. J Cell Physiol. 2010 Jul 6; Authors: Rasmussen TP, Corry GN Mammals, like all multicellular organisms, develop from a single cell-the totipotent zygote. During preimplantation development and subsequent development in utero, over 200 distinct cell types are established and integrated into the organ systems and tissues of the developing organism. Much of the field of mammalian developmental bio ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24219.html</guid>
        
      <content:encoded> <![CDATA[
    

        Epigenetic pre-patterning and dynamics during initial stages of mammalian preimplantation development.
        J Cell Physiol. 2010 Jul 6;
        Authors:  Rasmussen TP, Corry GN
        Mammals, like all multicellular organisms, develop from a single cell-the totipotent zygote. During preimplantation development and subsequent development in utero, over 200 distinct cell types are established and integrated into the organ systems and tissues of the developing organism. Much of the field of mammalian developmental biology is devoted to investigation of mechanisms that govern the formation of complete organs and tissues. In contrast to later development, which consumes the vast majority of time associated with development in utero, preimplantation development and germ layer specification occur rapidly. Yet knowledge is limited regarding the regulatory mechanisms that specify the transient, but pluripotent, cellular lineages that form during the initial stages of mammalian development. Gametogenesis and preimplantation development are marked by dramatic and pervasive epigenetic changes rooted in chromatin dynamics. The fundamental mechanisms that specify subsequent cellular lineages of the conceptus are only now becoming understood, and tend to rely relatively heavily upon broad epigenetic mechanisms in addition to master transcription factors. This review considers epigenetic regulation in the very earliest stages of preimplantation development. In addition, recent advances which indicate that some epigenetic coding is imposed during gametogenesis and maintained during preimplantation development are considered. (c) 2010 Wiley-Liss, Inc.
        PMID: 20607796 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Controlled induction of distributed microdeformation in wounded tissue via a microchamber array dressing.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24220.html</link>
      <description> Controlled induction of distributed microdeformation in wounded tissue via a microchamber array dressing. J Biomed Mater Res A. 2010 Jul 6; Authors: Kane BJ, Younan G, Helm D, Dastouri P, Prentice-Mott H, Irimia D, Chan RK, Toner M, Orgill DP Mechanical stimuli are known to play an important role in determining the structure and function of living cells and tissues. Recent studies have highlighted the role of mechanical signals in mammalian dermal wound healing. However, the biological link bet ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24220.html</guid>
        
      <content:encoded> <![CDATA[
    

        Controlled induction of distributed microdeformation in wounded tissue via a microchamber array dressing.
        J Biomed Mater Res A. 2010 Jul 6;
        Authors:  Kane BJ, Younan G, Helm D, Dastouri P, Prentice-Mott H, Irimia D, Chan RK, Toner M, Orgill DP
        Mechanical stimuli are known to play an important role in determining the structure and function of living cells and tissues. Recent studies have highlighted the role of mechanical signals in mammalian dermal wound healing. However, the biological link between mechanical stimulation of wounded tissue and the subsequent cellular response has not been fully determined. The capacity for researchers to study this link is partially limited by the lack of instrumentation capable of applying controlled mechanical stimuli to wounded tissue. The studies outlined here tested the hypothesis that it was possible to control the magnitude of induced wound tissue deformation using a microfabricated dressing composed of an array of open-faced, hexagonally shaped microchambers rendered in a patch of silicone rubber. By connecting the dressing to a single vacuum source, the underlying wounded tissue was drawn up into each of the microchambers, thereby inducing tissue deformation. For these studies, the dressings were applied to full-thickness murine dermal wounds with 200 mmHg vacuum for 12 h. These studies demonstrated that the dressing was capable of inducing wound tissue deformation with values ranging from 11 to 29%. Through statistical analysis, the magnitude of the induced deformation was shown to be a function of both microchamber height and width. These results demonstrated that the dressing was capable of controlling the amount of deformation imparted in the underlying tissue. By allowing the application of mechanical stimulation with varying intensities, such a dressing will enable the performance of sophisticated mechanobiology studies in dermal wound healing. (c) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2010.
        PMID: 20607869 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A nonsynonymous polymorphism in IL23R gene is associated with risk of gastric cancer in a Chinese population.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24218.html</link>
      <description> A nonsynonymous polymorphism in IL23R gene is associated with risk of gastric cancer in a Chinese population. Mol Carcinog. 2010 Jul 6; Authors: Chen J, Lu Y, Zhang H, Ding Y, Ren C, Hua Z, Zhou Y, Deng B, Jin G, Hu Z, Xu Y, Shen H Interleukin-23 receptor (IL-23R) is a key element in T helper (Th)17 cell-mediated inflammatory process, which plays an important role in pathogenesis of gastric cancer. Genetic variants of IL-23R have been identified as the predisposing factors for immunopathologic  ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24218.html</guid>
        
      <content:encoded> <![CDATA[
    

        A nonsynonymous polymorphism in IL23R gene is associated with risk of gastric cancer in a Chinese population.
        Mol Carcinog. 2010 Jul 6;
        Authors:  Chen J, Lu Y, Zhang H, Ding Y, Ren C, Hua Z, Zhou Y, Deng B, Jin G, Hu Z, Xu Y, Shen H
        Interleukin-23 receptor (IL-23R) is a key element in T helper (Th)17 cell-mediated inflammatory process, which plays an important role in pathogenesis of gastric cancer. Genetic variants of IL-23R have been identified as the predisposing factors for immunopathologic process. In this study, we hypothesized that the functional genetic variants of IL-23R gene may modify the risk of gastric cancer. To test this hypothesis, we conducted a case-control study including 1043 gastric cancer patients and 1089 controls in a Chinese population to assess the association between two potentially functional single nucleotide polymorphisms (SNPs) rs6682925 T>C and rs1884444 T>G of IL-23R and risk of gastric cancer. We found that the variant allele (G) of rs1884444 T>G, with amino acid His substituted by Gln at codon 3, was significantly associated with a decreased risk of gastric cancer [adjusted allelic odds ratio (OR) = 0.78, 95% confidence interval (CI) = 0.68-0.88]. In the stratified analysis, we found that this protective effect of rs1884444 G allele was mainly evident in intestinal-type gastric cancer (adjusted allelic OR = 0.75, 95% CI = 0.65-0.87) other than in diffuse-type gastric cancer (adjusted allelic OR = 0.96, 95% CI = 0.76-1.22). However, we did not find any significant association of rs6682925 T>C with gastric cancer risk. These findings indicate, for the first time, that the nonsynonymous variant rs1884444 T>G of IL-23R may contribute to gastric cancer susceptibility, especially in intestinal-type gastric cancer, in Chinese population. (c) 2010 Wiley-Liss, Inc.
        PMID: 20607725 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24216.html</link>
      <description> Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy. Hepatology. 2010 May 20; Authors: Zhang Z, Oyesanya RA, Campbell DJ, Almenara JA, Dewitt JL, Sirica AE Overexpression of epidermal growth factor receptor (ErbB1) and/or ErbB2 has been implicated in the pathogenesis of cholangiocarcinoma, suggesting that combined ErbB1/ErbB2 targeting might serve as a target-based therapeutic strategy for this highl ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24216.html</guid>
        
      <content:encoded> <![CDATA[
    

        Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy.
        Hepatology. 2010 May 20;
        Authors:  Zhang Z, Oyesanya RA, Campbell DJ, Almenara JA, Dewitt JL, Sirica AE
        Overexpression of epidermal growth factor receptor (ErbB1) and/or ErbB2 has been implicated in the pathogenesis of cholangiocarcinoma, suggesting that combined ErbB1/ErbB2 targeting might serve as a target-based therapeutic strategy for this highly lethal cancer. To test this strategy, we investigated targeting with the ErbB1 inhibitor tryphostin AG1517 and the ErbB2 inhibitor tryphostin AG879, in combination and alone, as well as with the dual ErbB1/ErbB2 inhibitor lapatinib, to assess the effectiveness of simultaneous targeting of ErbB1 and ErbB2 signaling over single inhibitor treatments in suppressing cholangiocarcinoma cell growth in vitro and the therapeutic efficacy of lapatinib in vivo. Our in vitro studies were carried out using rat (BDEneu and C611B) and human (HuCCT1 and TFK1) cholangiocarcinoma cell lines. The efficacy of lapatinib to significantly suppress liver tumor growth was tested in an orthotopic, syngeneic rat model of intrahepatic cholangiocarcinoma progression. Our results demonstrated that simultaneous targeting of ErbB1 and ErbB2 signaling was significantly more effective in suppressing the in vitro growth of both rat and human cholangiocarcinoma cells than individual receptor targeting. Lapatinib was an even more potent inhibitor of cholangiocarcinoma cell growth and inducer of apoptosis than either tryphostin when tested in vitro against these respective cholangiocarcinoma cell lines, regardless of differences in their levels of ErbB1 or ErbB2 protein expression and/or mechanism of activation. Lapatinib treatment also produced a significant suppression of intrahepatic cholangiocarcinoma growth when administered early to rats, but was without effect in inhibiting liver tumor growth in rats with more advanced tumors. Conclusion: Our findings suggest that simultaneous targeting of ErbB1 and ErbB2 could be a potentially selective strategy for cholangiocarcinoma therapy, but is likely to be ineffective by itself against advanced cancer. (HEPATOLOGY 2010).
        PMID: 20607690 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24233.html</link>
      <description> Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion. Mol Carcinog. 2010 Jul 6; Authors: Lin ML, Lu YC, Chung JG, Wang SG, Lin HT, Kang SE, Tang CH, Ko JL, Chen SS Aloe-emodin (AE), extracted from the rhizome of Rheum palmatum, has an anti-proliferative effect on different human cancer cell lines. Nonetheless, the underlying mechanism by which AE inhibits nasopharyngeal carcinoma (NPC) cell invasio ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24233.html</guid>
        
      <content:encoded> <![CDATA[
    

        Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion.
        Mol Carcinog. 2010 Jul 6;
        Authors:  Lin ML, Lu YC, Chung JG, Wang SG, Lin HT, Kang SE, Tang CH, Ko JL, Chen SS
        Aloe-emodin (AE), extracted from the rhizome of Rheum palmatum, has an anti-proliferative effect on different human cancer cell lines. Nonetheless, the underlying mechanism by which AE inhibits nasopharyngeal carcinoma (NPC) cell invasion is still unclear. The results of this study show that treatment of NPC cells with growth suppressive concentrations of AE caused cell cycle arrest at the S-G(2)/M phase. Coimmunoprecipitation and small interfering RNA (siRNA) studies demonstrated that AE-induced cell cycle arrest in NPC cells was associated with increasing levels of cyclin B1 bound to cyclin-dependent kinase 1. The inhibition of NPC cell invasion by AE was evidenced through the suppression of matrix metalloproteinases-2 (MMP-2) expression. MMP-2 promoter activity and cell invasion were inhibited by p38 mitogen-activated protein kinase (MAPK) siRNA, inhibitor 4-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-5-(4-pyridyl)-1H-imidazole (SB203580), and AE, but not by JNK siRNA and inhibitor 1,9-pyrazoloanthrone. Treatment with AE, SB203580, NF-kappaB inhibitors N-p-tosyl-(L)-phenylalanine chloromethyl ketone (TPCK) and pyrrolidine dithiocarbamate (PDTC) or transfection with p38 MAPK siRNA significantly inhibited NF-kappaB transcriptional activity. In addition, TPCK and PDTC treatment inhibited the expression and promoter activity of MMP-2 and thereby significantly inhibited cell invasion activity. The involvement of p38 MAPK activity in NF-kappaB-mediated MMP-2 function was further confirmed through the attenuation of p38 MAPK by SB203580 and NF-kappaB ectopic expression. Collectively, our results indicate that AE inhibits invasion of NPC cells by suppressing the expression of MMP-2 via the p38 MAPK-NF-kappaB signaling pathway. (c) 2010 Wiley-Liss, Inc.
        PMID: 20607722 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24229.html</link>
      <description> Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L. Cancer Lett. 2010 May 31; Authors: Zhu H, Liu XW, Ding WJ, Xu DQ, Zhao YC, Lu W, He QJ, Yang B Our previous study demonstrated that celastrol combined with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo-2L) exhibited significant synergistic anti-cancer activities, thus we were promoted to investigate the molecular mechanism of this synergy. Here in this study, we show that ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24229.html</guid>
        
      <content:encoded> <![CDATA[
    

        Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L.
        Cancer Lett. 2010 May 31;
        Authors:  Zhu H, Liu XW, Ding WJ, Xu DQ, Zhao YC, Lu W, He QJ, Yang B
        Our previous study demonstrated that celastrol combined with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo-2L) exhibited significant synergistic anti-cancer activities, thus we were promoted to investigate the molecular mechanism of this synergy. Here in this study, we show that celastrol up-regulates death receptor 4 (DR4) and 5 (DR5) expression at mRNA, total protein and cell surface levels, and the specific knockdown using DR4- or DR5-targeting siRNA transfection attenuates the PARP cleavage caused by the combination of celastrol and TRAIL/Apo-2L, denoting the critical roles of DR induction in this sensitization. Of note is that although celastrol activates p38 mitogen activated protein kinases (p38 MAPK), SB203580, one specific inhibitor of p38, fails to interrupt celastrol-induced DR4 expression and the enhanced apoptosis caused by celastrol plus TRAIL/Apo-2L. In addition, the protein expression of Mcl-1 and FLIP, two critical antiapoptotic factors, is not decreased upon celastrol treatment under our experimental conditions. Taken together, the present study demonstrates that the enhanced mRNA and protein expression of DR4 and DR5 play prominent roles in the sensitization of celastrol to TRAIL/Apo-2L-induced apoptosis, in a p38 MAPK-independent manner.
        PMID: 20605676 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Development of Non-viral Vector for Cancer Gene Therapy.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24232.html</link>
      <description> Development of Non-viral Vector for Cancer Gene Therapy. Yakugaku Zasshi. 2010 Jul;130(7):917-23 Authors: Hattori Y Cancer gene therapy has been intensively developed using non-viral vectors, among which cationic liposomes and nanoparticles are the most investigated. Optimal gene therapy for tumors must deliver plasmid DNA (pDNA) or synthetic small interfering RNA (siRNA) to tumor cells with high efficiency and minimal toxicity. We developed new cationic nanoparticles (NP) composed of cholester ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24232.html</guid>
        
      <content:encoded> <![CDATA[
    

        Development of Non-viral Vector for Cancer Gene Therapy.
        Yakugaku Zasshi. 2010 Jul;130(7):917-23
        Authors:  Hattori Y
        Cancer gene therapy has been intensively developed using non-viral vectors, among which cationic liposomes and nanoparticles are the most investigated. Optimal gene therapy for tumors must deliver plasmid DNA (pDNA) or synthetic small interfering RNA (siRNA) to tumor cells with high efficiency and minimal toxicity. We developed new cationic nanoparticles (NP) composed of cholesteryl-3beta-carboxyamidoethylene-N-hydroxyethylamine (OH-Chol) and Tween 80, and evaluated the transfection efficiencies of pDNA and siRNA into human prostate tumor PC-3 xenografts. NP showed effective transfection of pDNA and siRNA when directly injected into the xenografts. For targeted delivery to tumors, vitamin folic acid has been utilized for folate receptor (FR)-mediated drug delivery since FR is frequently overexpressed on many types of human tumors. We developed folate-linked nanoparticles (NP-F) composed of OH-Chol, Tween 80 and folate-poly(ethylene glycol)-distearoylphosphatidylethanolamine conjugate. Tumor growth of FR-positive human nasopharyngeal tumor KB xenografts was significantly inhibited when a complex of NP-F and a therapeutic gene was intratumorally injected. These findings suggested that cationic cholesterol-based nanoparticles are potential non-viral pDNA and siRNA vectors for local tumor treatment.
        PMID: 20606371 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Purinergic receptor-mediated rapid depletion of nuclear pAkt depends on PH domain leucine-rich repeat phosphatase (PHLPP), calcineurin, PP2A and PTEN phosphatases.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24230.html</link>
      <description> Purinergic receptor-mediated rapid depletion of nuclear pAkt depends on PH domain leucine-rich repeat phosphatase (PHLPP), calcineurin, PP2A and PTEN phosphatases. J Biol Chem. 2010 Jul 6; Authors: Mistafa O, Ghalali A, Kadekar S, HÃ¶gberg J, Stenius U Akt is an important oncoprotein and data suggest a critical role for nuclear Akt in cancer development. We have previously described a rapid (3-5 min) and P2X7-dependent depletion of nuclear phosphorylated Akt (pAkt) and effects on downstream  ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24230.html</guid>
        
      <content:encoded> <![CDATA[
    

        Purinergic receptor-mediated rapid depletion of nuclear pAkt depends on PH domain leucine-rich repeat phosphatase (PHLPP), calcineurin, PP2A and PTEN phosphatases.
        J Biol Chem. 2010 Jul 6;
        Authors:  Mistafa O, Ghalali A, Kadekar S, HÃ¶gberg J, Stenius U
        Akt is an important oncoprotein and data suggest a critical role for nuclear Akt in cancer development. We have previously described a rapid (3-5 min) and P2X7-dependent depletion of nuclear phosphorylated Akt (pAkt) and effects on downstream targets, and here we studied mechanisms behind the pAkt depletion. We show that cholesterol-lowering drugs, statins, or extra-cellular ATP, induced a complex and coordinated response in insulin-stimulated A549 cells leading to depletion of nuclear pAkt. It involved protein/lipid phosphatases PTEN, PH domain leucine-rich repeate phosphatase (PHLPP1 and 2), protein phosphatase 2A (PP2A) and calcineurin. We employed immunocytology, immunoprecipitation and proximity ligation assay techniques and show that PHLPP and calcineurin translocated to the nucleus, and formed complexes with Akt within 3 minutes. Also PTEN translocated to the nucleus and then co-localized with pAkt close to the nuclear membrane. An inhibitor of the scaffolding immunophilin FK506-binding protein 51 (FKBP51) and calcineurin, FK506, prevented depletion of nuclear pAkt. Furthermore, okadaic acid, an inhibitor of PP2A, prevented the nuclear pAkt depletion. Chemical inhibition and siRNA indicated that PHLPP, PP2A and PTEN were required for a robust depletion of nuclear pAkt and in prostate cancer cells lacking PTEN, transfection of PTEN restored the statin-induced pAkt depletion. The activation of protein and lipid phosphatases was paralleled by a rapid proliferating cell nuclear antigen (PCNA) translocation to the nucleus, a PCNA-p21cip1 complex formation and cyclin D1 degradation. We conclude that these effects reflect a signaling pathway for rapid depletion pAkt and that may stop the cell cycle.
        PMID: 20605778 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Involvement of caveolin in low K+-induced endocytic degradation of the cell surface hERG channels.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24231.html</link>
      <description> Involvement of caveolin in low K+-induced endocytic degradation of the cell surface hERG channels. J Biol Chem. 2010 Jul 6; Authors: Massaeli H, Sun T, Li X, Shallow H, Wu J, Xu J, Li W, Hanson C, Guo J, Zhang S Reduction in the rapidly activating delayed rectifier K(+) channel current (I(Kr)) due to either mutations in the human ether-a-go-go related gene (hERG), or drug block, causes inherited or drug-induced long QT syndrome (LQTS). A reduction in extracellular K(+) concentration ([K(+)](o)) ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24231.html</guid>
        
      <content:encoded> <![CDATA[
    

        Involvement of caveolin in low K+-induced endocytic degradation of the cell surface hERG channels.
        J Biol Chem. 2010 Jul 6;
        Authors:  Massaeli H, Sun T, Li X, Shallow H, Wu J, Xu J, Li W, Hanson C, Guo J, Zhang S
        Reduction in the rapidly activating delayed rectifier K(+) channel current (I(Kr)) due to either mutations in the human ether-a-go-go related gene (hERG), or drug block, causes inherited or drug-induced long QT syndrome (LQTS). A reduction in extracellular K(+) concentration ([K(+)](o)) exacerbates LQTS. Recently, we demonstrated that lowering [K(+)](o) promotes degradation of I(Kr) in rabbit ventricular myocytes and of the hERG channel stably expressed in human embryonic kidney (HEK) 293 cells. In this study, we investigated the degradation pathways of hERG channels under low K(+) conditions. We demonstrate that under low K(+) conditions, mature hERG channels and caveolin-1 (Cav1) displayed a parallel time-dependent reduction. The mature hERG channels co-precipitated with Cav1 in co-immunoprecipitation analysis, and internalized hERG channels co-localized with Cav1 in immunocytochemistry analysis. Overexpression of Cav1 accelerated the internalization of the mature hERG channels in 0 mM K(+)(o) while knockdown of Cav1 impeded this process. In addition, knockdown of dynamin 2 (Dyn2) using siRNA transfection significantly impeded hERG internalization and degradation under low K(+)(o) conditions. In cultured neonatal rat ventricular myocytes, knockdown of caveolin-3 (Cav3) significantly impeded low K(+)(o)-induced reduction of I(Kr). Our data indicate that a caveolin-dependent endocytic route is involved in low K(+)(o)-induced degradation of mature hERG channels.
        PMID: 20605793 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>biological chemistry; +213 new citations</title>
  <link>http://biomarket.jp/modules/pubmed/article-24388.html</link>
      <description>213 new pubmed citations were retrieved for your search.Click on the search hyperlink below to display the complete search results:biological chemistryThese pubmed results were generated on 2010/07/08PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950&apos;s.These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24388.html</guid>
        
      <content:encoded> <![CDATA[
    
213 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

biological chemistry
These pubmed results were generated on 2010/07/08PubMed, a service of the National Library of Medicine, includes over 15 million 
citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. 
PubMed includes links to many sites providing full text articles and other related resources.

    ]]> </content:encoded>
                                </item>
  <item>
  <title>生物化学; +213の新しい参照 (biological chemistry; +213 new citations)</title>
  <link>http://biomarket.jp/modules/pubmed/article-24234.html</link>
      <description>213の新しいpubmed参照はあなたの調査のために取り出された。完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:生物化学これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/08 PubMedの薬の国立図書館のサービスで、含んでいる発生した。これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:213 new pubmed citations were retrieved for your search.Click on the  ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24234.html</guid>
        
      <content:encoded> <![CDATA[
    213の新しいpubmed参照はあなたの調査のために取り出された。
完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:

生物化学
これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/08 PubMedの薬の国立図書館のサービスで、含んでいる発生した。
これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:213 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

biological chemistry
These pubmed results were generated on 2010/07/08PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.)
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Pericarditis and pleuritis associated with human parvovirus B19 infection in a systemic lupus erythematosus patient.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24270.html</link>
      <description>Related Articles Pericarditis and pleuritis associated with human parvovirus B19 infection in a systemic lupus erythematosus patient. Mod Rheumatol. 2010 Jul 7; Authors: Seishima M, Shibuya Y, Watanabe K, Kato G Human parvovirus B19 (PVB19) infection sometimes shows systemic lupus erythematosus (SLE)-like symptoms. We present an SLE patient showing pericarditis and pleuritis with a fever and an acute swelling of extremities 2 months after the fist consultation. Initially, a diagnosis of SLE exac ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24270.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Pericarditis and pleuritis associated with human parvovirus B19 infection in a systemic lupus erythematosus patient.
        Mod Rheumatol. 2010 Jul 7;
        Authors:  Seishima M, Shibuya Y, Watanabe K, Kato G
        Human parvovirus B19 (PVB19) infection sometimes shows systemic lupus erythematosus (SLE)-like symptoms. We present an SLE patient showing pericarditis and pleuritis with a fever and an acute swelling of extremities 2 months after the fist consultation. Initially, a diagnosis of SLE exacerbation was made. Additional laboratory examination showed positive results for immunoglobulin M (IgM) antibody to PVB19 and PVB19 DNA in serum and pleural effusion at that time. After 1 month, PVB19 DNA in serum and IgM antibody to PVB19 was negative. Based on these findings, a final diagnosis of PVB19 infection in an SLE patient was made. PVB19 infection should be taken into consideration for SLE with acute swelling of the extremities and fever, as these symptoms are often observed in adult cases of PVB19 infection. Steroid pulse therapy rapidly improved these symptoms, and later the dose of steroid was reduced to 5 mg/day of prednisolone. Thus, steroids may be one of the choices for severe and/or rapidly progressive symptoms of pericarditis and pleuritis due to PVB19 infection.
        PMID: 20607339 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Fournier&apos;s Gangrene of the Penis: A Rare Entity.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24269.html</link>
      <description>Related Articles Fournier&apos;s Gangrene of the Penis: A Rare Entity. J Cutan Aesthet Surg. 2010 Jan;3(1):41-4 Authors: Talwar A, Puri N, Singh M Fournier&apos;s gangrene is a rare, fulminant, but and usually a localized disease of the scrotum and penis, with an occasional extension up to the abdominal wall. The usual organism is an anaerobic streptococcus synergistic with other organisms. A 45-year-old male presented with fever and pain and a brownish-black discolouration of the penis, of four days. Our ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24269.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Fournier's Gangrene of the Penis: A Rare Entity.
        J Cutan Aesthet Surg. 2010 Jan;3(1):41-4
        Authors:  Talwar A, Puri N, Singh M
        Fournier's gangrene is a rare, fulminant, but and usually a localized disease of the scrotum and penis, with an occasional extension up to the abdominal wall. The usual organism is an anaerobic streptococcus synergistic with other organisms. A 45-year-old male presented with fever and pain and a brownish-black discolouration of the penis, of four days. Our case was unusual in that the penis was involved, which is very rare. Early therapy is the key, including hospitalization, debridement of the entire shaft of the penis distal to the devastated area, without excising the normal skin, parenteral broad-spectrum antibiotics, and skin grafting.
        PMID: 20606995 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>A modified surgical technique for steatocystoma multiplex.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24268.html</link>
      <description>Related Articles A modified surgical technique for steatocystoma multiplex. J Cutan Aesthet Surg. 2010 Jan;3(1):25-8 Authors: Choudhary S, Koley S, Salodkar A BACKGROUND: Steatocystoma multiplex (SM) is a disorder of the pilosebaceous unit characterized by multiple sebum-containing dermal cysts. Different surgical modalities like cryosurgery, aspiration, surgical excision, incision with a surgical blade or sharp-tipped cautery followed by expression of cyst contents and forceps-assisted removal  ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24268.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        A modified surgical technique for steatocystoma multiplex.
        J Cutan Aesthet Surg. 2010 Jan;3(1):25-8
        Authors:  Choudhary S, Koley S, Salodkar A
        BACKGROUND: Steatocystoma multiplex (SM) is a disorder of the pilosebaceous unit characterized by multiple sebum-containing dermal cysts. Different surgical modalities like cryosurgery, aspiration, surgical excision, incision with a surgical blade or sharp-tipped cautery followed by expression of cyst contents and forceps-assisted removal of the cyst wall and carbon dioxide laser have been used in the past. AIMS: To study the efficacy of a modified surgical technique in the treatment of steatocystoma multiplex. MATERIALS AND METHODS: We have used a simple modified surgical technique using a radiofrequency instrument as the incision tool for the treatment of SM in two patients. RESULTS: The results were cosmetically excellent with no complications developing during or after the procedure. No recurrences were observed after five and half months of follow-up. CONCLUSIONS: This is a simple, easy, fast office-based procedure that is associated with minimal blood loss and post inflammatory hypo or hyperpigmentation and scarring are practically absent.
        PMID: 20606990 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Lysophosphatidylcholine mediated functional inactivation of syndecan 4 results in decreased adhesion and motility of dendritic cells.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24271.html</link>
      <description>Related Articles Lysophosphatidylcholine mediated functional inactivation of syndecan 4 results in decreased adhesion and motility of dendritic cells. J Cell Physiol. 2010 Jul 6; Authors: BÃ?hligen J, Himmel M, Gebhardt C, Simon JC, Ziegler W, Averbeck M Following antigen contact, maturation and migration of DCs into lymphatic tissues are crucial to the developing immune response or maintenance of tolerance. Lysophosphatidylcholine (LysoPC) is generated during apoptosis of cells and acts as a  ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24271.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Lysophosphatidylcholine mediated functional inactivation of syndecan 4 results in decreased adhesion and motility of dendritic cells.
        J Cell Physiol. 2010 Jul 6;
        Authors:  BÃ?hligen J, Himmel M, Gebhardt C, Simon JC, Ziegler W, Averbeck M
        Following antigen contact, maturation and migration of DCs into lymphatic tissues are crucial to the developing immune response or maintenance of tolerance. Lysophosphatidylcholine (LysoPC) is generated during apoptosis of cells and acts as a "find-and-eat-me" signal thought to prevent autoimmunity. Moreover, LysoPC can activate PKCd and initiates a signalling cascade that leads to phosphorylation and inactivation of syndecan-4 (SDC4), a heparansulfate proteoglycan integrin co-receptor. In human monocyte-derived DCs, we recently demonstrated that SDC4 is upregulated during maturation thereby stimulating DC motility. Here, we investigate the effects of LysoPC on DC motility as well as on the involvement of PKCd phosphorylation-dependent regulation of DC motility by SDC4 and PKCa. Employing a static adhesion assay and videomicroscopy, we show that LysoPC inhibits adhesion of DCs to fibronectin and motility of DCs by decreasing podosome formation. Moreover DC podosome formation and motility, which both are regulated by SDC4 and subject to control by PKCd-dependent phosphorylation of SDC4, were inhibited in LysoPC-matured DCs. Thus, these DC are defective in adhesion and migration. Based on our results, we hypothesize that LysoPC released during apoptosis might delay DC migration to lymphoid organs and thus prevent autoimmunity. (c) 2010 Wiley-Liss, Inc.
        PMID: 20607801 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Biofilms: their role in dermal fillers.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24267.html</link>
      <description>Related Articles Biofilms: their role in dermal fillers. J Cutan Aesthet Surg. 2010 Jan;3(1):20-2 Authors: Sadashivaiah AB, Mysore V Fillers are commonly used in several aesthetic indications. Though considered safe, several side effects have been reported. The role of biofilms in the causation of some of these side effects has been elucidated only recently and this article presents a short review of the subject. PMID: 20606988 [PubMed - in process] </description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24267.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Biofilms: their role in dermal fillers.
        J Cutan Aesthet Surg. 2010 Jan;3(1):20-2
        Authors:  Sadashivaiah AB, Mysore V
        Fillers are commonly used in several aesthetic indications. Though considered safe, several side effects have been reported. The role of biofilms in the causation of some of these side effects has been elucidated only recently and this article presents a short review of the subject.
        PMID: 20606988 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>The gut microbiota modulates host energy and lipid metabolism in mice.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24272.html</link>
      <description> Related Articles The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res. 2010 May;51(5):1101-12 Authors: Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L, Islam S, Felin J, Perkins R, BorÃ©n J, Oresic M, BÃ¤ckhed F The gut microbiota has recently been identified as an environmental factor that may promote metabolic diseases. To investigate the effect of gut microbiota on host energy and lipid metabolism, we compared the serum metabolome and ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:09 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24272.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        The gut microbiota modulates host energy and lipid metabolism in mice.
        J Lipid Res. 2010 May;51(5):1101-12
        Authors:  Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L, Islam S, Felin J, Perkins R, BorÃ©n J, Oresic M, BÃ¤ckhed F
        The gut microbiota has recently been identified as an environmental factor that may promote metabolic diseases. To investigate the effect of gut microbiota on host energy and lipid metabolism, we compared the serum metabolome and the lipidomes of serum, adipose tissue, and liver of conventionally raised (CONV-R) and germ-free mice. The serum metabolome of CONV-R mice was characterized by increased levels of energy metabolites, e.g., pyruvic acid, citric acid, fumaric acid, and malic acid, while levels of cholesterol and fatty acids were reduced. We also showed that the microbiota modified a number of lipid species in the serum, adipose tissue, and liver, with its greatest effect on triglyceride and phosphatidylcholine species. Triglyceride levels were lower in serum but higher in adipose tissue and liver of CONV-R mice, consistent with increased lipid clearance. Our findings show that the gut microbiota affects both host energy and lipid metabolism and highlights its role in the development of metabolic diseases.
        PMID: 20040631 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>免疫学; +260の新しい参照 (immulogy; +260 new citations)</title>
  <link>http://biomarket.jp/modules/pubmed/article-24273.html</link>
      <description>260の新しいpubmed参照はあなたの調査のために取り出された。完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:免疫学これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/08 PubMedの薬の国立図書館のサービスで、含んでいる発生した。これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:260 new pubmed citations were retrieved for your search.Click on the se ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24273.html</guid>
        
      <content:encoded> <![CDATA[
    260の新しいpubmed参照はあなたの調査のために取り出された。
完全な調査の結果を表示するために次調査のハイパーリンクをつけなさい:

免疫学
これらのpubmed結果は50年代に戻って生物医学的な記事のための15,000,000の参照に2010/07/08 PubMedの薬の国立図書館のサービスで、含んでいる発生した。
これらの参照はMEDLINEおよび付加的な生命科学ジャーナルからある。 PubMedはフルテキストの記事および他の関連資源を提供する多くの場所にリンクを含んでいる。(原文:260 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

immunology
These pubmed results were generated on 2010/07/08PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.)
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Pro-Inflammatory Effects of Interleukin-17A on Vascular Smooth Muscle Cells Involve NAD(P)H- Oxidase Derived Reactive Oxygen Species.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24275.html</link>
      <description>Related Articles Pro-Inflammatory Effects of Interleukin-17A on Vascular Smooth Muscle Cells Involve NAD(P)H- Oxidase Derived Reactive Oxygen Species. J Vasc Res. 2010 Jul 6;48(1):52-58 Authors: Pietrowski E, Bender B, Huppert J, White R, Luhmann HJ, Kuhlmann CR T cells are known for their contribution to the inflammatory element of atherosclerosis. Recently, it has been demonstrated that the Th17 derived cytokine IL-17 is involved in the pro-inflammatory response of vascular smooth muscle cells ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24275.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Pro-Inflammatory Effects of Interleukin-17A on Vascular Smooth Muscle Cells Involve NAD(P)H- Oxidase Derived Reactive Oxygen Species.
        J Vasc Res. 2010 Jul 6;48(1):52-58
        Authors:  Pietrowski E, Bender B, Huppert J, White R, Luhmann HJ, Kuhlmann CR
        T cells are known for their contribution to the inflammatory element of atherosclerosis. Recently, it has been demonstrated that the Th17 derived cytokine IL-17 is involved in the pro-inflammatory response of vascular smooth muscle cells (VSMC). The aim of the present study was to examine whether reactive oxygen species (ROS) might be involved in this context. The effect of IL-17A on ROS generation was examined using the fluorescent dye 2'7'-dichlorodihydrofluorescein (H(2)DCF) in primary murine VSMC. IL-17A induced an increase in H(2)DCF fluorescence in VSMC, and this effect was blocked by the NAD(P)H-oxidase inhibitor apocynin and siRNA targeting Nox2. The p38-MAPK inhibitors SB203580 and SB202190 dose-dependently reduced the IL-17A induced ROS production. The IL-17A induced release of the pro-inflammatory cytokines IL-6, G-CSF, GM-CSF and MCP-1 from VSMC, as detected by the Luminex technology, was completely abolished by NAD(P)H-oxidase inhibition. Taken together, our data indicate that IL-17A causes the NAD(P)H-oxidase dependent generation of ROS leading to a pro-inflammatory activation of VSMC.
        PMID: 20606471 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24274.html</link>
      <description>Related Articles Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients. Tissue Antigens. 2010 Jul 1; Authors: Pavlova YA, Malek I, Honsova E, Netuka I, Sochman J, Lodererova A, Kolesar L, Striz I, Skibova J, Slavcev A Recent unconfirmed literature data suggest that elevated concentrations of the multifunctional cytokine hepatocyte growth factor (HGF) might be a marker of increased incidence of acute rejection after organ transplantation. The aim of this  ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24274.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
        Tissue Antigens. 2010 Jul 1;
        Authors:  Pavlova YA, Malek I, Honsova E, Netuka I, Sochman J, Lodererova A, Kolesar L, Striz I, Skibova J, Slavcev A
        Recent unconfirmed literature data suggest that elevated concentrations of the multifunctional cytokine hepatocyte growth factor (HGF) might be a marker of increased incidence of acute rejection after organ transplantation. The aim of this study was to test the hypothesis that HGF levels may correlate with the rejection and/or with the production of HLA and MHC Class I chain-related antigens A (MICA) specific antibodies. Sixty-three heart transplant recipients were included into the study. Hundred and eighty-five endomyocardial biopsies (EMB) obtained up to 6 months after transplantation were retrospectively analyzed for signs of cellular (CR) and antibody-mediated rejection (AMR). Pre- and post-transplant sera were tested for HGF concentrations and antibodies to HLA class I, class II and MICA antigens by xMap technology (Luminex). Pre-transplant HGF did not correlate with the incidence of CR or AMR. However, higher HGF concentrations correlated significantly with HLA antibody production before and after transplantation (P = 0.006 and P < 0.0001 respectively). Patients with both HLA class I and class II antibodies before transplantation had significantly lower AMR-free survival. Furthermore, recipients with pre-transplant donor-specific antibodies (DSA) had significantly lower AMR-free survival (50%) than recipients without pre-transplant HLA antibodies (90%) and patients with antibodies not specific to donor antigens (92%) (P = 0.005). Post-transplant MICA antibodies tended to be more frequent in patients with AMR (P = 0.063). In conclusion, elevated HGF concentrations in our study were not associated with the incidence of CR and/or AMR but with the presence of HLA-specific antibodies. Testing for DSA before heart transplantation by Luminex may be helpful for the identification of patients with increased risk of AMR.
        PMID: 20604893 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24301.html</link>
      <description>Related Articles Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer. J Cancer Res Clin Oncol. 2010 Jul 4; Authors: Enkelmann A, Heinzelmann J, von Eggeling F, Walter M, Berndt A, Wunderlich H, Junker K PURPOSE: Tumour development and progression are strongly affected by interaction of tumour cells and tumour stroma. Different tumour models demonstrate a supportive effect of tumour-associated fibroblasts (TAF) on the tumour genesis. Aims of the presen ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24301.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer.
        J Cancer Res Clin Oncol. 2010 Jul 4;
        Authors:  Enkelmann A, Heinzelmann J, von Eggeling F, Walter M, Berndt A, Wunderlich H, Junker K
        PURPOSE: Tumour development and progression are strongly affected by interaction of tumour cells and tumour stroma. Different tumour models demonstrate a supportive effect of tumour-associated fibroblasts (TAF) on the tumour genesis. Aims of the present study are the isolation of TAF from primary urinary bladder tumour specimens and the proteomic and epigenetic characterisation. METHODS: TAF were isolated from cultured urinary bladder tumour specimens. Therefore, primary tumour material was treated with EDTA followed by two separated detachment steps. Non-tumour fibroblasts were isolated from foreskin and normal bladder tissues. Proteins and total RNA were isolated from cultured fibroblasts. Protein pattern analyses were carried out by SELDI-TOF-MS. The miRNA expression profile was analysed by miRNA microarray. RESULTS: By optimising cell culture routines, we achieved to isolate and subsequently cultivate TAF from primary tumour material of the urinary bladder. SELDI-TOF-MS measurements reveal distinct differences in the proteomic patterns of TAF and non-tumour fibroblasts. Microarray analyses indicate specific expression of several miRNAs in TAF and non-tumour fibroblasts. CONCLUSION: In summary, we determined proteomic and epigenetic differences between non-tumour fibroblasts and TAF of urinary bladder carcinoma and identified specific protein expression patterns as well as miRNA profiles of TAF in comparison with non-tumour fibroblasts. These findings provide more insights into the complex tumour network and a good starting point for the identification of markers for the prediction of tumour development and progression based on specific TAF expression patterns.
        PMID: 20607552 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Let-7 microRNA inhibits the proliferation of human glioblastoma cells.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24300.html</link>
      <description>Related Articles Let-7 microRNA inhibits the proliferation of human glioblastoma cells. J Neurooncol. 2010 Jul 7; Authors: Lee ST, Chu K, Oh HJ, Im WS, Lim JY, Kim SK, Park CK, Jung KH, Lee SK, Kim M, Roh JK MicroRNAs (miRNAs) are small noncoding RNAs comprising 21-23 nucleotides that regulate gene expression by transcriptionally repressing their complementary mRNAs. In particular, let-7 miRNA has been postulated to function as a tumor suppressor in various cancer cells, but not yet in glioblast ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24300.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Let-7 microRNA inhibits the proliferation of human glioblastoma cells.
        J Neurooncol. 2010 Jul 7;
        Authors:  Lee ST, Chu K, Oh HJ, Im WS, Lim JY, Kim SK, Park CK, Jung KH, Lee SK, Kim M, Roh JK
        MicroRNAs (miRNAs) are small noncoding RNAs comprising 21-23 nucleotides that regulate gene expression by transcriptionally repressing their complementary mRNAs. In particular, let-7 miRNA has been postulated to function as a tumor suppressor in various cancer cells, but not yet in glioblastoma. In this study, we investigated the anti-tumorigenic effect of let-7 miRNA in glioblastoma cells. Human glioblastoma cells (U251 or U87 cells) were transfected with let-7 miRNA and assayed for in-vitro proliferation, migration, and in-vivo tumor formation. Transfection of let-7 miRNA reduced expression of pan-RAS, N-RAS, and K-RAS in the glioblastoma cells. Let-7 miRNA also reduced the in-vitro proliferation and migration of the cells, and reduced the sizes of the tumors produced after transplantation into nude mice. However, let-7 miRNA exerted no effect on the proliferation of normal human astrocytes. These results indicate that let-7 miRNA has an anti-tumorigenic effect on glioblastoma cells, and suggest possible use of let-7 miRNA for treating glioblastoma.
        PMID: 20607356 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24299.html</link>
      <description>Related Articles MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration. J Cereb Blood Flow Metab. 2010 Jul 7; Authors: Saugstad JA MicroRNAs are small RNAs that function as regulators of posttranscriptional gene expression. MicroRNAs are encoded by genes, and processed to form ribonucleoprotein complexes that bind to messenger RNA (mRNA) targets to repress translation or degrade mRNA transcripts. The microRNAs are particularly abundant ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24299.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration.
        J Cereb Blood Flow Metab. 2010 Jul 7;
        Authors:  Saugstad JA
        MicroRNAs are small RNAs that function as regulators of posttranscriptional gene expression. MicroRNAs are encoded by genes, and processed to form ribonucleoprotein complexes that bind to messenger RNA (mRNA) targets to repress translation or degrade mRNA transcripts. The microRNAs are particularly abundant in the brain where they serve as effectors of neuronal development and maintenance of the neuronal phenotype. They are also expressed in dendrites where they regulate spine structure and function as effectors in synaptic plasticity. MicroRNAs have been evaluated for their roles in brain ischemia, traumatic brain injury, and spinal cord injury, and in functional recovery after ischemia. They also serve as mediators in the brain's response to ischemic preconditioning that leads to endogenous neuroprotection. In addition, microRNAs are implicated in neurodegenerative disorders, including Alzheimer's, Huntington, Parkinson, and Prion disease. The discovery of microRNAs has expanded the potential for human diseases to arise from genetic mutations in microRNA genes or sequences within their target mRNAs. This review discusses microRNA discovery, biogenesis, mechanisms of gene regulation, their expression and function in the brain, and their roles in brain ischemia and injury, neuroprotection, and neurodegeneration.Journal of Cerebral Blood Flow &amp; Metabolism advance online publication, 7 July 2010; doi:10.1038/jcbfm.2010.101.
        PMID: 20606686 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Transcriptional regulatory networks associated with self-renewal and differentiation of neural stem cells.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24302.html</link>
      <description>Related Articles Transcriptional regulatory networks associated with self-renewal and differentiation of neural stem cells. J Cell Physiol. 2010 Jul 6; Authors: Yun SJ, Byun K, Bhin J, Oh JH, Nhung JH, Hwang D, Lee B Neural stem cells (NSCs) are self-renewing, multipotent cells that can generate neurons, astrocytes, and oligodendrocytes of the nervous system. NSCs have been extensively studied because they can be used to treat impaired cells and tissues or improve regenerative power of degenrati ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24302.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Transcriptional regulatory networks associated with self-renewal and differentiation of neural stem cells.
        J Cell Physiol. 2010 Jul 6;
        Authors:  Yun SJ, Byun K, Bhin J, Oh JH, Nhung JH, Hwang D, Lee B
        Neural stem cells (NSCs) are self-renewing, multipotent cells that can generate neurons, astrocytes, and oligodendrocytes of the nervous system. NSCs have been extensively studied because they can be used to treat impaired cells and tissues or improve regenerative power of degenrating cells in neurodegenerative diseases or spinal cord injuries. For successful clinical applications of NSCs, it is essential to understand the mechanisms underlying self-renewal and differentiation of NSCs, which involve complex interplays among key factors including transcription factors, epigenetic control, microRNAs, and signaling pathways. Despite numerous studies on such factors, a holistic view of their interplays during neural development still remains elusive. In this review, we present recently identified potential regulatory factors and their targets by genomics and proteomics technologies and then integrate them into regulatory networks that describe their complex interplays to achieve self-renewal and differentiation of NSCs. (c) 2010 Wiley-Liss, Inc.
        PMID: 20607797 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24298.html</link>
      <description>Related Articles Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy. Mol Ther. 2010 Jul 6; Authors: Chen Y, Zhu X, Zhang X, Liu B, Huang L Targeted delivery of RNA-based therapeutics for cancer therapy remains a challenge. We have developed a LPH (liposome-polycation-hyaluronic acid) nanoparticle formulation modified with tumor-targeting single-chain antibody fragment (scFv) for systemic delivery of small interfering RNA (siRNA) and microRNA (miRNA) into  ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24298.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy.
        Mol Ther. 2010 Jul 6;
        Authors:  Chen Y, Zhu X, Zhang X, Liu B, Huang L
        Targeted delivery of RNA-based therapeutics for cancer therapy remains a challenge. We have developed a LPH (liposome-polycation-hyaluronic acid) nanoparticle formulation modified with tumor-targeting single-chain antibody fragment (scFv) for systemic delivery of small interfering RNA (siRNA) and microRNA (miRNA) into experimental lung metastasis of murine B16F10 melanoma. The siRNAs delivered by the scFv targeted nanoparticles efficiently downregulated the target genes (c-Myc/MDM2/VEGF) in the lung metastasis. Two daily intravenous injections of the combined siRNAs in the GC4-targeted nanoparticles significantly reduced the tumor load in the lung. miRNA-34a (miR-34a) induced apoptosis, inhibited survivin expression, and downregulated MAPK pathway in B16F10 cells. miR-34a delivered by the GC4-targeted nanoparticles significantly downregulated the survivin expression in the metastatic tumor and reduced tumor load in the lung. When miR-34a and siRNAs were co-formulated in GC4-targeted nanoparticles, an enhanced anticancer effect was observed.
        PMID: 20606648 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Intranuclear DNA Release Is a Determinant of Transfection Activity for a Non-viral Vector: Biocleavable Polyrotaxane as a Supramolecularly Dissociative Condenser for Efficient Intranuclear DNA Release.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24304.html</link>
      <description>Related Articles Intranuclear DNA Release Is a Determinant of Transfection Activity for a Non-viral Vector: Biocleavable Polyrotaxane as a Supramolecularly Dissociative Condenser for Efficient Intranuclear DNA Release. Biol Pharm Bull. 2010;33(7):1218-22 Authors: Yamada Y, Nomura T, Harashima H, Yamashita A, Katoono R, Yui N It has been believed that nuclear gene delivery is the most important process for gene expression, and various non-viral vectors are currently being developed with this assu ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24304.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Intranuclear DNA Release Is a Determinant of Transfection Activity for a Non-viral Vector: Biocleavable Polyrotaxane as a Supramolecularly Dissociative Condenser for Efficient Intranuclear DNA Release.
        Biol Pharm Bull. 2010;33(7):1218-22
        Authors:  Yamada Y, Nomura T, Harashima H, Yamashita A, Katoono R, Yui N
        It has been believed that nuclear gene delivery is the most important process for gene expression, and various non-viral vectors are currently being developed with this assumption. However, some of our earlier studies revealed a surprising difference in transfection activity between viral and non-viral vectors: this difference is largely due to the result of the intranuclear disposition of DNA rather than its delivery to the nucleus (Hama S. et al. (2006), Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol. Ther., 13, 786-794). Here, we report on some direct evidence that demonstrates the importance of the release of intranuclear DNA on transfection activity. The data show that transfection activity can be substantially enhanced by integrating a multifunctional envelope-type nano device (MEND) and a biocleavable polyrotaxane (DMAE-SS-PRX) as an artificial condenser. Our integration system showed significantly higher transfection activity compared to conventional gene delivery system. Moreover, this system provides a strong support for our hypothesis that intranuclear DNA disposition plays a critical role in gene expression for non-viral vectors.
        PMID: 20606316 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Development of Non-viral Vector for Cancer Gene Therapy.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24305.html</link>
      <description>Related Articles Development of Non-viral Vector for Cancer Gene Therapy. Yakugaku Zasshi. 2010 Jul;130(7):917-23 Authors: Hattori Y Cancer gene therapy has been intensively developed using non-viral vectors, among which cationic liposomes and nanoparticles are the most investigated. Optimal gene therapy for tumors must deliver plasmid DNA (pDNA) or synthetic small interfering RNA (siRNA) to tumor cells with high efficiency and minimal toxicity. We developed new cationic nanoparticles (NP) compo ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24305.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Development of Non-viral Vector for Cancer Gene Therapy.
        Yakugaku Zasshi. 2010 Jul;130(7):917-23
        Authors:  Hattori Y
        Cancer gene therapy has been intensively developed using non-viral vectors, among which cationic liposomes and nanoparticles are the most investigated. Optimal gene therapy for tumors must deliver plasmid DNA (pDNA) or synthetic small interfering RNA (siRNA) to tumor cells with high efficiency and minimal toxicity. We developed new cationic nanoparticles (NP) composed of cholesteryl-3beta-carboxyamidoethylene-N-hydroxyethylamine (OH-Chol) and Tween 80, and evaluated the transfection efficiencies of pDNA and siRNA into human prostate tumor PC-3 xenografts. NP showed effective transfection of pDNA and siRNA when directly injected into the xenografts. For targeted delivery to tumors, vitamin folic acid has been utilized for folate receptor (FR)-mediated drug delivery since FR is frequently overexpressed on many types of human tumors. We developed folate-linked nanoparticles (NP-F) composed of OH-Chol, Tween 80 and folate-poly(ethylene glycol)-distearoylphosphatidylethanolamine conjugate. Tumor growth of FR-positive human nasopharyngeal tumor KB xenografts was significantly inhibited when a complex of NP-F and a therapeutic gene was intratumorally injected. These findings suggested that cationic cholesterol-based nanoparticles are potential non-viral pDNA and siRNA vectors for local tumor treatment.
        PMID: 20606371 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24303.html</link>
      <description> Related Articles Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma. Cancer Lett. 2010 Aug 1;294(1):25-34 Authors: Ishii T, Yasuchika K, Suemori H, Nakatsuji N, Ikai I, Uemoto S We aimed to demonstrate that alpha-fetoprotein (AFP)-producing cells in cholangiocarcinomas possessed cancer stem cell (CSC)-like properties. AFP enhancer/promoter-driven EGFP gene was transfected into human cholangiocarcinoma cell lines. One cell line, RBE, expressed both AFP a ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24303.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma.
        Cancer Lett. 2010 Aug 1;294(1):25-34
        Authors:  Ishii T, Yasuchika K, Suemori H, Nakatsuji N, Ikai I, Uemoto S
        We aimed to demonstrate that alpha-fetoprotein (AFP)-producing cells in cholangiocarcinomas possessed cancer stem cell (CSC)-like properties. AFP enhancer/promoter-driven EGFP gene was transfected into human cholangiocarcinoma cell lines. One cell line, RBE, expressed both AFP and EGFP. Clonal analyses revealed that one EGFP-positive cell generated both EGFP-positive and EGFP-negative cell fractions. However, one EGFP-negative cell never produced EGFP-positive cells. The EGFP-positive cells had a greater tumorigenic potential. Only the EGFP-positive cells expressed Notch1. AFP and Notch1 expression was observed in clinical intrahepatic cholangiocarcinomas. The AFP-producing cells were suggested to be CSCs. The Notch pathway might play an important role in maintaining the CSC characteristics.
        PMID: 20149523 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24306.html</link>
      <description>Related Articles p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells. Prostate. 2010 Jul 6; Authors: Tsui KH, Feng TH, Lin YF, Chang PL, Juang HH BACKGROUND: Mitochondrial aconitase (mACON) is regarded as the key enzyme in citrate oxidation in human prostate epithelial cells, and its abnormal expression has been implicated in tumorigenesis of the prostate. Evidence also supports a broad role for the p53 gene in suppressing prostatic tumorigenesis. W ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24306.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells.
        Prostate. 2010 Jul 6;
        Authors:  Tsui KH, Feng TH, Lin YF, Chang PL, Juang HH
        BACKGROUND: Mitochondrial aconitase (mACON) is regarded as the key enzyme in citrate oxidation in human prostate epithelial cells, and its abnormal expression has been implicated in tumorigenesis of the prostate. Evidence also supports a broad role for the p53 gene in suppressing prostatic tumorigenesis. We investigated whether p53 regulates mACON expression and explore the potential mechanisms responsible for its effect on prostate cancer cells. METHODS: Camptothecin (CPT) treatments and transient overexpression of p53 were used to investigate p53 regulation of mACON and may effects were assessed using immunoblotting and transient gene expression assays. RESULTS: In vitro enzymatic activity assays and immunoblot assays showed that CPT treatment induced p53 expression while reducing mACON protein biosynthesis in wild-type p53 expressing LNCaP cells. Immunoblot assays and reporter assays revealed that transient transfection of a p53 expression vector into p53-null PC-3 cells decreased mACON expression. Cyclic pifithrin-alpha, an inhibitor of p53 transcriptional activity, blocked the decrease in mACON gene expression resulting from CPT treatment in LNCaP cells. Two putative p53 response elements were identified within the mACON promoter; however, mutation of these putative p53 response elements did not abolish the effect of CPT whereby it decreased mACON expression. A similar result was obtained for the effect of these mutants on the promoter activity of the mACON gene after transient overexpression of p53. CONCLUSIONS: Together these results suggest that p53 downregulation of mACON gene expression in human prostate carcinoma cells may not occur through the putative consensus p53 response elements found within the mACON promoter. Prostate (c) 2010 Wiley-Liss, Inc.
        PMID: 20607720 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Sphingolipids in Multiple Sclerosis.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24386.html</link>
      <description>Related Articles Sphingolipids in Multiple Sclerosis. Neuromolecular Med. 2010 Jul 7; Authors: Jana A, Pahan K Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease of the CNS. Oligodendrocytes, the myelin-forming cells of the central nervous system (CNS), are target cells in MS. Although the etiology of MS is poorly known, new insights suggest oligodendrocyte apoptosis as one of the critical events followed by glial activation and infiltration of lymphocytes and macrophages. A m ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24386.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Sphingolipids in Multiple Sclerosis.
        Neuromolecular Med. 2010 Jul 7;
        Authors:  Jana A, Pahan K
        Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease of the CNS. Oligodendrocytes, the myelin-forming cells of the central nervous system (CNS), are target cells in MS. Although the etiology of MS is poorly known, new insights suggest oligodendrocyte apoptosis as one of the critical events followed by glial activation and infiltration of lymphocytes and macrophages. A major breakthrough in delineation of the mechanism of cell death, perivascular cuffing, and glial activation came from elucidation of the sphingolipid signal transduction pathway. The sphingolipid signal transduction pathway induces apoptosis, differentiation, proliferation, and growth arrest depending upon cell and receptor types, and downstream targets. Sphingomyelin, a major component of myelin membrane formed by mature oligodendrocytes, is abundant in the CNS and ceramide, its primary catabolic product released by activation of either neutral or acidic sphingomyelinase, serves as a potential lipid second messenger or mediator molecule modulating diverse cellular signaling pathways. Similarly, under certain conditions, sphingosine produced from ceramide by ceramidase is phosphorylated by sphingosine kinases to sphingosine-1 phosphate, another potent second messenger molecule. Both ceramide and sphingosine-1 phosphate regulate life and death of many cell types including brain cells and participate in pathogenic processes of MS. In this review, we have made an honest attempt to compile recent findings made by others and us relating to the role of sphingolipids in the disease process of MS.
        PMID: 20607622 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Viral Fusion Peptides Induce Several Signal Transduction Pathway Activations That Are Essential for Interleukin-10 and Beta-Interferon Production.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24383.html</link>
      <description>Related Articles Viral Fusion Peptides Induce Several Signal Transduction Pathway Activations That Are Essential for Interleukin-10 and Beta-Interferon Production. Intervirology. 2010 Jul 2;53(6):381-389 Authors: Vitiello M, Finamore E, Falanga A, Raieta K, Cantisani M, Galdiero F, Pedone C, Galdiero M, Galdiero S Objectives: The deciphering of intracellular signaling pathways that are activated by the interaction between viral fusion peptides and cellular membranes are important for the underst ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24383.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Viral Fusion Peptides Induce Several Signal Transduction Pathway Activations That Are Essential for Interleukin-10 and Beta-Interferon Production.
        Intervirology. 2010 Jul 2;53(6):381-389
        Authors:  Vitiello M, Finamore E, Falanga A, Raieta K, Cantisani M, Galdiero F, Pedone C, Galdiero M, Galdiero S
        Objectives: The deciphering of intracellular signaling pathways that are activated by the interaction between viral fusion peptides and cellular membranes are important for the understanding of both viral replication strategies and host defense mechanisms. Methods: Fusion peptides of several enveloped viruses belonging to different virus families were prepared by standard 9-fluorenylmethoxycarbonyl polyamine solid-phase synthesis and used to stimulate U937 cells in vitro to analyze the phosphorylation patterns of the signaling pathways (PKC, Src, Akt, and MAPK pathways). Immunoprecipitation and Western blotting were carried out by using phosphospecific antibodies. All samples were also assayed for the presence of IL-10 and IFN-beta by ELISA and activation of nuclear factors (AP-1 and NF-kappaB). Results: We have demonstrated that hydrophobic domains of fusion proteins are able to induce several transduction pathways that lead to cytokine (IFN-beta and IL-10) production, an event that appears to be dependent on early activation of AP-1 and NF-kappaB. Conclusions: The results obtained on the signaling activity of fusion peptides from different viruses enabled us to shed some light on the complex mechanism of viral entry and more precisely we focused on the exact signaling event induced by hydrophobic domains characteristic of fusion peptides interacting with the cell membrane.
        PMID: 20606459 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24385.html</link>
      <description>Related Articles TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin. Arch Pharm Res. 2010 Jun;33(6):939-45 Authors: Park SJ, Lee AN, Youn HS Toll-like receptors (TLRs) play an important role in induction of innate immune responses. The stimulation of TLRs by microbial components triggers two branches of downstream signaling pathways: myeloid differential factor 88 (MyD88)- and toll-interleukin-1 receptor domain-containing adapter inducing interfero ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24385.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin.
        Arch Pharm Res. 2010 Jun;33(6):939-45
        Authors:  Park SJ, Lee AN, Youn HS
        Toll-like receptors (TLRs) play an important role in induction of innate immune responses. The stimulation of TLRs by microbial components triggers two branches of downstream signaling pathways: myeloid differential factor 88 (MyD88)- and toll-interleukin-1 receptor domain-containing adapter inducing interferon-beta (TRIF)-dependent signaling pathways. Auranofin, a sulfur-containing gold compound (Au[I]), has been widely used for the treatment of rheumatoid arthritis. Since dysregulation of TLRs can lead to severe systemic inflammatory and joint destructive process in rheumatoid arthritis, auranofin-mediated modulation of TLR activation may have therapeutic potential against such diseases. Previously, we demonstrated that auranofin suppressed TLR4 signaling pathway by inhibiting TLR4 dimerization induced by LPS. Here, we examined the effect of auranofin on signal transduction via the TRIF-dependent pathway induced by a TLR3 agonist. Auranofin inhibited nuclear factor-kappaB and interferon (IFN) regulatory factor 3 (IRF3) activation induced by polyinosinic-polycytidylic acid (poly[I:C]). Auranofin inhibited poly[I:C]-induced phosphorylation of IRF3 as well as IFN-inducible genes such as IFN inducible protein-10. Furthermore, auranofin inhibited TBK1 kinase activity in vitro. All the results suggest that auranofin suppress TLR signaling at multiple steps.
        PMID: 20607500 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>(1)H, (13)C and (15)N chemical shift assignments for the N-terminal domain of the voltage-gated potassium channel-hERG.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24384.html</link>
      <description>Related Articles (1)H, (13)C and (15)N chemical shift assignments for the N-terminal domain of the voltage-gated potassium channel-hERG. Biomol NMR Assign. 2010 Jul 7; Authors: Li Q, Raida M, Kang C The human ether Ã? go-go related gene (hERG) voltage-gated potassium controls the rapid delayed rectifier potassium current (I(ks)) in heart. The N-terminal 135 amino acids (NTD) form a Per-Arnt-Sim (PAS) domain which involves in signal transduction and protein-protein interactions. NTD was shown t ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24384.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        (1)H, (13)C and (15)N chemical shift assignments for the N-terminal domain of the voltage-gated potassium channel-hERG.
        Biomol NMR Assign. 2010 Jul 7;
        Authors:  Li Q, Raida M, Kang C
        The human ether Ã? go-go related gene (hERG) voltage-gated potassium controls the rapid delayed rectifier potassium current (I(ks)) in heart. The N-terminal 135 amino acids (NTD) form a Per-Arnt-Sim (PAS) domain which involves in signal transduction and protein-protein interactions. NTD was shown to be necessary for the regulation of the channel activity through its interaction with the channel pore region of hERG. Mutations in NTD were related to serious heart diseases. We report the (1)H, (13)C and (15)N chemical shift assignments for NTD using 2D and 3D heteronuclear NMR experiments. More than 95% backbone resonance assignments were obtained.
        PMID: 20607461 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Bacterial stimulus perception and signal transduction: Response to osmotic stress.</title>
  <link>http://biomarket.jp/modules/pubmed/article-24387.html</link>
      <description>Related Articles Bacterial stimulus perception and signal transduction: Response to osmotic stress. Chem Rec. 2010 Jul 6; Authors: KrÃ¤mer R When exposed to osmotic stress from the environment, bacteria act to maintain cell turgor and hydration by responding both on the level of gene transcription and protein activity. Upon a sudden decrease in external osmolality, internal solutes are released by the action of membrane embedded mechanosensitive channels. In response to an osmotic upshift, t ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:08 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed/article-24387.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Bacterial stimulus perception and signal transduction: Response to osmotic stress.
        Chem Rec. 2010 Jul 6;
        Authors:  KrÃ¤mer R
        When exposed to osmotic stress from the environment, bacteria act to maintain cell turgor and hydration by responding both on the level of gene transcription and protein activity. Upon a sudden decrease in external osmolality, internal solutes are released by the action of membrane embedded mechanosensitive channels. In response to an osmotic upshift, the concentration of osmolytes in the cytoplasm is increased both by de novo synthesis and by active uptake. In order to coordinate these processes of osmoregulation, cells are equipped with systems and mechanisms of sensing physical stimuli correlated to changes in the external osmolality (osmosensing), with pathways to transduce these stimuli into useful signals which can be processed in the cell (signal transduction), and mechanisms of regulating proper responses in the cell to recover from the environmental stress and to maintain all necessary physiological functions (osmoregulation). These processes will be described by a number of representative examples, mainly of osmoreactive transport systems with a focus on available data of their molecular mechanism. (c) 2010 The Japan Chemical Journal Forum and Wiley Periodicals, Inc. 2010: Published online in Wiley InterScience (www.interscience.wiley.com) DOI 10.1002/tcr.201000005.
        PMID: 20607761 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10784.html</link>
      <description> Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L. Cancer Lett. 2010 May 31; Authors: Zhu H, Liu XW, Ding WJ, Xu DQ, Zhao YC, Lu W, He QJ, Yang B Our previous study demonstrated that celastrol combined with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo-2L) exhibited significant synergistic anti-cancer activities, thus we were promoted to investigate the molecular mechanism of this synergy. Here in this study, we show that ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10784.html</guid>
        
      <content:encoded> <![CDATA[
    

        Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L.
        Cancer Lett. 2010 May 31;
        Authors:  Zhu H, Liu XW, Ding WJ, Xu DQ, Zhao YC, Lu W, He QJ, Yang B
        Our previous study demonstrated that celastrol combined with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo-2L) exhibited significant synergistic anti-cancer activities, thus we were promoted to investigate the molecular mechanism of this synergy. Here in this study, we show that celastrol up-regulates death receptor 4 (DR4) and 5 (DR5) expression at mRNA, total protein and cell surface levels, and the specific knockdown using DR4- or DR5-targeting siRNA transfection attenuates the PARP cleavage caused by the combination of celastrol and TRAIL/Apo-2L, denoting the critical roles of DR induction in this sensitization. Of note is that although celastrol activates p38 mitogen activated protein kinases (p38 MAPK), SB203580, one specific inhibitor of p38, fails to interrupt celastrol-induced DR4 expression and the enhanced apoptosis caused by celastrol plus TRAIL/Apo-2L. In addition, the protein expression of Mcl-1 and FLIP, two critical antiapoptotic factors, is not decreased upon celastrol treatment under our experimental conditions. Taken together, the present study demonstrates that the enhanced mRNA and protein expression of DR4 and DR5 play prominent roles in the sensitization of celastrol to TRAIL/Apo-2L-induced apoptosis, in a p38 MAPK-independent manner.
        PMID: 20605676 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Purinergic receptor-mediated rapid depletion of nuclear pAkt depends on PH domain leucine-rich repeat phosphatase (PHLPP), calcineurin, PP2A and PTEN phosphatases.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10785.html</link>
      <description> Purinergic receptor-mediated rapid depletion of nuclear pAkt depends on PH domain leucine-rich repeat phosphatase (PHLPP), calcineurin, PP2A and PTEN phosphatases. J Biol Chem. 2010 Jul 6; Authors: Mistafa O, Ghalali A, Kadekar S, HÃ¶gberg J, Stenius U Akt is an important oncoprotein and data suggest a critical role for nuclear Akt in cancer development. We have previously described a rapid (3-5 min) and P2X7-dependent depletion of nuclear phosphorylated Akt (pAkt) and effects on downstream  ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10785.html</guid>
        
      <content:encoded> <![CDATA[
    

        Purinergic receptor-mediated rapid depletion of nuclear pAkt depends on PH domain leucine-rich repeat phosphatase (PHLPP), calcineurin, PP2A and PTEN phosphatases.
        J Biol Chem. 2010 Jul 6;
        Authors:  Mistafa O, Ghalali A, Kadekar S, HÃ¶gberg J, Stenius U
        Akt is an important oncoprotein and data suggest a critical role for nuclear Akt in cancer development. We have previously described a rapid (3-5 min) and P2X7-dependent depletion of nuclear phosphorylated Akt (pAkt) and effects on downstream targets, and here we studied mechanisms behind the pAkt depletion. We show that cholesterol-lowering drugs, statins, or extra-cellular ATP, induced a complex and coordinated response in insulin-stimulated A549 cells leading to depletion of nuclear pAkt. It involved protein/lipid phosphatases PTEN, PH domain leucine-rich repeate phosphatase (PHLPP1 and 2), protein phosphatase 2A (PP2A) and calcineurin. We employed immunocytology, immunoprecipitation and proximity ligation assay techniques and show that PHLPP and calcineurin translocated to the nucleus, and formed complexes with Akt within 3 minutes. Also PTEN translocated to the nucleus and then co-localized with pAkt close to the nuclear membrane. An inhibitor of the scaffolding immunophilin FK506-binding protein 51 (FKBP51) and calcineurin, FK506, prevented depletion of nuclear pAkt. Furthermore, okadaic acid, an inhibitor of PP2A, prevented the nuclear pAkt depletion. Chemical inhibition and siRNA indicated that PHLPP, PP2A and PTEN were required for a robust depletion of nuclear pAkt and in prostate cancer cells lacking PTEN, transfection of PTEN restored the statin-induced pAkt depletion. The activation of protein and lipid phosphatases was paralleled by a rapid proliferating cell nuclear antigen (PCNA) translocation to the nucleus, a PCNA-p21cip1 complex formation and cyclin D1 degradation. We conclude that these effects reflect a signaling pathway for rapid depletion pAkt and that may stop the cell cycle.
        PMID: 20605778 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Involvement of caveolin in low K+-induced endocytic degradation of the cell surface hERG channels.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10786.html</link>
      <description> Involvement of caveolin in low K+-induced endocytic degradation of the cell surface hERG channels. J Biol Chem. 2010 Jul 6; Authors: Massaeli H, Sun T, Li X, Shallow H, Wu J, Xu J, Li W, Hanson C, Guo J, Zhang S Reduction in the rapidly activating delayed rectifier K(+) channel current (I(Kr)) due to either mutations in the human ether-a-go-go related gene (hERG), or drug block, causes inherited or drug-induced long QT syndrome (LQTS). A reduction in extracellular K(+) concentration ([K(+)](o)) ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10786.html</guid>
        
      <content:encoded> <![CDATA[
    

        Involvement of caveolin in low K+-induced endocytic degradation of the cell surface hERG channels.
        J Biol Chem. 2010 Jul 6;
        Authors:  Massaeli H, Sun T, Li X, Shallow H, Wu J, Xu J, Li W, Hanson C, Guo J, Zhang S
        Reduction in the rapidly activating delayed rectifier K(+) channel current (I(Kr)) due to either mutations in the human ether-a-go-go related gene (hERG), or drug block, causes inherited or drug-induced long QT syndrome (LQTS). A reduction in extracellular K(+) concentration ([K(+)](o)) exacerbates LQTS. Recently, we demonstrated that lowering [K(+)](o) promotes degradation of I(Kr) in rabbit ventricular myocytes and of the hERG channel stably expressed in human embryonic kidney (HEK) 293 cells. In this study, we investigated the degradation pathways of hERG channels under low K(+) conditions. We demonstrate that under low K(+) conditions, mature hERG channels and caveolin-1 (Cav1) displayed a parallel time-dependent reduction. The mature hERG channels co-precipitated with Cav1 in co-immunoprecipitation analysis, and internalized hERG channels co-localized with Cav1 in immunocytochemistry analysis. Overexpression of Cav1 accelerated the internalization of the mature hERG channels in 0 mM K(+)(o) while knockdown of Cav1 impeded this process. In addition, knockdown of dynamin 2 (Dyn2) using siRNA transfection significantly impeded hERG internalization and degradation under low K(+)(o) conditions. In cultured neonatal rat ventricular myocytes, knockdown of caveolin-3 (Cav3) significantly impeded low K(+)(o)-induced reduction of I(Kr). Our data indicate that a caveolin-dependent endocytic route is involved in low K(+)(o)-induced degradation of mature hERG channels.
        PMID: 20605793 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10788.html</link>
      <description> Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion. Mol Carcinog. 2010 Jul 6; Authors: Lin ML, Lu YC, Chung JG, Wang SG, Lin HT, Kang SE, Tang CH, Ko JL, Chen SS Aloe-emodin (AE), extracted from the rhizome of Rheum palmatum, has an anti-proliferative effect on different human cancer cell lines. Nonetheless, the underlying mechanism by which AE inhibits nasopharyngeal carcinoma (NPC) cell invasio ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10788.html</guid>
        
      <content:encoded> <![CDATA[
    

        Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion.
        Mol Carcinog. 2010 Jul 6;
        Authors:  Lin ML, Lu YC, Chung JG, Wang SG, Lin HT, Kang SE, Tang CH, Ko JL, Chen SS
        Aloe-emodin (AE), extracted from the rhizome of Rheum palmatum, has an anti-proliferative effect on different human cancer cell lines. Nonetheless, the underlying mechanism by which AE inhibits nasopharyngeal carcinoma (NPC) cell invasion is still unclear. The results of this study show that treatment of NPC cells with growth suppressive concentrations of AE caused cell cycle arrest at the S-G(2)/M phase. Coimmunoprecipitation and small interfering RNA (siRNA) studies demonstrated that AE-induced cell cycle arrest in NPC cells was associated with increasing levels of cyclin B1 bound to cyclin-dependent kinase 1. The inhibition of NPC cell invasion by AE was evidenced through the suppression of matrix metalloproteinases-2 (MMP-2) expression. MMP-2 promoter activity and cell invasion were inhibited by p38 mitogen-activated protein kinase (MAPK) siRNA, inhibitor 4-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-5-(4-pyridyl)-1H-imidazole (SB203580), and AE, but not by JNK siRNA and inhibitor 1,9-pyrazoloanthrone. Treatment with AE, SB203580, NF-kappaB inhibitors N-p-tosyl-(L)-phenylalanine chloromethyl ketone (TPCK) and pyrrolidine dithiocarbamate (PDTC) or transfection with p38 MAPK siRNA significantly inhibited NF-kappaB transcriptional activity. In addition, TPCK and PDTC treatment inhibited the expression and promoter activity of MMP-2 and thereby significantly inhibited cell invasion activity. The involvement of p38 MAPK activity in NF-kappaB-mediated MMP-2 function was further confirmed through the attenuation of p38 MAPK by SB203580 and NF-kappaB ectopic expression. Collectively, our results indicate that AE inhibits invasion of NPC cells by suppressing the expression of MMP-2 via the p38 MAPK-NF-kappaB signaling pathway. (c) 2010 Wiley-Liss, Inc.
        PMID: 20607722 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Development of Non-viral Vector for Cancer Gene Therapy.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10787.html</link>
      <description> Development of Non-viral Vector for Cancer Gene Therapy. Yakugaku Zasshi. 2010 Jul;130(7):917-23 Authors: Hattori Y Cancer gene therapy has been intensively developed using non-viral vectors, among which cationic liposomes and nanoparticles are the most investigated. Optimal gene therapy for tumors must deliver plasmid DNA (pDNA) or synthetic small interfering RNA (siRNA) to tumor cells with high efficiency and minimal toxicity. We developed new cationic nanoparticles (NP) composed of cholester ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10787.html</guid>
        
      <content:encoded> <![CDATA[
    

        Development of Non-viral Vector for Cancer Gene Therapy.
        Yakugaku Zasshi. 2010 Jul;130(7):917-23
        Authors:  Hattori Y
        Cancer gene therapy has been intensively developed using non-viral vectors, among which cationic liposomes and nanoparticles are the most investigated. Optimal gene therapy for tumors must deliver plasmid DNA (pDNA) or synthetic small interfering RNA (siRNA) to tumor cells with high efficiency and minimal toxicity. We developed new cationic nanoparticles (NP) composed of cholesteryl-3beta-carboxyamidoethylene-N-hydroxyethylamine (OH-Chol) and Tween 80, and evaluated the transfection efficiencies of pDNA and siRNA into human prostate tumor PC-3 xenografts. NP showed effective transfection of pDNA and siRNA when directly injected into the xenografts. For targeted delivery to tumors, vitamin folic acid has been utilized for folate receptor (FR)-mediated drug delivery since FR is frequently overexpressed on many types of human tumors. We developed folate-linked nanoparticles (NP-F) composed of OH-Chol, Tween 80 and folate-poly(ethylene glycol)-distearoylphosphatidylethanolamine conjugate. Tumor growth of FR-positive human nasopharyngeal tumor KB xenografts was significantly inhibited when a complex of NP-F and a therapeutic gene was intratumorally injected. These findings suggested that cationic cholesterol-based nanoparticles are potential non-viral pDNA and siRNA vectors for local tumor treatment.
        PMID: 20606371 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10792.html</link>
      <description>Related Articles p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells. Prostate. 2010 Jul 6; Authors: Tsui KH, Feng TH, Lin YF, Chang PL, Juang HH BACKGROUND: Mitochondrial aconitase (mACON) is regarded as the key enzyme in citrate oxidation in human prostate epithelial cells, and its abnormal expression has been implicated in tumorigenesis of the prostate. Evidence also supports a broad role for the p53 gene in suppressing prostatic tumorigenesis. W ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10792.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells.
        Prostate. 2010 Jul 6;
        Authors:  Tsui KH, Feng TH, Lin YF, Chang PL, Juang HH
        BACKGROUND: Mitochondrial aconitase (mACON) is regarded as the key enzyme in citrate oxidation in human prostate epithelial cells, and its abnormal expression has been implicated in tumorigenesis of the prostate. Evidence also supports a broad role for the p53 gene in suppressing prostatic tumorigenesis. We investigated whether p53 regulates mACON expression and explore the potential mechanisms responsible for its effect on prostate cancer cells. METHODS: Camptothecin (CPT) treatments and transient overexpression of p53 were used to investigate p53 regulation of mACON and may effects were assessed using immunoblotting and transient gene expression assays. RESULTS: In vitro enzymatic activity assays and immunoblot assays showed that CPT treatment induced p53 expression while reducing mACON protein biosynthesis in wild-type p53 expressing LNCaP cells. Immunoblot assays and reporter assays revealed that transient transfection of a p53 expression vector into p53-null PC-3 cells decreased mACON expression. Cyclic pifithrin-alpha, an inhibitor of p53 transcriptional activity, blocked the decrease in mACON gene expression resulting from CPT treatment in LNCaP cells. Two putative p53 response elements were identified within the mACON promoter; however, mutation of these putative p53 response elements did not abolish the effect of CPT whereby it decreased mACON expression. A similar result was obtained for the effect of these mutants on the promoter activity of the mACON gene after transient overexpression of p53. CONCLUSIONS: Together these results suggest that p53 downregulation of mACON gene expression in human prostate carcinoma cells may not occur through the putative consensus p53 response elements found within the mACON promoter. Prostate (c) 2010 Wiley-Liss, Inc.
        PMID: 20607720 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Development of Non-viral Vector for Cancer Gene Therapy.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10791.html</link>
      <description>Related Articles Development of Non-viral Vector for Cancer Gene Therapy. Yakugaku Zasshi. 2010 Jul;130(7):917-23 Authors: Hattori Y Cancer gene therapy has been intensively developed using non-viral vectors, among which cationic liposomes and nanoparticles are the most investigated. Optimal gene therapy for tumors must deliver plasmid DNA (pDNA) or synthetic small interfering RNA (siRNA) to tumor cells with high efficiency and minimal toxicity. We developed new cationic nanoparticles (NP) compo ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10791.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Development of Non-viral Vector for Cancer Gene Therapy.
        Yakugaku Zasshi. 2010 Jul;130(7):917-23
        Authors:  Hattori Y
        Cancer gene therapy has been intensively developed using non-viral vectors, among which cationic liposomes and nanoparticles are the most investigated. Optimal gene therapy for tumors must deliver plasmid DNA (pDNA) or synthetic small interfering RNA (siRNA) to tumor cells with high efficiency and minimal toxicity. We developed new cationic nanoparticles (NP) composed of cholesteryl-3beta-carboxyamidoethylene-N-hydroxyethylamine (OH-Chol) and Tween 80, and evaluated the transfection efficiencies of pDNA and siRNA into human prostate tumor PC-3 xenografts. NP showed effective transfection of pDNA and siRNA when directly injected into the xenografts. For targeted delivery to tumors, vitamin folic acid has been utilized for folate receptor (FR)-mediated drug delivery since FR is frequently overexpressed on many types of human tumors. We developed folate-linked nanoparticles (NP-F) composed of OH-Chol, Tween 80 and folate-poly(ethylene glycol)-distearoylphosphatidylethanolamine conjugate. Tumor growth of FR-positive human nasopharyngeal tumor KB xenografts was significantly inhibited when a complex of NP-F and a therapeutic gene was intratumorally injected. These findings suggested that cationic cholesterol-based nanoparticles are potential non-viral pDNA and siRNA vectors for local tumor treatment.
        PMID: 20606371 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Intranuclear DNA Release Is a Determinant of Transfection Activity for a Non-viral Vector: Biocleavable Polyrotaxane as a Supramolecularly Dissociative Condenser for Efficient Intranuclear DNA Release.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10790.html</link>
      <description>Related Articles Intranuclear DNA Release Is a Determinant of Transfection Activity for a Non-viral Vector: Biocleavable Polyrotaxane as a Supramolecularly Dissociative Condenser for Efficient Intranuclear DNA Release. Biol Pharm Bull. 2010;33(7):1218-22 Authors: Yamada Y, Nomura T, Harashima H, Yamashita A, Katoono R, Yui N It has been believed that nuclear gene delivery is the most important process for gene expression, and various non-viral vectors are currently being developed with this assu ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10790.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Intranuclear DNA Release Is a Determinant of Transfection Activity for a Non-viral Vector: Biocleavable Polyrotaxane as a Supramolecularly Dissociative Condenser for Efficient Intranuclear DNA Release.
        Biol Pharm Bull. 2010;33(7):1218-22
        Authors:  Yamada Y, Nomura T, Harashima H, Yamashita A, Katoono R, Yui N
        It has been believed that nuclear gene delivery is the most important process for gene expression, and various non-viral vectors are currently being developed with this assumption. However, some of our earlier studies revealed a surprising difference in transfection activity between viral and non-viral vectors: this difference is largely due to the result of the intranuclear disposition of DNA rather than its delivery to the nucleus (Hama S. et al. (2006), Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol. Ther., 13, 786-794). Here, we report on some direct evidence that demonstrates the importance of the release of intranuclear DNA on transfection activity. The data show that transfection activity can be substantially enhanced by integrating a multifunctional envelope-type nano device (MEND) and a biocleavable polyrotaxane (DMAE-SS-PRX) as an artificial condenser. Our integration system showed significantly higher transfection activity compared to conventional gene delivery system. Moreover, this system provides a strong support for our hypothesis that intranuclear DNA disposition plays a critical role in gene expression for non-viral vectors.
        PMID: 20606316 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma.</title>
  <link>http://biomarket.jp/modules/d3pipes/article-10789.html</link>
      <description> Related Articles Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma. Cancer Lett. 2010 Aug 1;294(1):25-34 Authors: Ishii T, Yasuchika K, Suemori H, Nakatsuji N, Ikai I, Uemoto S We aimed to demonstrate that alpha-fetoprotein (AFP)-producing cells in cholangiocarcinomas possessed cancer stem cell (CSC)-like properties. AFP enhancer/promoter-driven EGFP gene was transfected into human cholangiocarcinoma cell lines. One cell line, RBE, expressed both AFP a ...</description>
        <pubDate>Sat, 10 Jul 2010 01:00:06 +0900</pubDate>
        <guid>http://biomarket.jp/modules/d3pipes/article-10789.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma.
        Cancer Lett. 2010 Aug 1;294(1):25-34
        Authors:  Ishii T, Yasuchika K, Suemori H, Nakatsuji N, Ikai I, Uemoto S
        We aimed to demonstrate that alpha-fetoprotein (AFP)-producing cells in cholangiocarcinomas possessed cancer stem cell (CSC)-like properties. AFP enhancer/promoter-driven EGFP gene was transfected into human cholangiocarcinoma cell lines. One cell line, RBE, expressed both AFP and EGFP. Clonal analyses revealed that one EGFP-positive cell generated both EGFP-positive and EGFP-negative cell fractions. However, one EGFP-negative cell never produced EGFP-positive cells. The EGFP-positive cells had a greater tumorigenic potential. Only the EGFP-positive cells expressed Notch1. AFP and Notch1 expression was observed in clinical intrahepatic cholangiocarcinomas. The AFP-producing cells were suggested to be CSCs. The Notch pathway might play an important role in maintaining the CSC characteristics.
        PMID: 20149523 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>[Direct enantioseparation of pantoprazole sodium by high performance liquid chromatography on teicoplanin-bonded chiral stationary phase]</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-115.html</link>
      <description>Related Articles [Direct enantioseparation of pantoprazole sodium by high performance liquid chromatography on teicoplanin-bonded chiral stationary phase] Se Pu. 2006 Jan;24(1):46-8 Authors: Ding G, Tang A, Wang J, Cong R, Bao J Teicoplanin-bonded chiral stationary phase was prepared and used for the direct chiral separation of racemic pantoprazole sodium by reversed-phase high performance liquid chromatography (HPLC). The influences of organic modifiers, the composition of mobile phase, the flo ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-115.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        [Direct enantioseparation of pantoprazole sodium by high performance liquid chromatography on teicoplanin-bonded chiral stationary phase]
        Se Pu. 2006 Jan;24(1):46-8
        Authors:  Ding G, Tang A, Wang J, Cong R, Bao J
        Teicoplanin-bonded chiral stationary phase was prepared and used for the direct chiral separation of racemic pantoprazole sodium by reversed-phase high performance liquid chromatography (HPLC). The influences of organic modifiers, the composition of mobile phase, the flow rate and column temperature on enantioseparation were studied. It was found that methanol was preferred than acetonitrile when used as organic modifier. With the increase of column temperature, chiral solutes were less retained and the separation factor value decreased indicating that lower temperature was better for the enantioseparation. Better resolution was obtained at lower flow rates as a result of minimization of the resistance of mass transfer. Based on these experimental data, the chiral HPLC method for the analysis of pantoprazole sodium on prepared chiral column (150 mm x 4.6 mm i. d., 5 microm) was established with simplicity and good reproducibility, by using methanol-water (35 : 65, v/v) as mobile phase at a flow rate of 0.6 mL/min and 20 degrees C.
        PMID: 16827310 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Central Role of Manganese in Regulation of Stress Responses, Physiology and Metabolism in Streptococcus pneumoniae.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-220.html</link>
      <description>Related Articles Central Role of Manganese in Regulation of Stress Responses, Physiology and Metabolism in Streptococcus pneumoniae. J Bacteriol. 2010 Jul 2; Authors: Ogunniyi AD, Mahdi LK, Jennings MP, McEwan AG, McDevitt CA, Van der Hoek MB, Bagley CJ, Hoffmann P, Gould KA, Paton JC The importance of Mn(2+) for pneumococcal physiology and virulence has been studied extensively. However, the specific cellular role(s) for which Mn(2+) is required are yet to be fully elucidated. Here, we analyzed ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-220.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Central Role of Manganese in Regulation of Stress Responses, Physiology and Metabolism in Streptococcus pneumoniae.
        J Bacteriol. 2010 Jul 2;
        Authors:  Ogunniyi AD, Mahdi LK, Jennings MP, McEwan AG, McDevitt CA, Van der Hoek MB, Bagley CJ, Hoffmann P, Gould KA, Paton JC
        The importance of Mn(2+) for pneumococcal physiology and virulence has been studied extensively. However, the specific cellular role(s) for which Mn(2+) is required are yet to be fully elucidated. Here, we analyzed the effect of Mn(2+) limitation on the transcriptome and proteome of Streptococcus pneumoniae D39. This was carried out by comparing a deletion mutant lacking the solute binding protein of the high-affinity Mn(2+) transporter, pneumococcal surface antigen A (PsaA) with its isogenic wild-type counterpart. We provide clear evidence for the Mn(2+)-dependent regulation of expression of oxidative stress-response enzymes SpxB and Mn(2+)-SodA, and of virulence-associated genes pcpA and prtA. We also demonstrate the upregulation of at least one oxidative and nitrosative stress-response gene cluster, comprising adhC, nmlRsp and czcD, in response to Mn(2+) stress. A significant increase in 6-phosphogluconate dehydrogenase activity in the psaA mutant grown under Mn(2+)-replete conditions, and upregulation of an oligopeptide ABC permease (AppDCBA), was also observed. Together, transcriptomic and proteomic analyses provided evidence for Mn(2+) having a central role in activating or stimulating enzymes involved in central carbon and general metabolism. Our results also highlight the importance of high-affinity Mn(2+) transport by PsaA in pneumococcal competence, physiology and metabolism, and elucidate mechanisms underlying the response to Mn(2+) stress.
        PMID: 20601473 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-214.html</link>
      <description> Related Articles Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. Anal Chem. 2010 Jun 15;82(12):5095-106 Authors: Alley WR, Madera M, Mechref Y, Novotny MV The study of protein glycosylation in biological fluids and tissues has substantial medical importance, as changes in glycan structures have now been associated with a number of diseases. Quantification of glycomic-profile changes is b ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-214.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery.
        Anal Chem. 2010 Jun 15;82(12):5095-106
        Authors:  Alley WR, Madera M, Mechref Y, Novotny MV
        The study of protein glycosylation in biological fluids and tissues has substantial medical importance, as changes in glycan structures have now been associated with a number of diseases. Quantification of glycomic-profile changes is becoming increasingly important in the search for disease biomarkers. Here, we report a highly reproducible combination of a glycomic sample preparation/solid-phase derivatization of glycoprotein-derived N-linked glycans with their subsequent microchip-based separation and mass-spectrometric (MS) measurements. Following our previously described reductive beta-elimination for O-linked glycans with ammonia-borane complex to reduce N-linked structures, the N-linked alditol structures are effectively methylated in dimethylformamide medium to avoid artefacts in MS measurements. Reversed-phase microfluidic liquid chromatography (LC) of methylated N-linked oligosaccharide alditols resolved some closely related structures into regular retention increments, aiding in their structural assignments. Optimized LC gradients, together with nanospray MS, have been applied here in the quantitative measurements of N-linked glycans in blood serum, distinguishing breast cancer patients from control individuals.
        PMID: 20491449 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Enzymatic synthesis of new oligosaccharides using mannosyltransferases from Candida species and their NMR assignments.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-213.html</link>
      <description> Related Articles Enzymatic synthesis of new oligosaccharides using mannosyltransferases from Candida species and their NMR assignments. Biol Pharm Bull. 2010;33(5):895-9 Authors: Shibata N, Okawa Y The outer layer of the cell wall of pathogenic fungi, Candida species, consists of mannan, which plays an important role in infection. In this study, we synthesized several oligosaccharides using mannosyltransferases obtained from Candida parapsilosis and Candida albicans. Namely, we synthesized mann ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-213.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Enzymatic synthesis of new oligosaccharides using mannosyltransferases from Candida species and their NMR assignments.
        Biol Pharm Bull. 2010;33(5):895-9
        Authors:  Shibata N, Okawa Y
        The outer layer of the cell wall of pathogenic fungi, Candida species, consists of mannan, which plays an important role in infection. In this study, we synthesized several oligosaccharides using mannosyltransferases obtained from Candida parapsilosis and Candida albicans. Namely, we synthesized mannotetraoses [Manalpha1--> 2Manalpha1-->3Manalpha1-->2Man and Manalpha1-->3(Manalpha1-->6)Manalpha1-->2Man] from mannotriose, Manalpha1-->3Manalpha1--> 2Man, and mannohexaoses [Manalpha1-->2Manalpha1-->3Manalpha1-->3Manalpha1-->2Manalpha1-->2Man and Manalpha1-->3(Manalpha1-->6)Manalpha1-->3Manalpha1-->2Manalpha1-->2Man] from mannopentaose, Manalpha1-->3Manalpha1-->3Manalpha1-->2Manalpha1-->2Man. The linkage sequence of these oligosaccharides was identified by a sequential (1)H-NMR assignment method combined with rotating frame nuclear Overhauser enhancement spectroscopy and relayed coherence transfer spectroscopy. The steric effect by the alpha-1,6-linked branching mannose residue to the H-1 proton chemical shift of the neighboring 3-O-substituted mannose residue was different from that of the 2-O-substituted mannose residue. These oligosaccharides having novel structures seem to be useful as the substrate or ligand for glycomics.
        PMID: 20460773 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Chiral-auxiliary-mediated 1,2-cis-glycosylations for the solid-supported synthesis of a biologically important branched alpha-glucan.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-219.html</link>
      <description>Related Articles Chiral-auxiliary-mediated 1,2-cis-glycosylations for the solid-supported synthesis of a biologically important branched alpha-glucan. Nat Chem. 2010 Jul;2(7):552-7 Authors: Boltje TJ, Kim JH, Park J, Boons GJ Solid-phase oligosaccharide synthesis offers the promise of providing libraries of oligosaccharides for glycomics research. A major stumbling block to solid-phase oligosaccharide synthesis has been a lack of general methods for the stereoselective installation of 1,2-cis-gl ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-219.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Chiral-auxiliary-mediated 1,2-cis-glycosylations for the solid-supported synthesis of a biologically important branched alpha-glucan.
        Nat Chem. 2010 Jul;2(7):552-7
        Authors:  Boltje TJ, Kim JH, Park J, Boons GJ
        Solid-phase oligosaccharide synthesis offers the promise of providing libraries of oligosaccharides for glycomics research. A major stumbling block to solid-phase oligosaccharide synthesis has been a lack of general methods for the stereoselective installation of 1,2-cis-glycosides, and intractable mixtures of compounds are obtained if several such glycosides need to be installed. We have prepared on-resin a biologically important glucoside containing multiple 1,2-cis-glycosidic linkages with complete anomeric control by using glycosyl donors having a participating (S)-(phenylthiomethyl)benzyl chiral auxiliary at C2. A branching point could be installed by using 9-fluorenylmethyloxycarbonyl (Fmoc) and allyloxycarbonyl (Alloc) as a versatile set of orthogonal protecting groups. The synthetic strategy made it possible to achieve partial on-resin deprotection of the completed oligosaccharide, thereby increasing the overall efficiency of the synthesis. The combination of classical and auxiliary-mediated neighbouring-group participation for controlling anomeric selectivity is bringing the promise of routine automated solid-supported oligosaccharide synthesis closer.
        PMID: 20571573 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Preparation of regioselectively feruloylated p-nitrophenyl alpha-L-arabinofuranosides and beta-D-xylopyranosides-convenient substrates for study of feruloyl esterase specificity.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-212.html</link>
      <description> Related Articles Preparation of regioselectively feruloylated p-nitrophenyl alpha-L-arabinofuranosides and beta-D-xylopyranosides-convenient substrates for study of feruloyl esterase specificity. Carbohydr Res. 2010 Jun 16;345(9):1094-8 Authors: Mastihubov</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-212.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Preparation of regioselectively feruloylated p-nitrophenyl alpha-L-arabinofuranosides and beta-D-xylopyranosides-convenient substrates for study of feruloyl esterase specificity.
        Carbohydr Res. 2010 Jun 16;345(9):1094-8
        Authors:  Mastihubov
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Platform technology to identify potential disease markers and establish heritability and environmental determinants of the human serum N-glycome.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-210.html</link>
      <description> Related Articles Platform technology to identify potential disease markers and establish heritability and environmental determinants of the human serum N-glycome. Carbohydr Res. 2010 Apr 18; Authors: Tharmalingam T, Mari</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-210.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Platform technology to identify potential disease markers and establish heritability and environmental determinants of the human serum N-glycome.
        Carbohydr Res. 2010 Apr 18;
        Authors:  Tharmalingam T, Mari
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glycopeptidome of a heavily N-glycosylated cell surface glycoprotein of Dictyostelium implicated in cell adhesion.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-208.html</link>
      <description> Related Articles Glycopeptidome of a heavily N-glycosylated cell surface glycoprotein of Dictyostelium implicated in cell adhesion. J Proteome Res. 2010 Jul 2;9(7):3495-510 Authors: Feasley CL, Johnson JM, West CM, Chia CP Genetic analysis has implicated the cell surface glycoprotein gp130 in cell interactions of the social amoeba Dictyostelium, and information about the utilization of the 18 N-glycosylation sequons present in gp130 is needed to identify critical molecular determinants of its a ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-208.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Glycopeptidome of a heavily N-glycosylated cell surface glycoprotein of Dictyostelium implicated in cell adhesion.
        J Proteome Res. 2010 Jul 2;9(7):3495-510
        Authors:  Feasley CL, Johnson JM, West CM, Chia CP
        Genetic analysis has implicated the cell surface glycoprotein gp130 in cell interactions of the social amoeba Dictyostelium, and information about the utilization of the 18 N-glycosylation sequons present in gp130 is needed to identify critical molecular determinants of its activity. Various glycomics strategies, including mass spectrometry of native and derivatized glycans, monosaccharide analysis, exoglycosidase digestion, and antibody binding, were applied to characterize a nonanchored version secreted from Dictyostelium. s-gp130 is modified by a predominant Man(8)GlcNAc(4) species containing bisecting and intersecting GlcNAc residues and additional high-mannose N-glycans substituted with sulfate, methyl-phosphate, and/or core alpha 3-fucose. Site mapping confirmed the occupancy of 15 sequons, some variably, and glycopeptide analysis confirmed 14 sites and revealed extensive heterogeneity at most sites. Glycopeptide glycoforms ranged from Man(6) to Man(9), GlcNAc(0-2) (peripheral), Fuc(0-2) (including core alpha 3 and peripheral), (SO(4))(0-1), and (MePO(4))(0-1), which represented elements of virtually the entire known cellular N-glycome as inferred from prior metabolic labeling and mass spectrometry studies. gp130, and a family of 14 related predicted glycoproteins whose polypeptide sequences are rapidly diverging in the Dictyostelium lineage, may contribute a functionally important shroud of high-mannose N-glycans at the interface of the amoebae with each other, their predators and prey, and the soil environment.
        PMID: 20443635 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Proteoglycomics: Recent Progress and Future Challenges.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-211.html</link>
      <description>Related Articles Proteoglycomics: Recent Progress and Future Challenges. OMICS. 2010 May 7; Authors: Ly M, Laremore TN, Linhardt RJ Abstract Proteoglycomics is a systematic study of structure, expression, and function of proteoglycans, a posttranslationally modified subset of a proteome. Although relying on the established technologies of proteomics and glycomics, proteoglycomics research requires unique approaches for elucidating structure-function relationships of both proteoglycan components, ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-211.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Proteoglycomics: Recent Progress and Future Challenges.
        OMICS. 2010 May 7;
        Authors:  Ly M, Laremore TN, Linhardt RJ
        Abstract Proteoglycomics is a systematic study of structure, expression, and function of proteoglycans, a posttranslationally modified subset of a proteome. Although relying on the established technologies of proteomics and glycomics, proteoglycomics research requires unique approaches for elucidating structure-function relationships of both proteoglycan components, glycosaminoglycan chain, and core protein. This review discusses our current understanding of structure and function of proteoglycans, major players in the development, normal physiology, and disease. A brief outline of the proteoglycomic sample preparation and analysis is provided along with examples of several recent proteoglycomic studies. Unique challenges in the characterization of glycosaminoglycan component of proteoglycans are discussed, with emphasis on the many analytical tools used and the types of information they provide.
        PMID: 20450439 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Altered Serum Glycomics in Alzheimer Disease: A Potential Blood Biomarker?</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-207.html</link>
      <description>Related Articles Altered Serum Glycomics in Alzheimer Disease: A Potential Blood Biomarker? Rejuvenation Res. 2010 Apr 28; Authors: Chen CC, Engelborghs S, Dewaele S, Le Bastard N, Martin JJ, Vanhooren V, Libert C, De Deyn PP Abstract We investigated whether blood N-glycan changes can be used as a diagnostic biomarker for Alzheimer disease (AD). We used DNA sequencer-assisted, fluorophore-assisted carbohydrate electrophoresis (DSA-FACE) technology to assay N-glycans in sera from 79 autopsy-confi ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-207.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Altered Serum Glycomics in Alzheimer Disease: A Potential Blood Biomarker?
        Rejuvenation Res. 2010 Apr 28;
        Authors:  Chen CC, Engelborghs S, Dewaele S, Le Bastard N, Martin JJ, Vanhooren V, Libert C, De Deyn PP
        Abstract We investigated whether blood N-glycan changes can be used as a diagnostic biomarker for Alzheimer disease (AD). We used DNA sequencer-assisted, fluorophore-assisted carbohydrate electrophoresis (DSA-FACE) technology to assay N-glycans in sera from 79 autopsy-confirmed dementia patients and 149 healthy controls. One N-glycan (NA2F) was substantially decreased in AD patients but not in controls. Use of NA2F for discriminating AD between dementia patients and healthy controls showed a diagnostic accuracy of 85.7% +/- 2.8% with 92% specificity and 70% sensitivity. The decrease in the level of NA2F in AD patients compared to non-AD patients was more pronounced in females (p < 0.0001) than in males (p < 0.014). Use of NA2F to differentiate female AD from female non-AD patients reached a diagnostic accuracy of 90.7% +/- 4.8 %. Pearson correlation analysis showed that in female dementia patients, serum NA2F levels were significantly correlated with the cerebrospinal fluid (CSF) beta-amyloid peptide of 42 amino acids (Abeta(1-42)) and tau phosphorylated at threonine 181 (P-tau(181P)) levels, whereas in male dementia patients serum NA2F levels were significantly correlated only with CSF total tau protein (T-tau) level. Thus, we suggest that the serum N-glycan marker might be suitable for longitudinal and follow-up studies.
        PMID: 20426627 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Mass Spectrometry and Glycomics.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-209.html</link>
      <description>Related Articles Mass Spectrometry and Glycomics. OMICS. 2010 May 5; Authors: Zaia J Abstract Glycosylation defines the adhesive properties of animal cell surfaces and the surrounding extracellular environments. Because cells respond to stimuli by altering glycan expression, glycan structures vary according to spatial location in tissue and temporal factors. These dynamic structural expression patterns, combined with the essential roles glycans play in physiology, drive the need for analytical m ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-209.html</guid>
        
      <content:encoded> <![CDATA[
    
Related Articles
        Mass Spectrometry and Glycomics.
        OMICS. 2010 May 5;
        Authors:  Zaia J
        Abstract Glycosylation defines the adhesive properties of animal cell surfaces and the surrounding extracellular environments. Because cells respond to stimuli by altering glycan expression, glycan structures vary according to spatial location in tissue and temporal factors. These dynamic structural expression patterns, combined with the essential roles glycans play in physiology, drive the need for analytical methods for glycoconjugates. In addition, recombinant glycoprotein drug products represent a multibillion dollar market. Effective analytical methods are needed to speed the identification of new targets and the development of industrial glycoprotein products, both new and biosimilar. Mass spectrometry is an enabling technology in glycomics. This review summarizes mass spectrometry of glycoconjugate glycans. The intent is to summarize appropriate methods for glycans given their chemical properties as distinct from those of proteins, lipids, and small molecule metabolites. Special attention is given to the uses of mass spectral profiling for glycomics with respect to the N-linked, O-linked, ganglioside, and glycosaminoglycan compound classes. Next, the uses of tandem mass spectrometry of glycans are summarized. The review finishes with an update on mass spectral glycoproteomics.
        PMID: 20443730 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Rescue of Drosophila Melanogaster l(2)35Aa lethality is only mediated by polypeptide GalNAc-transferase pgant35A, but not by the evolutionary conserved human ortholog GalNAc-transferase-T11.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-206.html</link>
      <description> Related Articles Rescue of Drosophila Melanogaster l(2)35Aa lethality is only mediated by polypeptide GalNAc-transferase pgant35A, but not by the evolutionary conserved human ortholog GalNAc-transferase-T11. Glycoconj J. 2010 May;27(4):435-44 Authors: Bennett EP, Chen YW, Schwientek T, Mandel U, Schjoldager KB, Cohen SM, Clausen H The Drosophila l(2)35Aa gene encodes a UDP-N-acetylgalactosamine: Polypeptide N-acetylgalactosaminyltransferase, essential for embryogenesis and development (J. Biol. ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-206.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Rescue of Drosophila Melanogaster l(2)35Aa lethality is only mediated by polypeptide GalNAc-transferase pgant35A, but not by the evolutionary conserved human ortholog GalNAc-transferase-T11.
        Glycoconj J. 2010 May;27(4):435-44
        Authors:  Bennett EP, Chen YW, Schwientek T, Mandel U, Schjoldager KB, Cohen SM, Clausen H
        The Drosophila l(2)35Aa gene encodes a UDP-N-acetylgalactosamine: Polypeptide N-acetylgalactosaminyltransferase, essential for embryogenesis and development (J. Biol. Chem. 277, 22623-22638; J. Biol. Chem. 277, 22616-22). l(2)35Aa, also known as pgant35A, is a member of a large evolutionarily conserved family of genes encoding polypeptide GalNAc-transferases. Phylogenetic and functional analyses have proposed that subfamilies of orthologous GalNAc-transferase genes are conserved in species, suggesting that they serve distinct functions in vivo. Based on sequence alignments, pgant35A and human GALNT11 are thought to belong to a distinct subfamily. Recent in vitro studies have shown that pgant35A and pgant7, encoding enzymes from different subfamilies, prefer different acceptor substrates, whereas the orthologous pgant35A and human GALNT11 gene products possess, 1) conserved substrate preferences and 2) similar acceptor site preferences in vitro. In line with the in vitro pgant7 studies, we show that l(2)35Aa lethality is not rescued by ectopic pgant7 expression. Remarkably and in contrast to this observation, the human pgant35A ortholog, GALNT11, was shown not to support rescue of the l(2)35Aa lethality. By use of genetic "domain swapping" experiments we demonstrate, that lack of rescue was not caused by inappropriate sub-cellular targeting of functionally active GalNAc-T11. Collectively our results show, that fly embryogenesis specifically requires functional pgant35A, and that the presence of this gene product during fly embryogenesis is functionally distinct from other Drosophila GalNAc-transferase isoforms and from the proposed human ortholog GALNT11.
        PMID: 20422447 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Developing high-affinity boron-based receptors for cell-surface carbohydrates.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-204.html</link>
      <description> Related Articles Developing high-affinity boron-based receptors for cell-surface carbohydrates. Chembiochem. 2010 May 3;11(7):954-7 Authors: Houston TA PMID: 20391454 [PubMed - in process] </description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-204.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Developing high-affinity boron-based receptors for cell-surface carbohydrates.
        Chembiochem. 2010 May 3;11(7):954-7
        Authors:  Houston TA
        
        PMID: 20391454 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Synthesis of alkyl and cycloalkyl alpha-d-mannopyranosides and derivatives thereof and their evaluation in the mycobacterial mannosyltransferase assay.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-199.html</link>
      <description> Related Articles Synthesis of alkyl and cycloalkyl alpha-d-mannopyranosides and derivatives thereof and their evaluation in the mycobacterial mannosyltransferase assay. Carbohydr Res. 2010 Mar 15; Authors: Pol</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-199.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Synthesis of alkyl and cycloalkyl alpha-d-mannopyranosides and derivatives thereof and their evaluation in the mycobacterial mannosyltransferase assay.
        Carbohydr Res. 2010 Mar 15;
        Authors:  Pol
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Chemical approaches to glycobiology.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-202.html</link>
      <description> Related Articles Chemical approaches to glycobiology. Annu Rev Biochem. 2010;79:619-53 Authors: Kiessling LL, Splain RA Glycans are ubiquitous components of all organisms. Efforts to elucidate glycan function and to understand how they are assembled and disassembled can reap benefits in fields ranging from bioenergy to human medicine. Significant advances in our knowledge of glycan biosynthesis and function are emerging, and chemical biology approaches are accelerating the pace of discovery. No ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-202.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Chemical approaches to glycobiology.
        Annu Rev Biochem. 2010;79:619-53
        Authors:  Kiessling LL, Splain RA
        Glycans are ubiquitous components of all organisms. Efforts to elucidate glycan function and to understand how they are assembled and disassembled can reap benefits in fields ranging from bioenergy to human medicine. Significant advances in our knowledge of glycan biosynthesis and function are emerging, and chemical biology approaches are accelerating the pace of discovery. Novel strategies for assembling oligosaccharides, glycoproteins, and other glycoconjugates are providing access to critical materials for interrogating glycan function. Chemoselective reactions that facilitate the synthesis of glycan-substituted imaging agents, arrays, and materials are yielding compounds to interrogate and perturb glycan function and dysfunction. To complement these advances, small molecules are being generated that inhibit key glycan-binding proteins or biosynthetic enzymes. These examples illustrate how chemical glycobiology is providing new insight into the functional roles of glycans and new opportunities to interfere with or exploit these roles.
        PMID: 20380561 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Carbohydrate vaccines: developing sweet solutions to sticky situations?</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-198.html</link>
      <description> Related Articles Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat Rev Drug Discov. 2010 Apr;9(4):308-24 Authors: Astronomo RD, Burton DR Recent technological advances in glycobiology and glycochemistry are paving the way for a new era in carbohydrate vaccine design. This is enabling greater efficiency in the identification, synthesis and evaluation of unique glycan epitopes found on a plethora of pathogens and malignant cells. Here, we review the progress being made i ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-198.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Carbohydrate vaccines: developing sweet solutions to sticky situations?
        Nat Rev Drug Discov. 2010 Apr;9(4):308-24
        Authors:  Astronomo RD, Burton DR
        Recent technological advances in glycobiology and glycochemistry are paving the way for a new era in carbohydrate vaccine design. This is enabling greater efficiency in the identification, synthesis and evaluation of unique glycan epitopes found on a plethora of pathogens and malignant cells. Here, we review the progress being made in addressing challenges posed by targeting the surface carbohydrates of bacteria, protozoa, helminths, viruses, fungi and cancer cells for vaccine purposes.
        PMID: 20357803 [PubMed - indexed for MEDLINE]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Simultaneous determination of nucleotide sugars with ion-pair reversed-phase HPLC.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-200.html</link>
      <description> Related Articles Simultaneous determination of nucleotide sugars with ion-pair reversed-phase HPLC. Glycobiology. 2010 Jul;20(7):865-71 Authors: Nakajima K, Kitazume S, Angata T, Fujinawa R, Ohtsubo K, Miyoshi E, Taniguchi N Nucleotide sugars are important in determining cell surface glycoprotein glycosylation, which can modulate cellular properties such as growth and arrest. We have developed a conventional HPLC method for simultaneous determination of nucleotide sugars. A mixture of nucleotid ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-200.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Simultaneous determination of nucleotide sugars with ion-pair reversed-phase HPLC.
        Glycobiology. 2010 Jul;20(7):865-71
        Authors:  Nakajima K, Kitazume S, Angata T, Fujinawa R, Ohtsubo K, Miyoshi E, Taniguchi N
        Nucleotide sugars are important in determining cell surface glycoprotein glycosylation, which can modulate cellular properties such as growth and arrest. We have developed a conventional HPLC method for simultaneous determination of nucleotide sugars. A mixture of nucleotide sugars (CMP-NeuAc, UDP-Gal, UDP-Glc, UDP-GalNAc, UDP-GlcNAc, GDP-Man, GDP-Fuc and UDP-GlcUA) and relevant nucleotides were perfectly separated in an optimized ion-pair reversed-phase mode using Inertsil ODS-4 and ODS-3 columns. The newly developed method enabled us to determine the nucleotide sugars in cellular extracts from 1 x 10(6) cells in a single run. We applied this method to characterize nucleotide sugar levels in breast and pancreatic cancer cell lines and revealed that the abundance of UDP-GlcNAc, UDP-GalNAc, UDP-GlcUA and GDP-Fuc were a cell-type-specific feature. To determine the physiological significance of changes in nucleotide sugar levels, we analyzed their changes by glucose deprivation and found that the determination of nucleotide sugar levels provided us with valuable information with respect to studying the overview of cellular glycosylation status.
        PMID: 20371511 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Glycomic Analysis of Sialic Acid Linkages in Glycans Derived from Blood Serum Glycoproteins.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-197.html</link>
      <description> Related Articles Glycomic Analysis of Sialic Acid Linkages in Glycans Derived from Blood Serum Glycoproteins. J Proteome Res. 2010 May 5; Authors: Alley WR, Novotny MV A number of alterations to the normal glycomic profile have been previously described for a number of diseases and disorders, thus underscoring the medical importance of studying the glycans associated with proteins present in biological samples. An important alteration in cancer progression is an increased level of alpha2,6-sial ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-197.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Glycomic Analysis of Sialic Acid Linkages in Glycans Derived from Blood Serum Glycoproteins.
        J Proteome Res. 2010 May 5;
        Authors:  Alley WR, Novotny MV
        A number of alterations to the normal glycomic profile have been previously described for a number of diseases and disorders, thus underscoring the medical importance of studying the glycans associated with proteins present in biological samples. An important alteration in cancer progression is an increased level of alpha2,6-sialylation, which aids in increasing the metastatic potential of tumor cells. Here we report a glycomic method that selectively amidates alpha2,6-linked sialic acids, while those that are alpha2,3-linked undergo spontaneous lactonization. Following subsequent permethylation, MALDI-TOF MS analysis revealed that many sialylated glycans present on glycoproteins found in blood serum featured increased levels of alpha2,6-sialylation in breast cancer samples. On the basis of the altered ratios of alpha2,3-linked to alpha2,6-linked sialic acids, many of these glycans became diagnostically relevant when they did not act as such indicators when based on traditional glycomic profiling alone.
        PMID: 20345175 [PubMed - as supplied by publisher]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Marine glycobiology: current status and future perspectives.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-203.html</link>
      <description> Related Articles Marine glycobiology: current status and future perspectives. Mar Biotechnol (NY). 2010 Jun;12(3):241-52 Authors: Caldwell GS, Pagett HE Glycobiology, which is the study of the structure and function of carbohydrates and carbohydrate containing molecules, is fundamental to all biological systems.Progress in glycobiology has shed light on a range of complex biological processes associated with, for example,disease and immunology, molecular and cellular communication,and developme ...</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-203.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Marine glycobiology: current status and future perspectives.
        Mar Biotechnol (NY). 2010 Jun;12(3):241-52
        Authors:  Caldwell GS, Pagett HE
        Glycobiology, which is the study of the structure and function of carbohydrates and carbohydrate containing molecules, is fundamental to all biological systems.Progress in glycobiology has shed light on a range of complex biological processes associated with, for example,disease and immunology, molecular and cellular communication,and developmental biology. There is an established,if rather modest, tradition of glycobiology research in marine systems that has primarily focused on reproduction,biofouling, and chemical communication. The current status of marine glycobiology research is primarily descriptive with very limited progress on structural elucidation and the subsequent definition of precise functional roles beyond a small number of classical examples, e.g., induction of the acrosome reaction in echinoderms. However, with recent advances in analytical instrumentation, there is now the capacity to begin to characterize marine glycoconjugates,many of which will have potential biomedical and biotechnological applications. The analytical approach to glycoscience has developed to such an extent that it has acquired its own "-omics" identity. Glycomics is the quest to decipher the complex information conveyed by carbohydrate molecules--the carbohydrate code or glycocode. Due to the paucity of structural information available, this article will highlight the fundamental importance of glycobiology for many biological processes in marine organisms and will draw upon the best defined systems. These systems therefore may prove genuine candidates for full carbohydrate characterization.
        PMID: 20390314 [PubMed - in process]
    
    ]]> </content:encoded>
                                </item>
  <item>
  <title>Enzymatic Oxidation and Separation of Various Saccharides with Immobilized Glucose Oxidase.</title>
  <link>http://biomarket.jp/modules/pubmed_sugarcomposition/article-196.html</link>
      <description> Related Articles Enzymatic Oxidation and Separation of Various Saccharides with Immobilized Glucose Oxidase. Appl Biochem Biotechnol. 2010 Mar 27; Authors: Mislovi</description>
        <pubDate>Fri, 09 Jul 2010 01:00:42 +0900</pubDate>
        <guid>http://biomarket.jp/modules/pubmed_sugarcomposition/article-196.html</guid>
        
      <content:encoded> <![CDATA[
    
 Related Articles
        Enzymatic Oxidation and Separation of Various Saccharides with Immobilized Glucose Oxidase.
        Appl Biochem Biotechnol. 2010 Mar 27;
        Authors:  Mislovi
    ]]> </content:encoded>
                                </item>
</channel>
</rss>